1	Genetic	JJ	O	genetic	amod	4	SENT_1	[p1l99t81r389b139],
2	and	CC	O	and	_	0	SENT_1	[p1l416t82r557b139],
3	immune	JJ	O	immune	conj_and	1	SENT_1	[p1l588t82r875b139],
4	predictors	NNS	O	predictor	_	0	SENT_1	[p1l903t82r1258b152],
5	for	IN	O	for	_	0	SENT_1	[p1l1282t82r1376b139],
6	hypersensitivity	NN	O	hypersensitivity	nn	7	SENT_1	[p1l1402t82r1932b152],
7	syndrome	NN	O	syndrome	prep_for	4	SENT_1	[p1l97t164r449b235],
8	to	TO	O	to	_	0	SENT_1	[p1l473t164r544b221],
9	antiepileptic	JJ	O	antiepileptic	amod	10	SENT_1	[p1l571t164r1019b235],
10	drugs	NNS	O	drug	prep_to	4	SENT_1	[p1l1046t164r1240b236],

1	MANUELA	NNP	PERSON	MANUELA	nn	3	SENT_2	[p1l99t312r311b347],
2	G.	NNP	PERSON	G.	nn	3	SENT_2	[p1l325t311r372b347],
3	NEUMAN	NNP	PERSON	NEUMAN	_	0	SENT_2	[p1l390t312r592b352],
4	,	,	O	,	_	0	SENT_2	[p1l390t312r592b352],
5	LAWRENCE	NNP	PERSON	LAWRENCE	nn	6	SENT_2	[p1l611t311r844b347],
6	COHEN	NNP	PERSON	COHEN	conj_and	3	SENT_2	[p1l860t311r1031b352],
7	,	,	O	,	_	0	SENT_2	[p1l860t311r1031b352],
8	RADU	NNP	PERSON	RADU	nn	10	SENT_2	[p1l1050t312r1165b347],
9	M.	NNP	PERSON	M.	nn	10	SENT_2	[p1l1184t312r1232b346],
10	NANAU	NNP	PERSON	NANAU	conj_and	3	SENT_2	[p1l1250t312r1421b352],
11	,	,	O	,	_	0	SENT_2	[p1l1250t312r1421b352],
12	and	CC	O	and	_	0	SENT_2	[p1l1438t312r1523b347],
13	PAUL	NNP	PERSON	PAUL	nn	15	SENT_2	[p1l1540t312r1646b347],
14	A.	NNP	PERSON	A.	nn	15	SENT_2	[p1l1659t312r1702b346],
15	HWANG	NNP	PERSON	HWANG	conj_and	3	SENT_2	[p1l1721t311r1895b347],

1	TORONTO	NNP	LOCATION	TORONTO	_	0	SENT_3	[p1l96t395r258b425],
2	,	,	O	,	_	0	SENT_3	[p1l96t395r258b425],
3	ONTARIO	NNP	LOCATION	ONTARIO	nn	5	SENT_3	[p1l271t395r425b425],
4	,	,	O	,	_	0	SENT_3	[p1l271t395r425b425],
5	CANADA	NNP	LOCATION	CANADA	appos	1	SENT_3	[p1l437t395r583b421],

1	Hypersensitivity	NN	O	hypersensitivity	nn	3	SENT_4	[p1l572t501r854b536],
2	syndrome	NN	O	syndrome	nn	3	SENT_4	[p1l866t501r1048b536],
3	reactions	NNS	O	reaction	nsubj	4	SENT_4	[p1l1061t501r1229b529],
4	(	VBP	O	(	_	0	SENT_4	[p1l1243t500r1334b533],
5	HSR	NN	O	hsr	nn	6	SENT_4	[p1l1243t500r1334b533],
6	)	NN	O	)	nsubj	10	SENT_4	[p1l1243t500r1334b533],
7	to	TO	O	to	_	0	SENT_4	[p1l1347t501r1382b529],
8	antiepileptic	JJ	O	antiepileptic	amod	9	SENT_4	[p1l1394t501r1623b536],
9	drugs	NNS	O	drug	prep_to	6	SENT_4	[p1l1635t501r1736b537],
10	(	VBP	O	(	ccomp	4	SENT_4	[p1l1749t501r1848b533],
11	AED	NN	O	aed	nn	12	SENT_4	[p1l1749t501r1848b533],
12	)	NN	O	)	nsubjpass	14	SENT_4	[p1l1749t501r1848b533],
13	are	VBP	O	be	auxpass	14	SENT_4	[p1l1861t507r1921b529],
14	associated	VBN	O	associate	ccomp	10	SENT_4	[p1l1933t501r2062b529, p1l570t545r654b574],
15	with	IN	O	with	_	0	SENT_4	[p1l664t545r736b573],
16	severe	JJ	O	severe	amod	20	SENT_4	[p1l747t551r869b574],
17	clinical	JJ	O	clinical	amod	20	SENT_4	[p1l879t545r1010b574],
18	cutaneous	JJ	O	cutaneous	amod	20	SENT_4	[p1l1022t545r1215b574],
19	adverse	JJ	O	adverse	amod	20	SENT_4	[p1l1225t545r1372b574],
20	reactions	NNS	O	reaction	prep_with	14	SENT_4	[p1l1384t545r1552b574],
21	(	VBP	O	(	dep	20	SENT_4	[p1l1564t545r1698b578],
22	SCAR	NN	O	scar	nn	23	SENT_4	[p1l1564t545r1698b578],
23	)	NN	O	)	dobj	21	SENT_4	[p1l1564t545r1698b578],
24	.	.	O	.	_	0	SENT_4	[p1l1564t545r1698b578],

1	We	PRP	O	we	nsubj	2	SENT_5	[p1l1710t545r1766b574],
2	aimed	VBD	O	aim	_	0	SENT_5	[p1l1777t545r1893b574],
3	(	CD	NUMBER	(	num	4	SENT_5	[p1l1906t545r1951b578],
4	l	NN	O	l	dobj	2	SENT_5	[p1l1906t545r1951b578],
5	)	CD	NUMBER	)	nsubj	7	SENT_5	[p1l1906t545r1951b578],
6	to	TO	O	to	aux	7	SENT_5	[p1l1962t545r1997b574],
7	assess	VB	O	assess	infmod	4	SENT_5	[p1l2007t551r2062b574, p1l570t596r643b618],
8	HSRs	NNS	O	hsr	dobj	7	SENT_5	[p1l656t589r737b618],
9	to	TO	O	to	_	0	SENT_5	[p1l748t589r783b618],
10	AEDs	NNS	MISC	aed	prep_to	7	SENT_5	[p1l793t589r883b618],
11	using	VBG	O	use	partmod	10	SENT_5	[p1l896t589r989b626],
12	the	DT	O	the	dobj	11	SENT_5	[p1l1001t589r1058b618],
13	in	FW	O	in	nn	14	SENT_5	[p1l1071t589r1101b618],
14	vitro	FW	O	vitro	advmod	20	SENT_5	[p1l1114t589r1191b618],
15	lymphocyte	NN	O	lymphocyte	nn	20	SENT_5	[p1l1201t589r1420b624],
16	toxicity	NN	O	toxicity	nn	20	SENT_5	[p1l1431t589r1564b624],
17	assay	NN	O	assay	nn	20	SENT_5	[p1l1576t596r1679b624],
18	(	CD	NUMBER	(	num	20	SENT_5	[p1l1693t589r1777b622],
19	LTA	NN	ORGANIZATION	lta	nn	20	SENT_5	[p1l1693t589r1777b622],
20	)	NN	O	)	dep	12	SENT_5	[p1l1693t589r1777b622],
21	in	IN	O	in	_	0	SENT_5	[p1l1791t589r1819b618],
22	patients	NNS	O	patient	prep_in	20	SENT_5	[p1l1833t589r1977b624],
23	who	WP	O	who	nsubj	24	SENT_5	[p1l1988t589r2064b618],
24	manifested	VBD	O	manifest	rcmod	12	SENT_5	[p1l571t634r773b664],
25	HSRs	NNS	MISC	hsr	dobj	24	SENT_5	[p1l790t634r871b664],
26	clinically	RB	O	clinically	advmod	24	SENT_5	[p1l885t635r1058b670],
27	;	:	O	;	_	0	SENT_5	[p1l885t635r1058b670],
28	(	NN	O	(	nn	30	SENT_5	[p1l1076t634r1121b668],
29	2	CD	NUMBER	2	num	30	SENT_5	[p1l1076t634r1121b668],
30	)	NN	O	)	dobj	2	SENT_5	[p1l1076t634r1121b668],
31	to	TO	O	to	aux	32	SENT_5	[p1l1136t635r1171b664],
32	correlate	VB	O	correlate	infmod	30	SENT_5	[p1l1185t635r1351b664],
33	LTA	NNP	ORGANIZATION	LTA	nsubj	34	SENT_5	[p1l1367t635r1425b663],
34	results	VBZ	O	result	ccomp	32	SENT_5	[p1l1440t635r1552b664],
35	with	IN	O	with	_	0	SENT_5	[p1l1566t635r1637b663],
36	the	DT	O	the	det	38	SENT_5	[p1l1652t635r1710b664],
37	clinical	JJ	O	clinical	amod	38	SENT_5	[p1l1724t635r1855b664],
38	syndrome	NN	O	syndrome	prep_with	34	SENT_5	[p1l1870t635r2061b670],
39	;	:	O	;	_	0	SENT_5	[p1l1870t635r2061b670],
40	(	CD	NUMBER	(	number	41	SENT_5	[p1l572t680r617b713],
41	3	CD	NUMBER	3	num	42	SENT_5	[p1l572t680r617b713],
42	)	NN	O	)	dobj	2	SENT_5	[p1l572t680r617b713],
43	to	TO	O	to	aux	44	SENT_5	[p1l632t680r667b709],
44	correlate	VB	O	correlate	infmod	42	SENT_5	[p1l682t680r847b709],
45	LTA	NNP	ORGANIZATION	LTA	dobj	44	SENT_5	[p1l863t680r921b709],
46	results	VBZ	O	result	dep	44	SENT_5	[p1l936t680r1048b709],
47	with	IN	O	with	_	0	SENT_5	[p1l1062t680r1133b709],
48	the	DT	O	the	det	51	SENT_5	[p1l1148t680r1206b709],
49	human	JJ	O	human	amod	51	SENT_5	[p1l1222t680r1347b709],
50	leukocyte	NN	O	leukocyte	nn	51	SENT_5	[p1l1364t680r1546b716],
51	antigen	NN	O	antigen	prep_with	46	SENT_5	[p1l1561t680r1699b717],
52	(	CD	NUMBER	(	num	53	SENT_5	[p1l1716t680r1811b713],
53	HLA	NN	O	hlum	dep	51	SENT_5	[p1l1716t680r1811b713],
54	)	CD	NUMBER	)	num	56	SENT_5	[p1l1716t680r1811b713],
55	allele	NN	O	allele	nn	56	SENT_5	[p1l1827t680r1926b709],
56	B	NN	O	b	dep	53	SENT_5	[p1l1942t680r2063b709],
57	*	CD	NUMBER	*	num	60	SENT_5	[p1l1942t680r2063b709],
58	l502	NN	O	l502	nn	60	SENT_5	[p1l1942t680r2063b709],
59	(	CD	NUMBER	(	num	60	SENT_5	[p1l572t725r808b759],
60	HLA-B	NN	O	hla-b	nsubj	46	SENT_5	[p1l572t725r808b759],
61	*	CD	NUMBER	*	num	64	SENT_5	[p1l572t725r808b759],
62	l502	NN	O	l502	nn	64	SENT_5	[p1l572t725r808b759],
63	)	NN	O	)	nn	64	SENT_5	[p1l572t725r808b759],
64	positivity	NN	O	positivity	dep	46	SENT_5	[p1l824t725r983b761],
65	in	IN	O	in	_	0	SENT_5	[p1l998t725r1027b754],
66	a	DT	O	a	det	69	SENT_5	[p1l1042t732r1065b755],
67	Han	NNP	MISC	Han	nn	69	SENT_5	[p1l1082t725r1151b755],
68	Chinese-Canadian	NNP	MISC	Chinese-Canadian	nn	69	SENT_5	[p1l1167t725r1515b755],
69	population	NN	O	population	prep_in	46	SENT_5	[p1l1531t725r1738b761],
70	;	:	O	;	_	0	SENT_5	[p1l1531t725r1738b761],
71	and	CC	O	and	_	0	SENT_5	[p1l1754t725r1825b755],
72	(	NN	O	(	nn	74	SENT_5	[p1l1842t725r1887b759],
73	4	CD	NUMBER	4	num	74	SENT_5	[p1l1842t725r1887b759],
74	)	NN	O	)	conj_and	4	SENT_5	[p1l1842t725r1887b759],
75	to	TO	O	to	aux	76	SENT_5	[p1l1903t725r1937b755],
76	determine	VB	O	determine	infmod	74	SENT_5	[p1l1952t725r2062b755, p1l571t771r660b800],
77	the	DT	O	the	det	79	SENT_5	[p1l675t771r733b800],
78	cytokine	NN	O	cytokine	nn	79	SENT_5	[p1l748t771r907b806],
79	network	NN	O	network	dobj	76	SENT_5	[p1l924t771r1069b800],
80	in	IN	O	in	_	0	SENT_5	[p1l1085t771r1114b799],
81	this	DT	O	this	det	82	SENT_5	[p1l1129t771r1189b800],
82	population	NN	O	population	prep_in	76	SENT_5	[p1l1205t771r1411b806],
83	.	.	O	.	_	0	SENT_5	[p1l1205t771r1411b806],

1	Patients	NNS	O	patient	nsubjpass	38	SENT_6	[p1l1430t771r1570b800],
2	that	WDT	O	that	nsubj	3	SENT_6	[p1l1584t771r1655b800],
3	developed	VBD	O	develop	rcmod	1	SENT_6	[p1l1670t771r1870b806],
4	fever	NN	O	fever	nn	7	SENT_6	[p1l1885t770r1977b800],
5	and	CC	O	and	_	0	SENT_6	[p1l1992t771r2063b800],
6	cutaneous	JJ	O	cutaneous	nn	7	SENT_6	[p1l570t816r764b845],
7	eruptions	NNS	O	eruption	dobj	3	SENT_6	[p1l780t816r948b852],
8	in	IN	O	in	_	0	SENT_6	[p1l966t816r994b845],
9	the	DT	O	the	det	10	SENT_6	[p1l1012t816r1069b845],
10	presence	NN	O	presence	prep_in	3	SENT_6	[p1l1087t822r1258b852],
11	or	CC	O	or	_	0	SENT_6	[p1l1276t822r1311b845],
12	absence	NN	O	absence	conj_or	10	SENT_6	[p1l1327t816r1488b845],
13	of	IN	O	of	_	0	SENT_6	[p1l1505t816r1538b845],
14	organ	NN	O	organ	nn	15	SENT_6	[p1l1555t823r1661b853],
15	involvement	NN	O	involvement	prep_of	10	SENT_6	[p1l1680t816r1905b845],
16	within	IN	O	within	_	0	SENT_6	[p1l1921t816r2026b845],
17	8	CD	DURATION	8	num	18	SENT_6	[p1l2044t816r2063b845],
18	weeks	NNS	NUMBER	week	prep_within	3	SENT_6	[p1l570t861r686b890],
19	of	IN	O	of	_	0	SENT_6	[p1l709t861r743b890],
20	exposure	NN	O	exposure	prep_of	18	SENT_6	[p1l765t868r934b896],
21	to	TO	O	to	_	0	SENT_6	[p1l956t861r991b890],
22	carbamazepine	NN	O	carbamazepine	nn	25	SENT_6	[p1l1013t861r1306b896],
23	(	CD	NUMBER	(	num	25	SENT_6	[p1l1331t861r1436b895],
24	CBZ	NN	ORGANIZATION	cbz	nn	25	SENT_6	[p1l1331t861r1436b895],
25	)	NN	O	)	prep_to	3	SENT_6	[p1l1331t861r1436b895],
26	,	,	O	,	_	0	SENT_6	[p1l1331t861r1436b895],
27	phenytoin	NN	O	phenytoin	nn	30	SENT_6	[p1l1462t861r1643b896],
28	(	CD	NUMBER	(	num	30	SENT_6	[p1l1669t861r1774b895],
29	PHY	NN	O	phy	nn	30	SENT_6	[p1l1669t861r1774b895],
30	)	NN	O	)	conj_or	25	SENT_6	[p1l1669t861r1774b895],
31	,	,	O	,	_	0	SENT_6	[p1l1669t861r1774b895],
32	or	CC	O	or	_	0	SENT_6	[p1l1799t868r1834b890],
33	lamotrigine	NN	O	lamotrigine	nn	36	SENT_6	[p1l1857t861r2063b898],
34	(	CD	NUMBER	(	num	36	SENT_6	[p1l572t906r660b939],
35	LTG	NN	O	ltg	nn	36	SENT_6	[p1l572t906r660b939],
36	)	NN	O	)	conj_or	25	SENT_6	[p1l572t906r660b939],
37	were	VBD	O	be	auxpass	38	SENT_6	[p1l678t913r767b935],
38	enrolled	VBN	O	enrol	_	0	SENT_6	[p1l784t907r943b935],
39	.	.	O	.	_	0	SENT_6	[p1l784t907r943b935],

1	Control	NN	O	control	nn	2	SENT_7	[p1l961t906r1093b935],
2	patients	NNS	O	patient	nsubj	3	SENT_7	[p1l1111t907r1255b942],
3	received	VBD	O	receive	_	0	SENT_7	[p1l1272t907r1434b935],
4	AEDs	NNS	MISC	aed	dobj	3	SENT_7	[p1l1451t907r1541b935],
5	without	IN	O	without	_	0	SENT_7	[p1l1556t907r1689b935],
6	presenting	VBG	O	present	prepc_without	3	SENT_7	[p1l1705t907r1897b943],
7	HSR	NN	O	hsr	dobj	6	SENT_7	[p1l1915t906r1989b935],
8	.	.	O	.	_	0	SENT_7	[p1l1915t906r1989b935],

1	We	PRP	O	we	nsubj	2	SENT_8	[p1l2006t907r2063b935],
2	investigated	VBD	O	investigate	dep	6	SENT_8	[p1l571t951r794b988],
3	10	CD	NUMBER	10	num	5	SENT_8	[p1l820t951r856b980],
4	CBZ-HSR	NN	O	cbz-hsr	nn	5	SENT_8	[p1l878t951r1030b980],
5	patients	NNS	O	patient	dobj	2	SENT_8	[p1l1052t951r1196b987],
6	(	VBP	O	(	_	0	SENT_8	[p1l1218t951r1250b984],
7	4	CD	NUMBER	4	dobj	6	SENT_8	[p1l1218t951r1250b984],
8	with	IN	O	with	_	0	SENT_8	[p1l1271t951r1342b980],
9	Stevens-Johnson	NN	MISC	stevens-johnson	nn	10	SENT_8	[p1l1364t951r1671b980],
10	syndrome	NN	O	syndrome	prep_with	6	SENT_8	[p1l1693t951r1874b987],
11	(	CD	NUMBER	(	num	13	SENT_8	[p1l1897t951r2000b985],
12	SJSJ	NN	O	sjsj	nn	13	SENT_8	[p1l1897t951r2000b985],
13	)	NN	O	)	nn	10	SENT_8	[p1l1897t951r2000b985],
14	,	,	O	,	_	0	SENT_8	[p1l1897t951r2000b985],
15	24	CD	NUMBER	24	num	16	SENT_8	[p1l2023t951r2063b980],
16	CBZ-controls	NNS	O	cbz-control	appos	10	SENT_8	[p1l570t996r810b1030],
17	,	,	O	,	_	0	SENT_8	[p1l570t996r810b1030],
18	lo	FW	O	lo	dep	10	SENT_8	[p1l839t996r875b1025],
19	PHY-HSR	NN	O	phy-hsr	nn	20	SENT_8	[p1l900t996r1051b1025],
20	patients	NNS	O	patient	nsubj	21	SENT_8	[p1l1075t996r1219b1031],
21	(	VBP	O	(	rcmod	10	SENT_8	[p1l1243t996r1275b1029],
22	4	CD	NUMBER	4	dobj	21	SENT_8	[p1l1243t996r1275b1029],
23	with	IN	O	with	_	0	SENT_8	[p1l1297t996r1369b1025],
24	drug-induced	JJ	O	drug-induced	amod	26	SENT_8	[p1l1393t996r1645b1033],
25	liver	NN	O	liver	nn	26	SENT_8	[p1l1669t996r1743b1025],
26	injury	NN	O	injury	prep_with	21	SENT_8	[p1l1766t996r1864b1031],
27	(	CD	NUMBER	(	num	28	SENT_8	[p1l1888t996r1998b1030],
28	DILIJ	NNP	O	DILIJ	nsubj	6	SENT_8	[p1l1888t996r1998b1030],
29	)	CD	NUMBER	)	num	28	SENT_8	[p1l1888t996r1998b1030],
30	,	,	O	,	_	0	SENT_8	[p1l1888t996r1998b1030],
31	24	CD	NUMBER	24	num	32	SENT_8	[p1l2023t996r2063b1025],
32	PHY-controls	NNS	O	phy-control	appos	28	SENT_8	[p1l572t1042r834b1075],
33	,6	CD	NUMBER	,6	num	35	SENT_8	[p1l572t1042r834b1075],
34	LTG-HSR	NN	O	ltg-hsr	nn	35	SENT_8	[p1l850t1041r995b1071],
35	patients	NNS	O	patient	nsubj	36	SENT_8	[p1l1011t1042r1155b1077],
36	(	VBP	O	(	rcmod	32	SENT_8	[p1l1171t1042r1198b1075],
37	1	CD	NUMBER	1	dobj	36	SENT_8	[p1l1171t1042r1198b1075],
38	with	IN	O	with	_	0	SENT_8	[p1l1217t1042r1289b1070],
39	SJS	NN	O	sj	prep_with	37	SENT_8	[p1l1305t1041r1361b1071],
40	and	CC	O	and	_	0	SENT_8	[p1l1376t1042r1446b1071],
41	l	NN	O	l	conj_and	37	SENT_8	[p1l1466t1042r1475b1070],
42	with	IN	O	with	_	0	SENT_8	[p1l1495t1042r1567b1070],
43	DILI	NNP	ORGANIZATION	DILI	prep_with	41	SENT_8	[p1l1584t1042r1670b1075],
44	)	CD	NUMBER	)	num	43	SENT_8	[p1l1584t1042r1670b1075],
45	,	,	O	,	_	0	SENT_8	[p1l1584t1042r1670b1075],
46	and	CC	O	and	_	0	SENT_8	[p1l1686t1042r1757b1071],
47	24	CD	NUMBER	24	num	48	SENT_8	[p1l1772t1041r1813b1070],
48	LTG-controls	NNS	O	ltg-control	conj_and	37	SENT_8	[p1l1829t1041r2061b1071],
49	.	.	O	.	_	0	SENT_8	[p1l1829t1041r2061b1071],

1	There	EX	O	there	expl	2	SENT_9	[p1l569t1087r668b1116],
2	were	VBD	O	be	_	0	SENT_9	[p1l679t1093r769b1116],
3	30	CD	NUMBER	30	num	6	SENT_9	[p1l780t1086r821b1116],
4	Han	NNP	O	Han	nn	6	SENT_9	[p1l835t1087r904b1116],
5	Chinese	NNP	MISC	Chinese	nn	6	SENT_9	[p1l917t1086r1065b1116],
6	individuals	NNS	O	individual	nsubj	2	SENT_9	[p1l1078t1087r1271b1116],
7	(	VBP	O	(	rcmod	6	SENT_9	[p1l1285t1087r1338b1120],
8	l4	NN	O	l4	nn	10	SENT_9	[p1l1285t1087r1338b1120],
9	HSR	NN	O	hsr	nn	10	SENT_9	[p1l1351t1086r1416b1116],
10	patients	NNS	O	patient	dobj	7	SENT_9	[p1l1428t1087r1573b1122],
11	and	CC	O	and	_	0	SENT_9	[p1l1584t1087r1654b1116],
12	I6	NN	O	i6	nn	13	SENT_9	[p1l1671t1087r1707b1116],
13	controls	NNS	O	control	conj_and	10	SENT_9	[p1l1719t1087r1876b1120],
14	)	RB	O	)	advmod	7	SENT_9	[p1l1719t1087r1876b1120],
15	in	IN	O	in	_	0	SENT_9	[p1l1890t1087r1919b1115],
16	our	PRP$	O	we	poss	17	SENT_9	[p1l1932t1093r1990b1116],
17	cohort	NN	O	cohort	prep_in	7	SENT_9	[p1l2001t1093r2062b1116, p1l571t1132r649b1161],
18	.	.	O	.	_	0	SENT_9	[p1l2001t1093r2062b1116, p1l571t1132r649b1161],

1	LTA	NN	ORGANIZATION	lta	nn	2	SENT_10	[p1l666t1132r724b1161],
2	toxicity	NN	O	toxicity	nsubjpass	11	SENT_10	[p1l737t1132r870b1168],
3	greater	JJR	O	greater	mwe	4	SENT_10	[p1l884t1132r1017b1169],
4	than	IN	O	than	quantmod	5	SENT_10	[p1l1030t1132r1111b1161],
5	12.5	CD	PERCENT	12.5	dep	6	SENT_10	[p1l1131t1132r1232b1161],
6	%	NN	PERCENT	%	dep	2	SENT_10	[p1l1131t1132r1232b1161],
7	1	CD	PERCENT	1	number	9	SENT_10	[p1l1250t1138r1273b1160],
8	2.5	CD	PERCENT	2.5	number	9	SENT_10	[p1l1290t1132r1374b1161],
9	%	NN	PERCENT	%	amod	2	SENT_10	[p1l1290t1132r1374b1161],
10	was	VBD	O	be	auxpass	11	SENT_10	[p1l1388t1138r1459b1161],
11	considered	VBN	O	consider	_	0	SENT_10	[p1l1472t1132r1678b1161],
12	positive	JJ	O	positive	acomp	11	SENT_10	[p1l1694t1132r1842b1168],
13	.	.	O	.	_	0	SENT_10	[p1l1694t1132r1842b1168],

1	Differences	NNS	O	difference	nsubjpass	5	SENT_11	[p1l1860t1132r2063b1161],
2	among	IN	O	among	_	0	SENT_11	[p1l570t1184r700b1214],
3	groups	NNS	O	group	prep_among	1	SENT_11	[p1l711t1184r836b1214],
4	were	VBD	O	be	auxpass	5	SENT_11	[p1l845t1184r934b1206],
5	determined	VBN	O	determine	_	0	SENT_11	[p1l944t1178r1156b1206],
6	by	IN	O	by	_	0	SENT_11	[p1l1168t1178r1212b1213],
7	analysis	NN	O	analysis	agent	5	SENT_11	[p1l1222t1178r1368b1213],
8	of	IN	O	of	_	0	SENT_11	[p1l1377t1177r1411b1206],
9	variance	NN	O	variance	prep_of	7	SENT_11	[p1l1419t1178r1592b1206],
10	.	.	O	.	_	0	SENT_11	[p1l1419t1178r1592b1206],

1	In	IN	O	in	_	0	SENT_12	[p1l1605t1178r1634b1206],
2	addition	NN	O	addition	prep_in	5	SENT_12	[p1l1645t1178r1805b1211],
3	,	,	O	,	_	0	SENT_12	[p1l1645t1178r1805b1211],
4	we	PRP	O	we	nsubj	5	SENT_12	[p1l1816t1184r1869b1206],
5	measured	VBD	O	measure	_	0	SENT_12	[p1l1880t1178r2062b1206],
6	cytokine	NN	O	cytokine	nn	7	SENT_12	[p1l570t1222r729b1257],
7	secretion	NN	O	secretion	dobj	5	SENT_12	[p1l739t1222r906b1251],
8	in	IN	O	in	_	0	SENT_12	[p1l918t1222r947b1250],
9	the	DT	O	the	det	11	SENT_12	[p1l957t1222r1014b1251],
10	patient	NN	O	patient	nn	11	SENT_12	[p1l1025t1222r1153b1257],
11	sera	NN	O	serum	prep_in	5	SENT_12	[p1l1162t1228r1238b1251],
12	between	IN	O	between	_	0	SENT_12	[p1l1249t1222r1407b1251],
13	1	CD	DURATION	1	num	14	SENT_12	[p1l1423t1222r1432b1250],
14	month	NN	NUMBER	month	prep_between	11	SENT_12	[p1l1448t1222r1562b1251],
15	and	CC	O	and	_	0	SENT_12	[p1l1573t1222r1643b1251],
16	3	CD	DURATION	3	num	17	SENT_12	[p1l1653t1222r1672b1251],
17	years	NNS	NUMBER	year	prep_between	11	SENT_12	[p1l1682t1228r1781b1257],
18	after	IN	O	after	_	0	SENT_12	[p1l1791t1222r1874b1251],
19	the	DT	O	the	det	20	SENT_12	[p1l1882t1222r1940b1251],
20	event	NN	O	event	prep_after	5	SENT_12	[p1l1950t1222r2062b1251],
21	.	.	O	.	_	0	SENT_12	[p1l1950t1222r2062b1251],

1	All	DT	O	all	det	4	SENT_13	[p1l570t1267r614b1295],
2	Han	NNP	MISC	Han	nn	4	SENT_13	[p1l636t1267r705b1295],
3	Chinese	NNP	MISC	Chinese	nn	4	SENT_13	[p1l726t1266r875b1295],
4	individuals	NNS	O	individual	nsubjpass	11	SENT_13	[p1l896t1267r1090b1295],
5	and	CC	O	and	_	0	SENT_13	[p1l1110t1267r1180b1295],
6	30	CD	PERCENT	30	num	7	SENT_13	[p1l1200t1266r1274b1295],
7	%	NN	PERCENT	%	conj_and	4	SENT_13	[p1l1200t1266r1274b1295],
8	of	IN	O	of	_	0	SENT_13	[p1l1294t1266r1327b1295],
9	Caucasians	NNPS	MISC	Caucasians	prep_of	7	SENT_13	[p1l1346t1266r1562b1295],
10	were	VBD	O	be	auxpass	11	SENT_13	[p1l1581t1273r1671b1295],
11	genotyped	VBN	O	genotype	_	0	SENT_13	[p1l1691t1267r1893b1303],
12	for	IN	O	for	_	0	SENT_13	[p1l1913t1266r1959b1295],
13	HLAB	NN	O	hlab	nn	15	SENT_13	[p1l1980t1267r2062b1295, p1l572t1311r702b1341],
14	*	CD	NUMBER	*	num	15	SENT_13	[p1l1980t1267r2062b1295, p1l572t1311r702b1341],
15	l502	NN	O	l502	prep_for	11	SENT_13	[p1l1980t1267r2062b1295, p1l572t1311r702b1341],
16	.	.	O	.	_	0	SENT_13	[p1l1980t1267r2062b1295, p1l572t1311r702b1341],

1	A	DT	O	a	det	8	SENT_14	[p1l719t1312r747b1340],
2	perfect	JJ	O	perfect	amod	5	SENT_14	[p1l763t1311r893b1347],
3	correlation	NN	O	correlation	nn	5	SENT_14	[p1l909t1312r1106b1341],
4	(	NN	O	(	nn	5	SENT_14	[p1l1124t1312r1152b1345],
5	r	NN	O	r	nn	8	SENT_14	[p1l1124t1312r1152b1345],
6	=	JJ	O	=	amod	5	SENT_14	[p1l1166t1322r1190b1334],
7	0.92	CD	NUMBER	0.92	number	6	SENT_14	[p1l1208t1311r1295b1345],
8	)	NN	O	)	nsubjpass	10	SENT_14	[p1l1208t1311r1295b1345],
9	was	VBD	O	be	auxpass	10	SENT_14	[p1l1312t1318r1383b1341],
10	observed	VBN	O	observe	_	0	SENT_14	[p1l1398t1312r1569b1341],
11	between	IN	O	between	_	0	SENT_14	[p1l1586t1312r1745b1341],
12	positive	JJ	O	positive	amod	13	SENT_14	[p1l1763t1312r1902b1347],
13	LTA	NN	ORGANIZATION	lta	prep_between	10	SENT_14	[p1l1919t1312r1977b1340],
14	and	CC	O	and	_	0	SENT_14	[p1l1992t1312r2063b1341],
15	clinical	JJ	O	clinical	amod	16	SENT_14	[p1l570t1357r701b1386],
16	diagnosis	NN	O	diagnosis	prep_between	10	SENT_14	[p1l712t1357r885b1394],
17	of	IN	O	of	_	0	SENT_14	[p1l894t1357r928b1386],
18	DILI	NNP	O	DILI	prep_of	13	SENT_14	[p1l938t1357r998b1386],
19	and	CC	O	and	_	0	SENT_14	[p1l1010t1357r1080b1386],
20	SJS/toxic	NNP	O	SJS/toxic	nn	22	SENT_14	[p1l1090t1357r1254b1390],
21	epidermal	JJ	O	epidermal	amod	22	SENT_14	[p1l1265t1357r1452b1393],
22	necrolysis	NN	O	necrolysis	prep_between	10	SENT_14	[p1l1463t1357r1643b1393],
23	(	CD	NUMBER	(	number	24	SENT_14	[p1l1655t1357r1753b1390],
24	TEN	CD	NUMBER	ten	num	25	SENT_14	[p1l1655t1357r1753b1390],
25	)	NN	O	)	dep	22	SENT_14	[p1l1655t1357r1753b1390],
26	.	.	O	.	_	0	SENT_14	[p1l1655t1357r1753b1390],

1	HLA-B	NN	O	hla-b	nn	4	SENT_15	[p1l1766t1357r1886b1386],
2	*	CD	NUMBER	*	num	4	SENT_15	[p1l1766t1357r1886b1386],
3	I502	NN	O	i502	nn	4	SENT_15	[p1l1895t1357r1973b1386],
4	positivity	NN	O	positivity	nsubj	10	SENT_15	[p1l1984t1363r2062b1393, p1l571t1403r664b1438],
5	in	IN	O	in	_	0	SENT_15	[p1l676t1403r704b1431],
6	Han	NNP	LOCATION	Han	nn	7	SENT_15	[p1l718t1403r787b1431],
7	Chinese	NNP	LOCATION	Chinese	prep_in	4	SENT_15	[p1l800t1402r948b1431],
8	is	VBZ	O	be	cop	10	SENT_15	[p1l960t1403r984b1431],
9	a	DT	O	a	det	10	SENT_15	[p1l995t1409r1017b1431],
10	predictor	NN	O	predictor	_	0	SENT_15	[p1l1030t1403r1196b1438],
11	of	IN	O	of	_	0	SENT_15	[p1l1207t1402r1241b1431],
12	CBZ-HSR	NN	O	cbz-hsr	prep_of	10	SENT_15	[p1l1252t1402r1405b1431],
13	and	CC	O	and	_	0	SENT_15	[p1l1416t1403r1487b1431],
14	PHY-HSR	NN	O	phy-hsr	conj_and	12	SENT_15	[p1l1500t1402r1661b1431],
15	.	.	O	.	_	0	SENT_15	[p1l1500t1402r1661b1431],

1	HLA-B	NN	O	hla-b	npadvmod	3	SENT_16	[p1l1676t1402r1796b1431],
2	*	CD	NUMBER	*	num	1	SENT_16	[p1l1676t1402r1796b1431],
3	I502-negative	JJ	O	i502-negative	amod	5	SENT_16	[p1l1805t1402r2064b1439],
4	Han	NNP	MISC	Han	nn	5	SENT_16	[p1l572t1448r641b1476],
5	Chinese	NNP	MISC	Chinese	nsubj	16	SENT_16	[p1l658t1447r805b1476],
6	receiving	VBG	O	receive	partmod	5	SENT_16	[p1l822t1448r992b1484],
7	only	RB	O	only	advmod	8	SENT_16	[p1l1008t1448r1085b1483],
8	CBZ	NN	ORGANIZATION	cbz	dobj	6	SENT_16	[p1l1100t1447r1169b1476],
9	or	CC	O	or	_	0	SENT_16	[p1l1185t1454r1220b1476],
10	a	DT	O	a	det	11	SENT_16	[p1l1235t1454r1257b1476],
11	combination	NN	O	combination	dobj	6	SENT_16	[p1l1273t1448r1505b1476],
12	of	IN	O	of	_	0	SENT_16	[p1l1521t1447r1555b1476],
13	CBZ	NN	ORGANIZATION	cbz	prep_of	11	SENT_16	[p1l1570t1447r1639b1476],
14	and	CC	O	and	_	0	SENT_16	[p1l1654t1448r1725b1476],
15	PHY	NN	O	phy	prep_of	11	SENT_16	[p1l1742t1448r1810b1476],
16	tolerated	VBD	O	tolerate	_	0	SENT_16	[p1l1824t1448r1990b1476],
17	the	DT	O	the	det	19	SENT_16	[p1l2006t1448r2063b1476],
18	drug	NN	O	drug	nn	19	SENT_16	[p1l570t1493r698b1529],
19	(	NN	O	(	nsubj	21	SENT_16	[p1l570t1493r698b1529],
20	s	VBZ	O	s	cop	21	SENT_16	[p1l570t1493r698b1529],
21	)	CD	NUMBER	)	ccomp	16	SENT_16	[p1l570t1493r698b1529],
22	clinically	RB	O	clinically	advmod	21	SENT_16	[p1l713t1493r886b1528],
23	,	,	O	,	_	0	SENT_16	[p1l713t1493r886b1528],
24	presenting	VBG	O	present	xcomp	21	SENT_16	[p1l903t1493r1094b1529],
25	negative	JJ	O	negative	amod	26	SENT_16	[p1l1109t1493r1270b1529],
26	CBZ-LTA	NN	O	cbz-lta	dobj	24	SENT_16	[p1l1284t1492r1431b1521],
27	and	CC	O	and	_	0	SENT_16	[p1l1444t1493r1515b1521],
28	PHY-LTA	NN	O	phy-lta	dobj	24	SENT_16	[p1l1531t1493r1684b1521],
29	.	.	O	.	_	0	SENT_16	[p1l1531t1493r1684b1521],

1	However	RB	O	however	advmod	19	SENT_17	[p1l1701t1493r1870b1526],
2	,	,	O	,	_	0	SENT_17	[p1l1701t1493r1870b1526],
3	3	CD	NUMBER	3	num	4	SENT_17	[p1l1885t1492r1904b1521],
4	patients	NNS	O	patient	nsubj	19	SENT_17	[p1l1919t1493r2064b1528],
5	presenting	VBG	O	present	partmod	4	SENT_17	[p1l571t1537r762b1574],
6	negative	JJ	O	negative	amod	7	SENT_17	[p1l790t1537r950b1574],
7	CBZ-LTA	NN	O	cbz-lta	dobj	5	SENT_17	[p1l976t1537r1123b1566],
8	and	CC	O	and	_	0	SENT_17	[p1l1148t1537r1218b1566],
9	PHY-LTA	NN	O	phy-lta	dobj	5	SENT_17	[p1l1246t1537r1400b1571],
10	,	,	O	,	_	0	SENT_17	[p1l1246t1537r1400b1571],
11	as	RB	O	as	_	0	SENT_17	[p1l1427t1544r1467b1566],
12	well	RB	O	well	_	0	SENT_17	[p1l1492t1537r1563b1566],
13	as	IN	O	as	_	0	SENT_17	[p1l1590t1543r1630b1566],
14	negative	JJ	O	negative	amod	15	SENT_17	[p1l1656t1537r1817b1574],
15	HLA-B	NN	O	hla-b	conj_and	7	SENT_17	[p1l1844t1537r2061b1571],
16	*	CD	NUMBER	*	num	17	SENT_17	[p1l1844t1537r2061b1571],
17	l502	NN	O	l502	dep	15	SENT_17	[p1l1844t1537r2061b1571],
18	,	,	O	,	_	0	SENT_17	[p1l1844t1537r2061b1571],
19	showed	VBD	O	show	_	0	SENT_17	[p1l570t1582r711b1611],
20	positive	JJ	O	positive	amod	21	SENT_17	[p1l731t1582r870b1618],
21	LTG-LTA	NN	O	ltg-lta	iobj	19	SENT_17	[p1l889t1582r1028b1611],
22	(	CD	PERCENT	(	num	24	SENT_17	[p1l1047t1582r1143b1616],
23	38	CD	PERCENT	38	num	24	SENT_17	[p1l1047t1582r1143b1616],
24	%	NN	PERCENT	%	dobj	19	SENT_17	[p1l1047t1582r1143b1616],
25	,	,	O	,	_	0	SENT_17	[p1l1047t1582r1143b1616],
26	28	CD	PERCENT	28	number	27	SENT_17	[p1l1162t1582r1245b1616],
27	%	NN	PERCENT	%	amod	24	SENT_17	[p1l1162t1582r1245b1616],
28	,	,	O	,	_	0	SENT_17	[p1l1162t1582r1245b1616],
29	and	CC	O	and	_	0	SENT_17	[p1l1265t1582r1335b1611],
30	25	CD	PERCENT	25	num	31	SENT_17	[p1l1354t1582r1436b1616],
31	%	NN	PERCENT	%	dobj	19	SENT_17	[p1l1354t1582r1436b1616],
32	,	,	O	,	_	0	SENT_17	[p1l1354t1582r1436b1616],
33	respectively	RB	O	respectively	advmod	34	SENT_17	[p1l1457t1582r1703b1618],
34	)	CD	NUMBER	)	appos	31	SENT_17	[p1l1457t1582r1703b1618],
35	,	,	O	,	_	0	SENT_17	[p1l1457t1582r1703b1618],
36	implying	VBG	O	imply	partmod	31	SENT_17	[p1l1723t1582r1878b1619],
37	that	IN	O	that	complm	42	SENT_17	[p1l1896t1582r1967b1611],
38	they	PRP	O	they	nsubjpass	42	SENT_17	[p1l1983t1582r2063b1618],
39	should	MD	O	should	aux	42	SENT_17	[p1l570t1628r689b1657],
40	not	RB	O	not	neg	42	SENT_17	[p1l708t1628r765b1657],
41	be	VB	O	be	auxpass	42	SENT_17	[p1l783t1628r829b1657],
42	prescribed	VBN	O	prescribe	ccomp	36	SENT_17	[p1l848t1628r1043b1663],
43	LTG	NN	O	ltg	dobj	42	SENT_17	[p1l1063t1627r1133b1657],
44	.	.	O	.	_	0	SENT_17	[p1l1063t1627r1133b1657],

1	Three	CD	NUMBER	three	num	2	SENT_18	[p1l1152t1628r1251b1657],
2	patients	NNS	O	patient	nsubj	3	SENT_18	[p1l1270t1628r1414b1663],
3	had	VBD	O	have	_	0	SENT_18	[p1l1432t1628r1502b1657],
4	LTA	NNP	ORGANIZATION	LTA	nsubj	5	SENT_18	[p1l1521t1628r1579b1656],
5	positive	JJ	O	positive	xcomp	3	SENT_18	[p1l1597t1628r1736b1663],
6	to	TO	O	to	_	0	SENT_18	[p1l1754t1628r1789b1657],
7	both	DT	O	both	det	8	SENT_18	[p1l1807t1628r1887b1657],
8	PHY	NN	O	phy	prep_to	5	SENT_18	[p1l1907t1628r1975b1656],
9	and	CC	O	and	_	0	SENT_18	[p1l1993t1628r2063b1657],
10	CBZ	NN	ORGANIZATION	cbz	prep_to	5	SENT_18	[p1l570t1672r648b1706],
11	,	,	O	,	_	0	SENT_18	[p1l570t1672r648b1706],
12	and	CC	O	and	_	0	SENT_18	[p1l666t1673r736b1702],
13	3	CD	NUMBER	3	num	14	SENT_18	[p1l751t1672r770b1702],
14	others	NNS	O	other	nsubj	15	SENT_18	[p1l787t1673r897b1702],
15	had	VBD	O	have	conj_and	3	SENT_18	[p1l913t1673r982b1702],
16	LTA	NNP	ORGANIZATION	LTA	nsubj	17	SENT_18	[p1l999t1673r1057b1701],
17	positive	JJ	O	positive	xcomp	15	SENT_18	[p1l1073t1673r1212b1708],
18	to	TO	O	to	_	0	SENT_18	[p1l1226t1673r1261b1702],
19	both	DT	O	both	det	20	SENT_18	[p1l1277t1673r1357b1702],
20	PHY	NN	O	phy	prep_to	17	SENT_18	[p1l1375t1673r1443b1701],
21	and	CC	O	and	_	0	SENT_18	[p1l1457t1673r1528b1702],
22	LTG	NN	O	ltg	conj_and	20	SENT_18	[p1l1545t1672r1615b1702],
23	.	.	O	.	_	0	SENT_18	[p1l1545t1672r1615b1702],

1	Clinically	RB	O	clinically	advmod	6	SENT_19	[p1l1632t1672r1810b1708],
2	,	,	O	,	_	0	SENT_19	[p1l1632t1672r1810b1708],
3	all	DT	O	all	det	5	SENT_19	[p1l1827t1673r1868b1702],
4	6	CD	NUMBER	6	num	5	SENT_19	[p1l1884t1673r1903b1702],
5	patients	NNS	O	patient	nsubj	6	SENT_19	[p1l1920t1673r2064b1708],
6	presented	VBD	O	present	_	0	SENT_19	[p1l571t1718r754b1754],
7	HSR	NN	O	hsr	dobj	6	SENT_19	[p1l768t1718r833b1747],
8	to	TO	O	to	_	0	SENT_19	[p1l844t1718r878b1747],
9	both	DT	O	both	det	10	SENT_19	[p1l891t1718r971b1747],
10	drugs	NNS	O	drug	prep_to	6	SENT_19	[p1l984t1718r1085b1755],
11	that	IN	O	that	complm	13	SENT_19	[p1l1096t1718r1166b1747],
12	they	PRP	O	they	nsubj	13	SENT_19	[p1l1177t1718r1257b1754],
13	tested	VBD	O	test	ccomp	6	SENT_19	[p1l1268t1718r1380b1747],
14	positive	JJ	O	positive	acomp	13	SENT_19	[p1l1393t1718r1532b1754],
15	to	TO	O	to	aux	16	SENT_19	[p1l1543t1718r1578b1747],
16	(	VB	O	(	xcomp	14	SENT_19	[p1l1592t1718r1908b1754],
17	cross-reactivity	NN	O	cross-reactivity	nn	18	SENT_19	[p1l1592t1718r1908b1754],
18	)	NN	O	)	dobj	16	SENT_19	[p1l1592t1718r1908b1754],
19	.	.	O	.	_	0	SENT_19	[p1l1592t1718r1908b1754],

1	Patients	NNS	O	patient	nsubjpass	3	SENT_20	[p1l1923t1718r2064b1747],
2	were	VBD	O	be	auxpass	3	SENT_20	[p1l570t1770r660b1792],
3	grouped	VBN	O	group	_	0	SENT_20	[p1l675t1764r831b1800],
4	based	VBN	O	base	_	0	SENT_20	[p1l847t1764r960b1792],
5	on	IN	O	on	prepc_based_on	3	SENT_20	[p1l976t1770r1019b1792],
6	the	DT	O	the	det	8	SENT_20	[p1l1035t1764r1093b1792],
7	clinical	JJ	O	clinical	amod	8	SENT_20	[p1l1108t1764r1239b1792],
8	presentation	NN	O	presentation	pobj	3	SENT_20	[p1l1256t1764r1482b1799],
9	of	IN	O	of	_	0	SENT_20	[p1l1499t1763r1532b1792],
10	their	PRP$	O	they	poss	11	SENT_20	[p1l1546t1764r1626b1792],
11	symptoms	NNS	O	symptom	prep_of	8	SENT_20	[p1l1640t1764r1826b1799],
12	as	IN	O	as	_	0	SENT_20	[p1l1841t1770r1881b1792],
13	only	JJ	O	only	amod	14	SENT_20	[p1l1896t1764r1973b1799],
14	rash	NN	O	rash	prep_as	3	SENT_20	[p1l1989t1764r2062b1792],
15	and	CC	O	and	_	0	SENT_20	[p1l570t1808r641b1837],
16	fever	NN	O	fever	conj_and	14	SENT_20	[p1l655t1808r747b1837],
17	or	CC	O	or	_	0	SENT_20	[p1l761t1815r796b1837],
18	as	IN	O	as	_	0	SENT_20	[p1l809t1814r849b1837],
19	a	DT	O	a	det	20	SENT_20	[p1l863t1814r885b1837],
20	triad	NN	O	triad	conj_or	14	SENT_20	[p1l898t1808r980b1837],
21	of	IN	O	of	_	0	SENT_20	[p1l994t1808r1028b1837],
22	rash	NN	O	rash	prep_of	20	SENT_20	[p1l1042t1808r1126b1842],
23	,	,	O	,	_	0	SENT_20	[p1l1042t1808r1126b1842],
24	fever	NN	O	fever	prep_of	20	SENT_20	[p1l1141t1808r1233b1837],
25	and	CC	O	and	_	0	SENT_20	[p1l1247t1808r1317b1837],
26	DILI	NN	ORGANIZATION	dili	prep_of	20	SENT_20	[p1l1333t1808r1393b1837],
27	or	CC	O	or	_	0	SENT_20	[p1l1409t1815r1444b1837],
28	SJS/TEN	NN	O	sjs/ten	conj_or	14	SENT_20	[p1l1457t1808r1593b1841],
29	that	WDT	O	that	nsubj	30	SENT_20	[p1l1608t1808r1679b1837],
30	characterizes	VBZ	O	characterize	rcmod	28	SENT_20	[p1l1692t1808r1940b1837],
31	“	RB	O	“	advmod	32	SENT_20	[p1l1956t1808r2061b1837],
32	true	JJ	O	true	acomp	30	SENT_20	[p1l1956t1808r2061b1837],
33	"	``	O	"	punct	34	SENT_20	[p1l1956t1808r2061b1837],
34	HSR	NN	O	hsr	dep	32	SENT_20	[p1l572t1853r645b1882],
35	.	.	O	.	_	0	SENT_20	[p1l572t1853r645b1882],

1	Levels	NNS	O	level	nsubj	7	SENT_21	[p1l662t1853r772b1882],
2	of	IN	O	of	_	0	SENT_21	[p1l785t1853r819b1882],
3	proinflammatory	JJ	O	proinflammatory	amod	4	SENT_21	[p1l833t1853r1136b1889],
4	cytokines	NNS	O	cytokine	prep_of	1	SENT_21	[p1l1149t1853r1326b1889],
5	were	VBD	O	be	cop	7	SENT_21	[p1l1338t1860r1428b1882],
6	significantly	RB	O	significantly	advmod	7	SENT_21	[p1l1441t1853r1659b1890],
7	higher	JJR	O	higher	_	0	SENT_21	[p1l1673t1853r1788b1890],
8	in	IN	O	in	_	0	SENT_21	[p1l1802t1853r1830b1882],
9	patient	NN	O	patient	nn	10	SENT_21	[p1l1846t1853r1974b1889],
10	sera	NNS	O	serum	prep_in	7	SENT_21	[p1l1987t1860r2063b1882],
11	compared	VBN	O	compare	_	0	SENT_21	[p1l570t1899r763b1934],
12	with	IN	O	with	prepc_compared_with	7	SENT_21	[p1l774t1899r846b1927],
13	control	NN	O	control	nn	14	SENT_21	[p1l859t1899r985b1927],
14	sera	NNS	O	serum	pobj	7	SENT_21	[p1l997t1905r1083b1927],
15	.	.	O	.	_	0	SENT_21	[p1l997t1905r1083b1927],

1	More	RBR	O	more	advmod	2	SENT_22	[p1l1097t1899r1188b1927],
2	specifically	RB	O	specifically	advmod	13	SENT_22	[p1l1199t1898r1416b1934],
3	,	,	O	,	_	0	SENT_22	[p1l1199t1898r1416b1934],
4	the	DT	O	the	det	6	SENT_22	[p1l1428t1899r1486b1927],
5	highest	JJS	O	highest	amod	6	SENT_22	[p1l1498t1899r1629b1935],
6	levels	NNS	O	level	nsubjpass	13	SENT_22	[p1l1640t1899r1743b1927],
7	of	IN	O	of	_	0	SENT_22	[p1l1754t1898r1788b1927],
8	tumor	NN	O	tumor	nn	10	SENT_22	[p1l1797t1899r1903b1927],
9	necrosis	NN	O	necrosis	nn	10	SENT_22	[p1l1915t1899r2064b1927],
10	factor-a	NN	O	factor-a	prep_of	6	SENT_22	[p1l570t1943r718b1972],
11	have	VBP	O	have	aux	13	SENT_22	[p1l731t1943r822b1972],
12	been	VBN	O	be	auxpass	13	SENT_22	[p1l835t1943r928b1972],
13	measured	VBN	O	measure	_	0	SENT_22	[p1l942t1943r1125b1972],
14	in	IN	O	in	_	0	SENT_22	[p1l1138t1943r1167b1972],
15	patients	NNS	O	patient	prep_in	13	SENT_22	[p1l1181t1943r1325b1979],
16	presenting	VBG	O	present	partmod	15	SENT_22	[p1l1338t1943r1529b1980],
17	“	RB	O	“	advmod	18	SENT_22	[p1l1544t1943r1649b1972],
18	true	JJ	O	true	acomp	16	SENT_22	[p1l1544t1943r1649b1972],
19	"	``	O	"	punct	20	SENT_22	[p1l1544t1943r1649b1972],
20	HSR	NN	O	hsr	dep	18	SENT_22	[p1l1665t1943r1738b1977],
21	,	,	O	,	_	0	SENT_22	[p1l1665t1943r1738b1977],
22	as	IN	O	as	mark	27	SENT_22	[p1l1752t1950r1792b1972],
23	were	VBD	O	be	cop	27	SENT_22	[p1l1804t1950r1894b1972],
24	the	DT	O	the	det	27	SENT_22	[p1l1905t1943r1963b1972],
25	apoptotic	JJ	O	apoptotic	amod	27	SENT_22	[p1l1975t1949r2062b1979, p1l571t1988r674b2023],
26	markers	NNS	O	marker	nn	27	SENT_22	[p1l685t1988r831b2017],
27	Fas	NN	O	fa	dep	20	SENT_22	[p1l842t1988r908b2021],
28	,	,	O	,	_	0	SENT_22	[p1l842t1988r908b2021],
29	caspase	NN	O	caspase	nn	31	SENT_22	[p1l920t1995r1074b2023],
30	8	CD	NUMBER	8	num	31	SENT_22	[p1l1084t1988r1103b2017],
31	activity	NN	O	activity	dep	20	SENT_22	[p1l1113t1988r1255b2023],
32	,	,	O	,	_	0	SENT_22	[p1l1113t1988r1255b2023],
33	and	CC	O	and	_	0	SENT_22	[p1l1267t1988r1337b2017],
34	M30	NN	O	m30	dep	20	SENT_22	[p1l1349t1988r1431b2017],
35	.	.	O	.	_	0	SENT_22	[p1l1349t1988r1431b2017],

1	The	DT	O	the	det	2	SENT_23	[p1l1442t1988r1504b2017],
2	LTA	NNP	ORGANIZATION	LTA	nsubj	4	SENT_23	[p1l1515t1988r1573b2016],
3	is	VBZ	O	be	cop	4	SENT_23	[p1l1583t1988r1607b2017],
4	sensitive	JJ	O	sensitive	_	0	SENT_23	[p1l1616t1988r1771b2017],
5	for	IN	O	for	mark	6	SENT_23	[p1l1780t1988r1827b2017],
6	DILI	NNP	ORGANIZATION	DILI	dep	4	SENT_23	[p1l1838t1988r1897b2016],
7	and	CC	O	and	_	0	SENT_23	[p1l1909t1988r1979b2017],
8	SJS	NNP	O	SJS	dep	4	SENT_23	[p1l1989t1988r2064b2021],
9	/	:	O	/	punct	6	SENT_23	[p1l1989t1988r2064b2021],

1	TEN	CD	NUMBER	ten	npadvmod	2	SENT_24	[p1l1054t2047r1188b2109],
2	regardless	RB	O	regardless	advmod	3	SENT_24	[p1l1246t2047r1664b2128],
3	of	IN	O	of	_	0	SENT_24	[p1l1715t2046r1789b2111],
4	drug	NN	O	drug	pobj	3	SENT_24	[p1l1840t2047r2023b2128],
5	or	CC	O	or	advmod	4	SENT_24	[p1l2076t2061r2153b2110],

1	From	IN	O	from	dep	51	SENT_25	[p1l6t2295r164b2345],
2	the	DT	O	the	det	6	SENT_25	[p1l208t2294r296b2345],
3	In	NNP	O	In	nn	6	SENT_25	[p1l340t2296r400b2345],
4	Vitro	NNP	O	Vitro	nn	6	SENT_25	[p1l450t2296r585b2346],
5	Drug	NNP	O	Drug	nn	6	SENT_25	[p1l630t2295r779b2360],
6	Safety	NNP	O	Safety	pobj	1	SENT_25	[p1l826t2294r1009b2360],
7	and	CC	O	and	_	0	SENT_25	[p1l1055t2294r1159b2345],
8	Biotechnology	NNP	O	Biotechnology	pobj	1	SENT_25	[p1l1203t2294r1652b2360],
9	;	:	O	;	_	0	SENT_25	[p1l1203t2294r1652b2360],
10	Department	NNP	ORGANIZATION	Department	dep	6	SENT_25	[p1l1699t2295r2046b2360],
11	of	IN	ORGANIZATION	of	_	0	SENT_25	[p1l8t2384r71b2435],
12	Pharmacology	NNP	ORGANIZATION	Pharmacology	prep_of	10	SENT_25	[p1l89t2384r512b2450],
13	and	CC	ORGANIZATION	and	_	0	SENT_25	[p1l536t2384r639b2435],
14	Toxicology	NNP	ORGANIZATION	Toxicology	conj_and	12	SENT_25	[p1l661t2384r1004b2450],
15	,	,	O	,	_	0	SENT_25	[p1l661t2384r1004b2450],
16	University	NNP	ORGANIZATION	University	appos	6	SENT_25	[p1l1030t2384r1335b2450],
17	of	IN	ORGANIZATION	of	_	0	SENT_25	[p1l1359t2384r1423b2435],
18	Toronto	NNP	ORGANIZATION	Toronto	prep_of	16	SENT_25	[p1l1440t2386r1687b2445],
19	;	:	ORGANIZATION	;	_	0	SENT_25	[p1l1440t2386r1687b2445],
20	Division	NNP	ORGANIZATION	Division	dep	6	SENT_25	[p1l1713t2384r1963b2436],
21	of	IN	ORGANIZATION	of	_	0	SENT_25	[p1l1987t2384r2050b2435],
22	Gastroenterology	NNP	ORGANIZATION	Gastroenterology	prep_of	20	SENT_25	[p1l8t2477r526b2544],
23	,	,	O	,	_	0	SENT_25	[p1l8t2477r526b2544],
24	Sunnybrook	NNP	O	Sunnybrook	nn	26	SENT_25	[p1l588t2477r944b2544],
25	Sciences	NNPS	O	Sciences	nn	26	SENT_25	[p1l1001t2477r1253b2529],
26	Centre	NNP	O	Centre	appos	6	SENT_25	[p1l1312t2477r1522b2538],
27	;	:	O	;	_	0	SENT_25	[p1l1312t2477r1522b2538],
28	Department	NNP	ORGANIZATION	Department	dep	6	SENT_25	[p1l1583t2478r1930b2544],
29	of	IN	ORGANIZATION	of	_	0	SENT_25	[p1l1987t2476r2050b2528],
30	Medicine	NNP	ORGANIZATION	Medicine	prep_of	28	SENT_25	[p1l6t2566r299b2626],
31	,	,	O	,	_	0	SENT_25	[p1l6t2566r299b2626],
32	University	NNP	ORGANIZATION	University	appos	6	SENT_25	[p1l347t2566r652b2632],
33	of	IN	ORGANIZATION	of	_	0	SENT_25	[p1l699t2566r763b2617],
34	Toronto	NNP	ORGANIZATION	Toronto	prep_of	32	SENT_25	[p1l804t2567r1050b2627],
35	;	:	O	;	_	0	SENT_25	[p1l804t2567r1050b2627],
36	North	NNP	ORGANIZATION	North	nn	39	SENT_25	[p1l1098t2566r1269b2617],
37	York	NNP	ORGANIZATION	York	nn	39	SENT_25	[p1l1314t2566r1456b2617],
38	General	NNP	ORGANIZATION	General	nn	39	SENT_25	[p1l1502t2566r1731b2618],
39	Hospital	NNP	ORGANIZATION	Hospital	dep	6	SENT_25	[p1l1777t2566r2042b2632],
40	;	:	ORGANIZATION	;	_	0	SENT_25	[p1l1777t2566r2042b2632],
41	University	NNP	ORGANIZATION	University	dep	6	SENT_25	[p1l7t2656r312b2722],
42	of	IN	ORGANIZATION	of	_	0	SENT_25	[p1l355t2656r418b2707],
43	Toronto	NNP	ORGANIZATION	Toronto	nn	45	SENT_25	[p1l454t2658r683b2707],
44	Epilepsy	NNP	ORGANIZATION	Epilepsy	nn	45	SENT_25	[p1l725t2656r980b2722],
45	Research	NNP	ORGANIZATION	Research	prep_of	41	SENT_25	[p1l1022t2656r1306b2717],
46	,	,	O	,	_	0	SENT_25	[p1l1022t2656r1306b2717],
47	University	NNP	ORGANIZATION	University	appos	6	SENT_25	[p1l1349t2656r1654b2722],
48	of	IN	ORGANIZATION	of	_	0	SENT_25	[p1l1698t2656r1761b2707],
49	Toronto	NNP	ORGANIZATION	Toronto	prep_of	47	SENT_25	[p1l1797t2658r2043b2717],
50	,	,	O	,	_	0	SENT_25	[p1l1797t2658r2043b2717],
51	Toronto	NNP	LOCATION	Toronto	_	0	SENT_25	[p1l7t2749r252b2808],
52	,	,	O	,	_	0	SENT_25	[p1l7t2749r252b2808],
53	Ontario	NNP	LOCATION	Ontario	appos	51	SENT_25	[p1l278t2748r516b2808],
54	,	,	O	,	_	0	SENT_25	[p1l278t2748r516b2808],
55	Canada	NNP	LOCATION	Canada	dep	51	SENT_25	[p1l541t2747r774b2799],
56	.	.	O	.	_	0	SENT_25	[p1l541t2747r774b2799],

1	Submitted	VBN	O	submit	_	0	SENT_26	[p1l9t2840r308b2892],
2	for	IN	O	for	_	0	SENT_26	[p1l325t2839r410b2891],
3	publication	NN	O	publication	prep_for	1	SENT_26	[p1l424t2839r755b2907],
4	December	NNP	DATE	December	dobj	1	SENT_26	[p1l772t2840r1073b2891],
5	2	CD	DATE	2	num	4	SENT_26	[p1l1090t2840r1139b2901],
6	,	,	DATE	,	_	0	SENT_26	[p1l1090t2840r1139b2901],
7	2011	CD	DATE	2011	num	4	SENT_26	[p1l1160t2840r1322b2901],
8	;	:	O	;	_	0	SENT_26	[p1l1160t2840r1322b2901],
9	accepted	VBN	O	accept	partmod	4	SENT_26	[p1l1343t2840r1599b2907],
10	for	IN	O	for	_	0	SENT_26	[p1l1615t2839r1700b2891],
11	publication	NN	O	publication	prep_for	9	SENT_26	[p1l1715t2840r2046b2907],
12	January	NNP	DATE	January	tmod	9	SENT_26	[p1l6t2933r233b2999],
13	5	CD	DATE	5	num	12	SENT_26	[p1l257t2931r306b2993],
14	,	,	DATE	,	_	0	SENT_26	[p1l257t2931r306b2993],
15	2012	CD	DATE	2012	num	12	SENT_26	[p1l332t2932r491b2984],
16	.	.	O	.	_	0	SENT_26	[p1l332t2932r491b2984],

1	patient	NN	O	patient	_	0	SENT_27	[p1l6t3165r286b3242],
2	ethnicity	NN	O	ethnicity	dep	1	SENT_27	[p1l338t3165r703b3242],
3	.	.	O	.	_	0	SENT_27	[p1l338t3165r703b3242],

1	HSR	NN	O	hsr	nn	2	SENT_28	[p1l763t3164r905b3228],
2	prediction	NN	O	prediction	nsubj	4	SENT_28	[p1l959t3165r1365b3242],
3	will	MD	O	will	aux	4	SENT_28	[p1l1418t3165r1542b3227],
4	prevent	VB	O	prevent	_	0	SENT_28	[p1l1598t3165r1905b3242],
5	AEDReprint	NN	O	aedreprint	dobj	4	SENT_28	[p1l1955t3165r2148b3227, p1l121t3408r340b3474],

1	requests	NNS	O	request	_	0	SENT_29	[p1l357t3416r610b3474],
2	:	:	O	:	_	0	SENT_29	[p1l357t3416r610b3474],
3	Manuela	NNP	PERSON	Manuela	nn	5	SENT_29	[p1l634t3408r890b3459],
4	G.	NNP	PERSON	G.	nn	5	SENT_29	[p1l908t3409r973b3460],
5	Neuman	NNP	PERSON	Neuman	dep	1	SENT_29	[p1l994t3410r1257b3469],
6	,	,	O	,	_	0	SENT_29	[p1l994t3410r1257b3469],
7	PhD	NNP	O	PhD	appos	5	SENT_29	[p1l1277t3408r1421b3469],
8	,	,	O	,	_	0	SENT_29	[p1l1277t3408r1421b3469],
9	In	IN	O	in	dep	5	SENT_29	[p1l1440t3410r1500b3459],
10	Vitro	NNP	O	Vitro	nn	12	SENT_29	[p1l1524t3410r1659b3460],
11	Drug	NNP	O	Drug	nn	12	SENT_29	[p1l1678t3410r1826b3474],
12	Safety	NNP	O	Safety	pobj	9	SENT_29	[p1l1846t3408r2030b3474],
13	and	CC	O	and	_	0	SENT_29	[p1l2050t3408r2153b3459],
14	BioTechnology	NNP	O	BioTechnology	conj_and	12	SENT_29	[p1l121t3498r581b3564],
15	,	,	O	,	_	0	SENT_29	[p1l121t3498r581b3564],
16	MaRS	NNP	O	MaRS	nn	18	SENT_29	[p1l609t3499r792b3550],
17	Discovery	NNP	O	Discovery	nn	18	SENT_29	[p1l820t3498r1116b3564],
18	District	NNP	O	District	appos	14	SENT_29	[p1l1143t3498r1377b3559],
19	,	,	O	,	_	0	SENT_29	[p1l1143t3498r1377b3559],
20	101	CD	NUMBER	101	num	22	SENT_29	[p1l1412t3499r1507b3550],
21	College	NNP	O	College	nn	22	SENT_29	[p1l1539t3498r1764b3564],
22	Street	NNP	O	Street	appos	14	SENT_29	[p1l1792t3499r1975b3559],
23	,	,	O	,	_	0	SENT_29	[p1l1792t3499r1975b3559],
24	Suite	NNP	O	Suite	appos	14	SENT_29	[p1l2005t3498r2152b3550],
25	300	CD	NUMBER	300	num	24	SENT_29	[p1l123t3590r245b3650],
26	,	,	O	,	_	0	SENT_29	[p1l123t3590r245b3650],
27	Lab	NN	O	lab	appos	14	SENT_29	[p1l302t3589r414b3641],
28	351	CD	NUMBER	351	num	27	SENT_29	[p1l473t3589r595b3650],
29	,	,	O	,	_	0	SENT_29	[p1l473t3589r595b3650],
30	Toronto	NNP	LOCATION	Toronto	appos	14	SENT_29	[p1l653t3591r898b3650],
31	,	,	O	,	_	0	SENT_29	[p1l653t3591r898b3650],
32	Ontario	NNP	LOCATION	Ontario	appos	14	SENT_29	[p1l958t3590r1194b3650],
33	,	,	O	,	_	0	SENT_29	[p1l958t3590r1194b3650],
34	Canada	NNP	LOCATION	Canada	appos	14	SENT_29	[p1l1253t3590r1487b3650],
35	,	,	O	,	_	0	SENT_29	[p1l1253t3590r1487b3650],
36	MSG	NNP	O	MSG	nn	37	SENT_29	[p1l1544t3589r1697b3641],
37	1L7	NN	O	1l7	appos	14	SENT_29	[p1l1760t3590r1886b3650],
38	;	:	O	;	_	0	SENT_29	[p1l1760t3590r1886b3650],
39	e	SYM	O	e	dep	41	SENT_29	[p1l1946t3590r2147b3641],
40	—	CD	NUMBER	—	num	41	SENT_29	[p1l1946t3590r2147b3641],
41	mail	NN	O	mail	dep	43	SENT_29	[p1l1946t3590r2147b3641],
42	:	:	O	:	_	0	SENT_29	[p1l1946t3590r2147b3641],
43	manuela.neuman@utoronto.ca	NN	O	manuela.neuman@utoronto.ca	dep	5	SENT_29	[p1l121t3680r1032b3732],
44	.	.	O	.	_	0	SENT_29	[p1l121t3680r1032b3732],

1	1931-5244	CD	DURATION	1931-5244	_	0	SENT_30	[p2l127t25r491b86],
2	/	:	O	/	punct	1	SENT_30	[p2l127t25r491b86],
3	$	$	MONEY	$	nsubj	5	SENT_30	[p2l127t25r491b86],
4	—	CD	MONEY	—	num	3	SENT_30	[p2l517t60r535b65],
5	see	VBP	O	see	dep	1	SENT_30	[p2l562t45r651b80],
6	front	JJ	O	front	amod	7	SENT_30	[p2l674t28r816b80],
7	matter	NN	O	matter	nsubj	9	SENT_30	[p2l837t36r1025b80],
8	©	CD	NUMBER	©	num	9	SENT_30	[p2l123t119r175b170],
9	2012	CD	DATE	2012	xcomp	5	SENT_30	[p2l200t119r343b170],
10	Mosby	NNP	ORGANIZATION	Mosby	nn	12	SENT_30	[p2l366t118r577b184],
11	,	,	ORGANIZATION	,	_	0	SENT_30	[p2l366t118r577b184],
12	Inc.	NNP	ORGANIZATION	Inc.	dep	9	SENT_30	[p2l603t120r709b169],
13	.	.	O	.	_	0	SENT_30	[p2l603t120r709b169],

1	All	DT	O	all	det	2	SENT_31	[p2l735t118r826b169],
2	rights	NNS	O	rights	nsubj	3	SENT_31	[p2l848t118r1013b184],
3	reserved	VBN	O	reserve	_	0	SENT_31	[p2l1035t118r1296b169],
4	.	.	O	.	_	0	SENT_31	[p2l1035t118r1296b169],

1	doi	FW	O	doi	_	0	SENT_32	[p2l122t208r1007b274],
2	:	:	O	:	_	0	SENT_32	[p2l122t208r1007b274],
3	l0	NN	O	l0	dep	1	SENT_32	[p2l122t208r1007b274],
4	.1016	CD	NUMBER	.1016	num	3	SENT_32	[p2l122t208r1007b274],
5	/	:	O	/	punct	7	SENT_32	[p2l122t208r1007b274],
6	j.	NN	O	j.	nn	7	SENT_32	[p2l122t208r1007b274],
7	trsl	NN	O	trsl	dep	3	SENT_32	[p2l122t208r1007b274],
8	.2012.0	CD	NUMBER	.2012.0	num	9	SENT_32	[p2l122t208r1007b274],
9	l.	NN	O	l.	dep	7	SENT_32	[p2l122t208r1007b274],
10	004	CD	NUMBER	004	dep	9	SENT_32	[p2l122t208r1007b274],

1	Translational	JJ	O	translational	amod	2	SENT_33	[p2l1705t578r1902b603],
2	Research	NN	O	research	nsubj	8	SENT_33	[p2l1916t578r2062b603],
3	398	CD	NUMBER	398	dep	2	SENT_33	[p2l96t618r151b644],
4	Neuman	NNP	O	Neuman	dep	2	SENT_33	[p2l200t618r336b644],
5	et	FW	O	et	nn	6	SENT_33	[p2l348t618r380b644],
6	al	FW	O	al	dep	4	SENT_33	[p2l390t618r417b644],
7	May	MD	DATE	may	aux	8	SENT_33	[p2l1913t618r1981b650],
8	2012	CD	DATE	2012	_	0	SENT_33	[p2l1991t618r2062b644],

1	induced	VBN	O	induce	_	0	SENT_34	[p2l571t726r721b755],
2	morbidity	NN	O	morbidity	dobj	1	SENT_34	[p2l733t726r914b761],
3	.	.	O	.	_	0	SENT_34	[p2l733t726r914b761],

1	In	IN	O	in	_	0	SENT_35	[p2l928t726r957b754],
2	Han	NNP	LOCATION	Han	nn	3	SENT_35	[p2l970t726r1039b755],
3	Chinese	NNP	LOCATION	Chinese	prep_in	11	SENT_35	[p2l1050t725r1208b759],
4	,	,	O	,	_	0	SENT_35	[p2l1050t725r1208b759],
5	HLA-B	NN	O	hla-b	nsubj	11	SENT_35	[p2l1221t725r1429b755],
6	*	CD	NUMBER	*	num	8	SENT_35	[p2l1221t725r1429b755],
7	l502	NN	O	l502	nn	8	SENT_35	[p2l1221t725r1429b755],
8	positivity	NN	O	positivity	dep	5	SENT_35	[p2l1441t726r1599b761],
9	is	VBZ	O	be	cop	11	SENT_35	[p2l1610t726r1633b755],
10	a	DT	O	a	det	11	SENT_35	[p2l1644t732r1666b755],
11	predictor	NN	O	predictor	_	0	SENT_35	[p2l1678t726r1844b761],
12	for	IN	O	for	_	0	SENT_35	[p2l1853t725r1900b755],
13	CBZ-HSR	NN	O	cbz-hsr	prep_for	11	SENT_35	[p2l1910t725r2063b755],
14	and	CC	O	and	_	0	SENT_35	[p2l570t771r640b800],
15	PHY-HSR	NN	O	phy-hsr	conj_and	13	SENT_35	[p2l658t771r819b800],
16	.	.	O	.	_	0	SENT_35	[p2l658t771r819b800],

1	Its	PRP$	O	its	poss	2	SENT_36	[p2l838t771r874b800],
2	negativity	NN	O	negativity	nsubj	5	SENT_36	[p2l891t771r1071b808],
3	does	VBZ	O	do	aux	5	SENT_36	[p2l1087t771r1175b800],
4	not	RB	O	not	neg	5	SENT_36	[p2l1192t771r1248b800],
5	predict	VB	O	predict	_	0	SENT_36	[p2l1265t771r1394b807],
6	a	DT	O	a	det	8	SENT_36	[p2l1410t777r1432b800],
7	negative	JJ	O	negative	amod	8	SENT_36	[p2l1450t771r1611b808],
8	LTG-HSR	NN	O	ltg-hsr	dobj	5	SENT_36	[p2l1628t771r1782b800],
9	.	.	O	.	_	0	SENT_36	[p2l1628t771r1782b800],

1	There	EX	O	there	expl	2	SENT_37	[p2l1799t771r1898b800],
2	is	VBZ	O	be	_	0	SENT_37	[p2l1915t771r1938b800],
3	crossreactivity	NN	O	crossreactivity	nsubj	2	SENT_37	[p2l1954t777r2061b800, p2l571t817r740b852],
4	between	IN	O	between	_	0	SENT_37	[p2l757t817r916b846],
5	AEDs	NNS	MISC	aed	prep_between	3	SENT_37	[p2l933t817r1032b846],
6	.	.	O	.	_	0	SENT_37	[p2l933t817r1032b846],

1	Additionally	RB	O	additionally	advmod	7	SENT_38	[p2l1050t817r1280b852],
2	,	,	O	,	_	0	SENT_38	[p2l1050t817r1280b852],
3	T-cell	NN	O	t-cell	nn	4	SENT_38	[p2l1298t817r1395b846],
4	cytokines	NNS	O	cytokine	nsubj	7	SENT_38	[p2l1413t817r1589b852],
5	and	CC	O	and	_	0	SENT_38	[p2l1605t817r1676b846],
6	chemokines	NNS	O	chemokine	conj_and	4	SENT_38	[p2l1693t817r1918b846],
7	control	VBP	O	control	_	0	SENT_38	[p2l1935t817r2061b846],
8	the	DT	O	the	det	9	SENT_38	[p2l569t861r627b890],
9	pathogenesis	NN	O	pathogenesis	dobj	7	SENT_38	[p2l643t861r889b898],
10	of	IN	O	of	_	0	SENT_38	[p2l904t861r938b890],
11	SJS/TEN	NN	O	sjs/ten	prep_of	9	SENT_38	[p2l952t861r1089b895],
12	and	CC	O	and	_	0	SENT_38	[p2l1106t861r1176b890],
13	DILI	NNP	LOCATION	DILI	conj_and	11	SENT_38	[p2l1194t861r1265b895],
14	,	,	O	,	_	0	SENT_38	[p2l1194t861r1265b895],
15	contributing	VBG	O	contribute	partmod	7	SENT_38	[p2l1282t861r1502b898],
16	to	TO	O	to	_	0	SENT_38	[p2l1517t861r1552b890],
17	apoptotic	JJ	O	apoptotic	amod	18	SENT_38	[p2l1568t861r1745b897],
18	processes	NNS	O	process	prep_to	15	SENT_38	[p2l1762t868r1944b897],
19	in	IN	O	in	_	0	SENT_38	[p2l1961t861r1989b890],
20	the	DT	O	the	det	21	SENT_38	[p2l2005t861r2062b890],
21	liver	NN	O	liver	prep_in	18	SENT_38	[p2l571t907r645b936],
22	and	CC	O	and	_	0	SENT_38	[p2l658t907r728b936],
23	in	IN	O	in	_	0	SENT_38	[p2l743t907r771b936],
24	the	DT	O	the	det	25	SENT_38	[p2l785t907r842b936],
25	skin	NN	O	skin	prep_in	15	SENT_38	[p2l856t907r934b936],
26	.	.	O	.	_	0	SENT_38	[p2l856t907r934b936],

1	(	RB	O	(	advmod	2	SENT_39	[p2l951t907r1191b940],
2	Translational	JJ	O	translational	amod	4	SENT_39	[p2l951t907r1191b940],
3	Research	NN	O	research	nn	4	SENT_39	[p2l1207t907r1374b936],
4	20l2	NN	O	20l2	_	0	SENT_39	[p2l1389t907r1720b941],
5	;	:	O	;	_	0	SENT_39	[p2l1389t907r1720b941],
6	l59	NN	O	l59	dep	4	SENT_39	[p2l1389t907r1720b941],
7	:397	CD	NUMBER	:397	num	8	SENT_39	[p2l1389t907r1720b941],
8	—	NN	O	—	dep	6	SENT_39	[p2l1389t907r1720b941],
9	406	CD	NUMBER	406	num	10	SENT_39	[p2l1389t907r1720b941],
10	)	NN	O	)	dep	4	SENT_39	[p2l1389t907r1720b941],

1	Abbreviations	NNS	O	abbreviation	_	0	SENT_40	[p2l569t1014r792b1040],
2	:	:	O	:	_	0	SENT_40	[p2l569t1014r792b1040],
3	ADR	NN	O	adr	dep	1	SENT_40	[p2l804t1014r871b1039],
4	:	:	O	:	_	0	SENT_40	[p2l882t1027r905b1035],
5	adverse	JJ	O	adverse	amod	7	SENT_40	[p2l918t1014r1042b1040],
6	drug	NN	O	drug	nn	7	SENT_40	[p2l1054t1014r1125b1046],
7	reaction	NN	O	reaction	dep	3	SENT_40	[p2l1138t1014r1275b1041],
8	;	:	O	;	_	0	SENT_40	[p2l1138t1014r1275b1041],
9	AED	NNP	O	AED	dep	3	SENT_40	[p2l1287t1014r1351b1039],
10	:	:	O	:	_	0	SENT_40	[p2l1363t1027r1386b1035],
11	antiepileptic	JJ	O	antiepileptic	amod	12	SENT_40	[p2l1399t1014r1592b1046],
12	drug	NN	O	drug	dep	9	SENT_40	[p2l1604t1014r1683b1046],
13	;	:	O	;	_	0	SENT_40	[p2l1604t1014r1683b1046],
14	CBZ	NNP	O	CBZ	dep	3	SENT_40	[p2l1696t1014r1756b1040],
15	:	:	O	:	_	0	SENT_40	[p2l1767t1027r1789b1035],
16	carbamazepine	NN	O	carbamazepine	dep	14	SENT_40	[p2l1802t1014r2061b1046],
17	:	:	O	:	_	0	SENT_40	[p2l1802t1014r2061b1046],
18	DIHS	NNS	O	dih	dep	1	SENT_40	[p2l571t1055r638b1081],
19	:	:	O	:	_	0	SENT_40	[p2l653t1068r676b1076],
20	drug	NN	O	drug	nn	21	SENT_40	[p2l691t1055r905b1087],
21	—	NN	O	—	nsubj	22	SENT_40	[p2l691t1055r905b1087],
22	induced	VBD	O	induce	dep	1	SENT_40	[p2l691t1055r905b1087],
23	hypersensitivity	NN	O	hypersensitivity	nn	24	SENT_40	[p2l921t1055r1149b1087],
24	syndrome	NN	O	syndrome	dobj	22	SENT_40	[p2l1162t1055r1323b1087],
25	;	:	O	;	_	0	SENT_40	[p2l1162t1055r1323b1087],
26	DILI	NNP	O	DILI	dep	24	SENT_40	[p2l1340t1055r1389b1080],
27	:	:	O	:	_	0	SENT_40	[p2l1405t1068r1428b1076],
28	drug	NN	O	drug	nn	29	SENT_40	[p2l1444t1055r1657b1087],
29	—	NN	O	—	nsubj	30	SENT_40	[p2l1444t1055r1657b1087],
30	induced	VBD	O	induce	rcmod	24	SENT_40	[p2l1444t1055r1657b1087],
31	liver	NN	O	liver	nn	32	SENT_40	[p2l1673t1055r1732b1081],
32	injury	NN	O	injury	dobj	30	SENT_40	[p2l1747t1055r1830b1087],
33	;	:	O	;	_	0	SENT_40	[p2l1747t1055r1830b1087],
34	DRESS	NNP	O	DRESS	dep	32	SENT_40	[p2l1847t1055r1938b1081],
35	:	:	O	:	_	0	SENT_40	[p2l1953t1068r1975b1076],
36	drug	NN	O	drug	nn	37	SENT_40	[p2l1991t1055r2062b1087],
37	rash	NN	O	rash	dep	32	SENT_40	[p2l571t1096r632b1122],
38	with	IN	O	with	_	0	SENT_40	[p2l642t1096r705b1122],
39	eosinophilia	NN	O	eosinophilia	nn	42	SENT_40	[p2l717t1096r898b1128],
40	and	CC	O	and	_	0	SENT_40	[p2l910t1096r972b1122],
41	systemic	JJ	O	systemic	conj_and	39	SENT_40	[p2l983t1096r1113b1128],
42	symptoms	NNS	O	symptom	prep_with	37	SENT_40	[p2l1123t1096r1287b1128],
43	;	:	O	;	_	0	SENT_40	[p2l1123t1096r1287b1128],
44	Fas	NN	O	fa	nn	46	SENT_40	[p2l1300t1096r1348b1122],
45	=	JJ	O	=	amod	46	SENT_40	[p2l1359t1109r1382b1117],
46	CD95	NN	O	cd95	dep	32	SENT_40	[p2l1393t1096r1487b1124],
47	,	,	O	,	_	0	SENT_40	[p2l1393t1096r1487b1124],
48	APO-I	NN	O	apo-i	appos	46	SENT_40	[p2l1497t1096r1592b1124],
49	;	:	O	;	_	0	SENT_40	[p2l1497t1096r1592b1124],
50	HLA	NN	O	hlum	nn	54	SENT_40	[p2l1606t1096r1665b1122],
51	=	JJ	O	=	amod	54	SENT_40	[p2l1675t1109r1698b1117],
52	human	JJ	O	human	amod	54	SENT_40	[p2l1710t1096r1820b1122],
53	leukocyte	NN	O	leukocyte	nn	54	SENT_40	[p2l1832t1096r1984b1128],
54	antigen	NN	O	antigen	dep	32	SENT_40	[p2l1994t1096r2063b1122, p2l570t1143r639b1169],
55	:	:	O	:	_	0	SENT_40	[p2l1994t1096r2063b1122, p2l570t1143r639b1169],
56	HSR	NN	O	hsr	dep	32	SENT_40	[p2l653t1137r709b1163],
57	:	:	O	:	_	0	SENT_40	[p2l721t1150r743b1158],
58	hypersensitivity	NN	O	hypersensitivity	nn	60	SENT_40	[p2l757t1137r985b1169],
59	syndrome	NN	O	syndrome	nn	60	SENT_40	[p2l995t1137r1148b1169],
60	reaction	NN	O	reaction	dep	32	SENT_40	[p2l1161t1137r1298b1164],
61	;	:	O	;	_	0	SENT_40	[p2l1161t1137r1298b1164],
62	IL	NN	O	il	dep	32	SENT_40	[p2l1312t1137r1333b1162],
63	:	:	O	:	_	0	SENT_40	[p2l1344t1150r1366b1158],
64	interleukin	NN	O	interleukin	dep	32	SENT_40	[p2l1380t1137r1541b1164],
65	;	:	O	;	_	0	SENT_40	[p2l1380t1137r1541b1164],
66	LTA	NNP	ORGANIZATION	LTA	dep	32	SENT_40	[p2l1555t1137r1606b1162],
67	:	:	O	:	_	0	SENT_40	[p2l1617t1150r1640b1158],
68	lymphocyte	NN	O	lymphocyte	nn	70	SENT_40	[p2l1653t1137r1838b1169],
69	toxicity	NN	O	toxicity	nn	70	SENT_40	[p2l1849t1137r1958b1169],
70	assay	NN	O	assay	dep	32	SENT_40	[p2l1969t1143r2061b1169],
71	:	:	O	:	_	0	SENT_40	[p2l1969t1143r2061b1169],
72	LTG	NN	O	ltg	dep	32	SENT_40	[p2l571t1178r625b1204],
73	:	:	O	:	_	0	SENT_40	[p2l640t1191r662b1199],
74	lamotrigine	NN	O	lamotrigine	dep	32	SENT_40	[p2l678t1178r859b1210],
75	;	:	O	;	_	0	SENT_40	[p2l678t1178r859b1210],
76	M30	NN	O	m30	dep	32	SENT_40	[p2l875t1178r938b1204],
77	:	:	O	:	_	0	SENT_40	[p2l952t1191r975b1199],
78	mitochondrial	JJ	O	mitochondrial	amod	79	SENT_40	[p2l990t1178r1204b1204],
79	marker	NN	O	marker	dep	32	SENT_40	[p2l1220t1178r1327b1204],
80	for	IN	O	for	_	0	SENT_40	[p2l1340t1178r1380b1204],
81	apoptosis	NN	O	apoptosis	nn	83	SENT_40	[p2l1393t1178r1543b1210],
82	(	NN	O	(	nn	83	SENT_40	[p2l1557t1178r1763b1210],
83	cytokeratine	NN	O	cytokeratine	prep_for	79	SENT_40	[p2l1557t1178r1763b1210],
84	18	CD	NUMBER	18	num	85	SENT_40	[p2l1781t1178r1830b1207],
85	)	NN	O	)	dep	79	SENT_40	[p2l1781t1178r1830b1207],
86	;	:	O	;	_	0	SENT_40	[p2l1781t1178r1830b1207],
87	MHC	NN	O	mhc	dep	32	SENT_40	[p2l1846t1178r1922b1204],
88	:	:	O	:	_	0	SENT_40	[p2l1937t1191r1959b1199],
89	major	JJ	O	major	amod	91	SENT_40	[p2l1975t1178r2063b1210],
90	histocompatibility	NN	O	histocompatibility	nn	91	SENT_40	[p2l571t1219r842b1251],
91	complex	NN	O	complex	dep	32	SENT_40	[p2l858t1219r1001b1251],
92	;	:	O	;	_	0	SENT_40	[p2l858t1219r1001b1251],
93	ox	NN	O	ox	dep	91	SENT_40	[p2l1019t1219r1126b1245],
94	.	.	O	.	_	0	SENT_40	[p2l1019t1219r1126b1245],

1	—	NN	O	—	_	0	SENT_41	[p2l1019t1219r1126b1245],
2	.	.	O	.	_	0	SENT_41	[p2l1019t1219r1126b1245],

1	CBZ	NNP	O	CBZ	_	0	SENT_42	[p2l1019t1219r1126b1245],
2	:	:	O	:	_	0	SENT_42	[p2l1142t1232r1164b1240],
3	oxcarbazepine	NN	O	oxcarbazepine	dep	1	SENT_42	[p2l1182t1219r1425b1251],
4	;	:	O	;	_	0	SENT_42	[p2l1182t1219r1425b1251],
5	PHY	NNP	O	PHY	dep	3	SENT_42	[p2l1443t1219r1502b1244],
6	:	:	O	:	_	0	SENT_42	[p2l1518t1232r1541b1240],
7	phenytoin	NN	O	phenytoin	dep	5	SENT_42	[p2l1559t1219r1722b1251],
8	;	:	O	;	_	0	SENT_42	[p2l1559t1219r1722b1251],
9	RANTES	NN	O	rante	dep	3	SENT_42	[p2l1741t1219r1853b1245],
10	:	:	O	:	_	0	SENT_42	[p2l1870t1232r1892b1240],
11	regulated	VBN	O	regulate	dep	1	SENT_42	[p2l1910t1219r2061b1251],
12	upon	IN	O	upon	_	0	SENT_42	[p2l571t1266r650b1292],
13	activation	NN	O	activation	prep_upon	11	SENT_42	[p2l661t1260r817b1286],
14	normal	JJ	O	normal	amod	17	SENT_42	[p2l829t1260r936b1286],
15	T	NN	O	t	nn	17	SENT_42	[p2l946t1260r1023b1286],
16	—	NN	O	—	nn	17	SENT_42	[p2l946t1260r1023b1286],
17	cell	NN	O	cell	dobj	11	SENT_42	[p2l946t1260r1023b1286],
18	expressed	VBN	O	express	partmod	17	SENT_42	[p2l1034t1260r1188b1292],
19	and	CC	O	and	_	0	SENT_42	[p2l1199t1260r1261b1286],
20	secreted	VBN	O	secrete	partmod	17	SENT_42	[p2l1271t1260r1417b1288],
21	;	:	O	;	_	0	SENT_42	[p2l1271t1260r1417b1288],
22	SCAR	NN	O	scar	dep	17	SENT_42	[p2l1428t1260r1514b1286],
23	=	JJ	O	=	amod	27	SENT_42	[p2l1524t1273r1546b1281],
24	severe	JJ	O	severe	amod	27	SENT_42	[p2l1557t1266r1658b1286],
25	cutaneous	JJ	O	cutaneous	amod	27	SENT_42	[p2l1669t1260r1835b1286],
26	adverse	JJ	O	adverse	amod	27	SENT_42	[p2l1845t1260r1969b1286],
27	reactions	NNS	O	reaction	dep	22	SENT_42	[p2l1980t1266r2062b1286, p2l569t1301r646b1329],
28	;	:	O	;	_	0	SENT_42	[p2l1980t1266r2062b1286, p2l569t1301r646b1329],
29	SJS	NN	O	sj	dep	17	SENT_42	[p2l658t1301r705b1327],
30	=	JJ	O	=	amod	29	SENT_42	[p2l716t1314r738b1322],
31	Stevens	NNP	PERSON	Stevens	dep	17	SENT_42	[p2l749t1301r1007b1327],
32	.	.	O	.	_	0	SENT_42	[p2l749t1301r1007b1327],

1	—	NN	O	—	_	0	SENT_43	[p2l749t1301r1007b1327],
2	.	.	O	.	_	0	SENT_43	[p2l749t1301r1007b1327],

1	Johnson	NNP	PERSON	Johnson	nn	2	SENT_44	[p2l749t1301r1007b1327],
2	syndrome	NN	O	syndrome	_	0	SENT_44	[p2l1018t1301r1179b1333],
3	;	:	O	;	_	0	SENT_44	[p2l1018t1301r1179b1333],
4	TEN	CD	NUMBER	ten	num	8	SENT_44	[p2l1189t1301r1243b1327],
5	=	JJ	O	=	amod	8	SENT_44	[p2l1255t1314r1277b1322],
6	toxic	JJ	O	toxic	amod	8	SENT_44	[p2l1288t1301r1362b1327],
7	epidermal	JJ	O	epidermal	amod	8	SENT_44	[p2l1373t1301r1531b1333],
8	necrolysis	NN	O	necrolysis	dep	2	SENT_44	[p2l1544t1301r1695b1333],
9	;	:	O	;	_	0	SENT_44	[p2l1544t1301r1695b1333],
10	Th	NN	O	th	dep	8	SENT_44	[p2l1706t1301r1738b1327],
11	=	JJ	O	=	amod	14	SENT_44	[p2l1750t1314r1773b1322],
12	T	NN	O	t	nn	14	SENT_44	[p2l1783t1301r1797b1327],
13	helper	NN	O	helper	nn	14	SENT_44	[p2l1808t1301r1906b1333],
14	response	NN	O	response	dep	10	SENT_44	[p2l1916t1307r2061b1333],
15	:	:	O	:	_	0	SENT_44	[p2l1916t1307r2061b1333],

1	TNF	NN	O	tnf	nn	2	SENT_45	[p2l1060t1356r1245b1411],
2	—	NN	O	—	_	0	SENT_45	[p2l1060t1356r1245b1411],
3	a	DT	O	a	det	7	SENT_45	[p2l1060t1356r1245b1411],
4	=	JJ	O	=	amod	7	SENT_45	[p2l1270t1384r1319b1402],
5	tumor	NN	O	tumor	nn	7	SENT_45	[p2l1341t1356r1547b1412],
6	necrosis	NN	O	necrosis	nn	7	SENT_45	[p2l1569t1356r1839b1412],
7	factor	NN	O	factor	dep	2	SENT_45	[p2l1859t1356r2092b1412],
8	—	CD	NUMBER	—	num	9	SENT_45	[p2l1859t1356r2092b1412],
9	oz	NN	O	oz	dep	2	SENT_45	[p2l2113t1378r2153b1412],

1	AT	IN	O	at	_	0	SENT_46	[p2l98t1580r204b1649],
2	A	DT	O	a	det	4	SENT_46	[p2l231t1580r299b1649],
3	GLANCE	NN	O	glance	nn	4	SENT_46	[p2l329t1579r698b1650],
4	COMMENTARY	NN	O	commentary	pobj	1	SENT_46	[p2l731t1579r1381b1650],

1	Neuman	NNP	PERSON	Neuman	nn	2	SENT_47	[p2l103t1757r441b1821],
2	M	NNP	O	M	_	0	SENT_47	[p2l474t1757r561b1831],
3	,	,	O	,	_	0	SENT_47	[p2l474t1757r561b1831],
4	et	FW	O	et	nn	5	SENT_47	[p2l592t1757r667b1821],
5	al.	FW	O	al.	appos	2	SENT_47	[p2l694t1757r784b1821],
6	.	.	O	.	_	0	SENT_47	[p2l694t1757r784b1821],

1	Serious	JJ	O	serious	amod	4	SENT_48	[p2l104t1943r373b2009],
2	adverse	JJ	O	adverse	amod	4	SENT_48	[p2l397t1943r675b2009],
3	drug	NN	O	drug	nn	4	SENT_48	[p2l699t1943r865b2028],
4	reactions	NNS	O	reaction	nsubj	8	SENT_48	[p2l884t1943r1218b2009],
5	are	VBP	O	be	cop	8	SENT_48	[p2l1241t1964r1349b2009],
6	a	DT	O	a	det	8	SENT_48	[p2l1373t1964r1412b2009],
7	major	JJ	O	major	amod	8	SENT_48	[p2l1430t1943r1647b2028],
8	cause	NN	O	cause	_	0	SENT_48	[p2l1668t1964r1868b2009],
9	of	IN	O	of	_	0	SENT_48	[p2l1893t1943r1977b2009],
10	morbidity	NN	O	morbidity	prep_of	8	SENT_48	[p2l98t2054r464b2139],
11	and	CC	O	and	_	0	SENT_48	[p2l501t2054r633b2120],
12	mortality	NN	O	mortality	prep_of	8	SENT_48	[p2l666t2054r1007b2139],
13	worldwide	RB	O	worldwide	advmod	8	SENT_48	[p2l1041t2054r1454b2120],
14	.	.	O	.	_	0	SENT_48	[p2l1041t2054r1454b2120],

1	The	DT	O	the	det	2	SENT_49	[p2l1497t2054r1636b2120],
2	identiﬁcation	NN	O	identiﬁcation	nsubj	7	SENT_49	[p2l1675t2054r1964b2120, p2l101t2165r325b2232],
3	of	IN	O	of	_	0	SENT_49	[p2l377t2165r461b2231],
4	predisposing	VBG	O	predispose	amod	5	SENT_49	[p2l500t2165r973b2250],
5	genotypes	NNS	O	genotype	prep_of	2	SENT_49	[p2l1025t2175r1396b2250],
6	may	MD	O	may	aux	7	SENT_49	[p2l1448t2187r1608b2250],
7	improve	VB	O	improve	_	0	SENT_49	[p2l1659t2165r1965b2250],
8	patient	NN	O	patient	nn	9	SENT_49	[p2l97t2276r351b2360],
9	management	NN	O	management	dobj	7	SENT_49	[p2l387t2285r880b2360],
10	.	.	O	.	_	0	SENT_49	[p2l387t2285r880b2360],

1	Immune-mediated	JJ	O	immune-mediated	amod	4	SENT_50	[p2l923t2275r1605b2342],
2	drug	NN	O	drug	nn	4	SENT_50	[p2l1641t2275r1807b2360],
3	hypersensitivity	NN	O	hypersensitivity	nn	4	SENT_50	[p2l1844t2276r1964b2360, p2l97t2387r598b2472],
4	reactions	NNS	O	reaction	nsubj	8	SENT_50	[p2l653t2387r987b2453],
5	are	VBP	O	be	cop	8	SENT_50	[p2l1046t2409r1154b2454],
6	uncommon	JJ	O	uncommon	amod	8	SENT_50	[p2l1211t2409r1629b2454],
7	adverse	JJ	O	adverse	amod	8	SENT_50	[p2l1686t2387r1964b2454],
8	events	NNS	O	event	_	0	SENT_50	[p2l101t2507r333b2564],
9	restricted	JJ	O	restricted	amod	8	SENT_50	[p2l361t2498r707b2564],
10	to	TO	O	to	_	0	SENT_50	[p2l734t2507r803b2564],
11	a	DT	O	a	det	12	SENT_50	[p2l834t2519r872b2564],
12	subset	NN	O	subset	prep_to	9	SENT_50	[p2l903t2498r1130b2564],
13	of	IN	O	of	_	0	SENT_50	[p2l1158t2498r1242b2564],
14	vulnerable	JJ	O	vulnerable	amod	15	SENT_50	[p2l1260t2498r1649b2564],
15	patients	NNS	O	patient	prep_of	12	SENT_50	[p2l1677t2498r1964b2583],
16	and	CC	O	and	_	0	SENT_50	[p2l101t2609r232b2675],
17	pharmaceutical	JJ	O	pharmaceutical	amod	18	SENT_50	[p2l312t2609r880b2693],
18	products	NNS	O	product	conj_and	12	SENT_50	[p2l963t2609r1280b2693],
19	including	VBG	O	include	_	0	SENT_50	[p2l1366t2609r1714b2694],
20	antiepileptics	NNS	O	antiepileptic	prep_including	18	SENT_50	[p2l1799t2609r1964b2675, p2l101t2720r472b2805],
21	.	.	O	.	_	0	SENT_50	[p2l1799t2609r1964b2675, p2l101t2720r472b2805],

1	Nevertheless	RB	O	nevertheless	advmod	8	SENT_51	[p2l502t2720r1003b2801],
2	,	,	O	,	_	0	SENT_51	[p2l502t2720r1003b2801],
3	such	JJ	O	such	amod	4	SENT_51	[p2l1037t2720r1202b2787],
4	reactions	NNS	O	reaction	nsubj	10	SENT_51	[p2l1229t2720r1561b2786],
5	are	VBP	O	be	cop	8	SENT_51	[p2l1593t2742r1701b2786],
6	potentially	RB	O	potentially	advmod	8	SENT_51	[p2l1729t2730r1964b2805, p2l98t2831r290b2916],
7	life	NN	O	life	npadvmod	8	SENT_51	[p2l350t2831r470b2897],
8	threatening	JJ	O	threatening	_	0	SENT_51	[p2l531t2831r948b2916],
9	and	CC	O	and	_	0	SENT_51	[p2l1011t2831r1142b2897],
10	have	VBP	O	have	conj_and	8	SENT_51	[p2l1201t2831r1373b2897],
11	a	DT	O	a	det	13	SENT_51	[p2l1437t2853r1475b2897],
12	tremendous	JJ	O	tremendous	amod	13	SENT_51	[p2l1534t2831r1965b2897],
13	impact	NN	O	impact	dobj	10	SENT_51	[p2l100t2942r351b3027],
14	on	IN	O	on	_	0	SENT_51	[p2l428t2963r518b3008],
15	clinical	JJ	O	clinical	amod	16	SENT_51	[p2l595t2942r864b3008],
16	practice	NN	O	practice	prep_on	13	SENT_51	[p2l940t2942r1252b3027],
17	.	.	O	.	_	0	SENT_51	[p2l940t2942r1252b3027],

1	In	IN	O	in	_	0	SENT_52	[p2l1335t2945r1410b3007],
2	1998	CD	DATE	1998	prep_in	7	SENT_52	[p2l1494t2943r1664b3008],
3	alone	RB	O	alone	advmod	2	SENT_52	[p2l1745t2942r1963b3022],
4	,	,	O	,	_	0	SENT_52	[p2l1745t2942r1963b3022],
5	immune-mediated	JJ	O	immune-mediated	amod	6	SENT_52	[p2l100t3053r777b3119],
6	reactions	NNS	O	reaction	nsubj	7	SENT_52	[p2l805t3053r1138b3119],
7	accounted	VBD	O	account	_	0	SENT_52	[p2l1172t3052r1547b3119],
8	for	IN	O	for	_	0	SENT_52	[p2l1579t3053r1685b3119],
9	13,000	CD	NUMBER	13,000	number	11	SENT_52	[p2l1723t3054r1964b3132],
10	to	TO	O	to	dep	11	SENT_52	[p2l98t3172r168b3229],
11	230,000	CD	NUMBER	230,000	num	13	SENT_52	[p2l230t3164r526b3243],
12	hospital	NN	O	hospital	nn	13	SENT_52	[p2l589t3163r880b3247],
13	admissions	NNS	O	admission	prep_for	7	SENT_52	[p2l944t3163r1351b3229],
14	in	IN	O	in	_	0	SENT_52	[p2l1414t3163r1483b3228],
15	the	DT	O	the	det	17	SENT_52	[p2l1542t3163r1653b3229],
16	United	NNP	LOCATION	United	nn	17	SENT_52	[p2l1715t3163r1968b3229],
17	States	NNPS	LOCATION	States	prep_in	7	SENT_52	[p2l104t3275r338b3353],
18	,	,	O	,	_	0	SENT_52	[p2l104t3275r338b3353],
19	with	IN	O	with	_	0	SENT_52	[p2l378t3274r542b3340],
20	estimated	VBN	O	estimate	amod	22	SENT_52	[p2l579t3274r935b3340],
21	attendant	JJ	O	attendant	amod	22	SENT_52	[p2l971t3274r1309b3340],
22	costs	NNS	O	cost	prep_with	7	SENT_52	[p2l1347t3283r1527b3340],
23	of	IN	O	of	_	0	SENT_52	[p2l1567t3274r1651b3340],
24	$	$	MONEY	$	dep	27	SENT_52	[p2l1679t3271r1854b3345],
25	275	CD	MONEY	275	number	27	SENT_52	[p2l1679t3271r1854b3345],
26	to	TO	O	to	dep	27	SENT_52	[p2l1895t3283r1965b3340],
27	$	$	MONEY	$	prep_of	22	SENT_52	[p2l102t3382r280b3456],
28	600	CD	MONEY	600	number	27	SENT_52	[p2l102t3382r280b3456],
29	million	CD	MONEY	million	number	27	SENT_52	[p2l320t3384r589b3450],
30	annually	RB	SET	annually	advmod	27	SENT_52	[p2l629t3384r964b3469],
31	.	.	O	.	_	0	SENT_52	[p2l629t3384r964b3469],

1	Moreover	RB	O	moreover	advmod	4	SENT_53	[p2l1008t3387r1392b3464],
2	,	,	O	,	_	0	SENT_53	[p2l1008t3387r1392b3464],
3	it	PRP	O	it	nsubj	4	SENT_53	[p2l1435t3384r1484b3450],
4	reduced	VBD	O	reduce	_	0	SENT_53	[p2l1522t3384r1817b3450],
5	the	DT	O	the	det	8	SENT_53	[p2l1853t3384r1964b3450],
6	bound	VBN	O	bind	amod	8	SENT_53	[p2l97t3495r330b3561],
7	of	IN	O	of	prep	6	SENT_53	[p2l363t3495r447b3561],
8	trust	NN	O	trust	dobj	4	SENT_53	[p2l468t3504r633b3561],
9	between	IN	O	between	_	0	SENT_53	[p2l663t3495r973b3561],
10	the	DT	O	the	det	11	SENT_53	[p2l1004t3495r1114b3561],
11	patient	NN	O	patient	prep_between	8	SENT_53	[p2l1147t3495r1401b3580],
12	and	CC	O	and	_	0	SENT_53	[p2l1435t3495r1567b3561],
13	his	PRP$	O	he	poss	14	SENT_53	[p2l1598t3495r1703b3561],
14	physician	NN	O	physician	conj_and	11	SENT_53	[p2l1735t3495r1964b3580, p2l101t3606r269b3672],
15	.	.	O	.	_	0	SENT_53	[p2l1735t3495r1964b3580, p2l101t3606r269b3672],

1	This	DT	O	this	nsubj	2	SENT_54	[p2l321t3606r481b3672],
2	works	VBZ	O	work	_	0	SENT_54	[p2l527t3606r750b3672],
3	brings	VBZ	O	bring	ccomp	2	SENT_54	[p2l795t3606r1025b3690],
4	a	DT	O	a	det	6	SENT_54	[p2l1073t3627r1111b3672],
5	translational	JJ	O	translational	amod	6	SENT_54	[p2l1154t3606r1612b3672],
6	research	NN	O	research	dobj	3	SENT_54	[p2l1658t3606r1967b3672],
7	and	CC	O	and	_	0	SENT_54	[p2l101t3717r232b3784],
8	laboratory	NN	O	laboratory	nn	10	SENT_54	[p2l262t3717r642b3802],
9	diagnostic	JJ	O	diagnostic	amod	10	SENT_54	[p2l673t3717r1050b3802],
10	approach	NN	O	approach	dobj	3	SENT_54	[p2l1084t3717r1421b3802],
11	to	TO	O	to	_	0	SENT_54	[p2l1450t3727r1519b3783],
12	the	DT	O	the	det	14	SENT_54	[p2l1551t3717r1661b3783],
13	clinical	JJ	O	clinical	amod	14	SENT_54	[p2l1695t3717r1965b3783],
14	diagnosis	NN	O	diagnosis	prep_to	3	SENT_54	[p3l101t20r465b105],
15	.	.	O	.	_	0	SENT_54	[p3l101t20r465b105],

1	Increasing	VBG	O	increase	amod	2	SENT_55	[p3l90t272r465b356],
2	knowledge	NN	O	knowledge	nsubj	30	SENT_55	[p3l491t272r886b356],
3	about	IN	O	about	_	0	SENT_55	[p3l914t272r1113b337],
4	the	DT	O	the	det	5	SENT_55	[p3l1138t272r1247b337],
5	mechanisms	NNS	O	mechanism	prep_about	2	SENT_55	[p3l1273t272r1720b337],
6	involved	VBN	O	involve	partmod	5	SENT_55	[p3l1747t272r2060b337],
7	in	IN	O	in	_	0	SENT_55	[p3l6t383r76b447],
8	the	DT	O	the	det	9	SENT_55	[p3l91t383r200b447],
9	development	NN	O	development	prep_in	6	SENT_55	[p3l218t383r684b467],
10	of	IN	O	of	_	0	SENT_55	[p3l698t383r778b447],
11	seizures	NNS	O	seizure	prep_of	9	SENT_55	[p3l790t383r1096b459],
12	,	,	O	,	_	0	SENT_55	[p3l790t383r1096b459],
13	as	RB	O	as	_	0	SENT_55	[p3l1117t403r1186b447],
14	well	RB	O	well	_	0	SENT_55	[p3l1204t383r1359b448],
15	as	IN	O	as	_	0	SENT_55	[p3l1376t403r1447b447],
16	improved	VBN	O	improve	amod	17	SENT_55	[p3l1464t383r1810b467],
17	understanding	NN	O	understanding	prep_about	2	SENT_55	[p3l1824t383r2055b447, p3l9t494r312b578],
18	of	IN	O	of	_	0	SENT_55	[p3l361t494r441b558],
19	the	DT	O	the	det	21	SENT_55	[p3l482t494r590b558],
20	cellular	JJ	O	cellular	amod	21	SENT_55	[p3l640t494r910b558],
21	effects	NNS	O	effect	prep_of	17	SENT_55	[p3l958t494r1193b558],
22	of	IN	O	of	_	0	SENT_55	[p3l1244t494r1324b558],
23	antiepileptic	JJ	O	antiepileptic	amod	24	SENT_55	[p3l1366t494r1809b578],
24	drugs	NNS	O	drug	nn	27	SENT_55	[p3l1860t494r2056b578],
25	(	JJ	O	(	amod	27	SENT_55	[p3l9t606r270b685],
26	AED	NN	O	aed	nn	27	SENT_55	[p3l9t606r270b685],
27	)	NN	O	)	prep_of	21	SENT_55	[p3l9t606r270b685],
28	,	,	O	,	_	0	SENT_55	[p3l9t606r270b685],
29	have	VBP	O	have	aux	30	SENT_55	[p3l296t605r464b670],
30	resulted	VBN	O	result	_	0	SENT_55	[p3l486t605r773b670],
31	in	IN	O	in	_	0	SENT_55	[p3l794t605r862b669],
32	links	NNS	O	link	prep_in	30	SENT_55	[p3l884t605r1056b670],
33	between	IN	O	between	_	0	SENT_55	[p3l1079t605r1383b670],
34	demonstrated	VBN	O	demonstrate	prepc_between	32	SENT_55	[p3l1405t605r1892b670],
35	molecular	JJ	O	molecular	amod	36	SENT_55	[p3l1913t626r2055b670, p3l7t715r254b780],
36	actions	NNS	O	action	dobj	34	SENT_55	[p3l288t715r539b780],
37	of	IN	O	of	_	0	SENT_55	[p3l575t715r655b780],
38	these	DT	O	these	det	39	SENT_55	[p3l681t715r866b780],
39	drugs	NNS	O	drug	prep_of	36	SENT_55	[p3l901t715r1096b799],
40	and	CC	O	and	_	0	SENT_55	[p3l1134t715r1263b780],
41	the	DT	O	the	det	42	SENT_55	[p3l1296t715r1404b780],
42	types	NNS	O	type	conj_and	36	SENT_55	[p3l1438t725r1626b799],
43	of	IN	O	of	_	0	SENT_55	[p3l1663t715r1742b780],
44	seizures	NNS	O	seizure	prep_of	42	SENT_55	[p3l1772t715r2056b780],
45	against	IN	O	against	_	0	SENT_55	[p3l8t826r263b910],
46	which	WDT	O	which	dobj	49	SENT_55	[p3l306t826r526b891],
47	they	PRP	O	they	nsubj	49	SENT_55	[p3l569t826r721b910],
48	are	VBP	O	be	cop	49	SENT_55	[p3l767t846r874b890],
49	effective	JJ	O	effective	prepc_against	34	SENT_55	[p3l919t826r1247b891],
50	.	.	O	.	_	0	SENT_55	[p3l919t826r1247b891],

1	A	DT	O	a	det	2	SENT_56	[p3l1294t826r1359b890],
2	number	NN	O	number	nsubjpass	7	SENT_56	[p3l1401t826r1680b890],
3	of	IN	O	of	_	0	SENT_56	[p3l1722t826r1802b890],
4	AEDs	NNS	MISC	aed	prep_of	2	SENT_56	[p3l1837t826r2057b890],
5	have	VBP	O	have	aux	7	SENT_56	[p3l6t937r174b1002],
6	been	VBN	O	be	auxpass	7	SENT_56	[p3l194t937r365b1002],
7	synthesized	VBN	O	synthesize	_	0	SENT_56	[p3l389t937r826b1021],
8	,	,	O	,	_	0	SENT_56	[p3l389t937r826b1021],
9	with	IN	O	with	_	0	SENT_56	[p3l850t937r1010b1002],
10	the	DT	O	the	det	11	SENT_56	[p3l1029t937r1138b1002],
11	goal	NN	O	goal	prep_with	7	SENT_56	[p3l1158t938r1312b1021],
12	of	IN	O	of	_	0	SENT_56	[p3l1334t937r1413b1002],
13	adapting	VBG	O	adapt	prepc_of	11	SENT_56	[p3l1428t937r1737b1021],
14	synaptic	JJ	O	synaptic	amod	15	SENT_56	[p3l1761t937r2057b1021],
15	function	NN	O	function	dobj	13	SENT_56	[p3l7t1048r308b1112],
16	to	TO	O	to	aux	17	SENT_56	[p3l355t1058r422b1112],
17	regulate	VB	O	regulate	xcomp	13	SENT_56	[p3l470t1048r760b1132],
18	seizure	NN	O	seizure	nn	19	SENT_56	[p3l811t1048r1062b1112],
19	frequency	NN	O	frequency	dobj	17	SENT_56	[p3l1111t1048r1470b1132],
20	or	CC	O	or	_	0	SENT_56	[p3l1520t1068r1595b1112],
21	occurrence	NN	O	occurrence	conj_or	19	SENT_56	[p3l1641t1068r2054b1112],
22	.	.	O	.	_	0	SENT_56	[p3l1641t1068r2054b1112],

1	“	NNP	O	“	nn	3	SENT_57	[p3l16t1159r219b1224],
2	First	NNP	ORDINAL	First	nn	3	SENT_57	[p3l16t1159r219b1224],
3	generation	NN	O	generation	nsubj	6	SENT_57	[p3l315t1159r734b1243],
4	”	CD	NUMBER	”	num	5	SENT_57	[p3l315t1159r734b1243],
5	AEDs	NNS	MISC	aed	dep	3	SENT_57	[p3l837t1160r1057b1224],
6	include	VBP	O	include	_	0	SENT_57	[p3l1153t1159r1418b1224],
7	carbamazepine	NN	O	carbamazepine	nn	10	SENT_57	[p3l1515t1159r2058b1243],
8	(	CD	NUMBER	(	num	10	SENT_57	[p3l9t1271r261b1350],
9	CBZ	NN	ORGANIZATION	cbz	nn	10	SENT_57	[p3l9t1271r261b1350],
10	)	NN	O	)	dobj	6	SENT_57	[p3l9t1271r261b1350],
11	,	,	O	,	_	0	SENT_57	[p3l9t1271r261b1350],
12	phenytoin	NN	O	phenytoin	nn	15	SENT_57	[p3l297t1270r658b1354],
13	(	CD	NUMBER	(	num	15	SENT_57	[p3l695t1271r949b1350],
14	PHY	NN	O	phy	nn	15	SENT_57	[p3l695t1271r949b1350],
15	)	NN	O	)	conj_and	10	SENT_57	[p3l695t1271r949b1350],
16	,	,	O	,	_	0	SENT_57	[p3l695t1271r949b1350],
17	phenobarbital	NN	O	phenobarbital	conj_and	10	SENT_57	[p3l985t1270r1502b1354],
18	,	,	O	,	_	0	SENT_57	[p3l985t1270r1502b1354],
19	and	CC	O	and	_	0	SENT_57	[p3l1541t1270r1670b1335],
20	valporate	NN	O	valporate	conj_and	10	SENT_57	[p3l1702t1270r2055b1354],
21	,	,	O	,	_	0	SENT_57	[p3l1702t1270r2055b1354],
22	whereas	IN	O	whereas	mark	23	SENT_57	[p3l7t1381r300b1446],
23	felbamate	NN	O	felbamate	advcl	6	SENT_57	[p3l321t1381r697b1457],
24	,	,	O	,	_	0	SENT_57	[p3l321t1381r697b1457],
25	gabapentin	NN	O	gabapentin	appos	23	SENT_57	[p3l719t1381r1134b1465],
26	,	,	O	,	_	0	SENT_57	[p3l719t1381r1134b1465],
27	1amotrigine	NN	TIME	1amotrigine	nn	30	SENT_57	[p3l1156t1381r1838b1465],
28	(	CD	NUMBER	(	num	30	SENT_57	[p3l1156t1381r1838b1465],
29	LTG	NN	O	ltg	nn	30	SENT_57	[p3l1156t1381r1838b1465],
30	)	NN	O	)	appos	23	SENT_57	[p3l1156t1381r1838b1465],
31	,	,	O	,	_	0	SENT_57	[p3l1156t1381r1838b1465],
32	topiramate	NN	O	topiramate	appos	23	SENT_57	[p3l1861t1381r2055b1465, p3l8t1502r242b1569],
33	,	,	O	,	_	0	SENT_57	[p3l1861t1381r2055b1465, p3l8t1502r242b1569],
34	levitracetam	NN	O	levitracetam	appos	23	SENT_57	[p3l272t1492r735b1569],
35	,	,	O	,	_	0	SENT_57	[p3l272t1492r735b1569],
36	oxcarbazepine	NN	O	oxcarbazepine	nn	38	SENT_57	[p3l766t1492r1288b1576],
37	(	CD	NUMBER	(	num	38	SENT_57	[p3l1317t1493r1689b1573],
38	ox	NN	O	ox	appos	23	SENT_57	[p3l1317t1493r1689b1573],
39	.	.	O	.	_	0	SENT_57	[p3l1317t1493r1689b1573],

1	—	NN	O	—	_	0	SENT_58	[p3l1317t1493r1689b1573],
2	.	.	O	.	_	0	SENT_58	[p3l1317t1493r1689b1573],

1	CBZ	NN	ORGANIZATION	cbz	nn	2	SENT_59	[p3l1317t1493r1689b1573],
2	)	NN	O	)	nsubjpass	7	SENT_59	[p3l1317t1493r1689b1573],
3	,	,	O	,	_	0	SENT_59	[p3l1317t1493r1689b1573],
4	and	CC	O	and	_	0	SENT_59	[p3l1720t1492r1849b1557],
5	zonisam1de	NN	O	zonisam1de	conj_and	2	SENT_59	[p3l1875t1492r2055b1557, p3l11t1584r273b1651],
6	are	VBP	O	be	auxpass	7	SENT_59	[p3l330t1606r441b1651],
7	classiﬁed	VBN	O	classiﬁed	_	0	SENT_59	[p3l496t1584r846b1651],
8	as	IN	O	as	_	0	SENT_59	[p3l899t1606r974b1651],
9	“	NN	O	“	nn	11	SENT_59	[p3l1037t1584r1340b1651],
10	second	JJ	ORDINAL	second	amod	11	SENT_59	[p3l1037t1584r1340b1651],
11	generation	NN	O	generation	prep_as	7	SENT_59	[p3l1393t1585r1830b1671],
12	”	CD	NUMBER	”	num	13	SENT_59	[p3l1393t1585r1830b1671],
13	AEDs	NNS	MISC	aed	dep	11	SENT_59	[p3l1893t1585r2142b1651],
14	.	.	O	.	_	0	SENT_59	[p3l1893t1585r2142b1651],

1	Aromatic	JJ	MISC	aromatic	amod	2	SENT_60	[p3l8t1700r363b1767],
2	AEDs	NNS	MISC	aed	nsubj	3	SENT_60	[p3l390t1701r619b1767],
3	include	VBP	O	include	_	0	SENT_60	[p3l647t1700r923b1767],
4	CBZ	NNP	ORGANIZATION	CBZ	nn	6	SENT_60	[p3l951t1701r1153b1779],
5	,	,	O	,	_	0	SENT_60	[p3l951t1701r1153b1779],
6	PHY	NNP	O	PHY	nsubj	15	SENT_60	[p3l1183t1702r1378b1779],
7	,	,	O	,	_	0	SENT_60	[p3l1183t1702r1378b1779],
8	and	CC	O	and	_	0	SENT_60	[p3l1410t1700r1544b1767],
9	phenobarbitall	NN	O	phenobarbitall	nn	10	SENT_60	[p3l1569t1679r2140b1787],
10	CBZ	NN	ORGANIZATION	cbz	conj_and	6	SENT_60	[p3l9t1816r192b1883],
11	and	CC	O	and	_	0	SENT_60	[p3l235t1816r369b1882],
12	PHY	NN	O	phy	conj_and	10	SENT_60	[p3l410t1817r599b1881],
13	are	VBP	O	be	cop	15	SENT_60	[p3l632t1837r744b1882],
14	structurally	RB	O	structurally	advmod	15	SENT_60	[p3l790t1816r1213b1902],
15	related	JJ	O	related	ccomp	3	SENT_60	[p3l1255t1815r1513b1883],
16	to	TO	O	to	_	0	SENT_60	[p3l1553t1826r1625b1882],
17	one	CD	NUMBER	one	prep_to	15	SENT_60	[p3l1668t1837r1801b1882],
18	another	DT	O	another	dep	17	SENT_60	[p3l1846t1816r2143b1895],
19	,	,	O	,	_	0	SENT_60	[p3l1846t1816r2143b1895],
20	while	IN	O	while	mark	23	SENT_60	[p3l8t1930r216b1998],
21	LT	NN	O	lt	nn	22	SENT_60	[p3l258t1932r365b1996],
22	G	NN	O	g	nsubj	23	SENT_60	[p3l368t1931r434b1997],
23	is	VBZ	O	be	advcl	15	SENT_60	[p3l475t1930r535b1997],
24	not	RB	O	not	neg	23	SENT_60	[p3l578t1940r715b1997],
25	.	.	O	.	_	0	SENT_60	[p3l578t1940r715b1997],

1	PHY	NN	O	phy	nsubjpass	3	SENT_61	[p3l761t1932r948b1996],
2	is	VBZ	O	be	auxpass	3	SENT_61	[p3l985t1930r1044b1997],
3	para-hydroxylated	VBN	O	para-hydroxylate	_	0	SENT_61	[p3l1086t1930r1780b2017],
4	by	IN	O	by	_	0	SENT_61	[p3l1819t1930r1914b2017],
5	cytochrome	NN	O	cytochrome	nn	7	SENT_61	[p3l1956t1940r2144b2017, p3l9t2045r290b2113],
6	p45	NN	O	p45	nn	7	SENT_61	[p3l308t2045r444b2132],
7	Os	NNS	O	os	agent	3	SENT_61	[p3l452t2046r531b2113],
8	primarily	RB	O	primarily	advmod	3	SENT_61	[p3l549t2045r900b2132],
9	to	TO	O	to	_	0	SENT_61	[p3l919t2055r990b2113],
10	2	CD	NUMBER	2	num	11	SENT_61	[p3l1010t2046r1053b2111],
11	enantiomers	NNS	O	enantiomer	prep_to	3	SENT_61	[p3l1073t2045r1554b2125],
12	,	,	O	,	_	0	SENT_61	[p3l1073t2045r1554b2125],
13	and	CC	O	and	_	0	SENT_61	[p3l1577t2045r1710b2112],
14	further	RB	O	further	advmod	3	SENT_61	[p3l1728t2045r1985b2113],
15	metabolized	VBN	O	metabolize	conj_and	3	SENT_61	[p3l2000t2067r2144b2112, p3l8t2160r355b2227],
16	to	TO	O	to	_	0	SENT_61	[p3l396t2170r466b2227],
17	a	DT	O	a	det	18	SENT_61	[p3l514t2181r553b2227],
18	catechol	NN	O	catechol	prep_to	15	SENT_61	[p3l597t2160r909b2227],
19	that	WDT	O	that	nsubj	21	SENT_61	[p3l953t2160r1094b2227],
20	spontaneously	RB	O	spontaneously	advmod	21	SENT_61	[p3l1140t2160r1674b2247],
21	oxidizes	VBZ	O	oxidize	rcmod	18	SENT_61	[p3l1719t2160r2029b2227],
22	to	TO	O	to	_	0	SENT_61	[p3l2074t2170r2146b2227],
23	serniquinone	NN	O	serniquinone	nn	27	SENT_61	[p3l11t2275r490b2362],
24	and	CC	O	and	_	0	SENT_61	[p3l580t2275r714b2342],
25	quinine	NN	O	quinine	conj_and	23	SENT_61	[p3l802t2275r1082b2362],
26	species	NNS	O	species	nn	27	SENT_61	[p3l1173t2254r1557b2362],
27	.2	NN	NUMBER	.2	prep_to	21	SENT_61	[p3l1173t2254r1557b2362],
28	'	''	O	'	_	0	SENT_61	[p3l1173t2254r1557b2362],
29	4	CD	NUMBER	4	num	33	SENT_61	[p3l1173t2254r1557b2362],
30	Major	JJ	O	major	amod	33	SENT_61	[p3l1645t2275r1877b2362],
31	CBZ	NN	O	cbz	nn	33	SENT_61	[p3l1964t2275r2147b2342],
32	metabolism	NN	O	metabolism	nn	33	SENT_61	[p3l8t2390r451b2457],
33	pathways	NNS	O	pathway	nsubj	34	SENT_61	[p3l477t2390r831b2477],
34	include	VBP	O	include	dep	21	SENT_61	[p3l863t2390r1140b2457],
35	oxidation	NN	O	oxidation	dobj	34	SENT_61	[p3l1171t2390r1546b2470],
36	,	,	O	,	_	0	SENT_61	[p3l1171t2390r1546b2470],
37	hydration	NN	O	hydration	appos	35	SENT_61	[p3l1578t2390r1940b2477],
38	to	TO	O	to	aux	39	SENT_61	[p3l1968t2400r2039b2457],
39	2and	VB	O	2and	infmod	37	SENT_61	[p3l2070t2391r2144b2456, p3l10t2505r144b2572],
40	3	CD	NUMBER	3	number	41	SENT_61	[p3l185t2505r810b2592],
41	—	CD	NUMBER	—	num	42	SENT_61	[p3l185t2505r810b2592],
42	hydroxy-CBZ	NN	O	hydroxy-cbz	dobj	39	SENT_61	[p3l185t2505r810b2592],
43	,	,	O	,	_	0	SENT_61	[p3l185t2505r810b2592],
44	which	WDT	O	which	nsubj	47	SENT_61	[p3l853t2505r1083b2573],
45	can	MD	O	can	aux	47	SENT_61	[p3l1122t2526r1252b2572],
46	be	VB	O	be	cop	47	SENT_61	[p3l1289t2505r1378b2572],
47	further	JJ	O	further	rcmod	42	SENT_61	[p3l1418t2505r1675b2572],
48	oxidized	VBN	O	oxidize	partmod	47	SENT_61	[p3l1712t2505r2037b2572],
49	to	TO	O	to	_	0	SENT_61	[p3l2074t2515r2146b2572],
50	a	DT	O	a	det	51	SENT_61	[p3l10t2641r50b2687],
51	catechol	NN	O	catechol	prep_to	48	SENT_61	[p3l119t2620r431b2687],
52	or	CC	O	or	_	0	SENT_61	[p3l503t2641r581b2687],
53	an	DT	O	a	det	58	SENT_61	[p3l650t2641r737b2687],
54	iminoquinone	NN	O	iminoquinone	nn	58	SENT_61	[p3l806t2599r1441b2707],
55	.5	CD	NUMBER	.5	num	58	SENT_61	[p3l806t2599r1441b2707],
56	’	NN	O	’	nn	58	SENT_61	[p3l806t2599r1441b2707],
57	6	CD	NUMBER	6	num	58	SENT_61	[p3l806t2599r1441b2707],
58	LTG	NN	O	ltg	nsubjpass	61	SENT_61	[p3l1510t2620r1687b2687],
59	is	VBZ	O	be	auxpass	61	SENT_61	[p3l1757t2620r1816b2687],
60	largely	RB	O	largely	advmod	61	SENT_61	[p3l1887t2620r2146b2707],
61	metabolized	VBN	O	metabolize	dep	21	SENT_61	[p3l8t2735r470b2802],
62	in	IN	O	in	_	0	SENT_61	[p3l498t2735r572b2801],
63	the	DT	O	the	det	64	SENT_61	[p3l599t2735r714b2802],
64	liver	NN	O	liver	prep_in	61	SENT_61	[p3l742t2735r913b2802],
65	by	IN	O	by	_	0	SENT_61	[p3l939t2735r1033b2822],
66	glucuronic	JJ	O	glucuronic	amod	68	SENT_61	[p3l1063t2735r1462b2822],
67	acid	NN	O	acid	nn	68	SENT_61	[p3l1495t2735r1650b2803],
68	conjugation	NN	O	conjugation	agent	61	SENT_61	[p3l1679t2735r2143b2822],
69	,	,	O	,	_	0	SENT_61	[p3l1679t2735r2143b2822],
70	producing	VBG	O	produce	xcomp	61	SENT_61	[p3l7t2850r388b2937],
71	a	DT	O	a	det	74	SENT_61	[p3l410t2872r449b2917],
72	2-N-glucuronide	JJ	O	2-n-glucuronide	amod	74	SENT_61	[p3l467t2850r1094b2937],
73	conju	NN	O	conju	nn	74	SENT_61	[p3l1113t2850r1320b2937],
74	gate	NN	O	gate	dobj	70	SENT_61	[p3l1325t2860r1498b2937],
75	,	,	O	,	_	0	SENT_61	[p3l1325t2860r1498b2937],
76	which	WDT	O	which	nsubjpass	79	SENT_61	[p3l1521t2850r1751b2918],
77	can	MD	O	can	aux	79	SENT_61	[p3l1768t2872r1898b2917],
78	be	VB	O	be	auxpass	79	SENT_61	[p3l1915t2850r2005b2917],
79	hydrolyzed	VBN	O	hydrolyze	rcmod	74	SENT_61	[p3l2021t2850r2144b2937, p3l9t2965r338b3052],
80	to	TO	O	to	_	0	SENT_61	[p3l362t2975r434b3032],
81	beta	NN	O	beta	nn	83	SENT_61	[p3l459t2945r1234b3052],
82	—	CD	NUMBER	—	num	83	SENT_61	[p3l459t2945r1234b3052],
83	glucuronidase	NN	O	glucuronidase	prep_to	79	SENT_61	[p3l459t2945r1234b3052],
84	.7	CD	NUMBER	.7	num	83	SENT_61	[p3l459t2945r1234b3052],

1	Interactions	NNS	O	interaction	nsubj	5	SENT_62	[p3l95t3080r547b3147],
2	between	IN	O	between	_	0	SENT_62	[p3l576t3080r897b3148],
3	AEDs	NNS	MISC	aed	prep_between	1	SENT_62	[p3l926t3081r1156b3147],
4	are	VBP	O	be	cop	5	SENT_62	[p3l1188t3101r1300b3147],
5	important	JJ	O	important	_	0	SENT_62	[p3l1329t3080r1705b3167],
6	in	IN	O	in	_	0	SENT_62	[p3l1732t3080r1805b3146],
7	examining	VBG	O	examine	prepc_in	5	SENT_62	[p3l1833t3080r2144b3147, p3l8t3195r128b3282],
8	drug	NN	O	drug	nn	9	SENT_62	[p3l165t3195r337b3282],
9	function	NN	O	function	dobj	7	SENT_62	[p3l373t3195r693b3262],
10	and	CC	O	and	_	0	SENT_62	[p3l730t3195r866b3262],
11	metabolism	NN	O	metabolism	dobj	7	SENT_62	[p3l900t3195r1369b3262],
12	.	.	O	.	_	0	SENT_62	[p3l900t3195r1369b3262],

1	CBZ	NN	ORGANIZATION	cbz	nsubj	4	SENT_63	[p3l1410t3195r1594b3262],
2	and	CC	O	and	_	0	SENT_63	[p3l1631t3195r1767b3262],
3	PHY	NN	O	phy	conj_and	1	SENT_63	[p3l1801t3196r1991b3261],
4	decrease	VBP	O	decrease	_	0	SENT_63	[p3l2026t3195r2143b3262, p3l9t3332r247b3377],
5	the	DT	O	the	det	8	SENT_63	[p3l324t3310r438b3377],
6	half	NN	O	half	nn	8	SENT_63	[p3l515t3310r825b3377],
7	—	JJ	O	—	amod	8	SENT_63	[p3l515t3310r825b3377],
8	life	NN	O	life	dobj	4	SENT_63	[p3l515t3310r825b3377],
9	of	IN	O	of	_	0	SENT_63	[p3l903t3310r986b3377],
10	LTG	NN	ORGANIZATION	ltg	prep_of	8	SENT_63	[p3l1055t3311r1233b3378],
11	in	IN	O	in	_	0	SENT_63	[p3l1309t3310r1382b3376],
12	the	DT	O	the	det	13	SENT_63	[p3l1457t3310r1572b3377],
13	body	NN	O	body	prep_in	4	SENT_63	[p3l1648t3310r1854b3397],
14	,	,	O	,	_	0	SENT_63	[p3l1648t3310r1854b3397],
15	while	IN	O	while	mark	17	SENT_63	[p3l1934t3310r2146b3378],
16	valporate	NN	O	valporate	nsubj	17	SENT_63	[p3l8t3426r364b3513],
17	increases	VBZ	O	increase	advcl	4	SENT_63	[p3l395t3426r744b3493],
18	it	PRP	O	it	nsubj	19	SENT_63	[p3l776t3405r886b3493],
19	.8	NN	NUMBER	.8	xcomp	17	SENT_63	[p3l776t3405r886b3493],

1	Hypersensitivity	NN	O	hypersensitivity	nn	2	SENT_64	[p3l95t3541r729b3628],
2	reactions	NNS	O	reaction	nsubj	3	SENT_64	[p3l759t3541r1105b3608],
3	(	VBP	O	(	_	0	SENT_64	[p3l1140t3541r1383b3624],
4	HSR	NN	O	hsr	nn	5	SENT_64	[p3l1140t3541r1383b3624],
5	)	NN	O	)	nsubj	9	SENT_64	[p3l1140t3541r1383b3624],
6	are	VBP	O	be	cop	9	SENT_64	[p3l1418t3562r1530b3608],
7	a	DT	O	a	det	9	SENT_64	[p3l1564t3562r1604b3608],
8	common	JJ	O	common	amod	9	SENT_64	[p3l1633t3562r1968b3608],
9	feature	NN	O	feature	ccomp	3	SENT_64	[p3l1999t3541r2143b3608, p3l8t3667r155b3723],
10	of	IN	O	of	_	0	SENT_64	[p3l182t3656r266b3723],
11	anticonvulsants	NNS	O	anticonvulsant	prep_of	9	SENT_64	[p3l287t3656r903b3736],
12	,	,	O	,	_	0	SENT_64	[p3l287t3656r903b3736],
13	being	VBG	O	be	auxpass	14	SENT_64	[p3l930t3656r1142b3743],
14	noted	VBN	O	note	csubj	26	SENT_64	[p3l1170t3657r1383b3723],
15	in	IN	O	in	_	0	SENT_64	[p3l1408t3656r1481b3722],
16	30	CD	PERCENT	30	num	17	SENT_64	[p3l1509t3657r1677b3724],
17	%	NN	PERCENT	%	prep_in	14	SENT_64	[p3l1509t3657r1677b3724],
18	and	CC	O	and	_	0	SENT_64	[p3l1708t3656r1844b3723],
19	70	CD	PERCENT	70	num	20	SENT_64	[p3l1869t3657r2039b3724],
20	%	NN	PERCENT	%	prep_in	14	SENT_64	[p3l1869t3657r2039b3724],
21	of	IN	O	of	_	0	SENT_64	[p3l2070t3656r2153b3723],
22	patients	NNS	O	patient	prep_of	20	SENT_64	[p4l7t21r305b108],
23	with	IN	O	with	_	0	SENT_64	[p4l329t21r498b89],
24	drug	NN	O	drug	nn	25	SENT_64	[p4l519t21r1032b108],
25	—	NN	O	—	prep_with	22	SENT_64	[p4l519t21r1032b108],
26	induced	VBD	O	induce	conj_and	3	SENT_64	[p4l519t21r1032b108],
27	liver	NN	O	liver	nn	28	SENT_64	[p4l1053t21r1227b88],
28	injury	NN	O	injury	iobj	26	SENT_64	[p4l1245t21r1474b108],
29	(	CD	NUMBER	(	num	31	SENT_64	[p4l1498t22r1747b104],
30	DILI	NNP	O	DILI	nn	31	SENT_64	[p4l1498t22r1747b104],
31	)	NN	O	)	dobj	26	SENT_64	[p4l1498t22r1747b104],
32	caused	VBN	O	cause	partmod	31	SENT_64	[p4l1772t21r2032b88],
33	by	IN	O	by	_	0	SENT_64	[p4l2052t21r2146b108],
34	CBZ	NN	ORGANIZATION	cbz	agent	32	SENT_64	[p4l9t137r193b204],
35	and	CC	O	and	_	0	SENT_64	[p4l239t137r374b203],
36	PHY	NN	O	phy	conj_and	34	SENT_64	[p4l418t138r616b216],
37	,	,	O	,	_	0	SENT_64	[p4l418t138r616b216],
38	respectively	RB	O	respectively	advmod	40	SENT_64	[p4l662t116r1271b223],
39	.9	CD	NUMBER	.9	number	40	SENT_64	[p4l662t116r1271b223],
40	’10	CD	NUMBER	’10	rcmod	34	SENT_64	[p4l662t116r1271b223],
41	To	TO	O	to	aux	42	SENT_64	[p4l1315t138r1412b203],
42	establish	VB	O	establish	xcomp	32	SENT_64	[p4l1458t136r1793b203],
43	whether	IN	O	whether	complm	48	SENT_64	[p4l1838t136r2148b203],
44	a	DT	O	a	det	45	SENT_64	[p4l10t272r50b318],
45	drug	NN	O	drug	nsubj	48	SENT_64	[p4l75t251r247b338],
46	is	VBZ	O	be	cop	48	SENT_64	[p4l274t251r333b318],
47	the	DT	O	the	det	48	SENT_64	[p4l360t251r475b318],
48	cause	NN	O	cause	ccomp	42	SENT_64	[p4l503t272r713b318],
49	of	IN	O	of	_	0	SENT_64	[p4l741t251r824b318],
50	an	DT	O	a	det	52	SENT_64	[p4l846t272r932b318],
51	immune	JJ	O	immune	amod	52	SENT_64	[p4l957t251r1662b318],
52	—	NN	O	—	prep_of	48	SENT_64	[p4l957t251r1662b318],
53	mediated	VBN	O	mediate	partmod	52	SENT_64	[p4l957t251r1662b318],
54	reaction	NN	O	reaction	dep	53	SENT_64	[p4l1686t251r2017b330],
55	,	,	O	,	_	0	SENT_64	[p4l1686t251r2017b330],
56	alternative	JJ	O	alternative	amod	57	SENT_64	[p4l2048t251r2144b318, p4l8t366r342b433],
57	causes	NNS	O	cause	appos	54	SENT_64	[p4l370t387r640b445],
58	,	,	O	,	_	0	SENT_64	[p4l370t387r640b445],
59	latency	NN	O	latency	appos	54	SENT_64	[p4l671t366r947b453],
60	of	IN	O	of	_	0	SENT_64	[p4l976t366r1059b433],
61	a	DT	O	a	det	62	SENT_64	[p4l1081t387r1120b433],
62	reaction	NN	O	reaction	prep_of	59	SENT_64	[p4l1145t366r1457b433],
63	after	IN	O	after	_	0	SENT_64	[p4l1486t366r1661b433],
64	drug	NN	O	drug	nn	65	SENT_64	[p4l1687t366r1859b453],
65	intake	NN	O	intake	prep_after	62	SENT_64	[p4l1887t366r2142b445],
66	,	,	O	,	_	0	SENT_64	[p4l1887t366r2142b445],
67	improvement	NN	O	improvement	appos	54	SENT_64	[p4l8t481r521b568],
68	after	IN	O	after	_	0	SENT_64	[p4l584t481r759b549],
69	drug	NN	O	drug	nn	70	SENT_64	[p4l820t481r992b568],
70	cessation	NN	O	cessation	prep_after	67	SENT_64	[p4l1057t481r1428b561],
71	,	,	O	,	_	0	SENT_64	[p4l1057t481r1428b561],
72	previous	JJ	O	previous	amod	74	SENT_64	[p4l1493t481r1820b568],
73	patient	NN	O	patient	nn	74	SENT_64	[p4l1883t481r2146b568],
74	cases	NNS	O	case	appos	54	SENT_64	[p4l9t618r229b675],
75	,	,	O	,	_	0	SENT_64	[p4l9t618r229b675],
76	and	CC	O	and	_	0	SENT_64	[p4l265t596r401b663],
77	rechallenge	NN	O	rechallenge	nsubj	78	SENT_64	[p4l429t596r874b683],
78	have	VBP	O	have	conj_and	3	SENT_64	[p4l905t596r1083b663],
79	to	TO	O	to	aux	81	SENT_64	[p4l1113t606r1185b663],
80	be	VB	O	be	auxpass	81	SENT_64	[p4l1215t596r1304b663],
81	eXamined	VBN	O	examine	xcomp	78	SENT_64	[p4l1336t575r1767b663],
82	.9	IN	NUMBER	.9	prep	81	SENT_64	[p4l1336t575r1767b663],

1	CBZ	NNP	ORGANIZATION	CBZ	nn	3	SENT_65	[p4l96t711r300b790],
2	,	,	O	,	_	0	SENT_65	[p4l96t711r300b790],
3	PHY	NNP	O	PHY	nsubjpass	9	SENT_65	[p4l361t712r560b790],
4	,	,	O	,	_	0	SENT_65	[p4l361t712r560b790],
5	and	CC	O	and	_	0	SENT_65	[p4l623t711r758b778],
6	LTG	NN	O	ltg	nsubjpass	9	SENT_65	[p4l815t711r993b778],
7	have	VBP	O	have	aux	9	SENT_65	[p4l1050t711r1227b778],
8	been	VBN	O	be	auxpass	9	SENT_65	[p4l1285t711r1466b778],
9	associated	VBN	O	associate	_	0	SENT_65	[p4l1525t711r1920b778],
10	with	IN	O	with	_	0	SENT_65	[p4l1977t711r2146b778],
11	HSRs	NNS	O	hsr	prep_with	9	SENT_65	[p4l8t827r248b894],
12	.	.	O	.	_	0	SENT_65	[p4l8t827r248b894],

1	LTG	NN	O	ltg	nsubjpass	3	SENT_66	[p4l290t827r469b894],
2	was	VBD	O	be	auxpass	3	SENT_66	[p4l506t848r650b894],
3	reported	VBN	O	report	_	0	SENT_66	[p4l688t826r1011b913],
4	to	TO	O	to	aux	5	SENT_66	[p4l1047t836r1119b893],
5	produce	VB	O	produce	xcomp	3	SENT_66	[p4l1155t827r1465b913],
6	Stevens	NNP	PERSON	Stevens	dobj	5	SENT_66	[p4l1506t826r2146b894],
7	.	.	O	.	_	0	SENT_66	[p4l1506t826r2146b894],

1	—	NN	O	—	_	0	SENT_67	[p4l1506t826r2146b894],
2	.	.	O	.	_	0	SENT_67	[p4l1506t826r2146b894],

1	Johnson	NNP	PERSON	Johnson	nsubj	5	SENT_68	[p4l1506t826r2146b894],
2	syndrome	NN	O	syndrome	nn	5	SENT_68	[p4l11t941r385b1028],
3	(	CD	NUMBER	(	num	5	SENT_68	[p4l424t942r540b1024],
4	SJ	NN	O	sj	nn	5	SENT_68	[p4l424t942r540b1024],
5	S	NN	O	s	_	0	SENT_68	[p4l546t941r846b1024],
6	)	CD	NUMBER	)	dobj	19	SENT_68	[p4l546t941r846b1024],
7	/	:	O	/	punct	10	SENT_68	[p4l546t941r846b1024],
8	toxic	JJ	O	toxic	amod	10	SENT_68	[p4l546t941r846b1024],
9	epidermal	JJ	O	epidermal	amod	10	SENT_68	[p4l883t941r1266b1028],
10	necrolysis	NN	O	necrolysis	dep	6	SENT_68	[p4l1301t941r1688b1028],
11	(	CD	NUMBER	(	number	12	SENT_68	[p4l1729t942r1972b1024],
12	TEN	CD	NUMBER	ten	dep	10	SENT_68	[p4l1729t942r1972b1024],
13	)	NN	O	)	dep	12	SENT_68	[p4l1729t942r1972b1024],
14	and	CC	O	and	_	0	SENT_68	[p4l2011t941r2147b1008],
15	DILLIH3	NN	O	dillih3	dep	12	SENT_68	[p4l8t1036r388b1123],
16	Most	JJS	O	most	amod	18	SENT_68	[p4l441t1058r638b1123],
17	HSR	NN	O	hsr	nn	18	SENT_68	[p4l688t1057r873b1124],
18	cases	NNS	O	case	nsubj	19	SENT_68	[p4l924t1078r1121b1123],
19	occur	VBP	O	occur	rcmod	5	SENT_68	[p4l1175t1078r1388b1123],
20	during	IN	O	during	_	0	SENT_68	[p4l1438t1056r1686b1143],
21	the	DT	O	the	det	22	SENT_68	[p4l1737t1056r1852b1123],
22	ﬁrst	NN	O	ﬁrst	prep_during	19	SENT_68	[p4l1904t1056r2051b1123],
23	8	CD	DURATION	8	num	24	SENT_68	[p4l2105t1057r2143b1124],
24	weeks	NNS	NUMBER	week	tmod	22	SENT_68	[p4l8t1200r244b1267],
25	of	IN	O	of	_	0	SENT_68	[p4l345t1200r428b1267],
26	treatment	NN	O	treatment	prep_of	22	SENT_68	[p4l518t1179r1075b1267],
27	.14	CD	NUMBER	.14	number	28	SENT_68	[p4l518t1179r1075b1267],
28	'17	CD	NUMBER	'17	num	29	SENT_68	[p4l518t1179r1075b1267],
29	HSRs	NNS	O	hsr	nsubj	30	SENT_68	[p4l1174t1201r1393b1267],
30	refer	VBP	O	refer	rcmod	22	SENT_68	[p4l1491t1200r1675b1267],
31	to	TO	O	to	dep	5	SENT_68	[p4l1769t1210r1842b1267],
32	doseindependent	JJ	O	doseindependent	pobj	31	SENT_68	[p4l1940t1200r2144b1267, p4l8t1315r500b1402],
33	,	,	O	,	_	0	SENT_68	[p4l1940t1200r2144b1267, p4l8t1315r500b1402],

1	idiosyncratic	JJ	O	idiosyncratic	amod	3	SENT_69	[p4l547t1315r1066b1402],
2	,	,	O	,	_	0	SENT_69	[p4l547t1315r1066b1402],
3	severe	JJ	O	severe	amod	6	SENT_69	[p4l1117t1336r1355b1382],
4	adverse	JJ	O	adverse	amod	6	SENT_69	[p4l1402t1315r1692b1382],
5	drug	NN	O	drug	nn	6	SENT_69	[p4l1738t1315r1909b1402],
6	reactions	NNS	O	reaction	nsubj	7	SENT_69	[p4l1954t1336r2143b1382, p4l8t1430r191b1497],
7	(	VBP	O	(	_	0	SENT_69	[p4l231t1410r679b1514],
8	ADR	NN	O	adr	nsubj	24	SENT_69	[p4l231t1410r679b1514],
9	)	CD	NUMBER	)	num	8	SENT_69	[p4l231t1410r679b1514],
10	.18	CD	NUMBER	.18	number	11	SENT_69	[p4l231t1410r679b1514],
11	’19	CD	NUMBER	’19	dep	8	SENT_69	[p4l231t1410r679b1514],
12	Clinically	RB	O	clinically	advmod	11	SENT_69	[p4l716t1430r1110b1517],
13	,	,	O	,	_	0	SENT_69	[p4l716t1430r1110b1517],
14	a	DT	O	a	det	15	SENT_69	[p4l1150t1452r1190b1497],
15	triad	NN	O	triad	appos	8	SENT_69	[p4l1222t1430r1398b1497],
16	of	IN	O	of	_	0	SENT_69	[p4l1434t1430r1517b1497],
17	fever	NN	O	fever	nn	19	SENT_69	[p4l1543t1430r1754b1510],
18	,	,	O	,	_	0	SENT_69	[p4l1543t1430r1754b1510],
19	rash	NN	O	rash	prep_of	15	SENT_69	[p4l1791t1430r1971b1510],
20	,	,	O	,	_	0	SENT_69	[p4l1791t1430r1971b1510],
21	and	CC	O	and	_	0	SENT_69	[p4l2011t1430r2146b1497],
22	organ	NN	O	organ	nn	23	SENT_69	[p4l9t1567r226b1633],
23	involvement	NN	O	involvement	conj_and	19	SENT_69	[p4l254t1546r732b1614],
24	deﬁnes	VBZ	O	deﬁnes	ccomp	7	SENT_69	[p4l763t1546r1030b1613],
25	a	DT	O	a	det	29	SENT_69	[p4l1064t1567r1104b1613],
26	“	RB	O	“	advmod	27	SENT_69	[p4l1142t1547r1377b1613],
27	true	JJ	O	true	amod	29	SENT_69	[p4l1142t1547r1377b1613],
28	”	RB	O	”	advmod	27	SENT_69	[p4l1142t1547r1377b1613],
29	HSR	NN	O	hsr	dobj	24	SENT_69	[p4l1416t1525r1926b1613],
30	.9	CD	NUMBER	.9	number	31	SENT_69	[p4l1416t1525r1926b1613],
31	’	CD	NUMBER	’	num	29	SENT_69	[p4l1416t1525r1926b1613],
32	18	CD	NUMBER	18	num	33	SENT_69	[p4l1416t1525r1926b1613],
33	’	NN	O	’	dep	29	SENT_69	[p4l1416t1525r1926b1613],
34	20	CD	NUMBER	20	number	35	SENT_69	[p4l1416t1525r1926b1613],
35	’21	CD	NUMBER	’21	dep	33	SENT_69	[p4l1416t1525r1926b1613],

1	Skin	NN	O	skin	nn	2	SENT_70	[p4l97t1661r269b1729],
2	manifestations	NNS	O	manifestation	nsubj	3	SENT_70	[p4l289t1661r850b1728],
3	include	VBP	O	include	_	0	SENT_70	[p4l872t1661r1154b1728],
4	exanthematous	JJ	O	exanthematous	amod	5	SENT_70	[p4l1177t1661r1752b1728],
5	rash	NN	O	rash	dobj	3	SENT_70	[p4l1773t1661r1952b1740],
6	,	,	O	,	_	0	SENT_70	[p4l1773t1661r1952b1740],
7	blistering	VBG	O	blister	partmod	3	SENT_70	[p4l1976t1661r2143b1728, p4l8t1776r230b1863],
8	eruptions	NNS	O	eruption	dobj	7	SENT_70	[p4l259t1776r613b1863],
9	such	JJ	O	such	_	0	SENT_70	[p4l646t1776r817b1843],
10	as	IN	O	as	_	0	SENT_70	[p4l846t1798r919b1843],
11	erythema	NN	O	erythema	nn	12	SENT_70	[p4l949t1776r1306b1863],
12	multiforme	NN	O	multiforme	prep_such_as	8	SENT_70	[p4l1332t1776r1787b1856],
13	,	,	O	,	_	0	SENT_70	[p4l1332t1776r1787b1856],
14	SJ	NN	O	sj	nn	15	SENT_70	[p4l1820t1777r1906b1844],
15	S	NN	O	s	conj_and	12	SENT_70	[p4l1911t1777r1979b1856],
16	,	,	O	,	_	0	SENT_70	[p4l1911t1777r1979b1856],
17	and	CC	O	and	_	0	SENT_70	[p4l2011t1776r2147b1844],
18	TEN	CD	NUMBER	ten	number	19	SENT_70	[p4l8t1871r474b1959],
19	.16	CD	NUMBER	.16	num	20	SENT_70	[p4l8t1871r474b1959],
20	’	NN	O	’	prep_such_as	8	SENT_70	[p4l8t1871r474b1959],
21	22	CD	NUMBER	22	number	22	SENT_70	[p4l8t1871r474b1959],
22	’25	CD	NUMBER	’25	num	24	SENT_70	[p4l8t1871r474b1959],
23	SJ	NN	O	sj	nn	24	SENT_70	[p4l504t1893r589b1959],
24	S	NN	O	s	nsubj	28	SENT_70	[p4l595t1893r638b1959],
25	and	CC	O	and	_	0	SENT_70	[p4l669t1892r804b1959],
26	TEN	CD	NUMBER	ten	nsubj	28	SENT_70	[p4l828t1894r1014b1959],
27	are	VBP	O	be	cop	28	SENT_70	[p4l1040t1914r1153b1959],
28	severe	JJ	O	severe	rcmod	8	SENT_70	[p4l1182t1914r1420b1959],
29	cutaneous	JJ	O	cutaneous	amod	31	SENT_70	[p4l1446t1902r1827b1959],
30	adverse	JJ	O	adverse	amod	31	SENT_70	[p4l1857t1892r2146b1959],
31	reactions	NNS	O	reaction	nsubj	32	SENT_70	[p4l7t2033r352b2100],
32	(	VBP	O	(	ccomp	28	SENT_70	[p4l410t2012r913b2116],
33	SCAR	NN	O	scar	dobj	32	SENT_70	[p4l410t2012r913b2116],
34	)	CD	NUMBER	)	number	35	SENT_70	[p4l410t2012r913b2116],
35	.26	CD	NUMBER	.26	num	33	SENT_70	[p4l410t2012r913b2116],
36	"	``	O	"	punct	33	SENT_70	[p4l410t2012r913b2116],
37	34	CD	NUMBER	34	num	39	SENT_70	[p4l410t2012r913b2116],
38	Epidermal	JJ	O	epidermal	amod	39	SENT_70	[p4l964t2033r1366b2120],
39	detachment	NN	O	detachment	dep	33	SENT_70	[p4l1419t2034r1864b2100],
40	below	IN	O	below	_	0	SENT_70	[p4l1913t2033r2145b2101],
41	Tronslotionol	NNP	MISC	Tronslotionol	nn	43	SENT_70	[p4l7t2137r464b2195],
42	Reseolrch	NNP	MISC	Reseolrch	nn	43	SENT_70	[p4l496t2137r835b2195],
43	Volume	NN	MISC	volume	prep_below	39	SENT_70	[p4l7t2233r293b2292],
44	159	CD	NUMBER	159	num	43	SENT_70	[p4l328t2232r464b2296],
45	,	,	O	,	_	0	SENT_70	[p4l328t2232r464b2296],
46	Number	NNP	O	Number	appos	33	SENT_70	[p4l492t2233r788b2292],
47	5	CD	NUMBER	5	num	46	SENT_70	[p4l811t2233r851b2292],

1	10	CD	PERCENT	10	number	2	SENT_71	[p4l17t2471r178b2538],
2	%	NN	PERCENT	%	dep	4	SENT_71	[p4l17t2471r178b2538],
3	is	VBZ	O	be	auxpass	4	SENT_71	[p4l221t2470r280b2537],
4	deﬁned	VBN	O	deﬁned	_	0	SENT_71	[p4l323t2470r604b2537],
5	as	IN	O	as	_	0	SENT_71	[p4l644t2492r718b2537],
6	SJS	NN	O	sj	prep_as	4	SENT_71	[p4l761t2471r920b2550],
7	,	,	O	,	_	0	SENT_71	[p4l761t2471r920b2550],
8	whereas	IN	O	whereas	mark	11	SENT_71	[p4l963t2470r1275b2538],
9	it	PRP	O	it	nsubjpass	11	SENT_71	[p4l1315t2470r1368b2537],
10	is	VBZ	O	be	auxpass	11	SENT_71	[p4l1406t2470r1465b2537],
11	considered	VBN	O	consider	advcl	4	SENT_71	[p4l1506t2470r1923b2537],
12	TEN	CD	NUMBER	ten	dobj	11	SENT_71	[p4l1961t2472r2147b2537],
13	above	IN	O	above	_	0	SENT_71	[p4l10t2586r235b2654],
14	30	CD	PERCENT	30	num	15	SENT_71	[p4l279t2565r637b2654],
15	%	NN	PERCENT	%	prep_above	11	SENT_71	[p4l279t2565r637b2654],
16	.35	CD	NUMBER	.35	number	17	SENT_71	[p4l279t2565r637b2654],
17	’36	CD	NUMBER	’36	num	15	SENT_71	[p4l279t2565r637b2654],
18	Epidermal	JJ	O	epidermal	amod	19	SENT_71	[p4l680t2586r1081b2673],
19	detachment	NN	O	detachment	nsubjpass	4	SENT_71	[p4l1125t2586r1570b2653],
20	between	IN	O	between	_	0	SENT_71	[p4l1609t2586r1931b2653],
21	10	CD	PERCENT	10	num	22	SENT_71	[p4l1982t2586r2143b2653],
22	%	NN	PERCENT	%	prep_between	19	SENT_71	[p4l1982t2586r2143b2653],

1	and	CC	O	and	dep	3	SENT_72	[p4l10t2746r146b2813],
2	30	CD	PERCENT	30	num	3	SENT_72	[p4l234t2746r401b2813],
3	%	NN	PERCENT	%	_	0	SENT_72	[p4l234t2746r401b2813],
4	deﬁnes	NNS	O	deﬁnes	nsubjpass	14	SENT_72	[p4l493t2746r760b2813],
5	transitional	JJ	O	transitional	amod	6	SENT_72	[p4l849t2746r1281b2813],
6	SJS/TEN	NNP	O	SJS/TEN	dep	4	SENT_72	[p4l1371t2725r1910b2813],
7	.37	CD	NUMBER	.37	number	8	SENT_72	[p4l1371t2725r1910b2813],
8	’38	CD	NUMBER	’38	num	10	SENT_72	[p4l1371t2725r1910b2813],
9	The	DT	O	the	det	10	SENT_72	[p4l1998t2746r2146b2813],
10	incidence	NN	O	incidence	dep	4	SENT_72	[p4l8t2860r377b2928],
11	of	IN	O	of	_	0	SENT_72	[p4l419t2860r502b2928],
12	TEN	CD	NUMBER	ten	prep_of	10	SENT_72	[p4l536t2862r722b2928],
13	is	VBZ	O	be	auxpass	14	SENT_72	[p4l762t2860r822b2928],
14	estimated	VBN	O	estimate	rcmod	3	SENT_72	[p4l864t2860r1234b2928],
15	between	IN	O	between	prep	14	SENT_72	[p4l1272t2860r1594b2928],
16	1	CD	NUMBER	1	dep	15	SENT_72	[p4l1643t2861r1671b2927],
17	to	TO	O	to	_	0	SENT_72	[p4l1720t2871r1791b2928],
18	2	CD	NUMBER	2	num	19	SENT_72	[p4l1833t2861r1877b2927],
19	cases	NNS	O	case	prep_to	16	SENT_72	[p4l1919t2861r2149b2929],
20	/	:	O	/	punct	16	SENT_72	[p4l1919t2861r2149b2929],

1	million	CD	NUMBER	million	dep	115	SENT_73	[p4l8t2975r287b3042],
2	people/year	JJ	O	people/year	dep	115	SENT_73	[p4l344t2975r812b3062],
3	,	,	O	,	_	0	SENT_73	[p4l344t2975r812b3062],
4	with	IN	O	with	dep	115	SENT_73	[p4l874t2975r1043b3043],
5	a	DT	O	a	dep	115	SENT_73	[p4l1103t2997r1142b3042],
6	mortality	NN	O	mortality	dep	115	SENT_73	[p4l1199t2975r1553b3062],
7	rate	NN	O	rate	dep	115	SENT_73	[p4l1610t2985r1754b3042],
8	of	IN	O	of	dep	115	SENT_73	[p4l1814t2975r1896b3042],
9	30	CD	PERCENT	30	dep	115	SENT_73	[p4l1951t2976r2143b3054],
10	%	NN	PERCENT	%	dep	115	SENT_73	[p4l1951t2976r2143b3054],
11	,	,	O	,	_	0	SENT_73	[p4l1951t2976r2143b3054],
12	whereas	IN	O	whereas	dep	115	SENT_73	[p4l8t3090r321b3157],
13	there	EX	O	there	dep	115	SENT_73	[p4l362t3090r552b3157],
14	are	VBP	O	be	dep	115	SENT_73	[p4l595t3111r708b3157],
15	2	CD	NUMBER	2	dep	115	SENT_73	[p4l750t3090r794b3156],
16	to	TO	O	to	dep	115	SENT_73	[p4l833t3100r904b3157],
17	7	CD	NUMBER	7	dep	115	SENT_73	[p4l946t3091r988b3156],
18	cases/million	NN	O	cases/million	dep	115	SENT_73	[p4l1031t3090r1540b3157],
19	people/year	NN	O	people/year	dep	115	SENT_73	[p4l1579t3090r2031b3177],
20	of	IN	O	of	dep	115	SENT_73	[p4l2070t3090r2153b3157],
21	SJ	NN	O	sj	dep	115	SENT_73	[p4l10t3206r96b3272],
22	S	NN	O	s	dep	115	SENT_73	[p4l101t3206r170b3285],
23	,	,	O	,	_	0	SENT_73	[p4l101t3206r170b3285],
24	with	IN	O	with	dep	115	SENT_73	[p4l206t3205r375b3273],
25	a	DT	O	a	dep	115	SENT_73	[p4l409t3227r449b3272],
26	mortality	NN	O	mortality	dep	115	SENT_73	[p4l480t3205r833b3292],
27	rate	NN	O	rate	dep	115	SENT_73	[p4l865t3215r1008b3272],
28	of	IN	O	of	dep	115	SENT_73	[p4l1042t3205r1125b3272],
29	l	NN	PERCENT	l	dep	115	SENT_73	[p4l1161t3206r1273b3272],
30	%	NN	PERCENT	%	dep	115	SENT_73	[p4l1161t3206r1273b3272],
31	to	TO	O	to	dep	115	SENT_73	[p4l1309t3215r1381b3272],
32	3	CD	PERCENT	3	dep	115	SENT_73	[p4l1417t3184r1598b3273],
33	%	NN	PERCENT	%	dep	115	SENT_73	[p4l1417t3184r1598b3273],
34	.3	NN	NUMBER	.3	dep	115	SENT_73	[p4l1417t3184r1598b3273],
35	941	CD	NUMBER	941	dep	115	SENT_73	[p4l1604t3184r1728b3230],
36	AEDs	NNS	MISC	aed	dep	115	SENT_73	[p4l1766t3206r1997b3272],
37	are	VBP	O	be	dep	115	SENT_73	[p4l2033t3226r2146b3272],
38	among	IN	O	among	dep	115	SENT_73	[p4l10t3341r268b3407],
39	the	DT	O	the	dep	115	SENT_73	[p4l302t3320r417b3387],
40	leading	VBG	O	lead	dep	115	SENT_73	[p4l451t3320r732b3407],
41	causes	NNS	O	cause	dep	115	SENT_73	[p4l767t3341r1013b3387],
42	of	IN	O	of	dep	115	SENT_73	[p4l1049t3320r1132b3387],
43	SCAR	NN	O	scar	dep	115	SENT_73	[p4l1162t3299r1600b3399],
44	,42	CD	NUMBER	,42	dep	115	SENT_73	[p4l1162t3299r1600b3399],
45	'44	CD	NUMBER	'44	dep	115	SENT_73	[p4l1162t3299r1600b3399],
46	drug	NN	O	drug	dep	115	SENT_73	[p4l1635t3320r2147b3407],
47	—	NN	O	—	dep	115	SENT_73	[p4l1635t3320r2147b3407],
48	induced	VBD	O	induce	dep	115	SENT_73	[p4l1635t3320r2147b3407],
49	hypersensitivity	NN	O	hypersensitivity	dep	115	SENT_73	[p4l7t3435r622b3522],
50	syndrome	NN	O	syndrome	dep	115	SENT_73	[p4l667t3435r1041b3522],
51	(	CD	NUMBER	(	dep	115	SENT_73	[p4l1087t3435r1573b3522],
52	DIHS	NN	O	dih	dep	115	SENT_73	[p4l1087t3435r1573b3522],
53	)	CD	NUMBER	)	dep	115	SENT_73	[p4l1087t3435r1573b3522],
54	/	:	O	/	dep	115	SENT_73	[p4l1087t3435r1573b3522],
55	drug	NN	O	drug	dep	115	SENT_73	[p4l1087t3435r1573b3522],
56	rash	NN	O	rash	dep	115	SENT_73	[p4l1615t3435r1774b3502],
57	with	IN	O	with	dep	115	SENT_73	[p4l1816t3435r1985b3503],
58	eosinophilia	NN	O	eosinophilia	dep	115	SENT_73	[p4l2027t3457r2144b3502, p4l11t3551r389b3638],
59	and	CC	O	and	dep	115	SENT_73	[p4l453t3551r588b3618],
60	systemic	JJ	O	systemic	dep	115	SENT_73	[p4l654t3551r984b3638],
61	symptoms	NNS	O	symptom	dep	115	SENT_73	[p4l1053t3561r1443b3638],
62	(	VBP	O	(	dep	115	SENT_73	[p4l1510t3530r2146b3634],
63	DRESS	NN	O	dress	dep	115	SENT_73	[p4l1510t3530r2146b3634],
64	)	CD	NUMBER	)	dep	115	SENT_73	[p4l1510t3530r2146b3634],
65	,42	CD	NUMBER	,42	dep	115	SENT_73	[p4l1510t3530r2146b3634],
66	’	NN	O	’	dep	115	SENT_73	[p4l1510t3530r2146b3634],
67	45	CD	NUMBER	45	dep	115	SENT_73	[p4l1510t3530r2146b3634],
68	’46	CD	NUMBER	’46	dep	115	SENT_73	[p4l1510t3530r2146b3634],
69	and	CC	O	and	dep	115	SENT_73	[p4l10t3666r146b3733],
70	DILL47	NNP	O	DILL47	dep	115	SENT_73	[p4l173t3645r458b3733],
71	Interestingly	RB	O	interestingly	dep	115	SENT_73	[p4l488t3666r990b3753],
72	,	,	O	,	_	0	SENT_73	[p4l488t3666r990b3753],
73	while	IN	O	while	dep	115	SENT_73	[p4l1022t3666r1233b3733],
74	AEDs	NNS	MISC	aed	dep	115	SENT_73	[p4l1263t3666r1493b3733],
75	were	VBD	O	be	dep	115	SENT_73	[p4l1524t3687r1708b3733],
76	the	DT	O	the	dep	115	SENT_73	[p4l1737t3666r1852b3733],
77	second	JJ	ORDINAL	second	dep	115	SENT_73	[p4l1884t3666r2148b3733],
78	leading	VBG	O	lead	dep	115	SENT_73	[p5l8t21r291b108],
79	cause	NN	O	cause	dep	115	SENT_73	[p5l333t43r544b88],
80	of	IN	O	of	dep	115	SENT_73	[p5l587t21r670b88],
81	cutaneous	JJ	O	cutaneous	dep	115	SENT_73	[p5l704t31r1087b88],
82	ADRs	NNPS	MISC	ADRs	dep	115	SENT_73	[p5l1129t22r1388b101],
83	,	,	O	,	_	0	SENT_73	[p5l1129t22r1388b101],
84	CBZ	NNP	O	CBZ	dep	115	SENT_73	[p5l1432t22r1616b89],
85	(	CD	PERCENT	(	dep	115	SENT_73	[p5l1660t22r1966b104],
86	10.3	CD	PERCENT	10.3	dep	115	SENT_73	[p5l1660t22r1966b104],
87	%	NN	PERCENT	%	dep	115	SENT_73	[p5l1660t22r1966b104],
88	)	NN	O	)	dep	115	SENT_73	[p5l1660t22r1966b104],
89	and	CC	O	and	dep	115	SENT_73	[p5l2011t21r2147b88],
90	PHY	NN	O	phy	dep	115	SENT_73	[p5l8t138r198b202],
91	(	CD	PERCENT	(	dep	115	SENT_73	[p5l249t136r506b219],
92	9.6	CD	PERCENT	9.6	dep	115	SENT_73	[p5l249t136r506b219],
93	%	NN	PERCENT	%	dep	115	SENT_73	[p5l249t136r506b219],
94	)	CD	NUMBER	)	dep	115	SENT_73	[p5l249t136r506b219],
95	were	VBD	O	be	dep	115	SENT_73	[p5l558t158r742b204],
96	the	DT	O	the	dep	115	SENT_73	[p5l791t136r906b203],
97	AEDs	NNS	MISC	aed	dep	115	SENT_73	[p5l955t137r1186b203],
98	most	RBS	O	most	dep	115	SENT_73	[p5l1236t146r1423b203],
99	often	RB	O	often	dep	115	SENT_73	[p5l1471t136r1667b203],
100	implicated	VBN	O	implicate	dep	115	SENT_73	[p5l1715t136r2143b223],
101	,	,	O	,	_	0	SENT_73	[p5l1715t136r2143b223],
102	with	IN	O	with	dep	115	SENT_73	[p5l8t251r178b318],
103	CBZ	NN	O	cbz	dep	115	SENT_73	[p5l221t251r405b318],
104	the	DT	O	the	dep	115	SENT_73	[p5l446t251r561b318],
105	primary	JJ	O	primary	dep	115	SENT_73	[p5l603t251r907b338],
106	cause	NN	O	cause	dep	115	SENT_73	[p5l950t272r1161b318],
107	of	IN	O	of	dep	115	SENT_73	[p5l1205t251r1288b318],
108	SJS/TEN	NNP	O	SJS/TEN	dep	115	SENT_73	[p5l1326t251r1679b318],
109	(	CD	PERCENT	(	dep	115	SENT_73	[p5l1724t251r2030b334],
110	24.0	CD	PERCENT	24.0	dep	115	SENT_73	[p5l1724t251r2030b334],
111	%	NN	PERCENT	%	dep	115	SENT_73	[p5l1724t251r2030b334],
112	)	CD	NUMBER	)	dep	115	SENT_73	[p5l1724t251r2030b334],
113	in	IN	O	in	dep	115	SENT_73	[p5l2074t251r2147b317],
114	Malaysia	NNP	LOCATION	Malaysia	dep	115	SENT_73	[p5l8t345r456b453],
115	.48	CD	NUMBER	.48	_	0	SENT_73	[p5l8t345r456b453],

1	Genetic	JJ	O	genetic	amod	2	SENT_74	[p5l97t481r392b548],
2	markers	NNS	O	marker	nsubj	13	SENT_74	[p5l417t481r724b548],
3	such	JJ	O	such	_	0	SENT_74	[p5l752t481r923b548],
4	as	IN	O	as	_	0	SENT_74	[p5l948t502r1021b548],
5	the	DT	O	the	det	8	SENT_74	[p5l1046t481r1161b548],
6	human	JJ	O	human	amod	8	SENT_74	[p5l1184t481r1445b548],
7	leukocyte	NN	O	leukocyte	nn	8	SENT_74	[p5l1468t481r1841b568],
8	antigen	NN	O	antigen	prep_such_as	2	SENT_74	[p5l1866t481r2146b568],
9	(	CD	NUMBER	(	num	11	SENT_74	[p5l11t597r265b679],
10	HLA	NN	O	hlum	nn	11	SENT_74	[p5l11t597r265b679],
11	)	NN	O	)	dep	8	SENT_74	[p5l11t597r265b679],
12	are	VBP	O	be	cop	13	SENT_74	[p5l293t618r407b663],
13	useful	JJ	O	useful	_	0	SENT_74	[p5l430t596r663b663],
14	in	IN	O	in	_	0	SENT_74	[p5l687t596r760b663],
15	predicting	VBG	O	predict	prepc_in	13	SENT_74	[p5l782t596r1172b683],
16	an	DT	O	a	det	17	SENT_74	[p5l1198t618r1285b663],
17	individual	JJ	O	individual	poss	19	SENT_74	[p5l1307t596r1759b664],
18	’s	POS	O	’s	_	0	SENT_74	[p5l1307t596r1759b664],
19	predisposition	NN	O	predisposition	dobj	15	SENT_74	[p5l1783t596r2144b683, p5l11t711r222b778],
20	to	TO	O	to	_	0	SENT_74	[p5l252t721r324b778],
21	AED	NNP	O	AED	prep_to	15	SENT_74	[p5l357t712r791b778],
22	.	.	O	.	_	0	SENT_74	[p5l357t712r791b778],

1	—	NN	O	—	_	0	SENT_75	[p5l357t712r791b778],
2	.	.	O	.	_	0	SENT_75	[p5l357t712r791b778],

1	HSR	NN	O	hsr	_	0	SENT_76	[p5l357t712r791b778],
2	.	.	O	.	_	0	SENT_76	[p5l357t712r791b778],

1	Ever	RB	O	ever	advmod	5	SENT_77	[p5l827t713r1009b778],
2	since	IN	O	since	dep	5	SENT_77	[p5l1041t711r1233b778],
3	it	PRP	O	it	nsubj	5	SENT_77	[p5l1265t711r1319b778],
4	was	VBD	O	be	cop	5	SENT_77	[p5l1350t733r1494b778],
5	ﬁrst	JJ	O	ﬁrst	advcl	28	SENT_77	[p5l1529t711r1676b778],
6	linked	VBN	O	link	ccomp	5	SENT_77	[p5l1707t711r1947b778],
7	with	IN	O	with	_	0	SENT_77	[p5l1978t711r2147b778],
8	CBZ-SJS	NN	O	cbz-sj	prep_with	6	SENT_77	[p5l9t826r366b893],
9	in	IN	O	in	_	0	SENT_77	[p5l442t826r515b892],
10	Han	NNP	LOCATION	Han	nn	11	SENT_77	[p5l587t827r745b893],
11	Chinese	NNP	LOCATION	Chinese	prep_in	8	SENT_77	[p5l819t805r1222b905],
12	,49	CD	NUMBER	,49	num	15	SENT_77	[p5l819t805r1222b905],
13	HLA	NN	O	hlum	nn	15	SENT_77	[p5l1295t826r1491b892],
14	allele	NN	O	allele	nn	15	SENT_77	[p5l1565t826r1770b893],
15	B	NN	O	b	dep	11	SENT_77	[p5l1844t825r2146b893],
16	*	CD	NUMBER	*	number	17	SENT_77	[p5l1844t825r2146b893],
17	1502	CD	DATE	1502	dep	15	SENT_77	[p5l1844t825r2146b893],
18	(	CD	NUMBER	(	num	19	SENT_77	[p5l11t942r376b1024],
19	HLA-B	NN	O	hla-b	dep	17	SENT_77	[p5l11t942r376b1024],
20	*	CD	NUMBER	*	number	21	SENT_77	[p5l11t942r376b1024],
21	1502	CD	DATE	1502	num	22	SENT_77	[p5l393t941r603b1024],
22	)	NN	O	)	dobj	6	SENT_77	[p5l393t941r603b1024],
23	has	VBZ	O	have	aux	28	SENT_77	[p5l632t941r757b1008],
24	become	VBN	O	become	cop	28	SENT_77	[p5l784t941r1083b1008],
25	the	DT	O	the	det	28	SENT_77	[p5l1111t941r1226b1008],
26	strongest	JJS	O	strongest	amod	28	SENT_77	[p5l1256t951r1601b1028],
27	HLA	NN	O	hlum	nn	28	SENT_77	[p5l1625t942r1821b1008],
28	correlation	NN	O	correlation	dep	32	SENT_77	[p5l1848t941r2144b1008, p5l8t1056r157b1123],
29	among	IN	O	among	_	0	SENT_77	[p5l199t1078r456b1143],
30	human	JJ	O	human	amod	31	SENT_77	[p5l497t1056r759b1123],
31	diseases	NNS	O	disease	prep_among	28	SENT_77	[p5l800t1056r1112b1123],
32	(	VBP	O	(	_	0	SENT_77	[p5l1157t1057r1356b1139],
33	98	CD	PERCENT	98	num	34	SENT_77	[p5l1157t1057r1356b1139],
34	%	NN	PERCENT	%	dobj	32	SENT_77	[p5l1157t1057r1356b1139],
35	negative	JJ	O	negative	amod	37	SENT_77	[p5l1401t1056r1723b1143],
36	predictive	JJ	O	predictive	amod	37	SENT_77	[p5l1763t1056r2147b1143],
37	value	NN	O	value	nsubj	32	SENT_77	[p5l8t1171r234b1250],
38	,	,	O	,	_	0	SENT_77	[p5l8t1171r234b1250],
39	92	CD	PERCENT	92	num	40	SENT_77	[p5l288t1171r457b1239],
40	%	NN	PERCENT	%	appos	37	SENT_77	[p5l288t1171r457b1239],
41	sensitivity	NN	O	sensitivity	dep	40	SENT_77	[p5l512t1171r917b1258],
42	,	,	O	,	_	0	SENT_77	[p5l512t1171r917b1258],
43	and	CC	O	and	_	0	SENT_77	[p5l971t1171r1107b1238],
44	4.2	CD	PERCENT	4.2	num	45	SENT_77	[p5l1155t1171r1575b1239],
45	%	NN	PERCENT	%	appos	37	SENT_77	[p5l1155t1171r1575b1239],
46	.	.	O	.	_	0	SENT_77	[p5l1155t1171r1575b1239],

1	—	NN	O	—	_	0	SENT_78	[p5l1155t1171r1575b1239],
2	.	.	O	.	_	0	SENT_78	[p5l1155t1171r1575b1239],

1	l9	CD	PERCENT	l9	num	2	SENT_79	[p5l1155t1171r1575b1239],
2	%	NN	PERCENT	%	nsubj	10	SENT_79	[p5l1155t1171r1575b1239],
3	false	JJ	O	false	amod	5	SENT_79	[p5l1627t1171r1806b1238],
4	positivity	NN	O	positivity	nn	5	SENT_79	[p5l1854t1171r2144b1258, p5l8t1265r237b1373],
5	)	NN	O	)	dep	2	SENT_79	[p5l1854t1171r2144b1258, p5l8t1265r237b1373],
6	.5	CD	NUMBER	.5	num	7	SENT_79	[p5l1854t1171r2144b1258, p5l8t1265r237b1373],
7	O	NN	O	o	dep	2	SENT_79	[p5l1854t1171r2144b1258, p5l8t1265r237b1373],
8	This	DT	O	this	det	9	SENT_79	[p5l287t1286r455b1353],
9	association	NN	O	association	dep	7	SENT_79	[p5l509t1286r935b1353],
10	holds	VBZ	O	hold	_	0	SENT_79	[p5l984t1286r1189b1353],
11	true	JJ	O	true	conj_and	11	SENT_79	[p5l1241t1296r1389b1353],
12	for	IN	O	for	_	0	SENT_79	[p5l1440t1286r1551b1353],
13	certain	JJ	O	certain	amod	15	SENT_79	[p5l1601t1286r1862b1353],
14	ethnic	JJ	O	ethnic	amod	15	SENT_79	[p5l1913t1286r2145b1353],
15	groups	NNS	O	group	prep_for	11	SENT_79	[p5l9t1422r266b1488],
16	only	RB	O	only	advmod	11	SENT_79	[p5l312t1401r494b1488],
17	,	,	O	,	_	0	SENT_79	[p5l312t1401r494b1488],
18	in	IN	O	in	_	0	SENT_79	[p5l540t1401r613b1467],
19	particular	JJ	O	particular	amod	25	SENT_79	[p5l653t1401r1026b1488],
20	Han	NNP	O	Han	nn	25	SENT_79	[p5l1066t1402r1225b1468],
21	Chinese	NNP	MISC	Chinese	nn	25	SENT_79	[p5l1268t1401r1597b1480],
22	,	,	O	,	_	0	SENT_79	[p5l1268t1401r1597b1480],
23	Thai	NNP	MISC	Thai	appos	25	SENT_79	[p5l1642t1401r1837b1480],
24	,	,	O	,	_	0	SENT_79	[p5l1642t1401r1837b1480],
25	Malay	NNP	MISC	Malay	prep_in	11	SENT_79	[p5l1883t1401r2144b1488],
26	,	,	O	,	_	0	SENT_79	[p5l1883t1401r2144b1488],
27	and	CC	O	and	_	0	SENT_79	[p5l10t1516r146b1583],
28	to	TO	O	to	_	0	SENT_79	[p5l172t1526r244b1583],
29	a	DT	O	a	det	31	SENT_79	[p5l274t1538r314b1583],
30	lesser	JJR	O	lesser	amod	31	SENT_79	[p5l340t1516r559b1583],
31	degree	NN	O	degree	prep_to	11	SENT_79	[p5l585t1516r860b1603],
32	,	,	O	,	_	0	SENT_79	[p5l585t1516r860b1603],
33	Indians	NNPS	MISC	Indians	appos	31	SENT_79	[p5l890t1495r1320b1583],
34	.50	CD	NUMBER	.50	number	35	SENT_79	[p5l890t1495r1320b1583],
35	’	CD	NUMBER	’	num	37	SENT_79	[p5l890t1495r1320b1583],
36	5	CD	NUMBER	5	number	37	SENT_79	[p5l890t1495r1320b1583],
37	1	CD	NUMBER	1	dep	33	SENT_79	[p5l1332t1496r1353b1540],

1	HSR	NN	O	hsr	nn	2	SENT_80	[p5l95t1632r280b1699],
2	cases	NNS	O	case	nsubj	7	SENT_80	[p5l310t1653r508b1698],
3	accompanied	VBN	O	accompany	partmod	2	SENT_80	[p5l543t1631r1051b1718],
4	by	IN	O	by	_	0	SENT_80	[p5l1078t1631r1173b1718],
5	hepatotoxicity	NN	O	hepatotoxicity	agent	3	SENT_80	[p5l1202t1631r1755b1718],
6	are	VBP	O	be	cop	7	SENT_80	[p5l1787t1653r1901b1698],
7	fewer	JJR	O	fewer	_	0	SENT_80	[p5l1932t1631r2148b1698],
8	than	IN	O	than	_	0	SENT_80	[p5l8t1746r172b1813],
9	HSR	NN	O	hsr	nn	10	SENT_80	[p5l248t1746r433b1813],
10	cases	NNS	O	case	prep_than	7	SENT_80	[p5l509t1767r708b1813],
11	with	IN	O	with	_	0	SENT_80	[p5l785t1746r954b1813],
12	dermatologic	JJ	O	dermatologic	amod	13	SENT_80	[p5l1030t1746r1536b1833],
13	presentations	NNS	O	presentation	prep_with	10	SENT_80	[p5l1613t1746r2142b1833],
14	.	.	O	.	_	0	SENT_80	[p5l1613t1746r2142b1833],

1	DILI	NNP	ORGANIZATION	DILI	nsubj	3	SENT_81	[p5l8t1862r199b1927],
2	may	MD	O	may	aux	3	SENT_81	[p5l224t1882r387b1948],
3	lead	VB	O	lead	_	0	SENT_81	[p5l413t1861r573b1927],
4	to	TO	O	to	_	0	SENT_81	[p5l597t1871r668b1927],
5	liver	NN	O	liver	nn	6	SENT_81	[p5l695t1861r870b1928],
6	failure	NN	O	failure	prep_to	3	SENT_81	[p5l892t1861r1142b1927],
7	necessitating	VBG	O	necessitate	partmod	6	SENT_81	[p5l1168t1861r1665b1948],
8	transplantation	NN	O	transplantation	prep	7	SENT_81	[p5l1691t1861r2144b1948, p5l8t1955r341b2043],
9	.10	CD	NUMBER	.10	num	10	SENT_81	[p5l1691t1861r2144b1948, p5l8t1955r341b2043],
10	’25	CD	NUMBER	’25	dep	8	SENT_81	[p5l1691t1861r2144b1948, p5l8t1955r341b2043],

1	Regardless	RB	O	regardless	_	0	SENT_82	[p5l95t2091r515b2178],
2	of	IN	O	of	_	0	SENT_82	[p5l559t2091r641b2158],
3	ethnicity	NN	O	ethnicity	prep_regardless_of	9	SENT_82	[p5l677t2091r1028b2178],
4	,	,	O	,	_	0	SENT_82	[p5l677t2091r1028b2178],
5	HSR	NN	O	hsr	nn	6	SENT_82	[p5l1072t2091r1258b2158],
6	predisposition	NN	O	predisposition	appos	3	SENT_82	[p5l1297t2091r1844b2178],
7	can	MD	O	can	aux	9	SENT_82	[p5l1886t2112r2017b2158],
8	be	VB	O	be	auxpass	9	SENT_82	[p5l2056t2091r2146b2158],
9	predicted	VBN	O	predict	_	0	SENT_82	[p5l7t2206r367b2293],
10	by	IN	O	by	_	0	SENT_82	[p5l418t2206r513b2293],
11	the	DT	O	the	agent	9	SENT_82	[p5l566t2206r681b2273],
12	in	FW	O	in	nn	13	SENT_82	[p5l738t2208r806b2273],
13	vitro	FW	O	vitro	advmod	16	SENT_82	[p5l858t2208r1032b2274],
14	lymphocyte	NN	O	lymphocyte	nn	16	SENT_82	[p5l1086t2206r1541b2293],
15	toxicity	NN	O	toxicity	nn	16	SENT_82	[p5l1593t2206r1886b2293],
16	assay	NN	O	assay	dep	11	SENT_82	[p5l1942t2227r2146b2293],
17	(	CD	NUMBER	(	num	18	SENT_82	[p5l11t2301r425b2405],
18	LTA	NN	ORGANIZATION	lta	dep	16	SENT_82	[p5l11t2301r425b2405],
19	)	CD	NUMBER	)	number	20	SENT_82	[p5l11t2301r425b2405],
20	.52	CD	NUMBER	.52	dep	11	SENT_82	[p5l11t2301r425b2405],
21	’53	CD	NUMBER	’53	dep	20	SENT_82	[p5l11t2301r425b2405],
22	The	DT	O	the	det	24	SENT_82	[p5l522t2322r669b2389],
23	mitochondrial	JJ	O	mitochondrial	amod	24	SENT_82	[p5l762t2322r1303b2389],
24	enzyme	NN	O	enzyme	tmod	9	SENT_82	[p5l1398t2343r1694b2409],
25	succinate	JJ	O	succinate	amod	27	SENT_82	[p5l1791t2322r2146b2389],
26	dehydrogenase-based	JJ	O	dehydrogenase-based	amod	27	SENT_82	[p5l9t2437r839b2524],
27	LTA	NN	ORGANIZATION	lta	nsubjpass	29	SENT_82	[p5l894t2438r1065b2504],
28	was	VBD	O	be	auxpass	29	SENT_82	[p5l1113t2459r1257b2505],
29	validated	VBN	O	validate	rcmod	24	SENT_82	[p5l1316t2437r1667b2505],
30	vs	CC	O	vs	_	0	SENT_82	[p5l1724t2459r1805b2505],
31	clinical	JJ	O	clinical	amod	32	SENT_82	[p5l1864t2437r2146b2504],
32	manifestations	NNS	O	manifestation	tmod	9	SENT_82	[p5l8t2532r665b2620],
33	.53	CD	NUMBER	.53	num	34	SENT_82	[p5l8t2532r665b2620],
34	Neuman	NNP	PERSON	Neuman	nsubj	38	SENT_82	[p5l721t2555r1048b2620],
35	et	FW	O	et	nn	36	SENT_82	[p5l1103t2563r1171b2620],
36	al53	FW	O	al53	dep	34	SENT_82	[p5l1226t2532r1361b2620],
37	also	RB	O	also	advmod	38	SENT_82	[p5l1421t2553r1570b2620],
38	validated	VBD	O	validate	rcmod	32	SENT_82	[p5l1625t2553r1977b2620],
39	the	DT	O	the	det	42	SENT_82	[p5l2031t2553r2146b2620],
40	new	JJ	O	new	amod	42	SENT_82	[p5l8t2689r164b2735],
41	colorimetric	JJ	O	colorimetric	amod	42	SENT_82	[p5l216t2668r686b2735],
42	methodology	NN	O	methodology	dobj	38	SENT_82	[p5l739t2668r1247b2755],
43	vs	CC	O	vs	_	0	SENT_82	[p5l1299t2689r1379b2735],
44	the	DT	O	the	det	46	SENT_82	[p5l1431t2668r1547b2735],
45	previous	JJ	O	previous	amod	46	SENT_82	[p5l1597t2668r1924b2755],
46	LTA	NN	ORGANIZATION	lta	conj_vs	24	SENT_82	[p5l1977t2668r2147b2734],
47	based	VBN	O	base	partmod	46	SENT_82	[p5l7t2783r226b2849],
48	on	IN	O	on	_	0	SENT_82	[p5l268t2804r362b2849],
49	trypan	NN	O	trypan	nn	51	SENT_82	[p5l402t2793r646b2870],
50	blue	JJ	O	blue	amod	51	SENT_82	[p5l687t2783r851b2849],
51	uptake	NN	O	uptake	prep_on	47	SENT_82	[p5l892t2783r1148b2870],
52	measured	VBN	O	measure	partmod	51	SENT_82	[p5l1189t2783r1559b2849],
53	by	IN	O	by	_	0	SENT_82	[p5l1598t2783r1692b2870],
54	the	DT	O	the	det	56	SENT_82	[p5l1734t2783r1849b2849],
55	microscopic	JJ	O	microscopic	amod	56	SENT_82	[p5l1890t2783r2144b2849, p5l11t2898r251b2985],
56	counting	NN	O	counting	agent	52	SENT_82	[p5l312t2898r646b2985],
57	of	IN	O	of	_	0	SENT_82	[p5l707t2898r790b2965],
58	cells	NNS	O	cell	prep_of	56	SENT_82	[p5l843t2877r1114b2965],
59	.52	CD	NUMBER	.52	num	61	SENT_82	[p5l843t2877r1114b2965],
60	Reactive	JJ	O	reactive	amod	61	SENT_82	[p5l1173t2898r1507b2966],
61	metabolites	NNS	O	metabolite	nsubjpass	65	SENT_82	[p5l1565t2898r2009b2965],
62	of	IN	O	of	_	0	SENT_82	[p5l2070t2898r2153b2965],
63	drugs	NNS	O	drug	prep_of	61	SENT_82	[p5l9t3013r217b3100],
64	are	VBP	O	be	auxpass	65	SENT_82	[p5l258t3034r371b3080],
65	generated	VBN	O	generate	rcmod	58	SENT_82	[p5l408t3013r782b3100],
66	using	VBG	O	use	xcomp	65	SENT_82	[p5l817t3013r1023b3100],
67	murine	JJ	O	murine	amod	69	SENT_82	[p5l1060t3013r1331b3080],
68	hepatic	JJ	O	hepatic	amod	69	SENT_82	[p5l1367t3013r1643b3100],
69	microsomes	NNS	O	microsome	dobj	66	SENT_82	[p5l1681t3013r2145b3080],
70	as	IN	O	as	_	0	SENT_82	[p5l10t3149r84b3195],
71	a	DT	O	a	det	72	SENT_82	[p5l132t3149r172b3195],
72	source	NN	O	source	prep_as	66	SENT_82	[p5l218t3149r464b3195],
73	of	IN	O	of	_	0	SENT_82	[p5l510t3128r593b3195],
74	cytochrome	NN	O	cytochrome	prep_of	72	SENT_82	[p5l632t3128r1084b3215],
75	p450s	CD	NUMBER	p450s	num	74	SENT_82	[p5l1128t3107r1635b3215],
76	.16	CD	NUMBER	.16	num	77	SENT_82	[p5l1128t3107r1635b3215],
77	’	NN	O	’	dep	24	SENT_82	[p5l1128t3107r1635b3215],
78	53	CD	NUMBER	53	number	79	SENT_82	[p5l1128t3107r1635b3215],
79	’54	CD	NUMBER	’54	nsubjpass	9	SENT_82	[p5l1128t3107r1635b3215],
80	The	DT	O	the	det	81	SENT_82	[p5l1679t3128r1827b3195],
81	LTA	NN	ORGANIZATION	lta	nsubjpass	83	SENT_82	[p5l1871t3129r2042b3194],
82	is	VBZ	O	be	auxpass	83	SENT_82	[p5l2085t3128r2145b3195],
83	based	VBN	O	base	rcmod	79	SENT_82	[p5l7t3243r226b3310],
84	on	IN	O	on	_	0	SENT_82	[p5l295t3264r387b3310],
85	the	DT	O	the	det	86	SENT_82	[p5l454t3243r569b3310],
86	hypothesis	NN	O	hypothesis	prep_on	83	SENT_82	[p5l638t3243r1046b3330],
87	that	IN	O	that	complm	92	SENT_82	[p5l1116t3243r1261b3310],
88	human	JJ	O	human	amod	89	SENT_82	[p5l1327t3243r1588b3310],
89	lymphocytes	NNS	O	lymphocyte	nsubj	92	SENT_82	[p5l1656t3243r2145b3330],
90	in	FW	O	in	nn	91	SENT_82	[p5l11t3362r80b3427],
91	vitro	FW	O	vitro	advmod	92	SENT_82	[p5l156t3362r331b3428],
92	mimic	VBP	O	mimic	ccomp	83	SENT_82	[p5l410t3359r654b3427],
93	functional	JJ	O	functional	amod	94	SENT_82	[p5l734t3359r1124b3427],
94	cells	NNS	O	cell	dobj	92	SENT_82	[p5l1203t3359r1376b3427],
95	in	FW	O	in	nn	96	SENT_82	[p5l1459t3362r1527b3427],
96	vivo	FW	O	vivo	advmod	92	SENT_82	[p5l1604t3362r1782b3428],
97	.	.	O	.	_	0	SENT_82	[p5l1604t3362r1782b3428],

1	Human	JJ	O	human	amod	2	SENT_83	[p5l1865t3361r2146b3427],
2	lymphocytes	NNS	O	lymphocyte	nsubjpass	10	SENT_83	[p5l8t3474r499b3561],
3	from	IN	O	from	_	0	SENT_83	[p5l540t3474r726b3541],
4	patients	NNS	O	patient	prep_from	2	SENT_83	[p5l764t3474r1062b3561],
5	with	IN	O	with	_	0	SENT_83	[p5l1104t3474r1273b3541],
6	a	DT	O	a	det	8	SENT_83	[p5l1315t3496r1355b3541],
7	suspected	VBN	O	suspect	amod	8	SENT_83	[p5l1396t3474r1767b3561],
8	HSR	NN	O	hsr	prep_with	4	SENT_83	[p5l1807t3475r1992b3542],
9	are	VBP	O	be	auxpass	10	SENT_83	[p5l2033t3496r2146b3541],
10	used	VBN	O	use	_	0	SENT_83	[p5l7t3589r183b3656],
11	as	IN	O	as	_	0	SENT_83	[p5l263t3610r337b3656],
12	surrogate	JJ	O	surrogate	amod	14	SENT_83	[p5l420t3599r774b3676],
13	target	NN	O	target	nn	14	SENT_83	[p5l853t3599r1072b3676],
14	cells	NNS	O	cell	prep_as	10	SENT_83	[p5l1150t3589r1322b3656],
15	for	IN	O	for	_	0	SENT_83	[p5l1403t3589r1514b3656],
16	safe	JJ	O	safe	dep	14	SENT_83	[p5l1594t3589r1743b3656],
17	in	FW	O	in	nn	18	SENT_83	[p5l1825t3591r1894b3656],
18	vitro	FW	O	vitro	dep	16	SENT_83	[p5l1971t3591r2145b3657],
19	rechallenge	NN	O	rechallenge	prep_for	14	SENT_83	[p5l7t3704r473b3791],
20	.	.	O	.	_	0	SENT_83	[p5l7t3704r473b3791],

1	Lymphocytes	NNS	O	lymphocyte	nsubj	3	SENT_84	[p5l512t3704r1029b3791],
2	are	VBP	O	be	cop	3	SENT_84	[p5l1068t3725r1181b3770],
3	suitable	JJ	O	suitable	_	0	SENT_84	[p5l1220t3703r1515b3770],
4	as	IN	O	as	mark	6	SENT_84	[p5l1552t3725r1626b3770],
5	they	PRP	O	they	nsubj	6	SENT_84	[p5l1663t3704r1826b3791],
6	possess	VBP	O	possess	ccomp	3	SENT_84	[p5l1859t3725r2145b3791],
7	the	DT	O	the	det	8	SENT_84	[p6l8t21r123b88],
8	patient	NN	O	patient	poss	10	SENT_84	[p6l227t21r553b108],
9	’s	POS	O	’s	_	0	SENT_84	[p6l227t21r553b108],
10	phenotype	NN	O	phenotype	dobj	6	SENT_84	[p6l657t21r1080b108],
11	,	,	O	,	_	0	SENT_84	[p6l657t21r1080b108],
12	particularly	RB	O	particularly	advmod	13	SENT_84	[p6l1186t21r1632b108],
13	expressing	VBG	O	express	partmod	6	SENT_84	[p6l1737t21r2145b108],
14	phenotypic	JJ	O	phenotypic	amod	16	SENT_84	[p6l7t136r434b223],
15	individual	JJ	O	individual	amod	16	SENT_84	[p6l606t136r995b203],
16	variability	NN	O	variability	dobj	13	SENT_84	[p6l1165t136r1559b223],
17	in	IN	O	in	_	0	SENT_84	[p6l1730t136r1803b202],
18	drug	NN	O	drug	nn	20	SENT_84	[p6l1974t136r2145b223],
19	detoxiﬁcation	NN	O	detoxiﬁcation	nn	20	SENT_84	[p6l9t251r539b318],
20	enzymes	NNS	O	enzyme	prep_in	13	SENT_84	[p6l581t273r915b338],
21	such	JJ	O	such	_	0	SENT_84	[p6l962t251r1133b318],
22	as	IN	O	as	_	0	SENT_84	[p6l1177t273r1250b318],
23	epoxide	NN	O	epoxide	nn	24	SENT_84	[p6l1294t251r1597b338],
24	hydroxylases	NNS	O	hydroxylase	prep_such_as	20	SENT_84	[p6l1639t251r2145b338],
25	and	CC	O	and	_	0	SENT_84	[p6l10t366r146b433],
26	glutathione	NN	O	glutathione	nn	28	SENT_84	[p6l180t366r611b453],
27	S	NN	O	s	nn	28	SENT_84	[p6l648t366r692b433],
28	transferases	NNS	O	transferase	prep_such_as	20	SENT_84	[p6l729t366r1202b433],
29	.	.	O	.	_	0	SENT_84	[p6l729t366r1202b433],

1	The	DT	O	the	det	2	SENT_85	[p6l1240t366r1388b433],
2	LTA	NNP	ORGANIZATION	LTA	nsubjpass	4	SENT_85	[p6l1421t367r1591b432],
3	was	VBD	O	be	auxpass	4	SENT_85	[p6l1616t387r1760b433],
4	validated	VBN	O	validate	_	0	SENT_85	[p6l1795t366r2148b433],
5	for	IN	O	for	_	0	SENT_85	[p6l8t481r120b547],
6	AEDs	NNS	MISC	aed	prep_for	4	SENT_85	[p6l209t481r439b547],
7	such	JJ	O	such	_	0	SENT_85	[p6l536t481r708b547],
8	as	IN	O	as	_	0	SENT_85	[p6l800t502r874b547],
9	CBZ	NN	ORGANIZATION	cbz	prep_such_as	6	SENT_85	[p6l968t481r1172b560],
10	,	,	O	,	_	0	SENT_85	[p6l968t481r1172b560],
11	PHY	NN	O	phy	prep_such_as	6	SENT_85	[p6l1266t482r1464b560],
12	,	,	O	,	_	0	SENT_85	[p6l1266t482r1464b560],
13	valproic	JJ	O	valproic	amod	14	SENT_85	[p6l1559t480r1871b568],
14	acid	NN	O	acid	prep_such_as	6	SENT_85	[p6l1965t481r2143b560],
15	,	,	O	,	_	0	SENT_85	[p6l1965t481r2143b560],
16	zonisomide	NN	O	zonisomide	prep_such_as	6	SENT_85	[p6l9t596r473b676],
17	,	,	O	,	_	0	SENT_85	[p6l9t596r473b676],
18	and	CC	O	and	_	0	SENT_85	[p6l509t596r644b663],
19	phenobarbital	JJ	O	phenobarbital	amod	21	SENT_85	[p6l672t575r1388b683],
20	.25	CD	NUMBER	.25	number	21	SENT_85	[p6l672t575r1388b683],
21	’53	CD	NUMBER	’53	prep_such_as	6	SENT_85	[p6l672t575r1388b683],

1	The	DT	O	the	det	2	SENT_86	[p6l95t711r243b778],
2	HSR	NN	O	hsr	nsubj	7	SENT_86	[p6l273t711r459b778],
3	is	VBZ	O	be	cop	7	SENT_86	[p6l487t711r547b778],
4	a	DT	O	a	det	7	SENT_86	[p6l581t732r621b778],
5	complex	JJ	O	complex	amod	7	SENT_86	[p6l650t711r980b798],
6	clinical	JJ	O	clinical	amod	7	SENT_86	[p6l1010t711r1293b778],
7	manifestation	NN	O	manifestation	_	0	SENT_86	[p6l1323t711r1869b790],
8	,	,	O	,	_	0	SENT_86	[p6l1323t711r1869b790],
9	whose	WP$	O	whose	poss	10	SENT_86	[p6l1903t711r2146b778],
10	diagnosis	NN	O	diagnosis	nsubj	11	SENT_86	[p6l9t826r369b913],
11	rests	VBZ	O	rest	rcmod	7	SENT_86	[p6l420t836r594b892],
12	mainly	RB	O	mainly	advmod	11	SENT_86	[p6l646t826r913b913],
13	on	IN	O	on	_	0	SENT_86	[p6l965t847r1059b892],
14	clinical	JJ	O	clinical	amod	15	SENT_86	[p6l1110t825r1392b892],
15	data	NNS	O	datum	prep_on	11	SENT_86	[p6l1444t826r1622b892],
16	.	.	O	.	_	0	SENT_86	[p6l1444t826r1622b892],

1	We	PRP	O	we	nsubj	2	SENT_87	[p6l1677t827r1802b893],
2	demonstrated	VBD	O	demonstrate	_	0	SENT_87	[p6l1854t826r2144b892, p6l11t941r265b1008],
3	that	IN	O	that	complm	6	SENT_87	[p6l301t941r445b1008],
4	predisposed	VBN	O	predispose	csubj	6	SENT_87	[p6l480t941r941b1028],
5	individuals	NNS	O	individual	dobj	4	SENT_87	[p6l977t941r1401b1009],
6	have	VBP	O	have	ccomp	2	SENT_87	[p6l1439t941r1618b1008],
7	lymphocytes	NNS	O	lymphocyte	dobj	6	SENT_87	[p6l1656t941r2145b1028],
8	that	WDT	O	that	nsubj	9	SENT_87	[p6l8t1056r152b1123],
9	show	VBP	O	show	rcmod	7	SENT_87	[p6l200t1056r395b1123],
10	cytotoxicity	NN	O	cytotoxicity	dobj	9	SENT_87	[p6l441t1056r900b1143],
11	when	WRB	O	when	advmod	12	SENT_87	[p6l947t1056r1154b1123],
12	exposed	VBN	O	expose	advcl	9	SENT_87	[p6l1199t1056r1513b1143],
13	to	TO	O	to	_	0	SENT_87	[p6l1557t1066r1629b1123],
14	the	DT	O	the	det	15	SENT_87	[p6l1675t1056r1790b1123],
15	incrimiNeumoln	NN	O	incrimineumoln	prep_to	12	SENT_87	[p6l1837t1056r2144b1123, p6l1405t1175r1720b1233],
16	e	SYM	O	e	dep	18	SENT_87	[p6l1749t1175r1821b1233],
17	’	CD	NUMBER	’	num	18	SENT_87	[p6l1749t1175r1821b1233],
18	r	NN	O	r	dep	19	SENT_87	[p6l1749t1175r1821b1233],
19	ol	NN	O	ol	dep	15	SENT_87	[p6l1846t1175r1907b1233],
20	399	CD	NUMBER	399	num	19	SENT_87	[p6l2019t1174r2147b1234],

1	nated	VBN	O	nate	_	0	SENT_88	[p6l8t1409r216b1475],
2	drug	NN	O	drug	dep	4	SENT_88	[p6l248t1409r420b1496],
3	in	FW	O	in	nn	4	SENT_88	[p6l456t1411r524b1476],
4	vitro	FW	O	vitro	advmod	1	SENT_88	[p6l554t1411r749b1476],
5	.	.	O	.	_	0	SENT_88	[p6l554t1411r749b1476],

1	The	DT	O	the	det	2	SENT_89	[p6l785t1409r932b1475],
2	LTA	NN	ORGANIZATION	lta	nsubj	3	SENT_89	[p6l964t1409r1134b1475],
3	remains	VBZ	O	remain	_	0	SENT_89	[p6l1163t1409r1467b1475],
4	a	DT	O	a	det	6	SENT_89	[p6l1502t1430r1542b1475],
5	diagnostic	JJ	O	diagnostic	amod	6	SENT_89	[p6l1573t1409r1966b1496],
6	tool	NN	O	tool	nsubj	7	SENT_89	[p6l1999t1409r2146b1475],
7	applied	VBD	O	apply	ccomp	3	SENT_89	[p6l10t1524r292b1611],
8	successfully	RB	O	successfully	advmod	7	SENT_89	[p6l333t1524r799b1611],
9	in	IN	O	in	_	0	SENT_89	[p6l839t1524r911b1590],
10	AED-HSR	NN	O	aed-hsr	prep_in	7	SENT_89	[p6l949t1525r1364b1592],
11	in	IN	O	in	_	0	SENT_89	[p6l1402t1524r1475b1590],
12	individuals	NNS	O	individual	prep_in	10	SENT_89	[p6l1513t1524r1937b1592],
13	with	IN	O	with	_	0	SENT_89	[p6l1978t1524r2147b1592],
14	different	JJ	O	different	amod	16	SENT_89	[p6l9t1639r339b1706],
15	ethnic	JJ	O	ethnic	amod	16	SENT_89	[p6l368t1639r600b1706],
16	backgrounds	NNS	O	background	prep_with	7	SENT_89	[p6l630t1639r1143b1726],
17	,	,	O	,	_	0	SENT_89	[p6l630t1639r1143b1726],
18	which	WDT	O	which	nsubj	21	SENT_89	[p6l1176t1639r1409b1706],
19	has	VBZ	O	have	aux	21	SENT_89	[p6l1437t1639r1562b1706],
20	never	RB	O	never	neg	21	SENT_89	[p6l1594t1660r1806b1706],
21	been	VBN	O	be	rcmod	16	SENT_89	[p6l1831t1639r2013b1706],
22	directly	RB	O	directly	advmod	21	SENT_89	[p6l2043t1639r2144b1706, p6l7t1754r226b1841],
23	compared	VBN	O	compare	_	0	SENT_89	[p6l258t1754r637b1841],
24	to	TO	O	to	prepc_compared_to	21	SENT_89	[p6l667t1764r738b1820],
25	results	NNS	O	result	pobj	21	SENT_89	[p6l768t1754r1017b1820],
26	of	IN	O	of	_	0	SENT_89	[p6l1050t1754r1133b1820],
27	HLA	NN	O	hlum	nn	28	SENT_89	[p6l1156t1754r1352b1820],
28	genotyping	NN	O	genotyping	prep_of	25	SENT_89	[p6l1383t1754r1834b1841],
29	.	.	O	.	_	0	SENT_89	[p6l1383t1754r1834b1841],

1	Oxidative	JJ	O	oxidative	dep	158	SENT_90	[p6l97t1869r478b1937],
2	cell	NN	O	cell	dep	158	SENT_90	[p6l516t1869r655b1936],
3	damage	NN	O	damage	dep	158	SENT_90	[p6l693t1869r995b1956],
4	caused	VBN	O	cause	dep	158	SENT_90	[p6l1032t1869r1298b1936],
5	by	IN	O	by	dep	158	SENT_90	[p6l1332t1869r1427b1956],
6	the	DT	O	the	dep	158	SENT_90	[p6l1464t1869r1581b1936],
7	generation	NN	O	generation	dep	158	SENT_90	[p6l1618t1869r2032b1956],
8	of	IN	O	of	dep	158	SENT_90	[p6l2070t1869r2153b1936],
9	reactive	JJ	O	reactive	dep	158	SENT_90	[p6l7t1984r317b2051],
10	drug	NN	O	drug	dep	158	SENT_90	[p6l369t1984r544b2071],
11	species	NNS	O	species	dep	158	SENT_90	[p6l600t1984r877b2071],
12	may	MD	O	may	dep	158	SENT_90	[p6l930t2005r1096b2071],
13	also	RB	O	also	dep	158	SENT_90	[p6l1149t1984r1302b2051],
14	cause	VB	O	cause	dep	158	SENT_90	[p6l1355t2005r1569b2051],
15	or	CC	O	or	dep	158	SENT_90	[p6l1622t2005r1701b2051],
16	contribute	VB	O	contribute	dep	158	SENT_90	[p6l1751t1984r2147b2051],
17	to	TO	O	to	dep	158	SENT_90	[p6l8t2109r81b2166],
18	the	DT	O	the	dep	158	SENT_90	[p6l114t2099r231b2166],
19	release	NN	O	release	dep	158	SENT_90	[p6l263t2099r536b2166],
20	of	IN	O	of	dep	158	SENT_90	[p6l570t2099r654b2166],
21	cytokines	NNS	O	cytokine	dep	158	SENT_90	[p6l681t2099r1052b2186],
22	that	WDT	O	that	dep	158	SENT_90	[p6l1086t2099r1233b2166],
23	warn	VBP	O	warn	dep	158	SENT_90	[p6l1265t2121r1457b2167],
24	the	DT	O	the	dep	158	SENT_90	[p6l1489t2099r1606b2166],
25	immune	JJ	O	immune	dep	158	SENT_90	[p6l1639t2099r1958b2166],
26	system	NN	O	system	dep	158	SENT_90	[p6l1995t2121r2143b2186, p6l8t2225r155b2282],
27	of	IN	O	of	dep	158	SENT_90	[p6l219t2215r302b2282],
28	cellular	JJ	O	cellular	dep	158	SENT_90	[p6l361t2215r658b2282],
29	stress	NN	O	stress	dep	158	SENT_90	[p6l724t2225r934b2282],
30	and	CC	O	and	dep	158	SENT_90	[p6l1003t2215r1140b2282],
31	damage	NN	O	damage	dep	158	SENT_90	[p6l1205t2193r1792b2302],
32	.16	CD	NUMBER	.16	dep	158	SENT_90	[p6l1205t2193r1792b2302],
33	’	CD	NUMBER	’	dep	158	SENT_90	[p6l1205t2193r1792b2302],
34	55	CD	NUMBER	55	dep	158	SENT_90	[p6l1205t2193r1792b2302],
35	’56	CD	NUMBER	’56	dep	158	SENT_90	[p6l1205t2193r1792b2302],
36	Several	JJ	O	several	dep	158	SENT_90	[p6l1859t2215r2146b2282],
37	signals	NNS	O	signal	dep	158	SENT_90	[p6l12t2330r278b2417],
38	may	MD	O	may	dep	158	SENT_90	[p6l321t2352r486b2417],
39	occur	VB	O	occur	dep	158	SENT_90	[p6l529t2352r746b2397],
40	in	IN	O	in	dep	158	SENT_90	[p6l785t2330r860b2397],
41	a	DT	O	a	dep	158	SENT_90	[p6l901t2352r941b2397],
42	variety	NN	O	variety	dep	158	SENT_90	[p6l980t2330r1250b2417],
43	of	IN	O	of	dep	158	SENT_90	[p6l1293t2330r1377b2397],
44	settings	NNS	O	setting	dep	158	SENT_90	[p6l1414t2330r1732b2417],
45	,	,	O	,	_	0	SENT_90	[p6l1414t2330r1732b2417],
46	including	VBG	O	include	dep	158	SENT_90	[p6l1776t2330r2146b2417],
47	infection	NN	O	infection	dep	158	SENT_90	[p6l8t2445r359b2512],
48	and	CC	O	and	dep	158	SENT_90	[p6l447t2445r585b2512],
49	surgery	NN	O	surgery	dep	158	SENT_90	[p6l674t2467r977b2532],
50	,	,	O	,	_	0	SENT_90	[p6l674t2467r977b2532],
51	where	WRB	O	where	dep	158	SENT_90	[p6l1069t2445r1305b2513],
52	they	PRP	O	they	dep	158	SENT_90	[p6l1392t2445r1557b2532],
53	promote	VBP	O	promote	dep	158	SENT_90	[p6l1644t2455r1970b2532],
54	an	DT	O	a	dep	158	SENT_90	[p6l2059t2467r2148b2512],
55	immune	JJ	O	immune	dep	158	SENT_90	[p6l9t2560r327b2627],
56	response	NN	O	response	dep	158	SENT_90	[p6l410t2581r752b2647],
57	to	TO	O	to	dep	158	SENT_90	[p6l835t2570r908b2627],
58	eliminate	VB	O	eliminate	dep	158	SENT_90	[p6l993t2560r1358b2627],
59	these	DT	O	these	dep	158	SENT_90	[p6l1442t2560r1641b2627],
60	potentially	RB	O	potentially	dep	158	SENT_90	[p6l1724t2560r2146b2647],
61	dangerous	JJ	O	dangerous	dep	158	SENT_90	[p6l10t2676r409b2763],
62	calls	NNS	O	call	dep	158	SENT_90	[p6l435t2654r710b2742],
63	.57	CD	NUMBER	.57	dep	158	SENT_90	[p6l435t2654r710b2742],
64	T-cell-dependent	JJ	O	t-cell-dependent	dep	158	SENT_90	[p6l735t2675r1403b2762],
65	immune	JJ	O	immune	dep	158	SENT_90	[p6l1424t2675r1743b2742],
66	responses	NNS	O	response	dep	158	SENT_90	[p6l1766t2697r2145b2762],
67	encompass	VBP	O	encompass	dep	158	SENT_90	[p6l9t2812r436b2877],
68	the	DT	O	the	dep	158	SENT_90	[p6l468t2790r585b2857],
69	type	NN	O	type	dep	158	SENT_90	[p6l617t2800r783b2877],
70	1	CD	NUMBER	1	dep	158	SENT_90	[p6l824t2791r852b2856],
71	T	NN	O	t	dep	158	SENT_90	[p6l891t2790r1221b2877],
72	—	CD	NUMBER	—	dep	158	SENT_90	[p6l891t2790r1221b2877],
73	helper	NN	O	helper	dep	158	SENT_90	[p6l891t2790r1221b2877],
74	response	NN	O	response	dep	158	SENT_90	[p6l1250t2812r1592b2877],
75	(	CD	NUMBER	(	dep	158	SENT_90	[p6l1627t2790r1842b2873],
76	Thl	NNP	O	Thl	dep	158	SENT_90	[p6l1627t2790r1842b2873],
77	)	NN	O	)	dep	158	SENT_90	[p6l1627t2790r1842b2873],
78	associated	VBN	O	associate	dep	158	SENT_90	[p6l1877t2790r2144b2857, p6l11t2905r171b2972],
79	with	IN	O	with	dep	158	SENT_90	[p6l232t2905r404b2972],
80	regulation	NN	O	regulation	dep	158	SENT_90	[p6l463t2905r862b2992],
81	of	IN	O	of	dep	158	SENT_90	[p6l924t2905r1008b2972],
82	cell-mediated	JJ	O	cell-mediated	dep	158	SENT_90	[p6l1063t2905r1600b2972],
83	immune	JJ	O	immune	dep	158	SENT_90	[p6l1660t2905r1979b2972],
84	responses	NNS	O	response	dep	158	SENT_90	[p6l2039t2926r2144b2972, p6l12t3041r332b3107],
85	,	,	O	,	_	0	SENT_90	[p6l2039t2926r2144b2972, p6l12t3041r332b3107],
86	or	CC	O	or	dep	158	SENT_90	[p6l371t3041r451b3087],
87	the	DT	O	the	dep	158	SENT_90	[p6l483t3020r600b3087],
88	type	NN	O	type	dep	158	SENT_90	[p6l634t3030r801b3107],
89	2	CD	NUMBER	2	dep	158	SENT_90	[p6l837t3020r880b3086],
90	T	NN	O	t	dep	158	SENT_90	[p6l915t3020r1246b3107],
91	—	CD	NUMBER	—	dep	158	SENT_90	[p6l915t3020r1246b3107],
92	helper	NN	O	helper	dep	158	SENT_90	[p6l915t3020r1246b3107],
93	response	NN	O	response	dep	158	SENT_90	[p6l1277t3041r1619b3107],
94	(	CD	NUMBER	(	dep	158	SENT_90	[p6l1657t3020r1872b3103],
95	Th2	NN	O	th2	dep	158	SENT_90	[p6l1657t3020r1872b3103],
96	)	NN	O	)	dep	158	SENT_90	[p6l1657t3020r1872b3103],
97	which	WDT	O	which	dep	158	SENT_90	[p6l1910t3020r2147b3087],
98	plays	VBZ	O	play	dep	158	SENT_90	[p6l8t3135r212b3222],
99	an	DT	O	a	dep	158	SENT_90	[p6l286t3156r373b3202],
100	important	JJ	O	important	dep	158	SENT_90	[p6l443t3135r826b3222],
101	role	NN	O	role	dep	158	SENT_90	[p6l894t3135r1045b3202],
102	in	IN	O	in	dep	158	SENT_90	[p6l1116t3135r1190b3201],
103	antibody	NN	O	antibody	dep	158	SENT_90	[p6l1262t3135r1601b3222],
104	or	CC	O	or	dep	158	SENT_90	[p6l1674t3156r1752b3202],
105	humoral	JJ	O	humoral	dep	158	SENT_90	[p6l1821t3135r2146b3202],
106	immune	JJ	O	immune	dep	158	SENT_90	[p6l9t3250r328b3316],
107	responses	NNS	O	response	dep	158	SENT_90	[p6l383t3228r861b3337],
108	.57	CD	NUMBER	.57	dep	158	SENT_90	[p6l383t3228r861b3337],
109	Cytokines	NNS	O	cytokine	dep	158	SENT_90	[p6l920t3249r1314b3336],
110	play	VBP	O	play	dep	158	SENT_90	[p6l1371t3249r1539b3336],
111	a	DT	O	a	dep	158	SENT_90	[p6l1597t3271r1637b3316],
112	role	NN	O	role	dep	158	SENT_90	[p6l1690t3249r1842b3316],
113	in	IN	O	in	dep	158	SENT_90	[p6l1899t3249r1973b3315],
114	the	DT	O	the	dep	158	SENT_90	[p6l2029t3249r2146b3316],
115	immunopathologic	JJ	O	immunopathologic	dep	158	SENT_90	[p6l8t3365r749b3452],
116	and	CC	O	and	dep	158	SENT_90	[p6l828t3365r966b3432],
117	molecular	JJ	O	molecular	dep	158	SENT_90	[p6l1040t3365r1435b3432],
118	mechanisms	NNS	O	mechanism	dep	158	SENT_90	[p6l1508t3365r1991b3432],
119	of	IN	O	of	dep	158	SENT_90	[p6l2069t3365r2153b3432],
120	drug	NN	O	drug	dep	158	SENT_90	[p6l9t3480r533b3567],
121	—	NN	O	—	dep	158	SENT_90	[p6l9t3480r533b3567],
122	induced	VBD	O	induce	dep	158	SENT_90	[p6l9t3480r533b3567],
123	HSR	NN	O	hsr	dep	158	SENT_90	[p6l592t3459r875b3547],
124	.55	CD	NUMBER	.55	dep	158	SENT_90	[p6l592t3459r875b3547],
125	Alteration	NN	O	alteration	dep	158	SENT_90	[p6l938t3480r1336b3547],
126	in	IN	O	in	dep	158	SENT_90	[p6l1397t3480r1470b3546],
127	the	DT	O	the	dep	158	SENT_90	[p6l1530t3480r1647b3547],
128	balance	NN	O	balance	dep	158	SENT_90	[p6l1708t3480r2007b3547],
129	of	IN	O	of	dep	158	SENT_90	[p6l2069t3480r2153b3547],
130	Th1	NN	O	th1	dep	158	SENT_90	[p6l9t3595r155b3662],
131	cytokines	NNS	O	cytokine	dep	158	SENT_90	[p6l204t3595r600b3682],
132	,	,	O	,	_	0	SENT_90	[p6l204t3595r600b3682],
133	such	JJ	O	such	dep	158	SENT_90	[p6l647t3595r821b3662],
134	as	IN	O	as	dep	158	SENT_90	[p6l863t3617r937b3662],
135	interleukins	NNS	O	interleukin	dep	158	SENT_90	[p6l979t3595r1442b3662],
136	(	CD	NUMBER	(	dep	158	SENT_90	[p6l1487t3596r1637b3679],
137	IL	NN	O	il	dep	158	SENT_90	[p6l1487t3596r1637b3679],
138	)	CD	NUMBER	)	dep	158	SENT_90	[p6l1487t3596r1637b3679],
139	(	CD	NUMBER	(	dep	158	SENT_90	[p6l1683t3596r1907b3678],
140	IL-1	NN	O	il-1	dep	158	SENT_90	[p6l1683t3596r1907b3678],
141	,	,	O	,	_	0	SENT_90	[p6l1683t3596r1907b3678],
142	IL-2	NN	O	il-2	dep	158	SENT_90	[p6l1950t3596r2143b3675],
143	,	,	O	,	_	0	SENT_90	[p6l1950t3596r2143b3675],
144	IL-6	NN	O	il-6	dep	158	SENT_90	[p6l9t3711r202b3791],
145	,	,	O	,	_	0	SENT_90	[p6l9t3711r202b3791],
146	IL-18	NN	O	il-18	dep	158	SENT_90	[p6l243t3712r494b3794],
147	)	NN	O	)	dep	158	SENT_90	[p6l243t3712r494b3794],
148	and	CC	O	and	dep	158	SENT_90	[p6l537t3711r674b3779],
149	tumor	NN	O	tumor	dep	158	SENT_90	[p6l710t3721r945b3779],
150	necrosis	NN	O	necrosis	dep	158	SENT_90	[p6l980t3711r1299b3779],
151	factor	NN	O	factor	dep	158	SENT_90	[p6l1339t3711r1569b3779],
152	(	CD	NUMBER	(	dep	158	SENT_90	[p6l1608t3712r1967b3795],
153	TNF	NN	O	tnf	dep	158	SENT_90	[p6l1608t3712r1967b3795],
154	)	SYM	O	)	dep	158	SENT_90	[p6l1608t3712r1967b3795],
155	-	:	O	-	_	0	SENT_90	[p6l1608t3712r1967b3795],
156	a	DT	O	a	dep	158	SENT_90	[p6l1608t3712r1967b3795],
157	,	,	O	,	_	0	SENT_90	[p6l1608t3712r1967b3795],
158	and	CC	O	and	_	0	SENT_90	[p6l2010t3711r2148b3779],

1	Th2	NN	O	th2	nn	2	SENT_91	[p7l9t22r163b88],
2	cytokines	NNS	O	cytokine	nsubj	3	SENT_91	[p7l205t22r577b109],
3	(	VBP	O	(	ccomp	10	SENT_91	[p7l623t22r846b105],
4	IL-4	NN	O	il-4	dobj	3	SENT_91	[p7l623t22r846b105],
5	,	,	O	,	_	0	SENT_91	[p7l623t22r846b105],
6	IL-10	NN	O	il-10	nn	7	SENT_91	[p7l891t22r1141b105],
7	)	NN	O	)	nsubj	10	SENT_91	[p7l891t22r1141b105],
8	are	VBP	O	be	cop	10	SENT_91	[p7l1187t43r1303b89],
9	important	JJ	O	important	amod	10	SENT_91	[p7l1344t22r1727b109],
10	factors	NNS	O	factor	_	0	SENT_91	[p7l1766t22r2030b89],
11	in	IN	O	in	_	0	SENT_91	[p7l2073t22r2147b88],
12	HSR	NN	O	hsr	prep_in	10	SENT_91	[p7l9t138r215b205],
13	.	.	O	.	_	0	SENT_91	[p7l9t138r215b205],

1	Proinﬂammatory	JJ	O	proinﬂammatory	amod	2	SENT_92	[p7l253t137r918b224],
2	cytokines	NNS	O	cytokine	nsubj	5	SENT_92	[p7l953t137r1325b224],
3	and	CC	O	and	_	0	SENT_92	[p7l1363t137r1500b204],
4	chemokines	NNS	O	chemokine	conj_and	2	SENT_92	[p7l1534t137r1999b204],
5	act	VBP	O	act	_	0	SENT_92	[p7l2036t147r2148b204],
6	as	IN	O	as	_	0	SENT_92	[p7l11t273r85b319],
7	signals	NNS	O	signal	prep_as	5	SENT_92	[p7l127t252r393b339],
8	for	IN	O	for	_	0	SENT_92	[p7l432t252r545b319],
9	antigen-presenting	JJ	O	antigen-presenting	amod	10	SENT_92	[p7l581t252r1312b339],
10	cells	NNS	O	cell	prep_for	7	SENT_92	[p7l1350t252r1550b331],
11	,	,	O	,	_	0	SENT_92	[p7l1350t252r1550b331],
12	leading	VBG	O	lead	xcomp	5	SENT_92	[p7l1590t252r1877b339],
13	to	TO	O	to	_	0	SENT_92	[p7l1914t262r1987b319],
14	necrosis	NN	O	necrosis	nn	19	SENT_92	[p7l2024t273r2144b319, p7l9t367r257b446],
15	,	,	O	,	_	0	SENT_92	[p7l2024t273r2144b319, p7l9t367r257b446],
16	apoptosis	NN	O	apoptosis	nn	19	SENT_92	[p7l295t367r660b454],
17	and	CC	O	and	_	0	SENT_92	[p7l697t367r835b433],
18	organ	NN	O	organ	nn	19	SENT_92	[p7l868t388r1087b454],
19	damage	NN	O	damage	prep_to	12	SENT_92	[p7l1120t345r1522b454],
20	.16	CD	NUMBER	.16	dep	19	SENT_92	[p7l1120t345r1522b454],

1	This	DT	O	this	det	2	SENT_93	[p7l95t482r263b549],
2	study	NN	O	study	nsubj	33	SENT_93	[p7l300t482r502b569],
3	aimed	VBN	O	aim	partmod	2	SENT_93	[p7l536t482r769b549],
4	to	TO	O	to	aux	5	SENT_93	[p7l800t492r872b549],
5	(	VB	O	(	xcomp	3	SENT_93	[p7l907t483r1011b565],
6	l	NN	O	l	nn	7	SENT_93	[p7l907t483r1011b565],
7	)	NN	O	)	nsubj	8	SENT_93	[p7l907t483r1011b565],
8	assess	VB	O	assess	ccomp	5	SENT_93	[p7l1048t504r1276b549],
9	AED-HSRs	NNS	O	aed-hsr	dobj	8	SENT_93	[p7l1309t483r1760b550],
10	using	VBG	O	use	partmod	9	SENT_93	[p7l1793t482r1999b569],
11	the	DT	O	the	dobj	10	SENT_93	[p7l2031t482r2146b549],
12	in	FW	O	in	nn	13	SENT_93	[p7l12t599r80b664],
13	vitro	FW	O	vitro	advmod	14	SENT_93	[p7l109t599r284b664],
14	LTA	NN	ORGANIZATION	lta	dep	11	SENT_93	[p7l316t597r486b663],
15	in	IN	O	in	_	0	SENT_93	[p7l516t597r589b663],
16	an	DT	O	a	det	19	SENT_93	[p7l621t618r709b664],
17	ethnically-diverse	JJ	O	ethnically-diverse	amod	19	SENT_93	[p7l739t597r1428b684],
18	Canadian	JJ	LOCATION	canadian	amod	19	SENT_93	[p7l1460t597r1823b664],
19	population	NN	O	population	prep_in	14	SENT_93	[p7l1853t597r2144b684, p7l9t712r157b778],
20	who	WP	O	who	nsubj	21	SENT_93	[p7l207t712r369b779],
21	manifested	VBD	O	manifest	rcmod	11	SENT_93	[p7l419t712r844b778],
22	HSRs	NNS	O	hsr	dobj	21	SENT_93	[p7l893t712r1135b791],
23	,	,	O	,	_	0	SENT_93	[p7l893t712r1135b791],
24	including	VBG	O	include	_	0	SENT_93	[p7l1189t712r1550b799],
25	Han	NNP	O	Han	nn	26	SENT_93	[p7l1602t713r1760b778],
26	Chinese	NNP	MISC	Chinese	prep_including	22	SENT_93	[p7l1812t712r2142b791],
27	;	:	O	;	_	0	SENT_93	[p7l1812t712r2142b791],
28	(	NN	O	(	dep	26	SENT_93	[p7l12t828r115b910],
29	2	CD	NUMBER	2	number	30	SENT_93	[p7l12t828r115b910],
30	)	CD	NUMBER	)	num	32	SENT_93	[p7l12t828r115b910],
31	correlate	NN	O	correlate	nn	32	SENT_93	[p7l148t827r483b894],
32	LTA	NN	ORGANIZATION	lta	dep	28	SENT_93	[p7l513t828r683b893],
33	results	VBZ	O	result	_	0	SENT_93	[p7l711t827r960b894],
34	to	TO	O	to	_	0	SENT_93	[p7l991t837r1062b894],
35	clinical	JJ	O	clinical	amod	36	SENT_93	[p7l1093t827r1375b894],
36	symptoms	NNS	O	symptom	prep_to	33	SENT_93	[p7l1408t837r1823b914],
37	;	:	O	;	_	0	SENT_93	[p7l1408t837r1823b914],
38	(	CD	NUMBER	(	number	39	SENT_93	[p7l1859t828r1964b910],
39	3	CD	NUMBER	3	num	40	SENT_93	[p7l1859t828r1964b910],
40	)	NN	O	)	nsubj	41	SENT_93	[p7l1859t828r1964b910],
41	correlate	VBP	O	correlate	parataxis	33	SENT_93	[p7l1996t849r2144b894, p7l8t942r221b1009],
42	LTA	NN	ORGANIZATION	lta	nsubj	43	SENT_93	[p7l268t943r438b1008],
43	results	VBZ	O	result	ccomp	41	SENT_93	[p7l484t942r732b1009],
44	to	TO	O	to	_	0	SENT_93	[p7l781t952r853b1009],
45	HLA	NN	O	hlum	prep_to	43	SENT_93	[p7l901t942r1433b1009],
46	.	.	O	.	_	0	SENT_93	[p7l901t942r1433b1009],

1	—	NN	O	—	_	0	SENT_94	[p7l901t942r1433b1009],
2	.	.	O	.	_	0	SENT_94	[p7l901t942r1433b1009],

1	B	NN	O	b	nn	3	SENT_95	[p7l901t942r1433b1009],
2	*	CD	NUMBER	*	num	3	SENT_95	[p7l901t942r1433b1009],
3	l502	NN	O	l502	nsubj	12	SENT_95	[p7l901t942r1433b1009],
4	in	IN	O	in	_	0	SENT_95	[p7l1481t942r1554b1008],
5	Han	NNP	MISC	Han	nn	6	SENT_95	[p7l1601t944r1759b1009],
6	ChineseCanadians	NNP	MISC	ChineseCanadians	prep_in	3	SENT_95	[p7l1807t942r2144b1009, p7l10t1057r431b1136],
7	;	:	O	;	_	0	SENT_95	[p7l1807t942r2144b1009, p7l10t1057r431b1136],
8	and	CC	O	and	_	0	SENT_95	[p7l468t1057r604b1124],
9	(	NN	O	(	nn	11	SENT_95	[p7l637t1058r740b1140],
10	4	CD	NUMBER	4	num	11	SENT_95	[p7l637t1058r740b1140],
11	)	NN	O	)	prep_in	3	SENT_95	[p7l637t1058r740b1140],
12	determine	VBD	O	determine	_	0	SENT_95	[p7l774t1057r1159b1124],
13	the	DT	O	the	det	15	SENT_95	[p7l1189t1057r1304b1124],
14	cytokine	NN	O	cytokine	nn	15	SENT_95	[p7l1335t1057r1664b1144],
15	network	NN	O	network	dobj	12	SENT_95	[p7l1695t1057r2028b1124],
16	.	.	O	.	_	0	SENT_95	[p7l1695t1057r2028b1124],

1	PATIENTS	NNS	O	patient	_	0	SENT_96	[p7l13t1318r370b1385],
2	AND	CC	O	and	_	0	SENT_96	[p7l397t1319r582b1384],
3	METHODS	NNS	O	method	conj_and	1	SENT_96	[p7l614t1318r1003b1385],

1	Patients	NNS	O	patient	_	0	SENT_97	[p7l99t1478r399b1537],
2	.	.	O	.	_	0	SENT_97	[p7l99t1478r399b1537],

1	Patients	NNS	O	patient	dep	7	SENT_98	[p7l443t1470r744b1537],
2	with	IN	O	with	_	0	SENT_98	[p7l806t1470r975b1537],
3	clinical	JJ	O	clinical	amod	4	SENT_98	[p7l1035t1470r1317b1537],
4	HSR	NN	O	hsr	prep_with	1	SENT_98	[p7l1378t1470r1563b1537],
5	manifestation	NN	O	manifestation	dep	7	SENT_98	[p7l1622t1470r2147b1537],
6	(	CD	NUMBER	(	num	5	SENT_98	[p7l11t1585r219b1668],
7	rash	NN	O	rash	dep	24	SENT_98	[p7l11t1585r219b1668],
8	,	,	O	,	_	0	SENT_98	[p7l11t1585r219b1668],
9	fever	NN	O	fever	conj_and	7	SENT_98	[p7l263t1584r473b1665],
10	,	,	O	,	_	0	SENT_98	[p7l263t1584r473b1665],
11	and	CC	O	and	_	0	SENT_98	[p7l518t1585r654b1652],
12	skin	NN	O	skin	conj_and	7	SENT_98	[p7l696t1585r851b1652],
13	and/or	NN	O	and/or	nn	15	SENT_98	[p7l892t1585r1136b1653],
14	liver	NN	O	liver	nn	15	SENT_98	[p7l1174t1585r1349b1653],
15	involvement	NN	O	involvement	dep	7	SENT_98	[p7l1385t1585r1864b1652],
16	within	IN	O	within	_	0	SENT_98	[p7l1903t1585r2147b1653],
17	8	CD	DURATION	8	num	18	SENT_98	[p7l13t1702r50b1769],
18	weeks	NNS	NUMBER	week	prep_within	15	SENT_98	[p7l76t1701r312b1769],
19	of	IN	O	of	_	0	SENT_98	[p7l337t1701r420b1768],
20	exposure	NN	O	exposure	prep_of	18	SENT_98	[p7l436t1723r780b1788],
21	to	TO	O	to	_	0	SENT_98	[p7l802t1711r873b1768],
22	AEDs	NNS	O	aed	prep_to	20	SENT_98	[p7l896t1702r1126b1768],
23	(	CD	NUMBER	(	num	24	SENT_98	[p7l1154t1702r1388b1784],
24	CBZ	NN	ORGANIZATION	cbz	dep	44	SENT_98	[p7l1154t1702r1388b1784],
25	,	,	O	,	_	0	SENT_98	[p7l1154t1702r1388b1784],
26	PHY	NN	O	phy	dep	44	SENT_98	[p7l1413t1703r1612b1781],
27	,	,	O	,	_	0	SENT_98	[p7l1413t1703r1612b1781],
28	and	CC	O	and	_	0	SENT_98	[p7l1639t1701r1774b1768],
29	LTG	NN	O	ltg	dep	44	SENT_98	[p7l1794t1702r2001b1784],
30	)	CD	NUMBER	)	nsubj	44	SENT_98	[p7l1794t1702r2001b1784],
31	belonging	VBG	O	belong	partmod	30	SENT_98	[p7l2025t1701r2144b1768, p7l9t1816r300b1903],
32	to	TO	O	to	_	0	SENT_98	[p7l327t1826r399b1883],
33	an	DT	O	a	det	36	SENT_98	[p7l428t1837r515b1883],
34	epilepsy	NN	O	epilepsy	nn	36	SENT_98	[p7l542t1816r860b1903],
35	clinic	NN	O	clinic	nn	36	SENT_98	[p7l889t1816r1099b1883],
36	(	NN	O	(	prep_to	31	SENT_98	[p7l1130t1817r1309b1899],
37	PH	NN	O	ph	dep	36	SENT_98	[p7l1130t1817r1309b1899],
38	)	CD	NUMBER	)	num	37	SENT_98	[p7l1130t1817r1309b1899],
39	or	CC	O	or	_	0	SENT_98	[p7l1339t1837r1418b1883],
40	referred	VBN	O	refer	conj_or	37	SENT_98	[p7l1441t1816r1747b1883],
41	for	IN	O	for	_	0	SENT_98	[p7l1772t1816r1884b1883],
42	a	DT	O	a	det	43	SENT_98	[p7l1910t1837r1950b1883],
43	liver	NN	O	liver	prep_for	40	SENT_98	[p7l1975t1816r2150b1883],
44	consult	VB	O	consult	csubjpass	49	SENT_98	[p7l9t1931r286b1998],
45	(	CD	NUMBER	(	num	47	SENT_98	[p7l323t1932r502b2014],
46	LC	NN	O	lc	nn	47	SENT_98	[p7l323t1932r502b2014],
47	)	NN	O	)	dobj	44	SENT_98	[p7l323t1932r502b2014],
48	were	VBD	O	be	auxpass	49	SENT_98	[p7l540t1953r724b1999],
49	included	VBN	O	include	_	0	SENT_98	[p7l760t1931r1091b1998],
50	in	IN	O	in	_	0	SENT_98	[p7l1125t1931r1198b1997],
51	the	DT	O	the	det	52	SENT_98	[p7l1232t1931r1347b1998],
52	study	NN	O	study	prep_in	49	SENT_98	[p7l1385t1931r1602b2018],
53	.	.	O	.	_	0	SENT_98	[p7l1385t1931r1602b2018],

1	Experts	NNS	O	expert	nsubj	3	SENT_99	[p7l1640t1933r1932b2018],
2	have	VBP	O	have	aux	3	SENT_99	[p7l1968t1931r2146b1998],
3	made	VBN	O	make	dep	24	SENT_99	[p7l8t2046r215b2113],
4	the	DT	O	the	det	6	SENT_99	[p7l262t2046r377b2113],
5	clinical	JJ	O	clinical	amod	6	SENT_99	[p7l425t2046r707b2113],
6	diagnosis	NN	O	diagnosis	dobj	3	SENT_99	[p7l755t2046r1115b2133],
7	of	IN	O	of	_	0	SENT_99	[p7l1164t2046r1247b2113],
8	type	NN	O	type	prep_of	6	SENT_99	[p7l1286t2056r1450b2133],
9	of	IN	O	of	_	0	SENT_99	[p7l1498t2046r1581b2113],
10	seizure	NN	O	seizure	nn	13	SENT_99	[p7l1623t2046r1892b2113],
11	(	CD	NUMBER	(	num	13	SENT_99	[p7l1941t2046r2143b2129],
12	PH	NN	O	ph	nn	13	SENT_99	[p7l1941t2046r2143b2129],
13	)	NN	O	)	prep_of	8	SENT_99	[p7l1941t2046r2143b2129],
14	,	,	O	,	_	0	SENT_99	[p7l1941t2046r2143b2129],
15	DILI	NNP	O	DILI	conj_and	6	SENT_99	[p7l8t2162r199b2227],
16	(	CD	NUMBER	(	num	18	SENT_99	[p7l234t2161r437b2244],
17	LC	NN	O	lc	nn	18	SENT_99	[p7l234t2161r437b2244],
18	)	NN	O	)	dep	15	SENT_99	[p7l234t2161r437b2244],
19	,	,	O	,	_	0	SENT_99	[p7l234t2161r437b2244],
20	and	CC	O	and	_	0	SENT_99	[p7l474t2161r610b2227],
21	dermatological	JJ	O	dermatological	amod	22	SENT_99	[p7l642t2161r1220b2248],
22	involvement	NN	O	involvement	dobj	3	SENT_99	[p7l1252t2160r1730b2228],
23	(	CD	NUMBER	(	dep	22	SENT_99	[p7l1765t2161r1968b2244],
24	burn	VBP	O	burn	_	0	SENT_99	[p7l1765t2161r1968b2244],
25	unit	NN	O	unit	nn	26	SENT_99	[p7l1998t2161r2148b2227],
26	surgeons	NNS	O	surgeon	dobj	24	SENT_99	[p7l12t2298r346b2363],
27	and	CC	O	and	_	0	SENT_99	[p7l395t2276r531b2343],
28	dermatologists	NNS	O	dermatologist	dobj	24	SENT_99	[p7l576t2276r1141b2363],
29	from	IN	O	from	_	0	SENT_99	[p7l1188t2276r1375b2343],
30	the	DT	O	the	det	32	SENT_99	[p7l1419t2276r1534b2343],
31	referral	NN	O	referral	nn	32	SENT_99	[p7l1579t2276r1862b2343],
32	hospitals	NNS	O	hospital	prep_from	24	SENT_99	[p7l1908t2276r2144b2363, p7l8t2391r192b2474],
33	)	CD	NUMBER	)	nsubj	24	SENT_99	[p7l1908t2276r2144b2363, p7l8t2391r192b2474],
34	.	.	O	.	_	0	SENT_99	[p7l1908t2276r2144b2363, p7l8t2391r192b2474],

1	Controls	NNP	O	Controls	nsubj	2	SENT_100	[p7l232t2391r560b2458],
2	consisted	VBD	O	consist	_	0	SENT_100	[p7l598t2391r955b2458],
3	of	IN	O	of	_	0	SENT_100	[p7l990t2391r1073b2458],
4	epilepsy	NN	O	epilepsy	nn	5	SENT_100	[p7l1102t2391r1421b2478],
5	patients	NNS	O	patient	prep_of	2	SENT_100	[p7l1456t2391r1753b2478],
6	receiving	VBG	O	receive	xcomp	2	SENT_100	[p7l1789t2391r2145b2478],
7	AEDS	NNS	O	aed	dobj	6	SENT_100	[p7l8t2506r239b2572],
8	without	IN	O	without	_	0	SENT_100	[p7l283t2506r578b2573],
9	developing	VBG	O	develop	amod	10	SENT_100	[p7l619t2506r1042b2593],
10	HSRS	NNS	O	hsr	prep_without	6	SENT_100	[p7l1085t2506r1326b2573],
11	.	.	O	.	_	0	SENT_100	[p7l1085t2506r1326b2573],

1	The	DT	O	the	det	2	SENT_101	[p7l1372t2506r1520b2572],
2	laboratory	NN	O	laboratory	nsubjpass	4	SENT_101	[p7l1563t2506r1957b2593],
3	was	VBD	O	be	auxpass	4	SENT_101	[p7l2001t2527r2145b2573],
4	blinded	VBN	O	blind	_	0	SENT_101	[p7l7t2621r297b2688],
5	for	IN	O	for	_	0	SENT_101	[p7l326t2621r438b2688],
6	clinical	JJ	O	clinical	amod	7	SENT_101	[p7l467t2621r750b2688],
7	phenotypes	NNS	O	phenotype	prep_for	4	SENT_101	[p7l779t2621r1216b2708],
8	of	IN	O	of	_	0	SENT_101	[p7l1249t2621r1332b2688],
9	the	DT	O	the	det	10	SENT_101	[p7l1356t2621r1471b2688],
10	participants	NNS	O	participant	prep_of	7	SENT_101	[p7l1500t2621r1971b2708],
11	.	.	O	.	_	0	SENT_101	[p7l1500t2621r1971b2708],

1	We	PRP	O	we	nsubj	2	SENT_102	[p7l94t2738r220b2803],
2	studied	VBD	O	study	_	0	SENT_102	[p7l248t2736r543b2803],
3	:	:	O	:	_	0	SENT_102	[p7l248t2736r543b2803],
4	10	CD	NUMBER	10	num	6	SENT_102	[p7l583t2737r668b2804],
5	PHY-HSR	NN	O	phy-hsr	nn	6	SENT_102	[p7l693t2737r1093b2804],
6	patients	NNS	O	patient	nsubj	7	SENT_102	[p7l1116t2736r1415b2823],
7	(	VBP	O	(	parataxis	2	SENT_102	[p7l1445t2737r1519b2819],
8	4	CD	NUMBER	4	num	9	SENT_102	[p7l1445t2737r1519b2819],
9	DILI	NNP	ORGANIZATION	DILI	nsubj	27	SENT_102	[p7l1544t2737r1788b2819],
10	)	CD	NUMBER	)	num	9	SENT_102	[p7l1544t2737r1788b2819],
11	,	,	O	,	_	0	SENT_102	[p7l1544t2737r1788b2819],
12	24	CD	NUMBER	24	num	13	SENT_102	[p7l1818t2737r1909b2802],
13	PHYcontrols	NNS	O	phycontrol	appos	9	SENT_102	[p7l1935t2738r2144b2802, p7l9t2851r338b2931],
14	,	,	O	,	_	0	SENT_102	[p7l1935t2738r2144b2802, p7l9t2851r338b2931],
15	10	CD	NUMBER	10	num	17	SENT_102	[p7l411t2852r495b2919],
16	CBZ-HSR	NN	O	cbz-hsr	nn	17	SENT_102	[p7l557t2852r962b2919],
17	patients	NNS	O	patient	appos	9	SENT_102	[p7l1020t2851r1317b2938],
18	(	CD	NUMBER	(	number	19	SENT_102	[p7l1383t2852r1457b2934],
19	4	CD	NUMBER	4	num	21	SENT_102	[p7l1383t2852r1457b2934],
20	SJS	NN	ORGANIZATION	sj	nn	21	SENT_102	[p7l1521t2852r1712b2935],
21	)	NN	O	)	dep	17	SENT_102	[p7l1521t2852r1712b2935],
22	,	,	O	,	_	0	SENT_102	[p7l1521t2852r1712b2935],
23	24	CD	NUMBER	24	num	24	SENT_102	[p7l1777t2852r1869b2918],
24	CBZcontrols	NNS	O	cbzcontrol	appos	9	SENT_102	[p7l1930t2852r2144b2919, p7l9t2966r338b3045],
25	,	,	O	,	_	0	SENT_102	[p7l1930t2852r2144b2919, p7l9t2966r338b3045],
26	6	CD	NUMBER	6	num	27	SENT_102	[p7l375t2966r417b3033],
27	LTG	NN	ORGANIZATION	ltg	xcomp	7	SENT_102	[p7l449t2966r847b3033],
28	.	.	O	.	_	0	SENT_102	[p7l449t2966r847b3033],

1	—	NN	O	—	_	0	SENT_103	[p7l449t2966r847b3033],
2	.	.	O	.	_	0	SENT_103	[p7l449t2966r847b3033],

1	HSR	NN	O	hsr	nn	2	SENT_104	[p7l449t2966r847b3033],
2	patients	NNS	O	patient	_	0	SENT_104	[p7l876t2966r1174b3053],
3	(	IN	O	(	dep	2	SENT_104	[p7l1210t2967r1276b3049],
4	1	CD	NUMBER	1	num	5	SENT_104	[p7l1210t2967r1276b3049],
5	SJS	NN	O	sj	pobj	3	SENT_104	[p7l1318t2966r1452b3033],
6	and	CC	O	and	_	0	SENT_104	[p7l1490t2966r1626b3033],
7	1	CD	NUMBER	1	num	8	SENT_104	[p7l1665t2967r1693b3032],
8	DILI	NNP	ORGANIZATION	DILI	pobj	3	SENT_104	[p7l1732t2967r1975b3049],
9	)	CD	NUMBER	)	num	8	SENT_104	[p7l1732t2967r1975b3049],
10	,	,	O	,	_	0	SENT_104	[p7l1732t2967r1975b3049],
11	and	CC	O	and	_	0	SENT_104	[p7l2012t2966r2147b3033],
12	24	CD	NUMBER	24	num	13	SENT_104	[p7l10t3081r101b3147],
13	LTG	NN	O	ltg	conj_and	5	SENT_104	[p7l145t3081r686b3148],
14	—	CD	NUMBER	—	num	15	SENT_104	[p7l145t3081r686b3148],
15	controls	NNS	O	control	dep	13	SENT_104	[p7l145t3081r686b3148],
16	.	.	O	.	_	0	SENT_104	[p7l145t3081r686b3148],

1	LTA	NN	ORGANIZATION	lta	nn	2	SENT_105	[p7l734t3081r904b3147],
2	toxicity	NN	O	toxicity	nsubjpass	11	SENT_105	[p7l947t3081r1240b3168],
3	higher	JJR	O	higher	amod	2	SENT_105	[p7l1284t3081r1530b3168],
4	than	IN	O	than	_	0	SENT_105	[p7l1572t3081r1736b3148],
5	12.5	CD	PERCENT	12.5	num	6	SENT_105	[p7l1788t3081r2022b3148],
6	%	NN	PERCENT	%	prep_than	3	SENT_105	[p7l1788t3081r2022b3148],
7	:	:	O	:	_	0	SENT_105	[p7l2079t3087r2137b3144],
8	2.5	CD	PERCENT	2.5	number	9	SENT_105	[p7l10t3196r202b3264],
9	%	NN	PERCENT	%	amod	6	SENT_105	[p7l10t3196r202b3264],
10	was	VBD	O	be	auxpass	11	SENT_105	[p7l237t3218r382b3264],
11	considered	VBN	O	consider	_	0	SENT_105	[p7l415t3196r831b3263],
12	positive	JJ	O	positive	acomp	11	SENT_105	[p7l859t3196r1182b3283],
13	.	.	O	.	_	0	SENT_105	[p7l859t3196r1182b3283],

1	The	DT	O	the	det	8	SENT_106	[p7l95t3311r243b3378],
2	median	JJ	O	median	amod	8	SENT_106	[p7l294t3311r577b3378],
3	time	NN	O	time	nn	8	SENT_106	[p7l627t3311r796b3378],
4	latency	NN	O	latency	nn	8	SENT_106	[p7l848t3311r1125b3398],
5	(	CD	NUMBER	(	num	8	SENT_106	[p7l1178t3311r1679b3398],
6	interquartile	NN	O	interquartile	nn	8	SENT_106	[p7l1178t3311r1679b3398],
7	range	NN	O	range	nn	8	SENT_106	[p7l1729t3312r1973b3398],
8	)	NN	O	)	nsubj	22	SENT_106	[p7l1729t3312r1973b3398],
9	between	IN	O	between	_	0	SENT_106	[p7l2024t3311r2144b3378, p7l8t3436r237b3493],
10	start	NN	O	start	prep_between	8	SENT_106	[p7l272t3436r434b3493],
11	of	IN	O	of	_	0	SENT_106	[p7l466t3426r549b3493],
12	drug	NN	O	drug	nn	13	SENT_106	[p7l575t3426r747b3513],
13	intake	NN	O	intake	prep_of	10	SENT_106	[p7l780t3426r1013b3493],
14	and	CC	O	and	_	0	SENT_106	[p7l1048t3426r1184b3493],
15	index	NN	O	index	prep_of	10	SENT_106	[p7l1215t3426r1598b3513],
16	—	CD	NUMBER	—	num	17	SENT_106	[p7l1215t3426r1598b3513],
17	day	NN	NUMBER	day	tmod	10	SENT_106	[p7l1215t3426r1598b3513],
18	was	VBD	O	be	cop	22	SENT_106	[p7l1630t3447r1775b3493],
19	less	JJR	DURATION	less	mwe	20	SENT_106	[p7l1809t3426r1949b3493],
20	than	IN	DURATION	than	quantmod	21	SENT_106	[p7l1982t3426r2146b3493],
21	3	CD	DURATION	3	num	22	SENT_106	[p7l11t3541r49b3608],
22	weeks	NNS	NUMBER	week	dep	28	SENT_106	[p7l92t3541r328b3608],
23	(	CD	NUMBER	(	num	24	SENT_106	[p7l369t3541r604b3623],
24	CBZ	NNP	O	CBZ	dep	22	SENT_106	[p7l369t3541r604b3623],
25	:	:	O	:	_	0	SENT_106	[p7l369t3541r604b3623],
26	12	CD	DURATION	12	num	27	SENT_106	[p7l657t3541r740b3607],
27	days	NNS	NUMBER	day	dep	22	SENT_106	[p7l779t3541r951b3628],
28	[	VBP	O	[	_	0	SENT_106	[p7l997t3540r1264b3622],
29	8	CD	NUMBER	8	number	30	SENT_106	[p7l997t3540r1264b3622],
30	—	CD	NUMBER	—	num	32	SENT_106	[p7l997t3540r1264b3622],
31	l6	NN	O	l6	nn	32	SENT_106	[p7l997t3540r1264b3622],
32	]	NN	O	]	dobj	28	SENT_106	[p7l997t3540r1264b3622],
33	,	,	O	,	_	0	SENT_106	[p7l997t3540r1264b3622],
34	PHY	NN	O	phy	appos	32	SENT_106	[p7l1305t3542r1507b3607],
35	:	:	O	:	_	0	SENT_106	[p7l1305t3542r1507b3607],
36	12	CD	DURATION	12	num	37	SENT_106	[p7l1560t3541r1643b3607],
37	days	NNS	NUMBER	day	nsubj	39	SENT_106	[p7l1682t3541r1853b3628],
38	[	RB	O	[	advmod	39	SENT_106	[p7l1899t3541r2139b3622],
39	lO	VBP	O	lo	rcmod	32	SENT_106	[p7l1899t3541r2139b3622],
40	—	CD	NUMBER	—	number	41	SENT_106	[p7l1899t3541r2139b3622],
41	8	CD	NUMBER	8	dobj	39	SENT_106	[p7l1899t3541r2139b3622],
42	]	NN	O	]	dep	41	SENT_106	[p7l1899t3541r2139b3622],
43	and	CC	O	and	_	0	SENT_106	[p7l10t3656r146b3723],
44	LTG	NN	O	ltg	dep	41	SENT_106	[p7l175t3657r372b3724],
45	:	:	O	:	_	0	SENT_106	[p7l175t3657r372b3724],
46	9	CD	DURATION	9	num	47	SENT_106	[p7l411t3657r453b3725],
47	days	NNS	NUMBER	day	dep	41	SENT_106	[p7l486t3656r658b3743],
48	[	RB	O	[	advmod	50	SENT_106	[p7l696t3657r996b3739],
49	4	CD	NUMBER	4	number	50	SENT_106	[p7l696t3657r996b3739],
50	—	CD	NUMBER	—	rcmod	47	SENT_106	[p7l696t3657r996b3739],
51	20	CD	NUMBER	20	num	53	SENT_106	[p7l696t3657r996b3739],
52	]	NN	O	]	nn	53	SENT_106	[p7l696t3657r996b3739],
53	)	NN	O	)	nsubj	28	SENT_106	[p7l696t3657r996b3739],
54	.	.	O	.	_	0	SENT_106	[p7l696t3657r996b3739],

1	400	CD	NUMBER	400	_	0	SENT_107	[p8l6t23r134b83],
2	Neumcm	NN	O	neumcm	dep	1	SENT_107	[p8l249t24r565b82],
3	e	SYM	O	e	dep	6	SENT_107	[p8l594t24r666b82],
4	’	CD	NUMBER	’	num	6	SENT_107	[p8l594t24r666b82],
5	r	NN	O	r	nn	6	SENT_107	[p8l594t24r666b82],
6	cal	NN	O	cal	rcmod	2	SENT_107	[p8l691t24r752b82],

1	There	EX	O	there	expl	2	SENT_108	[p8l95t257r318b324],
2	were	VBD	O	be	_	0	SENT_108	[p8l345t279r529b325],
3	30	CD	NUMBER	30	num	6	SENT_108	[p8l561t258r651b325],
4	Han	NNP	O	Han	nn	6	SENT_108	[p8l680t259r838b324],
5	Chinese	NNP	MISC	Chinese	nn	6	SENT_108	[p8l868t257r1175b325],
6	individuals	NNS	O	individual	nsubj	2	SENT_108	[p8l1204t257r1628b325],
7	(	VBP	O	(	rcmod	6	SENT_108	[p8l1661t258r1784b341],
8	14	CD	NUMBER	14	num	10	SENT_108	[p8l1661t258r1784b341],
9	HSR	NN	O	hsr	nn	10	SENT_108	[p8l1813t258r1998b325],
10	patients	NNS	O	patient	dobj	7	SENT_108	[p8l2024t279r2143b344, p8l7t373r214b441],
11	and	CC	O	and	_	0	SENT_108	[p8l242t373r378b441],
12	16	CD	NUMBER	16	num	13	SENT_108	[p8l410t373r494b441],
13	controls	NNS	O	control	conj_and	10	SENT_108	[p8l520t373r879b457],
14	)	RB	O	)	advmod	7	SENT_108	[p8l520t373r879b457],
15	.	.	O	.	_	0	SENT_108	[p8l520t373r879b457],

1	All	DT	O	all	det	4	SENT_109	[p8l909t373r1029b440],
2	Han	NNP	MISC	Han	nn	4	SENT_109	[p8l1055t375r1212b441],
3	Chinese	NNP	MISC	Chinese	nn	4	SENT_109	[p8l1237t373r1545b441],
4	individuals	NNS	O	individual	nsubj	5	SENT_109	[p8l1570t373r1993b441],
5	underwent	VBD	O	undergo	_	0	SENT_109	[p8l2019t395r2143b441, p8l8t488r318b555],
6	HLA	NN	O	hlum	nn	7	SENT_109	[p8l351t488r546b554],
7	genotyping	NN	O	genotyping	dobj	5	SENT_109	[p8l581t488r1032b575],
8	.	.	O	.	_	0	SENT_109	[p8l581t488r1032b575],

1	The	DT	O	the	det	3	SENT_110	[p8l1071t488r1218b555],
2	ethnical	JJ	O	ethnical	amod	3	SENT_110	[p8l1254t488r1557b555],
3	distribution	NN	O	distribution	nsubj	14	SENT_110	[p8l1593t488r2035b555],
4	of	IN	O	of	_	0	SENT_110	[p8l2070t488r2153b555],
5	HSR	NN	O	hsr	nn	6	SENT_110	[p8l8t603r193b670],
6	patients	NNS	O	patient	prep_of	3	SENT_110	[p8l236t603r535b690],
7	and	CC	O	and	_	0	SENT_110	[p8l583t603r719b669],
8	therapy-tolerant	JJ	O	therapy-tolerant	amod	9	SENT_110	[p8l763t603r1381b690],
9	controls	NNS	O	control	prep_of	3	SENT_110	[p8l1426t603r1733b669],
10	was	VBD	O	be	cop	14	SENT_110	[p8l1780t624r1925b670],
11	50	CD	PERCENT	50	number	12	SENT_110	[p8l1974t602r2142b670],
12	%	NN	PERCENT	%	amod	14	SENT_110	[p8l1974t602r2142b670],
13	Han	NNP	O	Han	nn	14	SENT_110	[p8l8t720r166b785],
14	Chinese	NNP	MISC	Chinese	_	0	SENT_110	[p8l204t718r533b798],
15	,	,	O	,	_	0	SENT_110	[p8l204t718r533b798],
16	40	CD	PERCENT	40	number	17	SENT_110	[p8l574t719r744b786],
17	%	NN	PERCENT	%	amod	18	SENT_110	[p8l574t719r744b786],
18	Caucasians	NNPS	MISC	Caucasians	appos	14	SENT_110	[p8l786t718r1239b798],
19	,	,	O	,	_	0	SENT_110	[p8l786t718r1239b798],
20	8	CD	PERCENT	8	num	21	SENT_110	[p8l1284t719r1401b786],
21	%	NN	PERCENT	%	npadvmod	22	SENT_110	[p8l1284t719r1401b786],
22	Hispanic	JJ	O	hispanic	amod	14	SENT_110	[p8l1443t718r1805b805],
23	,	,	O	,	_	0	SENT_110	[p8l1443t718r1805b805],
24	and	CC	O	and	_	0	SENT_110	[p8l1848t718r1983b785],
25	2	CD	PERCENT	2	number	26	SENT_110	[p8l2021t719r2142b786],
26	%	NN	PERCENT	%	conj_and	14	SENT_110	[p8l2021t719r2142b786],
27	African	JJ	MISC	african	amod	26	SENT_110	[p8l7t833r772b900],
28	.	.	O	.	_	0	SENT_110	[p8l7t833r772b900],

1	—	NN	O	—	_	0	SENT_111	[p8l7t833r772b900],
2	.	.	O	.	_	0	SENT_111	[p8l7t833r772b900],

1	Americans	NNPS	MISC	Americans	_	0	SENT_112	[p8l7t833r772b900],
2	.	.	O	.	_	0	SENT_112	[p8l7t833r772b900],

1	The	DT	O	the	det	2	SENT_113	[p8l811t833r959b900],
2	neurologist	NN	O	neurologist	nsubj	6	SENT_113	[p8l994t833r1428b920],
3	(	CD	NUMBER	(	num	4	SENT_113	[p8l1464t834r1681b916],
4	P.H.	NNP	PERSON	P.H.	dep	2	SENT_113	[p8l1464t834r1681b916],
5	)	CD	NUMBER	)	num	4	SENT_113	[p8l1464t834r1681b916],
6	established	VBD	O	establish	_	0	SENT_113	[p8l1719t833r2147b900],
7	the	DT	O	the	det	8	SENT_113	[p8l7t948r123b1015],
8	causality	NN	O	causality	dobj	6	SENT_113	[p8l171t948r513b1035],
9	to	TO	O	to	_	0	SENT_113	[p8l559t958r631b1015],
10	a	DT	O	a	det	12	SENT_113	[p8l681t970r721b1015],
11	speciﬁc	NN	O	speciﬁc	nn	12	SENT_113	[p8l770t948r1058b1035],
12	drug	NN	O	drug	prep_to	6	SENT_113	[p8l1108t948r1280b1035],
13	and	CC	O	and	_	0	SENT_113	[p8l1330t948r1465b1015],
14	the	DT	O	the	det	18	SENT_113	[p8l1512t948r1627b1015],
15	hepatologist	NN	O	hepatologist	nn	18	SENT_113	[p8l1674t948r2147b1035],
16	(	CD	NUMBER	(	num	18	SENT_113	[p8l10t1063r239b1146],
17	L.C.	NN	LOCATION	l.c.	nn	18	SENT_113	[p8l10t1063r239b1146],
18	)	NN	O	)	nsubjpass	20	SENT_113	[p8l10t1063r239b1146],
19	was	VBD	O	be	auxpass	20	SENT_113	[p8l268t1084r413b1130],
20	consulted	VBN	O	consult	conj_and	6	SENT_113	[p8l444t1063r812b1130],
21	for	IN	O	for	_	0	SENT_113	[p8l839t1063r951b1130],
22	cases	NNS	O	case	prep_for	20	SENT_113	[p8l976t1084r1175b1130],
23	presenting	VBG	O	present	partmod	22	SENT_113	[p8l1202t1063r1603b1150],
24	liver	NN	O	liver	nn	25	SENT_113	[p8l1632t1063r1807b1130],
25	involvement	NN	O	involvement	dobj	23	SENT_113	[p8l1831t1063r2143b1130, p8l7t1188r219b1245],
26	.	.	O	.	_	0	SENT_113	[p8l1831t1063r2143b1130, p8l7t1188r219b1245],

1	The	DT	O	the	det	3	SENT_114	[p8l260t1178r407b1244],
2	clinical	JJ	O	clinical	amod	3	SENT_114	[p8l446t1178r728b1244],
3	biochemist	NN	O	biochemist	nsubj	11	SENT_114	[p8l765t1178r1190b1244],
4	and	CC	O	and	_	0	SENT_114	[p8l1227t1178r1363b1244],
5	pharmacology	NN	O	pharmacology	nn	6	SENT_114	[p8l1399t1178r1951b1265],
6	specialist	NN	O	specialist	conj_and	3	SENT_114	[p8l1991t1199r2143b1265, p8l8t1293r239b1360],
7	(	CD	NUMBER	(	num	9	SENT_114	[p8l291t1294r550b1376],
8	M.N.	NNP	PERSON	M.N.	nn	9	SENT_114	[p8l291t1294r550b1376],
9	)	NNP	O	)	dep	3	SENT_114	[p8l291t1294r550b1376],
10	was	VBD	O	be	cop	11	SENT_114	[p8l603t1315r748b1360],
11	responsible	JJ	O	responsible	_	0	SENT_114	[p8l799t1293r1238b1380],
12	for	IN	O	for	_	0	SENT_114	[p8l1289t1293r1400b1360],
13	the	DT	O	the	det	15	SENT_114	[p8l1449t1293r1564b1360],
14	study	NN	O	study	nn	15	SENT_114	[p8l1618t1293r1822b1380],
15	design	NN	O	design	prep_for	11	SENT_114	[p8l1873t1293r2142b1380],
16	,	,	O	,	_	0	SENT_114	[p8l1873t1293r2142b1380],
17	the	DT	O	the	det	19	SENT_114	[p8l7t1408r122b1475],
18	laboratory	NN	O	laboratory	nn	19	SENT_114	[p8l156t1408r551b1495],
19	diagnosis	NN	O	diagnosis	prep_for	11	SENT_114	[p8l585t1408r966b1495],
20	,	,	O	,	_	0	SENT_114	[p8l585t1408r966b1495],
21	and	CC	O	and	_	0	SENT_114	[p8l1005t1408r1140b1475],
22	the	DT	O	the	det	24	SENT_114	[p8l1172t1408r1287b1475],
23	technical	JJ	O	technical	amod	24	SENT_114	[p8l1319t1408r1667b1475],
24	procedures	NNS	O	procedure	prep_for	11	SENT_114	[p8l1700t1408r2143b1495],
25	,	,	O	,	_	0	SENT_114	[p8l1700t1408r2143b1495],
26	as	IN	O	as	_	0	SENT_114	[p8l9t1544r83b1590],
27	Well	NNP	O	Well	prep_as	11	SENT_114	[p8l107t1523r270b1590],
28	as	IN	O	as	_	0	SENT_114	[p8l294t1544r368b1590],
29	writing	VBG	O	write	prepc_as	27	SENT_114	[p8l392t1523r666b1610],
30	the	DT	O	the	det	31	SENT_114	[p8l689t1523r804b1590],
31	article	NN	O	article	dobj	29	SENT_114	[p8l828t1523r1066b1590],
32	with	IN	O	with	_	0	SENT_114	[p8l1086t1523r1256b1590],
33	the	DT	O	the	det	35	SENT_114	[p8l1277t1523r1392b1590],
34	toxicology	NN	O	toxicology	nn	35	SENT_114	[p8l1414t1523r1825b1610],
35	specialist	NN	O	specialist	prep_with	29	SENT_114	[p8l1851t1523r2144b1610, p8l7t1638r98b1705],
36	(	CD	NUMBER	(	num	38	SENT_114	[p8l132t1639r393b1722],
37	R.N.	NN	O	r.n.	nn	38	SENT_114	[p8l132t1639r393b1722],
38	)	NN	O	)	dep	35	SENT_114	[p8l132t1639r393b1722],
39	.	.	O	.	_	0	SENT_114	[p8l132t1639r393b1722],

1	Ethical	JJ	O	ethical	amod	2	SENT_115	[p8l430t1638r702b1705],
2	approval	NN	O	approval	nsubjpass	7	SENT_115	[p8l738t1638r1069b1725],
3	for	IN	O	for	_	0	SENT_115	[p8l1103t1638r1215b1705],
4	the	DT	O	the	det	5	SENT_115	[p8l1246t1638r1361b1705],
5	study	NN	O	study	prep_for	2	SENT_115	[p8l1399t1638r1600b1725],
6	was	VBD	O	be	auxpass	7	SENT_115	[p8l1635t1660r1779b1706],
7	obtained	VBN	O	obtain	_	0	SENT_115	[p8l1816t1638r2147b1705],
8	from	IN	O	from	_	0	SENT_115	[p8l8t1753r194b1820],
9	the	DT	O	the	det	10	SENT_115	[p8l231t1753r346b1820],
10	Scientiﬁc	NNP	O	Scientiﬁc	prep_from	7	SENT_115	[p8l387t1753r745b1820],
11	and	CC	O	and	_	0	SENT_115	[p8l788t1753r924b1820],
12	Ethics	NNP	O	Ethics	nn	14	SENT_115	[p8l960t1753r1198b1820],
13	Review	NNP	O	Review	nn	14	SENT_115	[p8l1237t1753r1527b1820],
14	Committees	NNS	O	committee	prep_from	7	SENT_115	[p8l1566t1753r2029b1820],
15	of	IN	O	of	_	0	SENT_115	[p8l2070t1753r2153b1820],
16	the	DT	O	the	det	20	SENT_115	[p8l7t1868r123b1935],
17	North	NNP	ORGANIZATION	North	nn	20	SENT_115	[p8l177t1868r401b1936],
18	York	NNP	ORGANIZATION	York	nn	20	SENT_115	[p8l454t1868r642b1935],
19	General	NNP	ORGANIZATION	General	nn	20	SENT_115	[p8l695t1868r996b1936],
20	Hospital	NNP	ORGANIZATION	Hospital	prep_of	7	SENT_115	[p8l1051t1868r1396b1955],
21	,	,	O	,	_	0	SENT_115	[p8l1051t1868r1396b1955],
22	Toronto	NNP	LOCATION	Toronto	nn	24	SENT_115	[p8l1454t1870r1777b1948],
23	,	,	O	,	_	0	SENT_115	[p8l1454t1870r1777b1948],
24	Canada	NNP	LOCATION	Canada	appos	20	SENT_115	[p8l1835t1868r2140b1936],
25	.	.	O	.	_	0	SENT_115	[p8l1835t1868r2140b1936],

1	All	DT	O	all	det	2	SENT_116	[p8l7t1983r128b2049],
2	patients	NNS	O	patient	nsubj	3	SENT_116	[p8l171t1983r469b2070],
3	signed	VBD	O	sign	_	0	SENT_116	[p8l518t1983r765b2070],
4	an	DT	O	a	det	7	SENT_116	[p8l810t2004r897b2050],
5	informed	VBN	O	inform	amod	7	SENT_116	[p8l940t1983r1293b2050],
6	consent	NN	O	consent	nn	7	SENT_116	[p8l1337t1993r1630b2050],
7	form	NN	O	form	dobj	3	SENT_116	[p8l1673t1983r1859b2050],
8	before	IN	O	before	_	0	SENT_116	[p8l1900t1983r2146b2050],
9	participating	VBG	O	participate	prepc_before	3	SENT_116	[p8l6t2098r494b2185],
10	in	IN	O	in	_	0	SENT_116	[p8l538t2098r611b2164],
11	the	DT	O	the	det	12	SENT_116	[p8l652t2098r767b2165],
12	study	NN	O	study	prep_in	9	SENT_116	[p8l813t2098r1030b2185],
13	.	.	O	.	_	0	SENT_116	[p8l813t2098r1030b2185],

1	The	DT	O	the	det	2	SENT_117	[p8l1076t2098r1224b2165],
2	LTA	NNP	ORGANIZATION	LTA	nsubjpass	4	SENT_117	[p8l1265t2098r1436b2164],
3	was	VBD	O	be	auxpass	4	SENT_117	[p8l1470t2119r1614b2165],
4	performed	VBN	O	perform	_	0	SENT_117	[p8l1657t2098r2060b2185],
5	2	CD	DURATION	2	number	7	SENT_117	[p8l2102t2098r2145b2164],
6	to	TO	DURATION	to	dep	7	SENT_117	[p8l7t2223r79b2280],
7	3	CD	DURATION	3	num	8	SENT_117	[p8l122t2214r160b2281],
8	years	NNS	NUMBER	year	npadvmod	4	SENT_117	[p8l203t2235r402b2300],
9	after	IN	O	after	_	0	SENT_117	[p8l445t2213r620b2280],
10	the	DT	O	the	det	11	SENT_117	[p8l657t2213r773b2280],
11	HSR	NN	O	hsr	prep_after	4	SENT_117	[p8l812t2214r997b2281],
12	in	IN	O	in	_	0	SENT_117	[p8l1035t2213r1108b2280],
13	patients	NNS	O	patient	prep_in	11	SENT_117	[p8l1145t2213r1443b2300],
14	presenting	VBG	O	present	partmod	13	SENT_117	[p8l1483t2213r1884b2300],
15	at	IN	O	at	_	0	SENT_117	[p8l1925t2223r1993b2280],
16	the	DT	O	the	det	17	SENT_117	[p8l2030t2213r2145b2280],
17	clinic	NN	O	clinic	prep_at	14	SENT_117	[p8l8t2328r220b2395],
18	with	IN	O	with	_	0	SENT_117	[p8l259t2328r428b2395],
19	a	DT	O	a	det	21	SENT_117	[p8l468t2350r507b2395],
20	non-active	JJ	O	non-active	amod	21	SENT_117	[p8l544t2328r948b2395],
21	ADR	NN	O	adr	prep_with	17	SENT_117	[p8l985t2329r1206b2395],
22	.	.	O	.	_	0	SENT_117	[p8l985t2329r1206b2395],

1	A	DT	O	a	det	4	SENT_118	[p8l1248t2329r1315b2394],
2	single	JJ	O	single	amod	4	SENT_118	[p8l1356t2328r1580b2415],
3	blood	NN	O	blood	nn	4	SENT_118	[p8l1618t2328r1837b2395],
4	sample	NN	O	sample	nsubjpass	6	SENT_118	[p8l1878t2328r2145b2415],
5	was	VBD	O	be	auxpass	6	SENT_118	[p8l8t2464r153b2510],
6	drawn	VBN	O	draw	_	0	SENT_118	[p8l180t2443r417b2510],
7	from	IN	O	from	_	0	SENT_118	[p8l441t2443r627b2510],
8	each	DT	O	each	det	9	SENT_118	[p8l652t2443r826b2510],
9	patient	NN	O	patient	prep_from	6	SENT_118	[p8l849t2443r1133b2530],
10	,	,	O	,	_	0	SENT_118	[p8l849t2443r1133b2530],
11	which	WDT	O	which	nsubjpass	13	SENT_118	[p8l1161t2443r1394b2510],
12	was	VBD	O	be	auxpass	13	SENT_118	[p8l1419t2464r1564b2510],
13	used	VBN	O	use	rcmod	9	SENT_118	[p8l1589t2443r1765b2510],
14	to	TO	O	to	aux	15	SENT_118	[p8l1788t2453r1860b2510],
15	extract	VB	O	extract	ccomp	13	SENT_118	[p8l1886t2453r2147b2510],
16	the	DT	O	the	det	17	SENT_118	[p8l7t2558r123b2624],
17	lymphocytes	NNS	O	lymphocyte	dobj	15	SENT_118	[p8l155t2558r644b2645],
18	for	IN	O	for	_	0	SENT_118	[p8l677t2557r788b2624],
19	the	DT	O	the	det	20	SENT_118	[p8l817t2558r932b2624],
20	LTA	NNP	ORGANIZATION	LTA	prep_for	15	SENT_118	[p8l963t2558r1134b2624],
21	and	CC	O	and	_	0	SENT_118	[p8l1166t2558r1302b2624],
22	to	TO	O	to	aux	23	SENT_118	[p8l1332t2568r1404b2624],
23	obtain	VB	O	obtain	ccomp	13	SENT_118	[p8l1436t2558r1675b2624],
24	the	DT	O	the	det	25	SENT_118	[p8l1706t2558r1821b2624],
25	sera	NNS	O	serum	dobj	23	SENT_118	[p8l1855t2579r2007b2624],
26	for	IN	O	for	_	0	SENT_118	[p8l2036t2558r2148b2624],
27	the	DT	O	the	det	29	SENT_118	[p8l7t2673r123b2740],
28	cytokine	NN	O	cytokine	nn	29	SENT_118	[p8l160t2673r488b2760],
29	analysis	NN	O	analysis	prep_for	23	SENT_118	[p8l527t2673r854b2760],
30	.	.	O	.	_	0	SENT_118	[p8l527t2673r854b2760],

1	Anonymous	JJ	O	anonymous	amod	3	SENT_119	[p8l894t2674r1361b2760],
2	clinical	JJ	O	clinical	amod	3	SENT_119	[p8l1399t2673r1681b2740],
3	description	NN	O	description	nsubjpass	5	SENT_119	[p8l1719t2673r2146b2760],
4	was	VBD	O	be	auxpass	5	SENT_119	[p8l8t2809r153b2855],
5	matched	VBN	O	match	_	0	SENT_119	[p8l185t2788r512b2854],
6	to	TO	O	to	_	0	SENT_119	[p8l541t2797r613b2854],
7	each	DT	O	each	det	8	SENT_119	[p8l645t2788r819b2854],
8	sample	NN	O	sample	prep_to	5	SENT_119	[p8l852t2788r1140b2875],
9	.	.	O	.	_	0	SENT_119	[p8l852t2788r1140b2875],

1	Chemicals	NNS	O	chemical	_	0	SENT_120	[p8l95t2911r507b2970],
2	.	.	O	.	_	0	SENT_120	[p8l95t2911r507b2970],

1	Chemicals	NNS	O	chemical	nsubjpass	3	SENT_121	[p8l553t2903r957b2970],
2	were	VBD	O	be	auxpass	3	SENT_121	[p8l997t2924r1181b2970],
3	purchased	VBN	O	purchase	_	0	SENT_121	[p8l1219t2903r1609b2990],
4	from	IN	O	from	_	0	SENT_121	[p8l1647t2903r1833b2970],
5	SigmaAldrich	NNP	O	SigmaAldrich	nn	8	SENT_121	[p8l1872t2903r2143b2990, p8l7t3018r301b3085],
6	(	CD	NUMBER	(	num	8	SENT_121	[p8l352t3018r478b3101],
7	St.	NNP	LOCATION	St.	nn	8	SENT_121	[p8l352t3018r478b3101],
8	Louis	NNP	LOCATION	Louis	prep_from	3	SENT_121	[p8l531t3018r769b3098],
9	,	,	O	,	_	0	SENT_121	[p8l531t3018r769b3098],
10	Mo	NNP	LOCATION	Mo	nn	11	SENT_121	[p8l821t3018r1004b3101],
11	)	NNP	O	)	appos	8	SENT_121	[p8l821t3018r1004b3101],
12	.	.	O	.	_	0	SENT_121	[p8l821t3018r1004b3101],

1	Microsomes	NNS	O	microsome	nsubjpass	3	SENT_122	[p8l1057t3018r1531b3085],
2	were	VBD	O	be	auxpass	3	SENT_122	[p8l1582t3039r1765b3085],
3	obtained	VBN	O	obtain	_	0	SENT_122	[p8l1816t3018r2147b3085],
4	from	IN	O	from	_	0	SENT_122	[p8l8t3134r194b3201],
5	mice	NNS	O	mouse	prep_from	3	SENT_122	[p8l238t3134r424b3201],
6	induced	VBN	O	induce	partmod	5	SENT_122	[p8l471t3134r776b3201],
7	to	TO	O	to	_	0	SENT_122	[p8l820t3144r892b3201],
8	a	DT	O	a	det	11	SENT_122	[p8l941t3156r981b3201],
9	certain	JJ	O	certain	amod	11	SENT_122	[p8l1026t3134r1287b3201],
10	cytochrome	NN	O	cytochrome	nn	11	SENT_122	[p8l1333t3134r1786b3221],
11	p450	NN	O	p450	prep_to	6	SENT_122	[p8l1831t3134r2022b3221],
12	as	IN	O	as	mark	14	SENT_122	[p8l2070t3156r2144b3201],
13	previously	RB	DATE	previously	advmod	14	SENT_122	[p8l6t3250r411b3337],
14	described	VBN	O	describe	advcl	6	SENT_122	[p8l455t3229r915b3317],
15	.53	CD	NUMBER	.53	dobj	14	SENT_122	[p8l455t3229r915b3317],
16	The	DT	O	the	det	18	SENT_122	[p8l961t3250r1109b3317],
17	microsomal	JJ	O	microsomal	amod	18	SENT_122	[p8l1151t3250r1605b3317],
18	solution	NN	O	solution	nsubjpass	20	SENT_122	[p8l1651t3250r1957b3317],
19	was	VBD	O	be	auxpass	20	SENT_122	[p8l1999t3271r2144b3317],
20	diluted	VBN	O	dilute	rcmod	15	SENT_122	[p8l8t3365r276b3432],
21	in	IN	O	in	_	0	SENT_122	[p8l306t3365r379b3431],
22	HEPES	NN	O	hepe	nn	23	SENT_122	[p8l409t3365r696b3432],
23	buffer	NN	O	buffer	prep_in	20	SENT_122	[p8l730t3365r976b3432],
24	.	.	O	.	_	0	SENT_122	[p8l730t3365r976b3432],

1	Gibco	NNP	O	Gibco	nsubj	11	SENT_123	[p8l1013t3365r1244b3432],
2	(	CD	NUMBER	(	num	1	SENT_123	[p8l1280t3365r1747b3452],
3	InVitrogen	NNP	ORGANIZATION	InVitrogen	nn	7	SENT_123	[p8l1280t3365r1747b3452],
4	,	,	O	,	_	0	SENT_123	[p8l1280t3365r1747b3452],
5	Carlsbad	NNP	LOCATION	Carlsbad	appos	7	SENT_123	[p8l1781t3365r2143b3444],
6	,	,	O	,	_	0	SENT_123	[p8l1781t3365r2143b3444],
7	Calif	NNP	LOCATION	Calif	dep	1	SENT_123	[p8l8t3479r228b3561],
8	)	CD	NUMBER	)	num	7	SENT_123	[p8l8t3479r228b3561],
9	is	VBZ	O	be	cop	11	SENT_123	[p8l299t3479r358b3546],
10	the	DT	O	the	det	11	SENT_123	[p8l427t3479r542b3546],
11	manufacture	NN	O	manufacture	_	0	SENT_123	[p8l610t3479r1091b3546],
12	of	IN	O	of	_	0	SENT_123	[p8l1161t3479r1244b3546],
13	Dulbecco	NNP	PERSON	Dulbecco	poss	17	SENT_123	[p8l1305t3479r1736b3546],
14	’s	POS	O	’s	_	0	SENT_123	[p8l1305t3479r1736b3546],
15	modiﬁed	JJ	O	modiﬁed	amod	17	SENT_123	[p8l1804t3479r2147b3546],
16	eagle	NN	O	eagle	nn	17	SENT_123	[p8l8t3594r210b3681],
17	medium	NN	O	medium	prep_of	11	SENT_123	[p8l251t3594r567b3660],
18	(	CD	NUMBER	(	num	20	SENT_123	[p8l610t3594r1011b3676],
19	oz-MEM	NN	O	oz-mem	nn	20	SENT_123	[p8l610t3594r1011b3676],
20	)	NN	O	)	dep	17	SENT_123	[p8l610t3594r1011b3676],
21	.	.	O	.	_	0	SENT_123	[p8l610t3594r1011b3676],

1	Generic	JJ	O	generic	amod	2	SENT_124	[p8l1058t3594r1358b3661],
2	drugs	NNS	O	drug	nsubj	3	SENT_124	[p8l1402t3594r1611b3681],
3	(	VBP	O	(	_	0	SENT_124	[p8l1657t3594r1892b3676],
4	CBZ	NN	ORGANIZATION	cbz	nn	7	SENT_124	[p8l1657t3594r1892b3676],
5	,	,	O	,	_	0	SENT_124	[p8l1657t3594r1892b3676],
6	LTG	NN	O	ltg	dep	7	SENT_124	[p8l1937t3594r2143b3676],
7	)	NN	O	)	nsubjpass	9	SENT_124	[p8l1937t3594r2143b3676],
8	were	VBD	O	be	auxpass	9	SENT_124	[p8l8t3731r192b3777],
9	manufactured	VBN	O	manufacture	ccomp	3	SENT_124	[p8l266t3709r797b3776],
10	by	IN	O	by	_	0	SENT_124	[p8l869t3709r963b3796],
11	Apotex	NNP	ORGANIZATION	Apotex	nn	15	SENT_124	[p8l1036t3710r1318b3796],
12	Inc.	NNP	ORGANIZATION	Inc.	nn	15	SENT_124	[p8l1391t3711r1531b3776],
13	(	CD	NUMBER	(	num	15	SENT_124	[p8l1612t3709r1865b3793],
14	North	NNP	LOCATION	North	nn	15	SENT_124	[p8l1612t3709r1865b3793],
15	York	NNP	LOCATION	York	agent	9	SENT_124	[p8l1937t3709r2143b3789],
16	,	,	O	,	_	0	SENT_124	[p8l1937t3709r2143b3789],

1	Ontario	NNP	LOCATION	Ontario	nn	3	SENT_125	[p9l9t21r322b100],
2	,	,	O	,	_	0	SENT_125	[p9l9t21r322b100],
3	Canada	NNP	LOCATION	Canada	_	0	SENT_125	[p9l362t21r669b100],
4	,	,	O	,	_	0	SENT_125	[p9l362t21r669b100],
5	http://www.apotex.con1/ca/en/search	NN	O	http://www.apotex.con1/ca/en/search	appos	3	SENT_125	[p9l709t21r2140b108],
6	.	.	O	.	_	0	SENT_125	[p9l709t21r2140b108],

1	asp	NN	O	asp	_	0	SENT_126	[p9l10t137r185b223],
2	)	NN	O	)	dep	1	SENT_126	[p9l10t137r185b223],
3	.	.	O	.	_	0	SENT_126	[p9l10t137r185b223],

1	Preparation	NN	O	preparation	_	0	SENT_127	[p9l99t260r520b331],
2	of	IN	O	of	_	0	SENT_127	[p9l546t259r615b319],
3	the	DT	O	the	det	4	SENT_127	[p9l635t260r752b319],
4	LTA	NNP	ORGANIZATION	LTA	prep_of	1	SENT_127	[p9l778t260r913b317],
5	.	.	O	.	_	0	SENT_127	[p9l778t260r913b317],

1	Samples	NNS	O	sample	nsubj	10	SENT_128	[p9l960t251r1276b338],
2	belonging	VBG	O	belong	partmod	1	SENT_128	[p9l1300t251r1678b338],
3	to	TO	O	to	_	0	SENT_128	[p9l1703t261r1775b318],
4	both	DT	O	both	preconj	5	SENT_128	[p9l1798t251r1968b318],
5	sensitive	JJ	O	sensitive	amod	8	SENT_128	[p9l1994t273r2144b318, p9l11t366r207b433],
6	and	CC	O	and	_	0	SENT_128	[p9l229t366r364b433],
7	tolerant	JJ	O	tolerant	amod	8	SENT_128	[p9l382t366r672b433],
8	patients	NNS	O	patient	prep_to	2	SENT_128	[p9l689t366r981b453],
9	were	VBD	O	be	aux	10	SENT_128	[p9l1003t387r1183b433],
10	incubated	VBN	O	incubate	_	0	SENT_128	[p9l1204t366r1572b433],
11	in	IN	O	in	_	0	SENT_128	[p9l1591t366r1664b432],
12	the	DT	O	the	det	13	SENT_128	[p9l1682t366r1796b433],
13	presence	NN	O	presence	prep_in	10	SENT_128	[p9l1815t387r2146b453],
14	or	CC	O	or	_	0	SENT_128	[p9l9t502r87b547],
15	absence	NN	O	absence	conj_or	13	SENT_128	[p9l116t481r413b547],
16	of	IN	O	of	_	0	SENT_128	[p9l445t480r528b547],
17	the	DT	O	the	det	19	SENT_128	[p9l551t481r664b547],
18	microsomal	JJ	O	microsomal	amod	19	SENT_128	[p9l695t481r1141b547],
19	fraction	NN	O	fraction	prep_of	13	SENT_128	[p9l1172t480r1466b547],
20	as	IN	O	as	_	0	SENT_128	[p9l1496t502r1570b547],
21	previously	RB	DATE	previously	advmod	22	SENT_128	[p9l1600t480r1996b568],
22	described	VBN	O	describe	conj_as	10	SENT_128	[p9l2028t481r2144b547, p9l11t575r371b663],
23	.53	CD	NUMBER	.53	dobj	22	SENT_128	[p9l2028t481r2144b547, p9l11t575r371b663],
24	The	DT	O	the	det	26	SENT_128	[p9l408t596r554b663],
25	parent	NN	O	parent	nn	26	SENT_128	[p9l587t606r826b683],
26	drug	NN	O	drug	nsubjpass	28	SENT_128	[p9l859t596r1030b683],
27	was	VBD	O	be	auxpass	28	SENT_128	[p9l1064t618r1207b663],
28	added	VBN	O	add	rcmod	23	SENT_128	[p9l1246t596r1470b663],
29	at	IN	O	at	_	0	SENT_128	[p9l1506t606r1572b663],
30	its	PRP$	O	its	poss	32	SENT_128	[p9l1605t596r1691b663],
31	therapeutic	JJ	O	therapeutic	amod	32	SENT_128	[p9l1726t596r2144b683],
32	concentration	NN	O	concentration	prep_at	28	SENT_128	[p9l8t690r614b779],
33	.53	CD	NUMBER	.53	tmod	28	SENT_128	[p9l8t690r614b779],
34	The	DT	O	the	det	36	SENT_128	[p9l739t712r885b779],
35	HLA	NN	O	hlum	nn	36	SENT_128	[p9l1009t712r1203b778],
36	polymorphism	NN	O	polymorphism	nsubjpass	38	SENT_128	[p9l1325t712r1879b799],
37	was	VBD	O	be	auxpass	38	SENT_128	[p9l2002t733r2144b779],
38	determined	VBN	O	determine	rcmod	33	SENT_128	[p9l9t827r435b894],
39	using	VBG	O	use	xcomp	38	SENT_128	[p9l491t827r694b914],
40	the	DT	O	the	det	41	SENT_128	[p9l752t827r866b894],
41	method	NN	O	method	dobj	39	SENT_128	[p9l924t827r1209b894],
42	described	VBN	O	describe	partmod	41	SENT_128	[p9l1266t827r1628b894],
43	by	IN	O	by	_	0	SENT_128	[p9l1683t827r1778b914],
44	Kazeem	NNP	PERSON	Kazeem	agent	42	SENT_128	[p9l1838t829r2148b894],
45	et	FW	O	et	nn	46	SENT_128	[p9l8t952r76b1010],
46	al.	FW	O	al.	dep	33	SENT_128	[p9l102t922r259b1010],
47	58	CD	NUMBER	58	dobj	10	SENT_128	[p9l102t922r259b1010],

1	Enzyme-linked	JJ	O	enzyme-linked	amod	3	SENT_129	[p9l94t1057r686b1144],
2	immunosorbent	JJ	O	immunosorbent	amod	3	SENT_129	[p9l728t1057r1335b1124],
3	assay	NN	O	assay	_	0	SENT_129	[p9l1380t1079r1584b1144],
4	(	CD	NUMBER	(	num	7	SENT_129	[p9l1632t1058r1961b1141],
5	ELISA	NN	ORGANIZATION	elisa	nn	7	SENT_129	[p9l1632t1058r1961b1141],
6	)	CD	NUMBER	)	num	7	SENT_129	[p9l1632t1058r1961b1141],
7	kits	NNS	O	kit	dep	3	SENT_129	[p9l2008t1057r2144b1124],
8	for	IN	O	for	_	0	SENT_129	[p9l8t1172r119b1239],
9	human	JJ	O	human	amod	26	SENT_129	[p9l163t1172r424b1239],
10	IL-1	NN	O	il-1	nn	26	SENT_129	[p9l469t1173r659b1251],
11	,	,	O	,	_	0	SENT_129	[p9l469t1173r659b1251],
12	IL-2	NN	O	il-2	dep	26	SENT_129	[p9l709t1173r898b1251],
13	,	,	O	,	_	0	SENT_129	[p9l709t1173r898b1251],
14	IL-4	NN	O	il-4	dep	26	SENT_129	[p9l948t1173r1137b1252],
15	,	,	O	,	_	0	SENT_129	[p9l948t1173r1137b1252],
16	IL-5	NN	O	il-5	dep	26	SENT_129	[p9l1187t1172r1377b1252],
17	,	,	O	,	_	0	SENT_129	[p9l1187t1172r1377b1252],
18	IL-6	NN	O	il-6	dep	26	SENT_129	[p9l1427t1172r1616b1252],
19	,	,	O	,	_	0	SENT_129	[p9l1427t1172r1616b1252],
20	IL-8	NN	O	il-8	dep	26	SENT_129	[p9l1665t1173r1855b1252],
21	,	,	O	,	_	0	SENT_129	[p9l1665t1173r1855b1252],
22	IL-10	NN	O	il-10	dep	26	SENT_129	[p9l1904t1173r2142b1252],
23	,	,	O	,	_	0	SENT_129	[p9l1904t1173r2142b1252],
24	monocyte	NN	O	monocyte	dep	26	SENT_129	[p9l7t1297r386b1374],
25	chemoattractant	NN	O	chemoattractant	nn	26	SENT_129	[p9l423t1287r1041b1354],
26	protein	NN	O	protein	prep_for	7	SENT_129	[p9l1075t1287r1348b1374],
27	(	CD	NUMBER	(	num	29	SENT_129	[p9l1387t1287r1750b1370],
28	MCP	NN	O	mcp	nn	29	SENT_129	[p9l1387t1287r1750b1370],
29	)	NN	O	)	dep	26	SENT_129	[p9l1387t1287r1750b1370],
30	.	.	O	.	_	0	SENT_129	[p9l1387t1287r1750b1370],

1	—	NN	O	—	_	0	SENT_130	[p9l1387t1287r1750b1370],
2	.	.	O	.	_	0	SENT_130	[p9l1387t1287r1750b1370],

1	1	CD	NUMBER	1	nsubjpass	45	SENT_131	[p9l1387t1287r1750b1370],
2	,	,	O	,	_	0	SENT_131	[p9l1387t1287r1750b1370],
3	regulated	VBN	O	regulate	partmod	1	SENT_131	[p9l1788t1287r2147b1374],
4	upon	IN	O	upon	_	0	SENT_131	[p9l7t1423r198b1489],
5	activation	NN	O	activation	nn	7	SENT_131	[p9l242t1402r616b1469],
6	normal	JJ	O	normal	amod	7	SENT_131	[p9l657t1402r928b1468],
7	T-cell	NN	MISC	t-cell	prep_upon	3	SENT_131	[p9l971t1402r1191b1468],
8	expressed	VBN	O	express	partmod	7	SENT_131	[p9l1234t1402r1612b1489],
9	and	CC	O	and	_	0	SENT_131	[p9l1654t1402r1790b1468],
10	secreted	VBN	O	secrete	partmod	7	SENT_131	[p9l1834t1402r2147b1468],
11	(	JJ	O	(	amod	13	SENT_131	[p9l10t1518r442b1600],
12	RANTES	NN	O	rante	nn	13	SENT_131	[p9l10t1518r442b1600],
13	)	NN	O	)	dobj	8	SENT_131	[p9l10t1518r442b1600],
14	and	CC	O	and	_	0	SENT_131	[p9l515t1517r650b1584],
15	TNF-a	NN	O	tnf-a	nn	17	SENT_131	[p9l718t1519r985b1584],
16	(	CD	NUMBER	(	num	17	SENT_131	[p9l1060t1517r1607b1600],
17	e-Bioscience	NN	O	e-bioscience	dobj	8	SENT_131	[p9l1060t1517r1607b1600],
18	,	,	O	,	_	0	SENT_131	[p9l1060t1517r1607b1600],
19	San	NNP	LOCATION	San	nn	20	SENT_131	[p9l1682t1518r1822b1585],
20	Diego	NNP	LOCATION	Diego	dobj	3	SENT_131	[p9l1889t1517r2143b1604],
21	,	,	O	,	_	0	SENT_131	[p9l1889t1517r2143b1604],
22	Calif	NNP	LOCATION	Calif	nn	23	SENT_131	[p9l8t1632r252b1715],
23	)	NNP	O	)	appos	20	SENT_131	[p9l8t1632r252b1715],
24	,	,	O	,	_	0	SENT_131	[p9l8t1632r252b1715],
25	as	RB	O	as	_	0	SENT_131	[p9l326t1653r400b1699],
26	well	RB	O	well	_	0	SENT_131	[p9l472t1632r634b1699],
27	as	IN	O	as	_	0	SENT_131	[p9l706t1653r780b1699],
28	Fas	NN	O	fa	dobj	3	SENT_131	[p9l849t1634r1001b1711],
29	,	,	O	,	_	0	SENT_131	[p9l849t1634r1001b1711],
30	cleaved	VBN	O	cleave	partmod	28	SENT_131	[p9l1074t1632r1366b1699],
31	caspase	NN	O	caspase	dobj	30	SENT_131	[p9l1435t1653r1727b1719],
32	8	CD	NUMBER	8	num	31	SENT_131	[p9l1800t1632r1862b1711],
33	,	,	O	,	_	0	SENT_131	[p9l1800t1632r1862b1711],
34	M30Apoptosense	NN	O	m30apoptosense	nn	37	SENT_131	[p9l1934t1632r2143b1699, p9l7t1748r503b1834],
35	(	CD	NUMBER	(	num	37	SENT_131	[p9l552t1747r860b1830],
36	Bender	NNP	PERSON	Bender	nn	37	SENT_131	[p9l552t1747r860b1830],
37	MedSystems	NNP	PERSON	MedSystems	appos	31	SENT_131	[p9l902t1747r1419b1834],
38	,	,	O	,	_	0	SENT_131	[p9l902t1747r1419b1834],
39	Vienna	NNP	LOCATION	Vienna	appos	31	SENT_131	[p9l1467t1747r1759b1826],
40	,	,	O	,	_	0	SENT_131	[p9l1467t1747r1759b1826],
41	Austria	NNP	LOCATION	Austria	nn	42	SENT_131	[p9l1808t1747r2142b1830],
42	)	NNP	O	)	appos	31	SENT_131	[p9l1808t1747r2142b1830],
43	,	,	O	,	_	0	SENT_131	[p9l1808t1747r2142b1830],
44	were	VBD	O	be	auxpass	45	SENT_131	[p9l8t1883r192b1929],
45	used	VBN	O	use	_	0	SENT_131	[p9l217t1862r392b1929],
46	for	IN	O	for	_	0	SENT_131	[p9l416t1862r528b1929],
47	quantitative	JJ	O	quantitative	amod	48	SENT_131	[p9l551t1862r1004b1949],
48	determination	NN	O	determination	prep_for	45	SENT_131	[p9l1029t1862r1583b1929],
49	.	.	O	.	_	0	SENT_131	[p9l1029t1862r1583b1929],

1	We	PRP	O	we	nsubj	2	SENT_132	[p9l1612t1864r1737b1929],
2	used	VBD	O	use	_	0	SENT_132	[p9l1762t1862r1937b1929],
3	standards	NNS	O	standard	nsubj	7	SENT_132	[p9l1964t1872r2143b1929, p9l8t1977r212b2043],
4	and	CC	O	and	_	0	SENT_132	[p9l267t1977r403b2043],
5	reference	NN	O	reference	nn	6	SENT_132	[p9l453t1977r811b2043],
6	reagents	NNS	O	reagent	conj_and	3	SENT_132	[p9l862t1987r1182b2064],
7	available	JJ	O	available	xcomp	2	SENT_132	[p9l1237t1977r1580b2044],
8	from	IN	O	from	_	0	SENT_132	[p9l1632t1977r1819b2043],
9	Bender	NNP	PERSON	Bender	nn	12	SENT_132	[p9l1869t1977r2147b2043],
10	MedSystems	NNP	PERSON	MedSystems	nn	12	SENT_132	[p9l7t2092r502b2179],
11	(	NNP	O	(	nn	12	SENT_132	[p9l562t2092r883b2175],
12	Vienna	NNP	LOCATION	Vienna	prep_from	7	SENT_132	[p9l562t2092r883b2175],
13	,	,	O	,	_	0	SENT_132	[p9l562t2092r883b2175],
14	Austria	NNP	LOCATION	Austria	appos	12	SENT_132	[p9l941t2092r1275b2175],
15	)	CD	NUMBER	)	num	14	SENT_132	[p9l941t2092r1275b2175],
16	.	.	O	.	_	0	SENT_132	[p9l941t2092r1275b2175],

1	Each	DT	O	each	det	2	SENT_133	[p9l1334t2092r1526b2159],
2	specimen	NN	O	specimen	nsubjpass	4	SENT_133	[p9l1584t2092r1945b2179],
3	was	VBD	O	be	auxpass	4	SENT_133	[p9l1999t2114r2144b2160],
4	analyzed	VBN	O	analyze	_	0	SENT_133	[p9l9t2207r351b2294],
5	in	IN	O	in	_	0	SENT_133	[p9l398t2207r471b2273],
6	triplicate	NN	O	triplicate	prep_in	4	SENT_133	[p9l518t2207r860b2294],
7	with	IN	O	with	_	0	SENT_133	[p9l908t2207r1076b2274],
8	95	CD	PERCENT	95	number	9	SENT_133	[p9l1125t2207r1294b2275],
9	%	NN	PERCENT	%	amod	10	SENT_133	[p9l1125t2207r1294b2275],
10	sensitivity	NN	O	sensitivity	prep_with	4	SENT_133	[p9l1349t2207r1739b2294],
11	and	CC	O	and	_	0	SENT_133	[p9l1789t2207r1925b2274],
12	90	CD	PERCENT	90	number	13	SENT_133	[p9l1973t2207r2142b2275],
13	%	NN	PERCENT	%	amod	14	SENT_133	[p9l1973t2207r2142b2275],
14	speciﬁcity	NN	O	speciﬁcity	prep_with	4	SENT_133	[p9l11t2322r417b2409],
15	.	.	O	.	_	0	SENT_133	[p9l11t2322r417b2409],

1	Calculations	NNS	O	calculation	_	0	SENT_134	[p9l95t2445r557b2505],
2	and	CC	O	and	_	0	SENT_134	[p9l601t2446r744b2505],
3	statistics	NNS	O	statistics	conj_and	1	SENT_134	[p9l789t2446r1110b2505],
4	.	.	O	.	_	0	SENT_134	[p9l789t2446r1110b2505],

1	LTA	NN	ORGANIZATION	lta	nn	2	SENT_135	[p9l1155t2438r1324b2503],
2	toxicity	NN	O	toxicity	nsubjpass	11	SENT_135	[p9l1368t2437r1654b2524],
3	higher	JJR	O	higher	amod	2	SENT_135	[p9l1699t2437r1943b2524],
4	than	IN	O	than	_	0	SENT_135	[p9l1985t2437r2146b2504],
5	12.5	CD	PERCENT	12.5	num	6	SENT_135	[p9l17t2552r246b2619],
6	%	NN	PERCENT	%	prep_than	3	SENT_135	[p9l17t2552r246b2619],
7	i	FW	O	i	dep	6	SENT_135	[p9l300t2558r357b2615],
8	2.5	CD	PERCENT	2.5	number	9	SENT_135	[p9l409t2552r600b2619],
9	%	NN	PERCENT	%	amod	2	SENT_135	[p9l409t2552r600b2619],
10	was	VBD	O	be	auxpass	11	SENT_135	[p9l643t2573r787b2619],
11	considered	VBN	O	consider	_	0	SENT_135	[p9l828t2552r1235b2619],
12	positive	JJ	O	positive	acomp	11	SENT_135	[p9l1272t2552r1586b2639],
13	.	.	O	.	_	0	SENT_135	[p9l1272t2552r1586b2639],

1	These	DT	O	these	det	4	SENT_136	[p9l1630t2552r1854b2619],
2	cut-off	JJ	O	cut-off	amod	4	SENT_136	[p9l1894t2552r2153b2619],
3	Translational	JJ	O	translational	amod	4	SENT_136	[p9l1315t2656r1772b2714],
4	Research	NN	O	research	_	0	SENT_136	[p9l1803t2656r2143b2714],
5	May	NNP	DATE	May	dep	4	SENT_136	[p9l1797t2751r1956b2823],
6	2012	CD	DATE	2012	num	5	SENT_136	[p9l1979t2750r2144b2809],

1	toxicity	NN	O	toxicity	nn	2	SENT_137	[p9l7t3018r292b3105],
2	values	NNS	O	value	nsubjpass	5	SENT_137	[p9l324t3018r559b3086],
3	were	VBD	O	be	auxpass	5	SENT_137	[p9l593t3040r775b3086],
4	previously	RB	DATE	previously	advmod	5	SENT_137	[p9l805t3018r1199b3105],
5	validated	VBN	O	validate	_	0	SENT_137	[p9l1231t2997r1665b3086],
6	.53	CD	NUMBER	.53	num	7	SENT_137	[p9l1231t2997r1665b3086],
7	Results	NNS	O	result	dobj	5	SENT_137	[p9l1699t3018r1973b3085],
8	that	WDT	O	that	nsubj	11	SENT_137	[p9l2005t3018r2146b3085],
9	do	VBP	O	do	aux	11	SENT_137	[p9l8t3133r99b3200],
10	not	RB	O	not	neg	11	SENT_137	[p9l127t3143r247b3200],
11	exceed	VB	O	exceed	rcmod	7	SENT_137	[p9l273t3133r534b3200],
12	these	DT	O	these	det	13	SENT_137	[p9l560t3133r752b3200],
13	parameters	NNS	O	parameter	nsubj	14	SENT_137	[p9l778t3143r1191b3220],
14	indicate	VBP	O	indicate	ccomp	11	SENT_137	[p9l1220t3133r1518b3200],
15	a	DT	O	a	det	17	SENT_137	[p9l1547t3155r1587b3200],
16	negative	JJ	O	negative	amod	17	SENT_137	[p9l1613t3133r1927b3220],
17	LTA	NN	ORGANIZATION	lta	dobj	14	SENT_137	[p9l1954t3134r2141b3200],
18	.	.	O	.	_	0	SENT_137	[p9l1954t3134r2141b3200],

1	Differences	NNS	O	difference	nsubj	12	SENT_138	[p9l7t3248r442b3315],
2	among	IN	O	among	_	0	SENT_138	[p9l482t3269r735b3335],
3	groups	NNS	O	group	prep_among	1	SENT_138	[p9l774t3269r1026b3335],
4	were	VBD	O	be	auxpass	5	SENT_138	[p9l1063t3269r1246b3315],
5	determined	VBN	O	determine	rcmod	3	SENT_138	[p9l1283t3248r1708b3315],
6	by	IN	O	by	_	0	SENT_138	[p9l1741t3248r1836b3335],
7	the	DT	O	the	det	8	SENT_138	[p9l1872t3248r1985b3315],
8	use	NN	O	use	agent	5	SENT_138	[p9l2020t3269r2145b3315],
9	of	IN	O	of	_	0	SENT_138	[p9l8t3363r91b3429],
10	conﬁdence	NN	O	conﬁdence	nn	11	SENT_138	[p9l131t3362r537b3429],
11	intervals	NNS	O	interval	prep_of	8	SENT_138	[p9l584t3362r904b3430],
12	(	VBP	O	(	_	0	SENT_138	[p9l955t3363r1105b3445],
13	CI	NN	O	ci	nn	14	SENT_138	[p9l955t3363r1105b3445],
14	)	NN	O	)	dobj	12	SENT_138	[p9l955t3363r1105b3445],
15	and	CC	O	and	_	0	SENT_138	[p9l1155t3363r1289b3429],
16	analysis	NN	O	analysis	dobj	12	SENT_138	[p9l1336t3363r1634b3450],
17	of	IN	O	of	_	0	SENT_138	[p9l1683t3363r1766b3429],
18	variance	NN	O	variance	prep_of	14	SENT_138	[p9l1805t3363r2140b3430],
19	.	.	O	.	_	0	SENT_138	[p9l1805t3363r2140b3430],

1	The	DT	O	the	det	3	SENT_139	[p9l7t3478r153b3545],
2	X2	NN	O	x2	nn	3	SENT_139	[p9l197t3457r284b3563],
3	test	NN	O	test	nsubjpass	9	SENT_139	[p9l327t3488r457b3545],
4	or	CC	O	or	_	0	SENT_139	[p9l500t3500r578b3545],
5	Fisher	NNP	O	Fisher	nn	7	SENT_139	[p9l617t3478r853b3545],
6	exact	JJ	O	exact	amod	7	SENT_139	[p9l894t3488r1093b3545],
7	test	NN	O	test	conj_or	3	SENT_139	[p9l1133t3488r1264b3545],
8	was	VBD	O	be	auxpass	9	SENT_139	[p9l1305t3500r1448b3545],
9	used	VBN	O	use	_	0	SENT_139	[p9l1492t3478r1665b3545],
10	to	TO	O	to	aux	11	SENT_139	[p9l1706t3488r1777b3545],
11	compare	VB	O	compare	xcomp	9	SENT_139	[p9l1821t3500r2145b3565],
12	frequency	NN	O	frequency	nn	13	SENT_139	[p9l7t3593r382b3680],
13	data	NNS	O	datum	dobj	11	SENT_139	[p9l439t3593r595b3660],
14	between	IN	O	between	_	0	SENT_139	[p9l648t3593r965b3660],
15	groups	NNS	O	group	prep_between	13	SENT_139	[p9l1020t3614r1292b3680],
16	.	.	O	.	_	0	SENT_139	[p9l1020t3614r1292b3680],

1	The	DT	O	the	det	5	SENT_140	[p9l1352t3593r1498b3660],
2	Wilcoxon	NNP	PERSON	Wilcoxon	nn	5	SENT_140	[p9l1553t3593r1925b3660],
3	rank	NN	O	rank	nn	5	SENT_140	[p9l1978t3593r2148b3660],
4	sum	NN	O	sum	nn	5	SENT_140	[p9l10t3729r164b3775],
5	test	NN	O	test	nsubjpass	7	SENT_140	[p9l221t3718r353b3775],
6	was	VBD	O	be	auxpass	7	SENT_140	[p9l410t3729r552b3775],
7	used	VBN	O	use	_	0	SENT_140	[p9l612t3708r786b3775],
8	to	TO	O	to	aux	9	SENT_140	[p9l843t3718r914b3775],
9	compare	VB	O	compare	xcomp	7	SENT_140	[p9l974t3729r1298b3795],
10	differences	NNS	O	difference	dobj	9	SENT_140	[p9l1358t3708r1771b3775],
11	between	IN	O	between	_	0	SENT_140	[p9l1830t3708r2146b3775],
12	groups	NNS	O	group	prep_between	10	SENT_140	[p10l8t42r280b108],
13	.	.	O	.	_	0	SENT_140	[p10l8t42r280b108],

1	Binomial	JJ	MISC	binomial	amod	3	SENT_141	[p10l361t21r713b88],
2	logistic	JJ	O	logistic	amod	3	SENT_141	[p10l790t21r1063b108],
3	regression	NN	O	regression	nsubjpass	5	SENT_141	[p10l1141t21r1527b108],
4	was	VBD	O	be	auxpass	5	SENT_141	[p10l1604t42r1747b88],
5	used	VBN	O	use	_	0	SENT_141	[p10l1824t21r1998b88],
6	to	TO	O	to	aux	7	SENT_141	[p10l2073t31r2145b88],
7	calculate	VB	O	calculate	xcomp	5	SENT_141	[p10l8t136r341b203],
8	the	DT	O	the	det	9	SENT_141	[p10l376t136r490b203],
9	degree	NN	O	degree	dobj	7	SENT_141	[p10l526t136r775b223],
10	of	IN	O	of	_	0	SENT_141	[p10l811t136r894b203],
11	correlation	NN	O	correlation	prep_of	9	SENT_141	[p10l921t136r1328b203],
12	and	CC	O	and	_	0	SENT_141	[p10l1364t136r1498b203],
13	predictability	NN	O	predictability	nsubj	17	SENT_141	[p10l1531t136r2033b223],
14	of	IN	O	of	_	0	SENT_141	[p10l2069t136r2153b203],
15	the	DT	O	the	det	16	SENT_141	[p10l7t251r121b318],
16	variables	NNS	O	variable	prep_of	13	SENT_141	[p10l146t251r482b318],
17	(	VBP	O	(	conj_and	5	SENT_141	[p10l515t251r818b334],
18	clinical	JJ	O	clinical	amod	20	SENT_141	[p10l515t251r818b334],
19	drug	NN	O	drug	nn	20	SENT_141	[p10l847t251r1018b338],
20	exposure	NN	O	exposure	nsubj	21	SENT_141	[p10l1046t273r1383b338],
21	results	VBZ	O	result	ccomp	17	SENT_141	[p10l1410t251r1683b334],
22	)	CD	NUMBER	)	dobj	21	SENT_141	[p10l1410t251r1683b334],
23	to	TO	O	to	_	0	SENT_141	[p10l1714t261r1784b318],
24	the	DT	O	the	det	25	SENT_141	[p10l1813t251r1926b318],
25	LTA	NNP	ORGANIZATION	LTA	prep_to	21	SENT_141	[p10l1954t252r2140b318],
26	.	.	O	.	_	0	SENT_141	[p10l1954t252r2140b318],

1	The	DT	O	the	det	2	SENT_142	[p10l7t366r153b433],
2	method	NN	O	method	nsubj	13	SENT_142	[p10l180t366r464b433],
3	used	VBN	O	use	partmod	2	SENT_142	[p10l489t366r664b433],
4	to	TO	O	to	aux	5	SENT_142	[p10l689t376r760b433],
5	estimate	VB	O	estimate	xcomp	3	SENT_142	[p10l789t366r1102b433],
6	the	DT	O	the	det	7	SENT_142	[p10l1130t366r1243b433],
7	model	NN	O	model	dobj	5	SENT_142	[p10l1271t366r1507b433],
8	was	VBD	O	be	cop	13	SENT_142	[p10l1535t387r1678b433],
9	the	DT	O	the	det	13	SENT_142	[p10l1707t366r1820b433],
10	forward	JJ	O	forward	amod	13	SENT_142	[p10l1849t366r2147b433],
11	stepwise	JJ	O	stepwise	amod	13	SENT_142	[p10l10t481r329b568],
12	(	NN	O	(	nn	13	SENT_142	[p10l362t481r773b564],
13	likelihood	NN	O	likelihood	_	0	SENT_142	[p10l362t481r773b564],
14	ratio	NN	O	ratio	nn	16	SENT_142	[p10l799t481r1000b564],
15	)	NN	O	)	nn	16	SENT_142	[p10l799t481r1000b564],
16	method	NN	O	method	dep	13	SENT_142	[p10l1032t481r1334b547],
17	.	.	O	.	_	0	SENT_142	[p10l1032t481r1334b547],

1	The	DT	O	the	det	5	SENT_143	[p10l1367t481r1513b547],
2	Student	NN	O	student	nn	5	SENT_143	[p10l1545t481r1830b548],
3	2-tailed	JJ	O	2-tailed	amod	5	SENT_143	[p10l1859t481r2146b547],
4	t	NN	O	t	nn	5	SENT_143	[p10l7t606r33b663],
5	test	NN	O	test	nsubjpass	11	SENT_143	[p10l92t606r223b663],
6	for	IN	O	for	_	0	SENT_143	[p10l282t596r392b663],
7	independent	JJ	O	independent	amod	8	SENT_143	[p10l450t596r912b683],
8	samples	NNS	O	sample	prep_for	5	SENT_143	[p10l976t596r1274b683],
9	was	VBD	O	be	auxpass	11	SENT_143	[p10l1336t618r1479b664],
10	also	RB	O	also	advmod	11	SENT_143	[p10l1544t596r1692b663],
11	performed	VBN	O	perform	_	0	SENT_143	[p10l1752t596r2146b683],
12	against	IN	O	against	_	0	SENT_143	[p10l9t711r274b798],
13	subgroups	NNS	O	subgroup	prep_against	11	SENT_143	[p10l351t711r731b798],
14	that	WDT	O	that	nsubj	20	SENT_143	[p10l808t711r951b778],
15	were	VBD	O	be	cop	17	SENT_143	[p10l1024t732r1206b778],
16	clinically	RB	O	clinically	advmod	17	SENT_143	[p10l1283t711r1630b798],
17	tolerant	JJ	O	tolerant	rcmod	13	SENT_143	[p10l1707t711r1994b778],
18	or	CC	O	or	_	0	SENT_143	[p10l2070t732r2148b778],
19	clinically	RB	O	clinically	advmod	20	SENT_143	[p10l8t826r357b913],
20	hypersensitive	JJ	O	hypersensitive	conj_or	17	SENT_143	[p10l418t826r959b913],
21	within	IN	O	within	_	0	SENT_143	[p10l1020t826r1260b894],
22	each	DT	O	each	det	26	SENT_143	[p10l1322t826r1495b893],
23	drug	NN	O	drug	nn	26	SENT_143	[p10l1557t826r1726b913],
24	treatment	NN	O	treatment	nn	26	SENT_143	[p10l1789t836r2146b893],
25	(	CD	NUMBER	(	num	26	SENT_143	[p10l10t941r242b1024],
26	CBZ	NN	ORGANIZATION	cbz	prep_within	17	SENT_143	[p10l10t941r242b1024],
27	,	,	O	,	_	0	SENT_143	[p10l10t941r242b1024],
28	PHY	NN	O	phy	prep_within	17	SENT_143	[p10l298t943r492b1020],
29	,	,	O	,	_	0	SENT_143	[p10l298t943r492b1020],
30	and	CC	O	and	_	0	SENT_143	[p10l552t941r686b1008],
31	LTG	NN	O	ltg	prep_within	17	SENT_143	[p10l738t941r941b1024],
32	)	CD	NUMBER	)	num	31	SENT_143	[p10l738t941r941b1024],
33	to	TO	O	to	aux	34	SENT_143	[p10l997t951r1069b1008],
34	illustrate	VB	O	illustrate	xcomp	17	SENT_143	[p10l1123t941r1450b1008],
35	whether	IN	O	whether	complm	39	SENT_143	[p10l1502t941r1807b1008],
36	toxicity	NN	O	toxicity	nn	37	SENT_143	[p10l1858t941r2145b1028],
37	results	NNS	O	result	nsubj	39	SENT_143	[p10l6t1056r249b1122],
38	were	VBD	O	be	cop	39	SENT_143	[p10l285t1077r467b1123],
39	distinct	JJ	O	distinct	ccomp	34	SENT_143	[p10l502t1056r795b1123],
40	.	.	O	.	_	0	SENT_143	[p10l502t1056r795b1123],

1	Statistical	JJ	MISC	statistical	amod	2	SENT_144	[p10l836t1056r1204b1123],
2	analysis	NN	O	analysis	nsubjpass	4	SENT_144	[p10l1240t1056r1539b1143],
3	was	VBD	O	be	auxpass	4	SENT_144	[p10l1574t1077r1717b1123],
4	performed	VBN	O	perform	_	0	SENT_144	[p10l1752t1056r2146b1143],
5	using	VBG	O	use	xcomp	4	SENT_144	[p10l6t1171r209b1258],
6	SPSS	NNP	ORGANIZATION	SPSS	nn	7	SENT_144	[p10l243t1172r445b1239],
7	Version	NNP	O	Version	dobj	5	SENT_144	[p10l480t1171r767b1239],
8	12.0.1	CD	NUMBER	12.0.1	number	9	SENT_144	[p10l807t1172r1024b1239],
9	(	CD	NUMBER	(	dep	7	SENT_144	[p10l1065t1171r1427b1258],
10	Chicago	NNP	LOCATION	Chicago	nn	12	SENT_144	[p10l1065t1171r1427b1258],
11	,	,	O	,	_	0	SENT_144	[p10l1065t1171r1427b1258],
12	Ill	NNP	O	Ill	dep	9	SENT_144	[p10l1462t1171r1594b1254],
13	)	CD	NUMBER	)	num	12	SENT_144	[p10l1462t1171r1594b1254],
14	.	.	O	.	_	0	SENT_144	[p10l1462t1171r1594b1254],

1	We	PRP	O	we	nsubj	2	SENT_145	[p10l1628t1173r1752b1239],
2	presented	VBD	O	present	_	0	SENT_145	[p10l1784t1171r2146b1258],
3	the	DT	O	the	det	4	SENT_145	[p10l7t1286r121b1353],
4	results	NNS	O	result	dobj	2	SENT_145	[p10l184t1286r426b1353],
5	graphically	RB	O	graphically	advmod	6	SENT_145	[p10l493t1286r915b1373],
6	using	VBG	O	use	xcomp	2	SENT_145	[p10l979t1286r1181b1373],
7	Microsoft	NNP	ORGANIZATION	Microsoft	nn	8	SENT_145	[p10l1245t1286r1617b1353],
8	Excel	NNP	O	Excel	nsubj	10	SENT_145	[p10l1679t1286r1894b1353],
9	2000	CD	DATE	2000	num	10	SENT_145	[p10l1959t1286r2146b1353],
10	(	CD	NUMBER	(	xcomp	6	SENT_145	[p10l10t1401r425b1484],
11	Redmond	NNP	PERSON	Redmond	nn	13	SENT_145	[p10l10t1401r425b1484],
12	,	,	O	,	_	0	SENT_145	[p10l10t1401r425b1484],
13	Wash	NNP	O	Wash	dep	10	SENT_145	[p10l497t1401r755b1484],
14	)	CD	NUMBER	)	num	13	SENT_145	[p10l497t1401r755b1484],
15	.	.	O	.	_	0	SENT_145	[p10l497t1401r755b1484],

1	Most	JJS	O	most	nsubj	5	SENT_146	[p10l830t1402r1025b1468],
2	of	IN	O	of	_	0	SENT_146	[p10l1094t1401r1177b1468],
3	our	PRP$	O	we	poss	4	SENT_146	[p10l1241t1422r1365b1468],
4	patients	NNS	O	patient	prep_of	1	SENT_146	[p10l1432t1401r1723b1488],
5	took	VBD	O	take	_	0	SENT_146	[p10l1795t1401r1965b1468],
6	the	DT	O	the	det	7	SENT_146	[p10l2031t1401r2144b1468],
7	therapeutics	NNS	O	therapeutics	dobj	5	SENT_146	[p10l7t1516r460b1603],
8	because	IN	O	because	mark	18	SENT_146	[p10l524t1516r822b1583],
9	of	IN	O	of	_	0	SENT_146	[p10l888t1516r970b1583],
10	their	PRP$	O	they	poss	12	SENT_146	[p10l1026t1516r1200b1583],
11	chronic	JJ	O	chronic	amod	12	SENT_146	[p10l1262t1516r1541b1583],
12	condition	NN	O	condition	prep_of	18	SENT_146	[p10l1607t1516r1961b1583],
13	(	CD	NUMBER	(	dep	12	SENT_146	[p10l2027t1516r2143b1599],
14	ie	FW	O	ie	dep	13	SENT_146	[p10l2027t1516r2143b1599],
15	,	,	O	,	_	0	SENT_146	[p10l2027t1516r2143b1599],
16	epileptic	JJ	O	epileptic	amod	17	SENT_146	[p10l8t1631r328b1718],
17	seizures	NNS	O	seizure	nsubj	18	SENT_146	[p10l360t1631r709b1714],
18	)	VBP	O	)	advcl	5	SENT_146	[p10l360t1631r709b1714],
19	.	.	O	.	_	0	SENT_146	[p10l360t1631r709b1714],

1	We	PRP	O	we	nsubj	3	SENT_147	[p10l93t1748r218b1813],
2	also	RB	O	also	advmod	3	SENT_147	[p10l250t1746r400b1813],
3	took	VBD	O	take	_	0	SENT_147	[p10l430t1746r601b1813],
4	into	IN	O	into	_	0	SENT_147	[p10l628t1746r775b1813],
5	consideration	NN	O	consideration	prep_into	3	SENT_147	[p10l806t1746r1325b1813],
6	all	PDT	O	all	predet	10	SENT_147	[p10l1356t1746r1448b1813],
7	the	DT	O	the	det	10	SENT_147	[p10l1478t1746r1593b1813],
8	non-drug	JJ	O	non-drug	amod	10	SENT_147	[p10l1623t1746r1973b1833],
9	risk	NN	O	risk	nn	10	SENT_147	[p10l2002t1746r2147b1813],
10	factors	NNS	O	factor	nsubj	15	SENT_147	[p10l7t1861r265b1928],
11	such	JJ	O	such	_	0	SENT_147	[p10l292t1861r463b1928],
12	as	IN	O	as	_	0	SENT_147	[p10l486t1883r559b1928],
13	chronic	JJ	O	chronic	amod	14	SENT_147	[p10l582t1861r868b1928],
14	diseases	NNS	O	disease	prep_such_as	10	SENT_147	[p10l891t1861r1203b1928],
15	(	VBP	O	(	ccomp	3	SENT_147	[p10l1228t1862r1366b1948],
16	eg	FW	O	eg	dobj	15	SENT_147	[p10l1228t1862r1366b1948],
17	,	,	O	,	_	0	SENT_147	[p10l1228t1862r1366b1948],
18	cancer	NN	O	cancer	appos	16	SENT_147	[p10l1391t1883r1658b1940],
19	,	,	O	,	_	0	SENT_147	[p10l1391t1883r1658b1940],
20	trauma	NN	O	trauma	nn	21	SENT_147	[p10l1682t1862r1979b1944],
21	)	NN	O	)	appos	16	SENT_147	[p10l1682t1862r1979b1944],
22	that	WDT	O	that	nsubj	23	SENT_147	[p10l2002t1861r2146b1928],
23	required	VBD	O	require	rcmod	21	SENT_147	[p10l6t1976r328b2063],
24	chronic	JJ	O	chronic	amod	26	SENT_147	[p10l351t1976r636b2043],
25	therapeutic	JJ	O	therapeutic	amod	26	SENT_147	[p10l661t1976r1088b2063],
26	interventions	NNS	O	intervention	dobj	23	SENT_147	[p10l1113t1976r1613b2043],
27	in	IN	O	in	_	0	SENT_147	[p10l1639t1976r1712b2042],
28	addition	NN	O	addition	prep_in	23	SENT_147	[p10l1737t1976r2050b2043],
29	to	TO	O	to	_	0	SENT_147	[p10l2073t1986r2144b2043],
30	AEDs	NNS	MISC	aed	prep_to	23	SENT_147	[p10l7t2091r258b2157],
31	.	.	O	.	_	0	SENT_147	[p10l7t2091r258b2157],

1	Also	RB	O	also	advmod	4	SENT_148	[p10l293t2091r493b2170],
2	,	,	O	,	_	0	SENT_148	[p10l293t2091r493b2170],
3	we	PRP	O	we	nsubj	4	SENT_148	[p10l526t2112r635b2158],
4	noted	VBD	O	note	_	0	SENT_148	[p10l666t2091r879b2157],
5	existing	VBG	O	exist	amod	6	SENT_148	[p10l909t2091r1210b2178],
6	radiotherapy	NN	O	radiotherapy	dobj	4	SENT_148	[p10l1240t2091r1743b2178],
7	,	,	O	,	_	0	SENT_148	[p10l1240t2091r1743b2178],
8	recent	JJ	O	recent	amod	10	SENT_148	[p10l1775t2101r2011b2157],
9	viral	JJ	O	viral	amod	10	SENT_148	[p10l2040t2091r2142b2158, p10l6t2206r106b2273],
10	disease	NN	O	disease	conj_or	6	SENT_148	[p10l137t2206r434b2286],
11	,	,	O	,	_	0	SENT_148	[p10l137t2206r434b2286],
12	or	CC	O	or	_	0	SENT_148	[p10l468t2228r547b2273],
13	chronic	JJ	O	chronic	amod	15	SENT_148	[p10l576t2206r861b2273],
14	viral	JJ	O	viral	amod	15	SENT_148	[p10l893t2206r1068b2273],
15	infection	NN	O	infection	dobj	4	SENT_148	[p10l1098t2206r1460b2273],
16	.	.	O	.	_	0	SENT_148	[p10l1098t2206r1460b2273],

1	RESULTS	NNS	O	result	_	0	SENT_149	[p10l11t2460r319b2527],

1	All	DT	O	all	det	2	SENT_150	[p10l93t2614r214b2680],
2	patients	NNS	O	patient	nsubj	8	SENT_150	[p10l236t2614r534b2701],
3	with	IN	O	with	_	0	SENT_150	[p10l559t2614r728b2681],
4	clinical	JJ	O	clinical	amod	5	SENT_150	[p10l751t2614r1034b2681],
5	manifestations	NNS	O	manifestation	prep_with	2	SENT_150	[p10l1056t2614r1616b2681],
6	to	TO	O	to	_	0	SENT_150	[p10l1642t2624r1714b2681],
7	AEDs	NNS	MISC	aed	prep_to	5	SENT_150	[p10l1737t2615r1967b2681],
8	presented	VBN	O	present	_	0	SENT_150	[p10l1991t2635r2142b2701, p10l10t2729r252b2796],
9	positive	JJ	O	positive	amod	10	SENT_150	[p10l277t2729r580b2816],
10	LTA	NN	ORGANIZATION	lta	dobj	8	SENT_150	[p10l605t2729r776b2795],
11	to	TO	O	to	_	0	SENT_150	[p10l801t2739r873b2796],
12	the	DT	O	the	det	14	SENT_150	[p10l900t2729r1016b2796],
13	incriminating	VBG	O	incriminate	amod	14	SENT_150	[p10l1042t2729r1562b2816],
14	drug	NN	O	drug	prep_to	8	SENT_150	[p10l1591t2729r1784b2816],
15	.	.	O	.	_	0	SENT_150	[p10l1591t2729r1784b2816],

1	Controls	NNP	O	Controls	nsubj	6	SENT_151	[p10l1816t2729r2144b2796],
2	tolerant	JJ	O	tolerant	amod	1	SENT_151	[p10l7t2844r301b2911],
3	to	TO	O	to	_	0	SENT_151	[p10l337t2854r409b2911],
4	the	DT	O	the	det	5	SENT_151	[p10l446t2844r562b2911],
5	drug	NN	O	drug	prep_to	2	SENT_151	[p10l600t2844r772b2931],
6	presented	VBD	O	present	_	0	SENT_151	[p10l808t2844r1179b2931],
7	negative	JJ	O	negative	amod	8	SENT_151	[p10l1214t2844r1537b2931],
8	LTA	NN	ORGANIZATION	lta	dobj	6	SENT_151	[p10l1573t2845r1743b2911],
9	to	TO	O	to	_	0	SENT_151	[p10l1779t2855r1850b2911],
10	the	DT	O	the	det	12	SENT_151	[p10l1888t2844r2003b2911],
11	respective	JJ	O	respective	amod	12	SENT_151	[p10l2039t2866r2142b2911, p10l10t2959r320b3046],
12	drugs	NNS	O	drug	prep_to	6	SENT_151	[p10l350t2959r579b3046],
13	.	.	O	.	_	0	SENT_151	[p10l350t2959r579b3046],

1	The	DT	O	the	det	2	SENT_152	[p10l614t2959r761b3026],
2	ﬁgure	NN	O	ﬁgure	nsubj	3	SENT_152	[p10l793t2959r1013b3046],
3	presents	VBZ	O	present	_	0	SENT_152	[p10l1042t2969r1356b3046],
4	a	DT	O	a	det	6	SENT_152	[p10l1390t2981r1429b3026],
5	graphical	JJ	O	graphical	amod	6	SENT_152	[p10l1459t2959r1815b3046],
6	illustration	NN	O	illustration	dobj	3	SENT_152	[p10l1846t2959r2142b3026, p10l7t3074r155b3141],
7	of	IN	O	of	_	0	SENT_152	[p10l194t3074r277b3141],
8	the	DT	O	the	det	10	SENT_152	[p10l308t3074r423b3141],
9	LTA	NN	ORGANIZATION	lta	nn	10	SENT_152	[p10l460t3074r631b3140],
10	values	NNS	O	value	prep_of	6	SENT_152	[p10l661t3074r901b3141],
11	of	IN	O	of	_	0	SENT_152	[p10l941t3074r1025b3141],
12	all	DT	O	all	det	13	SENT_152	[p10l1058t3074r1150b3141],
13	subjects	NNS	O	subject	prep_of	10	SENT_152	[p10l1191t3074r1494b3161],
14	tested	VBN	O	test	partmod	13	SENT_152	[p10l1534t3074r1777b3141],
15	.	.	O	.	_	0	SENT_152	[p10l1534t3074r1777b3141],

1	Subjects	NNS	O	subject	nsubjpass	3	SENT_153	[p10l1823t3074r2144b3161],
2	were	VBD	O	be	auxpass	3	SENT_153	[p10l7t3210r191b3256],
3	grouped	VBN	O	group	_	0	SENT_153	[p10l218t3189r532b3276],
4	based	VBN	O	base	_	0	SENT_153	[p10l555t3189r774b3255],
5	on	IN	O	on	prepc_based_on	3	SENT_153	[p10l801t3210r894b3255],
6	the	DT	O	the	det	8	SENT_153	[p10l919t3189r1034b3255],
7	clinical	JJ	O	clinical	amod	8	SENT_153	[p10l1061t3189r1344b3255],
8	presentation	NN	O	presentation	pobj	3	SENT_153	[p10l1369t3189r1841b3276],
9	of	IN	O	of	_	0	SENT_153	[p10l1867t3189r1951b3255],
10	their	PRP$	O	they	poss	11	SENT_153	[p10l1969t3189r2146b3255],
11	symptoms	NNS	O	symptom	prep_of	8	SENT_153	[p10l10t3314r399b3391],
12	as	IN	O	as	_	0	SENT_153	[p10l430t3326r503b3371],
13	only	RB	O	only	advmod	14	SENT_153	[p10l533t3304r701b3391],
14	rush	NN	O	rush	prep_as	11	SENT_153	[p10l727t3304r892b3371],
15	and	CC	O	and	_	0	SENT_153	[p10l919t3304r1055b3371],
16	fever	NN	O	fever	conj_and	14	SENT_153	[p10l1081t3304r1292b3384],
17	,	,	O	,	_	0	SENT_153	[p10l1081t3304r1292b3384],
18	a	DT	O	a	det	19	SENT_153	[p10l1324t3326r1363b3371],
19	triad	NN	O	triad	appos	14	SENT_153	[p10l1389t3304r1564b3371],
20	that	WDT	O	that	nsubj	39	SENT_153	[p10l1591t3304r1735b3371],
21	characterizes	VBZ	O	characterize	rcmod	19	SENT_153	[p10l1761t3304r2142b3371, p10l7t3418r153b3485],
22	“	RB	O	“	advmod	23	SENT_153	[p10l202t3419r436b3485],
23	true	JJ	O	true	amod	25	SENT_153	[p10l202t3419r436b3485],
24	”	RB	O	”	advmod	23	SENT_153	[p10l202t3419r436b3485],
25	HSR	NN	O	hsr	dobj	21	SENT_153	[p10l484t3418r669b3485],
26	(	CD	NUMBER	(	num	27	SENT_153	[p10l709t3418r917b3500],
27	rash	NN	O	rash	dep	25	SENT_153	[p10l709t3418r917b3500],
28	,	,	O	,	_	0	SENT_153	[p10l709t3418r917b3500],
29	fever	NN	O	fever	dobj	21	SENT_153	[p10l958t3418r1154b3485],
30	and	CC	O	and	_	0	SENT_153	[p10l1192t3418r1327b3485],
31	DILI	NNP	LOCATION	DILI	conj_or	25	SENT_153	[p10l1364t3420r1576b3497],
32	,	,	O	,	_	0	SENT_153	[p10l1364t3420r1576b3497],
33	or	CC	O	or	_	0	SENT_153	[p10l1618t3439r1696b3485],
34	SJS/T	NNP	O	SJS/T	nn	35	SENT_153	[p10l1735t3418r1960b3485],
35	EN	NNP	O	EN	dobj	21	SENT_153	[p10l1962t3419r2141b3500],
36	)	CD	NUMBER	)	dep	35	SENT_153	[p10l1962t3419r2141b3500],
37	,	,	O	,	_	0	SENT_153	[p10l1962t3419r2141b3500],
38	and	CC	O	and	_	0	SENT_153	[p10l9t3533r145b3600],
39	controls	VBZ	O	control	conj_and	21	SENT_153	[p10l184t3533r491b3600],
40	(	CD	NUMBER	(	num	41	SENT_153	[p10l535t3533r988b3616],
41	individuals	NNS	O	individual	dobj	39	SENT_153	[p10l535t3533r988b3616],
42	tolerating	VBG	O	tolerate	partmod	41	SENT_153	[p10l1029t3533r1398b3620],
43	the	DT	O	the	det	45	SENT_153	[p10l1438t3533r1553b3600],
44	drug	NN	O	drug	nn	45	SENT_153	[p10l1594t3533r1820b3620],
45	)	NN	O	)	dobj	42	SENT_153	[p10l1594t3533r1820b3620],
46	.	.	O	.	_	0	SENT_153	[p10l1594t3533r1820b3620],

1	Results	NNS	O	result	nsubjpass	3	SENT_154	[p10l1863t3533r2144b3600],
2	are	VBP	O	be	auxpass	3	SENT_154	[p10l9t3669r122b3715],
3	given	VBN	O	give	_	0	SENT_154	[p10l147t3648r357b3735],
4	as	IN	O	as	_	0	SENT_154	[p10l381t3669r455b3715],
5	mean	JJ	O	mean	amod	6	SENT_154	[p10l480t3669r688b3715],
6	percentage	NN	O	percentage	prep_as	3	SENT_154	[p10l711t3658r1129b3735],
7	of	IN	O	of	_	0	SENT_154	[p10l1155t3648r1238b3715],
8	toxicity	NN	O	toxicity	prep_of	6	SENT_154	[p10l1256t3648r1549b3735],
9	:	:	O	:	_	0	SENT_154	[p10l1584t3654r1641b3712],
10	standard	JJ	O	standard	amod	11	SENT_154	[p10l1679t3648r2001b3715],
11	deviation	NN	O	deviation	dep	6	SENT_154	[p10l2025t3648r2142b3715, p11l7t20r274b88],

1	(	NN	O	(	nn	3	SENT_155	[p11l307t21r485b104],
2	SD	NN	O	sd	nn	3	SENT_155	[p11l307t21r485b104],
3	)	NN	O	)	_	0	SENT_155	[p11l307t21r485b104],
4	of	IN	O	of	_	0	SENT_155	[p11l519t21r602b87],
5	toxicity	NN	O	toxicity	prep_of	3	SENT_155	[p11l625t21r918b108],
6	for	IN	O	for	_	0	SENT_155	[p11l949t20r1061b87],
7	each	DT	O	each	det	8	SENT_155	[p11l1090t21r1265b87],
8	drug	NN	O	drug	prep_for	3	SENT_155	[p11l1295t21r1488b108],
9	.	.	O	.	_	0	SENT_155	[p11l1295t21r1488b108],

1	There	EX	O	there	expl	6	SENT_156	[p11l94t136r316b203],
2	were	VBD	O	be	cop	6	SENT_156	[p11l343t158r527b204],
3	no	DT	O	no	det	6	SENT_156	[p11l554t158r647b203],
4	statistically	RB	O	statistically	advmod	5	SENT_156	[p11l680t136r1116b223],
5	signiﬁcant	JJ	O	signiﬁcant	amod	6	SENT_156	[p11l1147t136r1545b223],
6	differences	NNS	O	difference	_	0	SENT_156	[p11l1572t136r1995b203],
7	between	IN	O	between	_	0	SENT_156	[p11l2023t136r2142b203, p11l7t261r235b318],
8	the	DT	O	the	det	10	SENT_156	[p11l261t251r376b318],
9	mean	NN	O	mean	nn	10	SENT_156	[p11l403t272r611b318],
10	ages	NNS	O	age	prep_between	6	SENT_156	[p11l638t272r803b338],
11	of	IN	O	of	_	0	SENT_156	[p11l833t251r916b318],
12	sensitive	JJ	O	sensitive	amod	17	SENT_156	[p11l938t251r1268b318],
13	and	CC	O	and	_	0	SENT_156	[p11l1295t251r1431b318],
14	c1inical1y	JJ	O	c1inical1y	amod	15	SENT_156	[p11l1457t251r2147b338],
15	—	NN	O	—	conj_and	12	SENT_156	[p11l1457t251r2147b338],
16	tolerant	JJ	O	tolerant	amod	17	SENT_156	[p11l1457t251r2147b338],
17	patients	NNS	O	patient	prep_of	10	SENT_156	[p11l6t366r304b453],
18	(	IN	O	(	_	0	SENT_156	[p11l347t366r538b449],
19	32.5	CD	NUMBER	32.5	prep_(	6	SENT_156	[p11l347t366r538b449],
20	:	:	O	:	_	0	SENT_156	[p11l590t372r648b429],
21	24.5	CD	NUMBER	24.5	dobj	6	SENT_156	[p11l698t366r858b433],
22	and	CC	O	and	_	0	SENT_156	[p11l903t366r1038b433],
23	38.5	CD	NUMBER	38.5	dobj	6	SENT_156	[p11l1078t366r1238b433],
24	:	:	O	:	_	0	SENT_156	[p11l1290t372r1348b429],
25	16.0	CD	NUMBER	16.0	number	26	SENT_156	[p11l1405t366r1591b449],
26	)	CD	NUMBER	)	num	31	SENT_156	[p11l1405t366r1591b449],
27	(	NN	O	(	nn	31	SENT_156	[p11l1635t367r1721b449],
28	P	NN	O	p	nn	31	SENT_156	[p11l1635t367r1721b449],
29	=	JJ	O	=	amod	31	SENT_156	[p11l1768t389r1826b412],
30	0.256	CD	NUMBER	0.256	num	31	SENT_156	[p11l1875t366r2140b449],
31	)	NN	O	)	dep	21	SENT_156	[p11l1875t366r2140b449],
32	.	.	O	.	_	0	SENT_156	[p11l1875t366r2140b449],

1	The	DT	O	the	det	3	SENT_157	[p11l7t481r154b548],
2	statistical	JJ	O	statistical	amod	3	SENT_157	[p11l200t481r561b548],
3	analysis	NN	O	analysis	_	0	SENT_157	[p11l605t481r911b568],
4	of	IN	O	of	_	0	SENT_157	[p11l955t481r1038b548],
5	patients	NNS	O	patient	prep_of	3	SENT_157	[p11l1072t481r1370b568],
6	with	IN	O	with	_	0	SENT_157	[p11l1415t481r1584b549],
7	DILI	NNP	ORGANIZATION	DILI	prep_with	5	SENT_157	[p11l1625t483r1816b548],
8	or	CC	O	or	_	0	SENT_157	[p11l1859t503r1937b548],
9	SJS	NNP	O	SJS	prep_with	5	SENT_157	[p11l1980t482r2147b549],
10	/	:	O	/	punct	3	SENT_157	[p11l1980t482r2147b549],
11	TEN	CD	NUMBER	ten	nsubj	12	SENT_157	[p11l7t598r193b663],
12	indicated	VBD	O	indicate	dep	3	SENT_157	[p11l235t596r588b663],
13	an	DT	O	a	det	15	SENT_157	[p11l633t618r720b663],
14	LTA	NN	ORGANIZATION	lta	nn	15	SENT_157	[p11l761t597r931b662],
15	sensitivity	NN	O	sensitivity	dobj	12	SENT_157	[p11l976t596r1366b683],
16	of	IN	O	of	_	0	SENT_157	[p11l1410t596r1493b663],
17	92.9	CD	PERCENT	92.9	num	18	SENT_157	[p11l1530t597r1795b665],
18	%	NN	PERCENT	%	prep_of	15	SENT_157	[p11l1530t597r1795b665],
19	.	.	O	.	_	0	SENT_157	[p11l1530t597r1795b665],

1	Patients	NNS	O	patient	nsubj	7	SENT_158	[p11l1842t596r2144b663],
2	presenting	VBG	O	present	partmod	1	SENT_158	[p11l6t711r407b798],
3	a	DT	O	a	det	5	SENT_158	[p11l471t733r511b778],
4	marginal	JJ	O	marginal	amod	5	SENT_158	[p11l571t711r912b798],
5	LTA	NN	ORGANIZATION	lta	dobj	2	SENT_158	[p11l974t712r1144b778],
6	clinically	RB	O	clinically	advmod	7	SENT_158	[p11l1205t711r1564b798],
7	demonstrated	VBD	O	demonstrate	_	0	SENT_158	[p11l1627t711r2146b779],
8	rash	NN	O	rash	dobj	7	SENT_158	[p11l6t826r165b893],
9	and	CC	O	and	_	0	SENT_158	[p11l225t826r361b893],
10	fever	NN	O	fever	dobj	7	SENT_158	[p11l418t826r614b894],
11	only	RB	O	only	advmod	7	SENT_158	[p11l671t826r852b913],
12	.	.	O	.	_	0	SENT_158	[p11l671t826r852b913],

1	The	DT	O	the	det	4	SENT_159	[p11l915t826r1062b893],
2	negative	JJ	O	negative	amod	4	SENT_159	[p11l1120t826r1443b913],
3	predictive	JJ	O	predictive	amod	4	SENT_159	[p11l1500t826r1884b913],
4	value	NN	O	value	nsubj	7	SENT_159	[p11l1940t826r2144b893],
5	was	VBD	O	be	cop	7	SENT_159	[p11l7t962r152b1008],
6	98.9	CD	PERCENT	98.9	num	7	SENT_159	[p11l198t941r463b1009],
7	%	NN	PERCENT	%	_	0	SENT_159	[p11l198t941r463b1009],
8	.	.	O	.	_	0	SENT_159	[p11l198t941r463b1009],

1	This	DT	O	this	nsubj	2	SENT_160	[p11l510t941r677b1008],
2	suggests	VBZ	O	suggest	_	0	SENT_160	[p11l724t951r1044b1028],
3	a	DT	O	a	det	6	SENT_160	[p11l1090t962r1130b1008],
4	strong	JJ	O	strong	amod	6	SENT_160	[p11l1173t951r1408b1028],
5	true-positive	JJ	O	true-positive	amod	6	SENT_160	[p11l1451t941r1936b1028],
6	rate	NN	O	rate	dobj	2	SENT_160	[p11l1977t951r2140b1008],
7	.	.	O	.	_	0	SENT_160	[p11l1977t951r2140b1008],

1	The	DT	O	the	det	2	SENT_161	[p11l7t1056r154b1122],
2	speciﬁcity	NN	O	speciﬁcity	nsubj	8	SENT_161	[p11l184t1055r576b1143],
3	of	IN	O	of	_	0	SENT_161	[p11l603t1056r686b1122],
4	the	DT	O	the	det	5	SENT_161	[p11l705t1056r821b1122],
5	reaction	NN	O	reaction	prep_of	2	SENT_161	[p11l845t1056r1157b1122],
6	was	VBD	O	be	cop	8	SENT_161	[p11l1183t1077r1327b1123],
7	99.1	CD	PERCENT	99.1	num	8	SENT_161	[p11l1356t1056r1622b1135],
8	%	NN	PERCENT	%	_	0	SENT_161	[p11l1356t1056r1622b1135],
9	,	,	O	,	_	0	SENT_161	[p11l1356t1056r1622b1135],
10	which	WDT	O	which	nsubj	12	SENT_161	[p11l1652t1056r1885b1123],
11	nicely	RB	O	nicely	advmod	12	SENT_161	[p11l1910t1056r2144b1143],
12	identiﬁes	VBZ	O	identiﬁes	rcmod	8	SENT_161	[p11l7t1171r357b1238],
13	patients	NNS	O	patient	dobj	12	SENT_161	[p11l383t1171r682b1258],
14	without	IN	O	without	_	0	SENT_161	[p11l710t1171r1003b1238],
15	the	DT	O	the	det	16	SENT_161	[p11l1028t1171r1143b1238],
16	disease	NN	O	disease	prep_without	12	SENT_161	[p11l1170t1171r1465b1238],
17	.	.	O	.	_	0	SENT_161	[p11l1170t1171r1465b1238],

1	There	EX	O	there	expl	2	SENT_162	[p11l1495t1171r1718b1238],
2	were	VBD	O	be	_	0	SENT_162	[p11l1743t1193r1927b1238],
3	3	CD	NUMBER	3	num	4	SENT_162	[p11l1956t1172r1994b1239],
4	patients	NNS	O	patient	nsubj	2	SENT_162	[p11l2023t1193r2142b1258, p11l7t1286r212b1353],
5	who	WP	O	who	nsubj	14	SENT_162	[p11l253t1286r414b1353],
6	presented	VBD	O	present	rcmod	4	SENT_162	[p11l452t1286r823b1373],
7	a	DT	O	a	det	9	SENT_162	[p11l862t1307r901b1353],
8	positive	JJ	O	positive	amod	9	SENT_162	[p11l937t1286r1239b1373],
9	LTA	NN	ORGANIZATION	lta	dobj	6	SENT_162	[p11l1276t1287r1447b1352],
10	to	TO	O	to	_	0	SENT_162	[p11l1484t1296r1555b1353],
11	CBZ	NNP	ORGANIZATION	CBZ	prep_to	6	SENT_162	[p11l1595t1286r1779b1353],
12	and	CC	O	and	_	0	SENT_162	[p11l1819t1286r1955b1353],
13	also	RB	O	also	advmod	14	SENT_162	[p11l1995t1286r2144b1353],
14	illustrated	VBD	O	illustrate	conj_and	6	SENT_162	[p11l7t1401r394b1467],
15	a	DT	O	a	det	17	SENT_162	[p11l429t1422r468b1467],
16	positive	JJ	O	positive	amod	17	SENT_162	[p11l499t1401r801b1488],
17	PHY-LTA	NN	O	phy-lta	dobj	14	SENT_162	[p11l834t1401r1238b1467],
18	.	.	O	.	_	0	SENT_162	[p11l834t1401r1238b1467],

1	Also	RB	O	also	dep	4	SENT_163	[p11l1276t1401r1476b1480],
2	,	,	O	,	_	0	SENT_163	[p11l1276t1401r1476b1480],
3	3	CD	NUMBER	3	num	4	SENT_163	[p11l1516t1401r1554b1468],
4	PHY	NN	O	phy	_	0	SENT_163	[p11l1592t1401r1992b1468],
5	.	.	O	.	_	0	SENT_163	[p11l1592t1401r1992b1468],

1	—	NN	O	—	_	0	SENT_164	[p11l1592t1401r1992b1468],
2	.	.	O	.	_	0	SENT_164	[p11l1592t1401r1992b1468],

1	HSR	NN	O	hsr	nn	2	SENT_165	[p11l1592t1401r1992b1468],
2	patients	NNS	O	patient	nsubj	3	SENT_165	[p11l2023t1422r2142b1488, p11l7t1516r212b1583],
3	showed	VBD	O	show	_	0	SENT_165	[p11l265t1516r552b1584],
4	a	DT	O	a	det	6	SENT_165	[p11l601t1538r640b1583],
5	positive	JJ	O	positive	amod	6	SENT_165	[p11l685t1516r988b1603],
6	LTG-HSR	NN	O	ltg-hsr	dobj	3	SENT_165	[p11l1034t1517r1450b1584],
7	.	.	O	.	_	0	SENT_165	[p11l1034t1517r1450b1584],

1	Clinically	RB	O	clinically	dep	6	SENT_166	[p11l1504t1516r1898b1603],
2	,	,	O	,	_	0	SENT_166	[p11l1504t1516r1898b1603],
3	these	DT	O	these	det	6	SENT_166	[p11l1949t1516r2144b1583],
4	Translational	JJ	O	translational	amod	6	SENT_166	[p11l7t1620r465b1678],
5	Research	NN	O	research	nn	6	SENT_166	[p11l496t1620r836b1678],
6	Volume	NN	O	volume	_	0	SENT_166	[p11l7t1716r293b1775],
7	159	CD	NUMBER	159	dep	6	SENT_166	[p11l328t1715r464b1779],
8	,	,	O	,	_	0	SENT_166	[p11l328t1715r464b1779],
9	Number	NNP	O	Number	dep	6	SENT_166	[p11l493t1716r789b1775],
10	5	CD	NUMBER	5	dep	6	SENT_166	[p11l812t1716r852b1775],

1	50	CD	NUMBER	50	num	2	SENT_167	[p11l260t1954r347b2017],
2	T	NN	O	t	_	0	SENT_167	[p11l399t1982r423b1983],
3	I	NN	O	i	dep	2	SENT_167	[p11l1402t2007r1444b2052],
4	:	:	O	:	_	0	SENT_167	[p11l1402t2007r1444b2052],
5	Control	NNP	O	Control	nn	7	SENT_167	[p11l1461t1999r1688b2056],
6	45	CD	NUMBER	45	num	7	SENT_167	[p11l259t2097r343b2164],
7	T	NN	O	t	dep	2	SENT_167	[p11l420t2134r422b2136],
8	-	:	O	-	_	0	SENT_167	[p11l1419t2132r1433b2147],
9	»	CD	NUMBER	»	num	10	SENT_167	[p11l1419t2132r1433b2147],
10	Rash	NNP	O	Rash	dep	7	SENT_167	[p11l1461t2111r1611b2167],
11	+	CC	O	+	_	0	SENT_167	[p11l1629t2119r1670b2164],
12	Fever	NN	O	fever	dep	7	SENT_167	[p11l1691t2112r1863b2167],

1	40	CD	NUMBER	40	_	0	SENT_168	[p11l256t2247r347b2311],
2	I	PRP	O	I	dep	1	SENT_168	[p11l1405t2247r1444b2286],
3	S-JSXTEN	NN	O	s-jsxten	tmod	2	SENT_168	[p11l1464t2237r1737b2293],
4	or	CC	O	or	advmod	3	SENT_168	[p11l1758t2254r1821b2293],

1	V	NNP	O	V	nn	2	SENT_169	[p11l341t2394r343b2397],
2	DILI	NNP	O	DILI	_	0	SENT_169	[p11l1461t2324r1604b2380],

1	%	NN	O	%	nn	2	SENT_170	[p11l95t2997r162b3063],
2	Toxicity	NN	O	toxicity	_	0	SENT_170	[p11l95t2693r176b2980],

1	Antliepilliegp-tics	NNS	O	antliepilliegp-tic	_	0	SENT_171	[p11l1031t3697r1555b3781],
2	.	.	O	.	_	0	SENT_171	[p11l1031t3697r1555b3781],

1	Fig	NN	O	fig	_	0	SENT_172	[p12l8t94r131b164],
2	.	.	O	.	_	0	SENT_172	[p12l8t94r131b164],

1	LTA	NN	ORGANIZATION	lta	nn	2	SENT_173	[p12l172t95r308b148],
2	values	NNS	O	value	nsubj	6	SENT_173	[p12l321t95r513b149],
3	of	IN	O	of	_	0	SENT_173	[p12l534t95r600b149],
4	all	DT	O	all	det	5	SENT_173	[p12l614t95r688b149],
5	subjects	NNS	O	subject	prep_of	2	SENT_173	[p12l709t95r953b165],
6	tested	VBN	O	test	_	0	SENT_173	[p12l972t95r1166b149],
7	.	.	O	.	_	0	SENT_173	[p12l972t95r1166b149],

1	Patients	NNS	O	patient	nsubjpass	3	SENT_174	[p12l1188t95r1429b149],
2	were	VBD	O	be	auxpass	3	SENT_174	[p12l1448t112r1595b149],
3	grouped	VBN	O	group	_	0	SENT_174	[p12l1614t95r1866b165],
4	based	VBN	O	base	_	0	SENT_174	[p12l1882t95r2057b149],
5	on	IN	O	on	prepc_based_on	3	SENT_174	[p12l2075t112r2150b149],
6	the	DT	O	the	det	8	SENT_174	[p12l8t191r100b245],
7	clinical	JJ	O	clinical	amod	8	SENT_174	[p12l127t191r353b245],
8	presentation	NN	O	presentation	pobj	3	SENT_174	[p12l378t191r755b261],
9	of	IN	O	of	_	0	SENT_174	[p12l782t191r848b245],
10	their	PRP$	O	they	poss	11	SENT_174	[p12l869t191r1011b245],
11	symptoms	NNS	O	symptom	prep_of	8	SENT_174	[p12l1037t199r1349b261],
12	as	IN	O	as	_	0	SENT_174	[p12l1377t208r1436b245],
13	controls	NNS	O	control	prep_as	11	SENT_174	[p12l1464t191r1709b245],
14	tolerating	VBG	O	tolerate	partmod	13	SENT_174	[p12l1737t191r2031b261],
15	the	DT	O	the	det	17	SENT_174	[p12l2057t191r2149b245],
16	drug	NN	O	drug	nn	17	SENT_174	[p12l8t285r147b355],
17	(	NN	O	(	dobj	14	SENT_174	[p12l194t285r429b352],
18	white	JJ	O	white	amod	19	SENT_174	[p12l194t285r429b352],
19	)	NN	O	)	dep	17	SENT_174	[p12l194t285r429b352],
20	,	,	O	,	_	0	SENT_174	[p12l194t285r429b352],
21	HSR	NN	O	hsr	nn	22	SENT_174	[p12l476t285r624b339],
22	patients	NNS	O	patient	conj_or	17	SENT_174	[p12l665t285r904b355],
23	presenting	VBG	O	present	partmod	22	SENT_174	[p12l948t285r1269b355],
24	with	IN	O	with	_	0	SENT_174	[p12l1313t285r1448b339],
25	only	JJ	O	only	amod	26	SENT_174	[p12l1493t285r1627b355],
26	rash	NN	O	rash	prep_with	23	SENT_174	[p12l1671t285r1798b339],
27	and	CC	O	and	_	0	SENT_174	[p12l1843t285r1952b339],
28	fever	NN	O	fever	nn	31	SENT_174	[p12l1996t285r2152b339],
29	(	CD	NUMBER	(	num	31	SENT_174	[p12l10t383r210b453],
30	grey	NN	O	grey	nn	31	SENT_174	[p12l10t383r210b453],
31	)	NN	O	)	prep_with	23	SENT_174	[p12l10t383r210b453],
32	,	,	O	,	_	0	SENT_174	[p12l10t383r210b453],
33	or	CC	O	or	_	0	SENT_174	[p12l236t400r299b437],
34	HSR	NN	O	hsr	nn	35	SENT_174	[p12l320t383r468b437],
35	patients	NNS	O	patient	conj_or	17	SENT_174	[p12l488t383r727b453],
36	presenting	VBG	O	present	partmod	35	SENT_174	[p12l749t383r1069b453],
37	a	DT	O	a	det	38	SENT_174	[p12l1094t400r1126b437],
38	triad	NN	O	triad	dobj	36	SENT_174	[p12l1147t383r1289b437],
39	of	IN	O	of	_	0	SENT_174	[p12l1311t383r1377b437],
40	rash	NN	O	rash	prep_of	38	SENT_174	[p12l1393t383r1537b446],
41	,	,	O	,	_	0	SENT_174	[p12l1393t383r1537b446],
42	fever	NN	O	fever	prep_of	38	SENT_174	[p12l1562t383r1718b437],
43	and	CC	O	and	_	0	SENT_174	[p12l1740t383r1849b437],
44	organ	NN	O	organ	prep_of	38	SENT_174	[p12l1871t400r2044b453],
45	involvement	NN	O	involvement	nn	48	SENT_174	[p12l2066t383r2147b436, p12l8t478r332b531],
46	(	CD	NUMBER	(	num	48	SENT_174	[p12l354t478r448b544],
47	SJ	NN	O	sj	nn	48	SENT_174	[p12l354t478r448b544],
48	S/TEN	NN	O	s/ten	nsubj	51	SENT_174	[p12l452t478r663b532],
49	or	CC	O	or	_	0	SENT_174	[p12l684t495r747b531],
50	DILI	NNP	O	DILI	nsubj	51	SENT_174	[p12l766t478r942b544],
51	)	VBD	O	)	rcmod	38	SENT_174	[p12l766t478r942b544],
52	that	IN	O	that	complm	53	SENT_174	[p12l965t478r1081b531],
53	characterizes	VBZ	O	characterize	dep	51	SENT_174	[p12l1101t478r1502b531],
54	“	RB	O	“	advmod	55	SENT_174	[p12l1532t478r1717b531],
55	true	JJ	O	true	amod	57	SENT_174	[p12l1532t478r1717b531],
56	”	RB	O	”	advmod	55	SENT_174	[p12l1532t478r1717b531],
57	HSR	NN	O	hsr	dobj	53	SENT_174	[p12l1746t478r1894b531],
58	(	CD	NUMBER	(	num	60	SENT_174	[p12l1916t478r2146b544],
59	black	JJ	O	black	amod	60	SENT_174	[p12l1916t478r2146b544],
60	)	NN	O	)	nsubj	53	SENT_174	[p12l1916t478r2146b544],
61	.	.	O	.	_	0	SENT_174	[p12l1916t478r2146b544],

1	LTA	NN	ORGANIZATION	lta	nn	2	SENT_175	[p12l7t572r143b626],
2	values	NNS	O	value	nsubjpass	4	SENT_175	[p12l159t572r351b626],
3	are	VBP	O	be	auxpass	4	SENT_175	[p12l376t589r467b626],
4	given	VBN	O	give	_	0	SENT_175	[p12l488t572r655b642],
5	as	IN	O	as	_	0	SENT_175	[p12l678t589r737b626],
6	mean	JJ	O	mean	amod	7	SENT_175	[p12l760t589r926b626],
7	percentage	NN	O	percentage	prep_as	4	SENT_175	[p12l946t580r1280b642],
8	of	IN	O	of	_	0	SENT_175	[p12l1302t572r1369b626],
9	toxicity	NN	O	toxicity	prep_of	7	SENT_175	[p12l1385t572r1619b642],
10	and	CC	O	and	_	0	SENT_175	[p12l1642t572r1752b626],
11	standard	JJ	O	standard	amod	12	SENT_175	[p12l1775t572r2033b626],
12	deviation	NN	O	deviation	prep_as	4	SENT_175	[p12l2054t572r2148b626, p12l8t670r221b724],
13	(	CD	NUMBER	(	num	15	SENT_175	[p12l247t670r390b737],
14	SD	NN	O	sd	nn	15	SENT_175	[p12l247t670r390b737],
15	)	NN	O	)	dep	12	SENT_175	[p12l247t670r390b737],
16	in	IN	O	in	_	0	SENT_175	[p12l415t670r474b723],
17	lymphocytes	NNS	O	lymphocyte	prep_in	4	SENT_175	[p12l498t670r889b740],
18	for	IN	O	for	_	0	SENT_175	[p12l913t670r1003b724],
19	each	DT	O	each	det	20	SENT_175	[p12l1025t670r1165b724],
20	drug	NN	O	drug	prep_for	17	SENT_175	[p12l1189t670r1343b740],
21	.	.	O	.	_	0	SENT_175	[p12l1189t670r1343b740],

1	Table	NNP	O	Table	_	0	SENT_176	[p12l7t915r251b981],
2	.	.	O	.	_	0	SENT_176	[p12l7t915r251b981],

1	Levels	NNS	O	level	_	0	SENT_177	[p12l307t915r550b981],
2	of	IN	O	of	advmod	3	SENT_177	[p12l579t915r661b981],
3	secreted	VBN	O	secrete	partmod	1	SENT_177	[p12l686t915r1053b981],
4	cytokines	NNS	O	cytokine	dep	10	SENT_177	[p12l1086t915r1474b996],
5	in	IN	O	in	_	0	SENT_177	[p12l1505t915r1565b980],
6	patient	NN	O	patient	nn	7	SENT_177	[p12l1600t915r1899b996],
7	sero	NN	O	sero	prep_in	4	SENT_177	[p12l1925t931r2094b981],
8	Neumoln	NNP	O	Neumoln	dep	10	SENT_177	[p12l1405t1032r1720b1090],
9	et	FW	O	et	nn	10	SENT_177	[p12l1749t1032r1821b1090],
10	ol	FW	O	ol	dep	1	SENT_177	[p12l1846t1032r1907b1090],
11	401	CD	NUMBER	401	dep	10	SENT_177	[p12l2018t1031r2135b1090],

1	transferase	NN	O	transferase	_	0	SENT_178	[p12l8t1265r424b1333],
2	(	CD	NUMBER	(	num	1	SENT_178	[p12l465t1266r726b1349],
3	AST	NNP	O	AST	dep	1	SENT_178	[p12l465t1266r726b1349],
4	)	CD	NUMBER	)	num	3	SENT_178	[p12l465t1266r726b1349],
5	,	,	O	,	_	0	SENT_178	[p12l465t1266r726b1349],
6	and	CC	O	and	_	0	SENT_178	[p12l768t1265r904b1333],
7	bilirubin	NN	O	bilirubin	conj_and	3	SENT_178	[p12l939t1266r1271b1333],
8	3	CD	NUMBER	3	number	9	SENT_178	[p12l1310t1266r1349b1334],
9	times	NNS	O	time	dep	1	SENT_178	[p12l1390t1266r1595b1333],
10	over	IN	O	over	_	0	SENT_178	[p12l1635t1287r1803b1333],
11	the	DT	O	the	det	13	SENT_178	[p12l1838t1266r1952b1333],
12	normal	JJ	O	normal	amod	13	SENT_178	[p12l1989t1287r2145b1333, p12l8t1382r151b1449],
13	limit	NN	O	limit	prep_over	9	SENT_178	[p12l199t1382r399b1449],
14	.	.	O	.	_	0	SENT_178	[p12l199t1382r399b1449],

1	Two	CD	NUMBER	two	num	5	SENT_179	[p12l451t1384r617b1450],
2	young	JJ	O	young	amod	5	SENT_179	[p12l664t1404r902b1469],
3	Han	NNP	O	Han	nn	5	SENT_179	[p12l950t1384r1109b1449],
4	Chinese	NNPS	MISC	Chinese	nn	5	SENT_179	[p12l1156t1382r1463b1450],
5	patients	NNS	O	patient	nsubj	6	SENT_179	[p12l1510t1382r1808b1469],
6	showed	VBD	O	show	dep	20	SENT_179	[p12l1860t1382r2147b1449],
7	SJ	NN	O	sj	nn	8	SENT_179	[p12l11t1497r97b1564],
8	S	NN	O	s	nsubj	9	SENT_179	[p12l101t1497r145b1564],
9	clinically	RB	O	clinically	xcomp	6	SENT_179	[p12l192t1497r550b1584],
10	to	TO	O	to	_	0	SENT_179	[p12l591t1507r663b1564],
11	both	DT	O	both	preconj	12	SENT_179	[p12l704t1497r875b1564],
12	CBZ	NN	ORGANIZATION	cbz	prep_to	9	SENT_179	[p12l917t1497r1101b1564],
13	and	CC	O	and	_	0	SENT_179	[p12l1144t1497r1280b1564],
14	PHY	NN	O	phy	conj_and	12	SENT_179	[p12l1321t1499r1510b1563],
15	with	IN	O	with	_	0	SENT_179	[p12l1552t1497r1721b1564],
16	extremely	RB	O	extremely	advmod	19	SENT_179	[p12l1763t1497r2146b1584],
17	elevated	JJ	O	elevated	amod	19	SENT_179	[p12l9t1612r327b1680],
18	LTA	NN	ORGANIZATION	lta	nn	19	SENT_179	[p12l367t1612r538b1679],
19	values	NNS	O	value	prep_with	12	SENT_179	[p12l573t1612r814b1680],
20	(	VBP	O	(	_	0	SENT_179	[p12l861t1612r1060b1695],
21	53	CD	PERCENT	53	num	22	SENT_179	[p12l861t1612r1060b1695],
22	%	NN	PERCENT	%	dobj	20	SENT_179	[p12l861t1612r1060b1695],
23	CBZ	NN	O	cbz	nsubj	20	SENT_179	[p12l1108t1612r1497b1680],
24	.	.	O	.	_	0	SENT_179	[p12l1108t1612r1497b1680],

1	—	NN	O	—	_	0	SENT_180	[p12l1108t1612r1497b1680],
2	.	.	O	.	_	0	SENT_180	[p12l1108t1612r1497b1680],

1	LTA	NN	ORGANIZATION	lta	_	0	SENT_181	[p12l1108t1612r1497b1680],
2	and	CC	O	and	_	0	SENT_181	[p12l1541t1612r1677b1679],
3	28	CD	PERCENT	28	number	4	SENT_181	[p12l1720t1612r1888b1680],
4	%	NN	PERCENT	%	amod	5	SENT_181	[p12l1720t1612r1888b1680],
5	PHYLTA	NN	O	phylta	conj_and	1	SENT_181	[p12l1935t1613r2144b1679, p12l8t1729r198b1808],
6	,	,	O	,	_	0	SENT_181	[p12l1935t1613r2144b1679, p12l8t1729r198b1808],
7	and	CC	O	and	_	0	SENT_181	[p12l239t1728r375b1795],
8	38	CD	PERCENT	38	number	9	SENT_181	[p12l412t1729r580b1796],
9	%	NN	PERCENT	%	amod	10	SENT_181	[p12l412t1729r580b1796],
10	CBZ	NN	O	cbz	conj_and	5	SENT_181	[p12l621t1729r1010b1796],
11	.	.	O	.	_	0	SENT_181	[p12l621t1729r1010b1796],

1	—	NN	O	—	_	0	SENT_182	[p12l621t1729r1010b1796],
2	.	.	O	.	_	0	SENT_182	[p12l621t1729r1010b1796],

1	LTA	NN	ORGANIZATION	lta	_	0	SENT_183	[p12l621t1729r1010b1796],
2	and	CC	O	and	_	0	SENT_183	[p12l1047t1728r1182b1795],
3	26	CD	PERCENT	26	number	4	SENT_183	[p12l1219t1728r1387b1796],
4	%	NN	PERCENT	%	amod	5	SENT_183	[p12l1219t1728r1387b1796],
5	PHY	NN	O	phy	conj_and	1	SENT_183	[p12l1427t1729r1831b1808],
6	.	.	O	.	_	0	SENT_183	[p12l1427t1729r1831b1808],

1	—	NN	O	—	_	0	SENT_184	[p12l1427t1729r1831b1808],
2	.	.	O	.	_	0	SENT_184	[p12l1427t1729r1831b1808],

1	LTA	NNP	ORGANIZATION	LTA	_	0	SENT_185	[p12l1427t1729r1831b1808],
2	,	,	O	,	_	0	SENT_185	[p12l1427t1729r1831b1808],
3	respectively	RB	O	respectively	advmod	4	SENT_185	[p12l1869t1750r2144b1815, p12l8t1843r276b1930],
4	)	CD	NUMBER	)	rcmod	1	SENT_185	[p12l1869t1750r2144b1815, p12l8t1843r276b1930],
5	.	.	O	.	_	0	SENT_185	[p12l1869t1750r2144b1815, p12l8t1843r276b1930],

1	The	DT	O	the	det	2	SENT_186	[p12l327t1843r474b1910],
2	LTA	NNP	ORGANIZATION	LTA	nsubj	7	SENT_186	[p12l521t1844r692b1909],
3	for	IN	O	for	_	0	SENT_186	[p12l738t1843r849b1910],
4	CBZ	NNP	ORGANIZATION	CBZ	prep_for	2	SENT_186	[p12l895t1844r1079b1911],
5	and	CC	O	and	_	0	SENT_186	[p12l1127t1843r1263b1910],
6	PHY	NNP	O	PHY	conj_and	4	SENT_186	[p12l1309t1845r1499b1909],
7	correlated	VBD	O	correlate	_	0	SENT_186	[p12l1546t1843r1932b1910],
8	with	IN	O	with	_	0	SENT_186	[p12l1978t1843r2147b1911],
9	the	DT	O	the	det	11	SENT_186	[p12l8t1958r123b2025],
10	clinical	JJ	O	clinical	amod	11	SENT_186	[p12l165t1958r447b2025],
11	presentation	NN	O	presentation	prep_with	7	SENT_186	[p12l486t1958r959b2045],
12	and	CC	O	and	_	0	SENT_186	[p12l1000t1958r1136b2025],
13	with	IN	O	with	_	0	SENT_186	[p12l1175t1958r1344b2026],
14	HLA	NN	O	hlum	prep_with	7	SENT_186	[p12l1384t1958r1916b2026],
15	.	.	O	.	_	0	SENT_186	[p12l1384t1958r1916b2026],

1	—	NN	O	—	_	0	SENT_187	[p12l1384t1958r1916b2026],
2	.	.	O	.	_	0	SENT_187	[p12l1384t1958r1916b2026],

1	B	NN	O	b	_	0	SENT_188	[p12l1384t1958r1916b2026],
2	*	CD	NUMBER	*	num	4	SENT_188	[p12l1384t1958r1916b2026],
3	l502	NN	O	l502	nn	4	SENT_188	[p12l1384t1958r1916b2026],
4	positivity	NN	O	positivity	dep	1	SENT_188	[p12l1955t1958r2144b2045, p12l8t2073r222b2160],
5	.	.	O	.	_	0	SENT_188	[p12l1955t1958r2144b2045, p12l8t2073r222b2160],

1	All	DT	O	all	det	5	SENT_189	[p12l273t2073r394b2139],
2	3	CD	NUMBER	3	num	5	SENT_189	[p12l442t2073r480b2140],
3	Han	NNP	MISC	Han	nn	5	SENT_189	[p12l531t2075r689b2140],
4	Chinese	NNP	MISC	Chinese	nn	5	SENT_189	[p12l736t2073r1043b2140],
5	patients	NNS	O	patient	nsubj	10	SENT_189	[p12l1089t2073r1387b2160],
6	that	WDT	O	that	nsubj	7	SENT_189	[p12l1435t2073r1579b2140],
7	had	VBD	O	have	rcmod	5	SENT_189	[p12l1623t2073r1762b2140],
8	SJS	NNP	O	SJS	dobj	7	SENT_189	[p12l1809t2073r1943b2140],
9	also	RB	O	also	advmod	10	SENT_189	[p12l1996t2073r2145b2140],
10	had	VBD	O	have	_	0	SENT_189	[p12l8t2188r146b2255],
11	positive	JJ	O	positive	amod	12	SENT_189	[p12l196t2188r498b2275],
12	HLA	NN	O	hlum	dobj	10	SENT_189	[p12l550t2188r1103b2255],
13	.	.	O	.	_	0	SENT_189	[p12l550t2188r1103b2255],

1	—	NN	O	—	_	0	SENT_190	[p12l550t2188r1103b2255],
2	.	.	O	.	_	0	SENT_190	[p12l550t2188r1103b2255],

1	B	NN	O	b	_	0	SENT_191	[p12l550t2188r1103b2255],
2	*	CD	NUMBER	*	num	3	SENT_191	[p12l550t2188r1103b2255],
3	l502	NN	O	l502	dep	1	SENT_191	[p12l550t2188r1103b2255],
4	.	.	O	.	_	0	SENT_191	[p12l550t2188r1103b2255],

1	Our	PRP$	O	we	poss	2	SENT_192	[p12l1161t2188r1308b2255],
2	study	NN	O	study	nsubj	3	SENT_192	[p12l1362t2188r1564b2275],
3	conﬁrms	VBZ	O	conﬁrms	_	0	SENT_192	[p12l1617t2188r1950b2255],
4	that	IN	O	that	complm	8	SENT_192	[p12l2004t2188r2148b2255],
5	CBZ-HSR	NN	O	cbz-hsr	nsubjpass	8	SENT_192	[p12l9t2304r414b2371],
6	can	MD	O	can	aux	8	SENT_192	[p12l490t2325r621b2370],
7	be	VB	O	be	auxpass	8	SENT_192	[p12l696t2303r785b2370],
8	predicted	VBN	O	predict	ccomp	3	SENT_192	[p12l861t2303r1220b2390],
9	by	IN	O	by	_	0	SENT_192	[p12l1294t2303r1389b2390],
10	the	DT	O	the	det	11	SENT_192	[p12l1465t2303r1580b2370],
11	presence	NN	O	presence	agent	8	SENT_192	[p12l1656t2325r1993b2390],
12	of	IN	O	of	_	0	SENT_192	[p12l2070t2303r2153b2370],
13	HLA-B	NN	O	hla-b	nn	15	SENT_192	[p12l9t2418r563b2498],
14	*	CD	NUMBER	*	num	15	SENT_192	[p12l9t2418r563b2498],
15	l502	NN	O	l502	prep_of	11	SENT_192	[p12l9t2418r563b2498],
16	,	,	O	,	_	0	SENT_192	[p12l9t2418r563b2498],
17	While	IN	O	while	mark	24	SENT_192	[p12l610t2418r821b2486],
18	an	DT	O	a	det	22	SENT_192	[p12l867t2440r953b2485],
19	HLA-B	NN	O	hla-b	nn	22	SENT_192	[p12l996t2418r1887b2505],
20	*	CD	NUMBER	*	num	22	SENT_192	[p12l996t2418r1887b2505],
21	l502-negative	JJ	O	l502-negative	amod	22	SENT_192	[p12l996t2418r1887b2505],
22	status	NN	O	status	nsubj	24	SENT_192	[p12l1932t2428r2144b2485],
23	is	VBZ	O	be	cop	24	SENT_192	[p12l8t2533r68b2600],
24	protective	JJ	O	protective	dep	8	SENT_192	[p12l112t2533r496b2620],
25	against	IN	O	against	_	0	SENT_192	[p12l541t2533r812b2620],
26	CBZ	NN	ORGANIZATION	cbz	nn	27	SENT_192	[p12l855t2533r1040b2600],
27	sensitivity	NN	O	sensitivity	prep_against	24	SENT_192	[p12l1086t2533r1476b2620],
28	in	IN	O	in	_	0	SENT_192	[p12l1521t2533r1593b2599],
29	Han	NNP	MISC	Han	nn	31	SENT_192	[p12l1636t2534r1794b2600],
30	Chinese	NNP	MISC	Chinese	nn	31	SENT_192	[p12l1839t2533r2146b2600],
31	patients	NNS	O	patient	prep_in	27	SENT_192	[p12l7t2648r326b2735],
32	.	.	O	.	_	0	SENT_192	[p12l7t2648r326b2735],

1	The	DT	O	the	det	2	SENT_193	[p12l384t2648r532b2714],
2	LTA	NNP	ORGANIZATION	LTA	nsubj	4	SENT_193	[p12l585t2648r755b2714],
3	is	VBZ	O	be	cop	4	SENT_193	[p12l807t2648r867b2714],
4	predictive	JJ	O	predictive	_	0	SENT_193	[p12l921t2648r1305b2735],
5	for	IN	O	for	_	0	SENT_193	[p12l1357t2648r1469b2714],
6	both	DT	O	both	preconj	7	SENT_193	[p12l1518t2648r1690b2714],
7	CBZ-HSR	NN	O	cbz-hsr	prep_for	4	SENT_193	[p12l1743t2648r2148b2715],
8	and	CC	O	and	_	0	SENT_193	[p12l10t2763r146b2830],
9	PHY-HSR	NN	O	phy-hsr	prep_for	4	SENT_193	[p12l208t2764r628b2843],
10	,	,	O	,	_	0	SENT_193	[p12l208t2764r628b2843],
11	and	CC	O	and	_	0	SENT_193	[p12l696t2763r831b2830],
12	can	MD	O	can	aux	14	SENT_193	[p12l894t2785r1026b2830],
13	be	VB	O	be	auxpass	14	SENT_193	[p12l1086t2763r1176b2830],
14	correlated	VBN	O	correlate	conj_and	4	SENT_193	[p12l1240t2763r1626b2830],
15	with	IN	O	with	_	0	SENT_193	[p12l1687t2763r1857b2831],
16	HLAB	NN	O	hlab	prep_with	14	SENT_193	[p12l1919t2764r2144b2829, p12l8t2877r310b2945],
17	*	CD	NUMBER	*	num	18	SENT_193	[p12l1919t2764r2144b2829, p12l8t2877r310b2945],
18	l502	NN	O	l502	nsubjpass	14	SENT_193	[p12l1919t2764r2144b2829, p12l8t2877r310b2945],
19	positive	JJ	O	positive	amod	20	SENT_193	[p12l359t2878r662b2965],
20	results	NNS	O	result	dep	14	SENT_193	[p12l710t2878r959b2944],
21	in	IN	O	in	_	0	SENT_193	[p12l1010t2878r1083b2944],
22	Han	NNP	LOCATION	Han	nn	24	SENT_193	[p12l1131t2879r1290b2944],
23	Chinese	NNP	LOCATION	Chinese	nn	24	SENT_193	[p12l1340t2878r1648b2945],
24	individuals	NNS	O	individual	prep_in	14	SENT_193	[p12l1697t2878r2142b2945],
25	.	.	O	.	_	0	SENT_193	[p12l1697t2878r2142b2945],

1	The	DT	O	the	det	3	SENT_194	[p12l8t2993r156b3060],
2	high	JJ	O	high	amod	3	SENT_194	[p12l209t2993r380b3080],
3	cytotoxicity	NN	O	cytotoxicity	nsubj	4	SENT_194	[p12l434t2993r893b3080],
4	conﬁrms	VBZ	O	conﬁrms	_	0	SENT_194	[p12l949t2993r1281b3060],
5	the	DT	O	the	det	7	SENT_194	[p12l1337t2993r1452b3060],
6	predictive	JJ	O	predictive	amod	7	SENT_194	[p12l1506t2993r1890b3080],
7	value	NN	O	value	dobj	4	SENT_194	[p12l1941t2993r2146b3060],
8	of	IN	O	of	_	0	SENT_194	[p12l10t3108r93b3175],
9	the	DT	O	the	det	10	SENT_194	[p12l125t3108r241b3175],
10	LTA	NNP	ORGANIZATION	LTA	prep_of	7	SENT_194	[p12l280t3109r451b3174],
11	in	IN	O	in	_	0	SENT_194	[p12l490t3108r563b3174],
12	this	DT	O	this	det	13	SENT_194	[p12l602t3108r737b3175],
13	population	NN	O	population	prep_in	4	SENT_194	[p12l777t3108r1210b3195],
14	.	.	O	.	_	0	SENT_194	[p12l777t3108r1210b3195],

1	In	IN	O	in	_	0	SENT_195	[p12l95t3224r174b3289],
2	the	DT	O	the	det	4	SENT_195	[p12l214t3223r331b3289],
3	present	JJ	DATE	present	amod	4	SENT_195	[p12l371t3233r656b3310],
4	work	NN	O	work	prep_in	7	SENT_195	[p12l695t3223r914b3302],
5	,	,	O	,	_	0	SENT_195	[p12l695t3223r914b3302],
6	We	PRP	O	we	nsubj	7	SENT_195	[p12l958t3244r1068b3290],
7	deﬁne	VBP	O	deﬁne	_	0	SENT_195	[p12l1110t3223r1346b3289],
8	the	DT	O	the	det	10	SENT_195	[p12l1386t3223r1503b3289],
9	cytokine	NN	O	cytokine	nn	10	SENT_195	[p12l1545t3223r1880b3310],
10	levels	NNS	O	level	dobj	7	SENT_195	[p12l1921t3223r2145b3290],
11	in	IN	O	in	_	0	SENT_195	[p12l8t3338r83b3405],
12	the	DT	O	the	det	13	SENT_195	[p12l134t3338r251b3405],
13	sera	NN	O	serum	prep_in	7	SENT_195	[p12l307t3360r460b3405],
14	of	IN	O	of	_	0	SENT_195	[p12l512t3338r596b3405],
15	AED-tolerant	JJ	O	aed-tolerant	amod	16	SENT_195	[p12l640t3338r1178b3405],
16	controls	NNS	O	control	prep_of	13	SENT_195	[p12l1229t3338r1542b3405],
17	and	CC	O	and	_	0	SENT_195	[p12l1598t3338r1735b3405],
18	HSR	NN	O	hsr	nn	19	SENT_195	[p12l1786t3339r1973b3406],
19	patients	NNS	O	patient	prep_of	13	SENT_195	[p12l2023t3360r2144b3425, p12l8t3453r219b3520],
20	(	RB	O	(	advmod	13	SENT_195	[p12l287t3453r586b3536],
21	Table	NNP	O	Table	dep	13	SENT_195	[p12l287t3453r586b3536],
22	)	CD	NUMBER	)	num	21	SENT_195	[p12l287t3453r586b3536],
23	.	.	O	.	_	0	SENT_195	[p12l287t3453r586b3536],

1	There	EX	O	there	expl	2	SENT_196	[p12l653t3453r880b3520],
2	is	VBZ	O	be	_	0	SENT_196	[p12l943t3453r1004b3520],
3	a	DT	O	a	det	5	SENT_196	[p12l1070t3474r1110b3520],
4	clear	JJ	O	clear	amod	5	SENT_196	[p12l1172t3453r1363b3520],
5	partition	NN	O	partition	nsubj	2	SENT_196	[p12l1423t3453r1760b3540],
6	between	IN	O	between	_	0	SENT_196	[p12l1821t3453r2148b3520],
7	the	DT	O	the	det	8	SENT_196	[p12l8t3568r126b3635],
8	levels	NNS	O	level	prep_between	5	SENT_196	[p12l170t3568r393b3635],
9	of	IN	O	of	_	0	SENT_196	[p12l440t3568r524b3635],
10	cytokines	NNS	O	cytokine	prep_of	8	SENT_196	[p12l561t3568r934b3655],
11	in	IN	O	in	_	0	SENT_196	[p12l979t3568r1054b3634],
12	controls	NNS	O	control	prep_in	10	SENT_196	[p12l1098t3568r1434b3647],
13	,	,	O	,	_	0	SENT_196	[p12l1098t3568r1434b3647],
14	patients	NNS	O	patient	conj_and	5	SENT_196	[p12l1480t3568r1785b3655],
15	presenting	VBG	O	present	partmod	14	SENT_196	[p12l1830t3578r2144b3655, p12l8t3683r130b3770],
16	with	IN	O	with	_	0	SENT_196	[p12l168t3683r341b3751],
17	only	RB	O	only	advmod	18	SENT_196	[p12l379t3683r550b3770],
18	rash	JJ	O	rash	prep_with	15	SENT_196	[p12l585t3683r749b3750],
19	and	CC	O	and	_	0	SENT_196	[p12l787t3683r925b3750],
20	fever	NN	O	fever	conj_and	18	SENT_196	[p12l962t3683r1177b3763],
21	,	,	O	,	_	0	SENT_196	[p12l962t3683r1177b3763],
22	and	CC	O	and	_	0	SENT_196	[p12l1220t3683r1358b3750],
23	patients	NNS	O	patient	conj_and	5	SENT_196	[p12l1393t3683r1698b3770],
24	presenting	VBG	O	present	partmod	23	SENT_196	[p12l1736t3683r2145b3770],
25	with	IN	O	with	_	0	SENT_196	[p13l9t21r181b88],
26	the	DT	O	the	det	27	SENT_196	[p13l223t21r340b87],
27	triad	NN	O	triad	prep_with	24	SENT_196	[p13l382t21r563b87],
28	of	IN	O	of	_	0	SENT_196	[p13l604t21r689b87],
29	rash	NN	O	rash	prep_of	27	SENT_196	[p13l723t21r907b100],
30	,	,	O	,	_	0	SENT_196	[p13l723t21r907b100],
31	fever	NN	O	fever	prep_of	27	SENT_196	[p13l952t20r1151b88],
32	and	CC	O	and	_	0	SENT_196	[p13l1193t21r1332b87],
33	organ	NN	O	organ	nn	34	SENT_196	[p13l1373t42r1593b108],
34	involvement	NN	O	involvement	prep_of	27	SENT_196	[p13l1635t21r2142b88],
35	.	.	O	.	_	0	SENT_196	[p13l1635t21r2142b88],

1	oooooo	NN	O	oooooo	nn	2	SENT_197	[p13l672t291r767b314],
2	ls	NNS	O	l	_	0	SENT_197	[p13l768t291r786b314],

1	Cytokines	NNS	O	cytokine	_	0	SENT_198	[p13l96t338r235b366],
2	(	CD	NUMBER	(	num	3	SENT_198	[p13l245t339r335b364],
3	mean	NN	O	mean	dep	1	SENT_198	[p13l245t339r335b364],
4	2	CD	NUMBER	2	num	6	SENT_198	[p13l348t343r366b360],
5	SD	NN	O	sd	nn	6	SENT_198	[p13l378t338r422b364],
6	)	NN	O	)	dep	1	SENT_198	[p13l378t338r422b364],

1	IL-1	NN	O	il-1	nn	20	SENT_199	[p13l14t473r165b551],
2	pg/mL	NN	O	pg/ml	nn	20	SENT_199	[p13l223t473r522b573],
3	IL-2	NN	O	il-2	nn	20	SENT_199	[p13l14t607r181b685],
4	pg/mL	NN	O	pg/ml	nn	20	SENT_199	[p13l223t606r522b706],
5	IL-4	NN	O	il-4	nn	20	SENT_199	[p13l14t741r184b819],
6	pg/mL	NN	O	pg/ml	nn	20	SENT_199	[p13l223t740r522b840],
7	IL-5	NN	O	il-5	nn	20	SENT_199	[p13l14t876r183b954],
8	pg/mL	NN	O	pg/ml	nn	20	SENT_199	[p13l223t875r522b975],
9	IL-6	NN	O	il-6	nn	20	SENT_199	[p13l14t1009r184b1087],
10	pg/mL	NN	O	pg/ml	nn	20	SENT_199	[p13l223t1008r523b1108],
11	IL-8	NN	O	il-8	nn	20	SENT_199	[p13l14t1143r184b1221],
12	pg/mL	NN	O	pg/ml	nn	20	SENT_199	[p13l223t1142r523b1242],
13	IL-10	NN	O	il-10	nn	20	SENT_199	[p13l14t1277r244b1357],
14	pg/mL	NN	O	pg/ml	nn	20	SENT_199	[p13l283t1276r581b1376],
15	MOP-1	NN	O	mop-1	nn	20	SENT_199	[p13l14t1410r317b1490],
16	pg/mL	NN	O	pg/ml	nn	20	SENT_199	[p13l375t1410r674b1510],
17	RANTES	NN	O	rante	nn	20	SENT_199	[p13l14t1544r410b1623],
18	pg/mL	NN	O	pg/ml	nn	20	SENT_199	[p13l448t1544r747b1644],
19	TNF	NN	O	tnf	nn	20	SENT_199	[p13l6t1679r301b1757],
20	—	NN	O	—	dep	29	SENT_199	[p13l6t1679r301b1757],
21	a	DT	O	a	det	25	SENT_199	[p13l6t1679r301b1757],
22	pg/mL	NN	O	pg/ml	nn	25	SENT_199	[p13l343t1678r641b1778],
23	Fas	NN	O	fa	nn	25	SENT_199	[p13l14t1813r170b1891],
24	ng/mL	NN	O	ng/ml	nn	25	SENT_199	[p13l209t1812r505b1912],
25	M30	NN	O	m30	dep	20	SENT_199	[p13l14t1947r213b2027],
26	(	CD	PERCENT	(	num	27	SENT_199	[p13l250t1946r387b2045],
27	%	NN	PERCENT	%	dep	29	SENT_199	[p13l250t1946r387b2045],
28	)	CD	NUMBER	)	num	29	SENT_199	[p13l250t1946r387b2045],
29	Caspase	NN	O	caspase	dep	34	SENT_199	[p13l11t2081r414b2180],
30	8	CD	NUMBER	8	num	32	SENT_199	[p13l448t2084r500b2162],
31	IU/mL	NN	O	iu/ml	nn	32	SENT_199	[p13l541t2081r815b2162],
32	Caspase	NN	O	caspase	dep	29	SENT_199	[p13l9t2216r413b2316],
33	3	CD	NUMBER	3	num	34	SENT_199	[p13l448t2219r500b2297],
34	IU/mL	NN	O	iu/ml	_	0	SENT_199	[p13l541t2216r815b2297],

1	18:12	CD	TIME	18:12	num	2	SENT_200	[p14l56t30r364b95],
2	35.0	CD	NUMBER	35.0	_	0	SENT_200	[p14l1654t29r2151b95],
3	:	:	O	:	_	0	SENT_200	[p14l1654t29r2151b95],
4	‘	CD	NUMBER	‘	num	5	SENT_200	[p14l1654t29r2151b95],
5	l0	NN	O	l0	dep	2	SENT_200	[p14l1654t29r2151b95],
6	.0	CD	NUMBER	.0	number	7	SENT_200	[p14l1654t29r2151b95],
7	*	CD	NUMBER	*	dep	10	SENT_200	[p14l1654t29r2151b95],
8	*	CD	NUMBER	*	num	9	SENT_200	[p14l96t144r125b166],
9	P	NN	O	p	npadvmod	10	SENT_200	[p14l96t144r125b166],
10	<	JJR	O	<	amod	5	SENT_200	[p14l133t148r153b165],
11	0.001	CD	NUMBER	0.001	npadvmod	12	SENT_200	[p14l164t144r231b166],
12	higher	JJR	O	higher	advmod	5	SENT_200	[p14l246t144r333b172],
13	vs	CC	O	vs	_	0	SENT_200	[p14l341t149r368b166],
14	control	NN	O	control	conj_vs	5	SENT_200	[p14l378t144r481b166],
15	.	.	O	.	_	0	SENT_200	[p14l378t144r481b166],

1	**	NN	O	**	nn	2	SENT_201	[p14l96t181r136b203],
2	P	NN	O	p	_	0	SENT_201	[p14l96t181r136b203],
3	<	JJR	O	<	dep	2	SENT_201	[p14l144t185r164b202],
4	0.05	CD	NUMBER	0.05	npadvmod	5	SENT_201	[p14l175t181r230b203],
5	higher	JJR	O	higher	advmod	3	SENT_201	[p14l240t181r327b209],
6	vs	CC	O	vs	_	0	SENT_201	[p14l336t186r362b203],
7	control	NN	O	control	conj_vs	3	SENT_201	[p14l372t181r475b203],
8	.	.	O	.	_	0	SENT_201	[p14l372t181r475b203],

1	***	CD	NUMBER	***	num	2	SENT_202	[p14l96t218r146b240],
2	P	NN	O	p	_	0	SENT_202	[p14l96t218r146b240],
3	<	JJR	O	<	dep	2	SENT_202	[p14l154t222r174b239],
4	0.05	CD	NUMBER	0.05	npadvmod	5	SENT_202	[p14l185t218r240b240],
5	lower	JJR	O	lower	advmod	3	SENT_202	[p14l250t218r325b240],
6	vs	CC	O	vs	_	0	SENT_202	[p14l334t223r360b240],
7	control	NN	O	control	conj_vs	3	SENT_202	[p14l370t218r474b240],
8	.	.	O	.	_	0	SENT_202	[p14l370t218r474b240],

1	patients	NNS	O	patient	nsubj	2	SENT_203	[p14l95t315r224b353],
2	developed	VBD	O	develop	_	0	SENT_203	[p14l244t315r414b353],
3	HSR	NN	O	hsr	dobj	2	SENT_203	[p14l432t315r512b344],
4	with	IN	O	with	_	0	SENT_203	[p14l531t315r604b344],
5	liver	NN	O	liver	nn	6	SENT_203	[p14l623t315r698b344],
6	involvement	NN	O	involvement	prep_with	2	SENT_203	[p14l716t315r922b344],
7	after	IN	O	after	_	0	SENT_203	[p14l942t315r1017b344],
8	AED	NN	O	aed	nn	9	SENT_203	[p14l96t364r179b393],
9	therapy	NN	O	therapy	prep_after	2	SENT_203	[p14l195t364r325b402],
10	.	.	O	.	_	0	SENT_203	[p14l195t364r325b402],

1	A	DT	O	a	det	4	SENT_204	[p14l134t413r162b442],
2	76-year-old	JJ	DURATION	76-year-old	amod	4	SENT_204	[p14l180t413r373b451],
3	Caucasian	JJ	MISC	caucasian	amod	4	SENT_204	[p14l391t413r561b442],
4	male	NN	O	male	nsubj	5	SENT_204	[p14l579t413r659b442],
5	demonstrated	VBD	O	demonstrate	_	0	SENT_204	[p14l677t413r901b442],
6	crossreactivity	NN	O	crossreactivity	dobj	5	SENT_204	[p14l919t422r1015b442, p14l95t463r252b500],
7	to	TO	O	to	_	0	SENT_204	[p14l268t467r299b492],
8	CBZ	NNP	ORGANIZATION	CBZ	prep_to	5	SENT_204	[p14l315t463r394b492],
9	and	CC	O	and	_	0	SENT_204	[p14l410t463r469b492],
10	PHY	NNP	O	PHY	prep_to	5	SENT_204	[p14l484t464r569b492],
11	.	.	O	.	_	0	SENT_204	[p14l484t464r569b492],

1	This	DT	O	this	det	2	SENT_205	[p14l587t463r659b492],
2	individual	JJ	O	individual	nsubj	3	SENT_205	[p14l675t463r842b492],
3	presented	VBN	O	present	_	0	SENT_205	[p14l857t463r1017b501],
4	S	NN	O	s	nn	6	SENT_205	[p14l97t512r134b541],
5	]	CD	NUMBER	]	num	6	SENT_205	[p14l97t512r134b541],
6	S	NN	O	s	dobj	3	SENT_205	[p14l136t512r155b541],
7	with	IN	O	with	_	0	SENT_205	[p14l174t512r247b541],
8	liver	NN	O	liver	nn	9	SENT_205	[p14l264t512r340b541],
9	involvement	NN	O	involvement	prep_with	3	SENT_205	[p14l355t512r561b541],
10	after	IN	O	after	_	0	SENT_205	[p14l579t512r655b541],
11	PHY	NN	O	phy	prep_after	3	SENT_205	[p14l671t512r843b541],
12	.	.	O	.	_	0	SENT_205	[p14l671t512r843b541],

1	—	NN	O	—	_	0	SENT_206	[p14l671t512r843b541],
2	.	.	O	.	_	0	SENT_206	[p14l671t512r843b541],

1	CBZ	NN	O	cbz	nn	2	SENT_207	[p14l671t512r843b541],
2	therapeuPatients	NNS	O	therapeupatient	nsubj	8	SENT_207	[p14l860t512r1016b550, p14l1142t315r1275b345],
3	presenting	VBG	O	present	partmod	2	SENT_207	[p14l1291t315r1467b353],
4	with	IN	O	with	_	0	SENT_207	[p14l1483t315r1557b345],
5	SJS/TEN	NN	O	sjs/ten	prep_with	3	SENT_207	[p14l1573t315r1728b345],
6	and	CC	O	and	_	0	SENT_207	[p14l1744t315r1803b345],
7	DILI	NNP	ORGANIZATION	DILI	prep_with	3	SENT_207	[p14l1818t316r1902b344],
8	show	VBP	O	show	_	0	SENT_207	[p14l1918t315r2004b345],
9	elevated	JJ	O	elevated	amod	10	SENT_207	[p14l2019t315r2061b345, p14l1143t365r1251b394],
10	levels	NNS	O	level	dobj	8	SENT_207	[p14l1271t365r1367b394],
11	of	IN	O	of	_	0	SENT_207	[p14l1389t364r1425b394],
12	Fas	NN	O	fa	prep_of	10	SENT_207	[p14l1442t365r1498b394],
13	and	CC	O	and	_	0	SENT_207	[p14l1520t365r1579b394],
14	caspase	NN	O	caspase	conj_and	12	SENT_207	[p14l1600t374r1728b402],
15	8	CD	NUMBER	8	num	14	SENT_207	[p14l1750t365r1777b399],
16	,	,	O	,	_	0	SENT_207	[p14l1750t365r1777b399],
17	pointing	VBG	O	point	partmod	8	SENT_207	[p14l1798t364r1939b402],
18	to	TO	O	to	_	0	SENT_207	[p14l1960t369r1991b394],
19	the	DT	O	the	det	21	SENT_207	[p14l2012t365r2062b394],
20	apoptotic	JJ	O	apoptotic	amod	21	SENT_207	[p14l1143t413r1299b451],
21	processes	NNS	O	process	prep_to	17	SENT_207	[p14l1324t422r1486b451],
22	involved	VBN	O	involve	partmod	21	SENT_207	[p14l1511t413r1657b442],
23	in	IN	O	in	_	0	SENT_207	[p14l1682t413r1714b442],
24	the	DT	O	the	det	25	SENT_207	[p14l1739t413r1789b442],
25	immunopathogenesis	NN	O	immunopathogenesis	prep_in	22	SENT_207	[p14l1814t413r2062b451, p14l1143t463r1265b501],
26	of	IN	O	of	_	0	SENT_207	[p14l1295t463r1331b492],
27	severe	JJ	O	severe	amod	28	SENT_207	[p14l1358t472r1463b492],
28	ADRs	NNS	MISC	adr	prep_of	25	SENT_207	[p14l1491t463r1594b492],
29	such	JJ	O	such	_	0	SENT_207	[p14l1624t463r1699b492],
30	as	IN	O	as	_	0	SENT_207	[p14l1728t472r1761b492],
31	DILI	NNP	ORGANIZATION	DILI	prep_such_as	28	SENT_207	[p14l1789t464r1873b492],
32	and	CC	O	and	_	0	SENT_207	[p14l1902t463r1961b492],
33	SJS	NNP	O	SJS	prep_such_as	28	SENT_207	[p14l1990t463r2063b492],
34	/	:	O	/	punct	35	SENT_207	[p14l1990t463r2063b492],
35	TEN	CD	NUMBER	ten	dep	28	SENT_207	[p14l1142t513r1232b542],
36	.	.	O	.	_	0	SENT_207	[p14l1142t513r1232b542],

1	There	EX	O	there	expl	2	SENT_208	[p14l1257t513r1355b542],
2	is	VBZ	O	be	_	0	SENT_208	[p14l1378t513r1404b542],
3	a	DT	O	a	det	5	SENT_208	[p14l1430t522r1447b542],
4	statistical	JJ	O	statistical	amod	5	SENT_208	[p14l1471t512r1630b542],
5	difference	NN	O	difference	nsubj	2	SENT_208	[p14l1654t512r1825b542],
6	between	IN	O	between	_	0	SENT_208	[p14l1848t513r1989b542],
7	the	DT	O	the	det	9	SENT_208	[p14l2012t513r2062b542],
8	tic	JJ	O	tic	amod	9	SENT_208	[p14l96t561r136b590],
9	doses	NNS	O	dose	prep_between	5	SENT_208	[p14l161t561r260b590],
10	.	.	O	.	_	0	SENT_208	[p14l161t561r260b590],

1	His	PRP$	O	he	poss	3	SENT_209	[p14l286t561r341b590],
2	laboratory	NN	O	laboratory	nn	3	SENT_209	[p14l366t561r536b599],
3	data	NNS	O	datum	nsubj	4	SENT_209	[p14l560t561r629b590],
4	showed	VBD	O	show	_	0	SENT_209	[p14l653t561r777b590],
5	high	JJ	O	high	amod	7	SENT_209	[p14l800t561r873b599],
6	alanine	NN	O	alanine	nn	7	SENT_209	[p14l898t561r1016b590],
7	aminotransferase	NN	O	aminotransferase	iobj	4	SENT_209	[p14l97t611r380b640],
8	(	CD	NUMBER	(	num	9	SENT_209	[p14l411t611r523b647],
9	ALT	NNP	O	ALT	dobj	4	SENT_209	[p14l411t611r523b647],
10	)	CD	NUMBER	)	num	9	SENT_209	[p14l411t611r523b647],
11	,	,	O	,	_	0	SENT_209	[p14l411t611r523b647],
12	elevated	JJ	O	elevated	amod	14	SENT_209	[p14l555t611r692b640],
13	aspartate	NN	O	aspartate	nn	14	SENT_209	[p14l723t615r869b649],
14	aminolevels	NNS	O	aminolevel	appos	9	SENT_209	[p14l900t611r1015b640, p14l1142t561r1239b590],
15	of	IN	O	of	_	0	SENT_209	[p14l1265t561r1301b590],
16	cytokines	NNS	O	cytokine	prep_of	14	SENT_209	[p14l1324t561r1484b599],
17	in	IN	O	in	_	0	SENT_209	[p14l1510t561r1542b590],
18	control	NN	O	control	nn	19	SENT_209	[p14l1568t561r1687b590],
19	individuals	NNS	O	individual	prep_in	16	SENT_209	[p14l1712t561r1899b590],
20	and	CC	O	and	_	0	SENT_209	[p14l1926t561r1985b590],
21	patients	NNS	O	patient	conj_and	19	SENT_209	[p14l2009t571r2061b599, p14l1142t611r1233b640],
22	presenting	VBG	O	present	dep	14	SENT_209	[p14l1275t611r1451b649],
23	ADRs	NNS	MISC	adr	dobj	22	SENT_209	[p14l1493t612r1606b646],
24	,	,	O	,	_	0	SENT_209	[p14l1493t612r1606b646],
25	and	CC	O	and	_	0	SENT_209	[p14l1649t611r1709b640],
26	between	IN	O	between	dep	14	SENT_209	[p14l1749t611r1890b640],
27	patients	NNS	O	patient	pobj	26	SENT_209	[p14l1931t611r2062b649],

1	402	CD	NUMBER	402	npadvmod	2	SENT_210	[p14l6t823r134b883],
2	Neumon	JJ	O	neumon	_	0	SENT_210	[p14l249t824r565b882],
3	e	SYM	O	e	dep	7	SENT_210	[p14l594t824r666b882],
4	’	CD	NUMBER	’	num	6	SENT_210	[p14l594t824r666b882],
5	r	NN	O	r	nn	6	SENT_210	[p14l594t824r666b882],
6	ol	NN	O	ol	nsubj	7	SENT_210	[p14l691t824r752b882],
7	presenting	VBG	O	present	dep	2	SENT_210	[p14l6t1057r416b1144],
8	only	RB	O	only	advmod	7	SENT_210	[p14l480t1057r650b1144],
9	with	IN	O	with	_	0	SENT_210	[p14l712t1057r885b1125],
10	rash	NN	O	rash	prep_with	7	SENT_210	[p14l945t1057r1108b1124],
11	and	CC	O	and	_	0	SENT_210	[p14l1171t1057r1308b1124],
12	patients	NNS	O	patient	nsubj	13	SENT_210	[p14l1368t1057r1673b1144],
13	presenting	VBG	O	present	dep	2	SENT_210	[p14l1735t1057r2145b1144],
14	with	IN	O	with	_	0	SENT_210	[p14l8t1173r180b1241],
15	DILI	NNP	ORGANIZATION	DILI	prep_with	13	SENT_210	[p14l222t1175r416b1240],
16	or	CC	O	or	_	0	SENT_210	[p14l459t1195r539b1241],
17	SJS/TEN	NNP	O	SJS/TEN	nn	20	SENT_210	[p14l581t1174r942b1241],
18	(	NNP	O	(	nn	20	SENT_210	[p14l987t1173r1286b1257],
19	Table	NNP	O	Table	nn	20	SENT_210	[p14l987t1173r1286b1257],
20	)	NN	O	)	prep_with	13	SENT_210	[p14l987t1173r1286b1257],
21	.	.	O	.	_	0	SENT_210	[p14l987t1173r1286b1257],

1	DISCUSSION	NN	O	discussion	_	0	SENT_211	[p14l12t1431r506b1498],

1	It	PRP	O	it	nsubj	3	SENT_212	[p14l95t1586r153b1652],
2	is	VBZ	O	be	cop	3	SENT_212	[p14l183t1585r243b1652],
3	crucial	JJ	O	crucial	_	0	SENT_212	[p14l278t1585r538b1652],
4	to	TO	O	to	aux	5	SENT_212	[p14l570t1595r642b1652],
5	have	VB	O	have	xcomp	3	SENT_212	[p14l674t1585r853b1652],
6	a	DT	O	a	det	8	SENT_212	[p14l887t1606r927b1652],
7	complete	JJ	O	complete	amod	8	SENT_212	[p14l958t1585r1311b1672],
8	understanding	NN	O	understanding	dobj	5	SENT_212	[p14l1342t1585r1888b1672],
9	of	IN	O	of	_	0	SENT_212	[p14l1922t1585r2005b1652],
10	the	DT	O	the	det	12	SENT_212	[p14l2030t1585r2145b1652],
11	biochemical	JJ	O	biochemical	amod	12	SENT_212	[p14l6t1700r480b1767],
12	processes	NNS	O	process	prep_of	8	SENT_212	[p14l516t1721r883b1787],
13	that	WDT	O	that	nsubj	14	SENT_212	[p14l922t1700r1066b1767],
14	occur	VBP	O	occur	rcmod	12	SENT_212	[p14l1104t1721r1317b1767],
15	during	IN	O	during	_	0	SENT_212	[p14l1353t1700r1600b1787],
16	HSR	NN	O	hsr	prep_during	14	SENT_212	[p14l1639t1700r1824b1767],
17	since	IN	O	since	mark	20	SENT_212	[p14l1865t1700r2057b1767],
18	it	PRP	O	it	nsubj	20	SENT_212	[p14l2094t1700r2147b1767],
19	would	MD	O	would	aux	20	SENT_212	[p14l8t1815r248b1882],
20	allow	VB	O	allow	advcl	14	SENT_212	[p14l280t1815r488b1882],
21	for	IN	O	for	_	0	SENT_212	[p14l521t1815r632b1882],
22	a	DT	O	a	det	24	SENT_212	[p14l663t1836r703b1882],
23	better	JJR	O	better	amod	24	SENT_212	[p14l732t1815r953b1882],
24	comprehension	NN	O	comprehension	prep_for	20	SENT_212	[p14l984t1815r1573b1902],
25	of	IN	O	of	_	0	SENT_212	[p14l1605t1815r1688b1882],
26	any	DT	O	any	det	28	SENT_212	[p14l1715t1836r1849b1902],
27	predisposing	NN	O	predisposing	nn	28	SENT_212	[p14l1879t1815r2143b1902, p14l6t1930r262b2017],
28	factors	NNS	O	factor	prep_of	24	SENT_212	[p14l311t1930r593b2010],
29	,	,	O	,	_	0	SENT_212	[p14l311t1930r593b2010],
30	potential	JJ	O	potential	amod	33	SENT_212	[p14l644t1930r982b2017],
31	cross	NN	O	cross	nn	33	SENT_212	[p14l1032t1930r1639b2017],
32	—	NN	O	—	nn	33	SENT_212	[p14l1032t1930r1639b2017],
33	reactivity	NN	O	reactivity	prep_of	8	SENT_212	[p14l1032t1930r1639b2017],
34	,	,	O	,	_	0	SENT_212	[p14l1032t1930r1639b2017],
35	and	CC	O	and	_	0	SENT_212	[p14l1693t1930r1829b1997],
36	the	DT	O	the	det	38	SENT_212	[p14l1876t1930r1992b1997],
37	required	VBN	O	require	amod	38	SENT_212	[p14l2040t1952r2143b1997, p14l8t2045r254b2132],
38	duration	NN	O	duration	prep_of	8	SENT_212	[p14l292t2045r612b2112],
39	of	IN	O	of	_	0	SENT_212	[p14l651t2045r733b2112],
40	treatment	NN	O	treatment	prep_of	38	SENT_212	[p14l766t2055r1148b2112],
41	.	.	O	.	_	0	SENT_212	[p14l766t2055r1148b2112],

1	Ultimately	RB	O	ultimately	advmod	6	SENT_213	[p14l1192t2045r1620b2132],
2	,	,	O	,	_	0	SENT_213	[p14l1192t2045r1620b2132],
3	this	DT	O	this	det	4	SENT_213	[p14l1662t2045r1797b2112],
4	analysis	NN	O	analysis	nsubj	6	SENT_213	[p14l1839t2045r2144b2132],
5	would	MD	O	would	aux	6	SENT_213	[p14l8t2160r248b2227],
6	aid	VB	O	aid	_	0	SENT_213	[p14l283t2160r398b2227],
7	clinicians	NNS	O	clinician	dobj	6	SENT_213	[p14l433t2160r800b2227],
8	in	IN	O	in	_	0	SENT_213	[p14l837t2160r910b2226],
9	their	PRP$	O	they	poss	10	SENT_213	[p14l945t2160r1121b2227],
10	assessment	NN	O	assessment	prep_in	7	SENT_213	[p14l1157t2170r1583b2227],
11	and	CC	O	and	_	0	SENT_213	[p14l1618t2160r1754b2227],
12	decisions	NNS	O	decision	conj_and	10	SENT_213	[p14l1789t2160r2144b2227],
13	regarding	VBG	O	regard	_	0	SENT_213	[p14l6t2275r374b2362],
14	potential	JJ	O	potential	amod	15	SENT_213	[p14l410t2275r748b2362],
15	therapies	NNS	O	therapy	prep_regarding	6	SENT_213	[p14l784t2275r1130b2362],
16	or	CC	O	or	_	0	SENT_213	[p14l1169t2296r1248b2341],
17	the	DT	O	the	det	19	SENT_213	[p14l1281t2275r1396b2341],
18	possible	JJ	O	possible	amod	19	SENT_213	[p14l1432t2275r1747b2362],
19	switch	NN	O	switch	prep_regarding	6	SENT_213	[p14l1786t2275r2033b2342],
20	of	IN	O	of	_	0	SENT_213	[p14l2070t2275r2153b2341],
21	the	DT	O	the	det	23	SENT_213	[p14l7t2390r123b2457],
22	present	JJ	DATE	present	amod	23	SENT_213	[p14l160t2400r439b2477],
23	therapy	NN	O	therapy	prep_of	19	SENT_213	[p14l475t2390r763b2477],
24	to	TO	O	to	_	0	SENT_213	[p14l801t2400r873b2457],
25	a	DT	O	a	det	27	SENT_213	[p14l913t2412r953b2457],
26	more	RBR	O	more	advmod	27	SENT_213	[p14l989t2412r1184b2457],
27	effective	JJ	O	effective	prep_to	23	SENT_213	[p14l1223t2390r1556b2457],
28	one	CD	NUMBER	one	num	27	SENT_213	[p14l1594t2412r1749b2457],
29	.	.	O	.	_	0	SENT_213	[p14l1594t2412r1749b2457],

1	The	DT	O	the	det	2	SENT_214	[p14l1791t2390r1938b2457],
2	LTA	NNP	ORGANIZATION	LTA	nsubj	4	SENT_214	[p14l1976t2391r2146b2456],
3	is	VBZ	O	be	cop	4	SENT_214	[p14l7t2505r67b2572],
4	an	DT	O	a	_	0	SENT_214	[p14l105t2526r192b2572],
5	in	FW	O	in	nn	6	SENT_214	[p14l229t2507r297b2572],
6	vitro	FW	O	vitro	advmod	7	SENT_214	[p14l329t2507r503b2573],
7	assay	NN	O	assay	dep	4	SENT_214	[p14l540t2526r745b2592],
8	that	WDT	O	that	nsubj	9	SENT_214	[p14l778t2505r923b2572],
9	allows	VBZ	O	allow	rcmod	4	SENT_214	[p14l957t2505r1201b2572],
10	assessment	NN	O	assessment	dobj	9	SENT_214	[p14l1239t2515r1664b2572],
11	of	IN	O	of	_	0	SENT_214	[p14l1699t2505r1782b2572],
12	potential	JJ	O	potential	amod	13	SENT_214	[p14l1808t2505r2145b2592],
13	HSRs	NNS	O	hsr	prep_of	10	SENT_214	[p14l8t2621r228b2688],
14	to	TO	O	to	_	0	SENT_214	[p14l261t2630r333b2687],
15	a	DT	O	a	det	17	SENT_214	[p14l367t2642r407b2687],
16	drug	NN	O	drug	nn	17	SENT_214	[p14l438t2620r610b2707],
17	metabolite	NN	O	metabolite	prep_to	9	SENT_214	[p14l643t2620r1070b2687],
18	.	.	O	.	_	0	SENT_214	[p14l643t2620r1070b2687],

1	This	DT	O	this	det	2	SENT_215	[p14l1106t2620r1274b2687],
2	test	NN	O	test	nsubjpass	4	SENT_215	[p14l1307t2630r1441b2687],
3	is	VBZ	O	be	auxpass	4	SENT_215	[p14l1471t2620r1530b2687],
4	based	VBN	O	base	_	0	SENT_215	[p14l1563t2620r1782b2687],
5	on	IN	O	on	_	0	SENT_215	[p14l1815t2642r1908b2687],
6	mitochondria	NN	O	mitochondrium	nn	7	SENT_215	[p14l1938t2620r2143b2687, p14l8t2735r345b2802],
7	dysfunction	NN	O	dysfunction	prep_on	4	SENT_215	[p14l378t2735r831b2822],
8	and	CC	O	and	_	0	SENT_215	[p14l866t2735r1002b2802],
9	a	DT	O	a	det	10	SENT_215	[p14l1035t2756r1075b2802],
10	lack	NN	O	lack	prep_on	4	SENT_215	[p14l1106t2735r1268b2802],
11	of	IN	O	of	_	0	SENT_215	[p14l1300t2735r1383b2802],
12	drug	NN	O	drug	nn	14	SENT_215	[p14l1410t2735r1582b2822],
13	detoxiﬁcation	NN	O	detoxiﬁcation	nn	14	SENT_215	[p14l1617t2735r2146b2802],
14	capabilities	NNS	O	capability	prep_of	10	SENT_215	[p14l8t2850r446b2937],
15	in	IN	O	in	_	0	SENT_215	[p14l473t2850r546b2916],
16	people	NNS	O	people	prep_in	4	SENT_215	[p14l571t2850r827b2937],
17	sensitive	JJ	O	sensitive	amod	16	SENT_215	[p14l857t2850r1188b2917],
18	to	TO	O	to	_	0	SENT_215	[p14l1213t2859r1285b2916],
19	certain	JJ	O	certain	amod	20	SENT_215	[p14l1313t2850r1573b2916],
20	drugs	NNS	O	drug	prep_to	17	SENT_215	[p14l1600t2850r1830b2937],
21	.	.	O	.	_	0	SENT_215	[p14l1600t2850r1830b2937],

1	Several	JJ	O	several	amod	3	SENT_216	[p14l1864t2850r2146b2917],
2	surveillance	NN	O	surveillance	nn	3	SENT_216	[p14l11t2965r472b3033],
3	strategies	NNS	O	strategy	nsubj	11	SENT_216	[p14l526t2965r883b3052],
4	have	VBP	O	have	aux	5	SENT_216	[p14l935t2965r1113b3033],
5	evolved	VBN	O	evolve	_	0	SENT_216	[p14l1165t2965r1465b3033],
6	that	IN	O	that	complm	7	SENT_216	[p14l1514t2965r1658b3032],
7	limit	NN	O	limit	ccomp	5	SENT_216	[p14l1708t2965r1890b3032],
8	mitochondrial	JJ	O	mitochondrial	amod	9	SENT_216	[p14l1938t2965r2143b3032, p14l8t3080r371b3147],
9	damage	NN	O	damage	dobj	7	SENT_216	[p14l400t3080r696b3167],
10	and	CC	O	and	_	0	SENT_216	[p14l727t3080r863b3147],
11	ensure	VB	O	ensure	conj_and	5	SENT_216	[p14l890t3101r1139b3147],
12	cellular	JJ	O	cellular	amod	13	SENT_216	[p14l1168t3080r1457b3147],
13	integrity	NN	O	integrity	dobj	11	SENT_216	[p14l1484t3080r1822b3167],
14	.	.	O	.	_	0	SENT_216	[p14l1484t3080r1822b3167],

1	Intraorganellar	JJ	O	intraorganellar	amod	4	SENT_217	[p14l1854t3082r2144b3147, p14l9t3195r320b3282],
2	proteases	NNS	O	protease	nn	4	SENT_217	[p14l353t3205r710b3282],
3	conduct	NN	O	conduct	nn	4	SENT_217	[p14l749t3195r1054b3262],
4	protein	NN	O	protein	_	0	SENT_217	[p14l1088t3195r1361b3282],
5	quality	NN	O	quality	nn	6	SENT_217	[p14l1398t3195r1663b3282],
6	control	NN	O	control	dep	4	SENT_217	[p14l1702t3195r1972b3262],
7	and	CC	O	and	_	0	SENT_217	[p14l2011t3195r2146b3262],
8	exert	VB	O	exert	dep	4	SENT_217	[p14l8t3320r198b3377],
9	regulatory	JJ	O	regulatory	amod	10	SENT_217	[p14l246t3310r642b3397],
10	functions	NNS	O	function	dobj	8	SENT_217	[p14l692t3310r1070b3390],
11	,	,	O	,	_	0	SENT_217	[p14l692t3310r1070b3390],
12	allowing	VBG	O	allow	partmod	8	SENT_217	[p14l1126t3310r1457b3397],
13	mitochondria	NN	O	mitochondrium	dobj	12	SENT_217	[p14l1508t3310r2024b3377],
14	to	TO	O	to	aux	15	SENT_217	[p14l2074t3321r2145b3377],
15	protect	VB	O	protect	xcomp	12	SENT_217	[p14l6t3435r276b3512],
16	against	IN	O	against	_	0	SENT_217	[p14l305t3425r577b3512],
17	apoptosis	NN	O	apoptosis	prep_against	15	SENT_217	[p14l606t3425r986b3512],
18	.	.	O	.	_	0	SENT_217	[p14l606t3425r986b3512],

1	Cell	NN	O	cell	nn	2	SENT_218	[p14l1020t3425r1177b3493],
2	death	NN	O	death	nsubjpass	9	SENT_218	[p14l1207t3425r1414b3492],
3	caused	VBN	O	cause	partmod	2	SENT_218	[p14l1443t3425r1703b3492],
4	by	IN	O	by	_	0	SENT_218	[p14l1730t3425r1825b3512],
5	the	DT	O	the	det	6	SENT_218	[p14l1854t3425r1969b3492],
6	metabolite	NN	O	metabolite	agent	3	SENT_218	[p14l1998t3447r2144b3492, p14l7t3540r296b3607],
7	can	MD	O	can	aux	9	SENT_218	[p14l326t3562r458b3607],
8	be	VB	O	be	auxpass	9	SENT_218	[p14l484t3540r574b3607],
9	detected	VBN	O	detect	_	0	SENT_218	[p14l603t3540r925b3607],
10	as	IN	O	as	_	0	SENT_218	[p14l954t3562r1028b3607],
11	mitochondrial	JJ	O	mitochondrial	amod	12	SENT_218	[p14l1058t3540r1599b3607],
12	damage	NN	O	damage	prep_as	9	SENT_218	[p14l1629t3540r1926b3627],
13	upon	IN	O	upon	_	0	SENT_218	[p14l1954t3562r2147b3627],
14	exposure	NN	O	exposure	prep_upon	12	SENT_218	[p14l8t3676r352b3742],
15	to	TO	O	to	_	0	SENT_218	[p14l383t3665r455b3722],
16	reactive	JJ	O	reactive	amod	18	SENT_218	[p14l485t3655r788b3722],
17	drug	NN	O	drug	nn	18	SENT_218	[p14l819t3655r991b3742],
18	metabolites	NNS	O	metabolite	prep_to	9	SENT_218	[p14l1022t3634r1562b3722],
19	.53	CD	NUMBER	.53	num	21	SENT_218	[p14l1022t3634r1562b3722],
20	Mitochondrial	JJ	O	mitochondrial	amod	21	SENT_218	[p14l1594t3655r2145b3722],
21	damage	NN	O	damage	nsubj	24	SENT_218	[p15l9t21r306b108],
22	may	MD	O	may	aux	24	SENT_218	[p15l347t43r510b108],
23	only	RB	O	only	advmod	24	SENT_218	[p15l553t21r720b108],
24	signify	VB	O	signify	rcmod	18	SENT_218	[p15l764t21r1026b108],
25	a	DT	O	a	det	26	SENT_218	[p15l1069t43r1109b88],
26	fraction	NN	O	fraction	dobj	24	SENT_218	[p15l1148t21r1447b88],
27	of	IN	O	of	_	0	SENT_218	[p15l1488t21r1571b88],
28	the	DT	O	the	det	29	SENT_218	[p15l1604t21r1720b88],
29	complications	NNS	O	complication	prep_of	26	SENT_218	[p15l1761t21r2143b108, p15l8t136r192b203],
30	involved	VBN	O	involve	partmod	29	SENT_218	[p15l225t136r559b204],
31	in	IN	O	in	_	0	SENT_218	[p15l590t136r663b202],
32	HSR	NN	O	hsr	prep_in	30	SENT_218	[p15l695t137r900b216],
33	,	,	O	,	_	0	SENT_218	[p15l695t137r900b216],
34	but	CC	O	but	_	0	SENT_218	[p15l934t136r1058b203],
35	it	PRP	O	it	nsubj	39	SENT_218	[p15l1088t136r1141b203],
36	is	VBZ	O	be	cop	39	SENT_218	[p15l1172t136r1232b203],
37	a	DT	O	a	det	39	SENT_218	[p15l1269t158r1309b203],
38	critical	JJ	O	critical	amod	39	SENT_218	[p15l1341t136r1607b203],
39	one	CD	NUMBER	one	conj_but	9	SENT_218	[p15l1642t158r1777b203],
40	nonetheless	RB	O	nonetheless	advmod	39	SENT_218	[p15l1810t136r2143b203, p15l8t251r170b318],
41	.	.	O	.	_	0	SENT_218	[p15l1810t136r2143b203, p15l8t251r170b318],

1	Defects	NNS	O	defect	nsubj	14	SENT_219	[p15l234t251r524b318],
2	in	IN	O	in	_	0	SENT_219	[p15l587t251r659b317],
3	any	DT	O	any	prep_in	1	SENT_219	[p15l721t272r855b338],
4	of	IN	O	of	_	0	SENT_219	[p15l916t251r998b318],
5	the	DT	O	the	det	7	SENT_219	[p15l1052t251r1167b318],
6	ﬁve	NN	O	ﬁve	nn	7	SENT_219	[p15l1229t251r1369b318],
7	complexes	NNS	O	complex	prep_of	3	SENT_219	[p15l1429t251r1837b338],
8	in	IN	O	in	_	0	SENT_219	[p15l1898t251r1971b317],
9	the	DT	O	the	det	11	SENT_219	[p15l2030t251r2145b318],
10	respiratory	JJ	O	respiratory	amod	11	SENT_219	[p15l7t366r424b453],
11	chain	NN	O	chain	prep_in	7	SENT_219	[p15l468t366r675b432],
12	would	MD	O	would	aux	14	SENT_219	[p15l718t366r957b433],
13	greatly	RB	O	greatly	advmod	14	SENT_219	[p15l1000t366r1265b453],
14	add	VB	O	add	_	0	SENT_219	[p15l1311t366r1447b432],
15	to	TO	O	to	_	0	SENT_219	[p15l1489t376r1561b432],
16	mitochondrial	JJ	O	mitochondrial	amod	17	SENT_219	[p15l1604t366r2145b432],
17	toXicity	NN	O	toxicity	prep_to	14	SENT_219	[p15l8t460r390b568],
18	.57	CD	NUMBER	.57	dobj	14	SENT_219	[p15l8t460r390b568],
19	The	DT	O	the	det	20	SENT_219	[p15l430t481r578b548],
20	LTA	NN	ORGANIZATION	lta	nsubj	23	SENT_219	[p15l615t482r786b547],
21	is	VBZ	O	be	cop	23	SENT_219	[p15l822t481r882b548],
22	a	DT	O	a	det	23	SENT_219	[p15l924t503r963b548],
23	marker	NN	O	marker	rcmod	18	SENT_219	[p15l999t481r1273b548],
24	of	IN	O	of	_	0	SENT_219	[p15l1310t481r1393b548],
25	one	CD	NUMBER	one	num	27	SENT_219	[p15l1426t503r1561b548],
26	such	JJ	O	such	amod	27	SENT_219	[p15l1602t481r1773b548],
27	disorder	NN	O	disorder	prep_of	23	SENT_219	[p15l1811t481r2143b561],
28	,	,	O	,	_	0	SENT_219	[p15l1811t481r2143b561],
29	as	IN	O	as	mark	31	SENT_219	[p15l9t617r83b663],
30	it	PRP	O	it	nsubj	31	SENT_219	[p15l120t596r173b663],
31	highlights	VBZ	O	highlight	dep	27	SENT_219	[p15l206t596r589b683],
32	genetic	JJ	O	genetic	amod	33	SENT_219	[p15l627t596r901b683],
33	deﬁciencies	NNS	O	deﬁciencies	dobj	31	SENT_219	[p15l939t596r1391b663],
34	in	IN	O	in	_	0	SENT_219	[p15l1428t596r1501b662],
35	succinate	NN	O	succinate	nn	36	SENT_219	[p15l1538t596r1893b663],
36	dehydrogenase	NN	O	dehydrogenase	prep_in	31	SENT_219	[p15l1930t596r2143b683, p15l8t711r418b798],
37	,	,	O	,	_	0	SENT_219	[p15l1930t596r2143b683, p15l8t711r418b798],
38	a	DT	O	a	det	41	SENT_219	[p15l474t732r514b778],
39	speciﬁc	JJ	O	speciﬁc	amod	41	SENT_219	[p15l566t711r853b798],
40	enzyme	NN	O	enzyme	nn	41	SENT_219	[p15l906t732r1204b798],
41	part	NN	O	part	appos	36	SENT_219	[p15l1254t721r1404b798],
42	of	IN	O	of	_	0	SENT_219	[p15l1455t711r1537b778],
43	complex	NN	O	complex	prep_of	41	SENT_219	[p15l1582t711r1912b798],
44	11	CD	NUMBER	11	num	43	SENT_219	[p15l1962t713r2023b777],
45	in	IN	O	in	_	0	SENT_219	[p15l2074t711r2146b777],
46	the	DT	O	the	det	49	SENT_219	[p15l7t826r122b893],
47	mitochondrial	JJ	O	mitochondrial	amod	49	SENT_219	[p15l176t826r717b893],
48	respiratory	JJ	O	respiratory	amod	49	SENT_219	[p15l769t826r1186b913],
49	chain	NN	O	chain	prep_in	43	SENT_219	[p15l1240t826r1465b893],
50	.	.	O	.	_	0	SENT_219	[p15l1240t826r1465b893],

1	Since	IN	O	since	mark	5	SENT_220	[p15l1525t826r1734b893],
2	succinate	NN	O	succinate	nn	3	SENT_220	[p15l1791t826r2146b893],
3	dehydrogenase	NN	O	dehydrogenase	nsubj	5	SENT_220	[p15l8t941r585b1028],
4	is	VBZ	O	be	cop	5	SENT_220	[p15l643t941r703b1007],
5	speciﬁc	NN	O	speciﬁc	advcl	13	SENT_220	[p15l765t940r1052b1028],
6	to	TO	O	to	_	0	SENT_220	[p15l1112t951r1183b1007],
7	mitochondrial	JJ	O	mitochondrial	amod	8	SENT_220	[p15l1242t941r1783b1007],
8	activity	NN	O	activity	prep_to	5	SENT_220	[p15l1843t941r2143b1028],
9	,	,	O	,	_	0	SENT_220	[p15l1843t941r2143b1028],
10	its	PRP$	O	its	poss	11	SENT_220	[p15l7t1056r94b1123],
11	dysfunction	NN	O	dysfunction	nsubj	13	SENT_220	[p15l152t1056r606b1143],
12	would	MD	O	would	aux	13	SENT_220	[p15l661t1056r899b1124],
13	indicate	VB	O	indicate	_	0	SENT_220	[p15l954t1056r1258b1123],
14	cell	NN	O	cell	nn	15	SENT_220	[p15l1315t1056r1451b1123],
15	death	NN	O	death	dobj	13	SENT_220	[p15l1507t1056r1714b1123],
16	when	WRB	O	when	advmod	20	SENT_220	[p15l1769t1056r1975b1124],
17	the	DT	O	the	det	18	SENT_220	[p15l2030t1056r2145b1123],
18	cell	NN	O	cell	nsubjpass	20	SENT_220	[p15l8t1171r146b1238],
19	is	VBZ	O	be	auxpass	20	SENT_220	[p15l172t1171r231b1238],
20	subjected	VBN	O	subject	dep	15	SENT_220	[p15l263t1171r623b1258],
21	to	TO	O	to	_	0	SENT_220	[p15l648t1181r720b1238],
22	stress	NN	O	stress	prep_to	20	SENT_220	[p15l751t1150r1052b1238],
23	.53	CD	NUMBER	.53	num	22	SENT_220	[p15l751t1150r1052b1238],
24	We	PRP	O	we	nsubj	27	SENT_220	[p15l1080t1172r1205b1238],
25	have	VBP	O	have	aux	27	SENT_220	[p15l1232t1171r1410b1238],
26	already	RB	O	already	advmod	27	SENT_220	[p15l1438t1171r1718b1258],
27	performed	VBN	O	perform	rcmod	22	SENT_220	[p15l1744t1171r2147b1258],
28	similar	JJ	O	similar	amod	29	SENT_220	[p15l11t1286r277b1352],
29	studies	NNS	O	study	dobj	27	SENT_220	[p15l318t1285r579b1352],
30	in	IN	O	in	_	0	SENT_220	[p15l620t1286r694b1352],
31	individuals	NNS	O	individual	prep_in	27	SENT_220	[p15l734t1286r1158b1353],
32	who	WP	O	who	nsubj	33	SENT_220	[p15l1200t1286r1362b1353],
33	presented	VBD	O	present	rcmod	31	SENT_220	[p15l1401t1286r1772b1373],
34	HSRs	NNS	O	hsr	dobj	33	SENT_220	[p15l1811t1286r2031b1353],
35	to	TO	O	to	_	0	SENT_220	[p15l2074t1296r2145b1352],
36	AEDs	NNS	MISC	aed	prep_to	33	SENT_220	[p15l7t1380r424b1468],
37	.16	CD	NUMBER	.16	number	38	SENT_220	[p15l7t1380r424b1468],
38	’53	CD	NUMBER	’53	num	41	SENT_220	[p15l7t1380r424b1468],
39	The	DT	O	the	det	41	SENT_220	[p15l474t1401r622b1468],
40	present	JJ	DATE	present	amod	41	SENT_220	[p15l667t1411r946b1488],
41	study	NN	O	study	dep	15	SENT_220	[p15l994t1401r1197b1488],
42	conﬁrms	NNS	O	conﬁrms	dep	15	SENT_220	[p15l1244t1401r1578b1468],
43	that	IN	O	that	complm	47	SENT_220	[p15l1625t1401r1770b1468],
44	the	DT	O	the	det	45	SENT_220	[p15l1815t1401r1930b1468],
45	LTA	NNP	ORGANIZATION	LTA	nsubj	47	SENT_220	[p15l1976t1402r2146b1467],
46	can	MD	O	can	aux	47	SENT_220	[p15l8t1537r140b1583],
47	predict	VB	O	predict	dep	42	SENT_220	[p15l175t1516r444b1603],
48	an	DT	O	a	det	49	SENT_220	[p15l482t1537r569b1583],
49	HSR	NN	O	hsr	dobj	47	SENT_220	[p15l605t1516r790b1583],
50	to	TO	O	to	_	0	SENT_220	[p15l825t1526r897b1583],
51	AEDs	NNS	MISC	aed	prep_to	47	SENT_220	[p15l934t1516r1164b1583],
52	in	IN	O	in	_	0	SENT_220	[p15l1203t1516r1276b1582],
53	an	DT	O	a	det	55	SENT_220	[p15l1314t1537r1401b1583],
54	ethnically-speciﬁc	JJ	O	ethnically-speciﬁc	amod	55	SENT_220	[p15l1438t1516r2144b1603],
55	population	NN	O	population	prep_in	51	SENT_220	[p15l7t1631r420b1718],
56	of	IN	O	of	_	0	SENT_220	[p15l460t1631r544b1698],
57	Han	NNP	LOCATION	Han	nn	59	SENT_220	[p15l576t1633r735b1698],
58	Chinese	NNP	LOCATION	Chinese	nn	59	SENT_220	[p15l775t1631r1082b1698],
59	individuals	NNS	O	individual	prep_of	55	SENT_220	[p15l1122t1631r1547b1698],
60	living	VBG	O	live	partmod	59	SENT_220	[p15l1588t1631r1808b1718],
61	in	IN	O	in	_	0	SENT_220	[p15l1848t1631r1921b1697],
62	Canada	NNP	LOCATION	Canada	prep_in	60	SENT_220	[p15l1961t1631r2144b1698, p15l10t1746r160b1825],
63	,	,	O	,	_	0	SENT_220	[p15l1961t1631r2144b1698, p15l10t1746r160b1825],
64	an	DT	O	a	det	65	SENT_220	[p15l215t1767r302b1813],
65	environment	NN	O	environment	npadvmod	66	SENT_220	[p15l351t1746r836b1813],
66	different	JJ	O	different	amod	15	SENT_220	[p15l884t1746r1214b1813],
67	from	IN	O	from	_	0	SENT_220	[p15l1262t1746r1448b1813],
68	that	DT	O	that	prep_from	13	SENT_220	[p15l1496t1746r1640b1813],
69	which	WDT	O	which	dobj	76	SENT_220	[p15l1688t1746r1922b1813],
70	their	PRP$	O	they	poss	72	SENT_220	[p15l1971t1746r2148b1813],
71	“	NN	O	“	nn	72	SENT_220	[p15l17t1861r463b1927],
72	mainland	NN	O	mainland	nsubjpass	76	SENT_220	[p15l17t1861r463b1927],
73	”	CD	NUMBER	”	num	74	SENT_220	[p15l17t1861r463b1927],
74	ancestors	NNS	O	ancestor	dep	72	SENT_220	[p15l522t1871r876b1927],
75	were	VBD	O	be	auxpass	76	SENT_220	[p15l927t1882r1111b1928],
76	exposed	VBN	O	expose	rcmod	68	SENT_220	[p15l1162t1861r1476b1948],
77	to	TO	O	to	xcomp	76	SENT_220	[p15l1523t1870r1615b1927],
78	.	.	O	.	_	0	SENT_220	[p15l1523t1870r1615b1927],

1	There	EX	O	there	expl	2	SENT_221	[p15l1669t1861r1892b1927],
2	is	VBZ	O	be	_	0	SENT_221	[p15l1942t1861r2002b1927],
3	no	DT	O	no	nsubj	2	SENT_221	[p15l2053t1882r2145b1927],
4	overlap	VBP	O	overlap	dep	3	SENT_221	[p15l9t1976r292b2063],
5	in	IN	O	in	_	0	SENT_221	[p15l339t1976r413b2042],
6	the	DT	O	the	det	7	SENT_221	[p15l458t1976r573b2043],
7	patients	NNS	O	patient	prep_in	4	SENT_221	[p15l618t1976r916b2063],
8	studied	VBN	O	study	partmod	7	SENT_221	[p15l968t1976r1241b2043],
9	in	IN	O	in	_	0	SENT_221	[p15l1287t1976r1360b2042],
10	our	PRP$	O	we	poss	12	SENT_221	[p15l1406t1998r1533b2043],
11	previous	JJ	O	previous	amod	12	SENT_221	[p15l1575t1976r1903b2063],
12	work	NN	O	work	prep_in	8	SENT_221	[p15l1951t1976r2148b2043],
13	and	CC	O	and	_	0	SENT_221	[p15l10t2091r145b2158],
14	the	DT	O	the	det	15	SENT_221	[p15l177t2091r292b2158],
15	patients	NNS	O	patient	nsubj	16	SENT_221	[p15l323t2091r621b2178],
16	studied	VBN	O	study	conj_and	4	SENT_221	[p15l659t2091r933b2158],
17	in	IN	O	in	_	0	SENT_221	[p15l963t2091r1037b2157],
18	the	DT	O	the	det	20	SENT_221	[p15l1068t2091r1183b2158],
19	present	JJ	DATE	present	amod	20	SENT_221	[p15l1215t2101r1494b2178],
20	work	NN	O	work	prep_in	16	SENT_221	[p15l1525t2091r1739b2158],
21	.	.	O	.	_	0	SENT_221	[p15l1525t2091r1739b2158],

1	The	DT	O	the	det	3	SENT_222	[p15l1776t2091r1923b2158],
2	present	JJ	DATE	present	amod	3	SENT_222	[p15l1954t2112r2144b2178, p15l8t2216r125b2272],
3	work	NN	O	work	nsubj	4	SENT_222	[p15l152t2206r350b2273],
4	validates	VBZ	O	validate	_	0	SENT_222	[p15l375t2206r713b2273],
5	the	DT	O	the	det	6	SENT_222	[p15l743t2206r858b2272],
6	usefulness	NN	O	usefulness	nsubjpass	15	SENT_222	[p15l887t2206r1284b2272],
7	of	IN	O	of	_	0	SENT_222	[p15l1316t2206r1399b2272],
8	this	DT	O	this	det	12	SENT_222	[p15l1421t2206r1556b2272],
9	diagnostic	JJ	O	diagnostic	amod	12	SENT_222	[p15l1587t2206r1980b2293],
10	and	CC	O	and	_	0	SENT_222	[p15l2011t2206r2147b2272],
11	predictive	JJ	O	predictive	conj_and	9	SENT_222	[p15l7t2321r391b2408],
12	assay	NN	O	assay	prep_of	6	SENT_222	[p15l445t2343r648b2408],
13	to	TO	O	to	aux	15	SENT_222	[p15l701t2331r773b2388],
14	be	VB	O	be	auxpass	15	SENT_222	[p15l825t2321r915b2388],
15	utilized	VBN	O	utilize	xcomp	4	SENT_222	[p15l966t2321r1257b2388],
16	in	IN	O	in	_	0	SENT_222	[p15l1308t2321r1382b2388],
17	possible	JJ	O	possible	amod	18	SENT_222	[p15l1432t2321r1747b2408],
18	HSRS	NN	O	hsr	prep_in	15	SENT_222	[p15l1800t2322r2019b2389],
19	to	TO	O	to	_	0	SENT_222	[p15l2074t2332r2145b2388],
20	AEDs	NNS	MISC	aed	prep_to	18	SENT_222	[p15l7t2437r261b2515],
21	,	,	O	,	_	0	SENT_222	[p15l7t2437r261b2515],
22	mainly	RB	O	mainly	advmod	15	SENT_222	[p15l308t2436r574b2523],
23	in	IN	O	in	_	0	SENT_222	[p15l619t2436r692b2502],
24	individuals	NNS	O	individual	prep_in	15	SENT_222	[p15l735t2436r1160b2503],
25	of	IN	O	of	_	0	SENT_222	[p15l1206t2436r1289b2503],
26	Asian	JJ	LOCATION	asian	amod	28	SENT_222	[p15l1327t2436r1549b2503],
27	descent	NN	O	descent	nn	28	SENT_222	[p15l1594t2436r1881b2503],
28	living	NN	O	living	prep_of	24	SENT_222	[p15l1924t2436r2145b2523],
29	in	IN	O	in	_	0	SENT_222	[p15l7t2551r81b2617],
30	Canada	NNP	LOCATION	Canada	prep_in	28	SENT_222	[p15l125t2551r432b2631],
31	,	,	O	,	_	0	SENT_222	[p15l125t2551r432b2631],
32	while	IN	O	while	mark	42	SENT_222	[p15l480t2551r690b2619],
33	the	DT	O	the	det	35	SENT_222	[p15l735t2551r850b2618],
34	main	JJ	O	main	amod	35	SENT_222	[p15l894t2551r1086b2618],
35	population	NN	O	population	nsubj	42	SENT_222	[p15l1128t2551r1541b2638],
36	studied	VBN	O	study	partmod	35	SENT_222	[p15l1587t2551r1862b2618],
37	in	IN	O	in	_	0	SENT_222	[p15l1904t2551r1978b2617],
38	our	PRP$	O	we	poss	40	SENT_222	[p15l2022t2573r2148b2618],
39	previous	JJ	O	previous	amod	40	SENT_222	[p15l7t2666r334b2753],
40	studies	NNS	O	study	prep_in	36	SENT_222	[p15l380t2666r641b2733],
41	was	VBD	O	be	cop	42	SENT_222	[p15l684t2687r829b2733],
42	Caucasian	JJ	LOCATION	caucasian	advcl	15	SENT_222	[p15l873t2666r1287b2733],
43	.	.	O	.	_	0	SENT_222	[p15l873t2666r1287b2733],

1	In	IN	O	in	_	0	SENT_223	[p15l1333t2668r1411b2732],
2	the	DT	O	the	det	4	SENT_223	[p15l1451t2666r1567b2733],
3	current	JJ	DATE	current	amod	4	SENT_223	[p15l1609t2676r1881b2733],
4	study	NN	O	study	prep_in	9	SENT_223	[p15l1925t2666r2143b2753],
5	,	,	O	,	_	0	SENT_223	[p15l1925t2666r2143b2753],
6	AED	NN	O	aed	nn	7	SENT_223	[p15l7t2781r201b2847],
7	samples	NNS	O	sample	nsubjpass	9	SENT_223	[p15l236t2781r541b2868],
8	were	VBD	O	be	auxpass	9	SENT_223	[p15l573t2802r757b2848],
9	segregated	VBN	O	segregate	_	0	SENT_223	[p15l791t2781r1199b2868],
10	into	IN	O	into	_	0	SENT_223	[p15l1228t2781r1375b2847],
11	tolerant	JJ	O	tolerant	amod	14	SENT_223	[p15l1406t2781r1701b2847],
12	and	CC	O	and	_	0	SENT_223	[p15l1732t2781r1868b2847],
13	hypersensitive	JJ	O	hypersensitive	amod	14	SENT_223	[p15l1896t2781r2144b2868, p15l11t2896r342b2964],
14	groups	NNS	O	group	prep_into	9	SENT_223	[p15l375t2918r653b2983],
15	.	.	O	.	_	0	SENT_223	[p15l375t2918r653b2983],

1	Cross-reactivity	NN	O	cross-reactivity	nsubjpass	5	SENT_224	[p15l96t3011r693b3098],
2	to	TO	O	to	_	0	SENT_224	[p15l772t3021r842b3078],
3	anticonvulsants	NNS	O	anticonvulsant	prep_to	1	SENT_224	[p15l925t3011r1503b3078],
4	was	VBD	O	be	auxpass	5	SENT_224	[p15l1585t3033r1728b3079],
5	observed	VBN	O	observe	ccomp	30	SENT_224	[p15l1809t3011r2147b3078],
6	clinically	RB	O	clinically	dep	5	SENT_224	[p15l8t3126r357b3213],
7	for	IN	O	for	_	0	SENT_224	[p15l390t3126r500b3193],
8	a	DT	O	a	det	9	SENT_224	[p15l532t3147r572b3193],
9	number	NN	O	number	prep_for	6	SENT_224	[p15l603t3126r894b3193],
10	of	IN	O	of	_	0	SENT_224	[p15l925t3126r1008b3193],
11	decades	NNS	DURATION	decade	prep_of	9	SENT_224	[p15l1033t3126r1328b3193],
12	between	IN	O	between	_	0	SENT_224	[p15l1362t3126r1678b3193],
13	CBZ	NNP	ORGANIZATION	CBZ	nn	15	SENT_224	[p15l1710t3126r1912b3205],
14	,	,	O	,	_	0	SENT_224	[p15l1710t3126r1912b3205],
15	PHY	NNP	O	PHY	prep_between	11	SENT_224	[p15l1947t3127r2143b3205],
16	,	,	O	,	_	0	SENT_224	[p15l1947t3127r2143b3205],
17	and	CC	O	and	_	0	SENT_224	[p15l10t3242r143b3308],
18	valproic	JJ	O	valproic	amod	19	SENT_224	[p15l212t3242r515b3329],
19	acid	NN	O	acid	prep_of	9	SENT_224	[p15l588t3220r1017b3308],
20	.33	CD	NUMBER	.33	number	21	SENT_224	[p15l588t3220r1017b3308],
21	’	CD	NUMBER	’	num	23	SENT_224	[p15l588t3220r1017b3308],
22	59	CD	NUMBER	59	number	23	SENT_224	[p15l588t3220r1017b3308],
23	'64	CD	NUMBER	'64	dep	19	SENT_224	[p15l588t3220r1017b3308],
24	In	IN	O	in	dep	6	SENT_224	[p15l1085t3243r1162b3307],
25	the	DT	O	the	det	27	SENT_224	[p15l1231t3241r1345b3308],
26	present	JJ	DATE	present	amod	27	SENT_224	[p15l1413t3251r1685b3328],
27	work	NN	O	work	pobj	24	SENT_224	[p15l1753t3241r1965b3320],
28	,	,	O	,	_	0	SENT_224	[p15l1753t3241r1965b3320],
29	we	PRP	O	we	nsubj	30	SENT_224	[p15l2038t3263r2146b3308],
30	observed	VBD	O	observe	_	0	SENT_224	[p15l9t3356r347b3423],
31	cross-reactivity	NN	O	cross-reactivity	dobj	30	SENT_224	[p15l384t3356r961b3442],
32	between	IN	O	between	_	0	SENT_224	[p15l997t3356r1313b3423],
33	LTG	NN	O	ltg	prep_between	31	SENT_224	[p15l1349t3356r1526b3423],
34	and	CC	O	and	_	0	SENT_224	[p15l1565t3356r1699b3423],
35	CBZ	NN	O	cbz	prep_between	31	SENT_224	[p15l1737t3356r1937b3423],
36	.	.	O	.	_	0	SENT_224	[p15l1737t3356r1937b3423],

1	This	DT	O	this	det	4	SENT_225	[p15l1980t3356r2144b3423],
2	Translational	JJ	O	translational	amod	4	SENT_225	[p15l1316t3460r1773b3518],
3	Research	NNP	O	Research	nn	4	SENT_225	[p15l1805t3460r2144b3518],
4	Moy	NNP	O	Moy	_	0	SENT_225	[p15l1798t3555r1957b3627],
5	2012	CD	DATE	2012	dep	4	SENT_225	[p15l1980t3554r2145b3613],

1	phenomenon	NN	O	phenomenon	nsubjpass	4	SENT_226	[p16l7t94r497b181],
2	may	MD	O	may	aux	4	SENT_226	[p16l528t116r690b181],
3	be	VB	O	be	auxpass	4	SENT_226	[p16l722t94r811b161],
4	explained	VBN	O	explain	_	0	SENT_226	[p16l844t94r1209b181],
5	by	IN	O	by	_	0	SENT_226	[p16l1240t94r1334b181],
6	the	DT	O	the	det	7	SENT_226	[p16l1366t94r1480b161],
7	ability	NN	O	ability	agent	4	SENT_226	[p16l1514t94r1751b181],
8	of	IN	O	of	_	0	SENT_226	[p16l1786t94r1869b161],
9	T-cells	NNS	O	t-cell	prep_of	7	SENT_226	[p16l1894t94r2144b161],
10	to	TO	O	to	aux	11	SENT_226	[p16l8t219r78b276],
11	recognize	VB	O	recognize	xcomp	4	SENT_226	[p16l150t209r517b296],
12	the	DT	O	the	det	18	SENT_226	[p16l588t209r702b276],
13	major	JJ	O	major	amod	18	SENT_226	[p16l774t209r996b296],
14	histocompatibility	NN	O	histocompatibility	nn	18	SENT_226	[p16l1064t209r1750b296],
15	complex	NN	O	complex	nn	18	SENT_226	[p16l1823t209r2146b296],
16	(	CD	NUMBER	(	num	18	SENT_226	[p16l11t324r282b407],
17	MHC	NN	O	mhc	nn	18	SENT_226	[p16l11t324r282b407],
18	)	NN	O	)	dobj	11	SENT_226	[p16l11t324r282b407],
19	of	IN	O	of	_	0	SENT_226	[p16l315t324r399b391],
20	a	DT	O	a	det	21	SENT_226	[p16l422t345r462b391],
21	drug	NN	O	drug	prep_of	18	SENT_226	[p16l491t324r907b411],
22	.	.	O	.	_	0	SENT_226	[p16l491t324r907b411],

1	—	NN	O	—	_	0	SENT_227	[p16l491t324r907b411],
2	.	.	O	.	_	0	SENT_227	[p16l491t324r907b411],

1	MHC	NN	O	mhc	_	0	SENT_228	[p16l491t324r907b411],
2	complex	NN	O	complex	dep	1	SENT_228	[p16l940t324r1282b411],
3	.	.	O	.	_	0	SENT_228	[p16l940t324r1282b411],

1	We	PRP	O	we	nsubj	2	SENT_229	[p16l1314t325r1439b391],
2	demonstrated	VBD	O	demonstrate	_	0	SENT_229	[p16l1470t324r1979b391],
3	that	IN	O	that	complm	7	SENT_229	[p16l2006t324r2147b391],
4	the	DT	O	the	det	5	SENT_229	[p16l8t439r122b505],
5	LTA	NNP	ORGANIZATION	LTA	nsubj	7	SENT_229	[p16l167t439r336b505],
6	is	VBZ	O	be	cop	7	SENT_229	[p16l382t439r441b505],
7	able	JJ	O	able	ccomp	2	SENT_229	[p16l490t439r644b505],
8	to	TO	O	to	aux	9	SENT_229	[p16l691t449r761b505],
9	indicate	VB	O	indicate	xcomp	7	SENT_229	[p16l809t439r1107b505],
10	a	DT	O	a	det	14	SENT_229	[p16l1155t460r1195b505],
11	possible	JJ	O	possible	amod	14	SENT_229	[p16l1239t439r1547b526],
12	clinical	JJ	O	clinical	amod	14	SENT_229	[p16l1594t439r1871b505],
13	AEDS	NNS	O	aed	nn	14	SENT_229	[p16l1916t439r2145b505],
14	cross-reactivity	NN	O	cross-reactivity	dobj	9	SENT_229	[p16l9t554r597b641],
15	.	.	O	.	_	0	SENT_229	[p16l9t554r597b641],

1	Early	RB	O	early	advmod	2	SENT_230	[p16l94t669r301b756],
2	diagnosis	NN	O	diagnosis	nsubj	7	SENT_230	[p16l331t669r691b756],
3	of	IN	O	of	_	0	SENT_230	[p16l721t669r804b736],
4	an	DT	O	a	det	5	SENT_230	[p16l828t690r915b736],
5	HSR	NN	O	hsr	prep_of	2	SENT_230	[p16l942t669r1127b736],
6	is	VBZ	O	be	cop	7	SENT_230	[p16l1155t669r1214b736],
7	important	JJ	O	important	_	0	SENT_230	[p16l1243t669r1620b756],
8	in	IN	O	in	_	0	SENT_230	[p16l1646t669r1719b735],
9	improving	VBG	O	improve	prepc_in	7	SENT_230	[p16l1746t669r2145b756],
10	the	DT	O	the	det	11	SENT_230	[p16l8t784r123b851],
11	quality	NN	O	quality	dobj	9	SENT_230	[p16l146t784r412b871],
12	of	IN	O	of	_	0	SENT_230	[p16l436t784r518b851],
13	life	NN	O	life	prep_of	11	SENT_230	[p16l534t784r660b851],
14	in	IN	O	in	_	0	SENT_230	[p16l683t784r756b850],
15	patients	NNS	O	patient	prep_in	9	SENT_230	[p16l776t784r1095b871],
16	.	.	O	.	_	0	SENT_230	[p16l776t784r1095b871],

1	A	DT	O	a	det	3	SENT_231	[p16l1122t785r1190b850],
2	high	JJ	O	high	amod	3	SENT_231	[p16l1210t784r1381b871],
3	frequency	NN	O	frequency	nsubj	13	SENT_231	[p16l1402t784r1786b871],
4	of	IN	O	of	_	0	SENT_231	[p16l1809t784r1892b851],
5	rashes	NNS	O	rash	prep_of	3	SENT_231	[p16l1906t784r2144b851],
6	and	CC	O	and	_	0	SENT_231	[p16l10t899r146b966],
7	lack	NN	O	lack	prep_of	3	SENT_231	[p16l168t899r330b966],
8	of	IN	O	of	_	0	SENT_231	[p16l352t899r435b966],
9	efﬁcacy	NN	O	efﬁcacy	prep_of	3	SENT_231	[p16l453t899r755b986],
10	are	VBP	O	be	cop	13	SENT_231	[p16l781t920r894b966],
11	the	DT	O	the	det	13	SENT_231	[p16l919t899r1034b966],
12	main	JJ	O	main	amod	13	SENT_231	[p16l1058t899r1249b966],
13	reasons	NNS	O	reason	_	0	SENT_231	[p16l1272t920r1558b966],
14	for	IN	O	for	_	0	SENT_231	[p16l1585t899r1695b966],
15	medication	NN	O	medication	nn	16	SENT_231	[p16l1717t899r2146b966],
16	substitution	NN	O	substitution	prep_for	13	SENT_231	[p16l11t1014r457b1080],
17	in	IN	O	in	_	0	SENT_231	[p16l489t1014r562b1080],
18	anti-epilepsy	JJ	O	anti-epilepsy	amod	19	SENT_231	[p16l595t1014r1090b1101],
19	therapy	NN	O	therapy	prep_in	16	SENT_231	[p16l1123t1014r1424b1101],
20	.	.	O	.	_	0	SENT_231	[p16l1123t1014r1424b1101],

1	To	TO	O	to	aux	2	SENT_232	[p16l1460t1015r1557b1080],
2	avoid	VB	O	avoid	purpcl	9	SENT_232	[p16l1592t1014r1801b1081],
3	possible	JJ	O	possible	amod	4	SENT_232	[p16l1831t1014r2145b1101],
4	HSRS	NNS	O	hsr	dobj	2	SENT_232	[p16l8t1130r250b1209],
5	,	,	O	,	_	0	SENT_232	[p16l8t1130r250b1209],
6	testing	NN	O	testing	nsubjpass	9	SENT_232	[p16l280t1129r535b1216],
7	is	VBZ	O	be	auxpass	9	SENT_232	[p16l561t1129r621b1196],
8	strongly	RB	O	strongly	advmod	9	SENT_232	[p16l653t1129r963b1216],
9	advised	VBN	O	advise	_	0	SENT_232	[p16l992t1129r1301b1197],
10	.	.	O	.	_	0	SENT_232	[p16l992t1129r1301b1197],

1	The	DT	O	the	det	2	SENT_233	[p16l1334t1129r1481b1196],
2	LTA	NN	ORGANIZATION	lta	nsubj	3	SENT_233	[p16l1507t1130r1677b1196],
3	allows	VBZ	O	allow	_	0	SENT_233	[p16l1705t1129r1949b1197],
4	neurologists	NNS	O	neurologist	nsubj	9	SENT_233	[p16l1976t1151r2143b1196, p16l7t1244r336b1331],
5	a	DT	O	a	det	7	SENT_233	[p16l382t1265r422b1311],
6	routine	JJ	O	routine	amod	7	SENT_233	[p16l461t1244r734b1311],
7	analysis	NN	O	analysis	dep	4	SENT_233	[p16l778t1244r1084b1331],
8	to	TO	O	to	aux	9	SENT_233	[p16l1127t1254r1199b1311],
9	predict	VB	O	predict	xcomp	3	SENT_233	[p16l1241t1244r1510b1331],
10	and	CC	O	and	_	0	SENT_233	[p16l1553t1244r1689b1311],
11	prevent	VB	O	prevent	xcomp	3	SENT_233	[p16l1729t1254r2017b1331],
12	an	DT	O	a	det	13	SENT_233	[p16l2060t1265r2146b1311],
13	ADR	NN	O	adr	dobj	9	SENT_233	[p16l8t1359r227b1426],
14	.	.	O	.	_	0	SENT_233	[p16l8t1359r227b1426],

1	The	DT	O	the	det	2	SENT_234	[p16l258t1359r405b1426],
2	test	NN	O	test	nsubj	5	SENT_234	[p16l431t1369r564b1426],
3	may	MD	O	may	aux	5	SENT_234	[p16l589t1380r752b1446],
4	eventually	RB	O	eventually	advmod	5	SENT_234	[p16l779t1359r1176b1446],
5	help	VB	O	help	_	0	SENT_234	[p16l1201t1359r1365b1446],
6	elucidate	VB	O	elucidate	xcomp	5	SENT_234	[p16l1392t1359r1739b1426],
7	the	DT	O	the	det	8	SENT_234	[p16l1765t1359r1880b1426],
8	mechanism	NN	O	mechanism	dobj	6	SENT_234	[p16l1907t1359r2143b1426, p16l10t1474r237b1541],
9	of	IN	O	of	_	0	SENT_234	[p16l282t1474r365b1541],
10	cytotoxicity	NN	O	cytotoxicity	prep_of	8	SENT_234	[p16l405t1474r864b1561],
11	caused	VBN	O	cause	partmod	10	SENT_234	[p16l910t1474r1171b1541],
12	by	IN	O	by	_	0	SENT_234	[p16l1214t1474r1309b1561],
13	reactive	JJ	O	reactive	amod	14	SENT_234	[p16l1352t1474r1656b1542],
14	metabolites	NNS	O	metabolite	agent	11	SENT_234	[p16l1701t1474r2144b1541],
15	and	CC	O	and	_	0	SENT_234	[p16l10t1589r146b1656],
16	the	DT	O	the	det	17	SENT_234	[p16l175t1589r290b1656],
17	pattems	NNS	O	pattem	agent	11	SENT_234	[p16l320t1599r623b1676],
18	of	IN	O	of	_	0	SENT_234	[p16l657t1589r740b1656],
19	inheritance	NN	O	inheritance	prep_of	17	SENT_234	[p16l762t1589r1190b1656],
20	of	IN	O	of	_	0	SENT_234	[p16l1223t1589r1306b1656],
21	defects	NNS	O	defect	prep_of	19	SENT_234	[p16l1330t1589r1599b1656],
22	in	IN	O	in	_	0	SENT_234	[p16l1631t1589r1705b1655],
23	detoxiﬁcation	NN	O	detoxiﬁcation	nn	24	SENT_234	[p16l1735t1589r2143b1656, p16l8t1704r156b1771],
24	pathways	NNS	O	pathway	prep_in	21	SENT_234	[p16l185t1704r567b1791],
25	.	.	O	.	_	0	SENT_234	[p16l185t1704r567b1791],

1	Our	PRP$	O	we	dep	113	SENT_235	[p16l96t1820r243b1887],
2	group	NN	O	group	dep	113	SENT_235	[p16l285t1841r504b1906],
3	analyzed	VBD	O	analyze	dep	113	SENT_235	[p16l551t1819r892b1906],
4	the	DT	O	the	dep	113	SENT_235	[p16l934t1819r1049b1886],
5	composition	NN	O	composition	dep	113	SENT_235	[p16l1094t1819r1570b1906],
6	of	IN	O	of	dep	113	SENT_235	[p16l1614t1819r1697b1886],
7	circulating	VBG	O	circulate	dep	113	SENT_235	[p16l1734t1819r2145b1906],
8	cytokines	NNS	O	cytokine	dep	113	SENT_235	[p16l9t1934r373b2021],
9	and	CC	O	and	dep	113	SENT_235	[p16l406t1934r542b2001],
10	their	PRP$	O	they	dep	113	SENT_235	[p16l569t1934r746b2001],
11	cellular	JJ	O	cellular	dep	113	SENT_235	[p16l775t1934r1064b2001],
12	expression	NN	O	expression	dep	113	SENT_235	[p16l1092t1934r1501b2021],
13	in	IN	O	in	dep	113	SENT_235	[p16l1529t1934r1602b2000],
14	lymphocytes	NNS	O	lymphocyte	dep	113	SENT_235	[p16l1631t1934r2143b2021],
15	,	,	O	,	_	0	SENT_235	[p16l1631t1934r2143b2021],
16	using	VBG	O	use	dep	113	SENT_235	[p16l7t2049r213b2136],
17	markers	NNS	O	marker	dep	113	SENT_235	[p16l246t2049r554b2115],
18	of	IN	O	of	dep	113	SENT_235	[p16l589t2048r672b2115],
19	cell	NN	O	cell	dep	113	SENT_235	[p16l698t2049r835b2115],
20	activation	NN	O	activation	dep	113	SENT_235	[p16l870t2049r1245b2116],
21	such	JJ	O	such	dep	113	SENT_235	[p16l1280t2049r1451b2115],
22	as	IN	O	as	dep	113	SENT_235	[p16l1485t2070r1559b2115],
23	the	DT	O	the	dep	113	SENT_235	[p16l1593t2049r1708b2115],
24	Fasﬂ3as	NN	O	fasﬂ3as	dep	113	SENT_235	[p16l1740t2049r2029b2116],
25	ligand	NN	O	ligand	dep	113	SENT_235	[p16l2063t2049r2144b2115, p16l9t2164r194b2251],
26	system	NN	O	system	dep	113	SENT_235	[p16l223t2143r582b2251],
27	.16	CD	NUMBER	.16	dep	113	SENT_235	[p16l223t2143r582b2251],
28	Our	PRP$	O	we	dep	113	SENT_235	[p16l611t2164r758b2231],
29	results	NNS	O	result	dep	113	SENT_235	[p16l782t2164r1031b2231],
30	conﬁrmed	VBD	O	conﬁrmed	dep	113	SENT_235	[p16l1060t2164r1449b2231],
31	that	IN	O	that	dep	113	SENT_235	[p16l1475t2164r1620b2231],
32	the	DT	O	the	dep	113	SENT_235	[p16l1645t2164r1760b2231],
33	apoptotic	JJ	O	apoptotic	dep	113	SENT_235	[p16l1790t2164r2144b2251],
34	pathway	NN	O	pathway	dep	113	SENT_235	[p16l7t2280r333b2366],
35	is	VBZ	O	be	dep	113	SENT_235	[p16l363t2279r423b2346],
36	signiﬁcantly	RB	O	signiﬁcantly	dep	113	SENT_235	[p16l459t2279r931b2366],
37	activated	VBN	O	activate	dep	113	SENT_235	[p16l964t2279r1306b2347],
38	in	IN	O	in	dep	113	SENT_235	[p16l1336t2279r1409b2345],
39	SJ	NN	O	sj	dep	113	SENT_235	[p16l1442t2280r1527b2347],
40	S/TEN	NN	O	s/ten	dep	113	SENT_235	[p16l1532t2258r1853b2347],
41	.5	CD	NUMBER	.5	dep	113	SENT_235	[p16l1532t2258r1853b2347],
42	5	CD	NUMBER	5	dep	113	SENT_235	[p16l1860t2258r1889b2304],
43	Fujita	NNP	PERSON	Fujita	dep	113	SENT_235	[p16l1922t2279r2148b2366],
44	et	FW	O	et	dep	113	SENT_235	[p16l9t2404r77b2461],
45	al	FW	O	al	dep	113	SENT_235	[p16l136t2394r201b2461],
46	described	VBN	O	describe	dep	113	SENT_235	[p16l260t2394r629b2461],
47	the	DT	O	the	dep	113	SENT_235	[p16l685t2394r801b2461],
48	role	NN	O	role	dep	113	SENT_235	[p16l858t2394r1007b2461],
49	of	IN	O	of	dep	113	SENT_235	[p16l1068t2394r1150b2461],
50	inﬂammatory	JJ	O	inﬂammatory	dep	113	SENT_235	[p16l1200t2394r1720b2481],
51	cytokines	NNS	O	cytokine	dep	113	SENT_235	[p16l1780t2394r2145b2481],
52	IL-1	NN	O	il-1	dep	113	SENT_235	[p16l8t2509r169b2575],
53	and	CC	O	and	dep	113	SENT_235	[p16l228t2509r364b2576],
54	IL-5	NN	O	il-5	dep	113	SENT_235	[p16l411t2509r601b2588],
55	,	,	O	,	_	0	SENT_235	[p16l411t2509r601b2588],
56	and	CC	O	and	dep	113	SENT_235	[p16l655t2509r791b2576],
57	chemokines	NNS	O	chemokine	dep	113	SENT_235	[p16l840t2509r1297b2576],
58	CCL5	NN	O	ccl5	dep	113	SENT_235	[p16l1349t2509r1601b2588],
59	,	,	O	,	_	0	SENT_235	[p16l1349t2509r1601b2588],
60	CCLI7	NN	O	ccli7	dep	113	SENT_235	[p16l1656t2509r1957b2588],
61	,	,	O	,	_	0	SENT_235	[p16l1656t2509r1957b2588],
62	and	CC	O	and	dep	113	SENT_235	[p16l2011t2509r2147b2576],
63	CXCLIO	NNP	ORGANIZATION	CXCLIO	dep	113	SENT_235	[p16l9t2624r358b2691],
64	in	IN	O	in	dep	113	SENT_235	[p16l393t2624r466b2690],
65	cutaneous	JJ	O	cutaneous	dep	113	SENT_235	[p16l499t2634r881b2691],
66	immune	JJ	O	immune	dep	113	SENT_235	[p16l917t2624r1231b2691],
67	inﬂammation	NN	O	inﬂammation	dep	113	SENT_235	[p16l1265t2603r1873b2691],
68	.65	CD	NUMBER	.65	dep	113	SENT_235	[p16l1265t2603r1873b2691],
69	In	IN	O	in	dep	113	SENT_235	[p16l1909t2626r1987b2690],
70	our	PRP$	O	we	dep	113	SENT_235	[p16l2022t2645r2148b2691],
71	previous	JJ	O	previous	dep	113	SENT_235	[p16l7t2739r334b2826],
72	work	NN	O	work	dep	113	SENT_235	[p16l373t2718r662b2818],
73	,55	CD	NUMBER	,55	dep	113	SENT_235	[p16l373t2718r662b2818],
74	we	PRP	O	we	dep	113	SENT_235	[p16l702t2760r810b2806],
75	demonstrated	VBD	O	demonstrate	dep	113	SENT_235	[p16l849t2739r1368b2806],
76	the	DT	O	the	dep	113	SENT_235	[p16l1404t2739r1519b2806],
77	immunochemi	JJ	O	immunochemi	dep	113	SENT_235	[p16l1557t2739r2143b2806],
78	—	NN	O	—	dep	113	SENT_235	[p16l1557t2739r2143b2806],
79	cal	JJ	O	cal	dep	113	SENT_235	[p16l9t2854r118b2921],
80	presence	NN	O	presence	dep	113	SENT_235	[p16l155t2876r492b2941],
81	of	IN	O	of	dep	113	SENT_235	[p16l532t2854r615b2921],
82	apoptosis	NN	O	apoptosis	dep	113	SENT_235	[p16l648t2854r1006b2941],
83	and	CC	O	and	dep	113	SENT_235	[p16l1048t2854r1184b2921],
84	necrosis	NN	O	necrosis	dep	113	SENT_235	[p16l1221t2854r1534b2921],
85	markers	NNS	O	marker	dep	113	SENT_235	[p16l1573t2854r1880b2921],
86	in	IN	O	in	dep	113	SENT_235	[p16l1919t2854r1993b2921],
87	the	DT	O	the	dep	113	SENT_235	[p16l2030t2855r2145b2921],
88	skin	NN	O	skin	dep	113	SENT_235	[p16l11t2969r166b3036],
89	biopsy	NN	O	biopsy	dep	113	SENT_235	[p16l196t2969r452b3056],
90	of	IN	O	of	dep	113	SENT_235	[p16l484t2969r567b3036],
91	a	DT	O	a	dep	113	SENT_235	[p16l595t2991r634b3036],
92	patient	NN	O	patient	dep	113	SENT_235	[p16l663t2969r927b3056],
93	with	IN	O	with	dep	113	SENT_235	[p16l958t2969r1127b3037],
94	TEN	CD	NUMBER	ten	dep	113	SENT_235	[p16l1158t2971r1363b3048],
95	,	,	O	,	_	0	SENT_235	[p16l1158t2971r1363b3048],
96	as	RB	O	as	dep	113	SENT_235	[p16l1401t2991r1475b3036],
97	well	RB	O	well	dep	113	SENT_235	[p16l1508t2969r1671b3037],
98	as	IN	O	as	dep	113	SENT_235	[p16l1705t2991r1779b3036],
99	the	DT	O	the	dep	113	SENT_235	[p16l1813t2969r1928b3036],
100	clear	JJ	O	clear	dep	113	SENT_235	[p16l1961t2969r2147b3036],
101	distribution	NN	O	distribution	dep	113	SENT_235	[p16l9t3084r451b3151],
102	of	IN	O	of	dep	113	SENT_235	[p16l496t3084r579b3151],
103	proinﬂammatory	JJ	O	proinﬂammatory	dep	113	SENT_235	[p16l614t3084r1263b3171],
104	cytokines	NNS	O	cytokine	dep	113	SENT_235	[p16l1308t3084r1673b3171],
105	in	IN	O	in	dep	113	SENT_235	[p16l1718t3084r1791b3150],
106	the	DT	O	the	dep	113	SENT_235	[p16l1834t3084r1949b3151],
107	sera	NN	O	serum	dep	113	SENT_235	[p16l1996t3105r2147b3151],
108	of	IN	O	of	dep	113	SENT_235	[p16l9t3198r92b3265],
109	patients	NNS	O	patient	dep	113	SENT_235	[p16l115t3199r412b3286],
110	with	IN	O	with	dep	113	SENT_235	[p16l445t3199r614b3266],
111	ibuprofen-induced	JJ	O	ibuprofen-induced	dep	113	SENT_235	[p16l643t3198r1356b3286],
112	SJ	NN	O	sj	dep	113	SENT_235	[p16l1388t3199r1473b3266],
113	S/TEN	NN	O	s/ten	_	0	SENT_235	[p16l1478t3199r1742b3266],
114	.	.	O	.	_	0	SENT_235	[p16l1750t3255r1761b3265],

1	The	DT	O	the	det	4	SENT_236	[p16l95t3314r242b3381],
2	present	JJ	DATE	present	amod	4	SENT_236	[p16l274t3324r554b3401],
3	work	NN	O	work	nn	4	SENT_236	[p16l585t3314r783b3382],
4	conﬁrms	NNS	O	conﬁrms	nsubj	21	SENT_236	[p16l814t3314r1146b3381],
5	that	IN	O	that	complm	11	SENT_236	[p16l1181t3314r1325b3381],
6	an	DT	O	a	det	7	SENT_236	[p16l1358t3336r1446b3381],
7	HSR	NN	O	hsr	nsubj	11	SENT_236	[p16l1478t3315r1663b3382],
8	is	VBZ	O	be	cop	11	SENT_236	[p16l1695t3314r1755b3381],
9	a	DT	O	a	det	11	SENT_236	[p16l1791t3336r1831b3381],
10	clinical	JJ	O	clinical	amod	11	SENT_236	[p16l1863t3314r2146b3381],
11	reaction	NN	O	reaction	dep	4	SENT_236	[p16l7t3429r317b3496],
12	with	IN	O	with	_	0	SENT_236	[p16l358t3429r527b3496],
13	genetic	JJ	O	genetic	amod	16	SENT_236	[p16l567t3429r841b3516],
14	(	NN	O	(	nn	16	SENT_236	[p16l886t3430r1140b3512],
15	HLA	NN	O	hlum	nn	16	SENT_236	[p16l886t3430r1140b3512],
16	)	NN	O	)	prep_with	11	SENT_236	[p16l886t3430r1140b3512],
17	and	CC	O	and	_	0	SENT_236	[p16l1185t3429r1321b3496],
18	immune	JJ	O	immune	amod	20	SENT_236	[p16l1359t3429r1674b3496],
19	(	JJ	O	(	amod	20	SENT_236	[p16l1717t3429r2144b3516],
20	cytokines	NNS	O	cytokine	prep_with	11	SENT_236	[p16l1717t3429r2144b3516],
21	)	VBP	O	)	_	0	SENT_236	[p16l1717t3429r2144b3516],
22	markers	NNS	O	marker	dobj	21	SENT_236	[p16l8t3544r315b3611],
23	signiﬁcantly	RB	O	signiﬁcantly	advmod	24	SENT_236	[p16l389t3544r861b3631],
24	different	JJ	O	different	amod	22	SENT_236	[p16l932t3544r1261b3611],
25	between	IN	O	between	_	0	SENT_236	[p16l1328t3544r1650b3612],
26	susceptible	JJ	O	susceptible	amod	29	SENT_236	[p16l1722t3544r2146b3631],
27	and	CC	O	and	_	0	SENT_236	[p16l10t3659r146b3726],
28	tolerant	JJ	O	tolerant	amod	29	SENT_236	[p16l171t3659r465b3726],
29	individuals	NNS	O	individual	prep_between	22	SENT_236	[p16l490t3659r935b3726],
30	.	.	O	.	_	0	SENT_236	[p16l490t3659r935b3726],

1	Also	RB	O	also	advmod	6	SENT_237	[p16l965t3659r1165b3738],
2	,	,	O	,	_	0	SENT_237	[p16l965t3659r1165b3738],
3	levels	NNS	O	level	nsubj	6	SENT_237	[p16l1194t3659r1413b3726],
4	of	IN	O	of	_	0	SENT_237	[p16l1442t3659r1524b3726],
5	cytokines	NNS	O	cytokine	prep_of	3	SENT_237	[p16l1543t3659r1909b3746],
6	differ	VBP	O	differ	_	0	SENT_237	[p16l1937t3659r2148b3726],
7	between	IN	O	between	_	0	SENT_237	[p17l7t21r328b88],
8	patients	NNS	O	patient	prep_between	6	SENT_237	[p17l350t21r647b108],
9	presenting	VBG	O	present	partmod	8	SENT_237	[p17l672t21r1073b108],
10	only	RB	O	only	advmod	11	SENT_237	[p17l1097t21r1264b108],
11	rash	JJ	O	rash	acomp	9	SENT_237	[p17l1287t21r1447b87],
12	and	CC	O	and	_	0	SENT_237	[p17l1471t21r1607b87],
13	fever	NN	O	fever	conj_and	11	SENT_237	[p17l1629t21r1839b100],
14	,	,	O	,	_	0	SENT_237	[p17l1629t21r1839b100],
15	and	CC	O	and	_	0	SENT_237	[p17l1867t21r2003b87],
16	patients	NNS	O	patient	nsubj	17	SENT_237	[p17l2024t42r2143b108, p17l8t136r213b203],
17	presenting	VBG	O	present	conj_and	6	SENT_237	[p17l248t136r649b223],
18	the	DT	O	the	det	19	SENT_237	[p17l684t136r800b203],
19	triad	NN	O	triad	nsubj	30	SENT_237	[p17l834t136r1010b203],
20	of	IN	O	of	_	0	SENT_237	[p17l1044t136r1127b203],
21	rash	NN	O	rash	nn	23	SENT_237	[p17l1154t136r1334b216],
22	,	,	O	,	_	0	SENT_237	[p17l1154t136r1334b216],
23	fever	NN	O	fever	prep_of	19	SENT_237	[p17l1372t136r1583b216],
24	,	,	O	,	_	0	SENT_237	[p17l1372t136r1583b216],
25	and	CC	O	and	_	0	SENT_237	[p17l1622t136r1758b203],
26	organ	NN	O	organ	nn	27	SENT_237	[p17l1792t158r2009b223],
27	involvement	NN	O	involvement	prep_of	19	SENT_237	[p17l2041t136r2144b203, p17l8t251r414b318],
28	(	CD	NUMBER	(	num	30	SENT_237	[p17l457t251r749b334],
29	Table	NNP	O	Table	nn	30	SENT_237	[p17l457t251r749b334],
30	)	NN	O	)	xcomp	17	SENT_237	[p17l457t251r749b334],
31	.	.	O	.	_	0	SENT_237	[p17l457t251r749b334],

1	Patients	NNS	O	patient	nsubj	9	SENT_238	[p17l795t251r1095b318],
2	presenting	VBG	O	present	partmod	1	SENT_238	[p17l1137t251r1538b338],
3	with	IN	O	with	_	0	SENT_238	[p17l1580t251r1749b318],
4	SJ	NN	O	sj	nn	6	SENT_238	[p17l1793t251r1878b318],
5	S/T	NN	O	s/t	nn	6	SENT_238	[p17l1883t251r2017b319],
6	EN	NN	O	en	prep_with	2	SENT_238	[p17l2019t253r2146b318],
7	or	CC	O	or	_	0	SENT_238	[p17l9t387r87b433],
8	DILI	NNP	O	DILI	prep_with	2	SENT_238	[p17l105t367r296b432],
9	show	VBP	O	show	_	0	SENT_238	[p17l318t366r514b433],
10	elevated	JJ	O	elevated	amod	11	SENT_238	[p17l534t366r852b433],
11	levels	NNS	O	level	dobj	9	SENT_238	[p17l871t366r1089b433],
12	of	IN	O	of	_	0	SENT_238	[p17l1112t366r1195b433],
13	Fas	NN	O	fa	prep_of	11	SENT_238	[p17l1208t367r1336b433],
14	and	CC	O	and	_	0	SENT_238	[p17l1360t366r1496b433],
15	caspase	NN	O	caspase	prep_of	11	SENT_238	[p17l1516t387r1808b453],
16	8	CD	NUMBER	8	num	15	SENT_238	[p17l1832t366r1894b445],
17	,	,	O	,	_	0	SENT_238	[p17l1832t366r1894b445],
18	pointing	VBG	O	point	partmod	9	SENT_238	[p17l1916t366r2143b453, p17l8t481r128b568],
19	to	TO	O	to	_	0	SENT_238	[p17l158t491r229b548],
20	the	DT	O	the	det	22	SENT_238	[p17l259t481r374b548],
21	apoptotic	JJ	O	apoptotic	amod	22	SENT_238	[p17l405t481r760b568],
22	processes	NNS	O	process	prep_to	18	SENT_238	[p17l790t503r1157b568],
23	involved	VBN	O	involve	partmod	22	SENT_238	[p17l1187t481r1520b549],
24	in	IN	O	in	_	0	SENT_238	[p17l1547t481r1621b548],
25	the	DT	O	the	det	26	SENT_238	[p17l1649t481r1764b548],
26	immunopathogenesis	NN	O	immunopathogenesis	prep_in	23	SENT_238	[p17l1794t481r2143b548, p17l7t596r503b683],
27	of	IN	O	of	_	0	SENT_238	[p17l548t596r632b663],
28	severe	JJ	O	severe	amod	29	SENT_238	[p17l670t618r908b664],
29	ADRs	NNS	MISC	adr	prep_of	26	SENT_238	[p17l950t597r1186b663],
30	such	JJ	O	such	_	0	SENT_238	[p17l1234t596r1405b663],
31	as	IN	O	as	_	0	SENT_238	[p17l1449t618r1522b663],
32	DILI	NNP	ORGANIZATION	DILI	prep_such_as	29	SENT_238	[p17l1566t598r1757b662],
33	and	CC	O	and	_	0	SENT_238	[p17l1801t596r1936b663],
34	SJS	NNP	O	SJS	prep_such_as	29	SENT_238	[p17l1980t597r2148b664],
35	/	:	O	/	punct	37	SENT_238	[p17l1980t597r2148b664],
36	TEN	CD	NUMBER	ten	number	37	SENT_238	[p17l8t713r193b778],
37	(	CD	NUMBER	(	dep	23	SENT_238	[p17l233t711r525b795],
38	Table	NNP	O	Table	prep	37	SENT_238	[p17l233t711r525b795],
39	)	NN	O	)	dep	38	SENT_238	[p17l233t711r525b795],
40	.	.	O	.	_	0	SENT_238	[p17l233t711r525b795],

1	Cytokines	NNS	O	cytokine	nsubj	7	SENT_239	[p17l567t711r954b798],
2	released	VBN	O	release	partmod	1	SENT_239	[p17l991t711r1308b778],
3	by	IN	O	by	_	0	SENT_239	[p17l1343t711r1437b798],
4	the	DT	O	the	det	6	SENT_239	[p17l1474t711r1590b778],
5	inﬂammatory	JJ	O	inﬂammatory	amod	6	SENT_239	[p17l1626t711r2145b798],
6	process	NN	O	process	agent	2	SENT_239	[p17l7t847r293b913],
7	have	VBP	O	have	_	0	SENT_239	[p17l317t826r495b893],
8	the	DT	O	the	det	9	SENT_239	[p17l518t826r633b893],
9	potential	JJ	O	potential	dobj	7	SENT_239	[p17l655t826r993b913],
10	to	TO	O	to	aux	11	SENT_239	[p17l1017t836r1088b893],
11	alter	VB	O	alter	dep	9	SENT_239	[p17l1114t826r1284b893],
12	oxidative	JJ	O	oxidative	amod	14	SENT_239	[p17l1306t826r1660b893],
13	drug	NN	O	drug	nn	14	SENT_239	[p17l1683t826r1856b913],
14	metabolism	NN	O	metabolism	dobj	11	SENT_239	[p17l1879t826r2143b893, p17l9t941r241b1020],
15	,	,	O	,	_	0	SENT_239	[p17l1879t826r2143b893, p17l9t941r241b1020],
16	thereby	RB	O	thereby	advmod	17	SENT_239	[p17l269t941r557b1028],
17	increasing	VBG	O	increase	dep	11	SENT_239	[p17l583t941r977b1028],
18	the	DT	O	the	det	19	SENT_239	[p17l1004t941r1119b1008],
19	production	NN	O	production	dobj	17	SENT_239	[p17l1144t941r1562b1028],
20	and	CC	O	and	_	0	SENT_239	[p17l1589t941r1725b1008],
21	toxicity	NN	O	toxicity	dobj	17	SENT_239	[p17l1750t941r2043b1028],
22	of	IN	O	of	_	0	SENT_239	[p17l2070t941r2153b1008],
23	reactive	JJ	O	reactive	amod	25	SENT_239	[p17l7t1055r310b1123],
24	drug	NN	O	drug	nn	25	SENT_239	[p17l331t1056r503b1143],
25	metabolites	NNS	O	metabolite	prep_of	19	SENT_239	[p17l524t1056r990b1135],
26	,	,	O	,	_	0	SENT_239	[p17l524t1056r990b1135],
27	leading	VBG	O	lead	dep	17	SENT_239	[p17l1014t1056r1296b1143],
28	to	TO	O	to	_	0	SENT_239	[p17l1317t1066r1389b1122],
29	toxic	JJ	O	toxic	amod	30	SENT_239	[p17l1409t1056r1599b1122],
30	events	NNS	O	event	prep_to	27	SENT_239	[p17l1622t1065r1883b1123],
31	.	.	O	.	_	0	SENT_239	[p17l1622t1065r1883b1123],

1	Proinﬂammatory	JJ	O	proinﬂammatory	amod	2	SENT_240	[p17l1908t1056r2143b1122, p17l9t1171r451b1258],
2	cytokines	NNS	O	cytokine	nsubj	11	SENT_240	[p17l498t1171r863b1258],
3	expressed	VBN	O	express	partmod	2	SENT_240	[p17l912t1171r1290b1258],
4	as	IN	O	as	_	0	SENT_240	[p17l1336t1193r1410b1238],
5	a	DT	O	a	det	6	SENT_240	[p17l1459t1193r1499b1238],
6	result	NN	O	result	prep_as	3	SENT_240	[p17l1542t1171r1758b1238],
7	of	IN	O	of	_	0	SENT_240	[p17l1802t1171r1885b1238],
8	T-cell	NN	MISC	t-cell	nn	9	SENT_240	[p17l1925t1171r2146b1238],
9	activation	NN	O	activation	prep_of	6	SENT_240	[p17l10t1286r385b1353],
10	may	MD	O	may	aux	11	SENT_240	[p17l425t1307r588b1373],
11	represent	VB	O	represent	_	0	SENT_240	[p17l627t1296r982b1373],
12	a	DT	O	a	det	14	SENT_240	[p17l1023t1307r1062b1353],
13	danger	NN	O	danger	nn	14	SENT_240	[p17l1102t1286r1364b1373],
14	signal	NN	O	signal	dobj	11	SENT_240	[p17l1405t1286r1630b1373],
15	for	IN	O	for	_	0	SENT_240	[p17l1671t1286r1782b1353],
16	HSR	NN	O	hsr	prep_for	11	SENT_240	[p17l1821t1286r2025b1365],
17	,	,	O	,	_	0	SENT_240	[p17l1821t1286r2025b1365],
18	as	IN	O	as	mark	19	SENT_240	[p17l2070t1307r2144b1353],
19	demonstrated	VBN	O	demonstrate	advcl	11	SENT_240	[p17l9t1401r528b1467],
20	by	IN	O	by	_	0	SENT_240	[p17l551t1401r646b1488],
21	our	PRP$	O	we	poss	22	SENT_240	[p17l673t1422r800b1467],
22	ﬁndings	NNS	O	ﬁndings	prep_by	19	SENT_240	[p17l825t1400r1150b1488],
23	.	.	O	.	_	0	SENT_240	[p17l825t1400r1150b1488],

1	However	RB	O	however	advmod	13	SENT_241	[p17l1180t1402r1545b1480],
2	,	,	O	,	_	0	SENT_241	[p17l1180t1402r1545b1480],
3	excluding	VBG	O	exclude	_	0	SENT_241	[p17l1574t1401r1951b1488],
4	neutrophils	NNS	O	neutrophil	prep_excluding	13	SENT_241	[p17l1976t1422r2143b1467, p17l8t1516r321b1603],
5	,	,	O	,	_	0	SENT_241	[p17l1976t1422r2143b1467, p17l8t1516r321b1603],
6	these	DT	O	these	det	7	SENT_241	[p17l368t1516r565b1583],
7	cells	NNS	O	cell	nsubj	18	SENT_241	[p17l610t1516r782b1583],
8	are	VBP	O	be	cop	13	SENT_241	[p17l830t1538r943b1583],
9	also	RB	O	also	advmod	13	SENT_241	[p17l989t1516r1139b1583],
10	antigen	JJ	O	antigen	amod	13	SENT_241	[p17l1186t1516r1902b1603],
11	—	NN	O	—	nn	13	SENT_241	[p17l1186t1516r1902b1603],
12	presenting	NN	O	presenting	nn	13	SENT_241	[p17l1186t1516r1902b1603],
13	cells	NNS	O	cell	_	0	SENT_241	[p17l1947t1516r2143b1596],
14	,	,	O	,	_	0	SENT_241	[p17l1947t1516r2143b1596],
15	and	CC	O	and	_	0	SENT_241	[p17l10t1631r146b1697],
16	are	VBP	O	be	cop	18	SENT_241	[p17l174t1652r286b1697],
17	thus	RB	O	thus	advmod	18	SENT_241	[p17l314t1631r470b1697],
18	capable	JJ	O	capable	conj_and	13	SENT_241	[p17l500t1631r793b1718],
19	of	IN	O	of	_	0	SENT_241	[p17l821t1631r904b1697],
20	biotransformation	NN	O	biotransformation	prep_of	18	SENT_241	[p17l923t1630r1636b1710],
21	,	,	O	,	_	0	SENT_241	[p17l923t1630r1636b1710],
22	conjugation	NN	O	conjugation	prep_of	18	SENT_241	[p17l1667t1631r2143b1718],
23	,	,	O	,	_	0	SENT_241	[p17l1667t1631r2143b1718],
24	and	CC	O	and	_	0	SENT_241	[p17l10t1746r146b1813],
25	immune	JJ	O	immune	amod	27	SENT_241	[p17l171t1746r486b1813],
26	cell	NN	O	cell	nn	27	SENT_241	[p17l513t1746r650b1813],
27	stimulation	NN	O	stimulation	conj_and	20	SENT_241	[p17l680t1746r1130b1813],
28	.	.	O	.	_	0	SENT_241	[p17l680t1746r1130b1813],

1	In	IN	O	in	_	0	SENT_242	[p17l1161t1748r1239b1812],
2	the	DT	O	the	det	4	SENT_242	[p17l1264t1746r1379b1813],
3	present	JJ	DATE	present	amod	4	SENT_242	[p17l1405t1756r1684b1833],
4	work	NN	O	work	prep_in	7	SENT_242	[p17l1710t1746r1925b1826],
5	,	,	O	,	_	0	SENT_242	[p17l1710t1746r1925b1826],
6	there	EX	O	there	expl	7	SENT_242	[p17l1955t1746r2145b1813],
7	is	VBZ	O	be	_	0	SENT_242	[p17l8t1861r68b1928],
8	a	DT	O	a	det	10	SENT_242	[p17l108t1882r148b1928],
9	positive	JJ	O	positive	amod	10	SENT_242	[p17l182t1861r485b1948],
10	correlation	NN	O	correlation	nsubj	7	SENT_242	[p17l523t1861r940b1928],
11	between	IN	O	between	_	0	SENT_242	[p17l976t1861r1298b1928],
12	LTG-DILI/SJ	NN	O	ltg-dili/sj	nn	14	SENT_242	[p17l1334t1861r1854b1928],
13	S	NN	O	s	nn	14	SENT_242	[p17l1859t1861r1903b1928],
14	cases	NNS	O	case	prep_between	10	SENT_242	[p17l1946t1882r2144b1928],
15	and	CC	O	and	_	0	SENT_242	[p17l10t1976r146b2043],
16	the	DT	O	the	det	18	SENT_242	[p17l205t1976r320b2043],
17	serum	NN	O	serum	nn	18	SENT_242	[p17l384t1997r617b2043],
18	level	NN	O	level	nsubj	25	SENT_242	[p17l676t1976r859b2044],
19	of	IN	O	of	_	0	SENT_242	[p17l920t1976r1003b2043],
20	chemoattractant	NN	O	chemoattractant	nn	21	SENT_242	[p17l1058t1976r1676b2043],
21	substances	NNS	O	substance	prep_of	18	SENT_242	[p17l1738t1976r2144b2043],
22	such	JJ	O	such	_	0	SENT_242	[p17l11t2093r183b2161],
23	as	IN	O	as	_	0	SENT_242	[p17l239t2115r313b2161],
24	chemokines	NNS	O	chemokine	prep_such_as	21	SENT_242	[p17l370t2093r828b2161],
25	(	VBP	O	(	conj_and	7	SENT_242	[p17l888t2094r1107b2177],
26	IL-8	NN	O	il-8	dobj	25	SENT_242	[p17l888t2094r1107b2177],
27	,	,	O	,	_	0	SENT_242	[p17l888t2094r1107b2177],
28	RANTES	NN	O	rante	dobj	25	SENT_242	[p17l1165t2094r1558b2173],
29	,	,	O	,	_	0	SENT_242	[p17l1165t2094r1558b2173],
30	and	CC	O	and	_	0	SENT_242	[p17l1619t2093r1755b2161],
31	MCP-1	NN	O	mcp-1	nn	32	SENT_242	[p17l1809t2094r2142b2177],
32	)	NN	O	)	conj_and	26	SENT_242	[p17l1809t2094r2142b2177],
33	.	.	O	.	_	0	SENT_242	[p17l1809t2094r2142b2177],

1	Similar	JJ	O	similar	amod	2	SENT_243	[p17l10t2208r292b2275],
2	results	NNS	O	result	nsubjpass	5	SENT_243	[p17l358t2208r606b2275],
3	have	VBP	O	have	aux	5	SENT_243	[p17l675t2208r853b2275],
4	been	VBN	O	be	auxpass	5	SENT_243	[p17l920t2208r1102b2275],
5	shown	VBN	O	show	_	0	SENT_243	[p17l1173t2208r1417b2275],
6	in	IN	O	in	_	0	SENT_243	[p17l1484t2208r1557b2274],
7	our	PRP$	O	we	poss	9	SENT_243	[p17l1625t2229r1752b2275],
8	previous	JJ	O	previous	amod	9	SENT_243	[p17l1817t2208r2144b2295],
9	worl	NN	O	worl	prep_in	5	SENT_243	[p17l8t2302r298b2391],
10	<	JJR	O	<	dep	20	SENT_243	[p17l8t2302r298b2391],
11	.57	CD	NUMBER	.57	num	13	SENT_243	[p17l8t2302r298b2391],
12	Proinﬂammatory	JJ	O	proinﬂammatory	amod	13	SENT_243	[p17l334t2323r988b2410],
13	cytokines	NNS	O	cytokine	nsubj	20	SENT_243	[p17l1023t2323r1388b2410],
14	such	JJ	O	such	_	0	SENT_243	[p17l1428t2323r1599b2390],
15	as	IN	O	as	_	0	SENT_243	[p17l1636t2345r1709b2390],
16	IL-la	NN	O	il-la	prep_such_as	13	SENT_243	[p17l1746t2324r1971b2390],
17	and	CC	O	and	_	0	SENT_243	[p17l2011t2323r2147b2390],
18	TNF-a	NN	O	tnf-a	prep_such_as	13	SENT_243	[p17l8t2439r275b2505],
19	are	VBP	O	be	cop	20	SENT_243	[p17l326t2459r439b2505],
20	molecules	NNS	O	molecule	dep	5	SENT_243	[p17l486t2438r875b2505],
21	that	WDT	O	that	nsubj	22	SENT_243	[p17l922t2438r1067b2505],
22	stimulate	VBP	O	stimulate	rcmod	20	SENT_243	[p17l1114t2438r1463b2505],
23	the	DT	O	the	det	24	SENT_243	[p17l1509t2438r1625b2505],
24	synthesis	NN	O	synthesis	dobj	22	SENT_243	[p17l1675t2438r2021b2524],
25	of	IN	O	of	_	0	SENT_243	[p17l2070t2438r2153b2505],
26	Translational	JJ	O	translational	amod	28	SENT_243	[p17l7t2542r464b2600],
27	Research	NN	O	research	nn	28	SENT_243	[p17l496t2542r835b2600],
28	Volume	NN	O	volume	prep_of	24	SENT_243	[p17l7t2638r293b2697],
29	159	CD	NUMBER	159	tmod	22	SENT_243	[p17l328t2637r464b2701],
30	,	,	O	,	_	0	SENT_243	[p17l328t2637r464b2701],
31	Number	NNP	O	Number	appos	29	SENT_243	[p17l493t2638r788b2697],
32	5	CD	NUMBER	5	num	31	SENT_243	[p17l811t2638r851b2697],

1	acute-phase	NN	O	acute-phase	nn	2	SENT_244	[p17l10t2896r463b2983],
2	proteins	NNS	O	protein	nsubj	6	SENT_244	[p17l519t2875r925b2983],
3	.66	CD	NUMBER	.66	num	4	SENT_244	[p17l519t2875r925b2983],
4	IL-18	NN	O	il-18	dep	2	SENT_244	[p17l983t2897r1196b2964],
5	is	VBZ	O	be	cop	6	SENT_244	[p17l1256t2896r1316b2963],
6	proinﬂammatory	JJ	O	proinﬂammatory	_	0	SENT_244	[p17l1373t2896r2023b2983],
7	at	IN	O	at	_	0	SENT_244	[p17l2081t2907r2148b2963],
8	a	DT	O	a	det	11	SENT_244	[p17l10t3033r50b3078],
9	very	RB	O	very	advmod	10	SENT_244	[p17l82t3033r250b3098],
10	early	JJ	O	early	amod	11	SENT_244	[p17l286t3011r475b3098],
11	step	NN	O	step	prep_at	6	SENT_244	[p17l514t3021r662b3098],
12	in	IN	O	in	_	0	SENT_244	[p17l698t3011r771b3077],
13	the	DT	O	the	det	15	SENT_244	[p17l804t3011r919b3078],
14	immune	JJ	O	immune	amod	15	SENT_244	[p17l955t3011r1270b3078],
15	response	NN	O	response	prep_in	11	SENT_244	[p17l1303t3033r1658b3098],
16	.	.	O	.	_	0	SENT_244	[p17l1303t3033r1658b3098],

1	IL-6	NN	MISC	il-6	nsubj	2	SENT_245	[p17l1698t3011r1866b3079],
2	stimulates	VBZ	O	stimulate	_	0	SENT_245	[p17l1905t3011r2144b3078, p17l8t3126r181b3193],
3	most	RBS	O	most	advmod	4	SENT_245	[p17l211t3136r398b3193],
4	acute-phase	JJ	O	acute-phase	amod	5	SENT_245	[p17l427t3126r879b3213],
5	proteins	NNS	O	protein	dobj	2	SENT_245	[p17l906t3126r1238b3213],
6	,	,	O	,	_	0	SENT_245	[p17l906t3126r1238b3213],
7	while	IN	O	while	mark	13	SENT_245	[p17l1270t3126r1481b3193],
8	IL-10	NN	O	il-10	nsubj	13	SENT_245	[p17l1510t3126r1727b3193],
9	is	VBZ	O	be	cop	13	SENT_245	[p17l1755t3126r1815b3193],
10	a	DT	O	a	det	13	SENT_245	[p17l1847t3147r1886b3193],
11	prototype	NN	O	prototype	nn	13	SENT_245	[p17l1912t3136r2144b3213, p17l8t3251r171b3328],
12	anti-inﬂammatory	JJ	O	anti-inﬂammatory	amod	13	SENT_245	[p17l218t3240r914b3328],
13	cytokine	NN	O	cytokine	advcl	2	SENT_245	[p17l960t3241r1289b3328],
14	that	WDT	O	that	nsubj	15	SENT_245	[p17l1334t3241r1478b3307],
15	regulates	VBZ	O	regulate	rcmod	13	SENT_245	[p17l1521t3241r1866b3328],
16	B-cell	NN	MISC	b-cell	nn	17	SENT_245	[p17l1912t3241r2146b3307],
17	function	NN	O	function	dobj	15	SENT_245	[p17l8t3356r348b3423],
18	.	.	O	.	_	0	SENT_245	[p17l8t3356r348b3423],

1	16	CD	NUMBER	16	nsubj	19	SENT_246	[p17l362t3335r424b3380],
2	Moreover	RB	O	moreover	advmod	19	SENT_246	[p17l446t3358r840b3435],
3	,	,	O	,	_	0	SENT_246	[p17l446t3358r840b3435],
4	Fas	NN	O	fa	nsubjpass	6	SENT_246	[p17l864t3358r994b3423],
5	was	VBD	O	be	auxpass	6	SENT_246	[p17l1016t3378r1161b3424],
6	shown	VBN	O	show	parataxis	19	SENT_246	[p17l1188t3356r1432b3423],
7	to	TO	O	to	aux	9	SENT_246	[p17l1452t3366r1524b3423],
8	be	VB	O	be	auxpass	9	SENT_246	[p17l1544t3356r1634b3423],
9	dysregulated	VBN	O	dysregulate	xcomp	6	SENT_246	[p17l1657t3356r2147b3443],
10	in	IN	O	in	_	0	SENT_246	[p17l8t3472r81b3538],
11	SJ	NN	O	sj	nn	12	SENT_246	[p17l120t3472r205b3539],
12	S/TEN	NN	O	s/ten	prep_in	9	SENT_246	[p17l210t3450r531b3539],
13	.5	CD	NUMBER	.5	number	14	SENT_246	[p17l210t3450r531b3539],
14	5	CD	NUMBER	5	dep	12	SENT_246	[p17l538t3450r567b3495],
15	’67	CD	NUMBER	’67	num	17	SENT_246	[p17l576t3450r659b3503],
16	T-cell	NN	O	t-cell	nn	17	SENT_246	[p17l697t3472r918b3539],
17	memory	NN	O	memory	nsubj	19	SENT_246	[p17l955t3493r1275b3559],
18	is	VBZ	O	be	cop	19	SENT_246	[p17l1313t3472r1372b3539],
19	responsible	JJ	O	responsible	_	0	SENT_246	[p17l1409t3472r1847b3559],
20	for	IN	O	for	_	0	SENT_246	[p17l1885t3472r1996b3539],
21	the	DT	O	the	det	22	SENT_246	[p17l2031t3472r2146b3539],
22	recognition	NN	O	recognition	prep_for	19	SENT_246	[p17l7t3587r448b3674],
23	of	IN	O	of	_	0	SENT_246	[p17l514t3587r597b3654],
24	“	JJ	O	“	amod	27	SENT_246	[p17l665t3587r962b3654],
25	stress	NN	O	stress	nn	27	SENT_246	[p17l665t3587r962b3654],
26	”	NN	O	”	nn	27	SENT_246	[p17l665t3587r962b3654],
27	signals	NNS	O	signal	prep_of	22	SENT_246	[p17l1035t3587r1296b3674],
28	represented	VBN	O	represent	partmod	27	SENT_246	[p17l1362t3587r1808b3674],
29	by	IN	O	by	_	0	SENT_246	[p17l1871t3587r1965b3674],
30	the	DT	O	the	det	31	SENT_246	[p17l2031t3587r2146b3654],
31	exposure	NN	O	exposure	agent	28	SENT_246	[p17l9t3723r353b3789],
32	of	IN	O	of	_	0	SENT_246	[p17l409t3702r491b3769],
33	lymphocytes	NNS	O	lymphocyte	prep_of	31	SENT_246	[p17l539t3702r1028b3789],
34	to	TO	O	to	_	0	SENT_246	[p17l1084t3712r1155b3769],
35	the	DT	O	the	det	37	SENT_246	[p17l1210t3702r1325b3769],
36	insulting	JJ	O	insulting	amod	37	SENT_246	[p17l1380t3702r1715b3789],
37	drug	NN	O	drug	prep_to	28	SENT_246	[p17l1771t3702r1963b3789],
38	.	.	O	.	_	0	SENT_246	[p17l1771t3702r1963b3789],

1	We	PRP	O	we	nsubj	2	SENT_247	[p17l2021t3703r2146b3769],
2	demonstrated	VBD	O	demonstrate	_	0	SENT_247	[p18l9t21r528b88],
3	a	DT	O	a	det	5	SENT_247	[p18l560t43r600b88],
4	clear	JJ	O	clear	amod	5	SENT_247	[p18l629t21r816b88],
5	link	NN	O	link	dobj	2	SENT_247	[p18l846t21r996b88],
6	between	IN	O	between	_	0	SENT_247	[p18l1022t21r1344b89],
7	genetic	JJ	O	genetic	amod	8	SENT_247	[p18l1374t21r1650b108],
8	factors	NNS	O	factor	prep_between	2	SENT_247	[p18l1682t21r1940b88],
9	such	JJ	O	such	_	0	SENT_247	[p18l1976t21r2147b88],
10	as	IN	O	as	_	0	SENT_247	[p18l10t158r84b203],
11	HLA	NN	O	hlum	prep_such_as	8	SENT_247	[p18l135t137r330b202],
12	and	CC	O	and	_	0	SENT_247	[p18l380t136r516b203],
13	immune	JJ	O	immune	amod	14	SENT_247	[p18l563t136r879b203],
14	responses	NNS	O	response	conj_and	11	SENT_247	[p18l926t158r1298b223],
15	to	TO	O	to	_	0	SENT_247	[p18l1349t146r1420b203],
16	a	DT	O	a	det	18	SENT_247	[p18l1471t158r1511b203],
17	speciﬁc	NN	O	speciﬁc	nn	18	SENT_247	[p18l1562t136r1850b223],
18	injury	NN	O	injury	prep_to	2	SENT_247	[p18l1900t136r2142b223],
19	.	.	O	.	_	0	SENT_247	[p18l1900t136r2142b223],

1	The	DT	O	the	det	3	SENT_248	[p18l8t251r156b318],
2	more	RBR	O	more	advmod	3	SENT_248	[p18l207t272r402b318],
3	severe	JJ	O	severe	dep	5	SENT_248	[p18l457t272r695b318],
4	the	DT	O	the	det	5	SENT_248	[p18l745t251r860b318],
5	injury	NN	O	injury	dep	10	SENT_248	[p18l912t251r1155b338],
6	,	,	O	,	_	0	SENT_248	[p18l912t251r1155b338],
7	the	DT	O	the	det	8	SENT_248	[p18l1208t251r1324b318],
8	higher	JJR	O	higher	dep	10	SENT_248	[p18l1374t251r1621b338],
9	the	DT	O	the	det	10	SENT_248	[p18l1669t251r1785b318],
10	level	NN	O	level	_	0	SENT_248	[p18l1836t251r2019b318],
11	of	IN	O	of	_	0	SENT_248	[p18l2070t251r2153b318],
12	inﬂammatory	JJ	O	inﬂammatory	amod	13	SENT_248	[p18l8t365r527b453],
13	responses	NNS	O	response	prep_of	10	SENT_248	[p18l555t387r927b453],
14	and	CC	O	and	_	0	SENT_248	[p18l960t366r1096b432],
15	apoptosis	NN	O	apoptosis	conj_and	13	SENT_248	[p18l1127t366r1485b453],
16	were	VBD	O	be	partmod	15	SENT_248	[p18l1516t387r1720b433],
17	.	.	O	.	_	0	SENT_248	[p18l1516t387r1720b433],

1	The	DT	O	the	det	3	SENT_249	[p18l95t481r243b548],
2	present	JJ	DATE	present	amod	3	SENT_249	[p18l285t491r564b568],
3	work	NN	O	work	nsubj	5	SENT_249	[p18l606t481r803b549],
4	also	RB	O	also	advmod	5	SENT_249	[p18l846t481r996b548],
5	takes	VBZ	O	take	_	0	SENT_249	[p18l1039t481r1233b548],
6	into	IN	O	into	_	0	SENT_249	[p18l1278t481r1425b548],
7	consideration	NN	O	consideration	prep_into	5	SENT_249	[p18l1470t481r1989b548],
8	the	DT	O	the	det	9	SENT_249	[p18l2031t481r2146b548],
9	possibility	NN	O	possibility	dobj	5	SENT_249	[p18l7t596r408b683],
10	that	IN	O	that	complm	18	SENT_249	[p18l459t596r603b663],
11	patients	NNS	O	patient	nsubj	18	SENT_249	[p18l651t596r949b683],
12	that	WDT	O	that	nsubj	14	SENT_249	[p18l1000t596r1145b663],
13	are	VBP	O	be	cop	14	SENT_249	[p18l1195t617r1308b663],
14	prone	JJ	O	prone	rcmod	11	SENT_249	[p18l1358t617r1576b683],
15	to	TO	O	to	_	0	SENT_249	[p18l1626t606r1698b663],
16	HSR	NN	O	hsr	prep_to	14	SENT_249	[p18l1749t596r1934b663],
17	may	MD	O	may	aux	18	SENT_249	[p18l1982t617r2146b683],
18	develop	VB	O	develop	dep	9	SENT_249	[p18l9t711r308b798],
19	cross-reactivity	NN	O	cross-reactivity	nsubj	20	SENT_249	[p18l354t711r946b798],
20	due	JJ	O	due	xcomp	18	SENT_249	[p18l991t711r1126b778],
21	to	TO	O	to	_	0	SENT_249	[p18l1170t721r1242b778],
22	a	DT	O	a	det	24	SENT_249	[p18l1288t733r1328b778],
23	structural	JJ	O	structural	amod	24	SENT_249	[p18l1373t711r1733b778],
24	similarity	NN	O	similarity	prep_to	20	SENT_249	[p18l1780t711r2146b798],
25	between	IN	O	between	_	0	SENT_249	[p18l7t826r329b893],
26	CBZ	NNP	ORGANIZATION	CBZ	prep_between	24	SENT_249	[p18l357t826r541b893],
27	and	CC	O	and	_	0	SENT_249	[p18l572t826r708b893],
28	PHY	NNP	O	PHY	prep_between	24	SENT_249	[p18l734t828r932b905],
29	,	,	O	,	_	0	SENT_249	[p18l734t828r932b905],
30	but	CC	O	but	_	0	SENT_249	[p18l962t826r1086b893],
31	also	RB	O	also	_	0	SENT_249	[p18l1113t826r1263b893],
32	to	TO	O	to	_	0	SENT_249	[p18l1292t836r1364b893],
33	an	DT	O	a	det	34	SENT_249	[p18l1394t847r1482b893],
34	agent	NN	O	agent	prep_to	20	SENT_249	[p18l1511t836r1718b913],
35	with	IN	O	with	_	0	SENT_249	[p18l1745t826r1915b893],
36	a	DT	O	a	det	38	SENT_249	[p18l1944t847r1983b893],
37	different	JJ	O	different	amod	38	SENT_249	[p18l2011t826r2144b893, p18l8t941r233b1007],
38	structure	NN	O	structure	prep_with	34	SENT_249	[p18l268t950r601b1007],
39	and	CC	O	and	_	0	SENT_249	[p18l637t941r773b1007],
40	chemical	NN	O	chemical	nn	41	SENT_249	[p18l806t941r1153b1007],
41	properties	NNS	O	property	conj_and	24	SENT_249	[p18l1185t940r1592b1028],
42	,	,	O	,	_	0	SENT_249	[p18l1185t940r1592b1028],
43	LTG	NN	O	ltg	appos	41	SENT_249	[p18l1629t941r1825b1008],
44	.	.	O	.	_	0	SENT_249	[p18l1629t941r1825b1008],

1	For	IN	O	for	_	0	SENT_250	[p18l1863t942r1996b1007],
2	example	NN	O	example	prep_for	8	SENT_250	[p18l2028t962r2145b1007, p18l10t1056r264b1143],
3	,	,	O	,	_	0	SENT_250	[p18l2028t962r2145b1007, p18l10t1056r264b1143],
4	one	CD	NUMBER	one	num	6	SENT_250	[p18l303t1078r439b1123],
5	Han	NNP	MISC	Han	nn	6	SENT_250	[p18l474t1058r632b1123],
6	Chinese	NNP	MISC	Chinese	nsubj	8	SENT_250	[p18l668t1056r976b1124],
7	individual	JJ	O	individual	amod	6	SENT_250	[p18l1011t1056r1400b1124],
8	presented	VBD	O	present	_	0	SENT_250	[p18l1434t1056r1805b1143],
9	an	DT	O	a	det	10	SENT_250	[p18l1840t1078r1928b1123],
10	HSR	NN	O	hsr	dobj	8	SENT_250	[p18l1962t1057r2147b1124],
11	to	TO	O	to	_	0	SENT_250	[p18l8t1181r79b1238],
12	both	DT	O	both	preconj	13	SENT_250	[p18l131t1171r302b1238],
13	CBZ	NN	ORGANIZATION	cbz	prep_to	8	SENT_250	[p18l354t1171r538b1238],
14	and	CC	O	and	_	0	SENT_250	[p18l591t1171r727b1238],
15	PHY	NN	O	phy	conj_and	13	SENT_250	[p18l778t1173r975b1238],
16	.	.	O	.	_	0	SENT_250	[p18l778t1173r975b1238],

1	The	DT	O	the	det	2	SENT_251	[p18l1031t1171r1178b1238],
2	drugs	NNS	O	drug	nsubjpass	4	SENT_251	[p18l1231t1171r1440b1258],
3	were	VBD	O	be	auxpass	4	SENT_251	[p18l1493t1192r1678b1238],
4	substituted	VBN	O	substitute	_	0	SENT_251	[p18l1733t1171r2147b1238],
5	with	IN	O	with	_	0	SENT_251	[p18l8t1286r178b1353],
6	phenobarbital	NN	O	phenobarbital	prep_with	4	SENT_251	[p18l216t1286r768b1373],
7	,	,	O	,	_	0	SENT_251	[p18l216t1286r768b1373],
8	which	WDT	O	which	nsubjpass	11	SENT_251	[p18l812t1286r1045b1353],
9	was	VBD	O	be	auxpass	11	SENT_251	[p18l1085t1307r1230b1353],
10	well	RB	O	well	advmod	11	SENT_251	[p18l1272t1286r1435b1353],
11	tolerated	VBN	O	tolerate	rcmod	6	SENT_251	[p18l1475t1286r1832b1353],
12	.	.	O	.	_	0	SENT_251	[p18l1475t1286r1832b1353],

1	Due	JJ	O	due	_	0	SENT_252	[p18l1876t1287r2034b1353],
2	to	TO	O	to	_	0	SENT_252	[p18l2074t1296r2146b1353],
3	clinically-insufﬁcient	JJ	O	clinically-insufﬁcient	amod	4	SENT_252	[p18l9t1401r837b1488],
4	efﬁcacy	NN	O	efﬁcacy	prep_due_to	11	SENT_252	[p18l901t1401r1204b1488],
5	of	IN	O	of	_	0	SENT_252	[p18l1270t1401r1353b1468],
6	phenobarbital	NN	O	phenobarbital	prep_of	4	SENT_252	[p18l1410t1401r1962b1488],
7	,	,	O	,	_	0	SENT_252	[p18l1410t1401r1962b1488],
8	the	DT	O	the	det	9	SENT_252	[p18l2031t1401r2146b1468],
9	patient	NN	O	patient	nsubjpass	11	SENT_252	[p18l7t1516r271b1603],
10	was	VBD	O	be	auxpass	11	SENT_252	[p18l319t1538r464b1584],
11	prescribed	VBN	O	prescribe	_	0	SENT_252	[p18l513t1516r915b1603],
12	LTG	NN	O	ltg	dobj	11	SENT_252	[p18l963t1517r1159b1584],
13	.	.	O	.	_	0	SENT_252	[p18l963t1517r1159b1584],

1	After	IN	O	after	_	0	SENT_253	[p18l1213t1516r1416b1583],
2	2	CD	DURATION	2	num	3	SENT_253	[p18l1464t1517r1507b1582],
3	weeks	NNS	NUMBER	week	prep_after	10	SENT_253	[p18l1557t1516r1793b1583],
4	of	IN	O	of	_	0	SENT_253	[p18l1845t1516r1928b1583],
5	LTG	NN	O	ltg	nn	6	SENT_253	[p18l1969t1517r2147b1584],
6	therapy	NN	O	therapy	prep_of	3	SENT_253	[p18l8t1631r311b1718],
7	,	,	O	,	_	0	SENT_253	[p18l8t1631r311b1718],
8	the	DT	O	the	det	9	SENT_253	[p18l368t1631r484b1698],
9	patient	NN	O	patient	nsubj	10	SENT_253	[p18l538t1631r802b1718],
10	presented	VBN	O	present	_	0	SENT_253	[p18l855t1631r1225b1718],
11	with	IN	O	with	_	0	SENT_253	[p18l1279t1631r1448b1699],
12	LTG-HSR	NN	O	ltg-hsr	prep_with	10	SENT_253	[p18l1502t1632r1918b1699],
13	.	.	O	.	_	0	SENT_253	[p18l1502t1632r1918b1699],

1	This	DT	O	this	det	2	SENT_254	[p18l1978t1631r2145b1698],
2	patient	NN	O	patient	nsubj	3	SENT_254	[p18l7t1746r271b1833],
3	presented	VBD	O	present	_	0	SENT_254	[p18l302t1746r673b1833],
4	a	DT	O	a	det	8	SENT_254	[p18l708t1767r747b1813],
5	highly	RB	O	highly	advmod	6	SENT_254	[p18l778t1746r1361b1833],
6	—	JJ	O	—	amod	8	SENT_254	[p18l778t1746r1361b1833],
7	positive	JJ	O	positive	amod	8	SENT_254	[p18l778t1746r1361b1833],
8	LTA	NN	ORGANIZATION	lta	dobj	3	SENT_254	[p18l1393t1747r1563b1812],
9	to	TO	O	to	_	0	SENT_254	[p18l1596t1756r1668b1813],
10	CBZ	NNP	ORGANIZATION	CBZ	prep_to	3	SENT_254	[p18l1703t1746r1908b1825],
11	,	,	O	,	_	0	SENT_254	[p18l1703t1746r1908b1825],
12	PHY	NNP	O	PHY	conj_and	10	SENT_254	[p18l1945t1748r2143b1825],
13	,	,	O	,	_	0	SENT_254	[p18l1945t1748r2143b1825],
14	and	CC	O	and	_	0	SENT_254	[p18l10t1861r146b1928],
15	LTG	NN	O	ltg	conj_and	10	SENT_254	[p18l174t1861r372b1940],
16	,	,	O	,	_	0	SENT_254	[p18l174t1861r372b1940],
17	but	CC	O	but	_	0	SENT_254	[p18l403t1861r527b1928],
18	negative	JJ	O	negative	advmod	3	SENT_254	[p18l553t1861r875b1948],
19	to	TO	O	to	_	0	SENT_254	[p18l904t1871r976b1928],
20	phenobarbital	NN	O	phenobarbital	conj_but	10	SENT_254	[p18l1005t1861r1556b1948],
21	.	.	O	.	_	0	SENT_254	[p18l1005t1861r1556b1948],

1	We	PRP	O	we	nsubj	3	SENT_255	[p18l1588t1862r1714b1928],
2	have	VBP	O	have	aux	3	SENT_255	[p18l1743t1861r1921b1928],
3	demonstrated	VBN	O	demonstrate	_	0	SENT_255	[p18l1951t1861r2144b1928, p18l9t1976r361b2042],
4	that	IN	O	that	complm	10	SENT_255	[p18l383t1976r527b2042],
5	the	DT	O	the	det	6	SENT_255	[p18l548t1976r664b2042],
6	LTA	NNP	ORGANIZATION	LTA	nsubj	10	SENT_255	[p18l685t1976r856b2042],
7	is	VBZ	O	be	cop	10	SENT_255	[p18l877t1976r938b2042],
8	a	DT	O	a	det	10	SENT_255	[p18l963t1997r1003b2042],
9	powerful	JJ	O	powerful	amod	10	SENT_255	[p18l1022t1976r1368b2063],
10	tool	NN	O	tool	ccomp	3	SENT_255	[p18l1390t1976r1538b2042],
11	that	WDT	O	that	nsubj	13	SENT_255	[p18l1560t1976r1705b2042],
12	can	MD	O	can	aux	13	SENT_255	[p18l1726t1997r1858b2042],
13	predict	VB	O	predict	rcmod	10	SENT_255	[p18l1879t1976r2147b2063],
14	an	DT	O	a	det	15	SENT_255	[p18l10t2113r97b2158],
15	HSR	NN	O	hsr	dobj	13	SENT_255	[p18l128t2092r313b2159],
16	and	CC	O	and	_	0	SENT_255	[p18l345t2091r481b2158],
17	cross-reactivity	NN	O	cross-reactivity	conj_and	15	SENT_255	[p18l512t2091r1104b2178],
18	to	TO	O	to	_	0	SENT_255	[p18l1135t2101r1207b2158],
19	AEDs	NNS	MISC	aed	prep_to	13	SENT_255	[p18l1238t2092r1470b2158],
20	regardless	RB	O	regardless	_	0	SENT_255	[p18l1502t2091r1889b2178],
21	of	IN	O	of	_	0	SENT_255	[p18l1923t2091r2007b2158],
22	the	DT	O	the	det	23	SENT_255	[p18l2031t2091r2146b2158],
23	patient	NN	O	patient	poss	26	SENT_255	[p18l7t2206r333b2293],
24	’s	POS	O	’s	_	0	SENT_255	[p18l7t2206r333b2293],
25	ethnic	JJ	O	ethnic	amod	26	SENT_255	[p18l365t2206r597b2273],
26	background	NN	O	background	prep_regardless_of	19	SENT_255	[p18l627t2206r1102b2293],
27	.	.	O	.	_	0	SENT_255	[p18l627t2206r1102b2293],

1	Should	MD	O	should	aux	6	SENT_256	[p18l1140t2206r1409b2273],
2	an	DT	O	a	det	3	SENT_256	[p18l1440t2227r1527b2273],
3	LTG-LTA	NN	O	ltg-lta	nsubjpass	6	SENT_256	[p18l1556t2206r1938b2273],
4	have	VBP	O	have	aux	6	SENT_256	[p18l1967t2206r2145b2273],
5	been	VBN	O	be	auxpass	6	SENT_256	[p18l7t2321r188b2387],
6	performed	VBN	O	perform	dep	18	SENT_256	[p18l228t2321r630b2408],
7	prior	RB	O	prior	_	0	SENT_256	[p18l669t2321r858b2408],
8	to	TO	O	to	_	0	SENT_256	[p18l897t2331r968b2387],
9	administering	VBG	O	administer	prepc_prior_to	6	SENT_256	[p18l1012t2321r1539b2408],
10	this	DT	O	this	det	11	SENT_256	[p18l1581t2321r1716b2387],
11	agent	NN	O	agent	dobj	9	SENT_256	[p18l1760t2331r1986b2408],
12	,	,	O	,	_	0	SENT_256	[p18l1760t2331r1986b2408],
13	the	DT	O	the	det	14	SENT_256	[p18l2031t2321r2146b2387],
14	LTG-HSR	NN	O	ltg-hsr	nsubjpass	18	SENT_256	[p18l8t2437r406b2503],
15	could	MD	O	could	aux	18	SENT_256	[p18l436t2436r648b2503],
16	have	VB	O	have	aux	18	SENT_256	[p18l676t2436r855b2503],
17	been	VBN	O	be	auxpass	18	SENT_256	[p18l884t2436r1066b2503],
18	avoided	VBN	O	avoid	_	0	SENT_256	[p18l1098t2436r1417b2503],
19	.	.	O	.	_	0	SENT_256	[p18l1098t2436r1417b2503],

1	Our	PRP$	O	we	poss	2	SENT_257	[p18l97t2551r244b2618],
2	results	NNS	O	result	nsubj	3	SENT_257	[p18l277t2551r526b2617],
3	show	VBP	O	show	dep	10	SENT_257	[p18l568t2551r762b2618],
4	that	IN	O	that	complm	7	SENT_257	[p18l798t2551r943b2617],
5	LTG	NN	O	ltg	nn	6	SENT_257	[p18l978t2551r1156b2618],
6	sensitivity	NN	O	sensitivity	nsubj	7	SENT_257	[p18l1195t2551r1584b2638],
7	is	VBZ	O	be	ccomp	3	SENT_257	[p18l1621t2551r1681b2617],
8	not	RB	O	not	neg	7	SENT_257	[p18l1719t2561r1841b2617],
9	signiﬁcantly	RB	O	signiﬁcantly	advmod	7	SENT_257	[p18l1880t2550r2144b2638, p18l9t2666r243b2753],
10	correlated	VBD	O	correlate	_	0	SENT_257	[p18l304t2666r688b2733],
11	to	TO	O	to	_	0	SENT_257	[p18l748t2676r819b2733],
12	the	DT	O	the	det	13	SENT_257	[p18l880t2666r996b2733],
13	presence	NN	O	presence	prep_to	10	SENT_257	[p18l1054t2688r1391b2753],
14	of	IN	O	of	_	0	SENT_257	[p18l1453t2666r1536b2733],
15	HLA-B	NN	O	hla-b	prep_of	13	SENT_257	[p18l1589t2666r2142b2734],
16	*	CD	NUMBER	*	num	17	SENT_257	[p18l1589t2666r2142b2734],
17	l502	NN	O	l502	nsubj	10	SENT_257	[p18l1589t2666r2142b2734],
18	.	.	O	.	_	0	SENT_257	[p18l1589t2666r2142b2734],

1	One	CD	NUMBER	one	_	0	SENT_258	[p18l10t2781r165b2848],
2	HLA	NN	O	hlum	dep	1	SENT_258	[p18l205t2781r1096b2868],
3	.	.	O	.	_	0	SENT_258	[p18l205t2781r1096b2868],

1	—	NN	O	—	_	0	SENT_259	[p18l205t2781r1096b2868],
2	.	.	O	.	_	0	SENT_259	[p18l205t2781r1096b2868],

1	B	NN	O	b	npadvmod	3	SENT_260	[p18l205t2781r1096b2868],
2	*	CD	NUMBER	*	num	1	SENT_260	[p18l205t2781r1096b2868],
3	l502-negative	JJ	O	l502-negative	amod	6	SENT_260	[p18l205t2781r1096b2868],
4	Han	NNP	MISC	Han	nn	6	SENT_260	[p18l1134t2783r1292b2848],
5	Chinese	NNP	MISC	Chinese	nn	6	SENT_260	[p18l1331t2781r1638b2848],
6	patient	NN	O	patient	nsubj	14	SENT_260	[p18l1676t2781r1940b2868],
7	with	IN	O	with	_	0	SENT_260	[p18l1978t2781r2147b2849],
8	negative	JJ	O	negative	amod	9	SENT_260	[p18l8t2896r331b2983],
9	CBZ-LTA	NN	O	cbz-lta	prep_with	6	SENT_260	[p18l394t2896r782b2963],
10	and	CC	O	and	_	0	SENT_260	[p18l846t2896r981b2962],
11	without	IN	O	without	_	0	SENT_260	[p18l1042t2896r1336b2963],
12	clinical	JJ	O	clinical	amod	13	SENT_260	[p18l1397t2896r1680b2962],
13	CBZ-HSR	NN	O	cbz-hsr	prep_without	6	SENT_260	[p18l1743t2896r2147b2963],
14	was	VBD	O	be	ccomp	41	SENT_260	[p18l8t3033r153b3079],
15	in	IN	O	in	_	0	SENT_260	[p18l211t3011r284b3078],
16	concordance	NN	O	concordance	prep_in	14	SENT_260	[p18l340t3011r826b3078],
17	with	IN	O	with	_	0	SENT_260	[p18l882t3011r1051b3079],
18	the	DT	O	the	det	20	SENT_260	[p18l1106t3011r1221b3078],
19	previous	JJ	O	previous	amod	20	SENT_260	[p18l1277t3011r1605b3098],
20	observations	NNS	O	observation	prep_with	14	SENT_260	[p18l1664t3011r2145b3079],
21	showing	VBG	O	show	partmod	20	SENT_260	[p18l11t3126r329b3213],
22	that	IN	O	that	complm	29	SENT_260	[p18l376t3126r520b3193],
23	a	DT	O	a	det	28	SENT_260	[p18l566t3148r606b3193],
24	negative	JJ	O	negative	amod	28	SENT_260	[p18l650t3126r972b3213],
25	HLA-B	NN	O	hla-b	nn	28	SENT_260	[p18l1017t3126r1550b3194],
26	*	CD	NUMBER	*	num	28	SENT_260	[p18l1017t3126r1550b3194],
27	l502	NN	O	l502	nn	28	SENT_260	[p18l1017t3126r1550b3194],
28	status	NN	O	status	nsubj	29	SENT_260	[p18l1600t3136r1811b3193],
29	permits	VBZ	O	permit	ccomp	21	SENT_260	[p18l1857t3126r2145b3213],
30	safe	JJ	O	safe	amod	32	SENT_260	[p18l11t3241r160b3308],
31	CBZ	NN	ORGANIZATION	cbz	nn	32	SENT_260	[p18l197t3241r381b3308],
32	use	NN	O	use	dobj	29	SENT_260	[p18l416t3262r542b3308],
33	in	IN	O	in	_	0	SENT_260	[p18l577t3241r651b3307],
34	Han	NNP	LOCATION	Han	nn	36	SENT_260	[p18l685t3242r843b3308],
35	Chinese	NNP	LOCATION	Chinese	nn	36	SENT_260	[p18l879t3241r1186b3308],
36	individuals	NNS	O	individual	prep_in	29	SENT_260	[p18l1222t3219r1742b3308],
37	.68	CD	NUMBER	.68	tmod	29	SENT_260	[p18l1222t3219r1742b3308],
38	However	RB	O	however	advmod	37	SENT_260	[p18l1780t3242r2144b3320],
39	,	,	O	,	_	0	SENT_260	[p18l1780t3242r2144b3320],
40	he	PRP	O	he	nsubj	41	SENT_260	[p18l7t3356r96b3423],
41	presented	VBD	O	present	_	0	SENT_260	[p18l130t3356r501b3443],
42	a	DT	O	a	det	44	SENT_260	[p18l536t3377r576b3423],
43	high	JJ	O	high	amod	44	SENT_260	[p18l607t3356r778b3443],
44	LTG-LTA	NN	O	ltg-lta	dobj	41	SENT_260	[p18l811t3356r1194b3423],
45	(	CD	PERCENT	(	number	46	SENT_260	[p18l1230t3356r1487b3439],
46	38	CD	PERCENT	38	dep	47	SENT_260	[p18l1230t3356r1487b3439],
47	%	NN	PERCENT	%	dep	44	SENT_260	[p18l1230t3356r1487b3439],
48	)	CD	NUMBER	)	tmod	41	SENT_260	[p18l1230t3356r1487b3439],
49	,	,	O	,	_	0	SENT_260	[p18l1230t3356r1487b3439],
50	showing	VBG	O	show	partmod	41	SENT_260	[p18l1528t3356r1845b3443],
51	that	IN	O	that	complm	54	SENT_260	[p18l1881t3356r2025b3423],
52	he	PRP	O	he	nsubj	54	SENT_260	[p18l2058t3356r2146b3423],
53	is	VBZ	O	be	cop	54	SENT_260	[p18l8t3471r68b3538],
54	sensitive	JJ	O	sensitive	ccomp	50	SENT_260	[p18l116t3471r446b3538],
55	to	TO	O	to	_	0	SENT_260	[p18l489t3481r560b3538],
56	LTG	NN	O	ltg	prep_to	54	SENT_260	[p18l604t3471r782b3538],
57	and	CC	O	and	_	0	SENT_260	[p18l826t3471r962b3538],
58	should	MD	O	should	aux	60	SENT_260	[p18l1008t3471r1261b3538],
59	not	RB	O	not	neg	60	SENT_260	[p18l1302t3481r1425b3538],
60	take	VB	O	take	ccomp	50	SENT_260	[p18l1466t3471r1624b3538],
61	it	PRP	O	it	dobj	60	SENT_260	[p18l1668t3471r1739b3538],
62	.	.	O	.	_	0	SENT_260	[p18l1668t3471r1739b3538],

1	The	DT	O	the	det	2	SENT_261	[p18l1787t3471r1934b3538],
2	LTA	NN	O	lta	_	0	SENT_261	[p18l1977t3472r2147b3537],

1	can	MD	O	can	aux	4	SENT_262	[p18l9t3607r140b3653],
2	thus	RB	O	thus	advmod	4	SENT_262	[p18l169t3586r325b3653],
3	be	VB	O	be	auxpass	4	SENT_262	[p18l355t3586r444b3653],
4	used	VBN	O	use	_	0	SENT_262	[p18l473t3586r649b3653],
5	to	TO	O	to	aux	6	SENT_262	[p18l677t3596r748b3653],
6	prevent	VB	O	prevent	xcomp	4	SENT_262	[p18l777t3596r1065b3673],
7	an	DT	O	a	det	8	SENT_262	[p18l1094t3607r1181b3653],
8	HSR	NN	O	hsr	dobj	6	SENT_262	[p18l1210t3586r1413b3653],
9	.	.	O	.	_	0	SENT_262	[p18l1210t3586r1413b3653],

1	Another	DT	O	another	det	4	SENT_263	[p18l1447t3586r1763b3653],
2	Han	NNP	O	Han	nn	4	SENT_263	[p18l1790t3587r1949b3653],
3	Chinese	NNP	MISC	Chinese	nn	4	SENT_263	[p18l1979t3586r2144b3653, p18l8t3722r177b3767],
4	patient	NN	O	patient	nsubj	5	SENT_263	[p18l214t3701r477b3788],
5	developed	VBD	O	develop	_	0	SENT_263	[p18l514t3701r906b3788],
6	clinical	JJ	O	clinical	amod	8	SENT_263	[p18l943t3701r1226b3767],
7	SJ	NN	O	sj	nn	8	SENT_263	[p18l1265t3701r1351b3768],
8	S	NN	O	s	dobj	5	SENT_263	[p18l1356t3701r1400b3768],
9	after	IN	O	after	_	0	SENT_263	[p18l1443t3701r1618b3767],
10	therapy	NN	O	therapy	prep_after	5	SENT_263	[p18l1653t3701r1939b3788],
11	with	IN	O	with	_	0	SENT_263	[p18l1978t3701r2147b3768],
12	oxy-CBZ	NN	O	oxy-cbz	prep_with	5	SENT_263	[p19l9t22r392b108],
13	,	,	O	,	_	0	SENT_263	[p19l9t22r392b108],
14	CBZ	NNP	ORGANIZATION	CBZ	prep_with	5	SENT_263	[p19l420t22r625b100],
15	,	,	O	,	_	0	SENT_263	[p19l420t22r625b100],
16	and	CC	O	and	_	0	SENT_263	[p19l655t21r791b88],
17	PHY	NN	O	phy	prep_with	5	SENT_263	[p19l814t23r1011b88],
18	.	.	O	.	_	0	SENT_263	[p19l814t23r1011b88],

1	The	DT	O	the	det	2	SENT_264	[p19l1040t21r1188b88],
2	patient	NN	O	patient	nsubj	3	SENT_264	[p19l1211t21r1476b108],
3	presented	VBD	O	present	_	0	SENT_264	[p19l1498t21r1868b108],
4	a	DT	O	a	det	8	SENT_264	[p19l1894t43r1934b88],
5	positive	JJ	O	positive	amod	8	SENT_264	[p19l1955t21r2144b108, p19l8t136r149b203],
6	HLA-B	NN	O	hla-b	nn	8	SENT_264	[p19l186t136r738b203],
7	*	CD	NUMBER	*	num	8	SENT_264	[p19l186t136r738b203],
8	l502	NN	O	l502	dobj	3	SENT_264	[p19l186t136r738b203],
9	.	.	O	.	_	0	SENT_264	[p19l186t136r738b203],

1	LTA-PHY	NN	O	lta-phy	nsubj	3	SENT_265	[p19l780t137r1175b202],
2	was	VBD	O	be	cop	3	SENT_265	[p19l1212t157r1356b203],
3	positive	JJ	O	positive	_	0	SENT_265	[p19l1394t136r1697b223],
4	(	CD	PERCENT	(	num	6	SENT_265	[p19l1737t136r1969b219],
5	20	CD	PERCENT	20	num	6	SENT_265	[p19l1737t136r1969b219],
6	%	NN	PERCENT	%	tmod	3	SENT_265	[p19l1737t136r1969b219],
7	)	CD	NUMBER	)	nsubj	13	SENT_265	[p19l1737t136r1969b219],
8	and	CC	O	and	_	0	SENT_265	[p19l2011t136r2147b203],
9	LTA-CBZ	NN	O	lta-cbz	nsubj	13	SENT_265	[p19l8t251r398b318],
10	was	VBD	O	be	cop	13	SENT_265	[p19l450t272r594b318],
11	highly	RB	O	highly	advmod	12	SENT_265	[p19l647t251r892b338],
12	positive	JJ	O	positive	amod	13	SENT_265	[p19l943t251r1246b338],
13	(	NN	O	(	rcmod	6	SENT_265	[p19l1300t250r1555b333],
14	53	CD	PERCENT	53	num	15	SENT_265	[p19l1300t250r1555b333],
15	%	NN	PERCENT	%	dep	13	SENT_265	[p19l1300t250r1555b333],
16	)	CD	NUMBER	)	dep	15	SENT_265	[p19l1300t250r1555b333],
17	.	.	O	.	_	0	SENT_265	[p19l1300t250r1555b333],

1	However	RB	O	however	advmod	6	SENT_266	[p19l1611t252r1976b330],
2	,	,	O	,	_	0	SENT_266	[p19l1611t252r1976b330],
3	the	DT	O	the	det	5	SENT_266	[p19l2031t251r2146b317],
4	same	JJ	O	same	amod	5	SENT_266	[p19l11t388r205b433],
5	patient	NN	O	patient	nsubj	6	SENT_266	[p19l250t366r513b453],
6	showed	VBD	O	show	_	0	SENT_266	[p19l562t366r849b434],
7	only	RB	O	only	advmod	6	SENT_266	[p19l896t366r1063b453],
8	7	CD	PERCENT	7	number	9	SENT_266	[p19l1111t367r1232b434],
9	%	NN	PERCENT	%	amod	10	SENT_266	[p19l1111t367r1232b434],
10	toxicity	NN	O	toxicity	dobj	6	SENT_266	[p19l1282t366r1576b453],
11	to	TO	O	to	_	0	SENT_266	[p19l1622t376r1694b433],
12	LTG-LTA	NN	O	ltg-lta	prep_to	6	SENT_266	[p19l1740t367r2142b434],
13	.	.	O	.	_	0	SENT_266	[p19l1740t367r2142b434],

1	Therefore	RB	O	therefore	advmod	19	SENT_267	[p19l8t481r408b560],
2	,	,	O	,	_	0	SENT_267	[p19l8t481r408b560],
3	if	IN	O	if	mark	8	SENT_267	[p19l447t481r510b547],
4	the	DT	O	the	det	5	SENT_267	[p19l537t481r652b548],
5	LTA	NNP	ORGANIZATION	LTA	nsubjpass	8	SENT_267	[p19l687t482r858b547],
6	would	MD	O	would	aux	8	SENT_267	[p19l884t481r1122b548],
7	be	VB	O	be	auxpass	8	SENT_267	[p19l1155t481r1245b548],
8	performed	VBN	O	perform	advcl	19	SENT_267	[p19l1278t481r1681b568],
9	before	IN	O	before	_	0	SENT_267	[p19l1714t481r1958b548],
10	prescribing	VBG	O	prescribe	prepc_before	8	SENT_267	[p19l1993t502r2144b568, p19l11t596r316b683],
11	the	DT	O	the	det	12	SENT_267	[p19l346t596r461b663],
12	drugs	NNS	O	drug	dobj	10	SENT_267	[p19l490t596r722b683],
13	,	,	O	,	_	0	SENT_267	[p19l490t596r722b683],
14	the	DT	O	the	det	16	SENT_267	[p19l753t596r868b663],
15	SJ	NN	O	sj	nn	16	SENT_267	[p19l899t597r985b664],
16	S	NN	O	s	nsubjpass	19	SENT_267	[p19l990t597r1033b664],
17	could	MD	O	could	aux	19	SENT_267	[p19l1067t596r1280b663],
18	be	VB	O	be	auxpass	19	SENT_267	[p19l1305t596r1394b663],
19	avoided	VBN	O	avoid	_	0	SENT_267	[p19l1425t596r1726b663],
20	by	IN	O	by	_	0	SENT_267	[p19l1752t596r1846b683],
21	administering	VBG	O	administer	agent	19	SENT_267	[p19l1877t596r2144b663, p19l8t711r295b798],
22	the	DT	O	the	det	24	SENT_267	[p19l332t711r447b778],
23	safe	JJ	O	safe	amod	24	SENT_267	[p19l487t711r636b778],
24	LTG	NN	O	ltg	dobj	21	SENT_267	[p19l671t711r868b778],
25	.	.	O	.	_	0	SENT_267	[p19l671t711r868b778],

1	This	DT	O	this	det	2	SENT_268	[p19l909t711r1076b778],
2	rationale	NN	O	rationale	nsubj	21	SENT_268	[p19l1113t711r1450b778],
3	has	VBZ	O	have	_	0	SENT_268	[p19l1486t711r1611b778],
4	an	DT	O	a	det	7	SENT_268	[p19l1650t732r1737b778],
5	important	JJ	O	important	amod	7	SENT_268	[p19l1773t711r2148b798],
6	clinical	JJ	O	clinical	amod	7	SENT_268	[p19l9t826r292b892],
7	implication	NN	O	implication	dobj	3	SENT_268	[p19l332t826r793b913],
8	,	,	O	,	_	0	SENT_268	[p19l332t826r793b913],
9	demonstrating	VBG	O	demonstrate	partmod	7	SENT_268	[p19l839t826r1388b913],
10	that	IN	O	that	complm	16	SENT_268	[p19l1430t826r1574b892],
11	HLA-B	NN	O	hla-b	nsubj	16	SENT_268	[p19l1614t825r2146b893],
12	*	CD	NUMBER	*	num	13	SENT_268	[p19l1614t825r2146b893],
13	l502	NN	O	l502	dep	11	SENT_268	[p19l1614t825r2146b893],
14	is	VBZ	O	be	cop	16	SENT_268	[p19l8t941r68b1008],
15	not	RB	O	not	neg	16	SENT_268	[p19l121t951r243b1008],
16	predictive	JJ	O	predictive	ccomp	9	SENT_268	[p19l292t941r676b1028],
17	of	IN	O	of	_	0	SENT_268	[p19l728t941r811b1008],
18	LTG-HSR	NN	O	ltg-hsr	prep_of	16	SENT_268	[p19l856t942r1254b1009],
19	and	CC	O	and	_	0	SENT_268	[p19l1306t941r1442b1009],
20	will	MD	O	will	aux	21	SENT_268	[p19l1493t941r1640b1009],
21	permit	VB	O	permit	conj_and	3	SENT_268	[p19l1690t941r1944b1028],
22	safe	JJ	O	safe	amod	24	SENT_268	[p19l1997t941r2146b1008],
23	LTG	NN	O	ltg	nn	24	SENT_268	[p19l8t1057r186b1124],
24	administration	NN	O	administration	dobj	21	SENT_268	[p19l218t1056r793b1123],
25	.	.	O	.	_	0	SENT_268	[p19l218t1056r793b1123],

1	These	DT	O	these	det	2	SENT_269	[p19l829t1056r1056b1123],
2	cases	NNS	O	case	nsubj	3	SENT_269	[p19l1089t1078r1287b1123],
3	represent	VBP	O	represent	_	0	SENT_269	[p19l1318t1066r1673b1143],
4	a	DT	O	a	det	5	SENT_269	[p19l1704t1078r1744b1123],
5	conﬁrmation	NN	O	conﬁrmation	dobj	3	SENT_269	[p19l1774t1056r2144b1123, p19l8t1171r156b1238],
6	that	IN	O	that	complm	14	SENT_269	[p19l208t1171r352b1238],
7	a	DT	O	a	det	11	SENT_269	[p19l405t1192r445b1238],
8	positive	JJ	O	positive	amod	11	SENT_269	[p19l494t1171r796b1258],
9	HLA-B	NN	O	hla-b	nn	11	SENT_269	[p19l848t1171r1380b1238],
10	*	CD	NUMBER	*	num	11	SENT_269	[p19l848t1171r1380b1238],
11	l502	NN	O	l502	nsubj	14	SENT_269	[p19l848t1171r1380b1238],
12	is	VBZ	O	be	cop	14	SENT_269	[p19l1432t1171r1492b1238],
13	a	DT	O	a	det	14	SENT_269	[p19l1548t1192r1588b1238],
14	predictor	NN	O	predictor	ccomp	3	SENT_269	[p19l1637t1171r1987b1258],
15	for	IN	O	for	_	0	SENT_269	[p19l2038t1171r2148b1238],
16	CBZ-HSR	NN	O	cbz-hsr	prep_for	14	SENT_269	[p19l9t1286r414b1353],
17	and	CC	O	and	_	0	SENT_269	[p19l452t1286r588b1352],
18	PHY	NN	O	phy	conj_and	16	SENT_269	[p19l624t1286r1024b1353],
19	.	.	O	.	_	0	SENT_269	[p19l624t1286r1024b1353],

1	—	NN	O	—	_	0	SENT_270	[p19l624t1286r1024b1353],
2	.	.	O	.	_	0	SENT_270	[p19l624t1286r1024b1353],

1	HSR	NN	O	hsr	_	0	SENT_271	[p19l624t1286r1024b1353],
2	in	IN	O	in	prep	1	SENT_271	[p19l1060t1286r1133b1352],
3	Han	NNP	LOCATION	Han	nn	5	SENT_271	[p19l1170t1287r1328b1352],
4	Chinese	NNP	LOCATION	Chinese	nn	5	SENT_271	[p19l1365t1286r1673b1353],
5	population	NN	O	population	pobj	2	SENT_271	[p19l1710t1286r2143b1373],
6	,	,	O	,	_	0	SENT_271	[p19l1710t1286r2143b1373],
7	but	CC	O	but	_	0	SENT_271	[p19l7t1401r130b1468],
8	not	RB	O	not	prep	1	SENT_271	[p19l158t1411r280b1468],
9	for	IN	O	for	dep	2	SENT_271	[p19l309t1401r421b1468],
10	LTG-HSR	NN	O	ltg-hsr	pobj	9	SENT_271	[p19l448t1402r865b1468],
11	.	.	O	.	_	0	SENT_271	[p19l448t1402r865b1468],

1	Neumon	NNP	PERSON	Neumon	_	0	SENT_272	[p19l1407t1522r1723b1581],
2	e	SYM	O	e	dep	5	SENT_272	[p19l1752t1522r1825b1581],
3	’	CD	NUMBER	’	num	5	SENT_272	[p19l1752t1522r1825b1581],
4	r	NN	O	r	nn	5	SENT_272	[p19l1752t1522r1825b1581],
5	ol	NN	O	ol	rcmod	1	SENT_272	[p19l1850t1522r1911b1581],
6	403	CD	NUMBER	403	dep	1	SENT_272	[p19l2022t1521r2150b1581],

1	Chung	NNP	PERSON	Chung	nn	3	SENT_273	[p19l96t1757r349b1844],
2	et	NNP	O	et	nn	3	SENT_273	[p19l384t1767r452b1824],
3	al	NNP	O	al	nsubj	4	SENT_273	[p19l486t1757r551b1824],
4	found	VBD	O	find	_	0	SENT_273	[p19l586t1757r809b1824],
5	that	IN	O	that	complm	10	SENT_273	[p19l842t1757r986b1824],
6	HLA-B	NN	O	hla-b	nsubj	10	SENT_273	[p19l1019t1757r1553b1824],
7	*	CD	NUMBER	*	num	8	SENT_273	[p19l1019t1757r1553b1824],
8	l502	NN	O	l502	dep	6	SENT_273	[p19l1019t1757r1553b1824],
9	was	VBD	O	be	cop	10	SENT_273	[p19l1588t1778r1733b1824],
10	present	JJ	DATE	present	ccomp	4	SENT_273	[p19l1766t1767r2047b1844],
11	in	IN	O	in	_	0	SENT_273	[p19l2078t1757r2152b1823],
12	100	CD	PERCENT	100	num	13	SENT_273	[p19l17t1872r226b1940],
13	%	NN	PERCENT	%	prep_in	10	SENT_273	[p19l17t1872r226b1940],
14	of	IN	O	of	_	0	SENT_273	[p19l277t1872r360b1939],
15	CBZ	NNP	O	CBZ	prep_of	13	SENT_273	[p19l400t1872r757b1940],
16	.	.	O	.	_	0	SENT_273	[p19l400t1872r757b1940],

1	—	NN	O	—	_	0	SENT_274	[p19l400t1872r757b1940],
2	.	.	O	.	_	0	SENT_274	[p19l400t1872r757b1940],

1	SJS	NN	O	sj	nn	2	SENT_275	[p19l400t1872r757b1940],
2	patients	NNS	O	patient	nsubj	53	SENT_275	[p19l805t1872r1126b1960],
3	,	,	O	,	_	0	SENT_275	[p19l805t1872r1126b1960],
4	3	CD	PERCENT	3	num	5	SENT_275	[p19l1178t1872r1298b1940],
5	%	NN	PERCENT	%	appos	2	SENT_275	[p19l1178t1872r1298b1940],
6	of	IN	O	of	_	0	SENT_275	[p19l1348t1872r1431b1939],
7	CBZ	NNP	O	CBZ	prep_of	5	SENT_275	[p19l1470t1872r1986b1940],
8	—	CD	NUMBER	—	num	10	SENT_275	[p19l1470t1872r1986b1940],
9	to1erant	JJ	O	to1erant	amod	10	SENT_275	[p19l1470t1872r1986b1940],
10	patients	NNS	O	patient	dep	7	SENT_275	[p19l2029t1893r2149b1960, p19l8t1988r236b2068],
11	,	,	O	,	_	0	SENT_275	[p19l2029t1893r2149b1960, p19l8t1988r236b2068],
12	and	CC	O	and	_	0	SENT_275	[p19l275t1988r411b2055],
13	8.6	CD	PERCENT	8.6	num	14	SENT_275	[p19l447t1988r638b2056],
14	%	NN	PERCENT	%	prep_of	5	SENT_275	[p19l447t1988r638b2056],
15	of	IN	O	of	_	0	SENT_275	[p19l677t1988r760b2055],
16	the	DT	O	the	det	18	SENT_275	[p19l787t1988r902b2055],
17	general	JJ	O	general	amod	18	SENT_275	[p19l936t1988r1219b2075],
18	population	NN	O	population	prep_of	14	SENT_275	[p19l1251t1988r1665b2075],
19	among	IN	O	among	_	0	SENT_275	[p19l1700t2010r1958b2075],
20	Han	NNP	LOCATION	Han	nn	21	SENT_275	[p19l1993t1990r2152b2055],
21	Chinese	NNP	LOCATION	Chinese	prep_among	18	SENT_275	[p19l9t2103r316b2171],
22	in	IN	O	in	_	0	SENT_275	[p19l359t2103r431b2169],
23	Taiwan	NNP	LOCATION	Taiwan	prep_in	21	SENT_275	[p19l472t2082r850b2171],
24	.49	CD	NUMBER	.49	num	23	SENT_275	[p19l472t2082r850b2171],
25	The	DT	O	the	det	26	SENT_275	[p19l891t2102r1039b2169],
26	presence	NN	O	presence	nsubj	31	SENT_275	[p19l1080t2124r1417b2189],
27	of	IN	O	of	_	0	SENT_275	[p19l1460t2102r1543b2169],
28	this	DT	O	this	det	29	SENT_275	[p19l1577t2102r1713b2169],
29	allele	NN	O	allele	prep_of	26	SENT_275	[p19l1758t2102r1964b2169],
30	was	VBD	O	be	cop	31	SENT_275	[p19l2005t2124r2150b2170],
31	predictive	JJ	O	predictive	rcmod	5	SENT_275	[p19l6t2218r392b2305],
32	in	IN	O	in	_	0	SENT_275	[p19l409t2218r483b2284],
33	93.6	CD	PERCENT	93.6	num	34	SENT_275	[p19l502t2218r744b2286],
34	%	NN	PERCENT	%	prep_in	31	SENT_275	[p19l502t2218r744b2286],
35	of	IN	O	of	_	0	SENT_275	[p19l768t2218r851b2285],
36	cases	NNS	O	case	prep_of	34	SENT_275	[p19l863t2240r1085b2298],
37	,	,	O	,	_	0	SENT_275	[p19l863t2240r1085b2298],
38	while	IN	O	while	mark	41	SENT_275	[p19l1107t2218r1319b2286],
39	its	PRP$	O	its	poss	40	SENT_275	[p19l1338t2218r1425b2285],
40	absence	NN	O	absence	nsubj	41	SENT_275	[p19l1447t2218r1750b2285],
41	had	VBD	O	have	advcl	31	SENT_275	[p19l1768t2218r1907b2285],
42	a	DT	O	a	det	46	SENT_275	[p19l1927t2240r1967b2285],
43	negative	JJ	O	negative	amod	46	SENT_275	[p19l1983t2240r2150b2305, p19l9t2333r610b2420],
44	—	NN	O	—	nn	46	SENT_275	[p19l1983t2240r2150b2305, p19l9t2333r610b2420],
45	predictive	JJ	O	predictive	amod	46	SENT_275	[p19l1983t2240r2150b2305, p19l9t2333r610b2420],
46	value	NN	O	value	dobj	41	SENT_275	[p19l678t2333r883b2400],
47	of	IN	O	of	_	0	SENT_275	[p19l954t2333r1037b2400],
48	lOO	JJ	PERCENT	loo	amod	52	SENT_275	[p19l1109t2312r1419b2400],
49	%	NN	PERCENT	%	nn	52	SENT_275	[p19l1109t2312r1419b2400],
50	.49	CD	NUMBER	.49	num	52	SENT_275	[p19l1109t2312r1419b2400],
51	Similar	JJ	O	similar	amod	52	SENT_275	[p19l1492t2333r1775b2400],
52	ﬁndings	NNS	O	ﬁndings	prep_of	46	SENT_275	[p19l1844t2333r2150b2420],
53	emerged	VBD	O	emerge	_	0	SENT_275	[p19l8t2448r340b2535],
54	from	IN	O	from	_	0	SENT_275	[p19l381t2448r568b2515],
55	other	JJ	O	other	amod	58	SENT_275	[p19l609t2448r807b2515],
56	Han	NNP	O	Han	nn	58	SENT_275	[p19l847t2450r1006b2515],
57	Chinese	NNP	MISC	Chinese	nn	58	SENT_275	[p19l1048t2448r1356b2515],
58	populations	NNS	O	population	prep_from	53	SENT_275	[p19l1398t2427r2038b2535],
59	.68	CD	NUMBER	.68	number	60	SENT_275	[p19l1398t2427r2038b2535],
60	’71	CD	NUMBER	’71	num	63	SENT_275	[p19l1398t2427r2038b2535],
61	A	DT	O	a	det	63	SENT_275	[p19l2084t2449r2152b2514],
62	signiﬁcant	JJ	O	signiﬁcant	amod	63	SENT_275	[p19l11t2563r411b2650],
63	association	NN	O	association	dobj	53	SENT_275	[p19l480t2563r908b2630],
64	between	IN	O	between	_	0	SENT_275	[p19l975t2563r1298b2630],
65	CBZ-SJS/TEN	NN	O	cbz-sjs/ten	prep_between	63	SENT_275	[p19l1368t2563r1945b2630],
66	and	CC	O	and	_	0	SENT_275	[p19l2016t2563r2152b2630],
67	HLA-B	NN	O	hla-b	prep_between	63	SENT_275	[p19l8t2678r542b2746],
68	*	CD	NUMBER	*	num	69	SENT_275	[p19l8t2678r542b2746],
69	l502	NN	O	l502	nsubjpass	72	SENT_275	[p19l8t2678r542b2746],
70	was	VBD	O	be	auxpass	72	SENT_275	[p19l595t2700r740b2746],
71	also	RB	O	also	advmod	72	SENT_275	[p19l796t2678r946b2745],
72	found	VBN	O	find	rcmod	63	SENT_275	[p19l1000t2678r1224b2745],
73	in	IN	O	in	_	0	SENT_275	[p19l1275t2678r1348b2744],
74	Thai	NNP	MISC	Thai	prep_in	72	SENT_275	[p19l1400t2658r1760b2758],
75	,72	CD	NUMBER	,72	num	74	SENT_275	[p19l1400t2658r1760b2758],
76	’73	CD	NUMBER	’73	num	77	SENT_275	[p19l1400t2658r1760b2758],
77	Malay	NNP	MISC	Malay	dobj	72	SENT_275	[p19l1815t2658r2152b2765],
78	,74	CD	NUMBER	,74	num	77	SENT_275	[p19l1815t2658r2152b2765],
79	and	CC	O	and	_	0	SENT_275	[p19l9t2821r166b2900],
80	,	,	O	,	_	0	SENT_275	[p19l9t2821r166b2900],
81	to	TO	O	to	dep	77	SENT_275	[p19l196t2831r267b2888],
82	a	DT	O	a	det	84	SENT_275	[p19l297t2842r337b2888],
83	lesser	JJR	O	lesser	amod	84	SENT_275	[p19l363t2821r583b2888],
84	degree	NN	O	degree	pobj	81	SENT_275	[p19l609t2821r883b2908],
85	,	,	O	,	_	0	SENT_275	[p19l609t2821r883b2908],
86	Indian	JJ	MISC	indian	amod	87	SENT_275	[p19l915t2821r1160b2888],
87	patients	NNS	O	patient	appos	84	SENT_275	[p19l1185t2800r1580b2908],
88	.75	CD	NUMBER	.75	dep	87	SENT_275	[p19l1185t2800r1580b2908],
89	In	IN	O	in	dep	81	SENT_275	[p19l1610t2823r1688b2887],
90	a	DT	O	a	det	92	SENT_275	[p19l1717t2842r1757b2888],
91	European	JJ	MISC	european	amod	92	SENT_275	[p19l1781t2823r2152b2908],
92	study	NN	O	study	pobj	89	SENT_275	[p19l11t2936r229b3024],
93	,	,	O	,	_	0	SENT_275	[p19l11t2936r229b3024],
94	the	DT	O	the	det	96	SENT_275	[p19l252t2936r368b3004],
95	only	JJ	O	only	amod	96	SENT_275	[p19l390t2936r557b3024],
96	HLA	NN	O	hlum	conj_and	77	SENT_275	[p19l578t2936r914b3003],
97	.	.	O	.	_	0	SENT_275	[p19l578t2936r914b3003],

1	—	NN	O	—	_	0	SENT_276	[p19l578t2936r914b3003],
2	.	.	O	.	_	0	SENT_276	[p19l578t2936r914b3003],

1	B	NN	O	b	_	0	SENT_277	[p19l578t2936r914b3003],
2	*	CD	NUMBER	*	num	1	SENT_277	[p19l578t2936r914b3003],
3	15	CD	NUMBER	15	number	4	SENT_277	[p19l930t2935r1010b3004],
4	O2	CD	NUMBER	o2	dep	1	SENT_277	[p19l1019t2936r1450b3024],
5	—	NN	O	—	nn	7	SENT_277	[p19l1019t2936r1450b3024],
6	positive	JJ	O	positive	amod	7	SENT_277	[p19l1019t2936r1450b3024],
7	CBZ	NN	O	cbz	dep	4	SENT_277	[p19l1470t2936r1779b3004],
8	.	.	O	.	_	0	SENT_277	[p19l1470t2936r1779b3004],

1	—	NN	O	—	_	0	SENT_278	[p19l1470t2936r1779b3004],
2	.	.	O	.	_	0	SENT_278	[p19l1470t2936r1779b3004],

1	SJ	NN	O	sj	nn	3	SENT_279	[p19l1470t2936r1779b3004],
2	S	NN	O	s	nn	3	SENT_279	[p19l1784t2936r1828b3004],
3	patients	NNS	O	patient	nsubj	9	SENT_279	[p19l1851t2936r2149b3024],
4	were	VBD	O	be	cop	9	SENT_279	[p19l8t3073r192b3120],
5	of	IN	O	of	_	0	SENT_279	[p19l218t3052r302b3119],
6	East	JJ	MISC	east	amod	8	SENT_279	[p19l319t3053r485b3119],
7	Asian	JJ	MISC	asian	amod	8	SENT_279	[p19l508t3052r731b3119],
8	descent	NN	O	descent	prep_of	9	SENT_279	[p19l756t3030r1140b3119],
9	.76	CD	NUMBER	.76	_	0	SENT_279	[p19l756t3030r1140b3119],
10	No	DT	O	no	det	11	SENT_279	[p19l1164t3053r1278b3119],
11	association	NN	O	association	nsubjpass	13	SENT_279	[p19l1306t3051r1733b3119],
12	was	VBD	O	be	auxpass	13	SENT_279	[p19l1758t3073r1903b3119],
13	found	VBN	O	find	rcmod	9	SENT_279	[p19l1929t3051r2152b3119],
14	in	IN	O	in	_	0	SENT_279	[p19l7t3168r81b3234],
15	Japanese	JJ	MISC	japanese	prep_in	13	SENT_279	[p19l121t3170r484b3255],
16	,	,	O	,	_	0	SENT_279	[p19l121t3170r484b3255],
17	Korean	JJ	MISC	korean	prep_in	13	SENT_279	[p19l530t3170r830b3248],
18	,	,	O	,	_	0	SENT_279	[p19l530t3170r830b3248],
19	or	CC	O	or	_	0	SENT_279	[p19l875t3190r954b3235],
20	Caucasian	JJ	MISC	caucasian	amod	21	SENT_279	[p19l994t3168r1390b3236],
21	individuals	NNS	O	individual	prep_in	13	SENT_279	[p19l1431t3168r1877b3235],
22	.	.	O	.	_	0	SENT_279	[p19l1431t3168r1877b3235],

1	HLAA	NN	O	hlaa	nn	3	SENT_280	[p19l1924t3169r2149b3234, p19l7t3283r308b3350],
2	*	CD	NUMBER	*	num	1	SENT_280	[p19l1924t3169r2149b3234, p19l7t3283r308b3350],
3	3l01	NN	O	3l01	nsubjpass	6	SENT_280	[p19l1924t3169r2149b3234, p19l7t3283r308b3350],
4	was	VBD	O	be	auxpass	6	SENT_280	[p19l393t3304r538b3350],
5	recently	RB	DATE	recently	advmod	6	SENT_280	[p19l615t3283r926b3370],
6	associated	VBN	O	associate	_	0	SENT_280	[p19l1005t3283r1400b3350],
7	with	IN	O	with	_	0	SENT_280	[p19l1476t3283r1646b3350],
8	CBZ-HSR	NN	O	cbz-hsr	prep_with	6	SENT_280	[p19l1723t3283r2148b3362],
9	,	,	O	,	_	0	SENT_280	[p19l1723t3283r2148b3362],

1	CBZ	NNP	O	CBZ	_	0	SENT_281	[p20l9t21r806b108],
2	—	CD	NUMBER	—	num	1	SENT_281	[p20l9t21r806b108],
3	maculopapular	JJ	O	maculopapular	amod	4	SENT_281	[p20l9t21r806b108],
4	exanthema	NN	O	exanthema	dep	1	SENT_281	[p20l834t21r1272b100],
5	,	,	O	,	_	0	SENT_281	[p20l834t21r1272b100],
6	and	CC	O	and	_	0	SENT_281	[p20l1307t21r1443b88],
7	CBZ-SJS/TEN	NN	O	cbz-sjs/ten	conj_and	4	SENT_281	[p20l1472t21r2050b89],
8	in	IN	O	in	_	0	SENT_281	[p20l2079t21r2152b87],
9	North	JJ	MISC	north	amod	11	SENT_281	[p20l7t137r231b204],
10	European	JJ	MISC	european	amod	11	SENT_281	[p20l273t138r643b224],
11	Caucasians	NNPS	MISC	Caucasians	prep_in	7	SENT_281	[p20l686t117r1214b216],
12	,77	CD	NUMBER	,77	dep	1	SENT_281	[p20l686t117r1214b216],
13	while	IN	O	while	_	0	SENT_281	[p20l1258t137r1469b204],
14	HLA	NN	O	hlum	prep_while	12	SENT_281	[p20l1513t136r2039b204],
15	.	.	O	.	_	0	SENT_281	[p20l1513t136r2039b204],

1	—	NN	O	—	_	0	SENT_282	[p20l1513t136r2039b204],
2	.	.	O	.	_	0	SENT_282	[p20l1513t136r2039b204],

1	B	NN	O	b	nsubjpass	5	SENT_283	[p20l1513t136r2039b204],
2	*	CD	NUMBER	*	num	3	SENT_283	[p20l1513t136r2039b204],
3	1511	CD	DATE	1511	dep	1	SENT_283	[p20l1513t136r2039b204],
4	is	VBZ	O	be	auxpass	5	SENT_283	[p20l2090t137r2150b204],
5	associated	VBN	O	associate	_	0	SENT_283	[p20l10t252r405b319],
6	with	IN	O	with	_	0	SENT_283	[p20l461t252r631b320],
7	CBZ-SJS/TEN	NN	O	cbz-sjs/ten	prep_with	5	SENT_283	[p20l687t232r1360b332],
8	,78	CD	NUMBER	,78	num	7	SENT_283	[p20l687t232r1360b332],
9	and	CC	O	and	_	0	SENT_283	[p20l1420t252r1556b319],
10	HLA-A	NN	O	hla-a	prep_with	5	SENT_283	[p20l1611t253r2143b320],
11	*	CD	NUMBER	*	number	12	SENT_283	[p20l1611t253r2143b320],
12	3101	CD	NUMBER	3101	dep	10	SENT_283	[p20l1611t253r2143b320],
13	with	IN	O	with	_	0	SENT_283	[p20l8t368r178b435],
14	CBZ-cutaneous	JJ	O	cbz-cutaneous	amod	15	SENT_283	[p20l207t369r810b436],
15	ADRS	NNS	O	adr	prep_with	5	SENT_283	[p20l842t369r1079b435],
16	in	IN	O	in	_	0	SENT_283	[p20l1109t368r1183b434],
17	J	NNP	O	J	nn	19	SENT_283	[p20l1211t370r1246b436],
18	apanese	JJ	O	apanese	amod	19	SENT_283	[p20l1250t347r1649b455],
19	.79	NNS	NUMBER	.79	prep_in	15	SENT_283	[p20l1250t347r1649b455],

1	HLA	NN	O	hlum	_	0	SENT_284	[p20l95t482r638b551],
2	.	.	O	.	_	0	SENT_284	[p20l95t482r638b551],

1	—	NN	O	—	_	0	SENT_285	[p20l95t482r638b551],
2	.	.	O	.	_	0	SENT_285	[p20l95t482r638b551],

1	B	NN	O	b	nsubj	9	SENT_286	[p20l95t482r638b551],
2	*	CD	NUMBER	*	number	3	SENT_286	[p20l95t482r638b551],
3	1502	CD	DATE	1502	nsubjpass	5	SENT_286	[p20l95t482r638b551],
4	was	VBD	O	be	auxpass	5	SENT_286	[p20l701t504r849b551],
5	associated	VBN	O	associate	rcmod	1	SENT_286	[p20l916t483r1320b551],
6	with	IN	O	with	_	0	SENT_286	[p20l1382t483r1554b551],
7	CBZ	NN	O	cbz	nn	8	SENT_286	[p20l1617t483r2153b551],
8	—	NN	O	—	prep_with	5	SENT_286	[p20l1617t483r2153b551],
9	induced	VBD	O	induce	_	0	SENT_286	[p20l1617t483r2153b551],

1	SJ	NN	O	sj	nn	2	SENT_287	[p20l10t600r97b667],
2	S/TEN	NN	O	s/ten	nsubj	9	SENT_287	[p20l103t600r393b679],
3	,	,	O	,	_	0	SENT_287	[p20l103t600r393b679],
4	but	CC	O	but	dep	5	SENT_287	[p20l445t599r570b666],
5	not	RB	O	not	dep	2	SENT_287	[p20l618t610r743b666],
6	with	IN	O	with	dep	5	SENT_287	[p20l792t599r966b667],
7	CBZ	NN	O	cbz	nn	8	SENT_287	[p20l1016t599r1552b667],
8	—	NN	O	—	pobj	6	SENT_287	[p20l1016t599r1552b667],
9	induced	VBD	O	induce	_	0	SENT_287	[p20l1016t599r1552b667],
10	mild	JJ	O	mild	amod	12	SENT_287	[p20l1601t599r1781b666],
11	maculopapular	JJ	O	maculopapular	amod	12	SENT_287	[p20l1830t599r2150b666, p20l7t715r304b802],
12	eruptions	NNS	O	eruption	dobj	9	SENT_287	[p20l356t715r719b802],
13	in	IN	O	in	_	0	SENT_287	[p20l774t715r848b781],
14	central	JJ	O	central	amod	15	SENT_287	[p20l902t715r1169b782],
15	China	NNP	LOCATION	China	prep_in	12	SENT_287	[p20l1223t695r1555b782],
16	.80	CD	NUMBER	.80	num	17	SENT_287	[p20l1223t695r1555b782],
17	HLA-B	NN	O	hla-b	tmod	9	SENT_287	[p20l1608t714r2151b782],
18	*	CD	NUMBER	*	number	19	SENT_287	[p20l1608t714r2151b782],
19	1502	CD	DATE	1502	nsubj	23	SENT_287	[p20l1608t714r2151b782],
20	was	VBD	O	be	cop	23	SENT_287	[p20l8t851r155b898],
21	a	DT	O	a	det	23	SENT_287	[p20l202t851r241b898],
22	risk	NN	O	risk	nn	23	SENT_287	[p20l282t830r430b898],
23	factor	NN	O	factor	rcmod	17	SENT_287	[p20l471t830r702b898],
24	for	IN	O	for	_	0	SENT_287	[p20l743t830r857b898],
25	oX	NN	O	ox	prep_for	23	SENT_287	[p20l899t830r1567b898],
26	.	.	O	.	_	0	SENT_287	[p20l899t830r1567b898],

1	—	NN	O	—	_	0	SENT_288	[p20l899t830r1567b898],
2	.	.	O	.	_	0	SENT_288	[p20l899t830r1567b898],

1	CBZ	NNP	O	CBZ	_	0	SENT_289	[p20l899t830r1567b898],
2	.	.	O	.	_	0	SENT_289	[p20l899t830r1567b898],

1	—	NN	O	—	_	0	SENT_290	[p20l899t830r1567b898],
2	.	.	O	.	_	0	SENT_290	[p20l899t830r1567b898],

1	induced	VBN	O	induce	_	0	SENT_291	[p20l899t830r1567b898],
2	mild	JJ	O	mild	amod	4	SENT_291	[p20l1608t830r1788b898],
3	maculo	NN	O	maculo	nn	4	SENT_291	[p20l1830t830r2149b898],
4	—	NN	O	—	nsubj	6	SENT_291	[p20l1830t830r2149b898],
5	papular	JJ	O	papular	amod	6	SENT_291	[p20l7t946r305b1033],
6	eruptions	NNS	O	eruption	xcomp	1	SENT_291	[p20l361t925r820b1033],
7	,81	CD	NUMBER	,81	num	8	SENT_291	[p20l361t925r820b1033],
8	oX	NN	O	ox	dep	6	SENT_291	[p20l884t946r1234b1013],
9	.	.	O	.	_	0	SENT_291	[p20l884t946r1234b1013],

1	—	NN	O	—	_	0	SENT_292	[p20l884t946r1234b1013],
2	.	.	O	.	_	0	SENT_292	[p20l884t946r1234b1013],

1	CBZ	NNP	O	CBZ	nn	4	SENT_293	[p20l884t946r1234b1013],
2	SJ	NNP	O	SJ	nn	4	SENT_293	[p20l1297t946r1383b1013],
3	S/T	NNP	O	S/T	nn	4	SENT_293	[p20l1390t946r1526b1013],
4	EN	NNP	O	EN	_	0	SENT_293	[p20l1530t948r1679b1025],
5	,	,	O	,	_	0	SENT_293	[p20l1530t948r1679b1025],
6	and	CC	O	and	dep	4	SENT_293	[p20l1742t946r1880b1013],
7	PHYSJ	NN	O	physj	nn	8	SENT_293	[p20l1936t948r2149b1012, p20l10t1061r97b1129],
8	S/TEN	NN	O	s/ten	dep	4	SENT_293	[p20l103t1040r468b1129],
9	.68	CD	NUMBER	.68	num	10	SENT_293	[p20l103t1040r468b1129],
10	PHY	NN	O	phy	dep	8	SENT_293	[p20l527t1061r934b1129],
11	.	.	O	.	_	0	SENT_293	[p20l527t1061r934b1129],

1	—	NN	O	—	_	0	SENT_294	[p20l527t1061r934b1129],
2	.	.	O	.	_	0	SENT_294	[p20l527t1061r934b1129],

1	HSR	NN	O	hsr	nsubjpass	4	SENT_295	[p20l527t1061r934b1129],
2	was	VBD	O	be	auxpass	4	SENT_295	[p20l990t1082r1137b1129],
3	further	RB	O	further	advmod	4	SENT_295	[p20l1195t1061r1465b1129],
4	associated	VBN	O	associate	_	0	SENT_295	[p20l1520t1061r1925b1129],
5	with	IN	O	with	prep	4	SENT_295	[p20l1980t1061r2153b1129],

1	HLA	NN	O	hlum	_	0	SENT_296	[p20l8t1178r573b1257],
2	.	.	O	.	_	0	SENT_296	[p20l8t1178r573b1257],

1	—	NN	O	—	_	0	SENT_297	[p20l8t1178r573b1257],
2	.	.	O	.	_	0	SENT_297	[p20l8t1178r573b1257],

1	B	NN	O	b	_	0	SENT_298	[p20l8t1178r573b1257],
2	*	CD	NUMBER	*	number	3	SENT_298	[p20l8t1178r573b1257],
3	1301	CD	DATE	1301	dep	1	SENT_298	[p20l8t1178r573b1257],
4	,	,	O	,	_	0	SENT_298	[p20l8t1178r573b1257],
5	Cw	NN	O	cw	appos	1	SENT_298	[p20l635t1178r1035b1257],
6	*	CD	NUMBER	*	number	7	SENT_298	[p20l635t1178r1035b1257],
7	0801	CD	DATE	0801	dep	5	SENT_298	[p20l635t1178r1035b1257],
8	,	,	O	,	_	0	SENT_298	[p20l635t1178r1035b1257],
9	and	CC	O	and	_	0	SENT_298	[p20l1097t1177r1234b1244],
10	HLA	NN	O	hlum	conj_and	5	SENT_298	[p20l1291t1177r2019b1245],
11	.	.	O	.	_	0	SENT_298	[p20l1291t1177r2019b1245],

1	—	NN	O	—	_	0	SENT_299	[p20l1291t1177r2019b1245],
2	.	.	O	.	_	0	SENT_299	[p20l1291t1177r2019b1245],

1	DRB1	NN	O	drb1	_	0	SENT_300	[p20l1291t1177r2019b1245],
2	*	CD	NUMBER	*	number	3	SENT_300	[p20l1291t1177r2019b1245],
3	1602	CD	DATE	1602	dep	1	SENT_300	[p20l1291t1177r2019b1245],
4	in	IN	O	in	_	0	SENT_300	[p20l2077t1177r2152b1243],
5	a	DT	O	a	det	7	SENT_300	[p20l10t1314r49b1359],
6	Chinese	JJ	LOCATION	chinese	amod	7	SENT_300	[p20l86t1292r400b1360],
7	population	NN	O	population	prep_in	3	SENT_300	[p20l437t1271r956b1379],
8	.68	CD	NUMBER	.68	dep	1	SENT_300	[p20l437t1271r956b1379],

1	The	DT	O	the	det	3	SENT_301	[p20l95t1407r242b1474],
2	high	JJ	O	high	amod	3	SENT_301	[p20l266t1407r437b1494],
3	incidence	NN	O	incidence	_	0	SENT_301	[p20l460t1407r830b1474],
4	of	IN	O	of	_	0	SENT_301	[p20l855t1407r938b1474],
5	HLA	NN	O	hlum	prep_of	3	SENT_301	[p20l956t1407r1291b1473],
6	.	.	O	.	_	0	SENT_301	[p20l956t1407r1291b1473],

1	—	NN	O	—	_	0	SENT_302	[p20l956t1407r1291b1473],
2	.	.	O	.	_	0	SENT_302	[p20l956t1407r1291b1473],

1	B	NN	O	b	nsubj	43	SENT_303	[p20l956t1407r1291b1473],
2	*	CD	NUMBER	*	number	3	SENT_303	[p20l956t1407r1291b1473],
3	1502	CD	DATE	1502	nsubj	7	SENT_303	[p20l1308t1407r1490b1474],
4	among	IN	O	among	_	0	SENT_303	[p20l1517t1428r1775b1494],
5	Asian	JJ	MISC	asian	amod	6	SENT_303	[p20l1800t1407r2023b1474],
6	individuals	NNS	O	individual	prep_among	3	SENT_303	[p20l2047t1407r2149b1473, p20l9t1521r357b1590],
7	(	VBP	O	(	rcmod	1	SENT_303	[p20l384t1522r584b1605],
8	10	CD	PERCENT	10	number	12	SENT_303	[p20l384t1522r584b1605],
9	%	NN	PERCENT	%	dep	12	SENT_303	[p20l384t1522r584b1605],
10	to	TO	O	to	dep	12	SENT_303	[p20l611t1532r683b1589],
11	15	CD	PERCENT	15	number	12	SENT_303	[p20l715t1521r910b1605],
12	%	NN	PERCENT	%	num	13	SENT_303	[p20l715t1521r910b1605],
13	)	CD	NUMBER	)	dobj	7	SENT_303	[p20l715t1521r910b1605],
14	correlates	VBZ	O	correlate	dep	13	SENT_303	[p20l937t1522r1309b1589],
15	with	IN	O	with	_	0	SENT_303	[p20l1334t1522r1504b1590],
16	a	DT	O	a	det	18	SENT_303	[p20l1528t1543r1568b1589],
17	high	JJ	O	high	amod	18	SENT_303	[p20l1588t1522r1758b1610],
18	incidence	NN	O	incidence	prep_with	14	SENT_303	[p20l1781t1522r2151b1589],
19	of	IN	O	of	_	0	SENT_303	[p20l9t1638r92b1705],
20	SJS/TEN	NNP	O	SJS/TEN	prep_of	18	SENT_303	[p20l109t1639r464b1706],
21	in	IN	O	in	_	0	SENT_303	[p20l484t1638r557b1704],
22	this	DT	O	this	det	23	SENT_303	[p20l578t1638r713b1705],
23	population	NN	O	population	prep_in	20	SENT_303	[p20l734t1638r1149b1725],
24	(	CD	NUMBER	(	num	25	SENT_303	[p20l1172t1638r1436b1721],
25	17-25	CD	NUMBER	17-25	dobj	14	SENT_303	[p20l1172t1638r1436b1721],
26	in	IN	O	in	_	0	SENT_303	[p20l1462t1638r1536b1704],
27	every	DT	O	every	det	29	SENT_303	[p20l1556t1660r1765b1725],
28	10000	CD	NUMBER	10000	num	29	SENT_303	[p20l1795t1639r2025b1706],
29	individuals	NNS	O	individual	prep_in	25	SENT_303	[p20l2047t1638r2149b1704, p20l9t1753r357b1820],
30	in	IN	O	in	_	0	SENT_303	[p20l396t1753r470b1819],
31	Taiwan	NNP	LOCATION	Taiwan	prep_in	14	SENT_303	[p20l506t1753r788b1820],
32	and	CC	O	and	_	0	SENT_303	[p20l827t1753r964b1820],
33	Thailand	NNP	LOCATION	Thailand	conj_and	31	SENT_303	[p20l1001t1753r1397b1836],
34	)	CD	NUMBER	)	num	33	SENT_303	[p20l1001t1753r1397b1836],
35	,	,	O	,	_	0	SENT_303	[p20l1001t1753r1397b1836],
36	compared	VBN	O	compare	_	0	SENT_303	[p20l1438t1753r1819b1840],
37	with	IN	O	with	prepc_compared_with	14	SENT_303	[p20l1856t1753r2025b1820],
38	its	PRP$	O	its	poss	40	SENT_303	[p20l2062t1753r2150b1820],
39	low	JJ	O	low	amod	40	SENT_303	[p20l8t1868r147b1935],
40	incidence	NN	O	incidence	pobj	14	SENT_303	[p20l174t1868r544b1935],
41	among	IN	O	among	_	0	SENT_303	[p20l573t1890r831b1955],
42	Caucasians	NNPS	MISC	Caucasians	prep_among	40	SENT_303	[p20l860t1868r1291b1936],
43	(	VBP	O	(	_	0	SENT_303	[p20l1323t1869r1708b1951],
44	1	CD	PERCENT	1	num	45	SENT_303	[p20l1323t1869r1708b1951],
45	%	NN	PERCENT	%	dobj	43	SENT_303	[p20l1323t1869r1708b1951],
46	.	.	O	.	_	0	SENT_303	[p20l1323t1869r1708b1951],

1	—	NN	O	—	_	0	SENT_304	[p20l1323t1869r1708b1951],
2	.	.	O	.	_	0	SENT_304	[p20l1323t1869r1708b1951],

1	2	CD	PERCENT	2	num	2	SENT_305	[p20l1323t1869r1708b1951],
2	%	NN	PERCENT	%	nsubj	20	SENT_305	[p20l1323t1869r1708b1951],
3	)	CD	NUMBER	)	tmod	2	SENT_305	[p20l1323t1869r1708b1951],
4	,	,	O	,	_	0	SENT_305	[p20l1323t1869r1708b1951],
5	which	WDT	O	which	nsubj	6	SENT_305	[p20l1739t1868r1973b1936],
6	correlates	VBZ	O	correlate	rcmod	3	SENT_305	[p20l2000t1890r2149b1935, p20l7t1983r257b2050],
7	with	IN	O	with	_	0	SENT_305	[p20l293t1983r462b2050],
8	a	DT	O	a	det	10	SENT_305	[p20l497t2004r537b2050],
9	low	JJ	O	low	amod	10	SENT_305	[p20l570t1983r710b2050],
10	incidence	NN	O	incidence	prep_with	6	SENT_305	[p20l743t1983r1112b2050],
11	in	IN	O	in	_	0	SENT_305	[p20l1148t1983r1220b2049],
12	this	DT	O	this	det	13	SENT_305	[p20l1253t1983r1389b2050],
13	population	NN	O	population	prep_in	10	SENT_305	[p20l1423t1983r1837b2070],
14	(	CD	NUMBER	(	number	15	SENT_305	[p20l1873t1983r2044b2066],
15	1-6	CD	NUMBER	1-6	num	13	SENT_305	[p20l1873t1983r2044b2066],
16	in	IN	O	in	_	0	SENT_305	[p20l2078t1983r2152b2049],
17	every	DT	O	every	det	19	SENT_305	[p20l8t2120r218b2187],
18	10000	CD	NUMBER	10000	num	19	SENT_305	[p20l256t2099r486b2167],
19	individuals	NNS	O	individual	prep_in	6	SENT_305	[p20l517t2077r1254b2182],
20	)	VBP	O	)	_	0	SENT_305	[p20l517t2077r1254b2182],
21	.49	CD	NUMBER	.49	number	22	SENT_305	[p20l517t2077r1254b2182],
22	’	CD	NUMBER	’	dobj	20	SENT_305	[p20l517t2077r1254b2182],
23	50	CD	NUMBER	50	num	24	SENT_305	[p20l517t2077r1254b2182],
24	’82	CD	NUMBER	’82	dep	22	SENT_305	[p20l517t2077r1254b2182],

1	No	DT	O	no	det	2	SENT_306	[p20l94t2217r209b2283],
2	association	NN	O	association	nsubjpass	4	SENT_306	[p20l262t2215r689b2283],
3	was	VBD	O	be	auxpass	4	SENT_306	[p20l740t2237r885b2283],
4	found	VBN	O	find	_	0	SENT_306	[p20l937t2215r1161b2283],
5	between	IN	O	between	_	0	SENT_306	[p20l1209t2215r1531b2283],
6	LTG	NN	O	ltg	prep_between	4	SENT_306	[p20l1581t2216r2151b2283],
7	.	.	O	.	_	0	SENT_306	[p20l1581t2216r2151b2283],

1	—	NN	O	—	_	0	SENT_307	[p20l1581t2216r2151b2283],
2	.	.	O	.	_	0	SENT_307	[p20l1581t2216r2151b2283],

1	SJS/TEN	NN	O	sjs/ten	_	0	SENT_308	[p20l1581t2216r2151b2283],
2	and	CC	O	and	_	0	SENT_308	[p20l10t2332r146b2399],
3	HLA	NN	O	hlum	conj_and	1	SENT_308	[p20l174t2331r708b2399],
4	.	.	O	.	_	0	SENT_308	[p20l174t2331r708b2399],

1	—	NN	O	—	_	0	SENT_309	[p20l174t2331r708b2399],
2	.	.	O	.	_	0	SENT_309	[p20l174t2331r708b2399],

1	B	NN	O	b	nsubj	15	SENT_310	[p20l174t2331r708b2399],
2	*	CD	NUMBER	*	number	3	SENT_310	[p20l174t2331r708b2399],
3	1502	CD	DATE	1502	dep	1	SENT_310	[p20l174t2331r708b2399],
4	in	IN	O	in	_	0	SENT_310	[p20l737t2332r810b2398],
5	Chinese68	NN	O	chinese68	prep_in	3	SENT_310	[p20l840t2311r1219b2399],
6	or	CC	O	or	_	0	SENT_310	[p20l1251t2353r1330b2399],
7	European	JJ	MISC	european	amod	8	SENT_310	[p20l1356t2333r1726b2419],
8	patients	NNS	O	patient	conj_or	1	SENT_310	[p20l1754t2311r2150b2419],
9	.58	CD	NUMBER	.58	dep	8	SENT_310	[p20l1754t2311r2150b2419],
10	In	IN	O	in	_	0	SENT_310	[p20l7t2449r86b2514],
11	our	PRP$	O	we	poss	12	SENT_310	[p20l123t2469r250b2514],
12	study	NN	O	study	prep_in	15	SENT_310	[p20l288t2447r507b2534],
13	,	,	O	,	_	0	SENT_310	[p20l288t2447r507b2534],
14	we	PRP	O	we	nsubj	15	SENT_310	[p20l547t2469r656b2515],
15	observed	VBD	O	observe	_	0	SENT_310	[p20l694t2447r1042b2515],
16	that	IN	O	that	complm	23	SENT_310	[p20l1076t2447r1221b2514],
17	negative	JJ	O	negative	amod	18	SENT_310	[p20l1257t2447r1580b2534],
18	HLA-B	NN	O	hla-b	nsubj	23	SENT_310	[p20l1617t2447r2150b2515],
19	*	CD	NUMBER	*	num	20	SENT_310	[p20l1617t2447r2150b2515],
20	1502	CD	DATE	1502	dep	18	SENT_310	[p20l1617t2447r2150b2515],
21	does	VBZ	O	do	aux	23	SENT_310	[p20l8t2562r180b2629],
22	not	RB	O	not	neg	23	SENT_310	[p20l213t2572r336b2629],
23	predict	VB	O	predict	ccomp	15	SENT_310	[p20l365t2562r634b2649],
24	negative	JJ	O	negative	amod	25	SENT_310	[p20l665t2562r988b2649],
25	LTG-HSR	NN	O	ltg-hsr	dobj	23	SENT_310	[p20l1018t2563r1436b2630],
26	.	.	O	.	_	0	SENT_310	[p20l1018t2563r1436b2630],

1	We	PRP	O	we	nsubj	2	SENT_311	[p20l1471t2564r1597b2629],
2	conclude	VBP	O	conclude	_	0	SENT_311	[p20l1629t2562r1976b2629],
3	that	IN	O	that	_	0	SENT_311	[p20l2008t2562r2153b2629],
4	HLA	NN	O	hlum	prep_that	2	SENT_311	[p20l8t2677r901b2764],
5	.	.	O	.	_	0	SENT_311	[p20l8t2677r901b2764],

1	—	NN	O	—	_	0	SENT_312	[p20l8t2677r901b2764],
2	.	.	O	.	_	0	SENT_312	[p20l8t2677r901b2764],

1	B	NN	O	b	nsubj	7	SENT_313	[p20l8t2677r901b2764],
2	*	CD	NUMBER	*	num	4	SENT_313	[p20l8t2677r901b2764],
3	1502-negative	JJ	O	1502-negative	amod	4	SENT_313	[p20l8t2677r901b2764],
4	status	NN	O	status	dep	1	SENT_313	[p20l943t2687r1156b2744],
5	is	VBZ	O	be	cop	7	SENT_313	[p20l1196t2677r1256b2744],
6	not	RB	O	not	neg	7	SENT_313	[p20l1297t2687r1419b2744],
7	protective	JJ	O	protective	_	0	SENT_313	[p20l1455t2677r1840b2764],
8	against	IN	O	against	_	0	SENT_313	[p20l1881t2677r2152b2764],
9	LTG-HSR	NN	O	ltg-hsr	prep_against	7	SENT_313	[p20l7t2793r424b2860],
10	.	.	O	.	_	0	SENT_313	[p20l7t2793r424b2860],

1	For	IN	O	for	_	0	SENT_314	[p20l453t2794r585b2859],
2	HLA-B	NN	O	hla-b	nsubj	6	SENT_314	[p20l607t2792r1501b2879],
3	*	CD	NUMBER	*	num	5	SENT_314	[p20l607t2792r1501b2879],
4	1502-negative	JJ	O	1502-negative	amod	5	SENT_314	[p20l607t2792r1501b2879],
5	patients	NNS	O	patient	dep	2	SENT_314	[p20l1523t2792r1822b2879],
6	wishing	VBG	O	wish	prepc_for	15	SENT_314	[p20l1848t2792r2151b2879],
7	to	TO	O	to	aux	8	SENT_314	[p20l7t2917r79b2974],
8	take	VB	O	take	xcomp	6	SENT_314	[p20l112t2907r271b2974],
9	LTG	NN	O	ltg	dobj	8	SENT_314	[p20l303t2907r502b2986],
10	,	,	O	,	_	0	SENT_314	[p20l303t2907r502b2986],
11	an	DT	O	a	det	12	SENT_314	[p20l539t2928r627b2974],
12	LTA	NN	ORGANIZATION	lta	nsubjpass	15	SENT_314	[p20l658t2907r829b2973],
13	is	VBZ	O	be	auxpass	15	SENT_314	[p20l861t2907r921b2974],
14	highly	RB	O	highly	advmod	15	SENT_314	[p20l953t2907r1199b2994],
15	advised	VBN	O	advise	_	0	SENT_314	[p20l1234t2907r1525b2974],
16	to	TO	O	to	aux	17	SENT_314	[p20l1557t2917r1629b2974],
17	ensure	VB	O	ensure	xcomp	15	SENT_314	[p20l1663t2928r1912b2974],
18	tolerance	NN	O	tolerance	dobj	17	SENT_314	[p20l1944t2907r2149b2974, p20l9t3043r182b3089],
19	towards	IN	O	towards	_	0	SENT_314	[p20l221t3022r521b3090],
20	this	DT	O	this	det	21	SENT_314	[p20l560t3022r696b3089],
21	anticonvulsant	NN	O	anticonvulsant	prep_towards	17	SENT_314	[p20l737t3022r1316b3090],
22	.	.	O	.	_	0	SENT_314	[p20l737t3022r1316b3090],

1	The	DT	O	the	det	3	SENT_315	[p20l1359t3022r1507b3089],
2	main	JJ	O	main	amod	3	SENT_315	[p20l1545t3022r1737b3089],
3	limitation	NN	O	limitation	nsubj	11	SENT_315	[p20l1775t3022r2152b3089],
4	of	IN	O	of	_	0	SENT_315	[p20l9t3138r92b3205],
5	our	PRP$	O	we	poss	6	SENT_315	[p20l115t3160r242b3205],
6	study	NN	O	study	prep_of	3	SENT_315	[p20l272t3138r475b3225],
7	is	VBZ	O	be	cop	11	SENT_315	[p20l504t3138r564b3205],
8	the	DT	O	the	det	11	SENT_315	[p20l594t3138r710b3205],
9	relatively	RB	O	relatively	advmod	10	SENT_315	[p20l738t3138r1101b3225],
10	small	JJ	O	small	amod	11	SENT_315	[p20l1133t3138r1337b3205],
11	number	NN	O	number	_	0	SENT_315	[p20l1366t3138r1662b3205],
12	of	IN	O	of	_	0	SENT_315	[p20l1689t3138r1773b3205],
13	Han	NNP	MISC	Han	nn	15	SENT_315	[p20l1795t3140r1954b3205],
14	Chinese	NNP	MISC	Chinese	nn	15	SENT_315	[p20l1983t3138r2148b3206, p20l7t3274r176b3320],
15	patients	NNS	O	patient	prep_of	11	SENT_315	[p20l203t3253r502b3340],
16	presenting	VBG	O	present	partmod	15	SENT_315	[p20l530t3253r932b3340],
17	AED-HSR	NN	O	aed-hsr	dobj	16	SENT_315	[p20l960t3254r1377b3320],
18	who	WP	O	who	nsubj	19	SENT_315	[p20l1404t3253r1566b3320],
19	participated	VBD	O	participate	rcmod	17	SENT_315	[p20l1593t3253r2052b3340],
20	in	IN	O	in	_	0	SENT_315	[p20l2078t3253r2152b3319],
21	the	DT	O	the	det	22	SENT_315	[p20l7t3368r123b3434],
22	study	NN	O	study	prep_in	19	SENT_315	[p20l157t3368r374b3455],
23	.	.	O	.	_	0	SENT_315	[p20l157t3368r374b3455],

1	CONCLUSION	NN	O	conclusion	_	0	SENT_316	[p20l8t3630r575b3698],

1	Current	JJ	DATE	current	amod	2	SENT_317	[p21l96t50r390b117],
2	results	NNS	O	result	nsubj	3	SENT_317	[p21l427t50r677b117],
3	demonstrate	VBP	O	demonstrate	_	0	SENT_317	[p21l719t50r1190b117],
4	that	IN	O	that	complm	11	SENT_317	[p21l1230t50r1375b117],
5	the	DT	O	the	det	6	SENT_317	[p21l1414t50r1529b117],
6	LTA	NNP	ORGANIZATION	LTA	nsubj	11	SENT_317	[p21l1569t50r1740b116],
7	is	VBZ	O	be	cop	11	SENT_317	[p21l1779t50r1839b117],
8	a	DT	O	a	det	11	SENT_317	[p21l1883t71r1922b117],
9	good	JJ	O	good	amod	11	SENT_317	[p21l1962t50r2152b137],
10	predictor	NN	O	predictor	nn	11	SENT_317	[p21l7t165r357b252],
11	tool	NN	O	tool	ccomp	3	SENT_317	[p21l382t165r529b232],
12	for	IN	O	for	_	0	SENT_317	[p21l557t165r669b232],
13	possible	JJ	O	possible	amod	14	SENT_317	[p21l692t165r1008b252],
14	HSRs	NNS	O	hsr	prep_for	11	SENT_317	[p21l1034t166r1254b233],
15	in	IN	O	in	_	0	SENT_317	[p21l1282t165r1355b232],
16	individuals	NNS	O	individual	prep_in	14	SENT_317	[p21l1381t165r1806b233],
17	with	IN	O	with	_	0	SENT_317	[p21l1835t165r2005b233],
18	epilepsy	NN	O	epilepsy	prep_with	16	SENT_317	[p21l2031t187r2148b252, p21l7t280r250b367],
19	.	.	O	.	_	0	SENT_317	[p21l2031t187r2148b252, p21l7t280r250b367],

1	HLA-B	NN	O	hla-b	nsubj	5	SENT_318	[p21l297t280r831b348],
2	*	CD	NUMBER	*	num	4	SENT_318	[p21l297t280r831b348],
3	l502	NN	O	l502	nn	4	SENT_318	[p21l297t280r831b348],
4	positivity	NN	O	positivity	dep	1	SENT_318	[p21l872t280r1235b367],
5	represent	VBP	O	represent	_	0	SENT_318	[p21l1276t290r1632b367],
6	a	DT	O	a	det	7	SENT_318	[p21l1675t302r1714b347],
7	biomarker	NN	O	biomarker	dobj	5	SENT_318	[p21l1754t280r2153b347],
8	for	IN	O	for	_	0	SENT_318	[p21l8t395r119b462],
9	possible	JJ	O	possible	amod	10	SENT_318	[p21l143t395r459b482],
10	CBZ-HSR	NN	O	cbz-hsr	prep_for	7	SENT_318	[p21l487t395r893b462],
11	and	CC	O	and	_	0	SENT_318	[p21l920t395r1057b462],
12	PHY	NN	O	phy	prep_for	7	SENT_318	[p21l1082t395r1483b462],
13	.	.	O	.	_	0	SENT_318	[p21l1082t395r1483b462],

1	—	NN	O	—	_	0	SENT_319	[p21l1082t395r1483b462],
2	.	.	O	.	_	0	SENT_319	[p21l1082t395r1483b462],

1	HSR	NN	O	hsr	_	0	SENT_320	[p21l1082t395r1483b462],
2	in	IN	O	in	_	0	SENT_320	[p21l1509t395r1581b461],
3	speciﬁc	JJ	O	speciﬁc	amod	5	SENT_320	[p21l1611t395r1899b482],
4	Asian	JJ	LOCATION	asian	amod	5	SENT_320	[p21l1928t395r2152b462],
5	populations	NNS	O	population	prep_in	1	SENT_320	[p21l7t510r478b598],
6	,	,	O	,	_	0	SENT_320	[p21l7t510r478b598],
7	especially	RB	O	especially	advmod	5	SENT_320	[p21l505t510r890b598],
8	Han	NNP	O	Han	nn	9	SENT_320	[p21l914t511r1072b577],
9	Chinese	NNP	MISC	Chinese	dep	5	SENT_320	[p21l1096t510r1424b578],
10	.	.	O	.	_	0	SENT_320	[p21l1096t510r1424b578],

1	More	RBR	O	more	advmod	2	SENT_321	[p21l1452t511r1658b577],
2	importantly	RB	O	importantly	advmod	6	SENT_321	[p21l1682t510r2148b598],
3	,	,	O	,	_	0	SENT_321	[p21l1682t510r2148b598],
4	this	DT	O	this	det	5	SENT_321	[p21l8t626r143b694],
5	work	NN	O	work	nsubj	6	SENT_321	[p21l189t626r387b694],
6	shows	VBZ	O	show	_	0	SENT_321	[p21l432t626r663b694],
7	for	IN	O	for	_	0	SENT_321	[p21l709t626r821b694],
8	the	DT	O	the	det	10	SENT_321	[p21l863t626r978b694],
9	ﬁrst	JJ	O	ﬁrst	amod	10	SENT_321	[p21l1024t626r1172b694],
10	time	NN	O	time	prep_for	6	SENT_321	[p21l1214t626r1384b694],
11	that	WDT	O	that	dep	12	SENT_321	[p21l1429t626r1574b694],
12	HLA	NN	O	hlum	rcmod	10	SENT_321	[p21l1617t626r2150b694],
13	.	.	O	.	_	0	SENT_321	[p21l1617t626r2150b694],

1	—	NN	O	—	_	0	SENT_322	[p21l1617t626r2150b694],
2	.	.	O	.	_	0	SENT_322	[p21l1617t626r2150b694],

1	B	NN	O	b	nsubj	7	SENT_323	[p21l1617t626r2150b694],
2	*	CD	NUMBER	*	num	4	SENT_323	[p21l1617t626r2150b694],
3	l502	NN	O	l502	nn	4	SENT_323	[p21l1617t626r2150b694],
4	negativity	NN	O	negativity	dep	1	SENT_323	[p21l8t742r390b829],
5	does	VBZ	O	do	aux	7	SENT_323	[p21l423t742r595b809],
6	not	RB	O	not	neg	7	SENT_323	[p21l628t752r750b809],
7	prevent	VB	O	prevent	_	0	SENT_323	[p21l778t752r1067b829],
8	LTG-HSR	NN	O	ltg-hsr	dobj	7	SENT_323	[p21l1095t742r1494b809],
9	in	IN	O	in	_	0	SENT_323	[p21l1524t742r1598b808],
10	Han	NNP	LOCATION	Han	nn	11	SENT_323	[p21l1628t744r1787b809],
11	Chinese	NNP	LOCATION	Chinese	prep_in	7	SENT_323	[p21l1818t742r2146b809],
12	.	.	O	.	_	0	SENT_323	[p21l1818t742r2146b809],

1	404	CD	NUMBER	404	_	0	SENT_324	[p21l7t861r135b920],
2	Neumon	JJ	O	neumon	dep	1	SENT_324	[p21l250t862r566b920],
3	e	SYM	O	e	dep	6	SENT_324	[p21l595t862r668b920],
4	’	CD	NUMBER	’	num	6	SENT_324	[p21l595t862r668b920],
5	r	NN	O	r	nn	6	SENT_324	[p21l595t862r668b920],
6	ol	NN	O	ol	rcmod	2	SENT_324	[p21l693t862r754b920],

1	The	DT	O	the	det	2	SENT_325	[p21l8t1095r157b1162],
2	study	NN	O	study	nsubj	4	SENT_325	[p21l221t1095r424b1182],
3	further	RBR	O	further	advmod	4	SENT_325	[p21l485t1095r747b1162],
4	illustrates	VBZ	O	illustrate	_	0	SENT_325	[p21l806t1095r1179b1162],
5	that	IN	O	that	complm	20	SENT_325	[p21l1242t1095r1386b1162],
6	immune-mediated	JJ	O	immune-mediated	amod	7	SENT_325	[p21l1445t1095r2151b1162],
7	components	NNS	O	component	nsubj	24	SENT_325	[p21l9t1220r495b1297],
8	,	,	O	,	_	0	SENT_325	[p21l9t1220r495b1297],
9	such	JJ	O	such	_	0	SENT_325	[p21l527t1210r698b1277],
10	as	IN	O	as	_	0	SENT_325	[p21l724t1232r798b1277],
11	T-cells	NNS	O	t-cell	prep_such_as	7	SENT_325	[p21l824t1210r1082b1277],
12	and	CC	O	and	_	0	SENT_325	[p21l1110t1210r1246b1277],
13	their	PRP$	O	they	poss	14	SENT_325	[p21l1269t1210r1446b1277],
14	cytokine	NN	O	cytokine	prep_such_as	7	SENT_325	[p21l1470t1210r1799b1297],
15	and	CC	O	and	_	0	SENT_325	[p21l1826t1210r1961b1277],
16	chemokine	NN	O	chemokine	nn	17	SENT_325	[p21l1986t1210r2146b1277, p21l8t1325r297b1392],
17	products	NNS	O	product	conj_and	14	SENT_325	[p21l322t1325r674b1412],
18	,	,	O	,	_	0	SENT_325	[p21l322t1325r674b1412],
19	can	MD	O	can	aux	20	SENT_325	[p21l704t1346r835b1392],
20	exacerbate	VB	O	exacerbate	ccomp	4	SENT_325	[p21l862t1325r1273b1392],
21	cellular	JJ	O	cellular	amod	22	SENT_325	[p21l1300t1325r1589b1392],
22	responses	NNS	O	response	dobj	20	SENT_325	[p21l1613t1346r1985b1412],
23	and	CC	O	and	_	0	SENT_325	[p21l2015t1325r2151b1392],
24	create	VB	O	create	conj_and	20	SENT_325	[p21l9t1449r238b1506],
25	complex	JJ	O	complex	amod	26	SENT_325	[p21l265t1440r595b1527],
26	pathways	NNS	O	pathway	dobj	24	SENT_325	[p21l619t1440r981b1527],
27	that	WDT	O	that	nsubj	28	SENT_325	[p21l1009t1440r1153b1506],
28	lead	VBP	O	lead	rcmod	26	SENT_325	[p21l1178t1440r1338b1506],
29	to	TO	O	to	_	0	SENT_325	[p21l1362t1449r1434b1506],
30	cell	NN	O	cell	nn	31	SENT_325	[p21l1461t1440r1598b1506],
31	apoptosis	NN	O	apoptosis	prep_to	28	SENT_325	[p21l1626t1440r1986b1527],
32	and	CC	O	and	_	0	SENT_325	[p21l2015t1440r2151b1506],
33	consequently	RB	O	consequently	advmod	28	SENT_325	[p21l9t1555r518b1642],
34	to	TO	O	to	_	0	SENT_325	[p21l541t1565r612b1622],
35	a	DT	O	a	det	36	SENT_325	[p21l637t1577r677b1622],
36	variety	NN	O	variety	prep_to	28	SENT_325	[p21l698t1555r961b1642],
37	of	IN	O	of	_	0	SENT_325	[p21l986t1555r1069b1622],
38	clinical	JJ	O	clinical	amod	39	SENT_325	[p21l1086t1555r1369b1622],
39	manifestations	NNS	O	manifestation	prep_of	36	SENT_325	[p21l1392t1555r1975b1622],
40	.	.	O	.	_	0	SENT_325	[p21l1392t1555r1975b1622],

1	Additionally	RB	O	additionally	advmod	6	SENT_326	[p21l2002t1555r2146b1622, p21l9t1670r393b1757],
2	,	,	O	,	_	0	SENT_326	[p21l2002t1555r2146b1622, p21l9t1670r393b1757],
3	it	PRP	O	it	nsubjpass	6	SENT_326	[p21l425t1670r478b1737],
4	has	VBZ	O	have	aux	6	SENT_326	[p21l504t1670r628b1737],
5	been	VBN	O	be	auxpass	6	SENT_326	[p21l657t1670r839b1737],
6	conﬁrmed	VBN	O	conﬁrmed	_	0	SENT_326	[p21l868t1670r1258b1737],
7	that	IN	O	that	complm	13	SENT_326	[p21l1285t1670r1430b1737],
8	the	DT	O	the	det	9	SENT_326	[p21l1456t1670r1572b1737],
9	LTA	NNP	ORGANIZATION	LTA	nsubj	13	SENT_326	[p21l1600t1671r1771b1736],
10	is	VBZ	O	be	cop	13	SENT_326	[p21l1798t1670r1858b1737],
11	a	DT	O	a	det	13	SENT_326	[p21l1889t1691r1929b1737],
12	valuable	JJ	O	valuable	amod	13	SENT_326	[p21l1955t1670r2147b1737, p21l10t1785r167b1852],
13	method	NN	O	method	ccomp	6	SENT_326	[p21l222t1785r511b1852],
14	for	IN	O	for	_	0	SENT_326	[p21l564t1785r676b1852],
15	predicting	VBG	O	predict	prepc_for	13	SENT_326	[p21l726t1785r1118b1872],
16	and	CC	O	and	_	0	SENT_326	[p21l1174t1785r1310b1852],
17	conﬁrming	VBG	O	conﬁrming	prepc_for	13	SENT_326	[p21l1363t1785r1784b1872],
18	HSR	NN	O	hsr	dobj	15	SENT_326	[p21l1839t1786r2024b1853],
19	to	TO	O	to	_	0	SENT_326	[p21l2077t1795r2149b1852],
20	a	DT	O	a	det	22	SENT_326	[p21l10t1921r50b1967],
21	speciﬁc	NN	O	speciﬁc	nn	22	SENT_326	[p21l87t1900r375b1987],
22	drug	NN	O	drug	prep_to	15	SENT_326	[p21l413t1900r605b1987],
23	.	.	O	.	_	0	SENT_326	[p21l413t1900r605b1987],

1	We	PRP	O	we	nsubj	3	SENT_327	[p21l644t1901r769b1967],
2	have	VBP	O	have	aux	3	SENT_327	[p21l804t1900r983b1967],
3	proposed	VBN	O	propose	_	0	SENT_327	[p21l1017t1900r1370b1987],
4	that	IN	O	that	complm	9	SENT_327	[p21l1404t1900r1549b1967],
5	the	DT	O	the	det	6	SENT_327	[p21l1582t1900r1698b1967],
6	LTA	NNP	ORGANIZATION	LTA	nsubjpass	9	SENT_327	[p21l1733t1900r1903b1966],
7	could	MD	O	could	aux	9	SENT_327	[p21l1938t1900r2150b1967],
8	be	VB	O	be	auxpass	9	SENT_327	[p21l7t2015r97b2081],
9	used	VBN	O	use	ccomp	3	SENT_327	[p21l137t2015r313b2081],
10	as	IN	O	as	_	0	SENT_327	[p21l355t2036r429b2081],
11	a	DT	O	a	det	13	SENT_327	[p21l473t2036r513b2081],
12	screen	NN	O	screen	nn	13	SENT_327	[p21l556t2036r797b2081],
13	tool	NN	O	tool	prep_as	9	SENT_327	[p21l838t2015r985b2081],
14	for	IN	O	for	_	0	SENT_327	[p21l1027t2015r1139b2081],
15	those	DT	O	those	prep_for	9	SENT_327	[p21l1177t2015r1378b2081],
16	considering	VBG	O	consider	partmod	15	SENT_327	[p21l1420t2015r1867b2102],
17	taking	VBG	O	take	xcomp	16	SENT_327	[p21l1910t2015r2148b2102],
18	or	CC	O	or	_	0	SENT_327	[p21l10t2152r88b2197],
19	changing	VBG	O	change	xcomp	16	SENT_327	[p21l132t2130r483b2217],
20	AEDs	NNS	MISC	aed	dobj	17	SENT_327	[p21l529t2131r782b2210],
21	,	,	O	,	_	0	SENT_327	[p21l529t2131r782b2210],
22	as	IN	O	as	_	0	SENT_327	[p21l833t2152r906b2197],
23	means	NNS	O	means	prep_as	9	SENT_327	[p21l952t2152r1196b2197],
24	to	TO	O	to	aux	25	SENT_327	[p21l1242t2140r1314b2197],
25	avoid	VB	O	avoid	infmod	23	SENT_327	[p21l1362t2130r1571b2197],
26	an	DT	O	a	det	27	SENT_327	[p21l1617t2152r1704b2197],
27	HSR	NN	O	hsr	dobj	25	SENT_327	[p21l1749t2131r1952b2198],
28	.	.	O	.	_	0	SENT_327	[p21l1749t2131r1952b2198],

1	Our	PRP$	O	we	poss	2	SENT_328	[p21l2004t2131r2151b2198],
2	study	NN	O	study	nsubj	3	SENT_328	[p21l12t2245r215b2332],
3	emphasizes	VBZ	O	emphasize	_	0	SENT_328	[p21l256t2245r698b2332],
4	the	DT	O	the	det	5	SENT_328	[p21l740t2245r855b2312],
5	necessity	NN	O	necessity	dobj	3	SENT_328	[p21l896t2245r1248b2332],
6	to	TO	O	to	aux	8	SENT_328	[p21l1289t2255r1360b2312],
7	wisely	RB	O	wisely	advmod	8	SENT_328	[p21l1400t2245r1648b2332],
8	monitor	VB	O	monitor	dep	5	SENT_328	[p21l1689t2245r1996b2312],
9	the	DT	O	the	det	10	SENT_328	[p21l2033t2245r2149b2312],
10	patients	NNS	O	patient	dobj	8	SENT_328	[p21l7t2360r306b2447],
11	clinically	RB	O	clinically	advmod	8	SENT_328	[p21l373t2360r732b2447],
12	and	CC	O	and	_	0	SENT_328	[p21l799t2360r935b2427],
13	by	IN	O	by	_	0	SENT_328	[p21l997t2360r1091b2447],
14	laboratory	NN	O	laboratory	nn	15	SENT_328	[p21l1157t2360r1552b2447],
15	investigations	NNS	O	investigation	prep_by	21	SENT_328	[p21l1618t2360r2148b2447],
16	when	WRB	O	when	advmod	17	SENT_328	[p21l9t2475r216b2543],
17	prescribing	VBG	O	prescribe	dep	15	SENT_328	[p21l246t2475r680b2562],
18	AEDs	NNS	MISC	aed	dobj	17	SENT_328	[p21l713t2476r967b2555],
19	,	,	O	,	_	0	SENT_328	[p21l713t2476r967b2555],
20	to	TO	O	to	aux	21	SENT_328	[p21l1002t2486r1073b2542],
21	avoid	VB	O	avoid	conj_and	8	SENT_328	[p21l1108t2475r1317b2543],
22	AED-HSRs	NNS	O	aed-hsr	dobj	21	SENT_328	[p21l1349t2476r1821b2543],
23	.	.	O	.	_	0	SENT_328	[p21l1349t2476r1821b2543],

1	Personalized	VBN	O	personalize	csubj	10	SENT_329	[p21l1857t2477r2147b2542, p21l10t2590r240b2657],
2	medicine	NN	O	medicine	dobj	1	SENT_329	[p21l276t2590r628b2657],
3	and	CC	O	and	_	0	SENT_329	[p21l669t2590r804b2657],
4	assessing	VBG	O	assess	csubj	10	SENT_329	[p21l843t2590r1197b2677],
5	individual	JJ	O	individual	amod	6	SENT_329	[p21l1234t2590r1623b2657],
6	risk	NN	O	risk	dobj	4	SENT_329	[p21l1660t2590r1805b2657],
7	to	TO	O	to	_	0	SENT_329	[p21l1840t2600r1911b2657],
8	ADR	NN	O	adr	prep_to	4	SENT_329	[p21l1949t2591r2151b2656],
9	is	VBZ	O	be	cop	10	SENT_329	[p21l8t2705r69b2772],
10	important	JJ	O	important	_	0	SENT_329	[p21l104t2705r480b2792],
11	for	IN	O	for	_	0	SENT_329	[p21l513t2705r625b2772],
12	physicians	NNS	O	physician	prep_for	10	SENT_329	[p21l655t2705r1061b2792],
13	and	CC	O	and	_	0	SENT_329	[p21l1099t2705r1234b2772],
14	patients	NNS	O	patient	conj_and	12	SENT_329	[p21l1266t2705r1587b2792],
15	,	,	O	,	_	0	SENT_329	[p21l1266t2705r1587b2792],
16	since	IN	O	since	mark	24	SENT_329	[p21l1628t2705r1821b2772],
17	alternatives	NNS	O	alternative	nsubjpass	24	SENT_329	[p21l1857t2705r2147b2772, p21l8t2820r185b2887],
18	for	IN	O	for	_	0	SENT_329	[p21l223t2820r335b2887],
19	the	DT	O	the	det	20	SENT_329	[p21l370t2820r485b2887],
20	drugs	NNS	O	drug	prep_for	17	SENT_329	[p21l523t2820r732b2907],
21	involved	VBN	O	involve	partmod	20	SENT_329	[p21l770t2820r1104b2887],
22	may	MD	O	may	aux	24	SENT_329	[p21l1139t2841r1303b2907],
23	be	VB	O	be	auxpass	24	SENT_329	[p21l1339t2820r1428b2887],
24	needed	VBN	O	need	advcl	10	SENT_329	[p21l1465t2820r1738b2887],
25	for	IN	O	for	_	0	SENT_329	[p21l1774t2820r1886b2887],
26	future	JJ	DATE	future	amod	28	SENT_329	[p21l1921t2820r2149b2887],
27	safe	JJ	O	safe	amod	28	SENT_329	[p21l12t2935r161b3002],
28	treatment	NN	O	treatment	prep_for	24	SENT_329	[p21l192t2945r576b3002],
29	.	.	O	.	_	0	SENT_329	[p21l192t2945r576b3002],

1	REFERENCES	NNS	O	reference	_	0	SENT_330	[p21l11t3177r396b3229],

1	1	LS	NUMBER	1	_	0	SENT_331	[p21l54t3307r99b3361],
2	.	.	O	.	_	0	SENT_331	[p21l54t3307r99b3361],

1	Ferrendelli	JJ	O	ferrendelli	amod	2	SENT_332	[p21l141t3307r478b3361],
2	JA	NN	O	ja	_	0	SENT_332	[p21l503t3307r598b3370],
3	,	,	O	,	_	0	SENT_332	[p21l503t3307r598b3370],
4	Mathews	NNP	PERSON	Mathews	nn	5	SENT_332	[p21l626t3307r903b3361],
5	GC	NN	O	gc	appos	2	SENT_332	[p21l930t3307r1049b3361],
6	.	.	O	.	_	0	SENT_332	[p21l930t3307r1049b3361],

1	Neuropharmacology	NNP	O	Neuropharmacology	_	0	SENT_333	[p21l1077t3307r1710b3377],
2	of	IN	O	of	_	0	SENT_333	[p21l1735t3306r1802b3361],
3	antiepileptic	JJ	O	antiepileptic	amod	4	SENT_333	[p21l1822t3306r2149b3377, p21l141t3401r215b3455],
4	medications	NNS	O	medication	prep_of	1	SENT_333	[p21l234t3401r622b3455],
5	:	:	O	:	_	0	SENT_333	[p21l234t3401r622b3455],
6	mechanisms	NNS	O	mechanism	dep	1	SENT_333	[p21l645t3401r1023b3455],
7	of	IN	O	of	_	0	SENT_333	[p21l1042t3401r1109b3455],
8	action	NN	O	action	prep_of	6	SENT_333	[p21l1122t3401r1324b3455],
9	.	.	O	.	_	0	SENT_333	[p21l1122t3401r1324b3455],

1	In	IN	O	in	dep	4	SENT_334	[p21l1344t3402r1422b3455],
2	:	:	O	:	_	0	SENT_334	[p21l1344t3402r1422b3455],
3	Wyllie	NNP	PERSON	Wyllie	nn	4	SENT_334	[p21l1444t3401r1648b3471],
4	E	NNP	O	E	_	0	SENT_334	[p21l1665t3402r1727b3465],
5	,	,	O	,	_	0	SENT_334	[p21l1665t3402r1727b3465],
6	ed	VBD	O	ed	rcmod	4	SENT_334	[p21l1747t3401r1833b3455],
7	.	.	O	.	_	0	SENT_334	[p21l1747t3401r1833b3455],

1	The	DT	O	the	det	2	SENT_335	[p21l1854t3401r1972b3455],
2	treatment	NN	O	treatment	_	0	SENT_335	[p21l1989t3409r2149b3455, p21l142t3505r296b3552],
3	of	IN	O	of	_	0	SENT_335	[p21l321t3497r388b3551],
4	epilepsy	NN	O	epilepsy	prep_of	2	SENT_335	[p21l410t3497r681b3567],
5	:	:	O	:	_	0	SENT_335	[p21l410t3497r681b3567],
6	principles	NNS	O	principle	dep	2	SENT_335	[p21l712t3497r1015b3567],
7	and	CC	O	and	_	0	SENT_335	[p21l1043t3497r1153b3552],
8	practice	NN	O	practice	dep	2	SENT_335	[p21l1177t3497r1437b3567],
9	.	.	O	.	_	0	SENT_335	[p21l1177t3497r1437b3567],

1	Philadelphia	NNP	LOCATION	Philadelphia	_	0	SENT_336	[p21l1467t3497r1868b3567],
2	:	:	O	:	_	0	SENT_336	[p21l1467t3497r1868b3567],
3	Lea	NNP	PERSON	Lea	dep	1	SENT_336	[p21l1899t3499r2015b3552],
4	and	CC	O	and	_	0	SENT_336	[p21l2042t3497r2151b3552],
5	Febiger	NNP	O	Febiger	dep	1	SENT_336	[p21l141t3595r389b3665],
6	,	,	O	,	_	0	SENT_336	[p21l141t3595r389b3665],
7	l993	CD	NUMBER	l993	num	8	SENT_336	[p21l423t3594r798b3650],
8	:735	CD	NUMBER	:735	appos	3	SENT_336	[p21l423t3594r798b3650],
9	—	NN	O	—	dep	8	SENT_336	[p21l423t3594r798b3650],
10	7	CD	NUMBER	7	num	9	SENT_336	[p21l423t3594r798b3650],
11	.	.	O	.	_	0	SENT_336	[p21l423t3594r798b3650],

1	2	LS	NUMBER	2	_	0	SENT_337	[p21l48t3690r99b3743],
2	.	.	O	.	_	0	SENT_337	[p21l48t3690r99b3743],

1	Hockings	NNS	O	hocking	_	0	SENT_338	[p21l142t3689r434b3759],
2	N	NN	O	n	dep	1	SENT_338	[p21l460t3690r530b3753],
3	,	,	O	,	_	0	SENT_338	[p21l460t3690r530b3753],
4	Pall	NN	O	pall	nn	5	SENT_338	[p21l558t3689r676b3743],
5	A	NN	O	a	appos	2	SENT_338	[p21l700t3690r770b3753],
6	,	,	O	,	_	0	SENT_338	[p21l700t3690r770b3753],
7	Moody	NNP	ORGANIZATION	Moody	nn	8	SENT_338	[p21l799t3689r1019b3759],
8	J	NNP	ORGANIZATION	J	appos	2	SENT_338	[p21l1044t3690r1089b3753],
9	,	,	O	,	_	0	SENT_338	[p21l1044t3690r1089b3753],
10	Davidson	NNP	PERSON	Davidson	nn	11	SENT_338	[p21l1117t3689r1410b3744],
11	AV	NNP	O	AV	appos	2	SENT_338	[p21l1435t3690r1540b3753],
12	,	,	O	,	_	0	SENT_338	[p21l1435t3690r1540b3753],
13	Davidson	NNP	PERSON	Davidson	nn	14	SENT_338	[p21l1569t3689r1862b3743],
14	DL	NNP	O	DL	appos	2	SENT_338	[p21l1887t3690r2003b3743],
15	.	.	O	.	_	0	SENT_338	[p21l1887t3690r2003b3743],

1	The	DT	O	the	det	2	SENT_339	[p21l2032t3689r2150b3743],
2	effects	NNS	O	effect	_	0	SENT_339	[p22l142t20r342b75],
3	of	IN	O	of	_	0	SENT_339	[p22l362t20r428b75],
4	age	NN	O	age	prep_of	2	SENT_339	[p22l441t37r544b90],
5	on	IN	O	on	_	0	SENT_339	[p22l562t37r636b75],
6	carbamazepine	NN	O	carbamazepine	nn	7	SENT_339	[p22l653t20r1115b90],
7	pharmacokinetics	NNS	O	pharmacokinetic	prep_on	2	SENT_339	[p22l1130t20r1673b90],
8	and	CC	O	and	_	0	SENT_339	[p22l1692t20r1801b75],
9	adverse	JJ	O	adverse	amod	10	SENT_339	[p22l1818t20r2049b75],
10	effects	NNS	O	effect	prep_on	2	SENT_339	[p22l2067t20r2148b75, p22l142t117r301b172],
11	.	.	O	.	_	0	SENT_339	[p22l2067t20r2148b75, p22l142t117r301b172],

1	Br	NN	O	br	nn	3	SENT_340	[p22l328t119r405b171],
2	J	NN	O	j	nn	3	SENT_340	[p22l427t119r455b172],
3	Clin	NN	O	clin	_	0	SENT_340	[p22l479t118r610b172],
4	Pharmacol	NNP	O	Pharmacol	dep	3	SENT_340	[p22l633t118r962b172],
5	1986	CD	DATE	1986	num	4	SENT_340	[p22l992t117r1466b181],
6	;	:	O	;	_	0	SENT_340	[p22l992t117r1466b181],
7	22:725	CD	NUMBER	22:725	num	8	SENT_340	[p22l992t117r1466b181],
8	-8	CD	NUMBER	-8	dep	3	SENT_340	[p22l992t117r1466b181],
9	.	.	O	.	_	0	SENT_340	[p22l992t117r1466b181],

1	.	.	O	.	_	0	SENT_341	[p22l89t258r99b268],

1	Bajpai	NNP	PERSON	Bajpai	nn	2	SENT_342	[p22l142t214r341b284],
2	M	NNP	PERSON	M	_	0	SENT_342	[p22l364t215r447b277],
3	,	,	O	,	_	0	SENT_342	[p22l364t215r447b277],
4	Roskos	NNP	ORGANIZATION	Roskos	nn	5	SENT_342	[p22l472t214r695b268],
5	LK	NNP	ORGANIZATION	LK	appos	2	SENT_342	[p22l718t215r835b277],
6	,	,	O	,	_	0	SENT_342	[p22l718t215r835b277],
7	Shen	NNP	ORGANIZATION	Shen	nn	8	SENT_342	[p22l862t214r1012b268],
8	DD	NNP	ORGANIZATION	DD	appos	2	SENT_342	[p22l1034t215r1160b277],
9	,	,	O	,	_	0	SENT_342	[p22l1034t215r1160b277],
10	Levy	NNP	PERSON	Levy	nn	11	SENT_342	[p22l1184t215r1339b284],
11	RH	NNP	O	RH	appos	2	SENT_342	[p22l1362t215r1482b268],
12	.	.	O	.	_	0	SENT_342	[p22l1362t215r1482b268],

1	Roles	NNS	O	role	_	0	SENT_343	[p22l1508t213r1681b268],
2	of	IN	O	of	_	0	SENT_343	[p22l1704t213r1771b268],
3	cytochrome	NN	O	cytochrome	nn	5	SENT_343	[p22l1789t214r2150b284],
4	P450	NN	O	p450	nn	5	SENT_343	[p22l141t308r297b363],
5	2C9	NN	O	2c9	prep_of	1	SENT_343	[p22l318t309r441b363],
6	and	CC	O	and	_	0	SENT_343	[p22l463t308r573b363],
7	cytochrome	NN	O	cytochrome	nn	8	SENT_343	[p22l591t308r953b378],
8	P4502C19	NN	O	p4502c19	prep_of	1	SENT_343	[p22l971t308r1293b363],
9	in	IN	O	in	_	0	SENT_343	[p22l1313t308r1371b362],
10	the	DT	O	the	det	12	SENT_343	[p22l1389t308r1482b363],
11	streoselective	JJ	O	streoselective	amod	12	SENT_343	[p22l1504t308r1919b363],
12	metabolism	NN	O	metabolism	prep_in	5	SENT_343	[p22l1937t308r2149b363, p22l142t405r312b460],
13	of	IN	O	of	_	0	SENT_343	[p22l341t405r407b460],
14	phenytoin	NN	O	phenytoin	prep_of	12	SENT_343	[p22l429t406r737b476],
15	to	TO	O	to	_	0	SENT_343	[p22l764t414r822b460],
16	its	PRP$	O	its	poss	18	SENT_343	[p22l851t405r921b460],
17	major	JJ	O	major	amod	18	SENT_343	[p22l951t405r1131b476],
18	metabolite	NN	O	metabolite	prep_to	1	SENT_343	[p22l1157t405r1499b460],
19	.	.	O	.	_	0	SENT_343	[p22l1157t405r1499b460],

1	Drug	NN	O	drug	nn	3	SENT_344	[p22l1531t407r1686b476],
2	Metab	NNP	O	Metab	nn	3	SENT_344	[p22l1715t406r1910b460],
3	Dispos	NNP	O	Dispos	_	0	SENT_344	[p22l1939t406r2149b476],
4	1996	CD	DATE	1996	num	3	SENT_344	[p22l149t501r660b565],
5	;	:	O	;	_	0	SENT_344	[p22l149t501r660b565],
6	24	CD	NUMBER	24	dep	3	SENT_344	[p22l149t501r660b565],
7	:	:	O	:	_	0	SENT_344	[p22l149t501r660b565],
8	l401-3	NN	O	l401-3	dep	6	SENT_344	[p22l149t501r660b565],
9	.	.	O	.	_	0	SENT_344	[p22l149t501r660b565],

1	.	.	O	.	_	0	SENT_345	[p22l89t643r99b652],

1	Cuttle	NNP	ORGANIZATION	Cuttle	nn	2	SENT_346	[p22l142t598r328b652],
2	L	NNP	ORGANIZATION	L	_	0	SENT_346	[p22l344t599r406b661],
3	,	,	O	,	_	0	SENT_346	[p22l344t599r406b661],
4	Munns	NNP	PERSON	Munns	nn	5	SENT_346	[p22l425t599r636b652],
5	AJ	NNP	PERSON	AJ	appos	2	SENT_346	[p22l653t598r753b661],
6	,	,	O	,	_	0	SENT_346	[p22l653t598r753b661],
7	Hogg	NNP	PERSON	Hogg	nn	8	SENT_346	[p22l771t599r940b668],
8	NA	NNP	O	NA	appos	2	SENT_346	[p22l956t598r1079b661],
9	,	,	O	,	_	0	SENT_346	[p22l956t598r1079b661],
10	et	FW	O	et	nn	11	SENT_346	[p22l1098t606r1153b652],
11	al.	FW	O	al.	appos	2	SENT_346	[p22l1169t598r1237b652],
12	.	.	O	.	_	0	SENT_346	[p22l1169t598r1237b652],

1	Phenytoin	NNP	O	Phenytoin	nn	2	SENT_347	[p22l1257t598r1568b668],
2	metabolism	NN	O	metabolism	_	0	SENT_347	[p22l1583t598r1944b652],
3	by	IN	O	by	_	0	SENT_347	[p22l1958t598r2033b668],
4	human	JJ	O	human	amod	6	SENT_347	[p22l2049t598r2149b652, p22l141t710r273b748],
5	cytochrome	NN	O	cytochrome	nn	6	SENT_347	[p22l294t694r656b764],
6	P450	NN	O	p450	prep_by	2	SENT_347	[p22l677t693r849b748],
7	:	:	O	:	_	0	SENT_347	[p22l677t693r849b748],
8	Involvement	NN	O	involvement	dep	2	SENT_347	[p22l876t694r1261b748],
9	of	IN	O	of	_	0	SENT_347	[p22l1282t693r1348b748],
10	P450	NN	O	p450	nn	11	SENT_347	[p22l1364t693r1521b748],
11	3A	NN	O	3a	prep_of	8	SENT_347	[p22l1544t694r1634b748],
12	and	CC	O	and	_	0	SENT_347	[p22l1656t694r1765b748],
13	2C	NN	O	2c	nn	14	SENT_347	[p22l1786t694r1872b748],
14	forms	NNS	O	form	conj_and	11	SENT_347	[p22l1894t693r2070b748],
15	in	IN	O	in	_	0	SENT_347	[p22l2092t693r2151b747],
16	secondary	JJ	O	secondary	amod	17	SENT_347	[p22l144t789r452b860],
17	metabolism	NN	O	metabolism	prep_in	8	SENT_347	[p22l480t789r840b844],
18	and	CC	O	and	_	0	SENT_347	[p22l867t789r976b844],
19	drug-protein	NN	O	drug-protein	nn	21	SENT_347	[p22l1003t789r1387b860],
20	adduct	NN	O	adduct	nn	21	SENT_347	[p22l1415t789r1619b844],
21	formation	NN	O	formation	prep_in	8	SENT_347	[p22l1645t789r1964b844],
22	.	.	O	.	_	0	SENT_347	[p22l1645t789r1964b844],

1	Drug	NN	O	drug	nn	3	SENT_348	[p22l1994t791r2150b860],
2	Metab	NNP	O	Metab	nn	3	SENT_348	[p22l141t886r336b940],
3	Dispos	NNP	O	Dispos	_	0	SENT_348	[p22l360t886r571b956],
4	2000	CD	DATE	2000	num	3	SENT_348	[p22l597t886r1115b949],
5	;	:	O	;	_	0	SENT_348	[p22l597t886r1115b949],
6	28:945	CD	NUMBER	28:945	number	7	SENT_348	[p22l597t886r1115b949],
7	—	CD	NUMBER	—	dep	3	SENT_348	[p22l597t886r1115b949],
8	50	CD	NUMBER	50	dep	7	SENT_348	[p22l597t886r1115b949],
9	.	.	O	.	_	0	SENT_348	[p22l597t886r1115b949],

1	.	.	O	.	_	0	SENT_349	[p22l89t1026r99b1036],

1	Lertratanangkoon	NN	PERSON	lertratanangkoon	nn	2	SENT_350	[p22l141t982r689b1052],
2	K	NN	PERSON	k	_	0	SENT_350	[p22l725t983r794b1045],
3	,	,	O	,	_	0	SENT_350	[p22l725t983r794b1045],
4	Homing	JJ	O	homing	amod	5	SENT_350	[p22l832t981r1086b1052],
5	MG	NN	O	mg	appos	2	SENT_350	[p22l1120t982r1258b1036],
6	.	.	O	.	_	0	SENT_350	[p22l1120t982r1258b1036],

1	Metabolism	NN	O	metabolism	_	0	SENT_351	[p22l1296t981r1665b1036],
2	of	IN	O	of	_	0	SENT_351	[p22l1699t981r1766b1036],
3	carbamazepine	NN	O	carbamazepine	prep_of	1	SENT_351	[p22l1796t982r2149b1036, p22l141t1078r288b1148],
4	.	.	O	.	_	0	SENT_351	[p22l1796t982r2149b1036, p22l141t1078r288b1148],

1	Drug	NN	O	drug	nn	3	SENT_352	[p22l315t1079r471b1148],
2	Metab	NNP	O	Metab	nn	3	SENT_352	[p22l495t1078r690b1132],
3	Dispos	NNP	O	Dispos	_	0	SENT_352	[p22l714t1078r925b1148],
4	1982,1021-10	CD	DATE	1982,1021-10	dep	3	SENT_352	[p22l956t1078r1391b1141],
5	.	.	O	.	_	0	SENT_352	[p22l956t1078r1391b1141],

1	.	.	O	.	_	0	SENT_353	[p22l89t1219r99b1228],

1	Lu	NNP	PERSON	Lu	nn	2	SENT_354	[p22l141t1175r225b1228],
2	W	NNP	PERSON	W	_	0	SENT_354	[p22l245t1175r327b1237],
3	,	,	O	,	_	0	SENT_354	[p22l245t1175r327b1237],
4	Uetrecht	NNP	O	Uetrecht	nn	5	SENT_354	[p22l350t1174r617b1228],
5	JP	NNP	O	JP	appos	2	SENT_354	[p22l635t1175r713b1228],
6	.	.	O	.	_	0	SENT_354	[p22l635t1175r713b1228],

1	PeroXidase	NN	O	peroxidase	nn	2	SENT_355	[p22l738t1174r1386b1228],
2	—	NN	O	—	nsubj	3	SENT_355	[p22l738t1174r1386b1228],
3	mediated	VBD	O	mediate	_	0	SENT_355	[p22l738t1174r1386b1228],
4	bioactivation	NN	O	bioactivation	dobj	3	SENT_355	[p22l1404t1174r1805b1228],
5	of	IN	O	of	_	0	SENT_355	[p22l1826t1174r1894b1228],
6	hydroxylated	VBN	O	hydroxylate	prepc_of	4	SENT_355	[p22l1908t1174r2149b1244, p22l141t1268r329b1338],
7	metabolites	NNS	O	metabolite	dobj	6	SENT_355	[p22l351t1268r704b1322],
8	of	IN	O	of	_	0	SENT_355	[p22l729t1268r796b1322],
9	carbamazepine	NN	O	carbamazepine	prep_of	7	SENT_355	[p22l813t1268r1275b1338],
10	and	CC	O	and	_	0	SENT_355	[p22l1299t1268r1408b1322],
11	phenytoin	NN	O	phenytoin	prep_of	7	SENT_355	[p22l1428t1268r1751b1338],
12	.	.	O	.	_	0	SENT_355	[p22l1428t1268r1751b1338],

1	Drug	NN	O	drug	nn	3	SENT_356	[p22l1777t1269r1932b1338],
2	Metab	NNP	O	Metab	nn	3	SENT_356	[p22l1954t1268r2150b1322],
3	Dispos	NNP	O	Dispos	_	0	SENT_356	[p22l141t1365r352b1436],
4	2008	CD	DATE	2008	num	3	SENT_356	[p22l378t1365r934b1429],
5	;	:	O	;	_	0	SENT_356	[p22l378t1365r934b1429],
6	36:1624	CD	NUMBER	36:1624	number	7	SENT_356	[p22l378t1365r934b1429],
7	-36	CD	NUMBER	-36	dep	3	SENT_356	[p22l378t1365r934b1429],
8	.	.	O	.	_	0	SENT_356	[p22l378t1365r934b1429],

1	.	.	O	.	_	0	SENT_357	[p22l89t1507r99b1516],

1	Hawes	NNP	ORGANIZATION	Hawes	nn	2	SENT_358	[p22l142t1463r347b1516],
2	EM	NNP	ORGANIZATION	EM	_	0	SENT_358	[p22l375t1463r505b1516],
3	.	.	O	.	_	0	SENT_358	[p22l375t1463r505b1516],

1	N	NN	O	n	_	0	SENT_359	[p22l535t1462r1185b1532],
2	+	CC	O	+	rcmod	1	SENT_359	[p22l535t1462r1185b1532],
3	.	.	O	.	_	0	SENT_359	[p22l535t1462r1185b1532],

1	—	NN	O	—	_	0	SENT_360	[p22l535t1462r1185b1532],
2	.	.	O	.	_	0	SENT_360	[p22l535t1462r1185b1532],

1	glucuronidation	NN	O	glucuronidation	_	0	SENT_361	[p22l535t1462r1185b1532],
2	,	,	O	,	_	0	SENT_361	[p22l535t1462r1185b1532],
3	a	DT	O	a	det	5	SENT_361	[p22l1216t1479r1248b1516],
4	common	JJ	O	common	amod	5	SENT_361	[p22l1275t1479r1544b1516],
5	pathway	NN	O	pathway	appos	1	SENT_361	[p22l1569t1462r1830b1532],
6	in	IN	O	in	_	0	SENT_361	[p22l1857t1462r1915b1515],
7	human	JJ	O	human	amod	8	SENT_361	[p22l1942t1462r2151b1516],
8	metabolism	NN	O	metabolism	prep_in	5	SENT_361	[p22l142t1556r502b1610],
9	of	IN	O	of	_	0	SENT_361	[p22l518t1556r585b1610],
10	drugs	NNS	O	drug	prep_of	8	SENT_361	[p22l596t1556r763b1626],
11	with	IN	O	with	_	0	SENT_361	[p22l782t1556r917b1610],
12	a	DT	O	a	det	15	SENT_361	[p22l934t1573r966b1610],
13	tertiary	JJ	O	tertiary	amod	15	SENT_361	[p22l981t1556r1202b1626],
14	amine	NN	O	amine	nn	15	SENT_361	[p22l1221t1556r1407b1610],
15	group	NN	O	group	prep_with	10	SENT_361	[p22l1423t1573r1616b1626],
16	.	.	O	.	_	0	SENT_361	[p22l1423t1573r1616b1626],

1	Drug	NN	O	drug	nn	3	SENT_362	[p22l1636t1557r1792b1626],
2	Metab	NNP	O	Metab	nn	3	SENT_362	[p22l1808t1556r2002b1610],
3	Dispos	NNP	O	Dispos	_	0	SENT_362	[p22l2020t1556r2149b1610, p22l140t1669r245b1722],
4	1998	CD	DATE	1998	num	3	SENT_362	[p22l277t1652r750b1716],
5	;	:	O	;	_	0	SENT_362	[p22l277t1652r750b1716],
6	26:830	CD	NUMBER	26:830	num	7	SENT_362	[p22l277t1652r750b1716],
7	—	NN	O	—	dep	3	SENT_362	[p22l277t1652r750b1716],
8	7	CD	NUMBER	7	dep	7	SENT_362	[p22l277t1652r750b1716],
9	.	.	O	.	_	0	SENT_362	[p22l277t1652r750b1716],

1	.	.	O	.	_	0	SENT_363	[p22l89t1795r99b1804],

1	Schlienger	NNP	PERSON	Schlienger	nn	2	SENT_364	[p22l143t1750r472b1820],
2	R	NNP	O	R	_	0	SENT_364	[p22l492t1751r557b1814],
3	,	,	O	,	_	0	SENT_364	[p22l492t1751r557b1814],
4	Shear	NNP	ORGANIZATION	Shear	nn	5	SENT_364	[p22l583t1750r756b1804],
5	NH	NNP	ORGANIZATION	NH	appos	2	SENT_364	[p22l776t1751r900b1804],
6	.	.	O	.	_	0	SENT_364	[p22l776t1751r900b1804],

1	Antiepileptic	JJ	O	antiepileptic	amod	2	SENT_365	[p22l925t1750r1326b1820],
2	drug	NN	O	drug	_	0	SENT_365	[p22l1349t1750r1487b1820],
3	hypersensitivity	NN	O	hypersensitivity	nn	4	SENT_365	[p22l1509t1750r1999b1820],
4	syndrome	NN	O	syndrome	dep	2	SENT_365	[p22l2023t1767r2149b1820, p22l142t1844r353b1898],
5	.	.	O	.	_	0	SENT_365	[p22l2023t1767r2149b1820, p22l142t1844r353b1898],

1	Epilepsia	NNP	O	Epilepsia	_	0	SENT_366	[p22l379t1844r668b1914],
2	l998	CD	NUMBER	l998	num	1	SENT_366	[p22l697t1844r1135b1908],
3	;	:	O	;	_	0	SENT_366	[p22l697t1844r1135b1908],
4	39	CD	NUMBER	39	dep	1	SENT_366	[p22l697t1844r1135b1908],
5	:	:	O	:	_	0	SENT_366	[p22l697t1844r1135b1908],
6	S3	NN	O	s3	nn	7	SENT_366	[p22l697t1844r1135b1908],
7	—	NN	O	—	dep	4	SENT_366	[p22l697t1844r1135b1908],
8	7	CD	NUMBER	7	dep	7	SENT_366	[p22l697t1844r1135b1908],
9	.	.	O	.	_	0	SENT_366	[p22l697t1844r1135b1908],

1	.	.	O	.	_	0	SENT_367	[p22l89t1985r99b1994],

1	Zimmerman	NNP	PERSON	Zimmerman	nn	2	SENT_368	[p22l141t1940r523b1994],
2	HJ	NNP	O	HJ	_	0	SENT_368	[p22l545t1941r643b1995],
3	.	.	O	.	_	0	SENT_368	[p22l545t1941r643b1995],

1	Hepatotoxicity	NN	O	hepatotoxicity	_	0	SENT_369	[p22l669t1940r1143b2010],
2	:	:	O	:	_	0	SENT_369	[p22l669t1940r1143b2010],
3	the	DT	O	the	det	5	SENT_369	[p22l1170t1940r1263b1994],
4	adverse	JJ	O	adverse	amod	5	SENT_369	[p22l1287t1940r1518b1994],
5	effects	NNS	O	effect	dep	1	SENT_369	[p22l1541t1940r1742b1994],
6	of	IN	O	of	_	0	SENT_369	[p22l1766t1940r1832b1994],
7	drugs	NNS	O	drug	prep_of	5	SENT_369	[p22l1851t1940r2017b2010],
8	and	CC	O	and	_	0	SENT_369	[p22l2043t1940r2151b1994],
9	other	JJ	O	other	amod	10	SENT_369	[p22l142t2036r300b2091],
10	chemicals	NNS	O	chemical	conj_and	5	SENT_369	[p22l316t2036r622b2091],
11	on	IN	O	on	_	0	SENT_369	[p22l642t2053r716b2090],
12	the	DT	O	the	det	13	SENT_369	[p22l733t2036r825b2090],
13	liver	NN	O	liver	prep_on	10	SENT_369	[p22l843t2036r991b2091],
14	.	.	O	.	_	0	SENT_369	[p22l843t2036r991b2091],

1	2nd	JJ	ORDINAL	2nd	nsubj	2	SENT_370	[p22l1014t2036r1127b2091],
2	ed	VBN	O	ed	_	0	SENT_370	[p22l1144t2036r1230b2091],
3	.	.	O	.	_	0	SENT_370	[p22l1144t2036r1230b2091],

1	Philadelphia	NNP	LOCATION	Philadelphia	_	0	SENT_371	[p22l1251t2036r1652b2106],
2	:	:	O	:	_	0	SENT_371	[p22l1251t2036r1652b2106],
3	Lippincott	NNP	PERSON	Lippincott	nn	4	SENT_371	[p22l1675t2036r1996b2106],
4	Williams	NNP	PERSON	Williams	dep	1	SENT_371	[p22l2012t2036r2148b2090, p22l142t2133r306b2187],
5	and	CC	O	and	_	0	SENT_371	[p22l333t2133r441b2187],
6	Wilkins	NNP	PERSON	Wilkins	dep	1	SENT_371	[p22l463t2133r721b2197],
7	,	,	O	,	_	0	SENT_371	[p22l463t2133r721b2197],
8	1999	CD	DATE	1999	appos	4	SENT_371	[p22l755t2133r916b2188],
9	.	.	O	.	_	0	SENT_371	[p22l755t2133r916b2188],

1	Bjornsson	NNP	PERSON	Bjornsson	nn	3	SENT_372	[p22l142t2227r452b2298],
2	E.	NNP	PERSON	E.	nn	3	SENT_372	[p22l477t2230r538b2282],
3	Hepatotoxicity	NN	PERSON	hepatotoxicity	nsubj	4	SENT_372	[p22l569t2228r1026b2298],
4	associated	VBN	O	associate	_	0	SENT_372	[p22l1054t2228r1369b2282],
5	with	IN	O	with	_	0	SENT_372	[p22l1394t2228r1529b2283],
6	antiepileptic	JJ	O	antiepileptic	amod	7	SENT_372	[p22l1556t2228r1935b2298],
7	drugs	NNS	O	drug	prep_with	4	SENT_372	[p22l1963t2228r2146b2298],
8	.	.	O	.	_	0	SENT_372	[p22l1963t2228r2146b2298],

1	Acta	NNP	O	Acta	nn	3	SENT_373	[p22l141t2326r286b2379],
2	Neurol	NNP	O	Neurol	nn	3	SENT_373	[p22l309t2325r521b2380],
3	Scand	NNP	O	Scand	_	0	SENT_373	[p22l547t2325r733b2380],
4	2008	CD	DATE	2008	num	3	SENT_373	[p22l756t2326r1313b2389],
5	;	:	O	;	_	0	SENT_373	[p22l756t2326r1313b2389],
6	118:281	CD	NUMBER	118:281	number	7	SENT_373	[p22l756t2326r1313b2389],
7	-90	CD	NUMBER	-90	dep	3	SENT_373	[p22l756t2326r1313b2389],
8	.	.	O	.	_	0	SENT_373	[p22l756t2326r1313b2389],

1	Sullivan	NNP	PERSON	Sullivan	nn	2	SENT_374	[p22l143t2420r394b2474],
2	JR	NNP	O	JR	_	0	SENT_374	[p22l413t2421r509b2484],
3	,	,	O	,	_	0	SENT_374	[p22l413t2421r509b2484],
4	Shear	NNP	ORGANIZATION	Shear	nn	5	SENT_374	[p22l534t2420r707b2474],
5	NH	NNP	ORGANIZATION	NH	appos	2	SENT_374	[p22l725t2421r849b2474],
6	.	.	O	.	_	0	SENT_374	[p22l725t2421r849b2474],

1	The	DT	O	the	det	2	SENT_375	[p22l873t2420r991b2474],
2	drug	NN	O	drug	_	0	SENT_375	[p22l1012t2420r1149b2490],
3	hypersensitvity	NN	O	hypersensitvity	nn	4	SENT_375	[p22l1169t2420r1639b2490],
4	syndrome	NN	O	syndrome	dep	2	SENT_375	[p22l1662t2420r1977b2490],
5	:	:	O	:	_	0	SENT_375	[p22l1662t2420r1977b2490],
6	what	WP	O	what	nsubj	9	SENT_375	[p22l2003t2420r2152b2474],
7	is	VBZ	O	be	cop	9	SENT_375	[p22l142t2516r189b2570],
8	the	DT	O	the	det	9	SENT_375	[p22l214t2516r306b2570],
9	pathogenesis	NN	O	pathogenesis	rcmod	2	SENT_375	[p22l330t2516r761b2586],
10	?	.	O	?	_	0	SENT_375	[p22l330t2516r761b2586],

1	Arch	NNP	O	Arch	nn	2	SENT_376	[p22l786t2516r938b2570],
2	Dematol	NNP	O	Dematol	_	0	SENT_376	[p22l961t2516r1225b2570],
3	2001	CD	DATE	2001	num	2	SENT_376	[p22l1251t2516r1808b2580],
4	;	:	O	;	_	0	SENT_376	[p22l1251t2516r1808b2580],
5	137:357	CD	NUMBER	137:357	number	6	SENT_376	[p22l1251t2516r1808b2580],
6	-64	CD	NUMBER	-64	dep	2	SENT_376	[p22l1251t2516r1808b2580],
7	.	.	O	.	_	0	SENT_376	[p22l1251t2516r1808b2580],

1	Overstreet	NNP	PERSON	Overstreet	nn	2	SENT_377	[p22l143t2613r462b2667],
2	K	NNP	PERSON	K	nsubj	13	SENT_377	[p22l491t2614r559b2676],
3	,	,	O	,	_	0	SENT_377	[p22l491t2614r559b2676],
4	Costanza	NNP	ORGANIZATION	Costanza	nn	5	SENT_377	[p22l592t2613r874b2667],
5	C	NNP	ORGANIZATION	C	appos	2	SENT_377	[p22l901t2613r967b2676],
6	,	,	O	,	_	0	SENT_377	[p22l901t2613r967b2676],
7	Behling	NNP	PERSON	Behling	nn	9	SENT_377	[p22l999t2612r1241b2682],
8	C.	NNP	PERSON	C.	nn	9	SENT_377	[p22l1271t2613r1335b2667],
9	Fatal	NNP	PERSON	Fatal	appos	2	SENT_377	[p22l1367t2612r1519b2667],
10	progressive	JJ	O	progressive	amod	12	SENT_377	[p22l1547t2612r1899b2682],
11	hepatic	JJ	O	hepatic	amod	12	SENT_377	[p22l1928t2612r2149b2682],
12	necrosis	NN	O	necrosis	dep	9	SENT_377	[p22l141t2708r391b2763],
13	associated	VBN	O	associate	_	0	SENT_377	[p22l441t2708r756b2763],
14	with	IN	O	with	_	0	SENT_377	[p22l801t2708r937b2763],
15	lamotrigine	NN	O	lamotrigine	nn	16	SENT_377	[p22l983t2708r1338b2778],
16	treatment	NN	O	treatment	prep_with	13	SENT_377	[p22l1384t2716r1691b2763],
17	.	.	O	.	_	0	SENT_377	[p22l1384t2716r1691b2763],

1	Dig	VB	O	dig	_	0	SENT_378	[p22l1742t2708r1855b2778],
2	Dis	NNP	O	Dis	nn	3	SENT_378	[p22l1902t2708r2005b2763],
3	Sci	NNP	O	Sci	dobj	1	SENT_378	[p22l2055t2708r2149b2763],
4	2002	CD	DATE	2002	dep	3	SENT_378	[p22l143t2805r409b2869],
5	;	:	O	;	_	0	SENT_378	[p22l143t2805r409b2869],
6	47	CD	NUMBER	47	num	8	SENT_378	[p22l143t2805r409b2869],
7	:	:	O	:	_	0	SENT_378	[p22l143t2805r409b2869],
8	1921-5	CD	NUMBER	1921-5	dep	3	SENT_378	[p22l424t2805r660b2860],
9	.	.	O	.	_	0	SENT_378	[p22l424t2805r660b2860],

1	Valencia	NNP	O	Valencia	nn	2	SENT_379	[p22l141t2900r408b2955],
2	I	NNP	O	I	_	0	SENT_379	[p22l426t2902r466b2964],
3	,	,	O	,	_	0	SENT_379	[p22l426t2902r466b2964],
4	Piﬁol-Ripoll	NNP	O	Piﬁol-Ripoll	nn	5	SENT_379	[p22l488t2899r869b2970],
5	G	NNP	O	G	appos	2	SENT_379	[p22l889t2901r958b2964],
6	,	,	O	,	_	0	SENT_379	[p22l889t2901r958b2964],
7	Khurana	NNP	PERSON	Khurana	nn	8	SENT_379	[p22l982t2900r1246b2955],
8	DS	NN	O	d	appos	2	SENT_379	[p22l1263t2901r1376b2964],
9	,	,	O	,	_	0	SENT_379	[p22l1263t2901r1376b2964],
10	et	FW	O	et	nn	11	SENT_379	[p22l1399t2909r1453b2955],
11	al.	FW	O	al.	appos	2	SENT_379	[p22l1474t2900r1541b2955],
12	.	.	O	.	_	0	SENT_379	[p22l1474t2900r1541b2955],

1	Efﬁcacy	NN	O	efﬁcacy	_	0	SENT_380	[p22l1564t2900r1819b2970],
2	and	CC	O	and	_	0	SENT_380	[p22l1840t2900r1950b2955],
3	safety	NN	O	safety	conj_and	1	SENT_380	[p22l1970t2900r2150b2970],
4	of	IN	O	of	_	0	SENT_380	[p22l142t2996r209b3051],
5	lamotrigine	NN	O	lamotrigine	nn	6	SENT_380	[p22l228t2996r582b3066],
6	monotherapy	NN	O	monotherapy	prep_of	1	SENT_380	[p22l606t2996r1012b3066],
7	in	IN	O	in	_	0	SENT_380	[p22l1035t2996r1093b3050],
8	children	NNS	O	child	prep_in	1	SENT_380	[p22l1118t2996r1369b3051],
9	and	CC	O	and	_	0	SENT_380	[p22l1393t2996r1503b3051],
10	adolescent	JJ	O	adolescent	conj_and	8	SENT_380	[p22l1527t2996r1851b3051],
11	with	IN	O	with	_	0	SENT_380	[p22l1874t2996r2009b3051],
12	epilepsy	NN	O	epilepsy	prep_with	1	SENT_380	[p22l2033t2996r2149b3066, p22l142t3094r313b3164],
13	.	.	O	.	_	0	SENT_380	[p22l2033t2996r2149b3066, p22l142t3094r313b3164],

1	Eur	NNP	O	Eur	nn	4	SENT_381	[p22l340t3095r452b3148],
2	J	NNP	O	J	nn	4	SENT_381	[p22l473t3095r502b3148],
3	Paediatr	NNP	O	Paediatr	nn	4	SENT_381	[p22l525t3094r777b3148],
4	Neurol	NNP	O	Neurol	_	0	SENT_381	[p22l799t3094r1012b3148],
5	2009	CD	DATE	2009	num	4	SENT_381	[p22l1036t3094r1303b3157],
6	;	:	O	;	_	0	SENT_381	[p22l1036t3094r1303b3157],
7	13	CD	NUMBER	13	num	9	SENT_381	[p22l1036t3094r1303b3157],
8	:	:	O	:	_	0	SENT_381	[p22l1036t3094r1303b3157],
9	141-5	CD	NUMBER	141-5	dep	4	SENT_381	[p22l1318t3093r1516b3148],
10	.	.	O	.	_	0	SENT_381	[p22l1318t3093r1516b3148],

1	Rzany	NN	O	rzany	nsubj	4	SENT_382	[p22l141t3190r336b3258],
2	B	NN	O	b	dep	1	SENT_382	[p22l355t3190r420b3252],
3	,	,	O	,	_	0	SENT_382	[p22l355t3190r420b3252],
4	Hering	VBG	PERSON	her	_	0	SENT_382	[p22l442t3188r654b3258],
5	O	NN	PERSON	o	dobj	4	SENT_382	[p22l675t3189r743b3252],
6	,	,	O	,	_	0	SENT_382	[p22l675t3189r743b3252],
7	Mockenhaupt	NNP	O	Mockenhaupt	nn	8	SENT_382	[p22l764t3188r1188b3258],
8	M	NNP	O	M	appos	5	SENT_382	[p22l1205t3190r1288b3252],
9	,	,	O	,	_	0	SENT_382	[p22l1205t3190r1288b3252],
10	et	FW	O	et	nn	11	SENT_382	[p22l1310t3196r1365b3243],
11	al.	FW	O	al.	appos	8	SENT_382	[p22l1384t3188r1452b3243],
12	.	.	O	.	_	0	SENT_382	[p22l1384t3188r1452b3243],

1	Histopathological	JJ	O	histopathological	amod	4	SENT_383	[p22l1475t3188r2022b3258],
2	and	CC	O	and	_	0	SENT_383	[p22l2043t3188r2151b3243],
3	epidemiological	JJ	O	epidemiological	conj_and	1	SENT_383	[p22l142t3284r638b3354],
4	characteristics	NNS	O	characteristic	_	0	SENT_383	[p22l709t3284r1147b3339],
5	of	IN	O	of	_	0	SENT_383	[p22l1220t3284r1287b3339],
6	patients	NNS	O	patient	prep_of	4	SENT_383	[p22l1350t3284r1588b3354],
7	with	IN	O	with	_	0	SENT_383	[p22l1660t3284r1795b3339],
8	erythema	NN	O	erythema	prep_with	6	SENT_383	[p22l1865t3284r2152b3354],
9	Translational	JJ	O	translational	amod	10	SENT_383	[p22l1315t3375r1773b3434],
10	Research	NN	O	research	dep	4	SENT_383	[p22l1804t3375r2144b3434],
11	May	NNP	DATE	May	tmod	10	SENT_383	[p22l1797t3471r1957b3543],
12	2012	CD	DATE	2012	num	11	SENT_383	[p22l1980t3470r2145b3529],

1	exudativum	NN	O	exudativum	nn	2	SENT_384	[p22l139t3718r500b3772],
2	multiforme	NN	O	multiforme	_	0	SENT_384	[p22l535t3718r881b3772],
3	major	JJ	O	major	dep	2	SENT_384	[p22l918t3718r1110b3788],
4	,	,	O	,	_	0	SENT_384	[p22l918t3718r1110b3788],
5	Stevens	NNP	PERSON	Stevens	appos	3	SENT_384	[p22l1151t3718r1663b3772],
6	.	.	O	.	_	0	SENT_384	[p22l1151t3718r1663b3772],

1	—	NN	O	—	_	0	SENT_385	[p22l1151t3718r1663b3772],
2	.	.	O	.	_	0	SENT_385	[p22l1151t3718r1663b3772],

1	Johnson	NNP	PERSON	Johnson	_	0	SENT_386	[p22l1151t3718r1663b3772],
2	syndrome	NN	O	syndrome	dep	1	SENT_386	[p22l1702t3718r2001b3788],
3	and	CC	O	and	_	0	SENT_386	[p22l2039t3718r2148b3772],
4	toxic	JJ	O	toxic	amod	6	SENT_386	[p23l138t19r290b73],
5	epidermal	JJ	O	epidermal	amod	6	SENT_386	[p23l315t19r622b89],
6	necrolysis	NN	O	necrolysis	dep	1	SENT_386	[p23l646t19r972b89],
7	.	.	O	.	_	0	SENT_386	[p23l646t19r972b89],

1	Br	NN	O	br	nn	2	SENT_387	[p23l1000t20r1076b73],
2	J	NN	O	j	_	0	SENT_387	[p23l1098t20r1126b73],
3	Dermatol	JJ	O	dermatol	amod	4	SENT_387	[p23l1150t19r1440b73],
4	1996	CD	DATE	1996	dep	2	SENT_387	[p23l1471t19r1883b83],
5	;	:	O	;	_	0	SENT_387	[p23l1471t19r1883b83],
6	135:6	CD	NUMBER	135:6	num	7	SENT_387	[p23l1471t19r1883b83],
7	—	NN	O	—	dep	2	SENT_387	[p23l1471t19r1883b83],
8	1	CD	NUMBER	1	number	9	SENT_387	[p23l1471t19r1883b83],
9	1	CD	NUMBER	1	dep	7	SENT_387	[p23l1899t20r1944b73],
10	.	.	O	.	_	0	SENT_387	[p23l1899t20r1944b73],

1	Rzany	NN	O	rzany	nn	2	SENT_388	[p23l138t116r332b185],
2	B	NN	O	b	_	0	SENT_388	[p23l378t116r443b179],
3	,	,	O	,	_	0	SENT_388	[p23l378t116r443b179],
4	Mockenhaupt	NNP	O	Mockenhaupt	nn	5	SENT_388	[p23l491t115r915b185],
5	M	NNP	O	M	appos	2	SENT_388	[p23l958t116r1041b179],
6	,	,	O	,	_	0	SENT_388	[p23l958t116r1041b179],
7	Baur	NNP	PERSON	Baur	nn	8	SENT_388	[p23l1089t116r1239b169],
8	S	NNP	O	S	appos	2	SENT_388	[p23l1284t115r1339b179],
9	,	,	O	,	_	0	SENT_388	[p23l1284t115r1339b179],
10	et	FW	O	et	nn	11	SENT_388	[p23l1387t123r1441b169],
11	al.	FW	O	al.	appos	2	SENT_388	[p23l1487t115r1554b169],
12	.	.	O	.	_	0	SENT_388	[p23l1487t115r1554b169],

1	Epidemiology	NNP	O	Epidemiology	_	0	SENT_389	[p23l1604t115r2039b185],
2	of	IN	O	of	_	0	SENT_389	[p23l2086t115r2152b169],
3	erythema	NN	O	erythema	nn	4	SENT_389	[p23l139t213r426b283],
4	exsudativum	NN	O	exsudativum	prep_of	1	SENT_389	[p23l493t213r884b267],
5	multiforme	JJ	O	multiforme	amod	6	SENT_389	[p23l950t213r1296b267],
6	majus	NN	O	majus	dep	1	SENT_389	[p23l1364t213r1564b283],
7	,	,	O	,	_	0	SENT_389	[p23l1364t213r1564b283],
8	Stevens	NNP	PERSON	Stevens	appos	6	SENT_389	[p23l1636t213r2148b267],
9	.	.	O	.	_	0	SENT_389	[p23l1636t213r2148b267],

1	—	NN	O	—	_	0	SENT_390	[p23l1636t213r2148b267],
2	.	.	O	.	_	0	SENT_390	[p23l1636t213r2148b267],

1	Johnson	NNP	PERSON	Johnson	nn	2	SENT_391	[p23l1636t213r2148b267],
2	syndrome	NN	O	syndrome	_	0	SENT_391	[p23l141t307r456b377],
3	,	,	O	,	_	0	SENT_391	[p23l141t307r456b377],
4	and	CC	O	and	_	0	SENT_391	[p23l497t307r605b361],
5	toxic	JJ	O	toxic	amod	7	SENT_391	[p23l640t307r791b361],
6	epidermal	JJ	O	epidermal	amod	7	SENT_391	[p23l829t307r1135b377],
7	necrolysis	NN	O	necrolysis	conj_and	2	SENT_391	[p23l1171t307r1481b377],
8	in	IN	O	in	_	0	SENT_391	[p23l1517t307r1575b361],
9	Germany	NNP	LOCATION	Germany	prep_in	7	SENT_391	[p23l1612t307r1895b377],
10	(	CD	NUMBER	(	num	9	SENT_391	[p23l1933t307r2149b374, p23l146t404r333b470],
11	1990I992	NN	O	1990i992	dep	7	SENT_391	[p23l1933t307r2149b374, p23l146t404r333b470],
12	)	CD	NUMBER	)	num	11	SENT_391	[p23l1933t307r2149b374, p23l146t404r333b470],
13	:	:	O	:	_	0	SENT_391	[p23l1933t307r2149b374, p23l146t404r333b470],
14	Structure	NN	O	structure	dep	2	SENT_391	[p23l389t404r669b458],
15	and	CC	O	and	_	0	SENT_391	[p23l720t403r828b457],
16	results	NNS	O	result	conj_and	14	SENT_391	[p23l876t403r1075b457],
17	of	IN	O	of	_	0	SENT_391	[p23l1127t403r1194b457],
18	a	DT	O	a	det	20	SENT_391	[p23l1240t420r1272b457],
19	population-based	JJ	O	population-based	amod	20	SENT_391	[p23l1319t403r1851b473],
20	registry	NN	O	registry	prep_of	14	SENT_391	[p23l1899t403r2143b473],
21	.	.	O	.	_	0	SENT_391	[p23l1899t403r2143b473],

1	J	NNP	O	J	nn	4	SENT_392	[p23l138t500r166b554],
2	Clin	NNP	O	Clin	nn	4	SENT_392	[p23l191t499r321b554],
3	Epidemiol	NNP	O	Epidemiol	nn	4	SENT_392	[p23l344t499r665b569],
4	l996	NN	O	l996	_	0	SENT_392	[p23l696t499r1208b563],
5	;	:	O	;	_	0	SENT_392	[p23l696t499r1208b563],
6	49:769	CD	NUMBER	49:769	number	7	SENT_392	[p23l696t499r1208b563],
7	—	CD	NUMBER	—	dep	4	SENT_392	[p23l696t499r1208b563],
8	73	CD	NUMBER	73	dep	7	SENT_392	[p23l696t499r1208b563],
9	.	.	O	.	_	0	SENT_392	[p23l696t499r1208b563],

1	Krivoy	NNP	ORGANIZATION	Krivoy	nn	2	SENT_393	[p23l140t595r351b665],
2	N	NNP	ORGANIZATION	N	_	0	SENT_393	[p23l373t596r443b659],
3	,	,	O	,	_	0	SENT_393	[p23l373t596r443b659],
4	Taeri	NNP	O	Taeri	nn	5	SENT_393	[p23l466t595r622b649],
5	M	NNP	O	M	appos	2	SENT_393	[p23l644t596r727b659],
6	,	,	O	,	_	0	SENT_393	[p23l644t596r727b659],
7	Neuman	NNP	PERSON	Neuman	nn	8	SENT_393	[p23l750t596r1010b649],
8	MG	NN	O	mg	appos	5	SENT_393	[p23l1031t595r1168b649],
9	.	.	O	.	_	0	SENT_393	[p23l1031t595r1168b649],

1	Antiepileptic	JJ	O	antiepileptic	amod	3	SENT_394	[p23l1192t595r1593b665],
2	drug	NN	O	drug	nn	3	SENT_394	[p23l1617t595r2026b665],
3	—	NN	O	—	nsubj	4	SENT_394	[p23l1617t595r2026b665],
4	induced	VBD	O	induce	_	0	SENT_394	[p23l1617t595r2026b665],
5	hypersensitivity	NN	O	hypersensitivity	nn	7	SENT_394	[p23l2046t595r2145b665, p23l137t691r551b761],
6	syndrome	NN	O	syndrome	nn	7	SENT_394	[p23l573t691r872b761],
7	reactions	NNS	O	reaction	dobj	4	SENT_394	[p23l892t691r1185b745],
8	.	.	O	.	_	0	SENT_394	[p23l892t691r1185b745],

1	Curr	NNP	O	Curr	nn	3	SENT_395	[p23l1209t691r1349b746],
2	Drug	NNP	O	Drug	nn	3	SENT_395	[p23l1367t692r1523b761],
3	Saf	NNP	O	Saf	_	0	SENT_395	[p23l1545t691r1648b746],
4	2006	CD	DATE	2006	num	3	SENT_395	[p23l1664t691r1833b755],
5	;	:	O	;	_	0	SENT_395	[p23l1664t691r1833b755],
6	1	CD	NUMBER	1	number	7	SENT_395	[p23l1846t692r1868b745],
7	:289	CD	NUMBER	:289	num	9	SENT_395	[p23l1882t692r2143b746],
8	—	CD	NUMBER	—	number	9	SENT_395	[p23l1882t692r2143b746],
9	99	CD	NUMBER	99	dep	3	SENT_395	[p23l1882t692r2143b746],
10	.	.	O	.	_	0	SENT_395	[p23l1882t692r2143b746],

1	Mockenhaupt	NNP	O	Mockenhaupt	nn	2	SENT_396	[p23l138t787r562b857],
2	M	NNP	O	M	_	0	SENT_396	[p23l594t788r677b851],
3	,	,	O	,	_	0	SENT_396	[p23l594t788r677b851],
4	Viboud	NNP	PERSON	Viboud	nn	5	SENT_396	[p23l713t787r940b841],
5	C	NNP	PERSON	C	appos	2	SENT_396	[p23l973t787r1038b851],
6	,	,	O	,	_	0	SENT_396	[p23l973t787r1038b851],
7	Dunant	NNP	PERSON	Dunant	nn	8	SENT_396	[p23l1074t788r1301b841],
8	A	NNP	O	A	appos	2	SENT_396	[p23l1333t788r1403b851],
9	,	,	O	,	_	0	SENT_396	[p23l1333t788r1403b851],
10	et	FW	O	et	nn	11	SENT_396	[p23l1440t795r1494b841],
11	al.	FW	O	al.	appos	2	SENT_396	[p23l1528t787r1596b841],
12	.	.	O	.	_	0	SENT_396	[p23l1528t787r1596b841],

1	Stevens	NNP	PERSON	Stevens	_	0	SENT_397	[p23l1636t787r2148b842],
2	.	.	O	.	_	0	SENT_397	[p23l1636t787r2148b842],

1	—	NN	O	—	_	0	SENT_398	[p23l1636t787r2148b842],
2	.	.	O	.	_	0	SENT_398	[p23l1636t787r2148b842],

1	Johnson	NNP	PERSON	Johnson	nn	2	SENT_399	[p23l1636t787r2148b842],
2	syndrome	NN	O	syndrome	_	0	SENT_399	[p23l141t883r440b953],
3	and	CC	O	and	_	0	SENT_399	[p23l463t883r573b938],
4	toxic	JJ	O	toxic	amod	6	SENT_399	[p23l593t883r746b938],
5	epidermal	JJ	O	epidermal	amod	6	SENT_399	[p23l769t883r1076b953],
6	necrolysis	NN	O	necrolysis	conj_and	2	SENT_399	[p23l1098t883r1425b953],
7	:	:	O	:	_	0	SENT_399	[p23l1098t883r1425b953],
8	assessment	NN	O	assessment	dep	2	SENT_399	[p23l1454t892r1795b938],
9	of	IN	O	of	_	0	SENT_399	[p23l1817t883r1883b937],
10	medication	NN	O	medication	nn	11	SENT_399	[p23l1899t883r2145b938, p23l138t979r257b1033],
11	risks	NNS	O	risk	prep_of	8	SENT_399	[p23l282t979r425b1033],
12	with	IN	O	with	_	0	SENT_399	[p23l453t979r588b1033],
13	emphasis	NN	O	emphasis	prep_with	11	SENT_399	[p23l615t979r898b1049],
14	on	IN	O	on	_	0	SENT_399	[p23l927t996r1001b1033],
15	recently	RB	DATE	recently	advmod	16	SENT_399	[p23l1027t979r1275b1049],
16	marketed	VBN	O	market	amod	17	SENT_399	[p23l1302t979r1589b1033],
17	drugs	NNS	O	drug	prep_on	13	SENT_399	[p23l1614t979r1799b1049],
18	.	.	O	.	_	0	SENT_399	[p23l1614t979r1799b1049],

1	The	DT	O	the	det	2	SENT_400	[p23l1829t979r1946b1033],
2	EuroSCAR-Study	NNP	O	EuroSCAR-Study	_	0	SENT_400	[p23l1973t980r2145b1033, p23l141t1075r553b1145],
3	.	.	O	.	_	0	SENT_400	[p23l1973t980r2145b1033, p23l141t1075r553b1145],

1	J	NNP	O	J	nn	3	SENT_401	[p23l579t1076r608b1130],
2	Invest	NNP	O	Invest	nn	3	SENT_401	[p23l632t1076r817b1129],
3	Dermatol	NNP	O	Dermatol	_	0	SENT_401	[p23l839t1075r1128b1129],
4	2008	CD	DATE	2008	num	3	SENT_401	[p23l1154t1075r1672b1139],
5	;	:	O	;	_	0	SENT_401	[p23l1154t1075r1672b1139],
6	l28	CD	NUMBER	l28	num	7	SENT_401	[p23l1154t1075r1672b1139],
7	:35	CD	NUMBER	:35	dep	3	SENT_401	[p23l1154t1075r1672b1139],
8	—	NN	O	—	dep	7	SENT_401	[p23l1154t1075r1672b1139],
9	44	CD	NUMBER	44	num	8	SENT_401	[p23l1154t1075r1672b1139],
10	.	.	O	.	_	0	SENT_401	[p23l1154t1075r1672b1139],

1	Zimmerman	NNP	PERSON	Zimmerman	nn	2	SENT_402	[p23l138t1171r519b1226],
2	HJ	NNP	O	HJ	_	0	SENT_402	[p23l550t1173r648b1226],
3	.	.	O	.	_	0	SENT_402	[p23l550t1173r648b1226],

1	The	DT	O	the	det	2	SENT_403	[p23l682t1171r800b1226],
2	spectrum	NN	O	spectrum	_	0	SENT_403	[p23l834t1179r1114b1241],
3	of	IN	O	of	_	0	SENT_403	[p23l1144t1171r1210b1225],
4	hepatotoxicity	NN	O	hepatotoxicity	prep_of	2	SENT_403	[p23l1235t1171r1687b1241],
5	.	.	O	.	_	0	SENT_403	[p23l1235t1171r1687b1241],

1	Prospect	NNP	O	Prospect	nn	2	SENT_404	[p23l1721t1173r1987b1241],
2	Biol	NNP	O	Biol	nsubj	3	SENT_404	[p23l2016t1171r2146b1226],
3	Med	VBD	O	med	_	0	SENT_404	[p23l138t1269r278b1323],
4	1968	CD	DATE	1968	dobj	3	SENT_404	[p23l308t1268r820b1332],
5	;	:	O	;	_	0	SENT_404	[p23l308t1268r820b1332],
6	12:135	CD	NUMBER	12:135	number	7	SENT_404	[p23l308t1268r820b1332],
7	—	CD	NUMBER	—	dep	4	SENT_404	[p23l308t1268r820b1332],
8	61	CD	NUMBER	61	dep	7	SENT_404	[p23l308t1268r820b1332],
9	.	.	O	.	_	0	SENT_404	[p23l308t1268r820b1332],

1	Neuman	NNP	PERSON	Neuman	nn	2	SENT_405	[p23l138t1364r394b1417],
2	MG	NN	O	mg	_	0	SENT_405	[p23l412t1364r548b1427],
3	,	,	O	,	_	0	SENT_405	[p23l412t1364r548b1427],
4	Cameron	NNP	PERSON	Cameron	nn	5	SENT_405	[p23l571t1364r845b1418],
5	RG	NNP	PERSON	RG	appos	2	SENT_405	[p23l864t1363r983b1427],
6	,	,	O	,	_	0	SENT_405	[p23l864t1363r983b1427],
7	Shear	NNP	ORGANIZATION	Shear	nn	8	SENT_405	[p23l1007t1363r1176b1418],
8	NH	NNP	ORGANIZATION	NH	appos	2	SENT_405	[p23l1194t1364r1317b1427],
9	,	,	O	,	_	0	SENT_405	[p23l1194t1364r1317b1427],
10	Feuer	NNP	PERSON	Feuer	nn	13	SENT_405	[p23l1339t1364r1511b1417],
11	G.	NNP	O	G.	nn	13	SENT_405	[p23l1529t1363r1596b1418],
12	Drug-induced	JJ	O	drug-induced	amod	13	SENT_405	[p23l1618t1363r2035b1433],
13	apoptosis	NN	O	apoptosis	conj_and	5	SENT_405	[p23l2054t1380r2145b1433, p23l139t1459r347b1529],
14	of	IN	O	of	_	0	SENT_405	[p23l365t1459r432b1514],
15	skin	NN	O	skin	nn	16	SENT_405	[p23l445t1459r567b1514],
16	cells	NNS	O	cell	prep_of	13	SENT_405	[p23l584t1459r718b1514],
17	and	CC	O	and	_	0	SENT_405	[p23l737t1459r844b1514],
18	liver	NN	O	liver	conj_and	5	SENT_405	[p23l860t1459r1004b1514],
19	.	.	O	.	_	0	SENT_405	[p23l860t1459r1004b1514],

1	In	IN	O	in	dep	4	SENT_406	[p23l1024t1461r1101b1514],
2	:	:	O	:	_	0	SENT_406	[p23l1024t1461r1101b1514],
3	Cameron	NNP	ORGANIZATION	Cameron	nn	4	SENT_406	[p23l1123t1460r1398b1514],
4	RG	NNP	ORGANIZATION	RG	_	0	SENT_406	[p23l1414t1460r1534b1523],
5	,	,	O	,	_	0	SENT_406	[p23l1414t1460r1534b1523],
6	Fauer	NNP	O	Fauer	nn	7	SENT_406	[p23l1553t1461r1725b1514],
7	G	NNP	O	G	appos	4	SENT_406	[p23l1740t1460r1808b1523],
8	,	,	O	,	_	0	SENT_406	[p23l1740t1460r1808b1523],
9	eds	NNS	O	ed	appos	4	SENT_406	[p23l1827t1459r1940b1514],
10	.	.	O	.	_	0	SENT_406	[p23l1827t1459r1940b1514],

1	Handbook	NN	O	handbook	_	0	SENT_407	[p23l1961t1459r2145b1514, p23l137t1557r289b1611],
2	of	IN	O	of	_	0	SENT_407	[p23l311t1556r377b1611],
3	experimental	JJ	O	experimental	amod	4	SENT_407	[p23l395t1556r785b1627],
4	pharmacology	NN	O	pharmacology	prep_of	1	SENT_407	[p23l807t1556r1251b1627],
5	:	:	O	:	_	0	SENT_407	[p23l807t1556r1251b1627],
6	apoptosis	NN	O	apoptosis	dep	1	SENT_407	[p23l1281t1557r1560b1627],
7	and	CC	O	and	_	0	SENT_407	[p23l1584t1557r1691b1611],
8	its	PRP$	O	its	poss	9	SENT_407	[p23l1714t1557r1782b1611],
9	modulation	NN	O	modulation	dep	1	SENT_407	[p23l1805t1557r2146b1611],
10	by	IN	O	by	_	0	SENT_407	[p23l137t1651r212b1721],
11	drugs	NNS	O	drug	prep_by	9	SENT_407	[p23l233t1651r412b1721],
12	.	.	O	.	_	0	SENT_407	[p23l233t1651r412b1721],

1	Heidelberg	NNP	LOCATION	Heidelberg	_	0	SENT_408	[p23l436t1651r782b1721],
2	:	:	O	:	_	0	SENT_408	[p23l436t1651r782b1721],
3	Springer	NNP	ORGANIZATION	Springer	nn	5	SENT_408	[p23l810t1651r1066b1721],
4	Verlag	NNP	ORGANIZATION	Verlag	nn	5	SENT_408	[p23l1084t1651r1278b1721],
5	Publishers	NNPS	ORGANIZATION	Publishers	dep	1	SENT_408	[p23l1299t1651r1624b1715],
6	,	,	O	,	_	0	SENT_408	[p23l1299t1651r1624b1715],
7	1999:344	CD	NUMBER	1999:344	number	8	SENT_408	[p23l1654t1651r2054b1706],
8	—	CD	NUMBER	—	appos	5	SENT_408	[p23l1654t1651r2054b1706],
9	55	CD	NUMBER	55	dep	8	SENT_408	[p23l1654t1651r2054b1706],
10	.	.	O	.	_	0	SENT_408	[p23l1654t1651r2054b1706],

1	Bénichou	NNP	O	Bénichou	nn	3	SENT_409	[p23l138t1744r432b1801],
2	C.	NNP	O	C.	nn	3	SENT_409	[p23l451t1747r514b1801],
3	Criteria	NNP	O	Criteria	nsubj	7	SENT_409	[p23l537t1746r773b1801],
4	of	IN	O	of	_	0	SENT_409	[p23l790t1746r856b1801],
5	drug	NN	O	drug	nn	6	SENT_409	[p23l870t1746r1281b1816],
6	—	NN	O	—	prep_of	3	SENT_409	[p23l870t1746r1281b1816],
7	induced	VBD	O	induce	_	0	SENT_409	[p23l870t1746r1281b1816],
8	liver	NN	O	liver	nn	9	SENT_409	[p23l1297t1746r1436b1801],
9	disorders	NNS	O	disorder	dobj	7	SENT_409	[p23l1453t1746r1749b1801],
10	.	.	O	.	_	0	SENT_409	[p23l1453t1746r1749b1801],

1	Report	NNP	O	Report	_	0	SENT_410	[p23l1770t1748r1980b1816],
2	of	IN	O	of	_	0	SENT_410	[p23l1997t1746r2063b1801],
3	an	DT	O	a	det	6	SENT_410	[p23l2077t1764r2147b1801],
4	international	JJ	O	international	amod	6	SENT_410	[p23l138t1843r527b1898],
5	consensus	NN	O	consensus	nn	6	SENT_410	[p23l552t1860r861b1898],
6	meeting	NN	O	meeting	prep_of	1	SENT_410	[p23l885t1844r1148b1914],
7	.	.	O	.	_	0	SENT_410	[p23l885t1844r1148b1914],

1	J	NNP	O	J	nn	3	SENT_411	[p23l1176t1845r1204b1898],
2	Hepatol	NNP	O	Hepatol	nn	3	SENT_411	[p23l1227t1844r1469b1914],
3	l990	NN	O	l990	_	0	SENT_411	[p23l1500t1843r1974b1907],
4	;	:	O	;	_	0	SENT_411	[p23l1500t1843r1974b1907],
5	11:272	CD	NUMBER	11:272	number	6	SENT_411	[p23l1500t1843r1974b1907],
6	—	CD	NUMBER	—	dep	3	SENT_411	[p23l1500t1843r1974b1907],
7	6	CD	NUMBER	6	dep	6	SENT_411	[p23l1500t1843r1974b1907],
8	.	.	O	.	_	0	SENT_411	[p23l1500t1843r1974b1907],

1	Bell	NNP	ORGANIZATION	Bell	nn	2	SENT_412	[p23l138t1940r265b1994],
2	LN	NN	ORGANIZATION	ln	_	0	SENT_412	[p23l312t1941r429b2004],
3	,	,	O	,	_	0	SENT_412	[p23l312t1941r429b2004],
4	Chalasani	NNP	PERSON	Chalasani	nn	6	SENT_412	[p23l479t1940r781b1994],
5	N.	NNP	PERSON	N.	nn	6	SENT_412	[p23l828t1941r897b1994],
6	Epidemiology	NNP	PERSON	Epidemiology	appos	2	SENT_412	[p23l947t1940r1383b2010],
7	of	IN	O	of	_	0	SENT_412	[p23l1431t1940r1497b1994],
8	idiosyncratic	JJ	O	idiosyncratic	amod	9	SENT_412	[p23l1538t1940r1934b2010],
9	druginduced	JJ	O	druginduced	amod	11	SENT_412	[p23l1983t1940r2145b2010, p23l138t2034r383b2089],
10	liver	NN	O	liver	nn	11	SENT_412	[p23l405t2034r545b2089],
11	injury	NN	O	injury	prep_of	6	SENT_412	[p23l566t2034r759b2104],
12	.	.	O	.	_	0	SENT_412	[p23l566t2034r759b2104],

1	Semin	NNP	O	Semin	nn	3	SENT_413	[p23l788t2034r982b2089],
2	Liver	NN	O	liver	nn	3	SENT_413	[p23l1005t2034r1170b2089],
3	Dis	NNP	O	Dis	_	0	SENT_413	[p23l1192t2034r1296b2089],
4	2009	CD	DATE	2009	dep	3	SENT_413	[p23l1322t2035r1840b2098],
5	;	:	O	;	_	0	SENT_413	[p23l1322t2035r1840b2098],
6	29:337	CD	NUMBER	29:337	number	7	SENT_413	[p23l1322t2035r1840b2098],
7	—	CD	NUMBER	—	dep	3	SENT_413	[p23l1322t2035r1840b2098],
8	47	CD	NUMBER	47	dep	7	SENT_413	[p23l1322t2035r1840b2098],
9	.	.	O	.	_	0	SENT_413	[p23l1322t2035r1840b2098],

1	Stevens	NNP	ORGANIZATION	Stevens	nn	2	SENT_414	[p23l141t2132r373b2186],
2	AM	NNP	ORGANIZATION	AM	_	0	SENT_414	[p23l400t2132r539b2195],
3	,	,	O	,	_	0	SENT_414	[p23l400t2132r539b2195],
4	Johnson	NNP	PERSON	Johnson	nn	5	SENT_414	[p23l567t2132r818b2186],
5	FC	NNP	O	FC	appos	2	SENT_414	[p23l843t2132r952b2186],
6	.	.	O	.	_	0	SENT_414	[p23l843t2132r952b2186],

1	A	DT	O	a	det	4	SENT_415	[p23l982t2132r1036b2185],
2	new	JJ	O	new	amod	4	SENT_415	[p23l1062t2148r1186b2186],
3	eruptive	JJ	O	eruptive	amod	4	SENT_415	[p23l1213t2132r1462b2202],
4	fever	NN	O	fever	nsubj	5	SENT_415	[p23l1489t2131r1645b2186],
5	associated	VBN	O	associate	_	0	SENT_415	[p23l1671t2131r1986b2186],
6	with	IN	O	with	_	0	SENT_415	[p23l2012t2132r2147b2186],
7	stomatitis	NN	O	stomatitis	prep_with	5	SENT_415	[p23l141t2228r436b2282],
8	and	CC	O	and	_	0	SENT_415	[p23l466t2228r575b2282],
9	ophthalmia	NN	O	ophthalmia	prep_with	5	SENT_415	[p23l603t2228r964b2298],
10	.	.	O	.	_	0	SENT_415	[p23l603t2228r964b2298],

1	Report	NNP	O	Report	_	0	SENT_416	[p23l995t2229r1204b2298],
2	of	IN	O	of	_	0	SENT_416	[p23l1231t2228r1298b2282],
3	two	CD	NUMBER	two	num	4	SENT_416	[p23l1320t2236r1433b2282],
4	cases	NNS	O	case	prep_of	1	SENT_416	[p23l1462t2245r1621b2282],
5	in	IN	O	in	_	0	SENT_416	[p23l1649t2228r1708b2281],
6	children	NNS	O	child	prep_in	1	SENT_416	[p23l1736t2228r2003b2282],
7	.	.	O	.	_	0	SENT_416	[p23l1736t2228r2003b2282],

1	Am	NNP	O	Am	nn	4	SENT_417	[p23l2033t2228r2148b2281],
2	J	NNP	O	J	nn	4	SENT_417	[p23l138t2325r166b2378],
3	Dis	NNP	O	Dis	nn	4	SENT_417	[p23l189t2324r293b2378],
4	Child	NNP	O	Child	_	0	SENT_417	[p23l319t2324r489b2378],
5	1922	CD	DATE	1922	num	4	SENT_417	[p23l519t2324r992b2387],
6	;	:	O	;	_	0	SENT_417	[p23l519t2324r992b2387],
7	4:526	CD	NUMBER	4:526	number	8	SENT_417	[p23l519t2324r992b2387],
8	—	CD	NUMBER	—	dep	4	SENT_417	[p23l519t2324r992b2387],
9	33	CD	NUMBER	33	dep	8	SENT_417	[p23l519t2324r992b2387],
10	.	.	O	.	_	0	SENT_417	[p23l519t2324r992b2387],

1	Lyell	NNP	PERSON	Lyell	nn	2	SENT_418	[p23l138t2420r296b2490],
2	A.	NNP	O	A.	_	0	SENT_418	[p23l338t2420r407b2474],
3	Toxic	JJ	O	toxic	amod	5	SENT_418	[p23l453t2420r625b2474],
4	epidermal	JJ	O	epidermal	amod	5	SENT_418	[p23l669t2420r976b2490],
5	necrolysis	NN	O	necrolysis	dep	2	SENT_418	[p23l1019t2419r1346b2490],
6	:	:	O	:	_	0	SENT_418	[p23l1019t2419r1346b2490],
7	an	DT	O	a	det	8	SENT_418	[p23l1396t2436r1466b2474],
8	eruption	NN	O	eruption	dep	2	SENT_418	[p23l1509t2420r1764b2490],
9	resembling	VBG	O	resemble	partmod	8	SENT_418	[p23l1805t2419r2147b2490],
10	scalding	NN	O	scalding	attr	9	SENT_418	[p23l141t2516r393b2586],
11	of	IN	O	of	_	0	SENT_418	[p23l419t2516r485b2570],
12	the	DT	O	the	det	13	SENT_418	[p23l503t2516r596b2570],
13	skin	NN	O	skin	prep_of	10	SENT_418	[p23l622t2516r762b2570],
14	.	.	O	.	_	0	SENT_418	[p23l622t2516r762b2570],

1	Br	NN	O	br	nn	4	SENT_419	[p23l789t2517r866b2569],
2	J	NN	O	j	nn	4	SENT_419	[p23l887t2517r915b2570],
3	Dermatol	NN	O	dermatol	nn	4	SENT_419	[p23l939t2516r1229b2570],
4	l956	NN	O	l956	_	0	SENT_419	[p23l1260t2515r1772b2579],
5	;	:	O	;	_	0	SENT_419	[p23l1260t2515r1772b2579],
6	68:355	CD	NUMBER	68:355	number	7	SENT_419	[p23l1260t2515r1772b2579],
7	—	CD	NUMBER	—	dep	4	SENT_419	[p23l1260t2515r1772b2579],
8	61	CD	NUMBER	61	dep	7	SENT_419	[p23l1260t2515r1772b2579],
9	.	.	O	.	_	0	SENT_419	[p23l1260t2515r1772b2579],

1	Caraco	NNP	O	Caraco	nn	2	SENT_420	[p23l139t2612r355b2666],
2	Y	NN	O	y	_	0	SENT_420	[p23l378t2613r438b2675],
3	,	,	O	,	_	0	SENT_420	[p23l378t2613r438b2675],
4	Zylber	NNP	O	Zylber	appos	2	SENT_420	[p23l463t2612r837b2682],
5	.	.	O	.	_	0	SENT_420	[p23l463t2612r837b2682],

1	—	NN	O	—	_	0	SENT_421	[p23l463t2612r837b2682],
2	.	.	O	.	_	0	SENT_421	[p23l463t2612r837b2682],

1	Katz	NNP	PERSON	Katz	nn	2	SENT_422	[p23l463t2612r837b2682],
2	E	NNP	O	E	nsubj	15	SENT_422	[p23l860t2613r922b2675],
3	,	,	O	,	_	0	SENT_422	[p23l860t2613r922b2675],
4	Berry	NNP	ORGANIZATION	Berry	nn	5	SENT_422	[p23l947t2613r1120b2682],
5	EM	NNP	ORGANIZATION	EM	appos	2	SENT_422	[p23l1143t2613r1274b2675],
6	,	,	O	,	_	0	SENT_422	[p23l1143t2613r1274b2675],
7	Levy	NNP	PERSON	Levy	nn	11	SENT_422	[p23l1298t2613r1453b2682],
8	M.	NNP	PERSON	M.	nn	11	SENT_422	[p23l1475t2613r1558b2666],
9	Signiﬁcant	NNP	PERSON	Signiﬁcant	nn	11	SENT_422	[p23l1586t2612r1917b2682],
10	weight	NN	O	weight	nn	11	SENT_422	[p23l1939t2612r2148b2682],
11	reduction	NN	O	reduction	appos	2	SENT_422	[p23l137t2707r429b2762],
12	in	IN	O	in	_	0	SENT_422	[p23l449t2708r508b2761],
13	obese	JJ	O	obese	amod	14	SENT_422	[p23l529t2707r702b2762],
14	subjects	NNS	O	subject	prep_in	11	SENT_422	[p23l726t2707r969b2778],
15	enhances	VBZ	O	enhance	_	0	SENT_422	[p23l991t2708r1271b2762],
16	carbamazepine	NN	O	carbamazepine	nn	17	SENT_422	[p23l1293t2708r1756b2778],
17	elimination	NN	O	elimination	dobj	15	SENT_422	[p23l1777t2707r2144b2762],
18	.	.	O	.	_	0	SENT_422	[p23l1777t2707r2144b2762],

1	Clin	NNP	O	Clin	nn	4	SENT_423	[p23l139t2804r270b2858],
2	Pharmacol	NNP	O	Pharmacol	nn	4	SENT_423	[p23l293t2804r622b2858],
3	Ther	NNP	O	Ther	nn	4	SENT_423	[p23l646t2804r791b2858],
4	l992	NN	O	l992	_	0	SENT_423	[p23l820t2803r1294b2867],
5	;	:	O	;	_	0	SENT_423	[p23l820t2803r1294b2867],
6	5l	NN	O	5l	dep	4	SENT_423	[p23l820t2803r1294b2867],
7	:50	CD	NUMBER	:50	num	8	SENT_423	[p23l820t2803r1294b2867],
8	l	NN	O	l	dep	6	SENT_423	[p23l820t2803r1294b2867],
9	—	CD	NUMBER	—	number	10	SENT_423	[p23l820t2803r1294b2867],
10	6	CD	NUMBER	6	dep	8	SENT_423	[p23l820t2803r1294b2867],
11	.	.	O	.	_	0	SENT_423	[p23l820t2803r1294b2867],

1	Neuman	NNP	PERSON	Neuman	nn	2	SENT_424	[p23l138t2901r398b2954],
2	MG	NN	O	mg	_	0	SENT_424	[p23l430t2900r568b2963],
3	,	,	O	,	_	0	SENT_424	[p23l430t2900r568b2963],
4	Shear	NNP	ORGANIZATION	Shear	nn	5	SENT_424	[p23l605t2900r779b2954],
5	NH	NNP	ORGANIZATION	NH	appos	2	SENT_424	[p23l809t2901r935b2963],
6	,	,	O	,	_	0	SENT_424	[p23l809t2901r935b2963],
7	Malkiewicz	NNP	PERSON	Malkiewicz	nn	8	SENT_424	[p23l969t2900r1331b2954],
8	IM	NNP	O	IM	appos	2	SENT_424	[p23l1364t2901r1473b2963],
9	,	,	O	,	_	0	SENT_424	[p23l1364t2901r1473b2963],
10	Kessas	NNP	O	Kessas	nn	11	SENT_424	[p23l1509t2901r1716b2954],
11	M	NNP	O	M	appos	2	SENT_424	[p23l1749t2901r1832b2963],
12	,	,	O	,	_	0	SENT_424	[p23l1749t2901r1832b2963],
13	Lee	NNP	PERSON	Lee	nn	14	SENT_424	[p23l1867t2901r1981b2954],
14	AW	NNP	O	AW	appos	2	SENT_424	[p23l2015t2900r2144b2963],
15	,	,	O	,	_	0	SENT_424	[p23l2015t2900r2144b2963],
16	Cohen	NNP	PERSON	Cohen	nn	17	SENT_424	[p23l139t2994r338b3048],
17	L.	NNP	O	L.	nsubj	18	SENT_424	[p23l372t2995r433b3048],
18	Predicting	VBG	O	predict	dep	2	SENT_424	[p23l471t2994r787b3064],
19	possible	JJ	O	possible	amod	22	SENT_424	[p23l821t2994r1073b3064],
20	zonisamide	NN	O	zonisamide	nn	22	SENT_424	[p23l1108t2994r1458b3048],
21	hypersensitivity	NN	O	hypersensitivity	nn	22	SENT_424	[p23l1492t2994r1982b3064],
22	syndrome	NN	O	syndrome	dobj	18	SENT_424	[p23l2019t3011r2145b3064, p23l139t3092r349b3146],
23	.	.	O	.	_	0	SENT_424	[p23l2019t3011r2145b3064, p23l139t3092r349b3146],

1	Exp	NNP	MISC	Exp	nn	2	SENT_425	[p23l376t3093r498b3162],
2	Dermatol	NNP	MISC	Dermatol	_	0	SENT_425	[p23l522t3092r812b3146],
3	2008	CD	DATE	2008	num	2	SENT_425	[p23l837t3092r1104b3155],
4	;	:	O	;	_	0	SENT_425	[p23l837t3092r1104b3155],
5	17	CD	NUMBER	17	num	7	SENT_425	[p23l837t3092r1104b3155],
6	:	:	O	:	_	0	SENT_425	[p23l837t3092r1104b3155],
7	1045-51	CD	NUMBER	1045-51	dep	2	SENT_425	[p23l1119t3092r1394b3146],
8	.	.	O	.	_	0	SENT_425	[p23l1119t3092r1394b3146],

1	Chan	NNP	O	Chan	nn	2	SENT_426	[p23l139t3186r299b3240],
2	HL	NNS	O	hl	_	0	SENT_426	[p23l323t3187r440b3249],
3	,	,	O	,	_	0	SENT_426	[p23l323t3187r440b3249],
4	Stern	NNP	ORGANIZATION	Stern	nn	5	SENT_426	[p23l469t3186r627b3240],
5	RS	NN	ORGANIZATION	r	appos	2	SENT_426	[p23l651t3186r760b3250],
6	,	,	O	,	_	0	SENT_426	[p23l651t3186r760b3250],
7	Arndt	NNP	PERSON	Arndt	nn	8	SENT_426	[p23l786t3186r965b3240],
8	KA	NN	O	ka	appos	2	SENT_426	[p23l989t3186r1113b3250],
9	,	,	O	,	_	0	SENT_426	[p23l989t3186r1113b3250],
10	et	FW	O	et	nn	11	SENT_426	[p23l1140t3194r1194b3240],
11	al.	FW	O	al.	appos	2	SENT_426	[p23l1219t3186r1287b3240],
12	.	.	O	.	_	0	SENT_426	[p23l1219t3186r1287b3240],

1	The	DT	O	the	det	2	SENT_427	[p23l1314t3186r1432b3240],
2	incidence	NN	O	incidence	_	0	SENT_427	[p23l1456t3186r1751b3240],
3	of	IN	O	of	_	0	SENT_427	[p23l1776t3186r1843b3240],
4	erythema	NN	O	erythema	nn	5	SENT_427	[p23l1862t3186r2149b3256],
5	multiforme	NN	O	multiforme	prep_of	2	SENT_427	[p23l138t3282r502b3346],
6	,	,	O	,	_	0	SENT_427	[p23l138t3282r502b3346],
7	Stevens	NNP	PERSON	Stevens	appos	5	SENT_427	[p23l524t3282r1035b3336],
8	.	.	O	.	_	0	SENT_427	[p23l524t3282r1035b3336],

1	—	NN	O	—	_	0	SENT_428	[p23l524t3282r1035b3336],
2	.	.	O	.	_	0	SENT_428	[p23l524t3282r1035b3336],

1	Johnson	NNP	PERSON	Johnson	_	0	SENT_429	[p23l524t3282r1035b3336],
2	syndrome	NN	O	syndrome	dep	1	SENT_429	[p23l1055t3282r1371b3352],
3	,	,	O	,	_	0	SENT_429	[p23l1055t3282r1371b3352],
4	and	CC	O	and	_	0	SENT_429	[p23l1393t3282r1502b3336],
5	toxic	JJ	O	toxic	amod	7	SENT_429	[p23l1519t3282r1671b3336],
6	epidermal	JJ	O	epidermal	amod	7	SENT_429	[p23l1691t3282r1998b3352],
7	necrolysis	NN	O	necrolysis	conj_and	2	SENT_429	[p23l2016t3299r2145b3336, p23l137t3378r357b3448],
8	.	.	O	.	_	0	SENT_429	[p23l2016t3299r2145b3336, p23l137t3378r357b3448],

1	A	DT	O	a	det	2	SENT_430	[p23l381t3379r435b3432],
2	population	NN	O	population	dep	4	SENT_430	[p23l454t3378r806b3448],
3	-	:	O	-	_	0	SENT_430	[p23l454t3378r806b3448],
4	based	VBN	O	base	_	0	SENT_430	[p23l828t3378r1004b3432],
5	study	NN	O	study	dobj	4	SENT_430	[p23l1026t3378r1188b3448],
6	with	IN	O	with	_	0	SENT_430	[p23l1209t3378r1344b3433],
7	particular	JJ	O	particular	amod	8	SENT_430	[p23l1362t3378r1660b3448],
8	reference	NN	O	reference	prep_with	4	SENT_430	[p23l1678t3378r1965b3432],
9	to	TO	O	to	_	0	SENT_430	[p23l1984t3386r2042b3432],
10	reactions	NNS	O	reaction	prep_to	4	SENT_430	[p23l2063t3395r2145b3432, p23l140t3474r354b3528],
11	caused	VBN	O	cause	partmod	10	SENT_430	[p23l376t3474r584b3528],
12	by	IN	O	by	_	0	SENT_430	[p23l602t3474r678b3544],
13	drugs	NNS	O	drug	agent	11	SENT_430	[p23l699t3474r866b3544],
14	among	IN	O	among	_	0	SENT_430	[p23l889t3491r1095b3544],
15	outpatients	NNS	O	outpatient	prep_among	13	SENT_430	[p23l1116t3474r1468b3544],
16	.	.	O	.	_	0	SENT_430	[p23l1116t3474r1468b3544],

1	Arch	NNP	O	Arch	nn	2	SENT_431	[p23l1491t3474r1644b3528],
2	Dermatol	NNP	O	Dermatol	_	0	SENT_431	[p23l1663t3474r1953b3528],
3	1990	CD	DATE	1990	num	2	SENT_431	[p23l1981t3474r2144b3538],
4	;	:	O	;	_	0	SENT_431	[p23l1981t3474r2144b3538],
5	l26	CD	NUMBER	l26	num	6	SENT_431	[p23l145t3570r443b3624],
6	:43	CD	NUMBER	:43	dep	2	SENT_431	[p23l145t3570r443b3624],
7	—	NN	O	—	dep	6	SENT_431	[p23l145t3570r443b3624],
8	7	CD	NUMBER	7	num	7	SENT_431	[p23l145t3570r443b3624],
9	.	.	O	.	_	0	SENT_431	[p23l145t3570r443b3624],

1	Naldi	NNP	PERSON	Naldi	nn	2	SENT_432	[p23l138t3666r307b3720],
2	L	NNP	PERSON	L	_	0	SENT_432	[p23l329t3667r391b3730],
3	,	,	O	,	_	0	SENT_432	[p23l329t3667r391b3730],
4	Locati	NNP	O	Locati	nn	5	SENT_432	[p23l415t3666r611b3720],
5	F	NN	O	f	appos	2	SENT_432	[p23l634t3667r685b3730],
6	,	,	O	,	_	0	SENT_432	[p23l634t3667r685b3730],
7	Marchesi	NNP	PERSON	Marchesi	nn	8	SENT_432	[p23l710t3666r995b3720],
8	L	NNP	PERSON	L	appos	2	SENT_432	[p23l1017t3667r1079b3730],
9	,	,	O	,	_	0	SENT_432	[p23l1017t3667r1079b3730],
10	Cainelli	NNP	O	Cainelli	nn	12	SENT_432	[p23l1104t3666r1346b3721],
11	T.	NNP	O	T.	nn	12	SENT_432	[p23l1369t3667r1424b3720],
12	Incidence	NN	O	incidence	appos	2	SENT_432	[p23l1450t3666r1749b3720],
13	of	IN	O	of	_	0	SENT_432	[p23l1771t3666r1838b3720],
14	toxic	JJ	O	toxic	amod	15	SENT_432	[p23l1854t3666r2006b3720],
15	epidermal	JJ	O	epidermal	prep_of	12	SENT_432	[p23l2030t3666r2145b3736, p24l139t20r351b74],

1	necrolysis	NN	O	necrolysis	_	0	SENT_433	[p24l374t20r684b90],
2	in	IN	O	in	_	0	SENT_433	[p24l710t20r768b74],
3	Italy	NNP	LOCATION	Italy	prep_in	1	SENT_433	[p24l791t20r942b90],
4	.	.	O	.	_	0	SENT_433	[p24l791t20r942b90],

1	Arch	NNP	O	Arch	nn	2	SENT_434	[p24l969t20r1122b74],
2	Dermatol	NNP	O	Dermatol	_	0	SENT_434	[p24l1145t20r1435b74],
3	1990	CD	DATE	1990	num	2	SENT_434	[p24l1466t20r2016b84],
4	;	:	O	;	_	0	SENT_434	[p24l1466t20r2016b84],
5	126	CD	NUMBER	126	num	7	SENT_434	[p24l1466t20r2016b84],
6	:	:	O	:	_	0	SENT_434	[p24l1466t20r2016b84],
7	l103	CD	NUMBER	l103	dep	2	SENT_434	[p24l1466t20r2016b84],
8	—	CD	NUMBER	—	number	9	SENT_434	[p24l1466t20r2016b84],
9	4	CD	NUMBER	4	dep	7	SENT_434	[p24l1466t20r2016b84],
10	.	.	O	.	_	0	SENT_434	[p24l1466t20r2016b84],

1	Roujeau	NNP	O	Roujeau	nn	2	SENT_435	[p24l138t116r395b186],
2	JC	NNP	O	JC	_	0	SENT_435	[p24l434t116r530b180],
3	,	,	O	,	_	0	SENT_435	[p24l434t116r530b180],
4	Guillaume	NNP	PERSON	Guillaume	nn	5	SENT_435	[p24l574t116r898b170],
5	JC	NNP	PERSON	JC	appos	2	SENT_435	[p24l938t116r1034b180],
6	,	,	O	,	_	0	SENT_435	[p24l938t116r1034b180],
7	Fabre	NNP	ORGANIZATION	Fabre	nn	8	SENT_435	[p24l1077t116r1251b170],
8	JP	NNP	ORGANIZATION	JP	appos	5	SENT_435	[p24l1290t117r1369b180],
9	,	,	O	,	_	0	SENT_435	[p24l1290t117r1369b180],
10	Penso	NNP	ORGANIZATION	Penso	nn	11	SENT_435	[p24l1412t117r1593b170],
11	D	NNP	ORGANIZATION	D	appos	5	SENT_435	[p24l1635t117r1704b180],
12	,	,	O	,	_	0	SENT_435	[p24l1635t117r1704b180],
13	Flechet	NNP	O	Flechet	nn	14	SENT_435	[p24l1748t116r1975b170],
14	ML	NNP	O	ML	appos	5	SENT_435	[p24l2014t117r2144b180],
15	,	,	O	,	_	0	SENT_435	[p24l2014t117r2144b180],
16	Girre	NNP	O	Girre	nn	17	SENT_435	[p24l139t212r299b267],
17	JP	NNP	O	JP	appos	5	SENT_435	[p24l319t213r397b267],
18	.	.	O	.	_	0	SENT_435	[p24l319t213r397b267],

1	Toxic	JJ	O	toxic	amod	3	SENT_436	[p24l422t212r593b266],
2	epidermal	JJ	O	epidermal	amod	3	SENT_436	[p24l616t212r924b282],
3	necrolysis	NN	O	necrolysis	_	0	SENT_436	[p24l944t212r1254b282],
4	(	CD	NUMBER	(	num	7	SENT_436	[p24l1279t212r1459b282],
5	Lyell	NNP	PERSON	Lyell	nn	7	SENT_436	[p24l1279t212r1459b282],
6	syndrome	NN	O	syndrome	nn	7	SENT_436	[p24l1483t212r1823b282],
7	)	NN	O	)	dep	3	SENT_436	[p24l1483t212r1823b282],
8	.	.	O	.	_	0	SENT_436	[p24l1483t212r1823b282],

1	Incidence	NN	O	incidence	nn	4	SENT_437	[p24l1848t212r2147b266],
2	and	CC	O	and	_	0	SENT_437	[p24l140t308r249b363],
3	drug	NN	O	drug	nn	4	SENT_437	[p24l279t308r417b378],
4	etiology	NN	O	etiology	_	0	SENT_437	[p24l448t308r699b378],
5	in	IN	O	in	_	0	SENT_437	[p24l730t308r788b362],
6	France	NNP	LOCATION	France	prep_in	4	SENT_437	[p24l818t310r1043b372],
7	,	,	O	,	_	0	SENT_437	[p24l818t310r1043b372],
8	1981-1985	CD	DATE	1981-1985	appos	6	SENT_437	[p24l1083t308r1437b363],
9	.	.	O	.	_	0	SENT_437	[p24l1083t308r1437b363],

1	Arch	NNP	O	Arch	nn	2	SENT_438	[p24l1470t308r1623b363],
2	Dermatol	NNP	O	Dermatol	_	0	SENT_438	[p24l1653t308r1943b363],
3	1990	CD	DATE	1990	num	2	SENT_438	[p24l1981t309r2144b372],
4	;	:	O	;	_	0	SENT_438	[p24l1981t309r2144b372],
5	126:37	CD	NUMBER	126:37	number	6	SENT_438	[p24l145t404r482b458],
6	—	CD	NUMBER	—	dep	2	SENT_438	[p24l145t404r482b458],
7	42	CD	NUMBER	42	dep	6	SENT_438	[p24l145t404r482b458],
8	.	.	O	.	_	0	SENT_438	[p24l145t404r482b458],

1	Assier	NN	O	assier	nn	2	SENT_439	[p24l138t500r335b554],
2	H	NN	O	h	_	0	SENT_439	[p24l353t501r423b564],
3	,	,	O	,	_	0	SENT_439	[p24l353t501r423b564],
4	Bastuji-Garin	NNP	PERSON	Bastuji-Garin	nn	5	SENT_439	[p24l446t500r864b570],
5	S	NNP	O	S	appos	2	SENT_439	[p24l887t500r941b564],
6	,	,	O	,	_	0	SENT_439	[p24l887t500r941b564],
7	Revuz	NNP	PERSON	Revuz	nn	8	SENT_439	[p24l965t501r1158b554],
8	J	NNP	PERSON	J	appos	2	SENT_439	[p24l1178t501r1206b555],
9	,	,	O	,	_	0	SENT_439	[p24l1212t545r1223b564],
10	Roujeau	NNP	PERSON	Roujeau	nn	14	SENT_439	[p24l1246t500r1502b570],
11	J	NNP	PERSON	J	nn	14	SENT_439	[p24l1521t501r1550b555],
12	C.	NNP	PERSON	C.	nn	14	SENT_439	[p24l1553t501r1617b555],
13	Erythema	NNP	PERSON	Erythema	nn	14	SENT_439	[p24l1640t500r1940b570],
14	multiforme	NN	O	multiforme	conj_and	5	SENT_439	[p24l1960t500r2145b554, p24l138t596r321b651],
15	with	IN	O	with	_	0	SENT_439	[p24l340t596r476b651],
16	mucous	JJ	O	mucous	amod	18	SENT_439	[p24l497t613r733b651],
17	membrane	NN	O	membrane	nn	18	SENT_439	[p24l755t596r1080b651],
18	involvement	NN	O	involvement	prep_with	14	SENT_439	[p24l1101t596r1483b651],
19	and	CC	O	and	_	0	SENT_439	[p24l1505t596r1614b651],
20	Stevens	NNP	PERSON	Stevens	appos	2	SENT_439	[p24l1636t596r2148b651],
21	.	.	O	.	_	0	SENT_439	[p24l1636t596r2148b651],

1	—	NN	O	—	_	0	SENT_440	[p24l1636t596r2148b651],
2	.	.	O	.	_	0	SENT_440	[p24l1636t596r2148b651],

1	Johnson	NNP	PERSON	Johnson	nn	2	SENT_441	[p24l1636t596r2148b651],
2	syndrome	NN	O	syndrome	nsubj	6	SENT_441	[p24l141t694r440b764],
3	are	VBP	O	be	cop	6	SENT_441	[p24l471t710r562b748],
4	clinically	RB	O	clinically	advmod	5	SENT_441	[p24l592t693r878b764],
5	different	JJ	O	different	amod	6	SENT_441	[p24l908t693r1172b748],
6	disorders	NNS	O	disorder	_	0	SENT_441	[p24l1200t693r1479b748],
7	with	IN	O	with	_	0	SENT_441	[p24l1509t693r1645b748],
8	distinct	JJ	O	distinct	amod	9	SENT_441	[p24l1674t694r1901b748],
9	causes	NNS	O	cause	prep_with	6	SENT_441	[p24l1929t710r2143b748],
10	.	.	O	.	_	0	SENT_441	[p24l1929t710r2143b748],

1	Arch	NNP	O	Arch	nn	2	SENT_442	[p24l138t789r291b843],
2	Dermatol	NNP	O	Dermatol	_	0	SENT_442	[p24l314t789r604b843],
3	1995	CD	DATE	1995	num	2	SENT_442	[p24l635t789r1185b853],
4	;	:	O	;	_	0	SENT_442	[p24l635t789r1185b853],
5	131:539	CD	NUMBER	131:539	number	6	SENT_442	[p24l635t789r1185b853],
6	—	CD	NUMBER	—	dep	2	SENT_442	[p24l635t789r1185b853],
7	43	CD	NUMBER	43	dep	6	SENT_442	[p24l635t789r1185b853],
8	.	.	O	.	_	0	SENT_442	[p24l635t789r1185b853],

1	Chan	NNP	O	Chan	_	0	SENT_443	[p24l139t884r299b939],
2	HL	NNS	O	hl	dep	1	SENT_443	[p24l320t886r435b939],
3	.	.	O	.	_	0	SENT_443	[p24l320t886r435b939],

1	Toxic	JJ	O	toxic	amod	3	SENT_444	[p24l459t884r631b939],
2	epidermal	JJ	O	epidermal	amod	3	SENT_444	[p24l652t884r959b954],
3	necrolysis	NN	O	necrolysis	_	0	SENT_444	[p24l978t884r1289b954],
4	in	IN	O	in	_	0	SENT_444	[p24l1310t884r1368b938],
5	Singapore	NNP	LOCATION	Singapore	prep_in	3	SENT_444	[p24l1390t884r1715b954],
6	,	,	O	,	_	0	SENT_444	[p24l1390t884r1715b954],
7	1989	CD	DATE	1989	appos	5	SENT_444	[p24l1745t885r1888b939],
8	through	IN	DATE	through	_	0	SENT_444	[p24l1909t884r2148b954],
9	1993	CD	DATE	1993	prep_through	7	SENT_444	[p24l145t982r307b1036],
10	:	:	O	:	_	0	SENT_444	[p24l145t982r307b1036],
11	Incidence	NN	O	incidence	dep	3	SENT_444	[p24l343t982r642b1036],
12	and	CC	O	and	_	0	SENT_444	[p24l676t982r784b1036],
13	antecedent	JJ	O	antecedent	amod	15	SENT_444	[p24l816t982r1146b1036],
14	drug	NN	O	drug	nn	15	SENT_444	[p24l1177t982r1315b1052],
15	exposure	NN	O	exposure	dep	3	SENT_444	[p24l1347t998r1638b1052],
16	.	.	O	.	_	0	SENT_444	[p24l1347t998r1638b1052],

1	Arch	NNP	O	Arch	nn	2	SENT_445	[p24l1673t982r1826b1036],
2	Dermatol	NNP	O	Dermatol	_	0	SENT_445	[p24l1857t982r2147b1036],
3	1995	CD	DATE	1995	num	2	SENT_445	[p24l145t1077r696b1141],
4	;	:	O	;	_	0	SENT_445	[p24l145t1077r696b1141],
5	131:1212	CD	NUMBER	131:1212	number	6	SENT_445	[p24l145t1077r696b1141],
6	—	CD	NUMBER	—	dep	2	SENT_445	[p24l145t1077r696b1141],
7	3	CD	NUMBER	3	dep	6	SENT_445	[p24l145t1077r696b1141],
8	.	.	O	.	_	0	SENT_445	[p24l145t1077r696b1141],

1	Kelemen	NNP	PERSON	Kelemen	_	0	SENT_446	[p24l140t1173r414b1227],
2	JJ	NN	PERSON	jj	dep	1	SENT_446	[p24l462t1175r520b1228],
3	III	CD	PERSON	iii	num	2	SENT_446	[p24l568t1175r659b1237],
4	,	,	O	,	_	0	SENT_446	[p24l568t1175r659b1237],
5	Ciofﬁ	NNP	O	Ciofﬁ	nn	6	SENT_446	[p24l711t1173r887b1228],
6	WG	NNP	O	WG	appos	2	SENT_446	[p24l935t1174r1079b1237],
7	,	,	O	,	_	0	SENT_446	[p24l935t1174r1079b1237],
8	McManus	NNP	PERSON	McManus	nn	9	SENT_446	[p24l1130t1175r1439b1227],
9	WF	NNP	PERSON	WF	appos	2	SENT_446	[p24l1488t1175r1613b1237],
10	,	,	O	,	_	0	SENT_446	[p24l1488t1175r1613b1237],
11	Mason	NNP	ORGANIZATION	Mason	nn	13	SENT_446	[p24l1663t1175r1872b1227],
12	AD	NN	ORGANIZATION	ad	nn	13	SENT_446	[p24l1920t1174r2028b1227],
13	Jr	NNP	ORGANIZATION	Jr	appos	2	SENT_446	[p24l2076t1175r2144b1237],
14	,	,	O	,	_	0	SENT_446	[p24l2076t1175r2144b1237],
15	Pruitt	NNP	PERSON	Pruitt	nn	17	SENT_446	[p24l138t1269r310b1324],
16	BA	NN	O	ba	nn	17	SENT_446	[p24l336t1270r438b1323],
17	Jr.	NNP	O	Jr.	appos	2	SENT_446	[p24l465t1271r531b1324],
18	.	.	O	.	_	0	SENT_446	[p24l465t1271r531b1324],

1	Burn	VB	O	burn	_	0	SENT_447	[p24l563t1271r715b1324],
2	center	NN	O	center	nn	3	SENT_447	[p24l743t1278r932b1324],
3	care	NN	O	care	dobj	1	SENT_447	[p24l958t1286r1084b1324],
4	for	IN	O	for	_	0	SENT_447	[p24l1113t1269r1202b1324],
5	patients	NNS	O	patient	prep_for	1	SENT_447	[p24l1228t1269r1466b1340],
6	with	IN	O	with	_	0	SENT_447	[p24l1496t1269r1631b1324],
7	toxic	JJ	O	toxic	amod	9	SENT_447	[p24l1658t1269r1810b1324],
8	epidermal	JJ	O	epidermal	amod	9	SENT_447	[p24l1840t1270r2147b1340],
9	necrolysis	NN	O	necrolysis	prep_with	5	SENT_447	[p24l138t1366r464b1436],
10	.	.	O	.	_	0	SENT_447	[p24l138t1366r464b1436],

1	J	NNP	O	J	nn	4	SENT_448	[p24l492t1367r520b1420],
2	Am	NNP	O	Am	nn	4	SENT_448	[p24l540t1366r654b1419],
3	Coll	NNP	O	Coll	nn	4	SENT_448	[p24l677t1366r807b1420],
4	Surg	NNP	O	Surg	_	0	SENT_448	[p24l834t1366r974b1436],
5	1995	CD	DATE	1995	num	4	SENT_448	[p24l1005t1365r1517b1429],
6	;	:	O	;	_	0	SENT_448	[p24l1005t1365r1517b1429],
7	180:273	CD	NUMBER	180:273	number	8	SENT_448	[p24l1005t1365r1517b1429],
8	—	CD	NUMBER	—	dep	4	SENT_448	[p24l1005t1365r1517b1429],
9	8	CD	NUMBER	8	dep	8	SENT_448	[p24l1005t1365r1517b1429],
10	.	.	O	.	_	0	SENT_448	[p24l1005t1365r1517b1429],

1	Kamaliah	NNP	O	Kamaliah	nn	2	SENT_449	[p24l140t1460r438b1515],
2	MD	NNP	O	MD	_	0	SENT_449	[p24l459t1462r597b1524],
3	,	,	O	,	_	0	SENT_449	[p24l459t1462r597b1524],
4	Zainal	NNP	PERSON	Zainal	nn	5	SENT_449	[p24l622t1460r818b1515],
5	D	NNP	PERSON	D	appos	2	SENT_449	[p24l841t1462r911b1524],
6	,	,	O	,	_	0	SENT_449	[p24l841t1462r911b1524],
7	Mokhtar	NNP	PERSON	Mokhtar	nn	8	SENT_449	[p24l936t1460r1202b1515],
8	N	NNP	PERSON	N	appos	2	SENT_449	[p24l1221t1462r1292b1524],
9	,	,	O	,	_	0	SENT_449	[p24l1221t1462r1292b1524],
10	Nazmi	NNP	PERSON	Nazmi	nn	13	SENT_449	[p24l1317t1460r1521b1515],
11	N.	NNP	PERSON	N.	nn	13	SENT_449	[p24l1543t1462r1612b1515],
12	Erythema	NNP	PERSON	Erythema	nn	13	SENT_449	[p24l1638t1460r1939b1530],
13	multiforme	NNP	O	multiforme	conj_and	5	SENT_449	[p24l1960t1460r2145b1515, p24l138t1557r338b1621],
14	,	,	O	,	_	0	SENT_449	[p24l1960t1460r2145b1515, p24l138t1557r338b1621],
15	Stevens-Johnson	NNP	O	Stevens-Johnson	nn	16	SENT_449	[p24l361t1558r873b1612],
16	syndrome	NN	O	syndrome	conj_and	5	SENT_449	[p24l893t1558r1192b1628],
17	and	CC	O	and	_	0	SENT_449	[p24l1212t1558r1321b1612],
18	toxic	JJ	O	toxic	amod	20	SENT_449	[p24l1338t1557r1490b1612],
19	epidermal	JJ	O	epidermal	amod	20	SENT_449	[p24l1511t1558r1818b1628],
20	necrolysis	NN	O	necrolysis	appos	2	SENT_449	[p24l1836t1558r2146b1628],
21	in	IN	O	in	_	0	SENT_449	[p24l138t1654r197b1707],
22	Northeastern	NNP	LOCATION	Northeastern	nn	23	SENT_449	[p24l220t1654r617b1708],
23	Malaysia	NNP	LOCATION	Malaysia	prep_in	20	SENT_449	[p24l640t1654r938b1724],
24	.	.	O	.	_	0	SENT_449	[p24l640t1654r938b1724],

1	Intern	NNP	O	Intern	nn	3	SENT_450	[p24l965t1655r1148b1708],
2	J	NNP	O	J	nn	3	SENT_450	[p24l1170t1655r1199b1708],
3	Dermatol	NNP	O	Dermatol	_	0	SENT_450	[p24l1222t1654r1512b1708],
4	1998	CD	DATE	1998	num	3	SENT_450	[p24l1543t1653r2016b1717],
5	;	:	O	;	_	0	SENT_450	[p24l1543t1653r2016b1717],
6	37:520	CD	NUMBER	37:520	number	7	SENT_450	[p24l1543t1653r2016b1717],
7	—	CD	NUMBER	—	dep	3	SENT_450	[p24l1543t1653r2016b1717],
8	3	CD	NUMBER	3	dep	7	SENT_450	[p24l1543t1653r2016b1717],
9	.	.	O	.	_	0	SENT_450	[p24l1543t1653r2016b1717],

1	Kim	NNP	PERSON	Kim	nn	2	SENT_451	[p24l140t1750r275b1803],
2	CW	NNP	PERSON	CW	_	0	SENT_451	[p24l303t1750r434b1813],
3	,	,	O	,	_	0	SENT_451	[p24l303t1750r434b1813],
4	Choi	NNP	O	Choi	nn	5	SENT_451	[p24l468t1750r614b1804],
5	GS	NN	O	g	appos	2	SENT_451	[p24l645t1750r756b1813],
6	,	,	O	,	_	0	SENT_451	[p24l645t1750r756b1813],
7	Yun	NNP	PERSON	Yun	nn	8	SENT_451	[p24l789t1751r911b1804],
8	CH	NN	O	ch	appos	2	SENT_451	[p24l941t1750r1061b1813],
9	,	,	O	,	_	0	SENT_451	[p24l941t1750r1061b1813],
10	Kim	NNP	PERSON	Kim	nn	11	SENT_451	[p24l1094t1750r1229b1803],
11	DI	NNP	O	DI	appos	2	SENT_451	[p24l1257t1751r1352b1804],
12	.	.	O	.	_	0	SENT_451	[p24l1257t1751r1352b1804],

1	Drug	NN	O	drug	nn	2	SENT_452	[p24l1385t1751r1540b1820],
2	hypersensitivity	NN	O	hypersensitivity	nsubj	10	SENT_452	[p24l1569t1750r2059b1820],
3	to	TO	O	to	aux	5	SENT_452	[p24l2088t1758r2146b1804],
4	previously	RB	DATE	previously	advmod	5	SENT_452	[p24l137t1846r460b1916],
5	tolerated	VBN	O	tolerate	infmod	2	SENT_452	[p24l536t1846r807b1900],
6	phenytoin	NN	O	phenytoin	dobj	5	SENT_452	[p24l880t1845r1188b1916],
7	by	IN	O	by	_	0	SENT_452	[p24l1262t1846r1338b1916],
8	carbamazepine	NN	O	carbamazepine	nn	9	SENT_452	[p24l1414t1846r2149b1916],
9	—	NN	O	—	prep_by	5	SENT_452	[p24l1414t1846r2149b1916],
10	induced	VBD	O	induce	_	0	SENT_452	[p24l1414t1846r2149b1916],
11	DRESS	NN	O	dress	nn	12	SENT_452	[p24l138t1942r372b1996],
12	syndrome	NN	O	syndrome	dobj	10	SENT_452	[p24l401t1942r717b2012],
13	.	.	O	.	_	0	SENT_452	[p24l401t1942r717b2012],

1	J	NN	O	j	_	0	SENT_453	[p24l743t1943r772b1996],
2	Korean	JJ	O	korean	amod	3	SENT_453	[p24l797t1943r1019b1996],
3	Med	JJ	O	med	amod	1	SENT_453	[p24l1041t1942r1182b1996],
4	Sci	NNP	O	Sci	dep	1	SENT_453	[p24l1206t1941r1300b1996],
5	2006	CD	DATE	2006	num	4	SENT_453	[p24l1326t1941r1844b2005],
6	;	:	O	;	_	0	SENT_453	[p24l1326t1941r1844b2005],
7	21:768	CD	NUMBER	21:768	number	8	SENT_453	[p24l1326t1941r1844b2005],
8	—	CD	NUMBER	—	dep	1	SENT_453	[p24l1326t1941r1844b2005],
9	72	CD	NUMBER	72	dep	8	SENT_453	[p24l1326t1941r1844b2005],
10	.	.	O	.	_	0	SENT_453	[p24l1326t1941r1844b2005],

1	Li	NNP	PERSON	Li	nn	2	SENT_454	[p24l138t2038r205b2091],
2	LF	NNP	O	LF	_	0	SENT_454	[p24l227t2039r326b2101],
3	,	,	O	,	_	0	SENT_454	[p24l227t2039r326b2101],
4	Ma	NNP	ORGANIZATION	Ma	nn	7	SENT_454	[p24l351t2039r454b2092],
5	C.	NNP	ORGANIZATION	C.	nn	7	SENT_454	[p24l476t2038r539b2092],
6	Epidemiological	NNP	ORGANIZATION	Epidemiological	nn	7	SENT_454	[p24l565t2038r1075b2108],
7	study	NN	O	study	appos	2	SENT_454	[p24l1100t2038r1262b2108],
8	of	IN	O	of	_	0	SENT_454	[p24l1285t2038r1352b2092],
9	severe	JJ	O	severe	amod	13	SENT_454	[p24l1372t2055r1561b2092],
10	cutaneous	JJ	O	cutaneous	amod	13	SENT_454	[p24l1585t2046r1891b2092],
11	adverse	JJ	O	adverse	amod	13	SENT_454	[p24l1916t2038r2146b2092],
12	drug	NN	O	drug	nn	13	SENT_454	[p24l139t2132r277b2202],
13	reactions	NNS	O	reaction	prep_of	7	SENT_454	[p24l294t2132r571b2186],
14	in	IN	O	in	_	0	SENT_454	[p24l590t2132r648b2186],
15	a	DT	O	a	det	17	SENT_454	[p24l667t2149r699b2186],
16	city	NN	O	city	nn	17	SENT_454	[p24l716t2132r829b2202],
17	district	NN	O	district	prep_in	13	SENT_454	[p24l848t2132r1061b2186],
18	of	IN	O	of	_	0	SENT_454	[p24l1079t2132r1146b2186],
19	China	NNP	LOCATION	China	prep_of	17	SENT_454	[p24l1158t2132r1356b2186],
20	.	.	O	.	_	0	SENT_454	[p24l1158t2132r1356b2186],

1	Clin	NNP	O	Clin	nn	3	SENT_455	[p24l1378t2132r1508b2186],
2	Exp	NNP	O	Exp	nn	3	SENT_455	[p24l1525t2133r1647b2202],
3	Dermatol	NNP	O	Dermatol	_	0	SENT_455	[p24l1666t2132r1955b2186],
4	2006	CD	DATE	2006	num	3	SENT_455	[p24l1974t2132r2144b2196],
5	;	:	O	;	_	0	SENT_455	[p24l1974t2132r2144b2196],
6	31	CD	NUMBER	31	num	7	SENT_455	[p24l141t2229r207b2283],
7	1642-7	CD	NUMBER	1642-7	dep	3	SENT_455	[p24l221t2228r444b2283],
8	.	.	O	.	_	0	SENT_455	[p24l221t2228r444b2283],

1	Tronslofionol	NNP	MISC	Tronslofionol	nn	2	SENT_456	[p24l6t2320r465b2378],
2	Reseolrch	NNP	MISC	Reseolrch	_	0	SENT_456	[p24l496t2320r836b2378],
3	Volume	NN	MISC	volume	dep	2	SENT_456	[p24l6t2416r293b2475],
4	159	CD	NUMBER	159	num	3	SENT_456	[p24l328t2415r464b2479],
5	,	,	O	,	_	0	SENT_456	[p24l328t2415r464b2479],
6	Number	NNP	O	Number	appos	3	SENT_456	[p24l493t2416r789b2475],
7	5	CD	NUMBER	5	num	6	SENT_456	[p24l812t2416r852b2475],

1	Tennis	NN	O	tennis	nn	2	SENT_457	[p24l140t2654r343b2708],
2	P	NN	O	p	_	0	SENT_457	[p24l367t2656r416b2718],
3	,	,	O	,	_	0	SENT_457	[p24l367t2656r416b2718],
4	Stern	NNP	O	Stern	nn	5	SENT_457	[p24l444t2655r604b2709],
5	RS	NN	O	r	appos	2	SENT_457	[p24l627t2655r734b2709],
6	.	.	O	.	_	0	SENT_457	[p24l627t2655r734b2709],

1	Risk	NN	O	risk	_	0	SENT_458	[p24l761t2654r902b2708],
2	of	IN	O	of	_	0	SENT_458	[p24l924t2654r991b2708],
3	serious	JJ	O	serious	amod	5	SENT_458	[p24l1011t2654r1225b2708],
4	cutaneous	JJ	O	cutaneous	amod	5	SENT_458	[p24l1249t2662r1555b2708],
5	disorders	NNS	O	disorder	prep_of	1	SENT_458	[p24l1580t2654r1859b2708],
6	after	IN	O	after	_	0	SENT_458	[p24l1884t2654r2025b2708],
7	initiation	NN	O	initiation	prep_after	5	SENT_458	[p24l2047t2654r2150b2708, p24l140t2751r337b2805],
8	of	IN	O	of	_	0	SENT_458	[p24l361t2750r428b2805],
9	use	NN	O	use	prep_of	7	SENT_458	[p24l445t2767r546b2805],
10	of	IN	O	of	_	0	SENT_458	[p24l571t2750r638b2805],
11	phenytoin	NN	O	phenytoin	nn	13	SENT_458	[p24l655t2751r979b2821],
12	,	,	O	,	_	0	SENT_458	[p24l655t2751r979b2821],
13	carbamazepine	NN	O	carbamazepine	prep_of	9	SENT_458	[p24l1006t2750r1485b2821],
14	,	,	O	,	_	0	SENT_458	[p24l1006t2750r1485b2821],
15	or	CC	O	or	_	0	SENT_458	[p24l1512t2768r1575b2805],
16	sodium	NN	O	sodium	nn	17	SENT_458	[p24l1599t2750r1824b2805],
17	valproate	NN	O	valproate	conj_or	13	SENT_458	[p24l1845t2751r2147b2821],
18	:	:	O	:	_	0	SENT_458	[p24l1845t2751r2147b2821],
19	a	DT	O	a	det	20	SENT_458	[p24l142t2864r174b2901],
20	record	NN	O	record	dep	1	SENT_458	[p24l196t2847r393b2901],
21	linkage	NN	O	linkage	nn	22	SENT_458	[p24l416t2847r642b2917],
22	study	NN	O	study	dep	20	SENT_458	[p24l668t2847r841b2917],
23	.	.	O	.	_	0	SENT_458	[p24l668t2847r841b2917],

1	Neurology	NNP	O	Neurology	_	0	SENT_459	[p24l869t2847r1197b2917],
2	1997	CD	DATE	1997	num	1	SENT_459	[p24l1228t2847r1702b2910],
3	;	:	O	;	_	0	SENT_459	[p24l1228t2847r1702b2910],
4	49:542	CD	NUMBER	49:542	number	5	SENT_459	[p24l1228t2847r1702b2910],
5	—	CD	NUMBER	—	dep	1	SENT_459	[p24l1228t2847r1702b2910],
6	6	CD	NUMBER	6	dep	5	SENT_459	[p24l1228t2847r1702b2910],
7	.	.	O	.	_	0	SENT_459	[p24l1228t2847r1702b2910],

1	Allam	NNP	PERSON	Allam	nn	2	SENT_460	[p24l140t2941r332b2996],
2	JP	NNP	O	JP	_	0	SENT_460	[p24l353t2943r431b3005],
3	,	,	O	,	_	0	SENT_460	[p24l353t2943r431b3005],
4	Paus	NNP	PERSON	Paus	nn	5	SENT_460	[p24l455t2943r596b2996],
5	T	NN	O	t	appos	2	SENT_460	[p24l619t2943r675b3005],
6	,	,	O	,	_	0	SENT_460	[p24l619t2943r675b3005],
7	Reichel	NNP	PERSON	Reichel	nn	8	SENT_460	[p24l699t2941r933b2996],
8	C	NNP	PERSON	C	appos	2	SENT_460	[p24l955t2942r1021b3005],
9	,	,	O	,	_	0	SENT_460	[p24l955t2942r1021b3005],
10	Bieber	NNP	PERSON	Bieber	nn	12	SENT_460	[p24l1044t2941r1250b2996],
11	T.	NNP	PERSON	T.	nn	12	SENT_460	[p24l1270t2943r1325b2996],
12	Novak	NNP	PERSON	Novak	appos	2	SENT_460	[p24l1349t2941r1567b2996],
13	.	.	O	.	_	0	SENT_460	[p24l1349t2941r1567b2996],

1	DRESS	NN	O	dress	nn	2	SENT_461	[p24l1591t2942r1826b2996],
2	syndrome	NN	O	syndrome	nsubj	3	SENT_461	[p24l1852t2941r2152b3011],
3	associated	VBN	O	associate	_	0	SENT_461	[p24l142t3038r457b3093],
4	with	IN	O	with	_	0	SENT_461	[p24l490t3038r626b3093],
5	carbamazepine	NN	O	carbamazepine	prep_with	3	SENT_461	[p24l659t3038r1121b3109],
6	and	CC	O	and	_	0	SENT_461	[p24l1157t3039r1266b3093],
7	phenytoin	NN	O	phenytoin	prep_with	3	SENT_461	[p24l1297t3038r1621b3109],
8	.	.	O	.	_	0	SENT_461	[p24l1297t3038r1621b3109],

1	Eur	NNP	MISC	Eur	nn	3	SENT_462	[p24l1657t3040r1769b3093],
2	J	NNP	O	J	nn	3	SENT_462	[p24l1800t3040r1828b3093],
3	Dermatol	NNP	O	Dermatol	_	0	SENT_462	[p24l1862t3038r2152b3093],
4	2004	CD	DATE	2004	num	3	SENT_462	[p24l141t3135r660b3198],
5	;	:	O	;	_	0	SENT_462	[p24l141t3135r660b3198],
6	14:339	CD	NUMBER	14:339	number	7	SENT_462	[p24l141t3135r660b3198],
7	—	CD	NUMBER	—	dep	3	SENT_462	[p24l141t3135r660b3198],
8	42	CD	NUMBER	42	dep	7	SENT_462	[p24l141t3135r660b3198],
9	.	.	O	.	_	0	SENT_462	[p24l141t3135r660b3198],

1	Khoo	NNP	PERSON	Khoo	nn	2	SENT_463	[p24l141t3229r309b3283],
2	AKM	NNP	O	AKM	_	0	SENT_463	[p24l332t3229r527b3293],
3	,	,	O	,	_	0	SENT_463	[p24l332t3229r527b3293],
4	Foo	NNP	O	Foo	nn	5	SENT_463	[p24l551t3230r669b3283],
5	CL	NN	O	cl	appos	2	SENT_463	[p24l693t3229r804b3283],
6	.	.	O	.	_	0	SENT_463	[p24l693t3229r804b3283],

1	Toxic	JJ	O	toxic	amod	3	SENT_464	[p24l831t3229r1002b3283],
2	epidermal	JJ	O	epidermal	amod	3	SENT_464	[p24l1028t3229r1335b3299],
3	necrolysis	NN	O	necrolysis	_	0	SENT_464	[p24l1357t3229r1668b3299],
4	in	IN	O	in	_	0	SENT_464	[p24l1693t3229r1751b3283],
5	a	DT	O	a	det	7	SENT_464	[p24l1775t3246r1807b3283],
6	burns	NNS	O	burn	nn	7	SENT_464	[p24l1829t3229r1996b3283],
7	centre	NN	O	centre	prep_in	3	SENT_464	[p24l2021t3246r2150b3283, p24l140t3335r236b3381],
8	:	:	O	:	_	0	SENT_464	[p24l2021t3246r2150b3283, p24l140t3335r236b3381],
9	a	DT	O	a	det	11	SENT_464	[p24l267t3343r299b3381],
10	6-year	JJ	DURATION	6-year	amod	11	SENT_464	[p24l323t3326r519b3397],
11	review	NN	O	review	dep	3	SENT_464	[p24l540t3326r757b3381],
12	.	.	O	.	_	0	SENT_464	[p24l540t3326r757b3381],

1	Burns	NNP	O	Burns	_	0	SENT_465	[p24l784t3328r965b3381],
2	1996	CD	DATE	1996	num	1	SENT_465	[p24l997t3326r1472b3390],
3	;	:	O	;	_	0	SENT_465	[p24l997t3326r1472b3390],
4	22:275	CD	NUMBER	22:275	number	5	SENT_465	[p24l997t3326r1472b3390],
5	—	CD	NUMBER	—	dep	1	SENT_465	[p24l997t3326r1472b3390],
6	8	CD	NUMBER	8	dep	5	SENT_465	[p24l997t3326r1472b3390],
7	.	.	O	.	_	0	SENT_465	[p24l997t3326r1472b3390],

1	Garcia	NNP	PERSON	Garcia	_	0	SENT_466	[p24l141t3423r556b3477],
2	.	.	O	.	_	0	SENT_466	[p24l141t3423r556b3477],

1	—	NN	O	—	_	0	SENT_467	[p24l141t3423r556b3477],
2	.	.	O	.	_	0	SENT_467	[p24l141t3423r556b3477],

1	Doval	NNP	O	Doval	nn	2	SENT_468	[p24l141t3423r556b3477],
2	I	NNP	O	I	_	0	SENT_468	[p24l581t3424r621b3486],
3	,	,	O	,	_	0	SENT_468	[p24l581t3424r621b3486],
4	LeCleach	NNP	O	LeCleach	nn	5	SENT_468	[p24l647t3423r944b3477],
5	L	NNP	O	L	appos	2	SENT_468	[p24l966t3424r1029b3486],
6	,	,	O	,	_	0	SENT_468	[p24l966t3424r1029b3486],
7	Bocquet	NNP	PERSON	Bocquet	nn	8	SENT_468	[p24l1055t3424r1312b3493],
8	H	NNP	O	H	appos	2	SENT_468	[p24l1335t3424r1405b3486],
9	,	,	O	,	_	0	SENT_468	[p24l1335t3424r1405b3486],
10	Otero	NNP	PERSON	Otero	nn	11	SENT_468	[p24l1433t3423r1605b3477],
11	XL	NNP	O	XL	conj_and	5	SENT_468	[p24l1629t3424r1748b3486],
12	,	,	O	,	_	0	SENT_468	[p24l1629t3424r1748b3486],
13	Roujeau	NNP	PERSON	Roujeau	nn	15	SENT_468	[p24l1774t3423r2031b3493],
14	J	NNP	O	J	nn	15	SENT_468	[p24l2053t3424r2082b3477],
15	C.	NNP	O	C.	conj_and	5	SENT_468	[p24l2084t3423r2148b3477],
16	Toxic	JJ	O	toxic	amod	18	SENT_468	[p24l140t3517r312b3571],
17	epidermal	JJ	O	epidermal	amod	18	SENT_468	[p24l368t3517r676b3587],
18	necrolysis	NN	O	necrolysis	dep	15	SENT_468	[p24l731t3517r1042b3587],
19	and	CC	O	and	_	0	SENT_468	[p24l1099t3517r1207b3571],
20	Stevens	NNP	PERSON	Stevens	appos	2	SENT_468	[p24l1264t3517r1776b3571],
21	.	.	O	.	_	0	SENT_468	[p24l1264t3517r1776b3571],

1	—	NN	O	—	_	0	SENT_469	[p24l1264t3517r1776b3571],
2	.	.	O	.	_	0	SENT_469	[p24l1264t3517r1776b3571],

1	Johnson	NNP	PERSON	Johnson	_	0	SENT_470	[p24l1264t3517r1776b3571],
2	syndrome	NN	O	syndrome	dep	1	SENT_470	[p24l1833t3517r2148b3587],
3	.	.	O	.	_	0	SENT_470	[p24l1833t3517r2148b3587],

1	Arch	NNP	O	Arch	nn	2	SENT_471	[p24l140t3614r293b3668],
2	Dermatol	NNP	O	Dermatol	_	0	SENT_471	[p24l316t3614r606b3668],
3	2000	CD	DATE	2000	num	2	SENT_471	[p24l631t3614r1150b3678],
4	;	:	O	;	_	0	SENT_471	[p24l631t3614r1150b3678],
5	136:323	CD	NUMBER	136:323	num	6	SENT_471	[p24l631t3614r1150b3678],
6	—	NN	O	—	dep	2	SENT_471	[p24l631t3614r1150b3678],
7	7	CD	NUMBER	7	dep	6	SENT_471	[p24l631t3614r1150b3678],
8	.	.	O	.	_	0	SENT_471	[p24l631t3614r1150b3678],

1	Maldonado	NNP	PERSON	Maldonado	nn	2	SENT_472	[p24l140t3711r490b3765],
2	NR	NNP	O	NR	_	0	SENT_472	[p24l514t3712r635b3774],
3	,	,	O	,	_	0	SENT_472	[p24l514t3712r635b3774],
4	Tello	NNP	PERSON	Tello	nn	6	SENT_472	[p24l662t3711r818b3765],
5	J	NNP	PERSON	J	nn	6	SENT_472	[p24l842t3712r871b3765],
6	S	NN	PERSON	s	appos	2	SENT_472	[p24l875t3711r930b3774],
7	,	,	O	,	_	0	SENT_472	[p24l875t3711r930b3774],
8	Garcia	NNP	PERSON	Garcia	appos	6	SENT_472	[p24l957t3711r1447b3781],
9	.	.	O	.	_	0	SENT_472	[p24l957t3711r1447b3781],

1	—	NN	O	—	_	0	SENT_473	[p24l957t3711r1447b3781],
2	.	.	O	.	_	0	SENT_473	[p24l957t3711r1447b3781],

1	Baquero	NNP	PERSON	Baquero	nn	2	SENT_474	[p24l957t3711r1447b3781],
2	ER	NN	O	er	_	0	SENT_474	[p24l1471t3712r1585b3774],
3	,	,	O	,	_	0	SENT_474	[p24l1471t3712r1585b3774],
4	Castano	NNP	O	Castano	nn	5	SENT_474	[p24l1612t3711r1858b3765],
5	AH	NNP	O	AH	appos	2	SENT_474	[p24l1882t3711r2007b3765],
6	.	.	O	.	_	0	SENT_474	[p24l1882t3711r2007b3765],

1	Anticonvulsant	JJ	O	anticonvulsant	_	0	SENT_475	[p24l2034t3711r2150b3764, p25l140t19r516b73],

1	hypersensitivity	NN	O	hypersensitivity	nn	2	SENT_476	[p25l544t19r1035b89],
2	syndrome	NN	O	syndrome	_	0	SENT_476	[p25l1067t19r1368b89],
3	with	IN	O	with	_	0	SENT_476	[p25l1397t19r1532b73],
4	fatal	JJ	O	fatal	amod	5	SENT_476	[p25l1562t19r1697b73],
5	outcome	NN	O	outcome	prep_with	2	SENT_476	[p25l1729t27r2009b73],
6	.	.	O	.	_	0	SENT_476	[p25l1729t27r2009b73],

1	Eur	NNP	MISC	Eur	nn	3	SENT_477	[p25l2042t20r2153b73],
2	J	NNP	O	J	nn	3	SENT_477	[p25l140t117r168b170],
3	Dermatol	NNP	O	Dermatol	_	0	SENT_477	[p25l192t116r482b170],
4	2002	CD	DATE	2002	num	3	SENT_477	[p25l507t116r987b180],
5	;	:	O	;	_	0	SENT_477	[p25l507t116r987b180],
6	12:503	CD	NUMBER	12:503	number	7	SENT_477	[p25l507t116r987b180],
7	—	CD	NUMBER	—	dep	3	SENT_477	[p25l507t116r987b180],
8	5	CD	NUMBER	5	dep	7	SENT_477	[p25l507t116r987b180],
9	.	.	O	.	_	0	SENT_477	[p25l507t116r987b180],

1	Hirsch	NNP	PERSON	Hirsch	nn	2	SENT_478	[p25l140t211r344b265],
2	LJ	NNP	PERSON	LJ	_	0	SENT_478	[p25l360t212r452b275],
3	,	,	O	,	_	0	SENT_478	[p25l360t212r452b275],
4	Arif	NNP	PERSON	Arif	nn	5	SENT_478	[p25l472t211r604b265],
5	H	NNP	PERSON	H	appos	2	SENT_478	[p25l615t212r685b275],
6	,	,	O	,	_	0	SENT_478	[p25l615t212r685b275],
7	Nahm	NNP	ORGANIZATION	Nahm	nn	8	SENT_478	[p25l704t211r893b265],
8	EA	NN	ORGANIZATION	ea	appos	2	SENT_478	[p25l908t212r1026b275],
9	,	,	O	,	_	0	SENT_478	[p25l908t212r1026b275],
10	et	FW	O	et	nn	11	SENT_478	[p25l1046t219r1101b265],
11	al.	FW	O	al.	appos	2	SENT_478	[p25l1118t211r1186b265],
12	.	.	O	.	_	0	SENT_478	[p25l1118t211r1186b265],

1	Cross-sensitivity	NN	O	cross-sensitivity	_	0	SENT_479	[p25l1207t211r1722b281],
2	of	IN	O	of	_	0	SENT_479	[p25l1740t211r1806b265],
3	skin	NN	O	skin	nn	4	SENT_479	[p25l1821t211r1945b265],
4	rashes	NNS	O	rash	prep_of	1	SENT_479	[p25l1961t211r2151b265],
5	with	IN	O	with	_	0	SENT_479	[p25l141t307r276b361],
6	antiepileptic	JJ	O	antiepileptic	amod	8	SENT_479	[p25l301t307r680b377],
7	drug	NN	O	drug	nn	8	SENT_479	[p25l706t307r844b377],
8	use	NN	O	use	prep_with	1	SENT_479	[p25l868t324r985b361],
9	.	.	O	.	_	0	SENT_479	[p25l868t324r985b361],

1	Neurology	NNP	O	Neurology	_	0	SENT_480	[p25l1011t307r1340b377],
2	2008	CD	DATE	2008	num	1	SENT_480	[p25l1365t307r1922b371],
3	;	:	O	;	_	0	SENT_480	[p25l1365t307r1922b371],
4	71:1527	CD	NUMBER	71:1527	number	5	SENT_480	[p25l1365t307r1922b371],
5	-34	CD	NUMBER	-34	dep	1	SENT_480	[p25l1365t307r1922b371],
6	.	.	O	.	_	0	SENT_480	[p25l1365t307r1922b371],

1	Knowles	NNP	PERSON	Knowles	_	0	SENT_481	[p25l141t403r409b457],
2	SR	JJ	O	sr	dep	1	SENT_481	[p25l444t403r551b467],
3	,	,	O	,	_	0	SENT_481	[p25l444t403r551b467],
4	Shear	NNP	ORGANIZATION	Shear	nn	5	SENT_481	[p25l587t403r761b457],
5	NH	NNP	ORGANIZATION	NH	appos	2	SENT_481	[p25l790t404r915b457],
6	.	.	O	.	_	0	SENT_481	[p25l790t404r915b457],

1	Clinical	JJ	O	clinical	amod	3	SENT_482	[p25l951t403r1194b457],
2	risk	NN	O	risk	nn	3	SENT_482	[p25l1225t403r1341b457],
3	management	NN	O	management	_	0	SENT_482	[p25l1371t411r1766b473],
4	of	IN	O	of	_	0	SENT_482	[p25l1798t403r1864b457],
5	StevensJohnson	NNP	O	StevensJohnson	nn	9	SENT_482	[p25l1893t403r2151b457, p25l140t499r391b554],
6	syndrome/toxic	JJ	O	syndrome/toxic	amod	9	SENT_482	[p25l418t499r894b569],
7	epidermal	JJ	O	epidermal	amod	9	SENT_482	[p25l922t499r1229b569],
8	necrolysis	NN	O	necrolysis	nn	9	SENT_482	[p25l1254t499r1565b569],
9	spectrum	NN	O	spectrum	prep_of	3	SENT_482	[p25l1594t507r1889b569],
10	.	.	O	.	_	0	SENT_482	[p25l1594t507r1889b569],

1	Dermatol	NNP	O	Dermatol	nn	2	SENT_483	[p25l1918t500r2150b553, p25l140t596r219b650],
2	Ther	NNP	O	Ther	_	0	SENT_483	[p25l244t596r390b650],
3	2009	CD	DATE	2009	num	2	SENT_483	[p25l413t596r932b660],
4	;	:	O	;	_	0	SENT_483	[p25l413t596r932b660],
5	22:441	CD	NUMBER	22:441	number	6	SENT_483	[p25l413t596r932b660],
6	-51	CD	NUMBER	-51	dep	2	SENT_483	[p25l413t596r932b660],
7	.	.	O	.	_	0	SENT_483	[p25l413t596r932b660],

1	East	NNP	O	East	_	0	SENT_484	[p25l140t691r450b745],
2	.	.	O	.	_	0	SENT_484	[p25l140t691r450b745],

1	—	NN	O	—	_	0	SENT_485	[p25l140t691r450b745],
2	.	.	O	.	_	0	SENT_485	[p25l140t691r450b745],

1	Innis	NNP	PERSON	Innis	nn	2	SENT_486	[p25l140t691r450b745],
2	AD	NN	O	ad	_	0	SENT_486	[p25l481t691r606b755],
3	,	,	O	,	_	0	SENT_486	[p25l481t691r606b755],
4	Thompson	NNP	PERSON	Thompson	nn	5	SENT_486	[p25l638t691r967b761],
5	DS	NN	O	d	appos	2	SENT_486	[p25l995t691r1107b745],
6	.	.	O	.	_	0	SENT_486	[p25l995t691r1107b745],

1	Cutaneous	JJ	O	cutaneous	amod	3	SENT_487	[p25l1140t691r1463b745],
2	drug	NN	O	drug	nn	3	SENT_487	[p25l1493t691r1631b761],
3	reactions	NNS	O	reaction	nsubj	6	SENT_487	[p25l1660t691r1938b745],
4	in	IN	O	in	_	0	SENT_487	[p25l1968t691r2026b745],
5	patients	NNS	O	patient	prep_in	3	SENT_487	[p25l2054t708r2150b761, p25l140t787r304b841],
6	admitted	VBN	O	admit	_	0	SENT_487	[p25l329t787r598b841],
7	to	TO	O	to	_	0	SENT_487	[p25l617t795r675b841],
8	the	DT	O	the	det	10	SENT_487	[p25l697t787r789b841],
9	dermatology	NN	O	dermatology	nn	10	SENT_487	[p25l811t787r1200b857],
10	unit	NN	O	unit	prep_to	6	SENT_487	[p25l1220t787r1341b841],
11	at	IN	O	at	_	0	SENT_487	[p25l1362t795r1416b841],
12	the	DT	O	the	det	14	SENT_487	[p25l1435t787r1528b841],
13	University	NNP	ORGANIZATION	University	nn	14	SENT_487	[p25l1549t787r1870b857],
14	Hospital	NNP	ORGANIZATION	Hospital	prep_at	6	SENT_487	[p25l1892t787r2152b857],
15	of	IN	O	of	_	0	SENT_487	[p25l141t883r208b938],
16	the	DT	O	the	det	22	SENT_487	[p25l227t883r319b938],
17	West	NNP	LOCATION	West	dep	22	SENT_487	[p25l343t885r497b938],
18	Indies	NNP	LOCATION	Indies	nn	17	SENT_487	[p25l520t883r724b947],
19	,	,	O	,	_	0	SENT_487	[p25l520t883r724b947],
20	Kingston	NNP	LOCATION	Kingston	dep	17	SENT_487	[p25l751t883r1048b953],
21	,	,	O	,	_	0	SENT_487	[p25l751t883r1048b953],
22	Jamaica	NNP	LOCATION	Jamaica	prep_of	14	SENT_487	[p25l1074t883r1339b938],
23	.	.	O	.	_	0	SENT_487	[p25l1074t883r1339b938],

1	West	NNP	MISC	West	nn	4	SENT_488	[p25l1365t885r1519b938],
2	Indian	NNP	MISC	Indian	nn	4	SENT_488	[p25l1542t883r1738b938],
3	Med	NNP	O	Med	nn	4	SENT_488	[p25l1762t883r1903b938],
4	J	NNP	O	J	_	0	SENT_488	[p25l1926t885r1954b938],
5	2009	CD	DATE	2009	num	4	SENT_488	[p25l1979t884r2149b947],
6	;	:	O	;	_	0	SENT_488	[p25l1979t884r2149b947],
7	5	CD	NUMBER	5	number	8	SENT_488	[p25l141t979r173b1034],
8	8:227	CD	NUMBER	8:227	dep	4	SENT_488	[p25l182t980r484b1034],
9	-30	CD	NUMBER	-30	dep	8	SENT_488	[p25l182t980r484b1034],
10	.	.	O	.	_	0	SENT_488	[p25l182t980r484b1034],

1	Lee	NNP	PERSON	Lee	nn	2	SENT_489	[p25l140t1076r254b1129],
2	HY	NNP	PERSON	HY	_	0	SENT_489	[p25l279t1076r394b1139],
3	,	,	O	,	_	0	SENT_489	[p25l279t1076r394b1139],
4	Tay	NNP	ORGANIZATION	Tay	nn	5	SENT_489	[p25l422t1076r534b1145],
5	LK	NNP	ORGANIZATION	LK	appos	2	SENT_489	[p25l558t1076r676b1139],
6	,	,	O	,	_	0	SENT_489	[p25l558t1076r676b1139],
7	Thirumoorthy	NNP	O	Thirumoorthy	nn	8	SENT_489	[p25l703t1075r1134b1145],
8	T	NN	O	t	appos	2	SENT_489	[p25l1159t1076r1215b1139],
9	,	,	O	,	_	0	SENT_489	[p25l1159t1076r1215b1139],
10	Pang	NNP	PERSON	Pang	nn	11	SENT_489	[p25l1242t1076r1393b1145],
11	SM	NNP	O	SM	appos	2	SENT_489	[p25l1420t1076r1543b1130],
12	.	.	O	.	_	0	SENT_489	[p25l1420t1076r1543b1130],

1	Cutaneous	JJ	O	cutaneous	amod	4	SENT_490	[p25l1571t1075r1892b1130],
2	adverse	JJ	O	adverse	amod	4	SENT_490	[p25l1920t1075r2152b1129],
3	drug	NN	O	drug	nn	4	SENT_490	[p25l141t1171r279b1241],
4	reactions	NNS	O	reaction	_	0	SENT_490	[p25l311t1171r588b1226],
5	in	IN	O	in	_	0	SENT_490	[p25l621t1171r680b1225],
6	hospitalised	JJ	O	hospitalised	amod	7	SENT_490	[p25l712t1171r1080b1241],
7	patients	NNS	O	patient	prep_in	4	SENT_490	[p25l1111t1171r1367b1241],
8	.	.	O	.	_	0	SENT_490	[p25l1111t1171r1367b1241],

1	Singapore	NNP	LOCATION	Singapore	nn	3	SENT_491	[p25l1405t1171r1714b1241],
2	Med	NNP	O	Med	nn	3	SENT_491	[p25l1746t1171r1887b1226],
3	J	NNP	O	J	_	0	SENT_491	[p25l1918t1173r1946b1226],
4	2010	CD	DATE	2010	num	3	SENT_491	[p25l1979t1172r2149b1235],
5	;	:	O	;	_	0	SENT_491	[p25l1979t1172r2149b1235],
6	5	CD	NUMBER	5	number	7	SENT_491	[p25l141t1267r173b1322],
7	1	CD	NUMBER	1	dep	3	SENT_491	[p25l186t1268r209b1321],
8	:767	CD	NUMBER	:767	num	9	SENT_491	[p25l222t1267r484b1322],
9	—	NN	O	—	dep	7	SENT_491	[p25l222t1267r484b1322],
10	74	CD	NUMBER	74	dep	7	SENT_491	[p25l222t1267r484b1322],
11	.	.	O	.	_	0	SENT_491	[p25l222t1267r484b1322],

1	Huang	NNP	PERSON	Huang	nn	2	SENT_492	[p25l140t1364r343b1433],
2	HY	NNP	PERSON	HY	_	0	SENT_492	[p25l366t1364r481b1427],
3	,	,	O	,	_	0	SENT_492	[p25l366t1364r481b1427],
4	Luo	NNP	PERSON	Luo	nn	5	SENT_492	[p25l506t1364r628b1417],
5	XQ	NNP	O	XQ	appos	2	SENT_492	[p25l650t1364r776b1430],
6	,	,	O	,	_	0	SENT_492	[p25l650t1364r776b1430],
7	Chan	NNP	O	Chan	nn	8	SENT_492	[p25l802t1363r962b1418],
8	LS	NN	O	l	appos	5	SENT_492	[p25l983t1363r1088b1427],
9	,	,	O	,	_	0	SENT_492	[p25l983t1363r1088b1427],
10	Cao	NNP	ORGANIZATION	Cao	nn	11	SENT_492	[p25l1114t1363r1235b1418],
11	ZH	NNP	ORGANIZATION	ZH	appos	5	SENT_492	[p25l1257t1364r1375b1427],
12	,	,	O	,	_	0	SENT_492	[p25l1257t1364r1375b1427],
13	Sun	NNP	O	Sun	nn	14	SENT_492	[p25l1401t1364r1517b1418],
14	XF	NNP	O	XF	appos	5	SENT_492	[p25l1539t1364r1646b1427],
15	,	,	O	,	_	0	SENT_492	[p25l1539t1364r1646b1427],
16	Xu	NNP	O	Xu	nn	17	SENT_492	[p25l1670t1364r1763b1417],
17	JH	NNP	O	JH	appos	5	SENT_492	[p25l1784t1364r1883b1418],
18	.	.	O	.	_	0	SENT_492	[p25l1784t1364r1883b1418],

1	Cutaneous	JJ	O	cutaneous	amod	4	SENT_493	[p25l1909t1363r2150b1418, p25l141t1476r244b1514],
2	adverse	JJ	O	adverse	amod	4	SENT_493	[p25l276t1459r508b1514],
3	drug	NN	O	drug	nn	4	SENT_493	[p25l539t1459r677b1529],
4	reactions	NNS	O	reaction	_	0	SENT_493	[p25l707t1459r985b1514],
5	in	IN	O	in	_	0	SENT_493	[p25l1015t1459r1073b1513],
6	a	DT	O	a	det	9	SENT_493	[p25l1105t1476r1137b1514],
7	hospital-based	JJ	O	hospital-based	amod	9	SENT_493	[p25l1165t1459r1613b1529],
8	Chinese	JJ	LOCATION	chinese	amod	9	SENT_493	[p25l1641t1459r1888b1514],
9	population	NN	O	population	prep_in	4	SENT_493	[p25l1916t1459r2150b1529, p25l140t1557r274b1611],
10	.	.	O	.	_	0	SENT_493	[p25l1916t1459r2150b1529, p25l140t1557r274b1611],

1	Clin	NNP	O	Clin	nn	3	SENT_494	[p25l303t1557r434b1611],
2	Exp	NNP	O	Exp	nn	3	SENT_494	[p25l457t1558r579b1627],
3	Dermatol	NNP	O	Dermatol	_	0	SENT_494	[p25l603t1557r893b1611],
4	2011	CD	DATE	2011	num	3	SENT_494	[p25l918t1556r1185b1620],
5	;	:	O	;	_	0	SENT_494	[p25l918t1556r1185b1620],
6	36	CD	NUMBER	36	num	8	SENT_494	[p25l918t1556r1185b1620],
7	:	:	O	:	_	0	SENT_494	[p25l918t1556r1185b1620],
8	135-41	CD	NUMBER	135-41	dep	3	SENT_494	[p25l1200t1556r1437b1611],
9	.	.	O	.	_	0	SENT_494	[p25l1200t1556r1437b1611],

1	Chen	NNP	PERSON	Chen	nn	2	SENT_495	[p25l141t1651r301b1706],
2	YC	NNP	PERSON	YC	_	0	SENT_495	[p25l320t1651r442b1715],
3	,	,	O	,	_	0	SENT_495	[p25l320t1651r442b1715],
4	Chiu	NNP	PERSON	Chiu	nn	5	SENT_495	[p25l464t1651r612b1706],
5	HC	NNP	PERSON	HC	appos	2	SENT_495	[p25l630t1652r751b1715],
6	,	,	O	,	_	0	SENT_495	[p25l630t1652r751b1715],
7	Chu	NNP	O	Chu	nn	8	SENT_495	[p25l774t1651r900b1706],
8	CY	NNP	O	CY	appos	5	SENT_495	[p25l919t1652r1029b1706],
9	.	.	O	.	_	0	SENT_495	[p25l919t1652r1029b1706],

1	Drug	NN	O	drug	nn	2	SENT_496	[p25l1051t1652r1207b1721],
2	reaction	NN	O	reaction	_	0	SENT_496	[p25l1226t1651r1475b1705],
3	with	IN	O	with	_	0	SENT_496	[p25l1493t1651r1629b1705],
4	eosinophilia	NN	O	eosinophilia	nn	7	SENT_496	[p25l1648t1651r2025b1721],
5	and	CC	O	and	_	0	SENT_496	[p25l2044t1651r2153b1705],
6	systemic	JJ	O	systemic	conj_and	4	SENT_496	[p25l142t1747r408b1817],
7	symptoms	NNS	O	symptom	prep_with	2	SENT_496	[p25l434t1756r764b1817],
8	:	:	O	:	_	0	SENT_496	[p25l434t1756r764b1817],
9	a	DT	O	a	det	11	SENT_496	[p25l793t1764r825b1802],
10	retrospective	JJ	O	retrospective	amod	11	SENT_496	[p25l846t1747r1242b1817],
11	study	NN	O	study	dep	2	SENT_496	[p25l1267t1747r1430b1817],
12	of	IN	O	of	_	0	SENT_496	[p25l1454t1747r1520b1802],
13	60	CD	NUMBER	60	num	14	SENT_496	[p25l1539t1747r1613b1802],
14	cases	NNS	O	case	prep_of	11	SENT_496	[p25l1636t1764r1812b1802],
15	.	.	O	.	_	0	SENT_496	[p25l1636t1764r1812b1802],

1	Arch	NNP	O	Arch	nn	2	SENT_497	[p25l1838t1747r1991b1802],
2	Dermatol	NNP	O	Dermatol	_	0	SENT_497	[p25l2013t1749r2151b1802, p25l140t1845r315b1899],
3	2010	CD	DATE	2010	num	2	SENT_497	[p25l340t1844r897b1908],
4	;	:	O	;	_	0	SENT_497	[p25l340t1844r897b1908],
5	146:1373	CD	NUMBER	146:1373	number	6	SENT_497	[p25l340t1844r897b1908],
6	-9	CD	NUMBER	-9	dep	2	SENT_497	[p25l340t1844r897b1908],
7	.	.	O	.	_	0	SENT_497	[p25l340t1844r897b1908],

1	Um	NN	O	um	nn	2	SENT_498	[p25l140t1942r254b1995],
2	SJ	NN	O	sj	_	0	SENT_498	[p25l277t1941r362b2004],
3	,	,	O	,	_	0	SENT_498	[p25l277t1941r362b2004],
4	Lee	NNP	PERSON	Lee	nn	5	SENT_498	[p25l385t1942r499b1995],
5	SK	NNP	O	SK	appos	2	SENT_498	[p25l522t1941r633b2004],
6	,	,	O	,	_	0	SENT_498	[p25l522t1941r633b2004],
7	Kim	NNP	PERSON	Kim	nn	8	SENT_498	[p25l658t1941r793b1994],
8	YH	NNP	O	YH	appos	2	SENT_498	[p25l813t1942r938b2004],
9	,	,	O	,	_	0	SENT_498	[p25l813t1942r938b2004],
10	et	FW	O	et	nn	11	SENT_498	[p25l962t1949r1016b1995],
11	al.	FW	O	al.	appos	2	SENT_498	[p25l1037t1941r1106b1995],
12	.	.	O	.	_	0	SENT_498	[p25l1037t1941r1106b1995],

1	Clinical	JJ	O	clinical	amod	2	SENT_499	[p25l1131t1941r1374b1995],
2	features	NNS	O	feature	_	0	SENT_499	[p25l1395t1941r1637b1995],
3	of	IN	O	of	_	0	SENT_499	[p25l1660t1941r1727b1995],
4	drug-induced	JJ	O	drug-induced	amod	6	SENT_499	[p25l1743t1941r2153b2011],
5	hypersensitivity	NN	O	hypersensitivity	nn	6	SENT_499	[p25l140t2035r630b2105],
6	syndrome	NN	O	syndrome	prep_of	2	SENT_499	[p25l655t2035r955b2105],
7	in	IN	O	in	_	0	SENT_499	[p25l975t2035r1034b2089],
8	38	CD	NUMBER	38	num	9	SENT_499	[p25l1057t2036r1127b2090],
9	patients	NNS	O	patient	prep_in	2	SENT_499	[p25l1150t2035r1406b2105],
10	.	.	O	.	_	0	SENT_499	[p25l1150t2035r1406b2105],

1	J	NNP	O	J	nn	4	SENT_500	[p25l1430t2037r1459b2090],
2	Investig	NNP	O	Investig	nn	4	SENT_500	[p25l1480t2035r1723b2105],
3	A1lergolClin	NNP	O	A1lergolClin	nn	4	SENT_500	[p25l1744t2035r2152b2105],
4	Immunol	NNP	O	Immunol	_	0	SENT_500	[p25l140t2133r422b2187],
5	2010	CD	DATE	2010	num	4	SENT_500	[p25l446t2132r965b2196],
6	;	:	O	;	_	0	SENT_500	[p25l446t2132r965b2196],
7	20:556	CD	NUMBER	20:556	number	8	SENT_500	[p25l446t2132r965b2196],
8	—	CD	NUMBER	—	dep	4	SENT_500	[p25l446t2132r965b2196],
9	62	CD	NUMBER	62	dep	8	SENT_500	[p25l446t2132r965b2196],
10	.	.	O	.	_	0	SENT_500	[p25l446t2132r965b2196],

1	Devarbhavi	JJ	O	devarbhavi	amod	2	SENT_501	[p25l140t2229r494b2283],
2	H	NN	O	h	nsubj	21	SENT_501	[p25l517t2230r587b2292],
3	,	,	O	,	_	0	SENT_501	[p25l517t2230r587b2292],
4	Karanth	NNP	PERSON	Karanth	nn	5	SENT_501	[p25l613t2229r859b2283],
5	D	NNP	PERSON	D	appos	2	SENT_501	[p25l880t2230r950b2292],
6	,	,	O	,	_	0	SENT_501	[p25l880t2230r950b2292],
7	Prasanna	NNP	PERSON	Prasanna	nn	8	SENT_501	[p25l975t2230r1253b2283],
8	K	NNP	PERSON	K	appos	2	SENT_501	[p25l1275t2230r1344b2292],
9	,	,	O	,	_	0	SENT_501	[p25l1275t2230r1344b2292],
10	Adarsh	NNP	ORGANIZATION	Adarsh	nn	11	SENT_501	[p25l1368t2229r1589b2283],
11	C	NNP	ORGANIZATION	C	appos	2	SENT_501	[p25l1611t2229r1676b2292],
12	,	,	O	,	_	0	SENT_501	[p25l1611t2229r1676b2292],
13	Patil	NNP	PERSON	Patil	nn	17	SENT_501	[p25l1701t2229r1840b2283],
14	M.	NNP	O	M.	nn	17	SENT_501	[p25l1862t2230r1944b2283],
15	DrugInduced	NNP	O	DrugInduced	nn	17	SENT_501	[p25l1970t2230r2150b2299, p25l140t2325r388b2379],
16	liver	NN	O	liver	nn	17	SENT_501	[p25l404t2325r543b2379],
17	injury	NN	O	injury	appos	2	SENT_501	[p25l557t2325r740b2395],
18	with	IN	O	with	_	0	SENT_501	[p25l756t2325r892b2379],
19	hypersensitivity	NN	O	hypersensitivity	nn	20	SENT_501	[p25l907t2325r1398b2395],
20	features	NNS	O	feature	prep_with	17	SENT_501	[p25l1414t2325r1656b2379],
21	has	VBZ	O	have	_	0	SENT_501	[p25l1673t2325r1772b2379],
22	a	DT	O	a	det	24	SENT_501	[p25l1792t2342r1823b2379],
23	better	JJR	O	better	amod	24	SENT_501	[p25l1838t2325r2016b2379],
24	outcome	NN	O	outcome	dobj	21	SENT_501	[p25l2030t2333r2150b2379, p25l141t2437r322b2475],
25	:	:	O	:	_	0	SENT_501	[p25l2030t2333r2150b2379, p25l141t2437r322b2475],
26	a	DT	O	a	det	29	SENT_501	[p25l353t2437r386b2475],
27	single	JJ	O	single	amod	29	SENT_501	[p25l410t2420r590b2491],
28	center	NN	O	center	nn	29	SENT_501	[p25l615t2429r804b2475],
29	experience	NN	O	experience	dep	24	SENT_501	[p25l827t2421r1158b2491],
30	of	IN	O	of	_	0	SENT_501	[p25l1184t2420r1251b2475],
31	39	CD	NUMBER	39	num	32	SENT_501	[p25l1271t2421r1342b2475],
32	children	NNS	O	child	prep_of	29	SENT_501	[p25l1369t2420r1621b2475],
33	and	CC	O	and	_	0	SENT_501	[p25l1645t2421r1755b2475],
34	adolescents	NNS	O	adolescent	prep_of	29	SENT_501	[p25l1779t2421r2147b2475],
35	.	.	O	.	_	0	SENT_501	[p25l1779t2421r2147b2475],

1	Hepatology	NN	O	hepatology	_	0	SENT_502	[p25l140t2517r499b2587],
2	201	CD	NUMBER	201	number	3	SENT_502	[p25l523t2517r629b2571],
3	1	CD	NUMBER	1	dep	1	SENT_502	[p25l645t2516r790b2580],
4	;	:	O	;	_	0	SENT_502	[p25l645t2516r790b2580],
5	54	CD	NUMBER	54	num	7	SENT_502	[p25l645t2516r790b2580],
6	:	:	O	:	_	0	SENT_502	[p25l645t2516r790b2580],
7	1344-50	CD	NUMBER	1344-50	dep	1	SENT_502	[p25l805t2516r1081b2571],
8	.	.	O	.	_	0	SENT_502	[p25l805t2516r1081b2571],

1	Ding	VBG	O	ding	_	0	SENT_503	[p25l140t2613r292b2683],
2	WY	NN	O	wy	dobj	1	SENT_503	[p25l314t2614r448b2676],
3	,	,	O	,	_	0	SENT_503	[p25l314t2614r448b2676],
4	Lee	NNP	PERSON	Lee	nn	5	SENT_503	[p25l473t2614r587b2667],
5	CK	NNP	O	CK	appos	2	SENT_503	[p25l610t2613r731b2676],
6	,	,	O	,	_	0	SENT_503	[p25l610t2613r731b2676],
7	Choon	NNP	O	Choon	nn	8	SENT_503	[p25l757t2613r960b2667],
8	SE	NN	O	se	appos	5	SENT_503	[p25l983t2613r1085b2667],
9	.	.	O	.	_	0	SENT_503	[p25l983t2613r1085b2667],

1	Cutaneous	JJ	O	cutaneous	amod	4	SENT_504	[p25l1111t2613r1434b2667],
2	adverse	JJ	O	adverse	amod	4	SENT_504	[p25l1459t2613r1690b2667],
3	drug	NN	O	drug	nn	4	SENT_504	[p25l1714t2613r1852b2683],
4	reactions	NNS	O	reaction	nsubj	5	SENT_504	[p25l1873t2613r2151b2667],
5	seen	VBN	O	see	_	0	SENT_504	[p25l142t2725r276b2763],
6	in	IN	O	in	_	0	SENT_504	[p25l294t2708r352b2762],
7	a	DT	O	a	det	9	SENT_504	[p25l372t2725r403b2763],
8	tertiary	JJ	O	tertiary	amod	9	SENT_504	[p25l420t2708r642b2779],
9	hospital	NN	O	hospital	prep_in	5	SENT_504	[p25l661t2709r904b2779],
10	in	IN	O	in	_	0	SENT_504	[p25l922t2709r980b2762],
11	Johor	NNP	LOCATION	Johor	nn	13	SENT_504	[p25l998t2709r1182b2772],
12	,	,	O	,	_	0	SENT_504	[p25l998t2709r1182b2772],
13	Malaysia	NNP	LOCATION	Malaysia	prep_in	9	SENT_504	[p25l1202t2708r1500b2779],
14	.	.	O	.	_	0	SENT_504	[p25l1202t2708r1500b2779],

1	Int	NN	O	int	nn	2	SENT_505	[p25l1521t2710r1607b2763],
2	J	NN	O	j	_	0	SENT_505	[p25l1623t2710r1652b2763],
3	Dermatol	JJ	O	dermatol	amod	4	SENT_505	[p25l1669t2709r1960b2763],
4	2010	CD	DATE	2010	dep	2	SENT_505	[p25l1979t2709r2149b2772],
5	;	:	O	;	_	0	SENT_505	[p25l1979t2709r2149b2772],
6	49:834	CD	NUMBER	49:834	num	7	SENT_505	[p25l140t2805r484b2860],
7	-41	CD	NUMBER	-41	dep	2	SENT_505	[p25l140t2805r484b2860],
8	.	.	O	.	_	0	SENT_505	[p25l140t2805r484b2860],

1	Chung	NNP	PERSON	Chung	nn	2	SENT_506	[p25l141t2901r343b2971],
2	WH	NNP	PERSON	WH	_	0	SENT_506	[p25l377t2902r521b2964],
3	,	,	O	,	_	0	SENT_506	[p25l377t2902r521b2964],
4	Hung	NNP	O	Hung	nn	5	SENT_506	[p25l558t2902r726b2971],
5	SI	NNP	O	SI	appos	2	SENT_506	[p25l763t2901r844b2964],
6	,	,	O	,	_	0	SENT_506	[p25l763t2901r844b2964],
7	Hong	NNP	LOCATION	Hong	nn	8	SENT_506	[p25l881t2902r1050b2971],
8	HS	NN	LOCATION	h	appos	2	SENT_506	[p25l1084t2901r1197b2964],
9	,	,	O	,	_	0	SENT_506	[p25l1084t2901r1197b2964],
10	et	FW	O	et	nn	11	SENT_506	[p25l1234t2909r1289b2955],
11	al.	FW	O	al.	appos	2	SENT_506	[p25l1323t2901r1391b2955],
12	.	.	O	.	_	0	SENT_506	[p25l1323t2901r1391b2955],

1	A	DT	O	a	det	2	SENT_507	[p25l1429t2901r1483b2954],
2	marker	NN	O	marker	_	0	SENT_507	[p25l1517t2901r1736b2955],
3	for	IN	O	for	_	0	SENT_507	[p25l1769t2901r1858b2955],
4	StevensJohnson	NN	O	stevensjohnson	nn	5	SENT_507	[p25l1893t2901r2151b2955, p25l140t2995r391b3049],
5	syndrome	NN	O	syndrome	prep_for	2	SENT_507	[p25l417t2995r733b3065],
6	.	.	O	.	_	0	SENT_507	[p25l417t2995r733b3065],

1	Nature	NNP	O	Nature	_	0	SENT_508	[p25l760t2996r968b3049],
2	2004	CD	DATE	2004	num	1	SENT_508	[p25l993t2995r1434b3059],
3	;	:	O	;	_	0	SENT_508	[p25l993t2995r1434b3059],
4	482:486	CD	NUMBER	482:486	dep	1	SENT_508	[p25l993t2995r1434b3059],
5	.	.	O	.	_	0	SENT_508	[p25l993t2995r1434b3059],

1	Locharemkul	NN	O	locharemkul	nn	2	SENT_509	[p25l140t3093r555b3147],
2	C	NN	O	c	_	0	SENT_509	[p25l598t3093r663b3156],
3	,	,	O	,	_	0	SENT_509	[p25l598t3093r663b3156],
4	Shotelersuk	NNP	O	Shotelersuk	nn	5	SENT_509	[p25l710t3093r1073b3147],
5	V	NNP	O	V	appos	2	SENT_509	[p25l1113t3094r1173b3156],
6	,	,	O	,	_	0	SENT_509	[p25l1113t3094r1173b3156],
7	Hirankam	NNP	O	Hirankam	nn	9	SENT_509	[p25l1218t3093r1530b3147],
8	N.	NNP	O	N.	nn	9	SENT_509	[p25l1570t3094r1640b3147],
9	HLA	NN	O	hlum	appos	5	SENT_509	[p25l1686t3093r1954b3146],
10	.	.	O	.	_	0	SENT_509	[p25l1686t3093r1954b3146],

1	—	NN	O	—	_	0	SENT_510	[p25l1686t3093r1954b3146],
2	.	.	O	.	_	0	SENT_510	[p25l1686t3093r1954b3146],

1	B	NN	O	b	_	0	SENT_511	[p25l1686t3093r1954b3146],
2	*	CD	NUMBER	*	number	3	SENT_511	[p25l1686t3093r1954b3146],
3	1502	CD	DATE	1502	num	4	SENT_511	[p25l2007t3093r2152b3147],
4	screening	NN	O	screening	dep	1	SENT_511	[p25l142t3189r451b3259],
5	:	:	O	:	_	0	SENT_511	[p25l142t3189r451b3259],
6	time	NN	O	time	dep	1	SENT_511	[p25l480t3189r616b3243],
7	to	TO	O	to	_	0	SENT_511	[p25l640t3197r698b3243],
8	clinical	JJ	O	clinical	amod	9	SENT_511	[p25l722t3189r948b3243],
9	practice	NN	O	practice	prep_to	6	SENT_511	[p25l972t3189r1232b3259],
10	.	.	O	.	_	0	SENT_511	[p25l972t3189r1232b3259],

1	Epilepsia	NNP	O	Epilepsia	_	0	SENT_512	[p25l1259t3189r1547b3259],
2	2010	CD	DATE	2010	num	1	SENT_512	[p25l1571t3188r2051b3252],
3	;	:	O	;	_	0	SENT_512	[p25l1571t3188r2051b3252],
4	51:936	CD	NUMBER	51:936	number	5	SENT_512	[p25l1571t3188r2051b3252],
5	—	CD	NUMBER	—	dep	1	SENT_512	[p25l1571t3188r2051b3252],
6	8	CD	NUMBER	8	dep	5	SENT_512	[p25l1571t3188r2051b3252],
7	.	.	O	.	_	0	SENT_512	[p25l1571t3188r2051b3252],

1	Hakimian	JJ	MISC	hakimian	amod	2	SENT_513	[p25l140t3283r444b3337],
2	S	NN	O	s	_	0	SENT_513	[p25l491t3283r546b3347],
3	,	,	O	,	_	0	SENT_513	[p25l491t3283r546b3347],
4	Miller	NNP	PERSON	Miller	nn	5	SENT_513	[p25l594t3283r788b3337],
5	JW	NNP	O	JW	appos	2	SENT_513	[p25l831t3284r942b3337],
6	.	.	O	.	_	0	SENT_513	[p25l831t3284r942b3337],

1	The	DT	O	the	det	2	SENT_514	[p25l991t3283r1109b3337],
2	genetics	NNS	O	genetics	_	0	SENT_514	[p25l1155t3283r1404b3353],
3	of	IN	O	of	_	0	SENT_514	[p25l1453t3283r1519b3337],
4	antiepileptic	JJ	O	antiepileptic	amod	7	SENT_514	[p25l1561t3283r1940b3353],
5	druginduced	JJ	O	druginduced	amod	7	SENT_514	[p25l1988t3283r2150b3353, p25l140t3380r385b3434],
6	skin	NN	O	skin	nn	7	SENT_514	[p25l410t3380r534b3434],
7	reactions	NNS	O	reaction	prep_of	2	SENT_514	[p25l556t3380r851b3434],
8	.	.	O	.	_	0	SENT_514	[p25l556t3380r851b3434],

1	Clin	NNP	O	Clin	nn	3	SENT_515	[p25l879t3380r1009b3435],
2	Pharrnacol	NNP	O	Pharrnacol	nn	3	SENT_515	[p25l1032t3380r1362b3434],
3	Ther	NNP	O	Ther	_	0	SENT_515	[p25l1385t3380r1531b3434],
4	2011	CD	DATE	2011	num	3	SENT_515	[p25l1554t3380r2073b3444],
5	;	:	O	;	_	0	SENT_515	[p25l1554t3380r2073b3444],
6	89:908	CD	NUMBER	89:908	number	7	SENT_515	[p25l1554t3380r2073b3444],
7	-10	CD	NUMBER	-10	dep	3	SENT_515	[p25l1554t3380r2073b3444],
8	.	.	O	.	_	0	SENT_515	[p25l1554t3380r2073b3444],

1	Shear	NN	O	shear	nn	2	SENT_516	[p25l142t3477r316b3531],
2	NH	NNP	O	NH	_	0	SENT_516	[p25l353t3478r478b3540],
3	,	,	O	,	_	0	SENT_516	[p25l353t3478r478b3540],
4	Spielberg	NNP	PERSON	Spielberg	nn	5	SENT_516	[p25l522t3477r812b3547],
5	SP	NN	O	sp	appos	2	SENT_516	[p25l854t3477r943b3531],
6	.	.	O	.	_	0	SENT_516	[p25l854t3477r943b3531],

1	Anticonvulsant	JJ	O	anticonvulsant	amod	2	SENT_517	[p25l985t3477r1454b3531],
2	hypersensitivity	NN	O	hypersensitivity	_	0	SENT_517	[p25l1491t3477r1982b3547],
3	syndrome	NN	O	syndrome	dep	2	SENT_517	[p25l2024t3494r2150b3547, p25l141t3572r351b3626],
4	.	.	O	.	_	0	SENT_517	[p25l2024t3494r2150b3547, p25l141t3572r351b3626],

1	In	FW	O	in	nn	3	SENT_518	[p25l403t3574r466b3626],
2	vitro	FW	O	vitro	nn	3	SENT_518	[p25l514t3574r654b3627],
3	assessment	NN	O	assessment	_	0	SENT_518	[p25l706t3580r1047b3626],
4	of	IN	O	of	_	0	SENT_518	[p25l1095t3572r1162b3626],
5	risk	NN	O	risk	prep_of	3	SENT_518	[p25l1205t3572r1335b3626],
6	.	.	O	.	_	0	SENT_518	[p25l1205t3572r1335b3626],

1	J	NNP	O	J	nn	3	SENT_519	[p25l1388t3573r1416b3626],
2	Clin	NNP	O	Clin	nn	3	SENT_519	[p25l1466t3572r1597b3626],
3	Invest	NNP	O	Invest	_	0	SENT_519	[p25l1646t3573r1832b3626],
4	1988	CD	DATE	1988	num	3	SENT_519	[p25l1886t3572r2147b3636],
5	;	:	O	;	_	0	SENT_519	[p25l1886t3572r2147b3636],
6	82	CD	NUMBER	82	num	8	SENT_519	[p25l1886t3572r2147b3636],
7	:	:	O	:	_	0	SENT_519	[p25l1886t3572r2147b3636],
8	1826-32	CD	NUMBER	1826-32	dep	3	SENT_519	[p25l147t3667r424b3722],
9	.	.	O	.	_	0	SENT_519	[p25l147t3667r424b3722],

1	Neuman	NNP	PERSON	Neuman	nn	2	SENT_520	[p26l140t29r401b82],
2	MG	NN	O	mg	_	0	SENT_520	[p26l431t28r570b91],
3	,	,	O	,	_	0	SENT_520	[p26l431t28r570b91],
4	Malkiewicz	NNP	PERSON	Malkiewicz	nn	5	SENT_520	[p26l604t27r965b82],
5	IM	NNP	O	IM	appos	2	SENT_520	[p26l997t29r1106b91],
6	,	,	O	,	_	0	SENT_520	[p26l997t29r1106b91],
7	Shear	NNP	ORGANIZATION	Shear	nn	8	SENT_520	[p26l1142t27r1316b82],
8	NH	NNP	ORGANIZATION	NH	appos	5	SENT_520	[p26l1345t29r1469b82],
9	.	.	O	.	_	0	SENT_520	[p26l1345t29r1469b82],

1	A	DT	O	a	det	5	SENT_521	[p26l1505t28r1559b81],
2	novel	JJ	O	novel	amod	5	SENT_521	[p26l1589t27r1758b82],
3	lymphocyte	NN	O	lymphocyte	nn	5	SENT_521	[p26l1789t27r2152b97],
4	toxicity	NN	O	toxicity	nn	5	SENT_521	[p26l140t123r375b193],
5	assay	NN	O	assay	nsubj	7	SENT_521	[p26l413t140r576b193],
6	to	TO	O	to	aux	7	SENT_521	[p26l613t131r671b177],
7	assess	VB	O	assess	_	0	SENT_521	[p26l709t140r892b177],
8	drug	NN	O	drug	nn	10	SENT_521	[p26l931t123r1069b193],
9	hypersensitivity	NN	O	hypersensitivity	nn	10	SENT_521	[p26l1105t123r1596b193],
10	syndromes	NNS	O	syndrome	dobj	7	SENT_521	[p26l1635t123r1981b193],
11	.	.	O	.	_	0	SENT_521	[p26l1635t123r1981b193],

1	Clin	NNP	O	Clin	nn	2	SENT_522	[p26l2021t123r2152b177],
2	Biochem	NNP	O	Biochem	_	0	SENT_522	[p26l140t220r419b274],
3	2000	CD	DATE	2000	num	2	SENT_522	[p26l443t220r961b284],
4	;	:	O	;	_	0	SENT_522	[p26l443t220r961b284],
5	33:517	CD	NUMBER	33:517	number	6	SENT_522	[p26l443t220r961b284],
6	—	CD	NUMBER	—	dep	2	SENT_522	[p26l443t220r961b284],
7	24	CD	NUMBER	24	dep	6	SENT_522	[p26l443t220r961b284],
8	.	.	O	.	_	0	SENT_522	[p26l443t220r961b284],

1	Neuman	NNP	PERSON	Neuman	nn	2	SENT_523	[p26l140t317r401b370],
2	MG	NN	O	mg	_	0	SENT_523	[p26l426t316r564b379],
3	,	,	O	,	_	0	SENT_523	[p26l426t316r564b379],
4	Malkieiwcz	NNP	O	Malkieiwcz	nn	5	SENT_523	[p26l593t315r957b370],
5	IM	NNP	O	IM	appos	2	SENT_523	[p26l982t317r1091b379],
6	,	,	O	,	_	0	SENT_523	[p26l982t317r1091b379],
7	Phillips	NNP	PERSON	Phillips	nn	8	SENT_523	[p26l1120t315r1353b385],
8	EJ	NNP	O	EJ	appos	2	SENT_523	[p26l1379t317r1471b379],
9	,	,	O	,	_	0	SENT_523	[p26l1379t317r1471b379],
10	et	FW	O	et	nn	11	SENT_523	[p26l1501t324r1555b370],
11	al.	FW	O	al.	appos	2	SENT_523	[p26l1581t315r1649b370],
12	.	.	O	.	_	0	SENT_523	[p26l1581t315r1649b370],

1	Monitoring	VBG	O	monitor	_	0	SENT_524	[p26l1679t315r2028b385],
2	adverse	JJ	O	adverse	amod	4	SENT_524	[p26l2057t315r2150b370, p26l140t428r301b465],
3	drug	NN	O	drug	nn	4	SENT_524	[p26l360t411r498b481],
4	reactions	NNS	O	reaction	dobj	1	SENT_524	[p26l556t411r833b465],
5	to	TO	O	to	_	0	SENT_524	[p26l892t419r950b465],
6	sulfonamide	NN	O	sulfonamide	nn	7	SENT_524	[p26l1012t411r1389b465],
7	antibiotics	NNS	O	antibiotic	prep_to	1	SENT_524	[p26l1449t411r1768b465],
8	in	IN	O	in	_	0	SENT_524	[p26l1827t411r1885b465],
9	human	JJ	O	human	amod	13	SENT_524	[p26l1943t411r2152b465],
10	immunodeﬁciency	NN	O	immunodeﬁciency	nn	13	SENT_524	[p26l140t507r714b577],
11	virus	NN	O	virus	nn	13	SENT_524	[p26l746t507r896b561],
12	infected	JJ	O	infected	amod	13	SENT_524	[p26l930t507r1179b561],
13	individuals	NNS	O	individual	prep_in	7	SENT_524	[p26l1209t507r1565b561],
14	.	.	O	.	_	0	SENT_524	[p26l1209t507r1565b561],

1	Ther	NNP	O	Ther	nn	3	SENT_525	[p26l1601t507r1747b561],
2	Drug	NNP	O	Drug	nn	3	SENT_525	[p26l1777t508r1933b577],
3	Monit	NNP	O	Monit	_	0	SENT_525	[p26l1965t507r2153b561],
4	2002	CD	DATE	2002	num	3	SENT_525	[p26l141t604r660b668],
5	;	:	O	;	_	0	SENT_525	[p26l141t604r660b668],
6	24:728	CD	NUMBER	24:728	number	7	SENT_525	[p26l141t604r660b668],
7	—	CD	NUMBER	—	dep	3	SENT_525	[p26l141t604r660b668],
8	36	CD	NUMBER	36	dep	7	SENT_525	[p26l141t604r660b668],
9	.	.	O	.	_	0	SENT_525	[p26l141t604r660b668],

1	Neuman	NNP	PERSON	Neuman	nn	2	SENT_526	[p26l140t702r401b755],
2	MG	NN	O	mg	nsubj	8	SENT_526	[p26l420t701r558b764],
3	,	,	O	,	_	0	SENT_526	[p26l420t701r558b764],
4	Nicar	NNP	PERSON	Nicar	nn	6	SENT_526	[p26l580t701r752b755],
5	M.	NNP	PERSON	M.	nn	6	SENT_526	[p26l770t702r853b755],
6	Ibuprophen	NNP	PERSON	Ibuprophen	appos	2	SENT_526	[p26l876t700r1502b771],
7	—	NN	O	—	dep	6	SENT_526	[p26l876t700r1502b771],
8	induced	VBD	O	induce	_	0	SENT_526	[p26l876t700r1502b771],
9	toxic	JJ	O	toxic	amod	11	SENT_526	[p26l1519t701r1672b755],
10	epidermal	JJ	O	epidermal	amod	11	SENT_526	[p26l1693t701r2001b771],
11	necrolysis	NN	O	necrolysis	dobj	8	SENT_526	[p26l2020t717r2150b755, p26l139t795r359b865],
12	.	.	O	.	_	0	SENT_526	[p26l2020t717r2150b755, p26l139t795r359b865],

1	Transl	NNP	O	Transl	nn	2	SENT_527	[p26l387t795r579b849],
2	Res	NNP	O	Res	_	0	SENT_527	[p26l604t796r716b849],
3	2007	CD	DATE	2007	num	2	SENT_527	[p26l742t795r1261b859],
4	;	:	O	;	_	0	SENT_527	[p26l742t795r1261b859],
5	149:254	CD	NUMBER	149:254	number	6	SENT_527	[p26l742t795r1261b859],
6	—	CD	NUMBER	—	dep	2	SENT_527	[p26l742t795r1261b859],
7	9	CD	NUMBER	9	dep	6	SENT_527	[p26l742t795r1261b859],
8	.	.	O	.	_	0	SENT_527	[p26l742t795r1261b859],

1	Pichler	NNP	PERSON	Pichler	nn	2	SENT_528	[p26l140t891r359b946],
2	WJ	NNP	O	WJ	_	0	SENT_528	[p26l377t893r496b955],
3	,	,	O	,	_	0	SENT_528	[p26l377t893r496b955],
4	Yawalkar	NNP	ORGANIZATION	Yawalkar	nn	5	SENT_528	[p26l520t891r811b946],
5	N	NNP	ORGANIZATION	N	appos	2	SENT_528	[p26l830t893r900b955],
6	,	,	O	,	_	0	SENT_528	[p26l830t893r900b955],
7	Britschgi	NNP	O	Britschgi	nn	8	SENT_528	[p26l924t891r1205b961],
8	M	NNP	O	M	appos	2	SENT_528	[p26l1226t893r1309b955],
9	,	,	O	,	_	0	SENT_528	[p26l1226t893r1309b955],
10	et	FW	O	et	nn	11	SENT_528	[p26l1333t900r1388b946],
11	al.	FW	O	al.	appos	2	SENT_528	[p26l1408t891r1476b946],
12	.	.	O	.	_	0	SENT_528	[p26l1408t891r1476b946],

1	Cellular	JJ	O	cellular	amod	4	SENT_529	[p26l1502t891r1751b946],
2	and	CC	O	and	_	0	SENT_529	[p26l1771t891r1880b946],
3	molecular	JJ	O	molecular	conj_and	1	SENT_529	[p26l1900t891r2150b946, p26l140t989r222b1043],
4	pathophysiology	NN	O	pathophysiology	_	0	SENT_529	[p26l241t988r755b1059],
5	of	IN	O	of	_	0	SENT_529	[p26l779t988r846b1043],
6	cutaneous	JJ	O	cutaneous	amod	8	SENT_529	[p26l863t997r1169b1043],
7	drug	NN	O	drug	nn	8	SENT_529	[p26l1193t989r1331b1059],
8	reactions	NNS	O	reaction	prep_of	4	SENT_529	[p26l1353t989r1648b1043],
9	.	.	O	.	_	0	SENT_529	[p26l1353t989r1648b1043],

1	Am	NNP	O	Am	nn	4	SENT_530	[p26l1673t989r1788b1042],
2	J	NNP	O	J	nn	4	SENT_530	[p26l1809t990r1837b1043],
3	Clin	NNP	O	Clin	nn	4	SENT_530	[p26l1860t988r1991b1043],
4	Dermatol	NNP	O	Dermatol	_	0	SENT_530	[p26l2013t990r2151b1043, p26l140t1084r315b1138],
5	2002	CD	DATE	2002	num	4	SENT_530	[p26l340t1084r820b1145],
6	;	:	O	;	_	0	SENT_530	[p26l340t1084r820b1145],
7	3:229	CD	NUMBER	3:229	number	8	SENT_530	[p26l340t1084r820b1145],
8	—	CD	NUMBER	—	dep	4	SENT_530	[p26l340t1084r820b1145],
9	38	CD	NUMBER	38	dep	8	SENT_530	[p26l340t1084r820b1145],
10	.	.	O	.	_	0	SENT_530	[p26l340t1084r820b1145],

1	Neuman	NNP	PERSON	Neuman	_	0	SENT_531	[p26l1406t1190r1722b1249],
2	e	SYM	O	e	dep	5	SENT_531	[p26l1751t1190r1824b1249],
3	’	CD	NUMBER	’	num	5	SENT_531	[p26l1751t1190r1824b1249],
4	r	NN	O	r	nn	5	SENT_531	[p26l1751t1190r1824b1249],
5	cal	NN	O	cal	rcmod	1	SENT_531	[p26l1849t1190r1910b1249],
6	405	CD	NUMBER	405	dep	1	SENT_531	[p26l2021t1189r2149b1249],

1	Neuman	NNP	ORGANIZATION	Neuman	nn	2	SENT_532	[p26l139t1426r400b1479],
2	MG	NN	ORGANIZATION	mg	_	0	SENT_532	[p26l420t1425r559b1489],
3	,	,	O	,	_	0	SENT_532	[p26l420t1425r559b1489],
4	Shear	NN	ORGANIZATION	shear	nn	5	SENT_532	[p26l586t1425r759b1479],
5	N	NN	ORGANIZATION	n	appos	2	SENT_532	[p26l778t1426r849b1489],
6	,	,	O	,	_	0	SENT_532	[p26l778t1426r849b1489],
7	Malkiewicz	NNP	PERSON	Malkiewicz	appos	2	SENT_532	[p26l873t1425r1234b1479],
8	I	PRP	O	I	dep	7	SENT_532	[p26l1257t1426r1297b1489],
9	,	,	O	,	_	0	SENT_532	[p26l1257t1426r1297b1489],
10	et	FW	O	et	nn	11	SENT_532	[p26l1321t1433r1376b1479],
11	al.	FW	O	al.	appos	2	SENT_532	[p26l1398t1425r1467b1479],
12	.	.	O	.	_	0	SENT_532	[p26l1398t1425r1467b1479],

1	Immunopathogenesis	NN	O	immunopathogenesis	_	0	SENT_533	[p26l1492t1425r2150b1495],
2	of	IN	O	of	_	0	SENT_533	[p26l140t1521r207b1575],
3	hypersensitivity	NN	O	hypersensitivity	nn	5	SENT_533	[p26l234t1521r725b1591],
4	syndrome	NN	O	syndrome	nn	5	SENT_533	[p26l761t1521r1061b1591],
5	reactions	NNS	O	reaction	prep_of	1	SENT_533	[p26l1093t1521r1370b1575],
6	to	TO	O	to	_	0	SENT_533	[p26l1404t1529r1461b1575],
7	sulfonamides	NNS	O	sulfonamide	prep_to	1	SENT_533	[p26l1498t1521r1921b1575],
8	.	.	O	.	_	0	SENT_533	[p26l1498t1521r1921b1575],

1	Transl	NNP	O	Transl	nn	2	SENT_534	[p26l1958t1521r2151b1575],
2	Res	NNP	O	Res	_	0	SENT_534	[p26l140t1619r252b1672],
3	2007	CD	DATE	2007	num	2	SENT_534	[p26l277t1618r835b1682],
4	;	:	O	;	_	0	SENT_534	[p26l277t1618r835b1682],
5	l49	CD	NUMBER	l49	num	6	SENT_534	[p26l277t1618r835b1682],
6	:243	CD	NUMBER	:243	dep	2	SENT_534	[p26l277t1618r835b1682],
7	—	NN	O	—	dep	6	SENT_534	[p26l277t1618r835b1682],
8	53	CD	NUMBER	53	num	7	SENT_534	[p26l277t1618r835b1682],
9	.	.	O	.	_	0	SENT_534	[p26l277t1618r835b1682],

1	Kazeem	NNP	PERSON	Kazeem	nn	2	SENT_535	[p26l141t1714r392b1767],
2	GR	NN	O	gr	_	0	SENT_535	[p26l435t1713r555b1776],
3	,	,	O	,	_	0	SENT_535	[p26l435t1713r555b1776],
4	Cox	NN	ORGANIZATION	cox	nn	5	SENT_535	[p26l601t1713r726b1767],
5	C	NN	ORGANIZATION	c	appos	2	SENT_535	[p26l770t1713r835b1777],
6	,	,	O	,	_	0	SENT_535	[p26l770t1713r835b1777],
7	Aponte	NNP	PERSON	Aponte	nn	8	SENT_535	[p26l880t1713r1106b1783],
8	J	NNP	PERSON	J	appos	5	SENT_535	[p26l1147t1714r1192b1777],
9	,	,	O	,	_	0	SENT_535	[p26l1147t1714r1192b1777],
10	Messenheimer	NNP	O	Messenheimer	nn	11	SENT_535	[p26l1237t1713r1687b1767],
11	J	NNP	O	J	appos	5	SENT_535	[p26l1728t1714r1772b1777],
12	,	,	O	,	_	0	SENT_535	[p26l1728t1714r1772b1777],
13	Brazell	NNP	PERSON	Brazell	nn	14	SENT_535	[p26l1818t1713r2039b1767],
14	C	NNP	O	C	appos	5	SENT_535	[p26l2083t1713r2148b1777],
15	,	,	O	,	_	0	SENT_535	[p26l2083t1713r2148b1777],
16	Nelsen	NNP	PERSON	Nelsen	nn	17	SENT_535	[p26l139t1809r352b1863],
17	AC	NN	O	ac	appos	5	SENT_535	[p26l374t1809r493b1863],
18	.	.	O	.	_	0	SENT_535	[p26l374t1809r493b1863],

1	High-resolution	JJ	O	high-resolution	amod	3	SENT_536	[p26l519t1809r1007b1879],
2	HLA	NN	O	hlum	nn	3	SENT_536	[p26l1029t1809r1185b1863],
3	genotyping	NN	O	genotyping	_	0	SENT_536	[p26l1209t1809r1554b1879],
4	and	CC	O	and	_	0	SENT_536	[p26l1578t1809r1687b1863],
5	severe	JJ	O	severe	amod	8	SENT_536	[p26l1711t1826r1902b1863],
6	cutaneous	JJ	O	cutaneous	amod	8	SENT_536	[p26l1926t1817r2149b1863, p26l140t1922r243b1959],
7	adverse	JJ	O	adverse	amod	8	SENT_536	[p26l271t1905r503b1959],
8	reactions	NNS	O	reaction	conj_and	3	SENT_536	[p26l528t1905r805b1959],
9	in	IN	O	in	_	0	SENT_536	[p26l832t1905r890b1959],
10	lamotrigine-treated	JJ	O	lamotrigine-treated	amod	11	SENT_536	[p26l916t1905r1509b1975],
11	patients	NNS	O	patient	prep_in	3	SENT_536	[p26l1533t1905r1789b1975],
12	.	.	O	.	_	0	SENT_536	[p26l1533t1905r1789b1975],

1	Pharmacogenet	NNP	O	Pharmacogenet	nn	2	SENT_537	[p26l1818t1905r2150b1959, p26l140t2009r307b2071],
2	Genomics	NNP	O	Genomics	_	0	SENT_537	[p26l330t2001r639b2056],
3	2009	CD	DATE	2009	num	2	SENT_537	[p26l665t2001r1145b2065],
4	;	:	O	;	_	0	SENT_537	[p26l665t2001r1145b2065],
5	19:661	CD	NUMBER	19:661	number	6	SENT_537	[p26l665t2001r1145b2065],
6	—	CD	NUMBER	—	dep	2	SENT_537	[p26l665t2001r1145b2065],
7	5	CD	NUMBER	5	dep	6	SENT_537	[p26l665t2001r1145b2065],
8	.	.	O	.	_	0	SENT_537	[p26l665t2001r1145b2065],

1	Hyson	NN	PERSON	hyson	nn	2	SENT_538	[p26l140t2098r338b2167],
2	C	NN	O	c	_	0	SENT_538	[p26l361t2097r427b2161],
3	,	,	O	,	_	0	SENT_538	[p26l361t2097r427b2161],
4	Sadler	NNP	PERSON	Sadler	nn	7	SENT_538	[p26l454t2097r649b2151],
5	M.	NNP	PERSON	M.	nn	7	SENT_538	[p26l670t2098r752b2151],
6	Cross	NNP	PERSON	Cross	nn	7	SENT_538	[p26l779t2097r950b2151],
7	sensitivity	NN	O	sensitivity	appos	2	SENT_538	[p26l976t2097r1287b2167],
8	of	IN	O	of	_	0	SENT_538	[p26l1312t2097r1379b2151],
9	skin	NN	O	skin	nn	10	SENT_538	[p26l1398t2097r1523b2151],
10	rashes	NNS	O	rash	prep_of	7	SENT_538	[p26l1544t2097r1735b2151],
11	with	IN	O	with	_	0	SENT_538	[p26l1758t2097r1894b2151],
12	antiepi	JJ	O	antiepi	amod	13	SENT_538	[p26l1917t2097r2149b2167],
13	—	NN	O	—	prep_with	10	SENT_538	[p26l1917t2097r2149b2167],
14	leptic	JJ	O	leptic	amod	15	SENT_538	[p26l140t2193r309b2263],
15	drugs	NNS	O	drug	dep	7	SENT_538	[p26l334t2193r519b2263],
16	.	.	O	.	_	0	SENT_538	[p26l334t2193r519b2263],

1	Can	MD	O	can	aux	5	SENT_539	[p26l547t2193r669b2248],
2	J	NNP	O	J	nn	5	SENT_539	[p26l691t2194r720b2248],
3	Neurol	NNP	O	Neurol	nn	5	SENT_539	[p26l743t2193r956b2247],
4	Sci	NNP	O	Sci	nn	5	SENT_539	[p26l982t2193r1076b2248],
5	l997	NN	O	l997	_	0	SENT_539	[p26l1108t2193r1581b2257],
6	;	:	O	;	_	0	SENT_539	[p26l1108t2193r1581b2257],
7	24:245	CD	NUMBER	24:245	number	8	SENT_539	[p26l1108t2193r1581b2257],
8	—	CD	NUMBER	—	dep	5	SENT_539	[p26l1108t2193r1581b2257],
9	9	CD	NUMBER	9	dep	8	SENT_539	[p26l1108t2193r1581b2257],
10	.	.	O	.	_	0	SENT_539	[p26l1108t2193r1581b2257],

1	Moss	NNP	PERSON	Moss	nn	2	SENT_540	[p26l139t2291r298b2344],
2	DM	NN	O	dm	_	0	SENT_540	[p26l322t2291r457b2353],
3	,	,	O	,	_	0	SENT_540	[p26l322t2291r457b2353],
4	Rudis	NNP	PERSON	Rudis	nn	5	SENT_540	[p26l482t2289r653b2344],
5	M	NNP	O	M	appos	2	SENT_540	[p26l676t2291r757b2353],
6	,	,	O	,	_	0	SENT_540	[p26l676t2291r757b2353],
7	Henderson	NNP	PERSON	Henderson	nn	8	SENT_540	[p26l782t2289r1103b2344],
8	SO	NNP	O	SO	appos	5	SENT_540	[p26l1127t2290r1234b2344],
9	.	.	O	.	_	0	SENT_540	[p26l1127t2290r1234b2344],

1	Cross-sensitivity	NN	O	cross-sensitivity	_	0	SENT_541	[p26l1261t2289r1753b2359],
2	and	CC	O	and	_	0	SENT_541	[p26l1777t2289r1883b2344],
3	the	DT	O	the	det	6	SENT_541	[p26l1904t2289r1994b2344],
4	anticonvulsant	JJ	O	anticonvulsant	amod	6	SENT_541	[p26l2018t2289r2149b2344, p26l140t2387r459b2441],
5	hypersensitivity	NN	O	hypersensitivity	nn	6	SENT_541	[p26l471t2386r942b2457],
6	syndrome	NN	O	syndrome	conj_and	1	SENT_541	[p26l958t2387r1262b2457],
7	.	.	O	.	_	0	SENT_541	[p26l958t2387r1262b2457],

1	J	NN	O	j	nn	3	SENT_542	[p26l1280t2388r1308b2441],
2	Emerg	NNP	O	Emerg	nn	3	SENT_542	[p26l1321t2388r1519b2457],
3	Med	NNP	O	Med	_	0	SENT_542	[p26l1534t2386r1672b2441],
4	1999	CD	DATE	1999	num	3	SENT_542	[p26l1692t2387r1850b2450],
5	;	:	O	;	_	0	SENT_542	[p26l1692t2387r1850b2450],
6	l7	CD	NUMBER	l7	num	7	SENT_542	[p26l1862t2386r2147b2441],
7	:503	CD	NUMBER	:503	dep	3	SENT_542	[p26l1862t2386r2147b2441],
8	—	NN	O	—	dep	7	SENT_542	[p26l1862t2386r2147b2441],
9	6	CD	NUMBER	6	num	8	SENT_542	[p26l1862t2386r2147b2441],
10	.	.	O	.	_	0	SENT_542	[p26l1862t2386r2147b2441],

1	Kwong	NNP	ORGANIZATION	Kwong	nn	2	SENT_543	[p26l141t2482r364b2551],
2	KL	NNP	ORGANIZATION	KL	_	0	SENT_543	[p26l384t2482r500b2545],
3	,	,	O	,	_	0	SENT_543	[p26l384t2482r500b2545],
4	Lam	NNP	LOCATION	Lam	nn	5	SENT_543	[p26l523t2482r664b2535],
5	SY	NNP	LOCATION	SY	appos	2	SENT_543	[p26l685t2482r786b2545],
6	,	,	O	,	_	0	SENT_543	[p26l685t2482r786b2545],
7	Lui	NNP	PERSON	Lui	nn	8	SENT_543	[p26l807t2481r912b2535],
8	YS	NNP	O	YS	appos	2	SENT_543	[p26l933t2481r1045b2545],
9	,	,	O	,	_	0	SENT_543	[p26l933t2481r1045b2545],
10	Wong	NNP	PERSON	Wong	nn	11	SENT_543	[p26l1067t2482r1248b2551],
11	SN	NNP	O	SN	appos	2	SENT_543	[p26l1270t2482r1381b2545],
12	,	,	O	,	_	0	SENT_543	[p26l1270t2482r1381b2545],
13	So	RB	O	so	advmod	14	SENT_543	[p26l1405t2482r1481b2536],
14	KT	NN	O	kt	appos	2	SENT_543	[p26l1503t2482r1612b2535],
15	.	.	O	.	_	0	SENT_543	[p26l1503t2482r1612b2535],

1	Cross-sensitivity	NN	O	cross-sensitivity	_	0	SENT_544	[p26l1637t2481r2151b2551],
2	in	IN	O	in	_	0	SENT_544	[p26l140t2577r198b2631],
3	a	DT	O	a	det	4	SENT_544	[p26l225t2594r257b2632],
4	child	NN	O	child	prep_in	1	SENT_544	[p26l283t2577r436b2632],
5	with	IN	O	with	_	0	SENT_544	[p26l462t2577r598b2632],
6	anticonvulsant	JJ	O	anticonvulsant	amod	8	SENT_544	[p26l625t2577r1072b2632],
7	hypersensitivity	NN	O	hypersensitivity	nn	8	SENT_544	[p26l1096t2577r1588b2647],
8	syndrome	NN	O	syndrome	prep_with	1	SENT_544	[p26l1617t2577r1932b2647],
9	.	.	O	.	_	0	SENT_544	[p26l1617t2577r1932b2647],

1	J	NNP	O	J	nn	4	SENT_545	[p26l1962t2579r1990b2632],
2	Paediatr	NNP	O	Paediatr	nn	4	SENT_545	[p26l2016t2579r2150b2632, p26l140t2675r281b2729],
3	Child	NNP	O	Child	nn	4	SENT_545	[p26l304t2674r475b2729],
4	Health	NNP	O	Health	_	0	SENT_545	[p26l497t2674r702b2729],
5	2006	CD	DATE	2006	num	4	SENT_545	[p26l726t2674r1206b2738],
6	;	:	O	;	_	0	SENT_545	[p26l726t2674r1206b2738],
7	42:474	CD	NUMBER	42:474	number	8	SENT_545	[p26l726t2674r1206b2738],
8	—	CD	NUMBER	—	dep	4	SENT_545	[p26l726t2674r1206b2738],
9	6	CD	NUMBER	6	dep	8	SENT_545	[p26l726t2674r1206b2738],
10	.	.	O	.	_	0	SENT_545	[p26l726t2674r1206b2738],

1	Mendiratta	NNP	O	Mendiratta	nn	2	SENT_546	[p26l139t2771r479b2825],
2	V	NNP	O	V	_	0	SENT_546	[p26l499t2772r559b2835],
3	,	,	O	,	_	0	SENT_546	[p26l499t2772r559b2835],
4	Bhushan	NNP	PERSON	Bhushan	nn	7	SENT_546	[p26l585t2771r853b2825],
5	P.	NNP	PERSON	P.	nn	7	SENT_546	[p26l875t2772r923b2825],
6	Phenytoin-induced	JJ	PERSON	phenytoin-induced	amod	7	SENT_546	[p26l948t2771r1530b2841],
7	DRESS	NN	O	dress	appos	2	SENT_546	[p26l1552t2771r1786b2825],
8	with	IN	O	with	_	0	SENT_546	[p26l1812t2771r1947b2825],
9	crossreactivity	NN	O	crossreactivity	prep_with	7	SENT_546	[p26l1970t2788r2149b2825, p26l139t2865r429b2935],
10	to	TO	O	to	_	0	SENT_546	[p26l460t2874r518b2920],
11	carbamazepine	NN	O	carbamazepine	prep_to	9	SENT_546	[p26l551t2865r1013b2935],
12	in	IN	O	in	_	0	SENT_546	[p26l1045t2865r1103b2919],
13	a	DT	O	a	det	16	SENT_546	[p26l1136t2882r1169b2920],
14	10-year-old	JJ	DURATION	10-year-old	amod	16	SENT_546	[p26l1206t2865r1558b2935],
15	Indian	JJ	MISC	indian	amod	16	SENT_546	[p26l1588t2865r1785b2920],
16	child	NN	O	child	prep_in	11	SENT_546	[p26l1816t2865r1984b2920],
17	.	.	O	.	_	0	SENT_546	[p26l1816t2865r1984b2920],

1	Clin	NNP	O	Clin	nn	3	SENT_547	[p26l2020t2865r2151b2920],
2	Exp	NNP	O	Exp	nn	3	SENT_547	[p26l139t2964r261b3033],
3	Dermatol	NNP	O	Dermatol	_	0	SENT_547	[p26l285t2963r576b3017],
4	2006	CD	DATE	2006	num	3	SENT_547	[p26l601t2962r809b3026],
5	;	:	O	;	_	0	SENT_547	[p26l601t2962r809b3026],
6	3	CD	NUMBER	3	num	7	SENT_547	[p26l601t2962r809b3026],
7	l	NN	O	l	dep	3	SENT_547	[p26l822t2963r844b3016],
8	:720	CD	NUMBER	:720	num	9	SENT_547	[p26l858t2963r1058b3017],
9	—	NN	O	—	dep	7	SENT_547	[p26l858t2963r1058b3017],
10	l	NN	O	l	tmod	7	SENT_547	[p26l858t2963r1058b3017],
11	.	.	O	.	_	0	SENT_547	[p26l1072t3007r1080b3017],

1	Romano	NNP	MISC	Romano	nn	2	SENT_548	[p26l140t3060r399b3113],
2	A	NNP	MISC	A	_	0	SENT_548	[p26l419t3059r489b3122],
3	,	,	O	,	_	0	SENT_548	[p26l419t3059r489b3122],
4	Pettinato	NNP	PERSON	Pettinato	nn	5	SENT_548	[p26l511t3059r784b3113],
5	R	NNP	PERSON	R	appos	2	SENT_548	[p26l805t3060r871b3122],
6	,	,	O	,	_	0	SENT_548	[p26l805t3060r871b3122],
7	Andriolo	NNP	O	Andriolo	nn	8	SENT_548	[p26l893t3059r1170b3113],
8	M	NNP	O	M	appos	2	SENT_548	[p26l1189t3060r1273b3122],
9	,	,	O	,	_	0	SENT_548	[p26l1189t3060r1273b3122],
10	et	FW	O	et	nn	11	SENT_548	[p26l1295t3067r1350b3113],
11	al.	FW	O	al.	appos	2	SENT_548	[p26l1371t3059r1439b3113],
12	.	.	O	.	_	0	SENT_548	[p26l1371t3059r1439b3113],

1	Hypersensitivity	NN	O	hypersensitivity	_	0	SENT_549	[p26l1462t3059r1969b3129],
2	to	TO	O	to	_	0	SENT_549	[p26l1990t3067r2047b3113],
3	aromatic	JJ	O	aromatic	amod	4	SENT_549	[p26l2069t3076r2150b3113, p26l140t3153r347b3208],
4	anticonvulsants	NNS	O	anticonvulsant	prep_to	1	SENT_549	[p26l374t3153r866b3208],
5	:	:	O	:	_	0	SENT_549	[p26l374t3153r866b3208],
6	in	FW	O	in	dep	11	SENT_549	[p26l897t3155r952b3208],
7	vivo	FW	O	vivo	pobj	6	SENT_549	[p26l974t3155r1100b3208],
8	and	CC	O	and	_	0	SENT_549	[p26l1126t3153r1235b3208],
9	in	FW	O	in	nn	10	SENT_549	[p26l1260t3155r1315b3208],
10	vitro	FW	O	vitro	conj_and	6	SENT_549	[p26l1337t3155r1477b3208],
11	cross-reactivity	NN	O	cross-reactivity	dep	1	SENT_549	[p26l1502t3153r1975b3223],
12	studies	NNS	O	study	dep	11	SENT_549	[p26l2001t3153r2150b3208, p26l139t3251r239b3305],
13	.	.	O	.	_	0	SENT_549	[p26l2001t3153r2150b3208, p26l139t3251r239b3305],

1	Curr	NNP	MISC	Curr	nn	3	SENT_550	[p26l267t3251r407b3305],
2	Pharm	NNP	MISC	Pharm	nn	3	SENT_550	[p26l429t3251r630b3305],
3	Des	NNP	MISC	Des	_	0	SENT_550	[p26l652t3252r769b3305],
4	2006	CD	DATE	2006	num	3	SENT_550	[p26l796t3250r1353b3314],
5	;	:	O	;	_	0	SENT_550	[p26l796t3250r1353b3314],
6	l2	NN	O	l2	dep	3	SENT_550	[p26l796t3250r1353b3314],
7	:3373	CD	NUMBER	:3373	number	8	SENT_550	[p26l796t3250r1353b3314],
8	—	CD	NUMBER	—	num	9	SENT_550	[p26l796t3250r1353b3314],
9	8l	NN	O	8l	dep	6	SENT_550	[p26l796t3250r1353b3314],
10	.	.	O	.	_	0	SENT_550	[p26l796t3250r1353b3314],

1	Seitz	NNP	PERSON	Seitz	nn	2	SENT_551	[p26l141t3347r292b3401],
2	CS	NNP	O	CS	_	0	SENT_551	[p26l311t3347r419b3410],
3	,	,	O	,	_	0	SENT_551	[p26l311t3347r419b3410],
4	Pfeuffer	NNP	PERSON	Pfeuffer	nn	5	SENT_551	[p26l440t3347r691b3401],
5	P	NN	PERSON	p	appos	2	SENT_551	[p26l708t3348r758b3410],
6	,	,	O	,	_	0	SENT_551	[p26l708t3348r758b3410],
7	Raith	NN	ORGANIZATION	raith	nn	8	SENT_551	[p26l778t3347r945b3401],
8	P	NN	ORGANIZATION	p	appos	2	SENT_551	[p26l962t3348r1012b3410],
9	,	,	O	,	_	0	SENT_551	[p26l962t3348r1012b3410],
10	Brocker	NNP	PERSON	Brocker	nn	11	SENT_551	[p26l1033t3347r1282b3401],
11	EB	NNP	O	EB	appos	2	SENT_551	[p26l1298t3348r1412b3411],
12	,	,	O	,	_	0	SENT_551	[p26l1298t3348r1412b3411],
13	Trautmann	NNP	PERSON	Trautmann	nn	17	SENT_551	[p26l1433t3348r1769b3401],
14	A.	NNP	O	A.	nn	17	SENT_551	[p26l1787t3347r1856b3401],
15	Anticonvulsant	NNP	O	Anticonvulsant	nn	17	SENT_551	[p26l1878t3347r2150b3401, p26l140t3443r362b3497],
16	hypersensitivity	NN	O	hypersensitivity	nn	17	SENT_551	[p26l383t3443r874b3513],
17	syndrome	NN	O	syndrome	appos	2	SENT_551	[p26l899t3443r1215b3513],
18	:	:	O	:	_	0	SENT_551	[p26l899t3443r1215b3513],
19	cross-reactivity	NN	O	cross-reactivity	dep	2	SENT_551	[p26l1245t3443r1717b3513],
20	with	IN	O	with	_	0	SENT_551	[p26l1741t3443r1877b3497],
21	tricyclic	JJ	O	tricyclic	amod	23	SENT_551	[p26l1899t3443r2150b3513],
22	antidepressant	JJ	O	antidepressant	amod	23	SENT_551	[p26l141t3538r581b3609],
23	agents	NNS	O	agent	prep_with	19	SENT_551	[p26l619t3547r828b3609],
24	.	.	O	.	_	0	SENT_551	[p26l619t3547r828b3609],

1	Ann	NNP	PERSON	Ann	nn	4	SENT_552	[p26l868t3539r1000b3592],
2	Alergy	NNP	PERSON	Alergy	nn	4	SENT_552	[p26l1036t3539r1248b3609],
3	Asthma	NNP	O	Asthma	nn	4	SENT_552	[p26l1284t3539r1524b3593],
4	Immunol	NNP	O	Immunol	_	0	SENT_552	[p26l1560t3539r1842b3593],
5	2006	CD	DATE	2006	num	4	SENT_552	[p26l1879t3538r2145b3602],
6	;	:	O	;	_	0	SENT_552	[p26l1879t3538r2145b3602],
7	97	CD	NUMBER	97	num	9	SENT_552	[p26l1879t3538r2145b3602],
8	:	:	O	:	_	0	SENT_552	[p26l1879t3538r2145b3602],
9	698-702	CD	NUMBER	698-702	dep	4	SENT_552	[p26l141t3635r422b3690],
10	.	.	O	.	_	0	SENT_552	[p26l141t3635r422b3690],

1	Fujita	NNP	ORGANIZATION	Fujita	_	0	SENT_553	[p26l139t3731r315b3801],
2	T	NN	ORGANIZATION	t	dep	1	SENT_553	[p26l327t3732r382b3795],
3	,	,	O	,	_	0	SENT_553	[p26l327t3732r382b3795],
4	Matsuoka	NNP	PERSON	Matsuoka	nn	5	SENT_553	[p26l399t3731r697b3785],
5	T	NN	PERSON	t	appos	2	SENT_553	[p26l709t3732r764b3794],
6	,	,	O	,	_	0	SENT_553	[p26l709t3732r764b3794],
7	Honda	NNP	ORGANIZATION	Honda	nn	8	SENT_553	[p26l781t3731r981b3785],
8	T	NN	ORGANIZATION	t	appos	2	SENT_553	[p26l995t3732r1050b3794],
9	,	,	O	,	_	0	SENT_553	[p26l995t3732r1050b3794],
10	Kabashima	NNP	PERSON	Kabashima	nn	11	SENT_553	[p26l1068t3731r1406b3785],
11	K	NNP	PERSON	K	appos	2	SENT_553	[p26l1420t3732r1487b3794],
12	,	,	O	,	_	0	SENT_553	[p26l1420t3732r1487b3794],
13	Hirata	NNP	PERSON	Hirata	nn	14	SENT_553	[p26l1505t3731r1693b3785],
14	T	NN	O	t	appos	2	SENT_553	[p26l1706t3732r1761b3794],
15	,	,	O	,	_	0	SENT_553	[p26l1706t3732r1761b3794],
16	Narumiya	NNP	PERSON	Narumiya	nn	17	SENT_553	[p26l1778t3731r2079b3801],
17	S.	NNP	PERSON	S.	appos	2	SENT_553	[p26l2095t3731r2147b3785],

1	A	DT	O	a	det	4	SENT_554	[p27l139t19r193b73],
2	GPR40	NN	O	gpr40	nn	4	SENT_554	[p27l205t19r423b73],
3	agonist	NN	O	agonist	nn	4	SENT_554	[p27l439t19r654b89],
4	GW9508	NN	O	gw9508	nsubj	16	SENT_554	[p27l667t19r938b74],
5	suppresses	VBZ	O	suppress	_	0	SENT_554	[p27l957t36r1272b89],
6	CCL5	NN	O	ccl5	dobj	5	SENT_554	[p27l1287t19r1486b83],
7	,	,	O	,	_	0	SENT_554	[p27l1287t19r1486b83],
8	CCL17	NN	O	ccl17	dobj	5	SENT_554	[p27l1502t19r1737b83],
9	,	,	O	,	_	0	SENT_554	[p27l1502t19r1737b83],
10	and	CC	O	and	_	0	SENT_554	[p27l1756t19r1862b73],
11	CXCL10	NN	O	cxcl10	nn	12	SENT_554	[p27l1876t19r2150b73],
12	induction	NN	O	induction	dobj	5	SENT_554	[p27l140t117r421b171],
13	in	IN	O	in	_	0	SENT_554	[p27l437t117r495b170],
14	keratinocytes	NNS	O	keratinocyte	prep_in	5	SENT_554	[p27l508t117r905b187],
15	and	CC	O	and	_	0	SENT_554	[p27l924t117r1030b171],
16	attenuates	VBZ	O	attenuate	conj_and	5	SENT_554	[p27l1046t125r1343b171],
17	cutaneous	JJ	O	cutaneous	amod	19	SENT_554	[p27l1360t125r1656b171],
18	immune	JJ	O	immune	amod	19	SENT_554	[p27l1673t117r1919b171],
19	inﬂammation	NN	O	inﬂammation	dobj	16	SENT_554	[p27l1935t117r2149b171, p27l140t213r361b267],
20	.	.	O	.	_	0	SENT_554	[p27l1935t117r2149b171, p27l140t213r361b267],

1	J	NNP	O	J	nn	3	SENT_555	[p27l386t214r414b267],
2	Invest	NNP	O	Invest	nn	3	SENT_555	[p27l434t214r613b267],
3	Dermatol	NNP	O	Dermatol	_	0	SENT_555	[p27l633t213r915b267],
4	201	CD	NUMBER	201	number	5	SENT_555	[p27l937t213r1040b267],
5	1	CD	NUMBER	1	dep	3	SENT_555	[p27l1055t213r1078b266],
6	;	:	O	;	_	0	SENT_555	[p27l1092t213r1211b276],
7	l31	NN	O	l31	dep	3	SENT_555	[p27l1092t213r1211b276],
8	:	:	O	:	_	0	SENT_555	[p27l1225t230r1234b267],
9	1660-7	CD	NUMBER	1660-7	dep	7	SENT_555	[p27l1247t213r1477b267],
10	.	.	O	.	_	0	SENT_555	[p27l1247t213r1477b267],

1	Dinarello	NNP	O	Dinarello	nn	4	SENT_556	[p27l140t307r429b361],
2	C.	NNP	O	C.	nn	4	SENT_556	[p27l463t307r527b361],
3	Biologic	JJ	O	biologic	amod	4	SENT_556	[p27l564t307r828b377],
4	basis	NN	O	basis	_	0	SENT_556	[p27l861t307r1013b361],
5	for	IN	O	for	_	0	SENT_556	[p27l1047t307r1137b361],
6	inter1eukin	VBG	O	inter1eukin	prepc_for	4	SENT_556	[p27l1168t307r1560b361],
7	—	NN	O	—	dobj	6	SENT_556	[p27l1168t307r1560b361],
8	1	CD	NUMBER	1	num	7	SENT_556	[p27l1168t307r1560b361],
9	in	IN	O	in	_	0	SENT_556	[p27l1599t307r1658b361],
10	disease	NN	O	disease	prep_in	7	SENT_556	[p27l1691t307r1927b361],
11	.	.	O	.	_	0	SENT_556	[p27l1691t307r1927b361],

1	Blood	NN	O	blood	_	0	SENT_557	[p27l1964t307r2152b361],
2	1996	CD	DATE	1996	num	1	SENT_557	[p27l147t404r737b468],
3	;	:	O	;	_	0	SENT_557	[p27l147t404r737b468],
4	87:2095	CD	NUMBER	87:2095	number	5	SENT_557	[p27l147t404r737b468],
5	-147	CD	NUMBER	-147	dep	1	SENT_557	[p27l147t404r737b468],
6	.	.	O	.	_	0	SENT_557	[p27l147t404r737b468],

1	Abe	NN	PERSON	abe	nn	2	SENT_558	[p27l139t501r265b555],
2	R	NN	PERSON	r	_	0	SENT_558	[p27l313t502r379b564],
3	,	,	O	,	_	0	SENT_558	[p27l313t502r379b564],
4	Shimizu	NNP	ORGANIZATION	Shimizu	nn	5	SENT_558	[p27l431t501r685b555],
5	T	NN	ORGANIZATION	t	appos	2	SENT_558	[p27l733t502r789b564],
6	,	,	O	,	_	0	SENT_558	[p27l733t502r789b564],
7	Shibaki	NNP	PERSON	Shibaki	nn	8	SENT_558	[p27l841t501r1073b555],
8	A	NNP	O	A	appos	2	SENT_558	[p27l1121t501r1191b564],
9	,	,	O	,	_	0	SENT_558	[p27l1121t501r1191b564],
10	N	NNP	O	N	nn	12	SENT_558	[p27l1240t502r1295b555],
11	akamura	NN	O	akamura	nn	12	SENT_558	[p27l1298t501r1563b555],
12	H	NN	O	h	conj_and	5	SENT_558	[p27l1608t502r1678b564],
13	,	,	O	,	_	0	SENT_558	[p27l1608t502r1678b564],
14	Watanabe	NNP	PERSON	Watanabe	nn	15	SENT_558	[p27l1728t501r2031b555],
15	H	NNP	O	H	conj_and	5	SENT_558	[p27l2078t502r2148b565],
16	,	,	O	,	_	0	SENT_558	[p27l2078t502r2148b565],
17	Shimizu	NNP	PERSON	Shimizu	nn	18	SENT_558	[p27l141t595r395b649],
18	H.	NNP	O	H.	conj_and	5	SENT_558	[p27l415t596r483b649],
19	Toxic	JJ	O	toxic	amod	21	SENT_558	[p27l507t595r679b649],
20	epidermal	JJ	O	epidermal	amod	21	SENT_558	[p27l700t595r1008b665],
21	necrolysis	NN	O	necrolysis	dep	18	SENT_558	[p27l1027t595r1338b665],
22	and	CC	O	and	_	0	SENT_558	[p27l1359t595r1468b649],
23	Stevens	NNP	PERSON	Stevens	conj_and	5	SENT_558	[p27l1489t595r2002b649],
24	.	.	O	.	_	0	SENT_558	[p27l1489t595r2002b649],

1	—	NN	O	—	_	0	SENT_559	[p27l1489t595r2002b649],
2	.	.	O	.	_	0	SENT_559	[p27l1489t595r2002b649],

1	Johnson	NNP	PERSON	Johnson	nn	2	SENT_560	[p27l1489t595r2002b649],
2	syndrome	NN	O	syndrome	nsubjpass	4	SENT_560	[p27l2023t612r2149b665, p27l140t691r335b745],
3	are	VBP	O	be	auxpass	4	SENT_560	[p27l358t708r449b745],
4	induced	VBN	O	induce	_	0	SENT_560	[p27l472t691r716b745],
5	by	IN	O	by	_	0	SENT_560	[p27l736t691r811b761],
6	soluble	JJ	O	soluble	amod	8	SENT_560	[p27l837t691r1056b745],
7	Fas	NN	O	fa	nn	8	SENT_560	[p27l1077t692r1181b745],
8	ligand	NN	O	ligand	agent	4	SENT_560	[p27l1205t691r1412b761],
9	.	.	O	.	_	0	SENT_560	[p27l1205t691r1412b761],

1	Am	VBP	O	be	dep	3	SENT_561	[p27l1437t692r1552b745],
2	J	NN	O	j	nn	3	SENT_561	[p27l1573t692r1601b746],
3	Pathol	NN	O	pathol	_	0	SENT_561	[p27l1623t691r1817b745],
4	2003	CD	DATE	2003	dep	3	SENT_561	[p27l1841t692r2011b755],
5	;	:	O	;	_	0	SENT_561	[p27l1841t692r2011b755],
6	162	CD	NUMBER	162	dep	4	SENT_561	[p27l2024t691r2146b746],
7	:	:	O	:	_	0	SENT_561	[p27l2024t691r2146b746],
8	1515-20	CD	NUMBER	1515-20	dep	6	SENT_561	[p27l147t787r422b842],
9	.	.	O	.	_	0	SENT_561	[p27l147t787r422b842],

1	Hung	NNP	O	Hung	nn	2	SENT_562	[p27l140t884r308b953],
2	SI	NNP	O	SI	_	0	SENT_562	[p27l338t883r418b947],
3	,	,	O	,	_	0	SENT_562	[p27l338t883r418b947],
4	Chung	NNP	PERSON	Chung	nn	5	SENT_562	[p27l448t883r650b953],
5	WH	NNP	PERSON	WH	appos	2	SENT_562	[p27l677t884r821b947],
6	,	,	O	,	_	0	SENT_562	[p27l677t884r821b947],
7	Liu	NNP	PERSON	Liu	nn	8	SENT_562	[p27l849t883r956b937],
8	ZS	NNP	O	ZS	appos	2	SENT_562	[p27l982t883r1087b947],
9	,	,	O	,	_	0	SENT_562	[p27l982t883r1087b947],
10	et	FW	O	et	nn	11	SENT_562	[p27l1117t891r1171b937],
11	al.	FW	O	al.	appos	2	SENT_562	[p27l1199t883r1267b937],
12	.	.	O	.	_	0	SENT_562	[p27l1199t883r1267b937],

1	Common	JJ	O	common	amod	3	SENT_563	[p27l1298t883r1583b937],
2	risk	NN	O	risk	nn	3	SENT_563	[p27l1609t883r1725b937],
3	allele	NN	O	allele	nsubj	7	SENT_563	[p27l1751t883r1917b937],
4	in	IN	O	in	_	0	SENT_563	[p27l1943t883r2002b937],
5	aromatic	JJ	O	aromatic	amod	6	SENT_563	[p27l2029t900r2148b937, p27l140t979r309b1033],
6	antiepileptic-drug	NN	O	antiepileptic-drug	prep_in	3	SENT_563	[p27l336t979r883b1049],
7	induced	VBD	O	induce	_	0	SENT_563	[p27l908t979r1153b1033],
8	Stevens	NNP	PERSON	Stevens	dobj	7	SENT_563	[p27l1178t979r1690b1034],
9	.	.	O	.	_	0	SENT_563	[p27l1178t979r1690b1034],

1	—	NN	O	—	_	0	SENT_564	[p27l1178t979r1690b1034],
2	.	.	O	.	_	0	SENT_564	[p27l1178t979r1690b1034],

1	Johnson	NNP	PERSON	Johnson	nn	2	SENT_565	[p27l1178t979r1690b1034],
2	syndrome	NN	O	syndrome	_	0	SENT_565	[p27l1717t979r2016b1049],
3	and	CC	O	and	_	0	SENT_565	[p27l2043t979r2152b1033],
4	toxic	JJ	O	toxic	amod	6	SENT_565	[p27l139t1075r291b1130],
5	epidermal	JJ	O	epidermal	amod	6	SENT_565	[p27l324t1075r631b1145],
6	necrolysis	NN	O	necrolysis	conj_and	2	SENT_565	[p27l661t1075r972b1145],
7	in	IN	O	in	_	0	SENT_565	[p27l1004t1075r1062b1129],
8	Han	NNP	LOCATION	Han	nn	9	SENT_565	[p27l1093t1077r1219b1130],
9	Chinese	NNP	LOCATION	Chinese	prep_in	2	SENT_565	[p27l1251t1075r1513b1130],
10	.	.	O	.	_	0	SENT_565	[p27l1251t1075r1513b1130],

1	Pharmacogenomics	NNS	O	pharmacogenomic	_	0	SENT_566	[p27l1547t1075r2150b1145],
2	2010	CD	DATE	2010	num	1	SENT_566	[p27l141t1172r659b1236],
3	;	:	O	;	_	0	SENT_566	[p27l141t1172r659b1236],
4	11:349	CD	NUMBER	11:349	number	5	SENT_566	[p27l141t1172r659b1236],
5	-56	CD	NUMBER	-56	dep	1	SENT_566	[p27l141t1172r659b1236],
6	.	.	O	.	_	0	SENT_566	[p27l141t1172r659b1236],

1	Hung	NNP	O	Hung	nn	2	SENT_567	[p27l140t1268r308b1337],
2	SI	NNP	O	SI	_	0	SENT_567	[p27l346t1268r427b1331],
3	,	,	O	,	_	0	SENT_567	[p27l346t1268r427b1331],
4	Chung	NNP	PERSON	Chung	nn	5	SENT_567	[p27l466t1267r669b1337],
5	WH	NNP	PERSON	WH	appos	2	SENT_567	[p27l705t1268r849b1331],
6	,	,	O	,	_	0	SENT_567	[p27l705t1268r849b1331],
7	Jee	NNP	PERSON	Jee	nn	8	SENT_567	[p27l887t1268r984b1322],
8	SH	NNP	O	SH	appos	2	SENT_567	[p27l1022t1267r1133b1331],
9	,	,	O	,	_	0	SENT_567	[p27l1022t1267r1133b1331],
10	et	FW	O	et	nn	11	SENT_567	[p27l1172t1275r1227b1321],
11	al.	FW	O	al.	appos	2	SENT_567	[p27l1263t1267r1331b1321],
12	.	.	O	.	_	0	SENT_567	[p27l1263t1267r1331b1321],

1	Genetic	JJ	O	genetic	amod	2	SENT_568	[p27l1371t1267r1608b1322],
2	susceptibility	NN	O	susceptibility	_	0	SENT_568	[p27l1648t1267r2057b1337],
3	to	TO	O	to	_	0	SENT_568	[p27l2092t1275r2150b1321],
4	Carbamazepine-induced	JJ	MISC	carbamazepine-induced	amod	5	SENT_568	[p27l140t1363r892b1433],
5	cutaneous	JJ	O	cutaneous	amod	8	SENT_568	[p27l915t1372r1220b1418],
6	adverse	JJ	O	adverse	amod	8	SENT_568	[p27l1246t1363r1479b1418],
7	drug	NN	O	drug	nn	8	SENT_568	[p27l1503t1363r1641b1433],
8	reactions	NNS	O	reaction	prep_to	2	SENT_568	[p27l1665t1363r1960b1418],
9	.	.	O	.	_	0	SENT_568	[p27l1665t1363r1960b1418],

1	Pharmacogenet	NNP	O	Pharmacogenet	nn	2	SENT_569	[p27l1986t1363r2149b1418, p27l140t1467r475b1529],
2	Genomics	NNP	O	Genomics	_	0	SENT_569	[p27l498t1459r808b1513],
3	2006	CD	DATE	2006	num	2	SENT_569	[p27l833t1459r1002b1523],
4	;	:	O	;	_	0	SENT_569	[p27l833t1459r1002b1523],
5	16:297	CD	NUMBER	16:297	number	6	SENT_569	[p27l1016t1459r1390b1514],
6	-306	CD	NUMBER	-306	dep	2	SENT_569	[p27l1016t1459r1390b1514],
7	.	.	O	.	_	0	SENT_569	[p27l1016t1459r1390b1514],

1	Man	NN	O	man	_	0	SENT_570	[p27l139t1557r279b1610],
2	CB	NNP	O	CB	dep	1	SENT_570	[p27l313t1556r430b1620],
3	,	,	O	,	_	0	SENT_570	[p27l313t1556r430b1620],
4	Kwan	NNP	PERSON	Kwan	nn	5	SENT_570	[p27l469t1557r649b1610],
5	P	NN	O	p	appos	2	SENT_570	[p27l684t1557r733b1620],
6	,	,	O	,	_	0	SENT_570	[p27l684t1557r733b1620],
7	Baum	NNP	PERSON	Baum	nn	8	SENT_570	[p27l769t1557r953b1610],
8	L	NNP	O	L	appos	2	SENT_570	[p27l987t1557r1049b1620],
9	,	,	O	,	_	0	SENT_570	[p27l987t1557r1049b1620],
10	et	FW	O	et	nn	11	SENT_570	[p27l1086t1564r1141b1610],
11	al.	FW	O	al.	appos	2	SENT_570	[p27l1175t1556r1243b1610],
12	.	.	O	.	_	0	SENT_570	[p27l1175t1556r1243b1610],

1	Association	NNP	O	Association	_	0	SENT_571	[p27l1282t1556r1645b1610],
2	between	IN	O	between	_	0	SENT_571	[p27l1678t1556r1935b1610],
3	HLAB	NNP	O	HLAB	prep_between	1	SENT_571	[p27l1969t1557r2149b1610, p27l140t1651r381b1706],
4	*	CD	NUMBER	*	number	5	SENT_571	[p27l1969t1557r2149b1610, p27l140t1651r381b1706],
5	1502	CD	DATE	1502	dep	1	SENT_571	[p27l1969t1557r2149b1610, p27l140t1651r381b1706],
6	Allele	NNP	O	Allele	dep	5	SENT_571	[p27l415t1651r602b1706],
7	and	CC	O	and	_	0	SENT_571	[p27l637t1651r746b1706],
8	Antiepileptic	JJ	O	antiepileptic	amod	11	SENT_571	[p27l778t1651r1179b1721],
9	drug-induced	JJ	O	drug-induced	amod	11	SENT_571	[p27l1215t1651r1625b1721],
10	cutaneous	JJ	O	cutaneous	amod	11	SENT_571	[p27l1658t1660r1963b1706],
11	reactions	NNS	O	reaction	conj_and	5	SENT_571	[p27l1997t1668r2149b1706, p27l139t1748r286b1803],
12	in	IN	O	in	_	0	SENT_571	[p27l311t1749r370b1802],
13	Han	NNP	LOCATION	Han	nn	14	SENT_571	[p27l393t1750r520b1803],
14	Chinese	NNP	LOCATION	Chinese	prep_in	11	SENT_571	[p27l544t1748r806b1803],
15	.	.	O	.	_	0	SENT_571	[p27l544t1748r806b1803],

1	Epilepsia	NNP	O	Epilepsia	_	0	SENT_572	[p27l833t1749r1121b1819],
2	2007	CD	DATE	2007	num	1	SENT_572	[p27l1145t1749r1411b1812],
3	;	:	O	;	_	0	SENT_572	[p27l1145t1749r1411b1812],
4	48	CD	NUMBER	48	num	6	SENT_572	[p27l1145t1749r1411b1812],
5	:	:	O	:	_	0	SENT_572	[p27l1145t1749r1411b1812],
6	1015-8	CD	NUMBER	1015-8	dep	1	SENT_572	[p27l1426t1748r1664b1803],
7	.	.	O	.	_	0	SENT_572	[p27l1426t1748r1664b1803],

1	Odueyungbo	NNP	PERSON	Odueyungbo	nn	2	SENT_573	[p27l141t1843r535b1913],
2	MA	NNP	PERSON	MA	_	0	SENT_573	[p27l552t1844r691b1907],
3	,	,	O	,	_	0	SENT_573	[p27l552t1844r691b1907],
4	Sheehan	NNP	PERSON	Sheehan	nn	5	SENT_573	[p27l712t1843r971b1898],
5	MP	NNP	O	MP	appos	2	SENT_573	[p27l987t1844r1104b1907],
6	,	,	O	,	_	0	SENT_573	[p27l987t1844r1104b1907],
7	Haggstrom	NNP	PERSON	Haggstrom	appos	5	SENT_573	[p27l1124t1844r1467b1913],
8	AN	DT	O	a	dep	7	SENT_573	[p27l1482t1844r1607b1897],
9	.	.	O	.	_	0	SENT_573	[p27l1482t1844r1607b1897],

1	HLA-B	NN	O	hla-b	_	0	SENT_574	[p27l1628t1844r1896b1897],
2	*	CD	NUMBER	*	number	3	SENT_574	[p27l1628t1844r1896b1897],
3	1502	CD	DATE	1502	num	4	SENT_574	[p27l1909t1843r2054b1898],
4	allele	NN	O	allele	dep	1	SENT_574	[p27l2073t1843r2149b1897, p27l140t1939r250b1994],
5	associated	VBN	O	associate	partmod	1	SENT_574	[p27l282t1939r598b1994],
6	with	IN	O	with	_	0	SENT_574	[p27l627t1939r762b1994],
7	carbamazepine-induced	JJ	O	carbamazepine-induced	amod	9	SENT_574	[p27l792t1939r1528b2009],
8	epidermal	JJ	O	epidermal	amod	9	SENT_574	[p27l1557t1939r1864b2009],
9	necrolysis	NN	O	necrolysis	prep_with	5	SENT_574	[p27l1895t1939r2149b2009, p27l142t2037r234b2091],
10	.	.	O	.	_	0	SENT_574	[p27l1895t1939r2149b2009, p27l142t2037r234b2091],

1	Arch	NNP	O	Arch	nn	2	SENT_575	[p27l261t2037r414b2091],
2	Dermatol	NNP	O	Dermatol	_	0	SENT_575	[p27l437t2037r727b2091],
3	2010	CD	DATE	2010	num	2	SENT_575	[p27l752t2036r1058b2100],
4	;	:	O	;	_	0	SENT_575	[p27l752t2036r1058b2100],
5	146	CD	NUMBER	146	num	7	SENT_575	[p27l752t2036r1058b2100],
6	:	:	O	:	_	0	SENT_575	[p27l752t2036r1058b2100],
7	1437-8	CD	NUMBER	1437-8	dep	2	SENT_575	[p27l1073t2037r1310b2091],
8	.	.	O	.	_	0	SENT_575	[p27l1073t2037r1310b2091],

1	Locharemkul	NN	O	locharemkul	nn	2	SENT_576	[p27l139t2133r554b2187],
2	C	NN	O	c	_	0	SENT_576	[p27l581t2133r647b2196],
3	,	,	O	,	_	0	SENT_576	[p27l581t2133r647b2196],
4	Loplumlert	NNP	O	Loplumlert	nn	5	SENT_576	[p27l676t2133r1024b2203],
5	J	NNP	O	J	appos	2	SENT_576	[p27l1049t2134r1078b2187],
6	,	,	O	,	_	0	SENT_576	[p27l1082t2177r1094b2196],
7	Limotai	NNP	O	Limotai	nn	8	SENT_576	[p27l1123t2132r1367b2187],
8	C	NNP	O	C	appos	2	SENT_576	[p27l1395t2133r1460b2196],
9	,	,	O	,	_	0	SENT_576	[p27l1395t2133r1460b2196],
10	et	FW	O	et	nn	11	SENT_576	[p27l1490t2141r1544b2187],
11	al.	FW	O	al.	appos	2	SENT_576	[p27l1572t2133r1640b2187],
12	.	.	O	.	_	0	SENT_576	[p27l1572t2133r1640b2187],

1	Carbamazepine	NNP	O	Carbamazepine	nsubj	4	SENT_577	[p27l1672t2132r2150b2203],
2	and	CC	O	and	_	0	SENT_577	[p27l141t2227r250b2282],
3	phenytoin	NN	O	phenytoin	conj_and	1	SENT_577	[p27l276t2227r584b2297],
4	induced	VBD	O	induce	_	0	SENT_577	[p27l612t2227r857b2282],
5	Stevens	NNP	PERSON	Stevens	dobj	4	SENT_577	[p27l886t2227r1398b2282],
6	.	.	O	.	_	0	SENT_577	[p27l886t2227r1398b2282],

1	—	NN	O	—	_	0	SENT_578	[p27l886t2227r1398b2282],
2	.	.	O	.	_	0	SENT_578	[p27l886t2227r1398b2282],

1	Johnson	NNP	PERSON	Johnson	nn	2	SENT_579	[p27l886t2227r1398b2282],
2	syndrome	NN	O	syndrome	nsubjpass	4	SENT_579	[p27l1428t2227r1729b2297],
3	is	VBZ	O	be	auxpass	4	SENT_579	[p27l1757t2227r1805b2282],
4	associated	VBN	O	associate	_	0	SENT_579	[p27l1836t2227r2152b2282],
5	with	IN	O	with	_	0	SENT_579	[p27l140t2324r275b2379],
6	HLA-B	NN	O	hla-b	prep_with	4	SENT_579	[p27l300t2324r726b2379],
7	*	CD	NUMBER	*	number	8	SENT_579	[p27l300t2324r726b2379],
8	1502	CD	DATE	1502	num	9	SENT_579	[p27l300t2324r726b2379],
9	allele	NN	O	allele	dobj	4	SENT_579	[p27l753t2325r917b2379],
10	in	IN	O	in	_	0	SENT_579	[p27l944t2324r1002b2378],
11	Thai	NNP	LOCATION	Thai	nn	12	SENT_579	[p27l1027t2324r1166b2379],
12	population	NN	O	population	prep_in	9	SENT_579	[p27l1192t2325r1537b2395],
13	.	.	O	.	_	0	SENT_579	[p27l1192t2325r1537b2395],

1	Epilepsia	NNP	O	Epilepsia	_	0	SENT_580	[p27l1566t2324r1855b2395],
2	2008	CD	DATE	2008	num	1	SENT_580	[p27l1879t2325r2146b2388],
3	;	:	O	;	_	0	SENT_580	[p27l1879t2325r2146b2388],
4	49	CD	NUMBER	49	num	6	SENT_580	[p27l1879t2325r2146b2388],
5	:	:	O	:	_	0	SENT_580	[p27l1879t2325r2146b2388],
6	2087-91	CD	NUMBER	2087-91	dep	1	SENT_580	[p27l140t2421r422b2476],
7	.	.	O	.	_	0	SENT_580	[p27l140t2421r422b2476],

1	Tassaneeyakul	NNP	O	Tassaneeyakul	nn	2	SENT_581	[p27l140t2515r586b2585],
2	W	NNP	O	W	_	0	SENT_581	[p27l606t2516r688b2579],
3	,	,	O	,	_	0	SENT_581	[p27l606t2516r688b2579],
4	Tiamkao	NNP	O	Tiamkao	nn	5	SENT_581	[p27l711t2515r981b2569],
5	S	NNP	O	S	appos	2	SENT_581	[p27l1004t2515r1059b2579],
6	,	,	O	,	_	0	SENT_581	[p27l1004t2515r1059b2579],
7	J	NNP	O	J	nn	9	SENT_581	[p27l1081t2516r1109b2569],
8	antararoungtong	JJ	O	antararoungtong	amod	9	SENT_581	[p27l1113t2523r1616b2585],
9	T	NN	O	t	appos	2	SENT_581	[p27l1637t2516r1693b2579],
10	,	,	O	,	_	0	SENT_581	[p27l1637t2516r1693b2579],
11	et	FW	O	et	nn	12	SENT_581	[p27l1716t2523r1771b2569],
12	al.	FW	O	al.	appos	2	SENT_581	[p27l1791t2515r1859b2569],
13	.	.	O	.	_	0	SENT_581	[p27l1791t2515r1859b2569],

1	Association	NNP	O	Association	_	0	SENT_582	[p27l1883t2515r2149b2569, p27l139t2612r258b2667],
2	between	IN	O	between	_	0	SENT_582	[p27l291t2612r549b2667],
3	HLA-B	NN	O	hla-b	prep_between	1	SENT_582	[p27l584t2612r1009b2667],
4	*	CD	NUMBER	*	number	5	SENT_582	[p27l584t2612r1009b2667],
5	1502	CD	DATE	1502	dep	3	SENT_582	[p27l584t2612r1009b2667],
6	and	CC	O	and	_	0	SENT_582	[p27l1046t2613r1155b2667],
7	carbamazepine-induced	JJ	O	carbamazepine-induced	amod	12	SENT_582	[p27l1189t2612r1924b2683],
8	severe	JJ	O	severe	amod	12	SENT_582	[p27l1960t2629r2150b2667],
9	cutaneous	JJ	O	cutaneous	amod	12	SENT_582	[p27l140t2718r446b2764],
10	adverse	JJ	O	adverse	amod	12	SENT_582	[p27l472t2710r703b2764],
11	drug	NN	O	drug	nn	12	SENT_582	[p27l728t2710r866b2780],
12	reactions	NNS	O	reaction	prep_between	1	SENT_582	[p27l889t2710r1166b2764],
13	in	IN	O	in	_	0	SENT_582	[p27l1191t2710r1249b2763],
14	a	DT	O	a	det	16	SENT_582	[p27l1275t2727r1306b2764],
15	Thai	NNP	LOCATION	Thai	nn	16	SENT_582	[p27l1329t2710r1468b2764],
16	population	NN	O	population	prep_in	12	SENT_582	[p27l1492t2710r1838b2780],
17	.	.	O	.	_	0	SENT_582	[p27l1492t2710r1838b2780],

1	Epilepsia	NNP	O	Epilepsia	_	0	SENT_583	[p27l1864t2710r2153b2780],
2	2010	CD	DATE	2010	num	1	SENT_583	[p27l141t2807r659b2871],
3	;	:	O	;	_	0	SENT_583	[p27l141t2807r659b2871],
4	51:926	CD	NUMBER	51:926	number	5	SENT_583	[p27l141t2807r659b2871],
5	-30	CD	NUMBER	-30	dep	1	SENT_583	[p27l141t2807r659b2871],
6	.	.	O	.	_	0	SENT_583	[p27l141t2807r659b2871],

1	Chang	NNP	PERSON	Chang	nn	2	SENT_584	[p27l140t2904r338b2974],
2	CC	NN	O	cc	_	0	SENT_584	[p27l362t2904r479b2967],
3	,	,	O	,	_	0	SENT_584	[p27l362t2904r479b2967],
4	Too	RB	ORGANIZATION	too	advmod	5	SENT_584	[p27l504t2905r620b2958],
5	CL	NN	ORGANIZATION	cl	appos	2	SENT_584	[p27l645t2904r757b2967],
6	,	,	O	,	_	0	SENT_584	[p27l645t2904r757b2967],
7	Murad	NNP	PERSON	Murad	nn	8	SENT_584	[p27l782t2904r987b2958],
8	S	NNP	O	S	appos	2	SENT_584	[p27l1011t2904r1066b2967],
9	,	,	O	,	_	0	SENT_584	[p27l1011t2904r1066b2967],
10	Hussein	NNP	PERSON	Hussein	nn	11	SENT_584	[p27l1092t2904r1338b2958],
11	SH	NNP	O	SH	appos	2	SENT_584	[p27l1363t2904r1472b2958],
12	.	.	O	.	_	0	SENT_584	[p27l1363t2904r1472b2958],

1	Association	NNP	O	Association	_	0	SENT_585	[p27l1498t2904r1862b2958],
2	of	IN	O	of	_	0	SENT_585	[p27l1885t2903r1952b2958],
3	HLAB	NNP	O	HLAB	prep_of	1	SENT_585	[p27l1969t2904r2149b2957, p27l140t3000r381b3054],
4	*	CD	NUMBER	*	num	3	SENT_585	[p27l1969t2904r2149b2957, p27l140t3000r381b3054],
5	1502	CD	DATE	1502	num	6	SENT_585	[p27l1969t2904r2149b2957, p27l140t3000r381b3054],
6	allele	NN	O	allele	dep	1	SENT_585	[p27l437t3000r602b3054],
7	with	IN	O	with	_	0	SENT_585	[p27l657t3000r792b3054],
8	carbamazepine-induced	JJ	O	carbamazepine-induced	amod	11	SENT_585	[p27l847t3000r1581b3070],
9	toxic	JJ	O	toxic	amod	11	SENT_585	[p27l1635t3000r1787b3054],
10	epidermal	JJ	O	epidermal	amod	11	SENT_585	[p27l1843t3000r2151b3070],
11	necrolysis	NN	O	necrolysis	prep_with	6	SENT_585	[p27l139t3094r450b3164],
12	and	CC	O	and	_	0	SENT_585	[p27l469t3094r578b3148],
13	Stevens	NNP	PERSON	Stevens	conj_and	11	SENT_585	[p27l596t3094r1109b3148],
14	.	.	O	.	_	0	SENT_585	[p27l596t3094r1109b3148],

1	—	NN	O	—	_	0	SENT_586	[p27l596t3094r1109b3148],
2	.	.	O	.	_	0	SENT_586	[p27l596t3094r1109b3148],

1	Johnson	NNP	PERSON	Johnson	nn	2	SENT_587	[p27l596t3094r1109b3148],
2	syndrome	NN	O	syndrome	nsubj	6	SENT_587	[p27l1128t3094r1427b3164],
3	in	IN	O	in	_	0	SENT_587	[p27l1445t3094r1503b3148],
4	the	DT	O	the	det	5	SENT_587	[p27l1520t3094r1613b3148],
5	multi	NNS	O	multus	prep_in	2	SENT_587	[p27l1630t3094r2005b3148],
6	—	VBP	O	—	_	0	SENT_587	[p27l1630t3094r2005b3148],
7	ethnic	JJ	O	ethnic	amod	9	SENT_587	[p27l1630t3094r2005b3148],
8	Malaysian	JJ	LOCATION	malaysian	amod	9	SENT_587	[p27l2024t3095r2149b3148, p27l140t3190r357b3260],
9	population	NN	O	population	dobj	6	SENT_587	[p27l379t3190r725b3260],
10	.	.	O	.	_	0	SENT_587	[p27l379t3190r725b3260],

1	Int	NN	O	int	nn	2	SENT_588	[p27l753t3191r838b3244],
2	J	NN	O	j	_	0	SENT_588	[p27l859t3191r888b3245],
3	Dermatol	JJ	O	dermatol	amod	4	SENT_588	[p27l911t3190r1201b3244],
4	2011	CD	DATE	2011	dep	2	SENT_588	[p27l1227t3190r1707b3254],
5	;	:	O	;	_	0	SENT_588	[p27l1227t3190r1707b3254],
6	50:22	CD	NUMBER	50:22	num	7	SENT_588	[p27l1227t3190r1707b3254],
7	l-4	NN	O	l-4	dep	2	SENT_588	[p27l1227t3190r1707b3254],
8	.	.	O	.	_	0	SENT_588	[p27l1227t3190r1707b3254],

1	Mehta	NNP	ORGANIZATION	Mehta	nn	2	SENT_589	[p27l139t3288r336b3342],
2	TY	NNP	ORGANIZATION	TY	_	0	SENT_589	[p27l366t3289r473b3351],
3	,	,	O	,	_	0	SENT_589	[p27l366t3289r473b3351],
4	Prajapati	NNP	PERSON	Prajapati	nn	5	SENT_589	[p27l507t3288r780b3358],
5	LM	NNP	O	LM	appos	2	SENT_589	[p27l811t3289r942b3351],
6	,	,	O	,	_	0	SENT_589	[p27l811t3289r942b3351],
7	Mittal	NNP	PERSON	Mittal	nn	8	SENT_589	[p27l975t3288r1163b3342],
8	B	NNP	O	B	appos	2	SENT_589	[p27l1193t3289r1259b3351],
9	,	,	O	,	_	0	SENT_589	[p27l1193t3289r1259b3351],
10	et	FW	O	et	nn	11	SENT_589	[p27l1293t3296r1348b3342],
11	al.	FW	O	al.	appos	2	SENT_589	[p27l1380t3288r1447b3342],
12	.	.	O	.	_	0	SENT_589	[p27l1380t3288r1447b3342],

1	Association	NNP	O	Association	_	0	SENT_590	[p27l1482t3288r1846b3342],
2	of	IN	O	of	_	0	SENT_590	[p27l1877t3288r1943b3342],
3	HLAB	NNP	O	HLAB	prep_of	1	SENT_590	[p27l1969t3288r2149b3341, p27l140t3382r381b3436],
4	*	CD	NUMBER	*	num	3	SENT_590	[p27l1969t3288r2149b3341, p27l140t3382r381b3436],
5	1502	CD	DATE	1502	num	6	SENT_590	[p27l1969t3288r2149b3341, p27l140t3382r381b3436],
6	allele	NN	O	allele	dep	1	SENT_590	[p27l406t3382r571b3436],
7	and	CC	O	and	_	0	SENT_590	[p27l595t3382r704b3436],
8	carbamazepine-induced	JJ	O	carbamazepine-induced	amod	9	SENT_590	[p27l727t3382r1462b3452],
9	Stevens	NNP	PERSON	Stevens	dep	1	SENT_590	[p27l1486t3382r1998b3436],
10	.	.	O	.	_	0	SENT_590	[p27l1486t3382r1998b3436],

1	—	NN	O	—	_	0	SENT_591	[p27l1486t3382r1998b3436],
2	.	.	O	.	_	0	SENT_591	[p27l1486t3382r1998b3436],

1	Johnson	NNP	PERSON	Johnson	nn	2	SENT_592	[p27l1486t3382r1998b3436],
2	syndrome	NN	O	syndrome	_	0	SENT_592	[p27l2023t3399r2149b3452, p27l140t3478r335b3532],
3	among	IN	O	among	_	0	SENT_592	[p27l361t3495r568b3548],
4	Indians	NNPS	MISC	Indians	prep_among	2	SENT_592	[p27l593t3478r834b3532],
5	.	.	O	.	_	0	SENT_592	[p27l593t3478r834b3532],

1	Indian	JJ	MISC	indian	amod	5	SENT_593	[p27l862t3478r1058b3532],
2	J	NN	O	j	nn	5	SENT_593	[p27l1081t3479r1110b3533],
3	Dermatol	NNP	O	Dermatol	nn	5	SENT_593	[p27l1134t3478r1425b3532],
4	Venereol	NNP	O	Venereol	nn	5	SENT_593	[p27l1449t3478r1723b3532],
5	Leprol	NNP	O	Leprol	_	0	SENT_593	[p27l1747t3478r1952b3548],
6	2009	CD	DATE	2009	num	5	SENT_593	[p27l1978t3479r2148b3542],
7	;	:	O	;	_	0	SENT_593	[p27l1978t3479r2148b3542],
8	75:579	CD	NUMBER	75:579	number	9	SENT_593	[p27l140t3574r484b3629],
9	—	CD	NUMBER	—	dep	5	SENT_593	[p27l140t3574r484b3629],
10	82	CD	NUMBER	82	dep	9	SENT_593	[p27l140t3574r484b3629],
11	.	.	O	.	_	0	SENT_593	[p27l140t3574r484b3629],

1	406	CD	NUMBER	406	_	0	SENT_594	[p28l7t94r135b154],
2	Neuman	NNP	PERSON	Neuman	dep	1	SENT_594	[p28l250t95r566b153],
3	e	SYM	O	e	dep	5	SENT_594	[p28l595t95r668b153],
4	’	CD	NUMBER	’	num	5	SENT_594	[p28l595t95r668b153],
5	r	NN	O	r	rcmod	2	SENT_594	[p28l595t95r668b153],
6	al	NNP	O	al	dep	1	SENT_594	[p28l693t95r754b153],

1	Lonjou	NN	MISC	lonjou	nn	2	SENT_595	[p28l141t329r362b399],
2	C	NN	O	c	_	0	SENT_595	[p28l383t330r448b393],
3	,	,	O	,	_	0	SENT_595	[p28l383t330r448b393],
4	Thomas	NNP	PERSON	Thomas	nn	5	SENT_595	[p28l470t329r716b384],
5	L	NNP	PERSON	L	appos	2	SENT_595	[p28l736t331r798b393],
6	,	,	O	,	_	0	SENT_595	[p28l736t331r798b393],
7	Borot	NNP	O	Borot	nn	8	SENT_595	[p28l821t331r996b384],
8	N	NNP	O	N	appos	5	SENT_595	[p28l1013t331r1083b393],
9	,	,	O	,	_	0	SENT_595	[p28l1013t331r1083b393],
10	Ledger	NNP	O	Ledger	nn	11	SENT_595	[p28l1106t329r1325b399],
11	N	NNP	O	N	appos	5	SENT_595	[p28l1343t331r1413b393],
12	,	,	O	,	_	0	SENT_595	[p28l1343t331r1413b393],
13	de	FW	O	de	nn	15	SENT_595	[p28l1436t329r1506b384],
14	Toma	FW	O	toma	nn	15	SENT_595	[p28l1525t331r1700b384],
15	C	NN	O	c	appos	5	SENT_595	[p28l1719t330r1784b393],
16	,	,	O	,	_	0	SENT_595	[p28l1719t330r1784b393],
17	RegiSCAR	NNP	O	RegiSCAR	nn	18	SENT_595	[p28l1806t329r2151b399],
18	Group	NNP	O	Group	appos	5	SENT_595	[p28l143t427r352b497],
19	.	.	O	.	_	0	SENT_595	[p28l143t427r352b497],

1	A	DT	O	a	det	2	SENT_596	[p28l371t427r426b480],
2	marker	NN	O	marker	_	0	SENT_596	[p28l441t427r660b481],
3	for	IN	O	for	_	0	SENT_596	[p28l674t426r763b481],
4	Steven	NNP	PERSON	Steven	prep_for	2	SENT_596	[p28l779t427r1262b481],
5	.	.	O	.	_	0	SENT_596	[p28l779t427r1262b481],

1	—	NN	O	—	_	0	SENT_597	[p28l779t427r1262b481],
2	.	.	O	.	_	0	SENT_597	[p28l779t427r1262b481],

1	Johnson	NNP	PERSON	Johnson	nn	2	SENT_598	[p28l779t427r1262b481],
2	syndrome	NN	O	syndrome	_	0	SENT_598	[p28l1279t427r1889b497],
3	—	CD	NUMBER	—	num	5	SENT_598	[p28l1279t427r1889b497],
4	ethnicity	NN	O	ethnicity	nn	5	SENT_598	[p28l1279t427r1889b497],
5	matters	NNS	O	matter	dep	2	SENT_598	[p28l1905t435r2147b481],
6	.	.	O	.	_	0	SENT_598	[p28l1905t435r2147b481],

1	Pharrnacogenomics	NNS	O	pharrnacogenomic	_	0	SENT_599	[p28l141t523r743b593],
2	J	NNP	O	J	dep	1	SENT_599	[p28l768t524r796b577],
3	2006	CD	DATE	2006	num	2	SENT_599	[p28l820t523r1261b586],
4	;	:	O	;	_	0	SENT_599	[p28l820t523r1261b586],
5	6:265	CD	NUMBER	6:265	number	6	SENT_599	[p28l820t523r1261b586],
6	—	CD	NUMBER	—	dep	1	SENT_599	[p28l820t523r1261b586],
7	8	CD	NUMBER	8	dep	6	SENT_599	[p28l820t523r1261b586],
8	.	.	O	.	_	0	SENT_599	[p28l820t523r1261b586],

1	McCorrnack	NN	O	mccorrnack	nn	2	SENT_600	[p28l141t617r527b672],
2	M	NN	O	m	_	0	SENT_600	[p28l542t619r625b681],
3	,	,	O	,	_	0	SENT_600	[p28l542t619r625b681],
4	Alﬁrevic	NNP	MISC	Alﬁrevic	nn	5	SENT_600	[p28l645t617r915b672],
5	A	NNP	MISC	A	appos	2	SENT_600	[p28l934t618r1004b681],
6	,	,	O	,	_	0	SENT_600	[p28l934t618r1004b681],
7	Bourgeois	NNP	PERSON	Bourgeois	nn	8	SENT_600	[p28l1023t617r1336b687],
8	S	NNP	O	S	appos	2	SENT_600	[p28l1356t618r1411b681],
9	,	,	O	,	_	0	SENT_600	[p28l1356t618r1411b681],
10	et	FW	O	et	nn	11	SENT_600	[p28l1432t625r1487b672],
11	al.	FW	O	al.	appos	2	SENT_600	[p28l1504t617r1573b672],
12	.	.	O	.	_	0	SENT_600	[p28l1504t617r1573b672],

1	HLA-A	NN	O	hla-a	_	0	SENT_601	[p28l1594t618r1904b672],
2	*	CD	NUMBER	*	number	3	SENT_601	[p28l1594t618r1904b672],
3	3	CD	NUMBER	3	dep	1	SENT_601	[p28l1594t618r1904b672],
4	101	CD	NUMBER	101	dep	3	SENT_601	[p28l1918t618r2017b672],
5	and	CC	O	and	_	0	SENT_601	[p28l2043t617r2152b672],
6	carbamazepine-induced	JJ	O	carbamazepine-induced	amod	8	SENT_601	[p28l142t714r876b785],
7	hypersensitivity	NN	O	hypersensitivity	nn	8	SENT_601	[p28l901t714r1391b785],
8	reactions	NNS	O	reaction	conj_and	3	SENT_601	[p28l1418t715r1695b769],
9	in	IN	O	in	_	0	SENT_601	[p28l1723t714r1781b768],
10	Europeans	NNPS	MISC	Europeans	prep_in	8	SENT_601	[p28l1807t716r2146b785],
11	.	.	O	.	_	0	SENT_601	[p28l1807t716r2146b785],

1	N	NN	O	n	nn	3	SENT_602	[p28l141t812r195b865],
2	Engl	NNP	O	Engl	nn	3	SENT_602	[p28l219t811r363b881],
3	J	NNP	O	J	nsubj	4	SENT_602	[p28l386t812r414b865],
4	Med	VBD	O	med	_	0	SENT_602	[p28l437t811r577b865],
5	20l1	CD	NUMBER	20l1	dobj	4	SENT_602	[p28l601t811r1197b874],
6	;	:	O	;	_	0	SENT_602	[p28l601t811r1197b874],
7	364:1134	CD	NUMBER	364:1134	number	8	SENT_602	[p28l601t811r1197b874],
8	—	CD	NUMBER	—	dep	5	SENT_602	[p28l601t811r1197b874],
9	43	CD	NUMBER	43	dep	8	SENT_602	[p28l601t811r1197b874],
10	.	.	O	.	_	0	SENT_602	[p28l601t811r1197b874],

1	Kaniwa	NNP	O	Kaniwa	nn	2	SENT_603	[p28l143t906r381b960],
2	N	NNP	O	N	_	0	SENT_603	[p28l400t907r470b970],
3	,	,	O	,	_	0	SENT_603	[p28l400t907r470b970],
4	Saito	NNP	PERSON	Saito	nn	5	SENT_603	[p28l497t906r651b960],
5	Y	NN	PERSON	y	appos	2	SENT_603	[p28l673t907r733b970],
6	,	,	O	,	_	0	SENT_603	[p28l673t907r733b970],
7	Aihara	NNP	PERSON	Aihara	nn	8	SENT_603	[p28l758t906r968b960],
8	M	NNP	O	M	appos	2	SENT_603	[p28l987t907r1070b970],
9	,	,	O	,	_	0	SENT_603	[p28l987t907r1070b970],
10	et	FW	O	et	nn	11	SENT_603	[p28l1095t914r1149b960],
11	al.	FW	O	al.	appos	2	SENT_603	[p28l1171t906r1239b960],
12	.	.	O	.	_	0	SENT_603	[p28l1171t906r1239b960],

1	HLA	NN	O	hlum	_	0	SENT_604	[p28l1265t906r1532b959],
2	.	.	O	.	_	0	SENT_604	[p28l1265t906r1532b959],

1	—	NN	O	—	_	0	SENT_605	[p28l1265t906r1532b959],
2	.	.	O	.	_	0	SENT_605	[p28l1265t906r1532b959],

1	B	NN	O	b	nsubj	7	SENT_606	[p28l1265t906r1532b959],
2	*	CD	NUMBER	*	num	3	SENT_606	[p28l1265t906r1532b959],
3	1511	CD	DATE	1511	dep	1	SENT_606	[p28l1546t906r1684b960],
4	is	VBZ	O	be	cop	7	SENT_606	[p28l1712t906r1760b960],
5	a	DT	O	a	det	7	SENT_606	[p28l1784t923r1816b960],
6	risk	NN	O	risk	nn	7	SENT_606	[p28l1836t906r1952b960],
7	factor	NN	O	factor	_	0	SENT_606	[p28l1972t906r2152b960],
8	for	IN	O	for	_	0	SENT_606	[p28l142t1002r231b1057],
9	carbamazepine-induced	JJ	O	carbamazepine-induced	amod	10	SENT_606	[p28l252t1002r986b1073],
10	SteVens	NNP	O	SteVens	prep_for	7	SENT_606	[p28l1008t1003r1520b1057],
11	.	.	O	.	_	0	SENT_606	[p28l1008t1003r1520b1057],

1	—	NN	O	—	_	0	SENT_607	[p28l1008t1003r1520b1057],
2	.	.	O	.	_	0	SENT_607	[p28l1008t1003r1520b1057],

1	Johnson	NNP	PERSON	Johnson	nn	2	SENT_608	[p28l1008t1003r1520b1057],
2	syndrome	NN	O	syndrome	_	0	SENT_608	[p28l1544t1003r1844b1073],
3	and	CC	O	and	_	0	SENT_608	[p28l1867t1003r1976b1057],
4	toxic	JJ	O	toxic	amod	6	SENT_608	[p28l1997t1003r2150b1057],
5	epidermal	JJ	O	epidermal	amod	6	SENT_608	[p28l142t1099r449b1169],
6	necrolysis	NN	O	necrolysis	conj_and	2	SENT_608	[p28l490t1099r799b1169],
7	in	IN	O	in	_	0	SENT_608	[p28l841t1099r899b1152],
8	Japanese	JJ	MISC	japanese	amod	9	SENT_608	[p28l939t1100r1212b1169],
9	patients	NNS	O	patient	prep_in	2	SENT_608	[p28l1252t1099r1508b1169],
10	.	.	O	.	_	0	SENT_608	[p28l1252t1099r1508b1169],

1	Epilepsia	NNP	O	Epilepsia	_	0	SENT_609	[p28l1551t1099r1839b1169],
2	2010	CD	DATE	2010	num	1	SENT_609	[p28l1879t1098r2087b1162],
3	;	:	O	;	_	0	SENT_609	[p28l1879t1098r2087b1162],
4	5	CD	NUMBER	5	number	5	SENT_609	[p28l1879t1098r2087b1162],
5	1	CD	NUMBER	1	dep	1	SENT_609	[p28l2100t1099r2145b1153],
6	:	:	O	:	_	0	SENT_609	[p28l2100t1099r2145b1153],
7	2461-5	CD	NUMBER	2461-5	dep	1	SENT_609	[p28l143t1193r386b1247],
8	.	.	O	.	_	0	SENT_609	[p28l143t1193r386b1247],

1	Ozeki	NNP	PERSON	Ozeki	nn	2	SENT_610	[p28l143t1289r323b1343],
2	T	NN	PERSON	t	_	0	SENT_610	[p28l341t1290r397b1353],
3	,	,	O	,	_	0	SENT_610	[p28l341t1290r397b1353],
4	Mushiroda	NN	ORGANIZATION	mushiroda	nn	5	SENT_610	[p28l416t1289r749b1343],
5	T	NN	ORGANIZATION	t	appos	2	SENT_610	[p28l765t1290r821b1353],
6	,	,	O	,	_	0	SENT_610	[p28l765t1290r821b1353],
7	Yowang	NNP	O	Yowang	nn	8	SENT_610	[p28l841t1290r1089b1359],
8	A	NNP	O	A	appos	2	SENT_610	[p28l1106t1289r1176b1353],
9	,	,	O	,	_	0	SENT_610	[p28l1106t1289r1176b1353],
10	et	FW	O	et	nn	11	SENT_610	[p28l1197t1297r1251b1343],
11	al.	FW	O	al.	appos	2	SENT_610	[p28l1268t1289r1337b1343],
12	.	.	O	.	_	0	SENT_610	[p28l1268t1289r1337b1343],

1	Genome	NNP	O	Genome	_	0	SENT_611	[p28l1358t1289r1792b1343],
2	—	CD	NUMBER	—	num	5	SENT_611	[p28l1358t1289r1792b1343],
3	wide	JJ	O	wide	amod	5	SENT_611	[p28l1358t1289r1792b1343],
4	association	NN	O	association	nn	5	SENT_611	[p28l1811t1289r2151b1343],
5	study	NN	O	study	nsubj	6	SENT_611	[p28l144t1387r306b1457],
6	identiﬁes	VBZ	O	identiﬁes	rcmod	1	SENT_611	[p28l336t1387r617b1441],
7	HLA-A	NN	O	hla-a	nn	10	SENT_611	[p28l648t1387r1071b1441],
8	*	CD	NUMBER	*	num	10	SENT_611	[p28l648t1387r1071b1441],
9	310l	NN	O	310l	nn	10	SENT_611	[p28l648t1387r1071b1441],
10	allele	NN	O	allele	dobj	6	SENT_611	[p28l1109t1387r1273b1441],
11	as	IN	O	as	_	0	SENT_611	[p28l1305t1404r1364b1441],
12	a	DT	O	a	det	15	SENT_611	[p28l1397t1404r1430b1441],
13	genetic	JJ	O	genetic	amod	15	SENT_611	[p28l1460t1387r1679b1457],
14	risk	NN	O	risk	nn	15	SENT_611	[p28l1710t1387r1825b1441],
15	factor	NN	O	factor	prep_as	10	SENT_611	[p28l1854t1387r2034b1441],
16	for	IN	O	for	_	0	SENT_611	[p28l2063t1387r2152b1441],
17	Translational	JJ	O	translational	amod	18	SENT_611	[p28l1318t1477r1777b1535],
18	Research	NNP	O	Research	prep_for	15	SENT_611	[p28l1809t1477r2150b1535],
19	May	NNP	DATE	May	tmod	6	SENT_611	[p28l1802t1571r1962b1644],
20	2012	CD	DATE	2012	num	19	SENT_611	[p28l1985t1570r2151b1630],

1	carbamazepine-induced	JJ	O	carbamazepine-induced	amod	5	SENT_612	[p28l138t1819r873b1890],
2	cutaneous	JJ	O	cutaneous	amod	5	SENT_612	[p28l896t1828r1202b1874],
3	adverse	JJ	O	adverse	amod	5	SENT_612	[p28l1227t1820r1459b1874],
4	drug	NN	O	drug	nn	5	SENT_612	[p28l1483t1820r1621b1890],
5	reactions	NNS	O	reaction	_	0	SENT_612	[p28l1643t1819r1921b1874],
6	in	IN	O	in	_	0	SENT_612	[p28l1945t1820r2004b1873],
7	Japanese	JJ	MISC	japanese	amod	8	SENT_612	[p28l2026t1821r2151b1890, p28l139t1932r307b1970],
8	population	NN	O	population	prep_in	5	SENT_612	[p28l331t1915r676b1986],
9	.	.	O	.	_	0	SENT_612	[p28l331t1915r676b1986],

1	Hum	NNP	O	Hum	nn	3	SENT_613	[p28l705t1917r858b1970],
2	Mol	NNP	O	Mol	nn	3	SENT_613	[p28l880t1916r1007b1970],
3	Genet	NNP	PERSON	Genet	_	0	SENT_613	[p28l1032t1916r1215b1970],
4	201	CD	NUMBER	201	number	5	SENT_613	[p28l1239t1916r1345b1970],
5	1	CD	NUMBER	1	dep	3	SENT_613	[p28l1362t1916r1505b1979],
6	;	:	O	;	_	0	SENT_613	[p28l1362t1916r1505b1979],
7	20	CD	NUMBER	20	num	9	SENT_613	[p28l1362t1916r1505b1979],
8	:	:	O	:	_	0	SENT_613	[p28l1362t1916r1505b1979],
9	1034-41	CD	NUMBER	1034-41	dep	3	SENT_613	[p28l1520t1916r1797b1970],
10	.	.	O	.	_	0	SENT_613	[p28l1520t1916r1797b1970],

1	Wu	NNP	O	Wu	nn	2	SENT_614	[p28l137t2013r244b2066],
2	XT	NNP	O	XT	_	0	SENT_614	[p28l312t2013r424b2075],
3	,	,	O	,	_	0	SENT_614	[p28l312t2013r424b2075],
4	Hu	NNP	O	Hu	nn	5	SENT_614	[p28l496t2013r587b2066],
5	FY	NNP	O	FY	appos	2	SENT_614	[p28l655t2013r759b2075],
6	,	,	O	,	_	0	SENT_614	[p28l655t2013r759b2075],
7	An	DT	O	a	det	8	SENT_614	[p28l830t2012r922b2065],
8	DM	NN	O	dm	appos	2	SENT_614	[p28l990t2013r1129b2075],
9	,	,	O	,	_	0	SENT_614	[p28l990t2013r1129b2075],
10	et	FW	O	et	nn	11	SENT_614	[p28l1200t2020r1255b2066],
11	al.	FW	O	al.	appos	2	SENT_614	[p28l1324t2012r1392b2066],
12	.	.	O	.	_	0	SENT_614	[p28l1324t2012r1392b2066],

1	Association	NNP	O	Association	_	0	SENT_615	[p28l1464t2012r1829b2066],
2	between	IN	O	between	_	0	SENT_615	[p28l1895t2012r2153b2066],
3	carbamazepine-induced	JJ	O	carbamazepine-induced	amod	7	SENT_615	[p28l138t2107r873b2178],
4	cutaneous	JJ	O	cutaneous	amod	7	SENT_615	[p28l916t2116r1222b2162],
5	adverse	JJ	O	adverse	amod	7	SENT_615	[p28l1267t2108r1498b2162],
6	drug	NN	O	drug	nn	7	SENT_615	[p28l1541t2108r1680b2178],
7	reactions	NNS	O	reaction	prep_between	1	SENT_615	[p28l1721t2108r1999b2162],
8	and	CC	O	and	_	0	SENT_615	[p28l2044t2108r2153b2162],
9	the	DT	O	the	det	10	SENT_615	[p28l137t2204r230b2258],
10	HLA	NN	O	hlum	prep_between	1	SENT_615	[p28l248t2203r674b2258],
11	.	.	O	.	_	0	SENT_615	[p28l248t2203r674b2258],

1	—	NN	O	—	_	0	SENT_616	[p28l248t2203r674b2258],
2	.	.	O	.	_	0	SENT_616	[p28l248t2203r674b2258],

1	B	NN	O	b	nn	4	SENT_617	[p28l248t2203r674b2258],
2	*	CD	NUMBER	*	num	4	SENT_617	[p28l248t2203r674b2258],
3	l502	NN	O	l502	nn	4	SENT_617	[p28l248t2203r674b2258],
4	allele	NN	O	allele	_	0	SENT_617	[p28l694t2204r859b2258],
5	among	IN	O	among	_	0	SENT_617	[p28l879t2220r1085b2274],
6	patients	NNS	O	patient	prep_among	4	SENT_617	[p28l1103t2204r1342b2274],
7	in	IN	O	in	_	0	SENT_617	[p28l1360t2203r1419b2257],
8	central	JJ	O	central	amod	9	SENT_617	[p28l1437t2204r1646b2258],
9	China	NNP	LOCATION	China	prep_in	4	SENT_617	[p28l1664t2203r1863b2258],
10	.	.	O	.	_	0	SENT_617	[p28l1664t2203r1863b2258],

1	Epilepsy	NNP	O	Epilepsy	nn	3	SENT_618	[p28l1883t2203r2153b2274],
2	Behav	NNP	O	Behav	nn	3	SENT_618	[p28l138t2300r332b2354],
3	20l0	NN	O	20l0	_	0	SENT_618	[p28l358t2300r838b2363],
4	;	:	O	;	_	0	SENT_618	[p28l358t2300r838b2363],
5	19:405	CD	NUMBER	19:405	number	6	SENT_618	[p28l358t2300r838b2363],
6	—	CD	NUMBER	—	dep	3	SENT_618	[p28l358t2300r838b2363],
7	8	CD	NUMBER	8	dep	6	SENT_618	[p28l358t2300r838b2363],
8	.	.	O	.	_	0	SENT_618	[p28l358t2300r838b2363],

1	Hu	NNP	O	Hu	nn	2	SENT_619	[p28l138t2396r230b2449],
2	FY	NNP	O	FY	dep	20	SENT_619	[p28l251t2396r354b2459],
3	,	,	O	,	_	0	SENT_619	[p28l251t2396r354b2459],
4	Wu	NNP	O	Wu	nn	5	SENT_619	[p28l378t2396r485b2449],
5	XT	NNP	O	XT	appos	2	SENT_619	[p28l506t2396r618b2459],
6	,	,	O	,	_	0	SENT_619	[p28l506t2396r618b2459],
7	An	DT	O	a	det	8	SENT_619	[p28l643t2395r735b2448],
8	DM	NN	O	dm	appos	2	SENT_619	[p28l756t2396r895b2459],
9	,	,	O	,	_	0	SENT_619	[p28l756t2396r895b2459],
10	Yan	NN	PERSON	yan	nn	11	SENT_619	[p28l920t2396r1039b2449],
11	B	NN	PERSON	b	appos	2	SENT_619	[p28l1060t2396r1126b2459],
12	,	,	O	,	_	0	SENT_619	[p28l1060t2396r1126b2459],
13	Stefan	NNP	PERSON	Stefan	nn	14	SENT_619	[p28l1152t2395r1347b2449],
14	H	NNP	PERSON	H	appos	2	SENT_619	[p28l1368t2396r1438b2459],
15	,	,	O	,	_	0	SENT_619	[p28l1368t2396r1438b2459],
16	Zhou	NNP	PERSON	Zhou	nn	17	SENT_619	[p28l1462t2395r1624b2449],
17	D.	NNP	PERSON	D.	appos	2	SENT_619	[p28l1645t2396r1713b2449],
18	Pilot	NN	PERSON	pilot	dep	20	SENT_619	[p28l1739t2395r1885b2449],
19	association	NN	O	association	nn	20	SENT_619	[p28l1906t2395r2151b2449, p28l137t2491r257b2546],
20	study	NN	O	study	dep	24	SENT_619	[p28l275t2492r438b2562],
21	of	IN	O	of	_	0	SENT_619	[p28l455t2491r522b2546],
22	oxcarbazepine	NN	O	oxcarbazepine	nn	23	SENT_619	[p28l534t2492r1252b2562],
23	—	NN	O	—	prep_of	20	SENT_619	[p28l534t2492r1252b2562],
24	induced	VBD	O	induce	_	0	SENT_619	[p28l534t2492r1252b2562],
25	mild	JJ	O	mild	amod	28	SENT_619	[p28l1267t2491r1409b2546],
26	cutaneous	JJ	O	cutaneous	amod	28	SENT_619	[p28l1426t2500r1732b2546],
27	adverse	JJ	O	adverse	amod	28	SENT_619	[p28l1750t2492r1982b2546],
28	reactions	NNS	O	reaction	dobj	24	SENT_619	[p28l1999t2508r2151b2546, p28l138t2588r285b2642],
29	with	IN	O	with	_	0	SENT_619	[p28l337t2588r473b2642],
30	HLA	NN	O	hlum	prep_with	24	SENT_619	[p28l523t2588r792b2641],
31	.	.	O	.	_	0	SENT_619	[p28l523t2588r792b2641],

1	—	NN	O	—	_	0	SENT_620	[p28l523t2588r792b2641],
2	.	.	O	.	_	0	SENT_620	[p28l523t2588r792b2641],

1	B	NN	O	b	_	0	SENT_621	[p28l523t2588r792b2641],
2	*	CD	NUMBER	*	number	3	SENT_621	[p28l523t2588r792b2641],
3	1502	CD	DATE	1502	num	4	SENT_621	[p28l805t2588r950b2642],
4	allele	NN	O	allele	dep	1	SENT_621	[p28l1002t2588r1167b2642],
5	in	IN	O	in	_	0	SENT_621	[p28l1218t2588r1277b2641],
6	Chinese	JJ	MISC	chinese	amod	8	SENT_621	[p28l1329t2588r1575b2642],
7	Han	NN	O	han	nn	8	SENT_621	[p28l1626t2589r1753b2642],
8	population	NN	O	population	prep_in	4	SENT_621	[p28l1803t2588r2149b2658],
9	.	.	O	.	_	0	SENT_621	[p28l1803t2588r2149b2658],

1	Seizure	NN	O	seizure	_	0	SENT_622	[p28l140t2683r368b2737],
2	201	CD	NUMBER	201	number	3	SENT_622	[p28l393t2683r499b2737],
3	1	CD	NUMBER	1	dep	1	SENT_622	[p28l515t2683r660b2747],
4	;	:	O	;	_	0	SENT_622	[p28l515t2683r660b2747],
5	20	CD	NUMBER	20	num	7	SENT_622	[p28l515t2683r660b2747],
6	:	:	O	:	_	0	SENT_622	[p28l515t2683r660b2747],
7	160-2	CD	NUMBER	160-2	dep	1	SENT_622	[p28l675t2683r874b2737],
8	.	.	O	.	_	0	SENT_622	[p28l675t2683r874b2737],

1	Chung	NNP	PERSON	Chung	nn	2	SENT_623	[p28l139t2778r336b2848],
2	WH	NNP	PERSON	WH	_	0	SENT_623	[p28l351t2779r493b2842],
3	,	,	O	,	_	0	SENT_623	[p28l351t2779r493b2842],
4	Hung	NNP	O	Hung	nn	5	SENT_623	[p28l510t2779r676b2848],
5	SI	NNP	O	SI	appos	2	SENT_623	[p28l693t2779r772b2842],
6	,	,	O	,	_	0	SENT_623	[p28l693t2779r772b2842],
7	Chen	NNP	PERSON	Chen	nn	8	SENT_623	[p28l790t2778r949b2833],
8	YT	NNP	PERSON	YT	appos	5	SENT_623	[p28l963t2779r1070b2832],
9	.	.	O	.	_	0	SENT_623	[p28l963t2779r1070b2832],

1	Human	JJ	O	human	amod	2	SENT_624	[p28l1089t2779r1311b2832],
2	leukocyte	NN	O	leukocyte	_	0	SENT_624	[p28l1326t2778r1615b2848],
3	antigens	NNS	O	antigen	dep	2	SENT_624	[p28l1632t2778r1878b2848],
4	and	CC	O	and	_	0	SENT_624	[p28l1895t2778r2003b2832],
5	drug	NN	O	drug	nn	6	SENT_624	[p28l2017t2778r2152b2848],
6	hypersensitivity	NN	O	hypersensitivity	dep	2	SENT_624	[p28l137t2876r622b2946],
7	.	.	O	.	_	0	SENT_624	[p28l137t2876r622b2946],

1	Curr	NNP	O	Curr	nn	5	SENT_625	[p28l647t2876r785b2930],
2	Opin	NNP	O	Opin	nn	5	SENT_625	[p28l805t2876r953b2946],
3	Allergy	NNP	O	Allergy	nn	5	SENT_625	[p28l973t2876r1200b2946],
4	Clin	NNP	O	Clin	nn	5	SENT_625	[p28l1222t2876r1350b2930],
5	Immunol	NNP	O	Immunol	_	0	SENT_625	[p28l1370t2876r1644b2930],
6	2007	CD	DATE	2007	num	5	SENT_625	[p28l1666t2876r1812b2930],
7	;	:	O	;	_	0	SENT_625	[p28l1822t2876r2133b2939],
8	7:317	CD	NUMBER	7:317	number	9	SENT_625	[p28l1822t2876r2133b2939],
9	—	CD	NUMBER	—	dep	5	SENT_625	[p28l1822t2876r2133b2939],
10	23	CD	NUMBER	23	dep	9	SENT_625	[p28l1822t2876r2133b2939],
11	.	.	O	.	_	0	SENT_625	[p28l1822t2876r2133b2939],

